Citrus Sinensis ID: 036550
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | 2.2.26 [Sep-21-2011] | |||||||
| Q6Z8C8 | 459 | Cyclin-dependent kinase F | no | no | 0.837 | 0.649 | 0.596 | 1e-110 | |
| Q84SN3 | 433 | Cyclin-dependent kinase F | no | no | 0.828 | 0.681 | 0.505 | 4e-92 | |
| P20794 | 623 | Serine/threonine-protein | yes | no | 0.915 | 0.523 | 0.465 | 1e-90 | |
| Q04859 | 622 | Serine/threonine-protein | yes | no | 0.794 | 0.454 | 0.513 | 9e-90 | |
| P20793 | 622 | Serine/threonine-protein | yes | no | 0.794 | 0.454 | 0.510 | 3e-89 | |
| P43294 | 443 | Serine/threonine-protein | no | no | 0.783 | 0.629 | 0.536 | 4e-88 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | no | 0.794 | 0.449 | 0.510 | 1e-85 | |
| Q62726 | 629 | Serine/threonine-protein | no | no | 0.794 | 0.449 | 0.510 | 2e-85 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | no | 0.794 | 0.447 | 0.496 | 3e-85 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | no | 0.794 | 0.558 | 0.479 | 2e-84 |
| >sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 397 bits (1021), Expect = e-110, Method: Compositional matrix adjust.
Identities = 180/302 (59%), Positives = 233/302 (77%), Gaps = 4/302 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M+++ + K++G G+FG VW+A+NK +GEVVA+K +K K YS E+C++LREVK LR++NHP
Sbjct: 1 MDRFKMIKEVGDGTFGSVWRAINKQNGEVVAVKKMKRKYYSFEECMSLREVKSLRRMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++F+ E M+CNLYQLM K + + FSE+ V+ W FQ+F+ L YMH
Sbjct: 61 NIVKLKEVIRENDILYFIMEYMECNLYQLM---KDRVKPFSEAEVRNWCFQIFQALAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLVS+ IK+ADFGLARE+ + PPYTE V TRWY+APE+L +S +Y
Sbjct: 118 QRGYFHRDLKPENLLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLLQSSIYD 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
S VDMWAMGAIMAELL PLF GT EAD++ KIC+V+GSP SW GL A + +QF
Sbjct: 178 SAVDMWAMGAIMAELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAETMKFQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
PQ+SG L+ +M S S +A++LI SLCSWDPCKRP AAE LQH FF+ C +VPP +RS
Sbjct: 238 PQVSGNQLAEVMTSVSSEAVDLISSLCSWDPCKRPKAAEVLQHTFFQGCTFVPPTVRSKA 297
Query: 300 AV 301
V
Sbjct: 298 GV 299
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 151/299 (50%), Positives = 220/299 (73%), Gaps = 4/299 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHP 59
ME+Y + +++G G+ G V++A N + E+VA+K +K+ + + E+C++LREVK L+KLNHP
Sbjct: 1 MERYKVIREIGDGTCGNVFRAYNTETNEIVAVKKMKRKFFQWEECISLREVKALQKLNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+ +E +FF+FE M+CNLY ++ +++Q FSE ++ ++ Q+ +GL YMH
Sbjct: 61 NIVKLKEVTMENHELFFIFENMECNLYDVI---RERQAAFSEEEIRNFMVQILQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
GYFHRDLKPENLLV+ GT+KIADFGLARE+ + PPYT+ V TRWY+APE+L +S Y+
Sbjct: 118 NNGYFHRDLKPENLLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLLQSSAYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
+DMWA+GAI+AEL PLF G E DQ+YKIC+VLG+P W +G+ + ++ F
Sbjct: 178 PAIDMWAVGAILAELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPRSSSFNF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRST 298
Q+ NL L+P+A+ +AI+LI+ LCSWDP +RPTA ++LQHPFF +VP L ++
Sbjct: 238 FQIPPRNLWELIPNATLEAIDLIQQLCSWDPRRRPTAEQSLQHPFFNVGNWVPRPLHAS 296
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 156/335 (46%), Positives = 237/335 (70%), Gaps = 9/335 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL + RPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP---HL 295
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+ + P HL
Sbjct: 238 FPQCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSSNHL 297
Query: 296 RSTPAVAATRRGMLKQQGDRIDAEALPYPKIVKQL 330
S ++ + L+ + ++ E P P I+ Q+
Sbjct: 298 ESKQSLNKQLQP-LESKPSLVEVEPKPLPDIIDQV 331
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 9e-90, Method: Compositional matrix adjust.
Identities = 148/288 (51%), Positives = 217/288 (75%), Gaps = 5/288 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS-YSREKCLNLREVKCLRKLNHP 59
M +Y+ K+LG G++G V + SGE+VAIK +K+ YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++FVFE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFVFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL FRPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+
Sbjct: 238 FPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 147/288 (51%), Positives = 217/288 (75%), Gaps = 5/288 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL FRPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+
Sbjct: 238 FPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 155/289 (53%), Positives = 214/289 (74%), Gaps = 10/289 (3%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y + ++LG G+ G V++AVN + EVVA+K +K K Y E+C+NLREVK LRKLNHP
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+I+K+KE++ E +FF+FECM NLY +M K++++ FSE +++++ Q+ +GL +MH
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIM---KERERPFSEGEIRSFMSQMLQGLAHMH 125
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
+ GYFHRDLKPENLLV+ +KIADFGLARE+ + PPYTE V TRWY+APE+L +S LY+
Sbjct: 126 KNGYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYT 185
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW--ADGLRQAMAINY 237
VDMWA+GAI+AEL PLF G E DQ+YKIC VLG P ++ A + + M+I++
Sbjct: 186 PAVDMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISH 245
Query: 238 -QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+FPQ ++ L+P+A+ +AI+LI LCSWDP KRPTA EAL HPFF
Sbjct: 246 TEFPQ---TRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFF 291
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 147/288 (51%), Positives = 211/288 (73%), Gaps = 5/288 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS-YSREKCLNLREVKCLRKLNHP 59
M +Y+ K+LG G++G V + SGE++AIK +K+ YS E+C+NLREVK L+KLNH
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E +++F+FE M+ NLYQL+ K++ +LF ESA++ ++Q+ +GL ++H
Sbjct: 61 NIVKLKEVIRENDHLYFIFEYMKENLYQLI---KERNKLFPESAIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRDLKPENLL + +KIADFGLAREI + PPYT+ V TRWY+APE+L +S Y
Sbjct: 118 KHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G IMAE+ RPLF G E D ++KIC VLG+P W +G + + A+N+
Sbjct: 178 SSPIDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFL 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+PQ NL L+P+AS +AI L+ L WDP KRPTA++AL++P+F+
Sbjct: 238 WPQCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQ 285
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 147/288 (51%), Positives = 211/288 (73%), Gaps = 5/288 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS-YSREKCLNLREVKCLRKLNHP 59
M +Y+ K+LG G++G V + SGE++AIK +K+ YS E+C+NLREVK L+KLNH
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E +++F+FE M+ NLYQL+ K++ +LF ESA++ ++Q+ +GL ++H
Sbjct: 61 NIVKLKEVIRENDHLYFIFEYMKENLYQLI---KERNKLFPESAIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRDLKPENLL + +KIADFGLAREI + PPYT+ V TRWY+APE+L +S Y
Sbjct: 118 KHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G IMAE+ RPLF G E D ++KIC VLG+P W +G + + A+N+
Sbjct: 178 SSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFI 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+PQ NL L+P+AS +AI L+ L WDP KRPTA++AL++P+F+
Sbjct: 238 WPQCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQ 285
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (807), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 143/288 (49%), Positives = 212/288 (73%), Gaps = 5/288 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS-YSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE++AIK +K+ YS E+C+NLREVK L+KLNH
Sbjct: 1 MNRYTTIRQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N+VK+KE+I E +++F+FE M+ NLYQL+ K++ +LF ESA++ ++Q+ +GL ++H
Sbjct: 61 NVVKLKEVIRENDHLYFIFEYMKENLYQLI---KERNKLFPESAIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRDLKPENLL + +KIADFGLAREI + PPYT+ V TRWY+APE+L +S Y
Sbjct: 118 KHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRSTNY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G IMAE+ RPLF G E D ++KIC VLG+P W +G + + A+N++
Sbjct: 178 SSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+PQ NL L+P+AS +A+ L+ + WDP KRPTA++AL++P+F+
Sbjct: 238 WPQCVPNNLKTLIPNASSEAVQLLRDMLQWDPKKRPTASQALRYPYFQ 285
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 139/290 (47%), Positives = 213/290 (73%), Gaps = 7/290 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHP 59
MEKY K++G G++G V +A++ +GE+VAIK +KK +S ++C+ LRE+K L+KL HP
Sbjct: 1 MEKYQFIKQVGDGAYGDVIKAIDVKTGEIVAIKRMKKKFSDWKECIQLREIKALKKLKHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+ E+I+E+ +FFVFE ++ NLY E+ K + +L E+ ++ ++Q+ + L +MH
Sbjct: 61 NIVKLLEIILERDELFFVFEYLENNLY---ESIKDRTKLLPETTIRNIIYQILQALHFMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
G+FHRDLKPEN+++ +KIADFGLAREI++ PP+T+ + TRWY+APE+L + Y+
Sbjct: 118 TNGFFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTYYN 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
+ +D+WA+GAIMAEL +P+F G+ E DQ++KIC+++GSPT +W DG++ A ++ + F
Sbjct: 178 APIDIWAVGAIMAELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGFTF 237
Query: 240 P--QLSGVN-LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
P Q +N LS L+P+A++DAI LI L +DP KRPT +ALQH +FK
Sbjct: 238 PNVQPPSINPLSTLLPNANQDAIELITDLLQYDPLKRPTPLQALQHRYFK 287
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | ||||||
| 356496445 | 450 | PREDICTED: cyclin-dependent kinase F-4-l | 0.952 | 0.753 | 0.643 | 1e-128 | |
| 356531493 | 455 | PREDICTED: cyclin-dependent kinase F-4-l | 0.952 | 0.745 | 0.637 | 1e-128 | |
| 224074450 | 453 | predicted protein [Populus trichocarpa] | 0.921 | 0.724 | 0.641 | 1e-128 | |
| 357484657 | 449 | Serine/threonine protein kinase ICK [Med | 0.946 | 0.750 | 0.632 | 1e-127 | |
| 356559079 | 414 | PREDICTED: cyclin-dependent kinase F-4-l | 0.955 | 0.821 | 0.630 | 1e-126 | |
| 356558874 | 450 | PREDICTED: cyclin-dependent kinase F-4-l | 0.955 | 0.755 | 0.628 | 1e-125 | |
| 255557681 | 455 | mak, putative [Ricinus communis] gi|2235 | 0.845 | 0.661 | 0.691 | 1e-125 | |
| 297800140 | 460 | hypothetical protein ARALYDRAFT_492943 [ | 0.845 | 0.654 | 0.675 | 1e-124 | |
| 18415242 | 461 | putative serine/threonine protein kinase | 0.845 | 0.652 | 0.672 | 1e-123 | |
| 30684655 | 464 | putative serine/threonine protein kinase | 0.845 | 0.648 | 0.672 | 1e-123 |
| >gi|356496445|ref|XP_003517078.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1197), Expect = e-128, Method: Compositional matrix adjust.
Identities = 229/356 (64%), Positives = 279/356 (78%), Gaps = 17/356 (4%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y L K++G G+FG VW+A+NK +GEVVAIK +KK Y S E+C+NLREVK LRK+NHP
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K +++LFSE V+ W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRESDILYFVFEYMECNLYQLM---KDREKLFSEGEVRNWCFQVFQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLV++ IKIADFGLAREI + PPYTE V TRWY+APE+L +S LY+
Sbjct: 118 QRGYFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYLYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAEL RPLF G EAD++YKIC V+G+PT +SWADGL+ A INYQF
Sbjct: 178 SKVDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS-- 297
PQL+GV+LSAL+PSAS+DAI+LI SLCSWDPCKRPTA+EALQHPFF+ C Y+PP LR+
Sbjct: 238 PQLAGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRNRA 297
Query: 298 ---TPAVAATRRGMLKQQGDRIDAEALPYPKIVKQLSPLDIMTAMKL-PSMKAGVQ 349
TP A T RG L QQG + + ALP K+ S +MKL P + +GVQ
Sbjct: 298 VARTPPPAGT-RGALDQQGVKRYSGALPTSKLSNNFS------SMKLHPPLASGVQ 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531493|ref|XP_003534312.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1190), Expect = e-128, Method: Compositional matrix adjust.
Identities = 227/356 (63%), Positives = 279/356 (78%), Gaps = 17/356 (4%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y L K++G G+FG VW+A+NK +GEVVAIK +KK Y S E+C+NLREVK LRK+NHP
Sbjct: 1 MERYKLIKEIGDGTFGTVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K +++LFSE+ V+ W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRESDILYFVFEYMECNLYQLM---KDREKLFSEAEVRNWCFQVFQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLV++ IKIADFGLAREI + PPYTE V TRWY+APE+L +S +Y+
Sbjct: 118 QRGYFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYMYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAEL RPLF G EAD++YKIC V+G+PT +SWADGL+ A INYQF
Sbjct: 178 SKVDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS-- 297
PQL+GV+LSAL+PSAS+DAI+LI SLCSWDPCKRPTA+EALQHPFF+ C Y+PP LR+
Sbjct: 238 PQLAGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRNRA 297
Query: 298 ---TPAVAATRRGMLKQQGDRIDAEALPYPKIVKQLSPLDIMTAMKL-PSMKAGVQ 349
TP A T RG L QQ + + ALP K+ S +MKL P + +GVQ
Sbjct: 298 VARTPPPAGT-RGALDQQEVKRYSGALPTSKLSNNFS------SMKLHPPLASGVQ 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074450|ref|XP_002304373.1| predicted protein [Populus trichocarpa] gi|222841805|gb|EEE79352.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1190), Expect = e-128, Method: Compositional matrix adjust.
Identities = 222/346 (64%), Positives = 269/346 (77%), Gaps = 18/346 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y L K++G G+FG VW+A+NK SGEVVAIK +KK Y S E+C+NLREVK LRK+NHP
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK++E+I E ++FVFE M+CNLYQL K +++LFSE+ V+ W FQVF+GL YMH
Sbjct: 61 NIVKLREVIRENDILYFVFEYMECNLYQLT---KDREKLFSEAEVRNWCFQVFQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLVS+ IKIADFGLARE+++ PPYTE V TRWY+APE+L +S LYS
Sbjct: 118 QRGYFHRDLKPENLLVSKSIIKIADFGLAREVNSQPPYTEYVSTRWYRAPEVLLQSYLYS 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAEL RPLF GT EAD++YKICSV+GSPT D+WADGL A AINYQF
Sbjct: 178 SKVDMWAMGAIMAELFTLRPLFPGTSEADEIYKICSVIGSPTTDTWADGLNLARAINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLR--- 296
PQ +GV+L L+PSASEDAINLI+SLCSWDPC RP+AA+ALQHPFF+ C YVPP LR
Sbjct: 238 PQFAGVHLPTLIPSASEDAINLIKSLCSWDPCTRPSAADALQHPFFQSCFYVPPSLRPRA 297
Query: 297 ---STPAVAATRRGMLKQQGDRIDA--------EALPYPKIVKQLS 331
TPA A T+ G+ +Q G + + P PK+ LS
Sbjct: 298 AITRTPASAGTKGGLEQQCGRNLPGALSNSKLTNSFPSPKLHASLS 343
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357484657|ref|XP_003612616.1| Serine/threonine protein kinase ICK [Medicago truncatula] gi|355513951|gb|AES95574.1| Serine/threonine protein kinase ICK [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 459 bits (1182), Expect = e-127, Method: Compositional matrix adjust.
Identities = 225/356 (63%), Positives = 278/356 (78%), Gaps = 19/356 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y + K++G G+FG VW+A++K +GEVVAIK +KK Y S E+C+NLREVK LRK+NHP
Sbjct: 1 MERYKIIKEVGDGTFGSVWRAISKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K +++LFSE ++ W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRESDILYFVFEYMECNLYQLM---KDREKLFSEGEIRNWCFQVFQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLV++ IKIADFGLAREI++ PPYTE V TRWY+APE+L +S +YS
Sbjct: 118 QRGYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYIYS 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAEL RPLF G EAD++YKIC V+G+PT DSWADGL+ A INYQF
Sbjct: 178 SKVDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTTDSWADGLKLARDINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS-- 297
PQL+GVNLSAL+PSAS+ AI+LI+SLCSWDPCKRPTA+EALQHPFF+ C Y+PP LRS
Sbjct: 238 PQLAGVNLSALIPSASDHAISLIQSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRSRA 297
Query: 298 ---TPAVAATRRGMLKQQGDRIDAEALPYPKIVKQLSPLDIMTAMKL-PSMKAGVQ 349
TP A T RG L QQG + YP + P + ++ K+ PS +GVQ
Sbjct: 298 VARTPPPAGT-RGALDQQGVKR------YPGALHSSKPTNYFSSPKVQPS--SGVQ 344
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356559079|ref|XP_003547829.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1173), Expect = e-126, Method: Compositional matrix adjust.
Identities = 224/355 (63%), Positives = 273/355 (76%), Gaps = 15/355 (4%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y L K++G G+FG VW+A+NK SGEVVAIK +KK Y S E+C+NLREVK LRK+NH
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E + VFE M+ NLYQL+ K +++LFSE+ V+ W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRECDTLCLVFEYMEYNLYQLV---KNREKLFSENEVRNWCFQVFQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLV++G IKIADFGLAREI + PPYTE V TRWY+APE+L +S LYS
Sbjct: 118 QRGYFHRDLKPENLLVTKGVIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSHLYS 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAEL RPLF G+ EAD++YKICSV+GSPT +SWADGL+ A INYQF
Sbjct: 178 SKVDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVIGSPTTESWADGLKLARDINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS-- 297
PQL+ V+LS L+PS S+DAI+L+ SLCSWDPCKRPTAAEALQHPFF+ C Y+PP LR+
Sbjct: 238 PQLASVHLSTLIPSRSDDAISLVTSLCSWDPCKRPTAAEALQHPFFQSCFYIPPSLRTRA 297
Query: 298 ---TPAVAATRRGMLKQQGDRIDAEALPYPKIVKQLSPLDIMTAMKLPSMKAGVQ 349
TP A T RG L +QG + + ALP KI S + S+ +GVQ
Sbjct: 298 VTRTPPSAGT-RGSLDRQGLKRYSGALPNTKITNNFSSPKLQA-----SIASGVQ 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558874|ref|XP_003547727.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 455 bits (1170), Expect = e-125, Method: Compositional matrix adjust.
Identities = 223/355 (62%), Positives = 271/355 (76%), Gaps = 15/355 (4%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y L K++G G+FG VW+A+NK SGEVVAIK +KK Y S E+C+NLREVK LRK+NH
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E + VFE M+ NLYQLM K +++LFSE+ V+ W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRECDTLCLVFEYMEYNLYQLM---KNREKLFSENEVRNWCFQVFQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLV++ IKIADFGLAREI + PPYTE V TRWY+APE+L +S LYS
Sbjct: 118 QRGYFHRDLKPENLLVTKDVIKIADFGLAREISSLPPYTEYVSTRWYRAPEVLLQSHLYS 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAEL RPLF G+ EAD++YKICSVLGSPT +SWADGL+ A INYQF
Sbjct: 178 SKVDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVLGSPTTESWADGLKLARDINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS-- 297
PQL+GV+LS L+PS S+DAI+L+ SLCSWDPCKRPTAAE LQHPFF+ C Y+PP LR+
Sbjct: 238 PQLAGVHLSTLIPSRSDDAISLVTSLCSWDPCKRPTAAEVLQHPFFQSCFYIPPSLRTRA 297
Query: 298 ---TPAVAATRRGMLKQQGDRIDAEALPYPKIVKQLSPLDIMTAMKLPSMKAGVQ 349
TP A T RG L + G + + ALP KI + + S+ +GVQ
Sbjct: 298 VTRTPPSAGT-RGSLDRLGLKRYSGALPNTKITNNFTSPKVQA-----SIASGVQ 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557681|ref|XP_002519870.1| mak, putative [Ricinus communis] gi|223540916|gb|EEF42474.1| mak, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1164), Expect = e-125, Method: Compositional matrix adjust.
Identities = 211/305 (69%), Positives = 251/305 (82%), Gaps = 4/305 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y L K++G G+FG VW+A+NK SGEVVAIK +KK Y + E+C+NLREVK LR++NHP
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYTWEECVNLREVKSLRRMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M CNLYQL+ K + +LF E+ V+ W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMDCNLYQLI---KDRVKLFPEAEVRNWCFQVFQGLAYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLV++G IKIADFGLAREI++ PPYTE V TRWY+APE+L +S LYS
Sbjct: 118 QRGYFHRDLKPENLLVTKGIIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYLYS 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAEL RPLF GT EAD++YKIC+++GSPT DSWADGL A AINYQF
Sbjct: 178 SKVDMWAMGAIMAELFTLRPLFPGTSEADEIYKICNIIGSPTKDSWADGLNLARAINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
PQ GV LSAL+PSASEDA+NLI+SLCSWDP KRP+A EALQHPFF+ C YVPP LRS
Sbjct: 238 PQFGGVQLSALIPSASEDAVNLIKSLCSWDPSKRPSAGEALQHPFFQSCFYVPPTLRSRA 297
Query: 300 AVAAT 304
V T
Sbjct: 298 PVTRT 302
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297800140|ref|XP_002867954.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata] gi|297313790|gb|EFH44213.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1160), Expect = e-124, Method: Compositional matrix adjust.
Identities = 206/305 (67%), Positives = 253/305 (82%), Gaps = 4/305 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
M++Y L K++G G+FG VW+A+NK +GEVVAIK +KK Y S ++C+NLREVK LR++NHP
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K +Q+LF+E+ +K W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLM---KDRQKLFAEADIKNWCFQVFQGLSYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLVS+ IKIADFGLARE+++ PP+TE V TRWY+APE+L +S +Y+
Sbjct: 118 QRGYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAELL RP+F G EAD++YKICSV+G+PT ++W +GL A INYQF
Sbjct: 178 SKVDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
PQL GV LS+LMPSASEDAINLIE LCSWDPC RPTAAE LQHPFF+ C YVPP LR P
Sbjct: 238 PQLPGVPLSSLMPSASEDAINLIERLCSWDPCSRPTAAEVLQHPFFQSCFYVPPSLRPKP 297
Query: 300 AVAAT 304
+VA T
Sbjct: 298 SVART 302
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18415242|ref|NP_567574.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|13430556|gb|AAK25900.1|AF360190_1 putative kinase [Arabidopsis thaliana] gi|14532760|gb|AAK64081.1| putative kinase [Arabidopsis thaliana] gi|332658741|gb|AEE84141.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1152), Expect = e-123, Method: Compositional matrix adjust.
Identities = 205/305 (67%), Positives = 252/305 (82%), Gaps = 4/305 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
M++Y L K++G G+FG VW+A+NK +GEVVAIK +KK Y S ++C+NLREVK LR++NHP
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K +Q+LF+E+ +K W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLM---KDRQKLFAEADIKNWCFQVFQGLSYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLVS+ IKIADFGLARE+++ PP+TE V TRWY+APE+L +S +Y+
Sbjct: 118 QRGYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAELL RP+F G EAD++YKICSV+G+PT ++W +GL A INYQF
Sbjct: 178 SKVDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
PQL GV LS+LMPSASEDAINLIE LCSWDP RPTAAE LQHPFF+ C YVPP LR P
Sbjct: 238 PQLPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKP 297
Query: 300 AVAAT 304
+VA T
Sbjct: 298 SVART 302
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30684655|ref|NP_849407.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332658742|gb|AEE84142.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1151), Expect = e-123, Method: Compositional matrix adjust.
Identities = 205/305 (67%), Positives = 252/305 (82%), Gaps = 4/305 (1%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
M++Y L K++G G+FG VW+A+NK +GEVVAIK +KK Y S ++C+NLREVK LR++NHP
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K +Q+LF+E+ +K W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLM---KDRQKLFAEADIKNWCFQVFQGLSYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLVS+ IKIADFGLARE+++ PP+TE V TRWY+APE+L +S +Y+
Sbjct: 118 QRGYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAELL RP+F G EAD++YKICSV+G+PT ++W +GL A INYQF
Sbjct: 178 SKVDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
PQL GV LS+LMPSASEDAINLIE LCSWDP RPTAAE LQHPFF+ C YVPP LR P
Sbjct: 238 PQLPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKP 297
Query: 300 AVAAT 304
+VA T
Sbjct: 298 SVART 302
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | ||||||
| TAIR|locus:2134746 | 464 | AT4G19110 [Arabidopsis thalian | 0.845 | 0.648 | 0.672 | 1.1e-112 | |
| TAIR|locus:2163583 | 499 | AT5G45430 [Arabidopsis thalian | 0.859 | 0.613 | 0.654 | 4.8e-110 | |
| UNIPROTKB|P20794 | 623 | MAK "Serine/threonine-protein | 0.915 | 0.523 | 0.465 | 1.5e-83 | |
| UNIPROTKB|Q8IXN4 | 457 | MAK "MAK protein" [Homo sapien | 0.915 | 0.713 | 0.465 | 1.5e-83 | |
| MGI|MGI:96913 | 622 | Mak "male germ cell-associated | 0.915 | 0.524 | 0.471 | 5e-83 | |
| UNIPROTKB|Q6DCJ4 | 648 | mak "Mak-prov protein" [Xenopu | 0.794 | 0.436 | 0.527 | 2.2e-82 | |
| UNIPROTKB|F1RV90 | 624 | MAK "Uncharacterized protein" | 0.794 | 0.453 | 0.510 | 4.5e-82 | |
| RGD|3036 | 622 | Mak "male germ cell-associated | 0.794 | 0.454 | 0.510 | 4.5e-82 | |
| UNIPROTKB|P20793 | 622 | Mak "Serine/threonine-protein | 0.794 | 0.454 | 0.510 | 4.5e-82 | |
| UNIPROTKB|E1BDG4 | 623 | MAK "Uncharacterized protein" | 0.912 | 0.521 | 0.470 | 7.4e-82 |
| TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 1.1e-112, P = 1.1e-112
Identities = 205/305 (67%), Positives = 252/305 (82%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
M++Y L K++G G+FG VW+A+NK +GEVVAIK +KK Y S ++C+NLREVK LR++NHP
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K +Q+LF+E+ +K W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLM---KDRQKLFAEADIKNWCFQVFQGLSYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLVS+ IKIADFGLARE+++ PP+TE V TRWY+APE+L +S +Y+
Sbjct: 118 QRGYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAELL RP+F G EAD++YKICSV+G+PT ++W +GL A INYQF
Sbjct: 178 SKVDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
PQL GV LS+LMPSASEDAINLIE LCSWDP RPTAAE LQHPFF+ C YVPP LR P
Sbjct: 238 PQLPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKP 297
Query: 300 AVAAT 304
+VA T
Sbjct: 298 SVART 302
|
|
| TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 4.8e-110, P = 4.8e-110
Identities = 205/313 (65%), Positives = 251/313 (80%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHP 59
ME+Y+L K++G G+FG VW+AVNK + EVVAIK +KK Y S E+C+NLREVK L ++NHP
Sbjct: 1 MERYTLLKEVGDGTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMNHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIVK+KE+I E ++FVFE M+CNLYQLM K + + F+ES ++ W FQVF+GL YMH
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLM---KDRPKHFAESDIRNWCFQVFQGLSYMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q+GYFHRDLKPENLLVS+ IKIAD GLAREID+ PPYTE V TRWY+APE+L +S +Y+
Sbjct: 118 QRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYT 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
SKVDMWAMGAIMAELL RPLF G EAD++YKICSV+GSPT ++W +GL A INYQF
Sbjct: 178 SKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
PQ GV+LS++MP AS DA+NLIE LCSWDPC RPT AEALQHPFF+ C Y+PP LR P
Sbjct: 238 PQFPGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPSLR--P 295
Query: 300 AVAATRRGMLKQQ 312
++ R G L+QQ
Sbjct: 296 KLSEPR-GSLEQQ 307
|
|
| UNIPROTKB|P20794 MAK "Serine/threonine-protein kinase MAK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
Identities = 156/335 (46%), Positives = 237/335 (70%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL + RPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP---HL 295
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+ + P HL
Sbjct: 238 FPQCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSSNHL 297
Query: 296 RSTPAVAATRRGMLKQQGDRIDAEALPYPKIVKQL 330
S ++ + L+ + ++ E P P I+ Q+
Sbjct: 298 ESKQSLNKQLQP-LESKPSLVEVEPKPLPDIIDQV 331
|
|
| UNIPROTKB|Q8IXN4 MAK "MAK protein" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
Identities = 156/335 (46%), Positives = 237/335 (70%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL + RPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP---HL 295
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+ + P HL
Sbjct: 238 FPQCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSSNHL 297
Query: 296 RSTPAVAATRRGMLKQQGDRIDAEALPYPKIVKQL 330
S ++ + L+ + ++ E P P I+ Q+
Sbjct: 298 ESKQSLNKQLQP-LESKPSLVEVEPKPLPDIIDQV 331
|
|
| MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
Identities = 157/333 (47%), Positives = 232/333 (69%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ K+LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++FVFE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFVFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL FRPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK--RCLYVPPHLR 296
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+ + L H
Sbjct: 238 FPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGSSAHHL 297
Query: 297 STPAVAATRRGMLKQQGDRIDAEALPYPKIVKQ 329
T + L+ + + + P P I+ Q
Sbjct: 298 DTKQTLHKQLQPLEPKPSSSERDPKPLPNILDQ 330
|
|
| UNIPROTKB|Q6DCJ4 mak "Mak-prov protein" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 2.2e-82, P = 2.2e-82
Identities = 152/288 (52%), Positives = 214/288 (74%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ K+LG G++G V + SGE+VAIK +K K YS E+C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMKQLGDGTYGSVIMGRSNESGELVAIKRMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N+VK+KE+I E +++FVFE M+ NLYQLM K + +L ES ++ ++Q+ +GL ++H
Sbjct: 61 NVVKLKEVIRENDHLYFVFEYMKENLYQLM---KDRNKLLPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + IKIADFGL RE+ + PPYT+ V TRWY+APE+L +S Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELIKIADFGLVRELRSQPPYTDYVSTRWYRAPEVLLRSSSY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL RPLF GT E DQ++KIC VLG+P + W +G + A ++N++
Sbjct: 178 SSPIDLWAVGSIMAELYTLRPLFPGTSEVDQIFKICQVLGTPKKNDWPEGYQLAASMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FPQ +NL L+P+ASEDA+NL+ WDP KRPTA++AL+HP+F+
Sbjct: 238 FPQCIPINLKTLIPNASEDALNLMRDTMQWDPKKRPTASQALRHPYFQ 285
|
|
| UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 147/288 (51%), Positives = 217/288 (75%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL RPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FPQ + +NL L+P+AS +AI L+ + SWDP KRPTA++AL+HP+F+
Sbjct: 238 FPQCAPINLKTLIPNASNEAIQLMTEMLSWDPKKRPTASQALKHPYFQ 285
|
|
| RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 147/288 (51%), Positives = 217/288 (75%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL FRPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+
Sbjct: 238 FPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|P20793 Mak "Serine/threonine-protein kinase MAK" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 147/288 (51%), Positives = 217/288 (75%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S +Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL FRPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+
Sbjct: 238 FPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
Identities = 157/334 (47%), Positives = 231/334 (69%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHP 59
M +Y+ ++LG G++G V + SGE+VAIK +K K YS ++C+NLREVK L+KLNH
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++K+KE+I E +++F+FE M+ NLYQLM K + +LF ES ++ ++Q+ +GL ++H
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLM---KDRNKLFPESVIRNIMYQILQGLAFIH 117
Query: 120 QQGYFHRDLKPENLL-VSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G+FHRD+KPENLL + +KIADFGLARE+ + PPYT+ V TRWY+APE+L +S Y
Sbjct: 118 KHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
SS +D+WA+G+IMAEL RPLF GT E D+++KIC VLG+P W +G + A ++N++
Sbjct: 178 SSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFR 237
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP---HL 295
FPQ +NL L+P+AS +AI L+ + +WDP KRPTA++AL+HP+F+ + P HL
Sbjct: 238 FPQCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSSHHL 297
Query: 296 RSTPAVAATRRGMLKQQGDRIDAEALPYPKIVKQ 329
S + + L+ + D E P P I Q
Sbjct: 298 ESKQPLNKLVQP-LEPKPSAADPEPQPLPDINDQ 330
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q27032 | CDC2H_THEPA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.3791 | 0.8033 | 0.9597 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_III1771 | hypothetical protein (453 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | fgenesh4_pg.C_scaffold_1033000001 | hypothetical protein (371 aa) | • | 0.407 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 356 | |||
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-164 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-113 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-108 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-100 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-96 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-96 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-95 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-93 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-92 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-83 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-82 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-81 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-78 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-76 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-75 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-75 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-75 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-72 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-72 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-70 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-69 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-69 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-69 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-67 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-67 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-67 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-66 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-64 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-64 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-64 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-63 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-63 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-61 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-60 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-59 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-59 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-58 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-57 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-57 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-57 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-54 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-53 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-53 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-49 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-49 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-49 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-49 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-48 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-47 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-47 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-44 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-44 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-40 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-40 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-38 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-38 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-38 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-38 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-36 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-35 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-35 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-33 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-33 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-32 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-30 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-29 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-28 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-25 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-24 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-24 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-20 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-17 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-17 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-11 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 7e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 459 bits (1183), Expect = e-164
Identities = 164/285 (57%), Positives = 217/285 (76%), Gaps = 5/285 (1%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLN-HPNI 61
Y + K+LG G+FG V+ A NK +GE+VAIK +K K YS E+C+NLREVK LRKLN HPNI
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
VK+KE+ E ++FVFE M+ NLYQLM K +K + FSES +++ ++Q+ +GL ++H+
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLM--KDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 122 GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
G+FHRDLKPENLLVS +KIADFGLAREI + PPYT+ V TRWY+APEIL +S YSS
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS 178
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
VD+WA+G IMAEL RPLF G+ E DQ+YKICSVLG+PT W +G + A + ++FP
Sbjct: 179 PVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
Q + +L L+P+AS +AI+LI+ + WDP KRPTA++ALQHP+F
Sbjct: 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 330 bits (848), Expect = e-113
Identities = 111/289 (38%), Positives = 176/289 (60%), Gaps = 14/289 (4%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNI 61
Y +KLG G++G V++A +K +GE+VA+K ++ E LRE+ L++L HPNI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
VK+ ++I + ++ VFE +L + + ++ S + +K+ ++Q+ RGL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMDLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 122 GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF----PPYTERVGTRWYQAPEILFKSG 176
HRDLKP+N+L++ G +K+ADFGLAR AF YT V T WY+APEIL S
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLAR---AFGIPLRTYTHEVVTLWYRAPEILLGSK 174
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+ VD+W++G I AE++ +PLF G E DQ++KI +LG+PT +SW G+ +
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP-GVTKLPDYK 233
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
FP+ +L ++P + I+L+ + ++P KR +A EAL+HP+F
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-108
Identities = 126/286 (44%), Positives = 185/286 (64%), Gaps = 7/286 (2%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNI 61
Y K+G G++G V++A +K +GE+VAIK +K + E LRE+K L++LNHPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+K+ ++ KG+++ VFE M +LY+L+ K +Q+ ES +K++L+Q+ +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSGLYS 179
G HRDLKPENLL++ G +K+ADFGLAR + PYT V TRWY+APE+L YS
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
+ VD+W++G I AELL RPLF G E DQ++KI LG+P + W A + F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
P+ +G+ L L P+AS A++L+ + +DP KR TA +AL HP+F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 296 bits (761), Expect = e-100
Identities = 121/286 (42%), Positives = 190/286 (66%), Gaps = 8/286 (2%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLN-HPNI 61
Y + K+G G+F V +A ++ +G+ AIK +KK + S E+ NLRE++ LR+L+ HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 62 VKVKELIVEK--GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+++ E++ ++ G + VFE M NLY+L++ +K+ E VK++++Q+ + LD+MH
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMH 117
Query: 120 QQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
+ G FHRD+KPEN+L+ +K+ADFG R I + PPYTE + TRWY+APE L G Y
Sbjct: 118 RNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
K+D+WA+G + E+L PLF GT+E DQ+ KI VLG+P + R++ +NY F
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRHMNYNF 236
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
P G L L+P+AS + ++L++ L ++DP +R TA +AL+HP+F
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 288 bits (740), Expect = 1e-96
Identities = 116/293 (39%), Positives = 176/293 (60%), Gaps = 16/293 (5%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK-SYSREKC-LN---LREVKCLRKLN 57
+Y KKLG G++ V++A +K +G +VAIK +K K +N LRE+K L++L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HPNI+ + ++ K N+ VFE M+ +L +++ K K + + + +K+++ RGL+Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP--YTERVGTRWYQAPEILFK 174
+H HRDLKP NLL+ S G +K+ADFGLAR P T +V TRWY+APE+LF
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELLFG 176
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
+ Y VDMW++G I AELLL P G + DQ+ KI LG+PT ++W
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-- 234
Query: 235 INY-QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+Y +F L + P+AS+DA++L++ L + +P KR TA +AL+HP+F
Sbjct: 235 -DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 285 bits (733), Expect = 3e-96
Identities = 106/285 (37%), Positives = 156/285 (54%), Gaps = 34/285 (11%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPNIV 62
Y + +KLG GSFG V+ A +K +G++VAIK +KK ++ LRE+K L+KL HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 63 KVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
++ ++ ++ ++ V E C +L+ L++ + + SE + +L Q+ L+Y+H +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSK 116
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
G HRDLKPEN+L+ G +K+ADFGLAR++D T VGT Y APE+L G Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG-YGK 175
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
VD+W++G I+ ELL +P F G D+ +++K P
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI-GKPKPPFPPP--------------- 219
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
S +A +LI L DP KR TA EALQHPFF
Sbjct: 220 ----------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 284 bits (728), Expect = 6e-95
Identities = 111/292 (38%), Positives = 175/292 (59%), Gaps = 15/292 (5%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKC----LNLREVKCLRKLNHP 59
Y ++G G++G V++A NK +GE+VA+K ++ EK +RE+K L+KL HP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHP 58
Query: 60 NIVKVKELIVEK--GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
NIV++KE++ K G+++ VFE M +L L+++ + K F+ES +K ++ Q+ GL Y
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQY 115
Query: 118 MHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFK 174
+H G HRD+K N+L++ G +K+ADFGLAR YT RV T WY+ PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
+ Y +VDMW++G I+AEL L +P+FQG+ E +Q+ KI + GSPT ++W +
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
Query: 235 INYQFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
N + + L A++L++ L + DP KR +A +ALQH +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 8e-93
Identities = 119/307 (38%), Positives = 172/307 (56%), Gaps = 37/307 (12%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-----------LREVK 51
+Y L K +GSG++G V AV+K +G VAIK K N LRE+K
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---------KISNVFDDLIDAKRILREIK 51
Query: 52 CLRKLNHPNIVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKA 106
LR L H NI+ + +++ + +V+ V E M+ +L++++ K Q L ++ ++
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVI---KSPQPL-TDDHIQY 107
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPY----TERV 161
+L+Q+ RGL Y+H HRDLKP N+LV+ +KI DFGLAR +D TE V
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT 221
TRWY+APE+L S Y+ +D+W++G I AELL +PLF G D DQ+ I VLG+P+
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 222 MDSWADGLRQAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA 279
+ + A NY P+ LS L P AS +AI+L+E + +DP KR TA EA
Sbjct: 228 EED-LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286
Query: 280 LQHPFFK 286
L HP+
Sbjct: 287 LAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 276 bits (708), Expect = 2e-92
Identities = 111/287 (38%), Positives = 159/287 (55%), Gaps = 32/287 (11%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL--NLREVKCLRKLNHPNI 61
Y L +KLGSGSFG V++A +K +G++VA+K LKK + K RE++ LR+L+HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ + +K +++ V E + +L+ + SE K Q+ RGL+Y+H
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS 116
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTERVGTRWYQAPEILFKSGLY 178
G HRDLKPEN+L+ + G +KIADFGLA+++ T VGT WY APE+L Y
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
KVD+W++G I+ ELL +P F G + DQ+ I +LG P
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK----------- 225
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
S SE+A +LI+ + DP KRPTA E LQHP+F
Sbjct: 226 ------------WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 2e-87
Identities = 115/281 (40%), Positives = 166/281 (59%), Gaps = 11/281 (3%)
Query: 13 GSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVE 70
G++G V++A +K +GE+VA+K LK +E +LRE+ L KL HPNIV VKE++V
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 71 KG--NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL 128
++ V E ++ +L LME KQ F +S VK + Q+ G+ ++H HRDL
Sbjct: 76 SNLDKIYMVMEYVEHDLKSLMETMKQP---FLQSEVKCLMLQLLSGVAHLHDNWILHRDL 132
Query: 129 KPENLLVS-QGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWA 186
K NLL++ +G +KI DFGLARE PYT+ V T WY+APE+L + YS+ +DMW+
Sbjct: 133 KTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWS 192
Query: 187 MGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVN 246
+G I AELL +PLF G E DQ+ KI +LG+PT W A F +
Sbjct: 193 VGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQ 252
Query: 247 LSALMP--SASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
L P S S++ +L+ L ++DP KR +A +AL+HP+F
Sbjct: 253 LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 2e-83
Identities = 109/294 (37%), Positives = 175/294 (59%), Gaps = 20/294 (6%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIK--ALKKSYSREKCLN---LREVKCLRKLN 57
+Y + ++G G+ G V++A ++ +GE VA+K AL++ E + LRE+K L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR---LEGGIPNQALREIKALQACQ 57
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP +VK+ ++ V E M +L +++ + +++ E+ VK+++ + +G+ Y
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVL---RDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 118 MHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFK 174
MH G HRDLKP NLL+S G +KIADFGLAR + Y+ +V TRWY+APE+L+
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ--- 231
+ Y VD+WA+G I AELL PLF G ++ +Q+ + LG+P ++W GL
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP-GLTSLPD 233
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
I FP+ + L + P AS +A++L++ L +DP KR +AAEAL+HP+F
Sbjct: 234 YNKI--TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 4e-82
Identities = 107/308 (34%), Positives = 172/308 (55%), Gaps = 35/308 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS------REKCLNLREVKCLRK 55
+Y + +GSG++G V A++ SG+ VAIK + ++ R LRE+K LR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKR----TLRELKILRH 60
Query: 56 LNHPNIVKVKELIVEKGN----VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQV 111
H NI+ +++++ G V+ V + M+ +L+ ++ + Q +E ++ +L+Q+
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQL 116
Query: 112 FRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-----YTERVGTRW 165
RGL Y+H HRDLKP NLLV++ ++I DFG+AR + + P TE V TRW
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD-- 223
Y+APE+L Y++ +DMW++G I AE+L R LF G + Q+ I SVLGSP+ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 224 --SWADGLRQAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA 279
+D +R Y P+ V S + P AS +A++L+ + +DP +R T +A
Sbjct: 237 NRIGSDRVR-----KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291
Query: 280 LQHPFFKR 287
LQHPF +
Sbjct: 292 LQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 8e-81
Identities = 113/314 (35%), Positives = 176/314 (56%), Gaps = 46/314 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---------SREKCLNLREVK 51
+ KY + +KLG G++G VW+A+++ + EVVA LKK + R RE+
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVA---LKKIFDAFRNATDAQR----TFREIM 58
Query: 52 CLRKL-NHPNIVKVKELIVEKGN--VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWL 108
L++L +HPNIVK+ +I + + ++ VFE M+ +L+ ++ A + + + +
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN-----ILEDVHKRYIM 113
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAR------EIDAFPPYTERV 161
+Q+ + L Y+H HRDLKP N+L+ S +K+ADFGLAR E P T+ V
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT 221
TRWY+APEIL S Y+ VDMW++G I+ E+LL +PLF GT +Q+ KI V+G P+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233
Query: 222 MDSWADGLRQAMAINYQF--------PQLSGVNLSALMPSASEDAINLIESLCSWDPCKR 273
+ +I F P L L+P AS+DA++L++ L ++P KR
Sbjct: 234 AE-------DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286
Query: 274 PTAAEALQHPFFKR 287
TA EAL+HP+ +
Sbjct: 287 LTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 4e-78
Identities = 113/299 (37%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHP 59
KY + +G G++G V + NK +GE+VAIK K+S E K LREVK LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIV +KE KG ++ VFE ++ L +L+EA AV+++++Q+ + + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCH 117
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PYTERVGTRWYQAPEILFKSG 176
HRD+KPEN+LVS+ G +K+ DFG AR + A P P T+ V TRWY+APE+L
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y VD+WA+G IMAELL PLF G + DQ+Y I LG + +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG--PLPP------SHQELF 229
Query: 237 YQFPQLSGVNLSALMP----------SASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
P+ +GV S A++ +++ DP +R T E LQHP+F
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 1e-76
Identities = 111/289 (38%), Positives = 177/289 (61%), Gaps = 13/289 (4%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNI 61
Y +K+G G++G V++A +K +GE+VA+K ++ E +RE+ L++LNHPNI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V++ +++ + ++ VFE + +L + M++ +K++L+Q+ +G+ Y H
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIAYCHSH 118
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREIDAF--P--PYTERVGTRWYQAPEILFKSG 176
HRDLKP+NLL+ +G +K+ADFGLAR AF P YT V T WY+APEIL S
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLAR---AFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+ VD+W++G I AE++ RPLF G E DQ+++I LG+P D W G+
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP-GVTSLPDYK 234
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
FP+ + +LS ++P+ ED ++L+ + +DP KR +A ALQHP+F
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 234 bits (598), Expect = 3e-75
Identities = 111/284 (39%), Positives = 163/284 (57%), Gaps = 9/284 (3%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKE 66
++G G++G V++A + SGE+VA+K ++ R+ +LRE+ L L HPNIV++KE
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 67 LIVEK--GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
++V K ++F V E + +L L++ FSES VK + Q+ RGL Y+H+
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 125 HRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYTERVGTRWYQAPEILFKSGLYSSKV 182
HRDLK NLL++ G +KIADFGLAR P T +V T WY+APE+L Y++ +
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 183 DMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242
DMWA+G I+AELL +PL G E +Q+ I +LG+P W + + P+
Sbjct: 191 DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ 250
Query: 243 SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
NL P SE + L+ L +DP KR TA EAL+ +FK
Sbjct: 251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 4e-75
Identities = 105/288 (36%), Positives = 182/288 (63%), Gaps = 8/288 (2%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPN 60
Y+ +K+G G++G V++ NK +G++VA+K ++ E +RE+ L++L HPN
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV ++++++++ ++ +FE + +L + +++ + Q + +E VK++L+Q+ +G+ + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL-VKSYLYQILQGILFCHS 119
Query: 121 QGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFP--PYTERVGTRWYQAPEILFKSGL 177
+ HRDLKP+NLL+ ++G IK+ADFGLAR P YT V T WY+APE+L S
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
YS+ VD+W++G I AE+ +PLF G E DQ+++I +LG+PT D W G+
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP-GVTSLPDYKN 237
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
FP+ +L + + + ED ++L+E + +DP KR +A +AL HP+F
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 5e-75
Identities = 111/296 (37%), Positives = 166/296 (56%), Gaps = 19/296 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL-NLREVKCLRKLNHPN 60
+Y +G G++G V A +K +G VAIK + + C LRE+K LR+ H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 61 IVKVKELI----VEKGN-VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
I+ + ++I E N V+ V E M+ +LY+L+ K Q S ++ +L+Q+ RGL
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLI-----KTQHLSNDHIQYFLYQILRGL 119
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY----TERVGTRWYQAPE 170
Y+H HRDLKP NLL+ + +KI DFGLAR D + TE V TRWY+APE
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
I+ S Y+ +D+W++G I+AE+L RPLF G D Q+ I VLG+P+ + + +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL-NCII 238
Query: 231 QAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
A NY P V + L P+A A++L++ + +++P KR T EAL HP+
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 1e-72
Identities = 107/307 (34%), Positives = 165/307 (53%), Gaps = 30/307 (9%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNI 61
Y + KLG G+FG V++A +G VVA+K + ++ LRE+K L+KL HPN+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 62 VKVKELIVE--------KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
V + ++ VE +G+V+ V M +L L+E K +ES +K ++ Q+
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYMLQLLE 126
Query: 114 GLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPP------------YTER 160
G++Y+H+ HRD+K N+L+ QG +KIADFGLAR D PP YT
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220
V TRWY+ PE+L Y++ VD+W +G + AE+ RP+ QG + DQ++ I + G+P
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 221 TMDSW--ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE 278
T ++W L + F L + ++L+ L S DP KR TA++
Sbjct: 247 TEETWPGWRSLPGCEG-VHSFTNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304
Query: 279 ALQHPFF 285
AL+HP+F
Sbjct: 305 ALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 3e-72
Identities = 108/295 (36%), Positives = 167/295 (56%), Gaps = 21/295 (7%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKL---NH 58
Y ++G G++G V++A + ++G VA+K ++ S E LRE+ L++L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 59 PNIVKVKELIVEKGN-------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQV 111
PNIV++ L V G + VFE + +L + K + +K + Q+
Sbjct: 61 PNIVRL--LDVCHGPRTDRELKLTLVFEHVDQDLATYLS--KCPKPGLPPETIKDLMRQL 116
Query: 112 FRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPE 170
RG+D++H HRDLKP+N+LV+ G +KIADFGLAR T V T WY+APE
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+L +S Y++ VDMW++G I AEL RPLF+GT EADQ+ KI V+G P+ + W R
Sbjct: 177 VLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP---R 232
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
FP + + + +P E+ ++L++ + +++P KR +A EALQHP+F
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 3e-70
Identities = 113/285 (39%), Positives = 171/285 (60%), Gaps = 13/285 (4%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVKVK 65
+K+G G++G V++A NK +GEVVA+K ++ E + +RE+ L++LNHPNIVK+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 66 ELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFH 125
++I + ++ VFE + +L + M+A +K++LFQ+ +GL + H H
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 126 RDLKPENLLV-SQGTIKIADFGLAREIDAF--P--PYTERVGTRWYQAPEILFKSGLYSS 180
RDLKP+NLL+ ++G IK+ADFGLAR AF P YT V T WY+APEIL YS+
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
VD+W++G I AE++ R LF G E DQ+++I LG+P W G+ FP
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSLPDYKPSFP 239
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+ + + S ++P ED +L+ + +DP KR +A AL HPFF
Sbjct: 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 2e-69
Identities = 109/298 (36%), Positives = 173/298 (58%), Gaps = 22/298 (7%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHS--GEVVAIKALKKSYSREKCLN--LREVKCLRKL-NH 58
Y L K+LG G++G V A N + E VAIK + +S++ LRE+K LR H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 59 PNIVKVKEL-IVEKGN---VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
NI + ++ IV GN ++ E M+ +L+Q++ + Q L +++ +++++Q+ G
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQII---RSGQPL-TDAHFQSFIYQILCG 117
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFP----PY-TERVGTRWYQA 168
L Y+H HRDLKP NLLV + +KI DFGLAR P + TE V TRWY+A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PEI+ Y+ +D+W++G I+AELL +P+F+G D DQ+ +I VLG+P ++ +
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR- 236
Query: 229 LRQAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+ A NY P + ++ P+A+ A++L+E L ++DP KR + EAL+HP+
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 2e-69
Identities = 101/286 (35%), Positives = 170/286 (59%), Gaps = 7/286 (2%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHPNIV 62
+ +KLG G++ V++ N+ +GE+VA+K + + +RE+ +++L H NIV
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
++ ++I + + VFE M +L + M+ + L + VK++ +Q+ +G+ + H+
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGAL-DPNTVKSFTYQLLKGIAFCHENR 120
Query: 123 YFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PYTERVGTRWYQAPEILFKSGLYS 179
HRDLKP+NLL+++ G +K+ADFGLAR P ++ V T WY+AP++L S YS
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
+ +D+W++G IMAE++ RPLF GT+ DQ+ KI ++G+PT +W G+ Q F
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQLPEYKPTF 238
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
P+ +L L P A I+L+ L +P R +A +ALQHP+F
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 3e-69
Identities = 110/296 (37%), Positives = 165/296 (55%), Gaps = 20/296 (6%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPN 60
KY K +G G++G V A N + E VAIK + ++ + LRE+K LR L+H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 61 IVKVKELI--VEKGN---VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
++ +K+++ + V+ V+E M +L+Q++ + Q S+ + +L+Q+ RGL
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGL 121
Query: 116 DYMHQQGYFHRDLKPENLLVSQGT-IKIADFGLAR---EIDAFPPYTERVGTRWYQAPEI 171
Y+H HRDLKP NLL++ +KI DFGLAR E F TE V TRWY+APE+
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPEL 179
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
L Y++ +D+W++G I AELL +PLF G D Q+ I +LGSP+ + +R
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS-EEDLGFIRN 238
Query: 232 AMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
A Y P + + L P A+ AI+L+E + +DP KR T EAL HP+
Sbjct: 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 3e-67
Identities = 101/296 (34%), Positives = 178/296 (60%), Gaps = 18/296 (6%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
M++Y +K+G G++G V++A ++ + E +A+K ++ E + +RE+ L+++ H
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESA--VKAWLFQVFRGLD 116
NIV++++++ + ++ VFE + +L + M++ F+++ +K +L+Q+ RG+
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIA 116
Query: 117 YMHQQGYFHRDLKPENLLVSQGT--IKIADFGLAREIDAF----PPYTERVGTRWYQAPE 170
Y H HRDLKP+NLL+ + T +K+ADFGLAR AF +T V T WY+APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTFTHEVVTLWYRAPE 173
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
IL S YS+ VD+W++G I AE++ +PLF G E D+++KI +LG+P ++W G+
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP-GVT 232
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FP+ +L+ ++P+ ++L+ + DP KR TA AL+H +FK
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 4e-67
Identities = 108/312 (34%), Positives = 172/312 (55%), Gaps = 38/312 (12%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-------KSYSREKC-------LNLREVK 51
LG G++G V +A + +G++VAIK +K + R+ LRE+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 52 CLRKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQV 111
+ ++ H NI+ + ++ VE + V + M +L ++++ K +ES VK L Q+
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI----RLTESQVKCILLQI 128
Query: 112 FRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY------------- 157
GL+ +H+ + HRDL P N+ + S+G KIADFGLAR +PPY
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY-GYPPYSDTLSKDETMQRR 187
Query: 158 ---TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214
T +V T WY+APE+L + Y VDMW++G I AELL +PLF G +E DQ+ +I
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247
Query: 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP 274
+LG+P D+W + + + +F +L + P+AS+DAI+L++SL +P +R
Sbjct: 248 ELLGTPNEDNWPQAKK--LPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 275 TAAEALQHPFFK 286
+A EAL+H +FK
Sbjct: 306 SAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 5e-67
Identities = 102/316 (32%), Positives = 163/316 (51%), Gaps = 33/316 (10%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNK--HSGEVVAIKALKKSYSREKCL---NLREVKCLRKLN 57
KY + +G G++G V++A K G+ AIK K + + RE+ LR+L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 58 HPNIVKVKELIVEKGN--VFFVFECMQCNLYQLMEAKKQKQ-QLFSESAVKAWLFQVFRG 114
H N+V + E+ +E + V+ +F+ + +L+Q+++ +Q + S VK+ L+Q+ G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 115 LDYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDA--FPPYTER--VGTRW 165
+ Y+H HRDLKP N+LV +G +KI D GLAR +A P V T W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---------ADQMYKICSV 216
Y+APE+L + Y+ +D+WA+G I AELL P+F+G + DQ+ +I V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 217 LGSPTMDSWADGLR----QAMAINYQFPQLSGVNLSALMPSA---SEDAINLIESLCSWD 269
LG+PT W D + + +++ +L+ M +L+ L +D
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 270 PCKRPTAAEALQHPFF 285
P KR TA EAL+HP+F
Sbjct: 301 PTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 103/304 (33%), Positives = 162/304 (53%), Gaps = 35/304 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL----------KKSYSREKCLNLREVK 51
++Y +GSG++G V A + +G VAIK L K++Y RE++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--------RELR 66
Query: 52 CLRKLNHPNIVKV------KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVK 105
L+ ++H N++ + + + +V+ V M +L ++ K Q S+ ++
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIV-----KCQKLSDDHIQ 121
Query: 106 AWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGT-IKIADFGLAREIDAFPPYTERVGTR 164
++Q+ RGL Y+H G HRDLKP N+ V++ +KI DFGLAR D T V TR
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGYVATR 179
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
WY+APEI+ Y+ VD+W++G IMAELL + LF G+D DQ+ +I +++G+P +
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD-EE 238
Query: 225 WADGLRQAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
+ A NY PQ+ + + A+ AI+L+E + DP KR TAAEAL H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298
Query: 283 PFFK 286
P+
Sbjct: 299 PYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 1e-64
Identities = 110/305 (36%), Positives = 171/305 (56%), Gaps = 32/305 (10%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPN 60
+Y + + +G GS+G V A++ H+GE VAIK + + + LRE+K LR L HP+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 61 IVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAK----KQKQQLFSESAVKAWLFQV 111
IV++K +++ E +++ VFE M+ +L+Q+++A + Q F L+Q+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF--------LYQL 112
Query: 112 FRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP----YTERVGTRWY 166
R L Y+H FHRDLKP+N+L + +KI DFGLAR P +T+ V TRWY
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 167 QAPEI---LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223
+APE+ F Y+ +D+W++G I AE+L +PLF G + Q+ I +LG+P+ +
Sbjct: 173 RAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230
Query: 224 SWADGLRQAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ +R A Y + V S P+A A+ L+E L ++DP RPTA EAL
Sbjct: 231 T-ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 282 HPFFK 286
P+FK
Sbjct: 290 DPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 8e-64
Identities = 91/288 (31%), Positives = 144/288 (50%), Gaps = 35/288 (12%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPN 60
KY + K++G GSFG V+ K G++ +K + S EK L EVK L+KLNHPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 61 IVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
I+K E EKG + V E +L Q ++ +K++ + F E + W Q+ L Y+H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 120 QQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTE-RVGTRWYQAPEILFKSGL 177
+ HRD+KP+N L S G +K+ DFG+++ + + + VGT +Y +PE+ ++
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL-CQNKP 179
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y+ K D+W++G ++ EL + F+G + + KI G I
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPP------------IPS 225
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
Q+ S + NL+ SL DP +RP+ A+ LQ PF
Sbjct: 226 QY---------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 9e-64
Identities = 104/303 (34%), Positives = 172/303 (56%), Gaps = 26/303 (8%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
++K+ + ++G G++G V++A +K +GE+VA+K ++ +E +RE+K LR+LNH
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 59 PNIVKVKELIV----------EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWL 108
NIV +KE++ +KG + VFE M +L L+E+ FSE +K+++
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSFM 122
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAR--EIDAFPPYTERVGTRW 165
Q+ GL+Y H++ + HRD+K N+L++ +G IK+ADFGLAR + PYT +V T W
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225
Y+ PE+L Y +D+W+ G I+ EL +P+FQ E Q+ I + GSP W
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 226 ADGLR----QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
D ++ M Q+ + S +P+ A++L++ + + DP KR TA EAL
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFS-FIPT---PALDLLDHMLTLDPSKRCTAEEALN 298
Query: 282 HPF 284
P+
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-63
Identities = 110/294 (37%), Positives = 159/294 (54%), Gaps = 15/294 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLN 57
+E Y KLG GS+ V++ +K +G++VA+K + E+ +RE L+ L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLK 61
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
H NIV + ++I K + VFE + +L Q M+ S V+ +LFQ+ RGL Y
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMD---DCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 118 MHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPP--YTERVGTRWYQAPEILFK 174
HQ+ HRDLKP+NLL+S +G +K+ADFGLAR + P Y+ V T WY+ P++L
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQG-TDEADQMYKICSVLGSPTMDSWADGLRQAM 233
S YS+ +DMW +G I E+ RPLF G TD DQ++KI VLG+PT ++W
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 234 AINYQFPQLSGVNLSALMP--SASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
Y FP L P L ++P KR +AAEA++HP+F
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 4e-63
Identities = 78/198 (39%), Positives = 117/198 (59%), Gaps = 8/198 (4%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELI 68
LG G FG V+ A +K +G+ VAIK +KK S LRE++ L+KLNHPNIVK+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 69 VEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRD 127
++ +++ V E + +L L++ + K SE + L Q+ GL+Y+H G HRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 128 LKPENLLVS--QGTIKIADFGLAREIDAFPPY-TERVGTRWYQAPEILFKSGLYSSKVDM 184
LKPEN+L+ G +K+ADFGL++ + + VGT Y APE+L G YS K D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 185 WAMGAIMAELLLFRPLFQ 202
W++G I+ EL + L +
Sbjct: 178 WSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 7e-63
Identities = 104/293 (35%), Positives = 172/293 (58%), Gaps = 19/293 (6%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPN 60
KY +K+G G++G V++A N+ + E+VA+K ++ E + LRE+ L++L H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV++ +++ + VFE +L + ++ VK+++FQ+ +GL + H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHS 117
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF----PPYTERVGTRWYQAPEILFKS 175
HRDLKP+NLL+++ G +K+ADFGLAR AF Y+ V T WY+ P++LF +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 176 GLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
LYS+ +DMW+ G I AEL RPLF G D DQ+ +I +LG+PT +SW G+ +
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP-GVSKLP- 232
Query: 235 INYQF--PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+Y+ + +L ++P + +L+++L +P +R +A EALQHP+F
Sbjct: 233 -DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 5e-62
Identities = 104/302 (34%), Positives = 171/302 (56%), Gaps = 26/302 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKC--LNLREVKCLRKLNHP 59
+ Y +K+G G++G V++A +K++G++VA+K + E LRE+ L+ L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 60 NIVKVKELIVE-------KGNVFFVFECMQCNLYQLMEAKKQKQ-QLFSESAVKAWLFQV 111
+ V+ L VE K +++ VFE + +L + M++ + + +K++++Q+
Sbjct: 61 IYI-VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 112 FRGLDYMHQQGYFHRDLKPENLLV--SQGTIKIADFGLAREIDAFP----PYTERVGTRW 165
+G+ + H+ G HRDLKP+NLLV +G +KIAD GL R AF YT + T W
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR---AFSIPVKSYTHEIVTLW 176
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225
Y+APE+L S YS+ VD+W++G I AE+ +PLF G E Q+ I +LG+PT W
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236
Query: 226 AD--GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
LR ++FPQ +LS +P S + ++L++ + +DP KR +A AL HP
Sbjct: 237 PGVSKLRDW----HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 284 FF 285
+F
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-61
Identities = 103/294 (35%), Positives = 160/294 (54%), Gaps = 18/294 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-----KCLNLREVKCLRKL 56
EKY +G GS+G V + +K +G++VAIK K E K + +RE++ L++L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQL 57
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
H N+V + E+ K ++ VFE + + L + +K L ES V+ +LFQ+ RG++
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTV--LDDLEKYPNGL-DESRVRKYLFQILRGIE 114
Query: 117 YMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEIL 172
+ H HRD+KPEN+LVSQ G +K+ DFG AR + A P YT+ V TRWY+APE+L
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PGEVYTDYVATRWYRAPELL 172
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y VD+WA+G ++ E+L PLF G + DQ+Y I LG+ +
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 233 MAINYQFPQLSGV-NLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+ + P++ + L P S ++L + DP RP++++ L H FF
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 8e-60
Identities = 103/290 (35%), Positives = 162/290 (55%), Gaps = 12/290 (4%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
+Y + +G G+FG V A ++ +G+ VAIK + K +S RE+K L+ L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 60 NIVKVKEL-IVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI+ + ++ I +++FV E + +L++L+ ++ ++Q ++ +L+Q+ RGL Y+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF-----IQYFLYQILRGLKYV 124
Query: 119 HQQGYFHRDLKPENLLVSQGT-IKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
H G HRDLKP N+L+++ +KI DFGLAR D P T V TR+Y+APEI+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQK 182
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD-GLRQAMAIN 236
Y +VD+W+ G I AE+L +PLF G D +Q I +LG+P D +
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
P+ V S +A AI+L+E + +DP KR +AAEAL HP+
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-59
Identities = 103/303 (33%), Positives = 150/303 (49%), Gaps = 25/303 (8%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK----CLNLREVKCLRKLNH 58
KY K+G G+FG V++A +K + ++VA+K K EK LRE+K L+ L H
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKH 70
Query: 59 PNIVKVKELIVE--------KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
N+V + E+ KG+ + VFE + +L L+ K K F+ S +K +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKVMKM 127
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR-----EIDAFPPYTERVGTR 164
+ GL Y+H+ HRD+K N+L+++ G +K+ADFGLAR + YT RV T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
WY+ PE+L Y +DMW G IMAE+ P+ QG E Q+ I + GS T +
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247
Query: 225 WADGLRQAMAINYQFP--QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
W + + + P Q V A++LI+ L DP KR A AL H
Sbjct: 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307
Query: 283 PFF 285
FF
Sbjct: 308 DFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 9e-59
Identities = 109/295 (36%), Positives = 163/295 (55%), Gaps = 20/295 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
E+Y+ K++GSG++G V A++K +GE VAIK L + + E RE+ L+ + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 60 NIVKVKELIV------EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ E + + V MQ +L ++M SE V+ ++Q+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP------LSEDKVQYLVYQMLC 128
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H G HRDLKP NL V++ +KI DFGLAR DA T V TRWY+APE++
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVI 186
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y+ VD+W++G IMAE+L + LF+G D DQ+ +I V G P + L
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-PEFVQKLEDK 245
Query: 233 MAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
A +Y P+ + S L P AS A++L+E + D KR TA EAL+HP+F
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 5e-58
Identities = 104/296 (35%), Positives = 173/296 (58%), Gaps = 19/296 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
++Y K++GSG++G V A+++ +G VAIK L + + E RE++ L+ + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 60 NIVKVKELIVEKGNV------FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ ++ + V M +L +LM K + SE ++ ++Q+ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-----KHEKLSEDRIQFLVYQMLK 129
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQGT-IKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H G HRDLKP NL V++ +KI DFGLAR+ D+ T V TRWY+APE++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVI 187
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y+ VD+W++G IMAE+L +PLF+G D DQ+ +I V G+P+ + + L+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSE 246
Query: 233 MAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A NY + P+ + +L+P+A+ A+N++E + D R TAAEAL HP+F+
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-57
Identities = 102/310 (32%), Positives = 157/310 (50%), Gaps = 35/310 (11%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV 62
+Y + LG GS G V+ AV+ + VA+K + + + LRE+K +R+L+H NIV
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 63 KVKELIVEKGN--------------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWL 108
KV E++ G+ V+ V E M+ +L ++E Q SE + ++
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFM 120
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQGT--IKIADFGLAREIDAFPPY------TER 160
+Q+ RGL Y+H HRDLKP N+ ++ +KI DFGLAR +D P Y +E
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD--PHYSHKGYLSEG 178
Query: 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220
+ T+WY++P +L Y+ +DMWA G I AE+L +PLF G E +QM I L S
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI---LESV 235
Query: 221 TMDSWADGLRQAMAINYQFPQLSGV---NLSALMPSASEDAINLIESLCSWDPCKRPTAA 277
+ D I G L L+P + +A++ +E + +++P R TA
Sbjct: 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295
Query: 278 EALQHPFFKR 287
EAL HP+
Sbjct: 296 EALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-57
Identities = 100/289 (34%), Positives = 162/289 (56%), Gaps = 8/289 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHP 59
+E Y KLG G++ V++ +K + +VA+K ++ + C +REV L+ L H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIV + ++I + + VFE + +L Q ++ L S VK ++FQ+ RGL Y H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLD---NCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--YTERVGTRWYQAPEILFKSG 176
++ HRDLKP+NLL+++ G +K+ADFGLAR + P Y+ V T WY+ P++L S
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+ +DMW +G I+ E+ RP+F G+ ++++ I +LG+PT ++W +
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
Y FPQ L P D I+L+ SL ++ R +A AL+H +F
Sbjct: 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-57
Identities = 102/299 (34%), Positives = 162/299 (54%), Gaps = 28/299 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHP 59
EKY K+G GS+G V++ N+ +G++VAIK +S K + LRE++ L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N+V + E+ K + VFE C+ L E +K + + E +K ++Q + +++ H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFE--YCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNFCH 117
Query: 120 QQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKS 175
+ HRD+KPEN+L++ QG IK+ DFG AR + P YT+ V TRWY+APE+L
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILT--GPGDDYTDYVATRWYRAPELLVGD 175
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
Y VD+WA+G + AELL +PL+ G + DQ+Y I LG D + + I
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG--------DLIPRHQQI 227
Query: 236 NYQFPQLSGVN---------LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
G++ L + P+ S A++ ++ DP +R + E L+HP+F
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 2e-57
Identities = 86/293 (29%), Positives = 138/293 (47%), Gaps = 43/293 (14%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPN 60
+++ + LG GSFG V+ A++K +GE++A+K+++ S E+ L RE++ L L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 61 IVKVK--ELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
IV+ E EK + E +L L++ + E ++ + Q+ GL Y
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLAY 116
Query: 118 MHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID--AFPPYTE-RVGTRWYQAPEILF 173
+H G HRD+K N+LV G +K+ADFG A+ + T GT ++ APE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI- 175
Query: 174 KSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
+ Y D+W++G + E+ P + + +YKI S P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP------------ 223
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+ P+ SE+A + + DP KRPTA E LQHPF
Sbjct: 224 -----EIPE-----------HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 3e-57
Identities = 101/289 (34%), Positives = 164/289 (56%), Gaps = 8/289 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHP 59
+E Y KLG G++ V++ +K + +VA+K ++ + C +REV L+ L H
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIV + ++I + ++ VFE + +L Q ++ + VK +LFQ+ RGL+Y H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--YTERVGTRWYQAPEILFKSG 176
++ HRDLKP+NLL+++ G +K+ADFGLAR + P Y+ V T WY+ P+IL S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+++DMW +G I E+ RPLF G+ +Q++ I +LG+PT ++W L +
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
Y +P+ L P D L+ L ++ KR +A EA++HP+F
Sbjct: 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-55
Identities = 100/290 (34%), Positives = 163/290 (56%), Gaps = 8/290 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHP 59
ME Y +KLG G++ V++ +K + +VA+K ++ + C +REV L+ L H
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NIV + +++ ++ VFE + +L Q M+ + S VK +L+Q+ RGL Y H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMD---DCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--YTERVGTRWYQAPEILFKSG 176
++ HRDLKP+NLL+++ G +K+ADFGLAR + P Y+ V T WY+ P++L S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+++DMW +G I E+ RPLF G+ D+++ I +LG+PT ++W N
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
Y FP+ L P + I L+ ++ KR +A EA++H +F+
Sbjct: 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 5e-54
Identities = 90/311 (28%), Positives = 146/311 (46%), Gaps = 41/311 (13%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNHP 59
Y + +KLG GSFG V+ A ++ ++VA+K L K + LRE++ L LNHP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 60 -NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIVK+ + ++G+++ V E + + + K ++ SES L Q+ L+Y+
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 119 HQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAF-------PPYTERVGTRWYQAP 169
H +G HRD+KPEN+L+ + +K+ DFGLA+ + + VGT Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 170 EILF--KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMDS 224
E+L SS D+W++G + ELL P F+G + Q KI L +P++ S
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
++ P S+ A +L++ L + DP R +++ L H
Sbjct: 238 P---------LSPSNP-----------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 285 FKRCLYVPPHL 295
L
Sbjct: 278 LAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 6e-53
Identities = 106/293 (36%), Positives = 161/293 (54%), Gaps = 24/293 (8%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNHPNIVK 63
+ +G G+FG VW + G+ VA+K + + S ++ RE+K L H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVLS 63
Query: 64 VKELIVEKGN------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+ I++ + ++ V E MQ +L++++ + Q S VK +L+Q+ RGL Y
Sbjct: 64 ALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKY 118
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAR--EIDAFPPYTERVGTRWYQAPEILFK 174
+H G HRD+KP NLLV S +KI DFGLAR E D T+ V T++Y+APEIL
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT---MDSWADGLRQ 231
S Y+S VD+W++G I AELL R LFQ Q+ I +LG+P+ M S +G R
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+ P V L L A+ +A++L+ + +DP KR +AA+AL HP+
Sbjct: 239 HILRGPHKPPSLPV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 9e-53
Identities = 106/294 (36%), Positives = 164/294 (55%), Gaps = 17/294 (5%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKL---N 57
+Y ++G G++G V++A + HSG VA+K+++ + + +REV L++L +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 58 HPNIVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
HPNIV++ ++ + V VFE + +L ++ K L +E+ +K + Q
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLD-KVPPPGLPAET-IKDLMRQFL 118
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171
RGLD++H HRDLKPEN+LV S G +K+ADFGLAR T V T WY+APE+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
L +S Y++ VDMW++G I AE+ +PLF G EADQ+ KI ++G P D W R
Sbjct: 179 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP---RD 234
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
F + +++P E L+ + +++P KR +A ALQHPFF
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 9e-50
Identities = 100/295 (33%), Positives = 157/295 (53%), Gaps = 19/295 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHP 59
E+Y +GSG++G V A + +G VA+K L + + RE++ L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 60 NIVKVKELIV------EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ E +V+ V M +L +++ +K ++ V+ ++Q+ R
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILR 131
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H HRDLKP NL V++ +KI DFGLAR D T V TRWY+APEI+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 189
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y+ VD+W++G IMAELL R LF GTD DQ+ I ++G+P +
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 248
Query: 233 MAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
A NY Q+ +N + + A+ A++L+E + D KR TAA+AL H +F
Sbjct: 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-49
Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 41/289 (14%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPN 60
Y L +G G+FG V++ +N +G+ VAIK + +E+ L ++E+ L+ L HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 61 IVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IVK I +++ + E +L Q++ +K F ES V +++QV +GL Y+H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTERVGTRWYQAPEILFKSGL 177
+QG HRD+K N+L ++ G +K+ADFG+A +++ VGT ++ APE++ SG
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
S+ D+W++G + ELL P + + +++I P
Sbjct: 177 -STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP----------------- 218
Query: 238 QFPQLSGVNLSALMPSASEDAIN-LIESLCSWDPCKRPTAAEALQHPFF 285
P S + + L++ DP RPTA + L+HP+
Sbjct: 219 -LP-----------EGISPELKDFLMQCFQK-DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 89/285 (31%), Positives = 133/285 (46%), Gaps = 44/285 (15%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL---NLREVKCLRKLNHPNIVKVKE 66
LG GSFG V K +G++ A+K LKK ++ L E L ++NHP IVK+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 67 LIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFH 125
+ ++ V E L+ + K+ FSE + + ++ L+Y+H G +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 126 RDLKPENLLV-SQGTIKIADFGLAREIDAFPPYT-ERVGTRWYQAPEILFKSGLYSSKVD 183
RDLKPEN+L+ + G IK+ DFGLA+E+ + T GT Y APE+L G Y VD
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVD 175
Query: 184 MWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLS 243
W++G ++ E+L +P F D ++Y+ +L P +FP
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK-EIYE--KILKDP----------------LRFP--- 213
Query: 244 GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA---LQHPFF 285
S +A +LI L DP KR + A HPFF
Sbjct: 214 --------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 5e-49
Identities = 105/291 (36%), Positives = 159/291 (54%), Gaps = 23/291 (7%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL---NLREVKCLRKLNHPNIVKV 64
+KLG GS+ V++ +++ +G++VA+K + S E+ + +RE L+ L H NIV +
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
++I K + FVFE M +L Q M Q V+ ++FQ+ RGL Y+H Q
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 125 HRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PYTERVGTRWYQAPEILFKSGLYSSK 181
HRDLKP+NLL+S G +K+ADFGLAR + P Y+ V T WY+ P++L + YSS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 182 VDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMDSWADGLRQAMAINYQF- 239
+D+W G I E+L +P F G + +Q+ KI +VLG PT D+W G+ + ++
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP-GVSKLPNYKPEWF 243
Query: 240 -----PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
QL V P +ED L + P R +A +AL HP+F
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAED---LASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 6e-49
Identities = 99/299 (33%), Positives = 158/299 (52%), Gaps = 29/299 (9%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPN 60
K+ + +G G++G V + +K + E+VAIK K S E K LRE+K LR L N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV++KE +G ++ VFE ++ N+ +L+E V+++++Q+ + + + H+
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYIYQLIKAIHWCHK 118
Query: 121 QGYFHRDLKPENLLVSQGTI-KIADFGLAREID--AFPPYTERVGTRWYQAPEILFKSGL 177
HRD+KPENLL+S + K+ DFG AR + + YTE V TRWY++PE+L +
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP- 177
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGS-PTMDSWADGLRQAMAIN 236
Y VDMW++G I+ EL +PLF G E DQ++ I VLG P + M +
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA---------EQMKLF 228
Query: 237 YQFPQLSGVNLSALMPSASED----------AINLIESLCSWDPCKRPTAAEALQHPFF 285
Y P+ G+ A+ S + ++L+++L +P R + L HP F
Sbjct: 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 3e-48
Identities = 99/314 (31%), Positives = 166/314 (52%), Gaps = 27/314 (8%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
Y L +G+GSFG V++A+ + E VAIK + + + RE+ ++ LNH NI+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIF 123
Query: 64 VKELIV------EKGNVFF--VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
+K+ + N+F V E + +++ M+ + VK + +Q+ R L
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 116 DYMHQQGYFHRDLKPENLLVSQGT--IKIADFGLAREIDAFPPYTERVGTRWYQAPEILF 173
Y+H + HRDLKP+NLL+ T +K+ DFG A+ + A + +R+Y+APE++
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+ Y++ +D+W++G I+AE++L P+F G DQ+ +I VLG+PT D + M
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL-----KEM 298
Query: 234 AINY---QFPQLSGVNLSALMPSAS-EDAINLIESLCSWDPCKRPTAAEALQHPFFKR-- 287
NY +FP + +L + P + +DAIN I ++P KR EAL PFF
Sbjct: 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358
Query: 288 --CLYVPPHLRSTP 299
C+ +P ++ P
Sbjct: 359 DPCIKLPKYIDKLP 372
|
Length = 440 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 4e-48
Identities = 79/286 (27%), Positives = 143/286 (50%), Gaps = 37/286 (12%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV 62
+ + +K+G G FG V++A +K +G+ VAIK +K +K + E++ L+K HPNIV
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 63 KVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K ++K ++ V E +L L+++ Q +ES + ++ +GL+Y+H
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN 117
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
G HRD+K N+L++ G +K+ DFGL+ ++ VGT ++ APE++ Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDY 176
Query: 181 KVDMWAMGAIMAELLLFRPLFQ--GTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
K D+W++G EL +P + +A ++KI + G P + + +
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKA--LFKI-ATNGPPGLRN-----------PEK 222
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+ S++ + ++ +P KRPTA + L+HPF
Sbjct: 223 W---------------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 6e-47
Identities = 100/298 (33%), Positives = 159/298 (53%), Gaps = 25/298 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKL 56
E+Y +GSG++G V A + + VA+K L + + +R RE++ L+ +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR---TYRELRLLKHM 71
Query: 57 NHPNIVKVKEL------IVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
H N++ + ++ I V+ V M +L ++ K Q S+ V+ ++Q
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-----KCQKLSDEHVQFLIYQ 126
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVSQGT-IKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ RGL Y+H G HRDLKP N+ V++ ++I DFGLAR+ D T V TRWY+AP
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAP 184
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
EI+ Y+ VD+W++G IMAELL + LF G D DQ+ +I V+G+P+ + +
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK-I 243
Query: 230 RQAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
A Y P + +L + A+ AI+L+E + D KR +A+EAL HP+F
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-47
Identities = 99/298 (33%), Positives = 159/298 (53%), Gaps = 22/298 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVN-KHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLN- 57
++Y ++G G++G V++A + K+ G VA+K ++ E +REV LR L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 58 --HPNIVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
HPN+V++ ++ + + VFE + +L ++ K + +K +FQ
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQ 118
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ RGLD++H HRDLKP+N+LV S G IK+ADFGLAR T V T WY+AP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD-- 227
E+L +S Y++ VD+W++G I AE+ +PLF+G+ + DQ+ KI V+G P + W
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
L + F S + + E +L+ +++P KR +A AL HP+F
Sbjct: 238 ALPRQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 1e-44
Identities = 108/301 (35%), Positives = 157/301 (52%), Gaps = 14/301 (4%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ Y +KLG GS+ V++ +K +G++VA+K ++ +RE L+ L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV + ++I K + VFE + +L Q M+ K L E+ VK +LFQ+ RGL Y+HQ
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMD--KHPGGLHPEN-VKLFLFQLLRGLSYIHQ 121
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--YTERVGTRWYQAPEILFKSGL 177
+ HRDLKP+NLL+S G +K+ADFGLAR + P Y+ V T WY+ P++L S
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQG-TDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+ +DMW +G I E++ F G D DQ+ +I VLG+P D+W
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240
Query: 237 YQFPQLSGVNLSALMPSAS--EDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPH 294
+F S NL S A +L L P R +A AL H +F +PP
Sbjct: 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD---LPPR 297
Query: 295 L 295
L
Sbjct: 298 L 298
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 2e-44
Identities = 107/319 (33%), Positives = 157/319 (49%), Gaps = 55/319 (17%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL----------KKSYSREKCLNLREVKC 52
+Y K +GSG+ G V A + +G+ VAIK L K++Y RE+
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--------RELVL 68
Query: 53 LRKLNHPNIVKVKELIV------EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKA 106
++ +NH NI+ + + E +V+ V E M NL Q++ Q +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI------QMDLDHERMSY 122
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAR-EIDAF--PPYTERVG 162
L+Q+ G+ ++H G HRDLKP N++V S T+KI DFGLAR +F PY V
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VV 179
Query: 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM 222
TR+Y+APE++ G Y VD+W++G IM E++ LF GTD DQ KI LG+P+
Sbjct: 180 TRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS- 237
Query: 223 DSWADGLRQAMAINY--QFPQLSGVNLSALMP-----SASED--------AINLIESLCS 267
D + L Q NY P+ +G + L P SE A +L+ +
Sbjct: 238 DEFMSRL-QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 268 WDPCKRPTAAEALQHPFFK 286
DP KR + +ALQHP+
Sbjct: 297 IDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 88/309 (28%), Positives = 131/309 (42%), Gaps = 66/309 (21%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLN--LREVKCLRKLN-HPNIVK 63
K +G GSF V A K + + AIK L K +EK + E + L +LN HP I+K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 64 VKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ ++ N++FV E L Q + +K E + + ++ L+Y+H +G
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYI--RKYGS--LDEKCTRFYAAEILLALEYLHSKG 122
Query: 123 YFHRDLKPENLLVSQ-GTIKIADFGLAR---------------EIDAFPPYTER------ 160
HRDLKPEN+L+ + IKI DFG A+ R
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220
VGT Y +PE+L D+WA+G I+ ++L +P F+G++E Y
Sbjct: 183 VGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLT------- 230
Query: 221 TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA---- 276
++ + + Y FP P+ DA +LIE L DP R
Sbjct: 231 --------FQKILKLEYSFP-----------PNFPPDAKDLIEKLLVLDPQDRLGVNEGY 271
Query: 277 AEALQHPFF 285
E HPFF
Sbjct: 272 DELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 99/305 (32%), Positives = 154/305 (50%), Gaps = 28/305 (9%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
+++Y K +GSG+ G V A + G VA+K L + + + RE+ L+ +NH
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 59 PNIVKV------KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
NI+ + ++ + E +V+ V E M NL Q++ + +++ L+Q+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERM------SYLLYQML 133
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171
G+ ++H G HRDLKP N++V S T+KI DFGLAR T V TR+Y+APE+
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ G Y VD+W++G IM EL+ +FQGTD DQ K+ LG+P+ +
Sbjct: 194 ILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252
Query: 232 AMAINYQFPQLSGVNLSAL-----MPSASE-------DAINLIESLCSWDPCKRPTAAEA 279
PQ G++ L PS SE A +L+ + DP KR + EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 280 LQHPF 284
L+HP+
Sbjct: 313 LRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 67/201 (33%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 5 SLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHP 59
+L KKLG G+FG V++ VA+K LK+ S ++ LRE + +RKL+HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 60 NIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIVK+ + E+ + V E +L + +K + + S S + ++ Q+ RG++Y+
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 119 HQQGYFHRDLKPENLLVSQG-TIKIADFGLAREI---DAFPPYTERVGTRWYQAPEILFK 174
+ + HRDL N LV + +KI+DFGL+R++ D + ++ RW APE L K
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESL-K 177
Query: 175 SGLYSSKVDMWAMGAIMAELL 195
G ++SK D+W+ G ++ E+
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 94/305 (30%), Positives = 131/305 (42%), Gaps = 71/305 (23%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREV-------KCLRKL 56
+ K LG+GSFG V +K SG+ A+K L K K + L++V + L+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK----AKIVKLKQVEHVLNEKRILQSI 58
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESAVKAWL 108
HP +V N++ F+ NLY +ME + +K F E + +
Sbjct: 59 RHPFLV----------NLYGSFQDDS-NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQ 167
QV L+Y+H +RDLKPENLL+ S G IKI DFG A+ + YT GT Y
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYT-LCGTPEYL 165
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWA 226
APEI+ G Y VD WA+G ++ E+L P F D Q+Y KI
Sbjct: 166 APEIILSKG-YGKAVDWWALGILIYEMLAGYPPFF-DDNPIQIYEKILEG---------- 213
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQ 281
+FP S DA +LI +L D KR +
Sbjct: 214 ---------KVRFP-----------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253
Query: 282 HPFFK 286
HP+F
Sbjct: 254 HPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 66/201 (32%), Positives = 111/201 (55%), Gaps = 15/201 (7%)
Query: 5 SLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHP 59
+L KKLG G+FG V++ VA+K LK+ S ++ LRE + +RKL+HP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 60 NIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
N+VK+ + E+ ++ V E +L + + K S S + ++ Q+ RG++Y+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYL 118
Query: 119 HQQGYFHRDLKPENLLVSQG-TIKIADFGLAREI---DAFPPYTERVGTRWYQAPEILFK 174
+ + HRDL N LV + +KI+DFGL+R++ D + ++ RW APE L K
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESL-K 176
Query: 175 SGLYSSKVDMWAMGAIMAELL 195
G ++SK D+W+ G ++ E+
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-40
Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 52/295 (17%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNHPNIVKVKE 66
+ G++G V+ A K +G++ AIK +KK+ K L E L + P +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 67 LIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFH 125
K N++ V E +L L+E E + ++ ++ L+Y+H G H
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 126 RDLKPENLLV-SQGTIKIADFGLA------REIDAFPPYTER---VGTRWYQAPEILFKS 175
RDLKP+N+L+ S G +K+ DFGL+ R+I+ E VGT Y APE++
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWADGLRQAMA 234
G +S VD W++G I+ E L+ P F G + ++++ I +
Sbjct: 177 G-HSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNG------------------ 216
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA---EALQHPFFK 286
++P+ S++AI+LI L DP KR A E HPFFK
Sbjct: 217 -KIEWPED---------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 9e-40
Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 39/282 (13%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIK----ALKKSYSREKCLNL-REVKCLRKLNHPNIVKV 64
LGSGSFG V++ +N G+ A+K A +E L +E+ L KL HPNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 65 KELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
E+ N++ E + +L +L+ +K F E ++ + Q+ GL+Y+H +
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 124 FHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKV 182
HRD+K N+LV + G +K+ADFG+A+++ F G+ ++ APE++ + G Y
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 183 DMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242
D+W++G + E+ +P + + ++KI S + D L
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR---SKELPPIPDHL------------- 227
Query: 243 SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
S++A + I DP RPTAAE L+HPF
Sbjct: 228 ------------SDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-39
Identities = 81/289 (28%), Positives = 129/289 (44%), Gaps = 43/289 (14%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL--REVKCLRKLNHPNIVKVK 65
K+G G+FG V+ AVN +GE++A+K ++ + K + E+K L L HPN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 66 ELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ V + V+ E C L +L+E + E ++ + Q+ GL Y+H G
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILD----EHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 125 HRDLKPEN-LLVSQGTIKIADFGLAREI-DAFPPYTER----VGTRWYQAPEILFKSGL- 177
HRD+KP N L G IK+ DFG A ++ + E GT Y APE++
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 178 -YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ-MYKICSVLGSPTMDSWADGLRQAMAI 235
+ D+W++G ++ E+ + + D Q M+ + + G
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKP-------------- 225
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
P S + + ++ DP KRPTA+E LQHPF
Sbjct: 226 --PIPDSL---------QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-39
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 22/204 (10%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEV----VAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
L KKLG G+FG V++ K GE VA+K LK+ S E+ L E ++KL+HPN
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQK---QQLFSESAVKAWLFQVFRGLD 116
IV++ + + ++ V E M +L + +K + L Q+ +G++
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ------MALQIAKGME 116
Query: 117 YMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEI 171
Y+ + + HRDL N LV+ +KI+DFGL+R+I Y +R G +W APE
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APES 175
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
L G ++SK D+W+ G ++ E+
Sbjct: 176 LKD-GKFTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 89/293 (30%), Positives = 135/293 (46%), Gaps = 49/293 (16%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHPNIVKVKE 66
K LG GS G V++ +K +G++ A+K + + LRE+K LR P +VK
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 67 LIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY-F 124
++G + V E M +L L+ +K E + Q+ +GLDY+H + +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 125 HRDLKPENLLV-SQGTIKIADFGLAREID--AFPPYTERVGTRWYQAPEILFKSGLYSSK 181
HRD+KP NLL+ S+G +KIADFG+++ ++ T VGT Y +PE + YS
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPE-RIQGESYSYA 180
Query: 182 VDMWAMGAIMAELLL----FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
D+W++G + E L F P Q + M IC
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC----------------------- 216
Query: 238 QFPQLSGVNLSALMPS--ASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
P S +P+ S + + I + DP KRP+AAE LQHPF K+
Sbjct: 217 DGPPPS-------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 99/322 (30%), Positives = 159/322 (49%), Gaps = 33/322 (10%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
+++Y K +GSG+ G V A + VAIK L + + + RE+ ++ +NH
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 59 PNIVKV------KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
NI+ + ++ + E +V+ V E M NL Q+++ + +++ L+Q+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM------SYLLYQML 129
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171
G+ ++H G HRDLKP N++V S T+KI DFGLAR T V TR+Y+APE+
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ G Y VD+W++G IM E++ + LF G D DQ K+ LG+P + Q
Sbjct: 190 ILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK--LQ 246
Query: 232 AMAINY--QFPQLSGVNLSALMPSA------------SEDAINLIESLCSWDPCKRPTAA 277
NY P+ +G+ L P + + A +L+ + DP KR +
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 278 EALQHPFFKRCLYVPPHLRSTP 299
EALQHP+ Y P + + P
Sbjct: 307 EALQHPYIN-VWYDPAEVEAPP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-38
Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 48/297 (16%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS----REKCLNLREVKCLRKLNH 58
Y + + +G GSFG V + K G+++ K + Y +EK + EV LR+L H
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKH 58
Query: 59 PNIVKVKELIVEKGN--VFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
PNIV+ + I+++ N ++ V E C +L QL++ K++++ E + L Q+ L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 116 DYMHQQGY-----FHRDLKPENL-LVSQGTIKIADFGLAREI--DAFPPYTERVGTRWYQ 167
H + HRDLKP N+ L + +K+ DFGLA+ + D+ T VGT +Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYM 177
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
+PE L Y K D+W++G ++ EL P F ++ KI
Sbjct: 178 SPEQL-NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR------- 229
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
I Y++ S + +I+S+ + DP KRP+ E LQ P
Sbjct: 230 -------IPYRY---------------SSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 6e-38
Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 35/284 (12%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + KKLG GS+G V++ + A+K L +E+ + E++ L +NHPNI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ KE ++ + V E +L + + +K+K++L E + Q+ RGL +H+
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 121 QGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
Q HRDLK N+L+ + KI D G+++ + T+ +GT Y APE+ +K YS
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEV-WKGRPYS 179
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
K D+W++G ++ E+ F P F+ D YK+ ++
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------------KY 218
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
P + + S+D N I S+ P RP + L P
Sbjct: 219 PPIPPIY--------SQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-38
Identities = 98/315 (31%), Positives = 165/315 (52%), Gaps = 43/315 (13%)
Query: 9 KLGSGSFGCVWQAVNKHSGEV--VAIKALKKS-YSREKCLNLREVKCLRKLNHPNIVKVK 65
K+G G++G V++A K + A+K ++ + S C RE+ LR+L HPN++ ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC---REIALLRELKHPNVIALQ 64
Query: 66 ELIVEKGN--VFFVFECMQCNLYQLME------AKKQKQQLFSESAVKAWLFQVFRGLDY 117
++ + + V+ +F+ + +L+ +++ A K+ QL S VK+ L+Q+ G+ Y
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQILDGIHY 123
Query: 118 MHQQGYFHRDLKPENLLV-----SQGTIKIADFGLAREIDA-FPPYTER---VGTRWYQA 168
+H HRDLKP N+LV +G +KIAD G AR ++ P + V T WY+A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---------ADQMYKICSVLGS 219
PE+L + Y+ +D+WA+G I AELL P+F E DQ+ +I SV+G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 220 PTMDSWAD--GLRQAMAINYQFPQLSGVNLSALMPSASEDAIN-------LIESLCSWDP 270
P W D + + + F + + N S+L+ + + L++ L + DP
Sbjct: 244 PADKDWEDIRKMPEYPTLQKDFRRTTYAN-SSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302
Query: 271 CKRPTAAEALQHPFF 285
KR T+ +ALQ P+F
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 95/314 (30%), Positives = 162/314 (51%), Gaps = 41/314 (13%)
Query: 9 KLGSGSFGCVWQAVNKHSGEV--VAIKALKKS-YSREKCLNLREVKCLRKLNHPNIVKVK 65
K+G G++G V++A K + A+K ++ + S C RE+ LR+L HPN++ ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELKHPNVISLQ 64
Query: 66 ELIVEKGN--VFFVFECMQCNLYQLME------AKKQKQQLFSESAVKAWLFQVFRGLDY 117
++ + + V+ +F+ + +L+ +++ A K+ QL VK+ L+Q+ G+ Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDGIHY 123
Query: 118 MHQQGYFHRDLKPENLLV-----SQGTIKIADFGLAREIDA-FPPYTER---VGTRWYQA 168
+H HRDLKP N+LV +G +KIAD G AR ++ P + V T WY+A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---------ADQMYKICSVLGS 219
PE+L + Y+ +D+WA+G I AELL P+F E DQ+ +I +V+G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 220 PTMDSWAD--GLRQAMAINYQFPQLSGVNLSAL------MPSASEDAINLIESLCSWDPC 271
P W D + + + F + + N S + A +L++ L + DP
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303
Query: 272 KRPTAAEALQHPFF 285
KR T+ +A+Q P+F
Sbjct: 304 KRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 8e-37
Identities = 85/301 (28%), Positives = 142/301 (47%), Gaps = 57/301 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E Y +K+G G+ G V++A ++ +G+ VAIK ++ ++ L + E+ ++ HPNI
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE-LIINEILIMKDCKHPNI 77
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V + + ++ V E M L + Q +E + +V +GL+Y+H Q
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGG--SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILFKSGL 177
HRD+K +N+L+S+ G++K+ADFG A ++ ++R VGT ++ APE + K
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPE-VIKRKD 192
Query: 178 YSSKVDMWAMGAI---MAE----LLLFRPLFQGTDEADQMYKICSVLGSPTM---DSWAD 227
Y KVD+W++G + MAE L PL A ++ I + G P + + W
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RA--LFLI-TTKGIPPLKNPEKW-- 242
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
S + + + DP KRP+A E LQHPF K+
Sbjct: 243 ---------------------------SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
Query: 288 C 288
Sbjct: 276 A 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-36
Identities = 63/202 (31%), Positives = 110/202 (54%), Gaps = 17/202 (8%)
Query: 8 KKLGSGSFGCVWQAV--NKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRKLNHPNIVK 63
KKLG G+FG V++ K VA+K LK+ S E+ + L+E + ++KL HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 64 VKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQQLFSESAVK-----AWLFQVFRGLDY 117
+ + E+ ++ V E M +L + + +S + ++ Q+ +G++Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 118 MHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEIL 172
+ + + HRDL N LV +KI+DFGL+R++ Y ++ G RW APE L
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APESL 179
Query: 173 FKSGLYSSKVDMWAMGAIMAEL 194
K G+++SK D+W+ G ++ E+
Sbjct: 180 -KDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 9e-36
Identities = 96/320 (30%), Positives = 153/320 (47%), Gaps = 29/320 (9%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
+++Y K +GSG+ G V A + VAIK L + + + RE+ ++ +NH
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 59 PNIVKV------KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
NI+ + ++ + E +V+ V E M NL Q+++ + +++ L+Q+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM------SYLLYQML 136
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171
G+ ++H G HRDLKP N++V S T+KI DFGLAR T V TR+Y+APE+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ G Y VD+W++G IM E++ LF GTD DQ K+ LG+P +
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 232 AMAINYQFPQLSGVNLSALMPSA------------SEDAINLIESLCSWDPCKRPTAAEA 279
P+ +G + L P + A +L+ + D KR + EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 280 LQHPFFKRCLYVPPHLRSTP 299
LQHP+ Y P + P
Sbjct: 316 LQHPYIN-VWYDPSEAEAPP 334
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-------LREVKCLRKL 56
+ L + +G G+FG V + + ++ A+K + K +KC+ L E + L++L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK----QKCVEKGSVRNVLNERRILQEL 57
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQC-NL-YQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
NHP +V + ++ N++ V + + +L Y L ++ FSE VK W+ ++
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-----SQKVKFSEEQVKFWICEIVLA 112
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF 173
L+Y+H +G HRD+KP+N+L+ QG + I DF +A ++ T GT Y APE+L
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQG-----TDEADQMYKICSVLGSPTMDSWADG 228
+ G YS VD W++G E L + ++G D+ + VL T W
Sbjct: 173 RQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT---W--- 225
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR--PTAAEALQHPFF 285
S +AI+ I L DP KR + HP+F
Sbjct: 226 --------------------------STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 82/286 (28%), Positives = 125/286 (43%), Gaps = 37/286 (12%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSYSREKCLNLREVKCLRKLNHPNI 61
Y + LG G+FG +V K L + +E+ L E+ L L HPNI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ ++ + E LY + +QK QLF E V +LFQ+ + Y+H+
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 121 QGYFHRDLKPENL-LVSQGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGLY 178
G HRD+K N+ L G IK+ DFG+++ + + E VGT +Y +PE L + Y
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE-LCQGVKY 178
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
+ K D+WA+G ++ ELL + F T+ + + KI +P + ++ L
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELIS------- 231
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
L+ SL DP KRPTA E L P
Sbjct: 232 ----------------------LVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 87/294 (29%), Positives = 140/294 (47%), Gaps = 45/294 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E Y L +++GSG++G V++A + +GE+VAIK +K + + +E+ L++ HPNI
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V + + ++ V E C L + + + SE + + +GL Y+H+
Sbjct: 63 VAYFGSYLRRDKLWIVMEY--CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 122 GYFHRDLKPEN-LLVSQGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILF--KSGL 177
G HRD+K N LL G +K+ADFG++ ++ A +GT ++ APE+ + G
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 178 YSSKVDMWAMG--AI-MAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
Y K D+WA+G AI +AEL P+F + M R
Sbjct: 181 YDGKCDIWALGITAIELAELQ--PPMF----DLHPM-------------------RALFL 215
Query: 235 I---NYQFPQLSGVNL-SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
I N+ P+L S + + I+ + DP KRPTA + LQHPF
Sbjct: 216 ISKSNFPPPKLKDKEKWSPVF-------HDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 82/292 (28%), Positives = 146/292 (50%), Gaps = 46/292 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPN 60
E + + +KLG GS+G V++A++K +G+VVAIK + E + +E+ L++ + P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPY 59
Query: 61 IVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IVK + +++ V E C ++ +M+ + +E + A L+Q +GL+Y+H
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLH 116
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGL 177
HRD+K N+L+++ G K+ADFG++ ++ D +GT ++ APE++ + G
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG- 175
Query: 178 YSSKVDMWAMG--AI-MAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
Y++K D+W++G AI MAE +P + ++ I P
Sbjct: 176 YNNKADIWSLGITAIEMAE---GKPPYSDIHPMRAIFMI------PNKPP---------- 216
Query: 235 INYQFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
P LS P S + + ++ DP +RP+A + LQHPF
Sbjct: 217 -----PTLSD-------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 37/287 (12%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIK--ALKKSYSREKCLNLREVKCLRKLNHPN 60
KY KK+G GSFG +K G+ IK + K +E+ + +EV L + HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 61 IVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV+ +E E GN++ V + C +LY+ + A Q+ LF E + W Q+ L ++H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH 118
Query: 120 QQGYFHRDLKPENL-LVSQGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGL 177
+ HRD+K +N+ L GTIK+ DFG+AR +++ +GT +Y +PEI ++
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC-ENRP 177
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y++K D+WA+G ++ E+ + F+ + + + KI I
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---------------------IRG 216
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+P +S S D NL+ L +P RP+ L+ F
Sbjct: 217 SYPPVS--------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 43/287 (14%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNHPNIVKVKE 66
LG G FG V K A+K +KK + E E + L + NHP IVK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 67 LIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFH 125
+K ++ + E C+ L+ ++ + + LF E + ++ V +Y+H +G +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL----RDRGLFDEYTARFYIACVVLAFEYLHNRGIIY 116
Query: 126 RDLKPENLLV-SQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLYSSKVD 183
RDLKPENLL+ S G +K+ DFG A+++ +T GT Y APEI+ G Y VD
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKG-YDFSVD 174
Query: 184 MWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLS 243
W++G ++ ELL RP F DE D M +I + + G + +FP
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDE-DPM-EIYNDI--------LKGNGK-----LEFPNY- 218
Query: 244 GVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFF 285
+ A +LI+ L +P +R + +H +F
Sbjct: 219 ----------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 37/285 (12%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + K+G GSFG V++ V K V A+K L K RE+ + E + L KL+ I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
++ E ++KG + V E +L++L+ K Q+ + E V + Q+ GL ++H
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 121 QGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGLY 178
+ HRD+K NL + +KI D G+A+ + + VGT +Y +PE L + Y
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPY 178
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
+ K D+WA+G ++ E + F ++ + KI I
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKI---------------------IRGV 217
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
FP +S S+ LI+ + D +RP + L++P
Sbjct: 218 FPPVSQ--------MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 81/314 (25%), Positives = 137/314 (43%), Gaps = 84/314 (26%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-----------REV 50
E ++L + +G GSFG V++A++K + +VVAI K ++L +E+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAI----------KVIDLEEAEDEIEDIQQEI 50
Query: 51 KCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLME-------AKKQKQQLFSESA 103
+ L + P I K ++ L+ +ME K E+
Sbjct: 51 QFLSQCRSPYITKYYGSFLK-----------GSKLWIIMEYCGGGSCLDLLKPGKLDETY 99
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-------DAFP 155
+ L +V GL+Y+H++G HRD+K N+L+S +G +K+ADFG++ ++ + F
Sbjct: 100 IAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF- 158
Query: 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICS 215
VGT ++ APE++ +SG Y K D+W++G EL
Sbjct: 159 -----VGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELA-------------------- 192
Query: 216 VLGSPTMDSWADGLRQAMAINYQF-PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP 274
G P + S +R I P L G S+ + + + DP +RP
Sbjct: 193 -KGEPPL-SDLHPMRVLFLIPKNNPPSLEGNKF-------SKPFKDFVSLCLNKDPKERP 243
Query: 275 TAAEALQHPFFKRC 288
+A E L+H F K+
Sbjct: 244 SAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-33
Identities = 64/226 (28%), Positives = 124/226 (54%), Gaps = 21/226 (9%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-----KSYSREKCLNLREVKCLRK 55
+ + + KK+G G F V++A+ G VVA+K ++ + +R+ CL +E+ L++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL--KEIDLLKQ 58
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
L+HPN++K +E + V E +L ++++ K++++L E + + Q+
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 115 LDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAR-----EIDAFPPYTERVGTRWYQA 168
L++MH + HRD+KP N+ ++ G +K+ D GL R A VGT +Y +
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 174
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214
PE + ++G Y+ K D+W++G ++ E+ + F G D+ + +Y +C
Sbjct: 175 PERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYG-DKMN-LYSLC 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 90/297 (30%), Positives = 142/297 (47%), Gaps = 50/297 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----SREKCLN-LREVKCLRKL 56
+ ++ +++G GSFG V+ A + + EVVAIK K SY S EK + ++EV+ L++L
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQQL 72
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HPN ++ K + + + V E + ++E K+ Q E + A +GL
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ---EVEIAAICHGALQGLA 129
Query: 117 YMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF-- 173
Y+H HRD+K N+L+++ GT+K+ADFG A + P VGT ++ APE++
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSFVGTPYWMAPEVILAM 186
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFR-PLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
G Y KVD+W++G EL + PLF M+ A
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLF-------------------NMN--------A 219
Query: 233 MAINYQFPQLSGVNLSALMPSA--SEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
M+ Y Q N S + S S+ N ++S P RP++ E L+H F R
Sbjct: 220 MSALYHIAQ----NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 88/293 (30%), Positives = 140/293 (47%), Gaps = 45/293 (15%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS-----YSREKCLNLREVKCLRKLN 57
+Y L ++LG GSFG V+ +K + +K LK+ E +E + L KL+
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HP IVK +E+ + E C +L +E K + SE+ V W Q+ G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 117 YMHQQGYFHRDLKPENLLVSQGTIKIADFGLAR----EIDAFPPYTERVGTRWYQAPEIL 172
YMHQ+ HRDLK +N+ + +KI DFG++R D +T GT +Y +PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEAL 177
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLG-SPTMDSWADGLRQ 231
G Y SK D+W++G I+ E+ F+G + + +I V G +P++
Sbjct: 178 KHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI--VEGPTPSL--------- 225
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
P+ L+++M +S+ + DP RP+AAE L++PF
Sbjct: 226 --------PETYSRQLNSIM-----------QSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 88/289 (30%), Positives = 140/289 (48%), Gaps = 38/289 (13%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIK--ALKKSYSREKCLNLREVKCLRKLNHPN 60
+Y + KK+G GSFG ++ A K E IK L K +EK + +EV L K+ HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLME-AKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV E G +F V E C+ LM+ +Q+ LFSE + +W Q+ GL ++H
Sbjct: 61 IVTFFASFQENGRLFIVME--YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 120 QQGYFHRDLKPENLLVSQGTI--KIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSG 176
+ HRD+K +N+ +S+ + K+ DFG+AR+++ VGT +Y +PEI ++
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC-QNR 177
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y++K D+W++G ++ EL + F+G + + KIC +P
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---------------- 221
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+ P+ S D +LI L P RP+ L+ PF
Sbjct: 222 -------------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 80/292 (27%), Positives = 128/292 (43%), Gaps = 33/292 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR-EVKCLRKLNHPN 60
+ Y L + +G G+ V+ A+ + E VAIK + + LR EV+ + + NHPN
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+VK V ++ V + +L +M+ + E+ + L +V +GL+Y+H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER-----VGTRWYQAPEILF 173
G HRD+K N+L+ + G++KIADFG++ + T + VGT + APE++
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+ Y K D+W+ G EL + K P M +
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY---------SKY------PPMKVL------ML 218
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+ P L A S+ +I DP KRPTA E L+H FF
Sbjct: 219 TLQNDPPSL---ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 84/304 (27%), Positives = 137/304 (45%), Gaps = 70/304 (23%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKAL---KKSYSREKCLNLREVKCLRK-------LNHP 59
+G G++G V+ A+N +GE++A+K + R VK LR L+H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 60 NIVKVKELIVEKGNVFF-----------VFECMQCNLYQLMEAKKQKQQLFSESAVKAWL 108
NIV+ L E + + C++ + F E V+ +
Sbjct: 69 NIVQY--LGFETTEEYLSIFLEYVPGGSIGSCLR------TYGR------FEEQLVRFFT 114
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLARE----IDAFPPYTERVGT 163
QV GL Y+H +G HRDLK +NLLV G KI+DFG++++ D + + G+
Sbjct: 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GS 173
Query: 164 RWYQAPEILFKSGL-YSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQ-MYKICSVLGSP 220
++ APE++ YS+KVD+W++G ++ E+ RP +EA M+K+ +
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIAAMFKLGN----- 226
Query: 221 TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280
R A I P + + S A++ + + + +P RPTA E L
Sbjct: 227 --------KRSAPPI----P-------PDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
Query: 281 QHPF 284
QHPF
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-32
Identities = 86/293 (29%), Positives = 148/293 (50%), Gaps = 52/293 (17%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALK------KSYSREKCLN---LREVKCLRKLNHPN 60
+GSGSFG V+ +N SGE++A+K ++ S R++ + RE+ L++L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV+ ++ ++ E + + F E+ V+ ++ Q+ +GL+Y+H
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAAL---LNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 121 QGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTR-------WYQAPEIL 172
+G HRD+K N+LV ++G IKI+DFG++++++A T+ G R ++ APE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
K Y+ K D+W++G ++ E+L + F + ++KI
Sbjct: 185 -KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI------------------- 224
Query: 233 MAINYQFPQLSGVNLSALMPS-ASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
G N S +PS S +AI+ +E D KRPTAAE L+HPF
Sbjct: 225 -----------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 80/294 (27%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVKVK 65
+LG+G+ G V + +++ +G+++A+K ++ E LRE+ L K N P IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 66 ELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYF 124
G++ E M L + K+ Q E + V +GL Y+H++
Sbjct: 66 GAFYNNGDISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 125 HRDLKPENLLV-SQGTIKIADFGLAREI-----DAFPPYTERVGTRWYQAPEILFKSGLY 178
HRD+KP N+LV S+G IK+ DFG++ ++ F VGT Y APE + + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------VGTSSYMAPERI-QGNDY 176
Query: 179 SSKVDMWAMGAIMAELLLFR-PLFQGTDEA----DQMYKICSVLGSPTMDSWADGLRQAM 233
S K D+W++G + EL R P D + + I
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-------------------- 216
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+N P+L S D + + DP +RP+ E L+HPF K+
Sbjct: 217 -VNEPPPRLPSGKF-------SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 74/286 (25%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL--KKSYSREKCLNLREVKCLRKLNHPN 60
KY + +G G+FG V K ++V IK + ++ E+ E + L+ L+HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
I++ E +E + V E L + ++ K+ L E + + Q+ L ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 120 QQGYFHRDLKPENLLVS--QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
+ HRDLK +N+L+ + +KI DFG+++ + + VGT Y +PE+ +
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC-EGKP 177
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y+ K D+WA+G ++ EL + F+ + + KI S +P D ++ LRQ
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ------ 231
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
LI S+ + DP KRP ++ + P
Sbjct: 232 -----------------------LILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 48/289 (16%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS----REKCLN-LREVKCLRKLNHPNIVK 63
++G GSFG V+ A N H+ EVVA+K K SYS EK + ++EVK L++L HPN ++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVK--KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
K +++ + V E + L+E K+ Q E + A +GL Y+H
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAITHGALQGLAYLHSHNM 142
Query: 124 FHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF--KSGLYSS 180
HRD+K N+L+++ G +K+ADFG A + P VGT ++ APE++ G Y
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDG 199
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS--WADGLRQAMAINYQ 238
KVD+W++G EL +P + +Y I SPT+ S W D R ++Y
Sbjct: 200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWTDSFRG--FVDYC 256
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
++ P +RP +AE L+H F +R
Sbjct: 257 LQKI---------------------------PQERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 92/310 (29%), Positives = 140/310 (45%), Gaps = 63/310 (20%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCL----RKL----NHP 59
K LG GSFG V A K + E+ A+K LKK + L +V+C R L HP
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKK----DVILQDDDVECTMTEKRVLALAGKHP 56
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+ ++ K +FFV E N LM Q+ F E + + ++ GL ++H
Sbjct: 57 FLTQLHSCFQTKDRLFFVME--YVNGGDLM-FHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 120 QQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV--GTRWYQAPEILFKSG 176
++G +RDLK +N+L+ S+G IKIADFG+ +E T GT Y APEIL
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEIL-SYQ 171
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y VD WA+G ++ E+L + F+G DE + I +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI-------------------LEDE 212
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEAL-QHPFFK----- 286
++P+ S++A ++++S + +P KR PT + + HPFF+
Sbjct: 213 VRYPR-----------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261
Query: 287 ---RCLYVPP 293
R PP
Sbjct: 262 KLERKEIKPP 271
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 88/332 (26%), Positives = 136/332 (40%), Gaps = 77/332 (23%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKAL-KKSYSREKCLN--LREVKCLRKLNHPNIVKV 64
K LG G G V+ K +G++ A+K L KK + + L E + L L+HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 65 KELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+ + V + C L++L+ ++Q + SE + + +V L+Y+H G
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALEYLHLLGI 124
Query: 124 FHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER---------------------- 160
+RDLKPEN+L+ + G I ++DF L+++ D PP +
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 161 --------VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYK 212
VGT Y APE++ G + S VD W +G ++ E+L F+G++ +
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN 243
Query: 213 ICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK 272
I L FP V S A +LI L DP K
Sbjct: 244 I---LKKEVT----------------FPGSPPV---------SSSARDLIRKLLVKDPSK 275
Query: 273 R----PTAAEALQHPFFK-------RCLYVPP 293
R AAE QHPFF+ R P
Sbjct: 276 RLGSKRGAAEIKQHPFFRGVNWALIRHTTPPI 307
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 70/244 (28%), Positives = 126/244 (51%), Gaps = 19/244 (7%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSG--EVVAIKAL--------KKSYSREKCLN--LREVK 51
Y++ + LGSG+FGCV++ V K + ++A+K + K R+K + + EV
Sbjct: 2 YAVLEHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 52 CLRK-LNHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLF 109
+++ L HPNIV+ + +E ++ V + ++ L + + K+K+Q F+E +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 110 QVFRGLDYMHQQGYF-HRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGTRWYQ 167
Q+ L Y+H++ HRDL P N+++ + + I DFGLA++ T VGT Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS-WA 226
PEI+ K+ Y K D+WA G I+ ++ +P F T+ KI + P + ++
Sbjct: 181 CPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 227 DGLR 230
+ +
Sbjct: 240 EDVT 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 70/222 (31%), Positives = 120/222 (54%), Gaps = 7/222 (3%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR-EVKCLRKLNHPNI 61
+Y++ + +G GSFG + +S + A+K ++ S + R E L K+ HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V KE G+++ V E C +L Q + K Q+ +LF E + W Q+ G+ ++H+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQ--KIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT-ERVGTRWYQAPEILFKSGLY 178
+ HRD+K +N+ ++Q G +K+ DFG AR + + Y VGT +Y PEI +++ Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI-WENMPY 177
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220
++K D+W++G I+ EL + FQ + + K+C P
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-29
Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 44/292 (15%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLN-LREVKCLRKLNHPN 60
++ +++G GSFG V+ A + + EVVAIK + S S EK + ++EVK L+++ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
++ K + + + V E + L+E K+ Q E + A +GL Y+H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAITHGALQGLAYLHS 143
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF--KSGL 177
HRD+K N+L+++ G +K+ADFG A P VGT ++ APE++ G
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQ 200
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS--WADGLRQAMAI 235
Y KVD+W++G EL +P + +Y I SPT+ S W+D R
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSDYFR----- 254
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
N ++S P RPT+ E L+H F R
Sbjct: 255 ------------------------NFVDSCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 83/294 (28%), Positives = 128/294 (43%), Gaps = 55/294 (18%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNH-----PN 60
K + G+FG V+ A + +G+ AIK LKKS ++ + N VK R + P
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN---VKAERAIMMIQGESPY 58
Query: 61 IVKVKELIVEKGNVFFVFECMQ---CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+ K+ K ++ V E + C + + E K ++ +V G++
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDC------ASLIKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 118 MHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
+HQ+G HRD+KPENLL+ Q G +K+ DFGL+R + VGT Y APE + G
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVG 169
Query: 177 LYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
D W++G ++ E L + P T +A + + L + I
Sbjct: 170 -DDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----------------VFDNILSR--RI 210
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA---AEALQHPFFK 286
N+ + S +A++LI L DP KR A E HPFFK
Sbjct: 211 NWP---------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 88/332 (26%), Positives = 146/332 (43%), Gaps = 90/332 (27%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVK-CLRKLNH 58
+ + + K +G G+FG VW +K +G+V A+K L+KS R + ++R + L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESAVKAWLFQ 110
P IVK+ ++ F+ + +LY +ME ++ +F E + ++ +
Sbjct: 61 PWIVKL----------YYSFQ-DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE 109
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREID----------------- 152
+ LD +H+ G+ HRD+KP+N+L+ + G IK+ADFGL ++++
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 153 ------AFPPYTER-------VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRP 199
+ +R VGT Y APE+L + Y + D W++G I+ E+L P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFP 228
Query: 200 LFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ----FPQLSGVNLSALMPSAS 255
F + KI IN++ FP V S
Sbjct: 229 PFYSDTLQETYNKI---------------------INWKESLRFPPDPPV---------S 258
Query: 256 EDAINLIESLCSWDPCKRPTAAE-ALQHPFFK 286
+AI+LI L DP R + E HPFFK
Sbjct: 259 PEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-28
Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 40/288 (13%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL--KKSYSREKCLNLREVKCLRKLNHPNI 61
Y + +G GS+G V ++ G+ IK L + + RE+ +E + L +L HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 62 VKVKELIV-EKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
V +E E G ++ V C +LY + K+QK +L E+ V W Q+ L Y+H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSGL 177
++ HRDLK +N+ +++ IK+ D G+AR ++ + +GT +Y +PE LF +
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKP 178
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y+ K D+WA+G + E+ + F D +Y+I I
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI---------------------IEG 217
Query: 238 QFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+ P MP S + LI ++ S P KRP+ L+ P+
Sbjct: 218 KLPP---------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 39/304 (12%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
Y++ K L GS G V+ A + V +K +K + L E L+ +NHP++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIR 121
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+K+ +V V +LY + + + + ++ Q+ GL Y+H Q
Sbjct: 122 MKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK---QILEGLRYLHAQRI 178
Query: 124 FHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKV 182
HRD+K EN+ + + I D G A+ P + GT APE+L + Y+SK
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDK-YNSKA 237
Query: 183 DMWAMGAIMAELL-----LFRPLFQGTDEA-----DQMYKICSVLG--------SPTMDS 224
D+W+ G ++ E+L +F +E + KI S L P
Sbjct: 238 DIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL 297
Query: 225 WADGLRQAMAINY---QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ A ++P VNL D L+ + ++D RP+A E L
Sbjct: 298 VRGFIEYASLERQPYTRYPCFQRVNL-------PIDGEFLVHKMLTFDAAMRPSAEEILN 350
Query: 282 HPFF 285
+P F
Sbjct: 351 YPMF 354
|
Length = 357 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 75/222 (33%), Positives = 122/222 (54%), Gaps = 14/222 (6%)
Query: 8 KKLGSGSFGCVW---QAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIV 62
K LG GSFG V+ + +G++ A+K LKK+ R++ E L ++NHP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 63 KVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K+ +G ++ + + ++ +L+ + K+ +F+E VK +L ++ LD++H
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLF----TRLSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYS 179
G +RDLKPEN+L+ + G IK+ DFGL++E ID GT Y APE++ + G ++
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HT 176
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC-SVLGSP 220
D W+ G +M E+L FQG D + M I + LG P
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 84/294 (28%), Positives = 135/294 (45%), Gaps = 54/294 (18%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKAL----KKSYSREKCLNLREVKCLRKLNHPNIVK 63
++GSG+ G V++ +++ +G + A+K + + + R+ C RE++ LR +NHPN+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQIC---REIEILRDVNHPNVVK 136
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
++ G + + E M L +Q ++ A Q+ G+ Y+H++
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGG--SLEGTHIADEQFLADVA-----RQILSGIAYLHRRHI 189
Query: 124 FHRDLKPENLLV-SQGTIKIADFGLAREID-AFPPYTERVGTRWYQAPEIL---FKSGLY 178
HRD+KP NLL+ S +KIADFG++R + P VGT Y +PE + G Y
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 179 SSKV-DMWAMGAIMAELLLFRPLF----QGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
D+W++G + E L R F QG D A M IC M
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAIC------------------M 290
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ + P +AS + + I +P KR +A + LQHPF R
Sbjct: 291 SQPPEAP-----------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333
|
Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 40/286 (13%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSYSREKCLNLREVKCLRKLNHPNIVKVK 65
K+G GS G V A +K +G VA+K L+K RE N EV +R HPNIV++
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN--EVVIMRDYQHPNIVEMY 82
Query: 66 ELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ ++ V E ++ L ++ + +E + V + L ++H QG
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFLHAQGVI 137
Query: 125 HRDLKPEN-LLVSQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLYSSKV 182
HRD+K ++ LL S G +K++DFG ++ P VGT ++ APE++ + Y ++V
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEV 196
Query: 183 DMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242
D+W++G ++ E++ P + M +I D+ L+ ++ P+L
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--------RDNLPPKLKNLHKVS---PRL 245
Query: 243 SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
++ + DP +R TAAE L HPF +
Sbjct: 246 RS----------------FLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNL-REVKCLRKLNHPNIVKV 64
+++G GSFG V+ A + + EVVAIK + S S EK ++ +EV+ L+KL HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ + + + V E + L+E K+ Q E + A +GL Y+H
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAVTHGALQGLAYLHSHNMI 137
Query: 125 HRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF--KSGLYSSK 181
HRD+K N+L+S+ G +K+ DFG A P VGT ++ APE++ G Y K
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 182 VDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS--WADGLRQAMAINYQF 239
VD+W++G EL +P + +Y I SP + S W++ R
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPALQSGHWSEYFR--------- 244
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
N ++S P RPT+ L+H F R
Sbjct: 245 --------------------NFVDSCLQKIPQDRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 71/251 (28%), Positives = 131/251 (52%), Gaps = 20/251 (7%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKA-----LKKSYSREKCLNLREVKCLRK 55
+ + + KK+G G F V++A G VA+K L + +R C+ +E+ L++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQ 58
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
LNHPN++K +E + V E +L ++++ K++++L E V + Q+
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 115 LDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEIL 172
L++MH + HRD+KP N+ ++ G +K+ D GL R + VGT +Y +PE +
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGS---PTM--DSWAD 227
++G Y+ K D+W++G ++ E+ + F G + +Y +C + P + D +++
Sbjct: 179 HENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSE 235
Query: 228 GLRQA--MAIN 236
LRQ M IN
Sbjct: 236 ELRQLVNMCIN 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 48/295 (16%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALK-----KSYSREKCLNLR-EVKCLRKLNHPNI 61
++LG+G+F +QA + +G ++A+K + S E LR E++ + +LNHP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+++ E + E M + +K F E+ + + Q+ RGL Y+H+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN 122
Query: 122 GYFHRDLKPENLLV-SQGT-IKIADFGLAREIDAFPPYT-----ERVGTRWYQAPEILFK 174
HRD+K NLL+ S G ++IADFG A + A + +GT + APE+L +
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL-R 181
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ---MYKICSVLGSPTMDSWADGLRQ 231
Y D+W++G ++ E+ +P + ++ ++KI S +P++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP-------- 233
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
L P + + +E P RP + E L+HP F+
Sbjct: 234 ----------------EHLSPGLRDVTLRCLEL----QPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 80/281 (28%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV 69
LG G++G V+ A + + +AIK + + SR E+ L H NIV+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 70 EKGNV-FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL 128
E G F+ + +L L+ +K + +E + + Q+ GL Y+H HRD+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 129 KPENLLVS--QGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGL--YSSKVD 183
K +N+LV+ G +KI+DFG ++ + P TE GT Y APE++ K G Y + D
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK-GPRGYGAPAD 193
Query: 184 MWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLS 243
+W++G + E+ +P F LG P + G+ I+ + P+
Sbjct: 194 IWSLGCTIVEMATGKPPFIE-------------LGEPQAAMFKVGM---FKIHPEIPE-- 235
Query: 244 GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
S S +A N I DP KR +A + LQ PF
Sbjct: 236 ---------SLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 82/299 (27%), Positives = 140/299 (46%), Gaps = 54/299 (18%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKLNH 58
+ + ++G G +G V+ A K +GE+VA+K +KKS L R++ L
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI--LTTTKS 60
Query: 59 PNIVKVKELIVEKGNVF----FV----FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
+VK+ + ++ +V F + NL L SE + ++ +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVL-----------SEDHARFYMAE 109
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+F +D +H+ GY HRDLKPEN L+ G IK+ DFGL++ I + VG+ Y AP
Sbjct: 110 MFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA--NSVVGSPDYMAP 167
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
E+L G Y VD W++G ++ E L P F G ++ ++ + W + L
Sbjct: 168 EVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWE--------NLKYWKETL 217
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ-HPFFKR 287
++ + + +F + S++A +LI + DP +R + E ++ HPFFK
Sbjct: 218 QRPVYDDPRF-------------NLSDEAWDLI-TKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 49/299 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + + +LG G+FG V++A +K +G A K ++ E + E+ L + HPNI
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI 64
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V + E + ++ + E C L +M ++ +E ++ Q+ L+++H
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFG----LAREI---DAFPPYTERVGTRWYQAPEIL 172
HRDLK N+L++ G +K+ADFG + D F +GT ++ APE++
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF------IGTPYWMAPEVV 175
Query: 173 ----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
FK Y K D+W++G + EL P + + KI PT+D
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-EPPTLDQ---- 230
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
P + + + S DP RPTAAE L+HPF
Sbjct: 231 -----------PSKWSSSFNDFLKSCLVK-----------DPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 30/204 (14%)
Query: 5 SLTKKLGSGSFGCV----WQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
+ K+LGSG FG V W+ VAIK +++ E + E K + KL+HPN
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKID-----VAIKMIREGAMSEDDF-IEEAKVMMKLSHPN 60
Query: 61 IVKVKELIVEKGNVFFVFECMQ--C--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+V++ + ++ +F V E M C N + + K + L + V ++
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS------DVCEAME 114
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREI--DAFPPYTERVGTRW---YQAPE 170
Y+ G+ HRDL N LV +K++DFGLAR + D YT GT++ + PE
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPE 171
Query: 171 ILFKSGLYSSKVDMWAMGAIMAEL 194
+ F +SSK D+W+ G +M E+
Sbjct: 172 V-FDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSYSREKCLNLREVKCLRKLNHPNIVKVKE 66
K+G GS G V A KHSG VA+K L+K RE N EV +R H N+V++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN--EVVIMRDYQHQNVVEMYK 85
Query: 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126
+ ++ + E +Q + + Q +E + V + L Y+H QG HR
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 127 DLKPENLLVS-QGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSGLYSSKVDM 184
D+K +++L++ G +K++DFG +I P VGT ++ APE++ ++ Y ++VD+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDI 200
Query: 185 WAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244
W++G ++ E++ P + ++D QAM P
Sbjct: 201 WSLGIMVIEMVDGEPPY-----------------------FSDSPVQAMKRLRDSPPPKL 237
Query: 245 VNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
N + P + +E + + +P +R TA E L HPF +
Sbjct: 238 KNAHKISPVLRD----FLERMLTREPQERATAQELLDHPFLLQT 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 23/204 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
E L +KLG+G FG VW N + VA+K LK + L+E + ++KL H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAF-LQEAQIMKKLRHDK 62
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLM---EAKKQK-QQLFSESAVKAWLFQVFRGL 115
+V++ + E+ ++ V E M +L + E KK + QL +A Q+ G+
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA------QIAEGM 116
Query: 116 DYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPE- 170
Y+ + Y HRDL N+LV + + KIADFGLAR I+ YT R G ++ + APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPEA 175
Query: 171 ILFKSGLYSSKVDMWAMGAIMAEL 194
+ G ++ K D+W+ G ++ E+
Sbjct: 176 ANY--GRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLNHPNIVKVKE 66
LG G FG V K +G++ A K L K +++ + L E K L K++ IV +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 67 LIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K ++ V M + ++Y + E F E+ + Q+ GL+++HQ+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG------FPEARAIFYAAQIICGLEHLHQR 114
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RDLKPEN+L+ G ++I+D GLA E+ R GT Y APE+L + +Y
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL-QGEVYDF 173
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
VD +A+G + E++ R F+ E + ++ MA+ Y
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------------KRRTLEMAVEYP-- 218
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFFK 286
S +A +L E+L DP KR +A E +HP FK
Sbjct: 219 -----------DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 87/294 (29%), Positives = 131/294 (44%), Gaps = 56/294 (19%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVK--------CLRKLNHP 59
K +G GSFG V A +K G+ A+K L+K +K +E K L+ + HP
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNVLLKNVKHP 56
Query: 60 NIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+V + ++FV + + + L Q+++ F E + + ++ L Y
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGY 111
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKS 175
+H +RDLKPEN+L+ SQG + + DFGL +E I+ + GT Y APE+L K
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
Y VD W +GA++ E+L P F D A +MY ++L P LR
Sbjct: 172 P-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-EMYD--NILNKP--------LR----- 214
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ----HPFF 285
L P+ S A +L+E L D KR A + H FF
Sbjct: 215 --------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-25
Identities = 59/211 (27%), Positives = 116/211 (54%), Gaps = 11/211 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-----KSYSREKCLNLREVKCLRK 55
+ + + KK+G G F V++A + VA+K ++ + +R+ C+ +E+ L++
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV--KEIDLLKQ 58
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
LNHPN++K + +E + V E +L Q+++ K++++L E V + Q+
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 115 LDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEIL 172
+++MH + HRD+KP N+ ++ G +K+ D GL R + VGT +Y +PE +
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQG 203
++G Y+ K D+W++G ++ E+ + F G
Sbjct: 179 HENG-YNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 85/294 (28%), Positives = 135/294 (45%), Gaps = 50/294 (17%)
Query: 8 KKLGSGSFGCVWQA---VNKHSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNHPN 60
K LG G +G V+Q +G++ A+K LKK+ ++ E L + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV + G ++ + E + L+ +E ++ +F E +L ++ L+++H
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLH 117
Query: 120 QQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGL 177
QQG +RDLKPEN LL +QG +K+ DFGL +E T GT Y APEIL +SG
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG- 176
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
+ VD W++GA+M ++L P F + + KI L+ +
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI---------------LKGKL---- 217
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEALQ-HPFFK 286
L P + +A +L++ L +P R P A +Q HPFF+
Sbjct: 218 -----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 87/291 (29%), Positives = 126/291 (43%), Gaps = 50/291 (17%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVK----CLRKLNHPNIVK 63
LG G FG V A K +GE+ AIKALKK +R++ +L K HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+ + +V FV E LM FSE + V GL Y+H+
Sbjct: 67 LFACFQTEDHVCFVMEYAAGG--DLMMHIHTDV--FSEPRAVFYAACVVLGLQYLHENKI 122
Query: 124 FHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGLYSSK 181
+RDLK +NLL+ +G +KIADFGL +E F T GT + APE+L ++ Y+
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRA 181
Query: 182 VDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241
VD W +G ++ E+L+ F G DE + I
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI---------------------------- 213
Query: 242 LSGVNLSALMP-SASEDAINLIESLCSWDPCKR----PTAAEALQ-HPFFK 286
VN P S +AI+++ L +P +R AE ++ PFF+
Sbjct: 214 ---VNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 93/347 (26%), Positives = 149/347 (42%), Gaps = 95/347 (27%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLR-EVKCLRKLNHPNIVKV 64
K +G G+FG V K +G + A+K L+KS +E+ ++R E L + ++P +VK+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 65 KELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESAVKAWLFQVFRGLD 116
++ F+ LY +ME K+ F+E + ++ + +D
Sbjct: 67 ----------YYSFQDEN-YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAID 115
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGL------------AREIDAFPPYTER--- 160
+H+ GY HRD+KP+NLL+ ++G IK++DFGL R + P
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 161 ------------------------VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL 196
VGT Y APE+ ++G Y+ + D W++G IM E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLV 234
Query: 197 FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASE 256
P F + + KI +W + L QFP V L S
Sbjct: 235 GYPPFCSDNPQETYRKII---------NWKETL--------QFPD--EVPL-------SP 268
Query: 257 DAINLIESLCSWDPCKR---PTAAEALQHPFFKRCLYVPPHLRSTPA 300
+A +LI+ LC + +R E HPFFK + H+R PA
Sbjct: 269 EAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW--EHIRERPA 312
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKV 64
K LG G+FG V K +G+ A+K LKK E L E + L+ HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
K + FV E N +L ++++FSE + + ++ L Y+H
Sbjct: 61 KYSFQTHDRLCFVME--YANGGELF-FHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 125 HRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGLYSSKV 182
+RDLK ENL++ + G IKI DFGL +E + + GT Y APE+L + Y V
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAV 176
Query: 183 DMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242
D W +G +M E++ R F D ++++++ + +FP+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI------------------LMEEIRFPR- 216
Query: 243 SGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFF 285
+ S +A +L+ L DP +R A E ++H FF
Sbjct: 217 ----------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 10 LGSGSFGCVWQAVNKH-----SGEV-VAIKALKK-SYSREKCLNLREVKCLRKLNHPNIV 62
LGSG+FG V++ SG + VA+K L+K + +EK L+E + NHPNIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 63 KVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQ--LFSESAVKAWLFQVFRGLDYM 118
K+ + + + + E M+ L L +A+ ++ L + + V +G Y+
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 119 HQQGYFHRDLKPENLLVSQG------TIKIADFGLAREIDAFPPYTER----VGTRWYQA 168
Q + HRDL N LVS+ +KI DFGLAR+I Y + + RW A
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW-MA 181
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLF 197
PE L G ++++ D+W+ G +M E+L
Sbjct: 182 PESLLD-GKFTTQSDVWSFGVLMWEILTL 209
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-24
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKV 64
+L +++GSG FG VW +V AIK +++ E+ + E + + KL+HP +V++
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDF-IEEAQVMMKLSHPKLVQL 64
Query: 65 KELIVEKGNVFFVFECMQ--CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ E+ + VFE M+ C L + + ++ FS+ + V G+ Y+
Sbjct: 65 YGVCTERSPICLVFEFMEHGC----LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 123 YFHRDLKPENLLVSQGT-IKIADFGLAREIDAFPPYTERVGTRW---YQAPEILFKSGLY 178
HRDL N LV + +K++DFG+ R YT GT++ + +PE+ F Y
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEV-FSFSKY 178
Query: 179 SSKVDMWAMGAIMAEL 194
SSK D+W+ G +M E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 21/202 (10%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVK 65
L +KLG+G FG VW+ + ++ V A+K LK K L E + ++KL HP ++++
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPKDF-LAEAQIMKKLRHPKLIQLY 67
Query: 66 ELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQ----QLFSESAVKAWLFQVFRGLDYMHQ 120
+ + ++ V E M +L + ++ + QL +A QV G+ Y+
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA------QVASGMAYLEA 121
Query: 121 QGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPE-ILFKS 175
Q Y HRDL N+LV + I K+ADFGLAR I Y R G ++ + APE L+
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNR 180
Query: 176 GLYSSKVDMWAMGAIMAELLLF 197
+S K D+W+ G ++ E++ +
Sbjct: 181 --FSIKSDVWSFGILLTEIVTY 200
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 88/313 (28%), Positives = 136/313 (43%), Gaps = 57/313 (18%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SR-EKCLNLREVKCLRKLNHPNIVKVKE 66
+G GSFG V Q + + + A+K ++K++ SR E L E L ++N P IV +K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 67 LIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
++ V + + L Q++ F S + + ++ L+ +H+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 125 HRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGLYSSKV 182
+RDLKPEN+L+ QG I + DFGL + T GT Y APE+L G Y+ V
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAV 174
Query: 183 DMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242
D W +G ++ E+L P F + ++MY+ +L P + DG
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--FPDGFD------------ 217
Query: 243 SGVNLSALMPSASEDAINLIESLCSWDPCKR---PTAAEALQHPFF-----KRCL---YV 291
DA +L+ L S DP +R A E HPFF K+ L
Sbjct: 218 -------------RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQ 264
Query: 292 PPHLRSTPAVAAT 304
PP PAV++
Sbjct: 265 PPF---KPAVSSA 274
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 91/305 (29%), Positives = 139/305 (45%), Gaps = 65/305 (21%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
++ LG GSFG V A K + E+ AIK LKK + + +V+C +V+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKK----DVIIQDDDVEC-------TMVE 50
Query: 64 VKELIVEKGNVFFV--FECMQC--NLYQLMEAKK------QKQQL--FSESAVKAWLFQV 111
+ L + F C Q LY +ME QQ+ F E + ++
Sbjct: 51 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI 110
Query: 112 FRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV--GTRWYQA 168
GL ++H +G +RDLK +N+++ ++G IKIADFG+ +E + F T R GT Y A
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPDYIA 169
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PEI+ Y VD WA G ++ E+L +P F G DE D
Sbjct: 170 PEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------------------DE 208
Query: 229 LRQA-MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEALQ-H 282
L Q+ M N +P+ S S++A+++ + L + P KR PT ++ H
Sbjct: 209 LFQSIMEHNVSYPK-----------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257
Query: 283 PFFKR 287
FF+R
Sbjct: 258 AFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 7e-24
Identities = 73/213 (34%), Positives = 108/213 (50%), Gaps = 22/213 (10%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCL----RKL----NHP 59
K LG GSFG V A K + EV AIK LKK + L +V C R L HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKK----DVILQDDDVDCTMTEKRILALAAKHP 56
Query: 60 NIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+ + K +FFV E + ++Q+ ++K F E + + +V L +
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMF 111
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKS 175
+H+ G +RDLK +N+L+ ++G K+ADFG+ +E I T GT Y APEIL +
Sbjct: 112 LHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL-QE 170
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD 208
Y VD WA+G +M E++ +P F+ +E D
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 7e-24
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 30/206 (14%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVK-------CLRKLNHPNIV 62
LG+GSFG V A +K +GE AIK LKK + L +++V+ L +L+HP IV
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKK----REILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 63 KVKELIVEKGNVFFVFE-CMQCNLY-QLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ ++ V+F+ E + L+ L +A + F K + ++ +Y+H
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----FPNDVAKFYHAELVLAFEYLHS 136
Query: 121 QGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV----GTRWYQAPEILFKS 175
+ +RDLKPENLL+ ++G +K+ DFG A+++ +R GT Y APE++
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTPEYLAPEVIQSK 190
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLF 201
G + VD W MG ++ E + P F
Sbjct: 191 G-HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-24
Identities = 62/201 (30%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR----EVKCLRKLN 57
E+++L +KLGSG FG VW+ + K+ V AIK LK + L + EV+ L++L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILK----SDDLLKQQDFQKEVQALKRLR 60
Query: 58 HPNIVKVKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
H +++ + + V+ + E M + +L + + + + + A QV G+
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC--QVAEGMA 118
Query: 117 YMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREI--DAFPPYTERVGTRWYQAPEILF 173
Y+ +Q HRDL N+LV + + K+ADFGLAR I D + +++ +W APE
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPEAA- 176
Query: 174 KSGLYSSKVDMWAMGAIMAEL 194
G +S+K D+W+ G ++ E+
Sbjct: 177 SHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-24
Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 60/297 (20%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIK---------ALKKSYSREKCLNLREVKCLRKLNH 58
K LG G+FG V+ + +G +A+K KK + +C E++ L+ L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC----EIQLLKNLQH 63
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQL-----FSESAVKAWLFQVFR 113
IV+ + + + E M K QL +E+ + + Q+
Sbjct: 64 ERIVQYYGCLRDDETLSIFME--------YMPGGSVKDQLKAYGALTETVTRKYTRQILE 115
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV----GTRWYQA 168
G++Y+H HRD+K N+L S G +K+ DFG ++ + + GT ++ +
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PE++ G Y K D+W++G + E+L +P + E + M I + PT
Sbjct: 176 PEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPT------- 224
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
N Q P S DA N + + KRP+A E L+H F
Sbjct: 225 -------NPQLP-----------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 83/294 (28%), Positives = 126/294 (42%), Gaps = 54/294 (18%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVK-CLRKLNHPNIVKVKE 66
+G G FG V K +G++ A+K +KKS ++E E + L N P I +++
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126
+K N++ V E L+ + + F E + +L ++ + +HQ GY HR
Sbjct: 69 AFQDKDNLYLVMEYQPGG--DLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 127 DLKPENLLVSQ-GTIKIADFGLAREIDA----FPPYTERVGTRWYQAPEIL-----FKSG 176
D+KPEN+L+ + G IK+ADFG A + A VGT Y APE+L G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNS--KLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y + D W++G I E++ R F A I +N
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI---------------------MN 223
Query: 237 YQ----FPQLSGVNLSALMPSASEDAINLIESL-CSWDPCKRPTAAEALQHPFF 285
+Q FP+ P S D ++LI+SL C +R HPFF
Sbjct: 224 FQRFLKFPE---------DPKVSSDFLDLIQSLLCG--QKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 77/287 (26%), Positives = 137/287 (47%), Gaps = 39/287 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR-EVKCLRKLNHPN 60
E ++ +++G GSFG V++ ++ + +VVAIK + + ++ +++ E+ L + + P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+ K ++ ++ + E + + L+ A F E + L ++ +GLDY+H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLH 118
Query: 120 QQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGL 177
+ HRD+K N+L+S QG +K+ADFG+A ++ D VGT ++ APE++ +S
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA- 177
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y SK D+W++G EL P P D M + +
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--------------------PNSD------MHPMRVLF 211
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
P+ N L S+ I++ + DP RPTA E L+H F
Sbjct: 212 LIPKN---NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 40/289 (13%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSYSREKCLNLREVKCLRKLNHPNIVKVKE 66
K+G GS G V A KH+G+ VA+K L+K RE N EV +R +H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN--EVVIMRDYHHENVVDMYN 86
Query: 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126
+ ++ V E ++ + + +E + V R L Y+H QG HR
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 127 DLKPEN-LLVSQGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSGLYSSKVDM 184
D+K ++ LL S G IK++DFG ++ P VGT ++ APE++ + Y ++VD+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDI 201
Query: 185 WAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244
W++G ++ E++ P + M +I D+ ++ + +
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDNLPPRVKDSHKV--------- 244
Query: 245 VNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293
S+++ ++ + +P +R TA E LQHPF K L PP
Sbjct: 245 ---SSVLRG-------FLDLMLVREPSQRATAQELLQHPFLK--LAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 83/299 (27%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 8 KKLGSGSFGCVWQAV--NKHSGEV-VAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVK 63
K+LG G+FG V + V K EV VA+K LK+ + K LRE + +L+HP IV+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 64 VKELI-VEKGNVFFVFECM--QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
LI V KG + + L + + +K++ S +K QV G+ Y+
Sbjct: 61 ---LIGVCKGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 121 QGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPY--TERVG---TRWYQAPEILFK 174
+ + HRDL N LLV++ KI+DFG++R + A Y G +WY APE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APEC-IN 171
Query: 175 SGLYSSKVDMWAMGAIMAELLLF--RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
G +SSK D+W+ G + E + +P + A+ + + S
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKP-YGEMKGAEVIAMLES----------------- 213
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLC-SWDPCKRPTAAEALQHPFFKRCLY 290
+ P+ P I I C + P RPT +E F+R
Sbjct: 214 ---GERLPR----------PEECPQEIYSIMLSCWKYRPEDRPTFSEL--ESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 36/289 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E + L +++GSG++G V++A N ++GE+ AIK +K + + +E+ ++ H NI
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V + + ++ E C +L + SES + + +GL Y+H
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHS 124
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEI--LFKSG 176
+G HRD+K N+L++ G +K+ADFG++ +I A +GT ++ APE+ + + G
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD-SWADGLRQAMAI 235
Y+ D+WA+G EL +P P D L
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP--------------------PMFDLHPMRALFLMTKS 224
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
N+Q P+L S + ++ + +P KRPTA + LQHPF
Sbjct: 225 NFQPPKLKD------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 4e-23
Identities = 81/312 (25%), Positives = 148/312 (47%), Gaps = 43/312 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+KY+ +K+G G+ G V+ A++ +G+ VAIK + +K L + E+ +++L +PNI
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 62 VKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V + + +F V E + +L ++ + E+ + A + + L+++H
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHA 133
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILFKSG 176
HRD+K +N+L+ G++K+ DFG +I P ++R VGT ++ APE++ +
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y KVD+W++G + E++ P + + +Y I + G+P +
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL-------------- 235
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLR 296
Q P+ LS + + + D KR +A E LQHPF K P
Sbjct: 236 -QNPE----KLSPIFR-------DFLNRCLEMDVEKRGSAKELLQHPFLK---LAKPLSS 280
Query: 297 STPAVAATRRGM 308
TP + A + M
Sbjct: 281 LTPLILAAKEAM 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-23
Identities = 76/290 (26%), Positives = 136/290 (46%), Gaps = 39/290 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR-EVKCLRKLNHPN 60
E ++ +++G GSFG V++ ++ + EVVAIK + + ++ +++ E+ L + + P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
I + ++ ++ + E + + L+ K E+ + L ++ +GLDY+H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLH 118
Query: 120 QQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGL 177
+ HRD+K N+L+S QG +K+ADFG+A ++ D VGT ++ APE++ K
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y K D+W++G EL P P D M + +
Sbjct: 178 YDFKADIWSLGITAIELAKGEP--------------------PNSD------LHPMRVLF 211
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
P+ S L ++ +E+ + DP RPTA E L+H F R
Sbjct: 212 LIPKNSPPTLEGQYSKPFKE---FVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 75/316 (23%), Positives = 126/316 (39%), Gaps = 70/316 (22%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVK--------CLRKLNHPNI 61
LG G++G V + + +G ++A+K ++ + +N +E K +R ++ P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRAT------VNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V + +G+V+ E M +L + + K E + + + L+Y+H +
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 122 -GYFHRDLKPENLLVS-QGTIKIADFG--------LAREIDAFPPYTERVGTRWYQAPEI 171
HRD+KP N+L++ G +K+ DFG +A+ IDA G + Y APE
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--------GCKPYMAPER 174
Query: 172 L---FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
+ Y K D+W++G M EL G DSW
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIEL---------------------ATGRFPYDSWKTP 213
Query: 229 LRQ-AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+Q + PQL S + + + + +RP E LQHPFF+
Sbjct: 214 FQQLKQVVEEPSPQLP-------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE- 265
Query: 288 CLYVPPHLRSTPAVAA 303
HL VA+
Sbjct: 266 -----LHLSKNTDVAS 276
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 7e-23
Identities = 89/290 (30%), Positives = 135/290 (46%), Gaps = 49/290 (16%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCL---RKL-----NHP 59
K LG GSFG V A K + E AIKALKK + L +V+C R++ HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKK----DVVLEDDDVECTMVERRVLALAWEHP 56
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+ + K ++FFV E + N LM + + F E+ + + ++ GL ++H
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYL--NGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH 113
Query: 120 QQGYFHRDLKPENLLVS-QGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGL 177
++G +RDLK +N+L+ G IKIADFG+ +E ++ + GT Y APEIL K
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL-KGQK 172
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y+ VD W+ G ++ E+L+ + F G DE + I D
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-------ND------------RP 213
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-PTAAEALQHPFFK 286
FP+ S++A + + L DP KR + QHPFF+
Sbjct: 214 HFPR-----------WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 7e-23
Identities = 82/312 (26%), Positives = 149/312 (47%), Gaps = 43/312 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+KY+ +K+G G+ G V+ A++ +G+ VAIK + +K L + E+ +R+ +PNI
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 62 VKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V + + ++ V E + +L ++ + E + A + + LD++H
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHS 133
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILFKSG 176
HRD+K +N+L+ G++K+ DFG +I P ++R VGT ++ APE++ +
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y KVD+W++G + E++ P + + +Y I + G+P +
Sbjct: 192 -YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL-------------- 235
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLR 296
Q P+ LSA+ D +N + D +R +A E LQHPF K P
Sbjct: 236 -QNPE----RLSAVF----RDFLNRCLEM---DVDRRGSAKELLQHPFLK---LAKPLSS 280
Query: 297 STPAVAATRRGM 308
TP + A + +
Sbjct: 281 LTPLIIAAKEAI 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYS-REKCLNLREVKCLRKLNHPN 60
++ K +G G FG V + K G+ VAIK LK S +++ L E + + +HPN
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 61 IVKVKELIVEKGN-VFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
I+++ E +V K V + E M+ +L + + K F+ + L + G+ Y+
Sbjct: 67 IIRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYL 122
Query: 119 HQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAF-PPYTERVG---TRWYQAPE-IL 172
+ Y HRDL N+LV+ + K++DFGL+R ++ YT + G RW APE I
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEAIA 181
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLF--RP 199
++ ++S D+W+ G +M E++ + RP
Sbjct: 182 YRK--FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKC---LNLREVKCLRKLNHPNIVKVKE 66
LG G FG V K++G++ A K L K ++K + L E + L K+N P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 67 LIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K ++ V M + ++Y + E + +++ SA Q+ G+ ++H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA------QITCGILHLHSM 114
Query: 122 GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RD+KPEN+L+ QG +++D GLA E+ T+R GT Y APEIL K YS
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL-KEEPYSY 173
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDE 206
VD +AMG + E++ R F+ E
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-22
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 8 KKLGSGSFG----CVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPNIV 62
+ LG G FG C + ++GE VA+K+LK +L +E++ LR L H NIV
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 63 KVKELIVEKGN--VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
K K + E G + + E + +L + + K K L + Q+ +G+DY+
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL---KQQLKYAVQICKGMDYLG 126
Query: 120 QQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTR-----WYQAPEILF 173
+ Y HRDL N+LV S+ +KI DFGL + I+ Y WY APE L
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185
Query: 174 KSGLYSSKVDMWAMGAIMAELLLF 197
+S Y + D+W+ G + ELL +
Sbjct: 186 QSKFYIAS-DVWSFGVTLYELLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-22
Identities = 75/290 (25%), Positives = 137/290 (47%), Gaps = 39/290 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR-EVKCLRKLNHPN 60
E ++ +K+G GSFG V++ ++ + +VVAIK + + ++ +++ E+ L + + P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+ K ++ ++ + E + + L+E E+ + L ++ +GLDY+H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLH 118
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGL 177
+ HRD+K N+L+S+ G +K+ADFG+A ++ D VGT ++ APE++ K
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y SK D+W++G EL G P M + +
Sbjct: 178 YDSKADIWSLGITAIEL---------------------AKGEPPHSEL-----HPMKVLF 211
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
P+ N L + S+ +E+ + +P RPTA E L+H F R
Sbjct: 212 LIPK---NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 27/221 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLNL-REVKCLRK 55
++ +L K LG G+FG V +A ++ + VA+K LK + + +L E++ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 56 L-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVK-------- 105
+ H NI+ + + ++G ++ V E NL + A++ + S +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 106 ----AWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAR---EIDAFPPY 157
++ +QV RG++++ + HRDL N+LV++ +KIADFGLAR ID +
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 158 TE-RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF 197
T R+ +W APE LF +Y+ + D+W+ G ++ E+
Sbjct: 192 TNGRLPVKW-MAPEALF-DRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-22
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 20/205 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KKLG+G FG VW +V AIK+LK+ S L E +++L HP +
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQG-SMSPEAFLAEANLMKQLQHPRL 63
Query: 62 VKVKELIVEKGNVFFVFECMQ----CNLYQLMEAKKQK-QQLFSESAVKAWLFQVFRGLD 116
V++ +V + ++ + E M+ + + E K +L +A Q+ G+
Sbjct: 64 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA------QIAEGMA 116
Query: 117 YMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGTRW---YQAPEIL 172
++ ++ Y HRDL+ N+LVS+ KIADFGLAR I+ YT R G ++ + APE +
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAI 175
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLF 197
G ++ K D+W+ G ++ E++ +
Sbjct: 176 -NYGTFTIKSDVWSFGILLTEIVTY 199
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 4e-22
Identities = 77/311 (24%), Positives = 144/311 (46%), Gaps = 41/311 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+KY+ +K+G G+ G V+ A++ +G+ VAIK + +K L + E+ +R+ HPNI
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V + + ++ V E + L + + E + A + + L+++H
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 134
Query: 122 GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILFKSGL 177
HRD+K +N+L+ G++K+ DFG +I P ++R VGT ++ APE++ +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA- 191
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y KVD+W++G + E++ P + + +Y I + G+P + + + ++ +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQN-----PEKLSAIF 245
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS 297
+ + + D KR +A E LQHPF K P
Sbjct: 246 R---------------------DFLNRCLEMDVEKRGSAKELLQHPFLK---IAKPLSSL 281
Query: 298 TPAVAATRRGM 308
TP +AA +
Sbjct: 282 TPLIAAAKEAT 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-22
Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 48/290 (16%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKV 64
K LG G+FG V K SG+ A+K LKK E L E + L+ HP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 65 KELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
K K + FV E + + L ++++FSE + + ++ LDY+H
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 123 YFHRDLKPENLLVSQ-GTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RDLK ENL++ + G IKI DFGL +E I GT Y APE+L + Y
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL-EDNDYGR 174
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
VD W +G +M E++ R F D ++++++ + + +FP
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI------------------LMEDIKFP 215
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFF 285
+ + S DA +L+ L DP KR A E ++H FF
Sbjct: 216 R-----------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-22
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 41/213 (19%)
Query: 8 KKLGSGSFG----CVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPNIV 62
K+LG G FG C + + ++GE VA+K+L S + + RE++ LR L+H NIV
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLME----------AKKQKQQLFSESAVKAWLFQVF 112
K K + + G +L +ME ++ + Q+ + + + Q+
Sbjct: 70 KYKGVCEKPG---------GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQIC 119
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-----YTER----VG 162
+G+DY+ Q Y HRDL N+LV S+ +KI+DFGLA+ P Y +
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK----VLPEDKDYYYVKEPGESP 175
Query: 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
WY APE L ++ +SS D+W+ G + EL
Sbjct: 176 IFWY-APECL-RTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-22
Identities = 87/295 (29%), Positives = 132/295 (44%), Gaps = 56/295 (18%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVK--------CLRKLNHP 59
K +G GSFG V A K G+ A+K L+K LN +E K L+ + HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI----VLNRKEQKHIMAERNVLLKNVKHP 56
Query: 60 NIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+V + ++FV + + + L Q+++ F E + + ++ L Y
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGY 111
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKS 175
+H +RDLKPEN+L+ SQG + + DFGL +E I T GT Y APE++ K
Sbjct: 112 LHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
Y + VD W +GA++ E+L P F D A +MY ++L P +
Sbjct: 172 P-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMYD--NILHKPLV------------- 214
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL----QHPFFK 286
L P AS A +++E L D +R A E +HPFF+
Sbjct: 215 --------------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 9e-22
Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 47/295 (15%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKAL-KKSYSREK--CLNLREVKCLRKLNHPNIVKVKE 66
LG G FG V + +G++ A K L KK + K + L E + L K+N +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 67 LIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K + V M + ++Y + F E + ++ GL+ +H++
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFYAAEITCGLEDLHRE 121
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RDLKPEN+L+ G I+I+D GLA EI RVGT Y APE++ K+ Y+
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KNERYTF 180
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
D W +G ++ E++ + F+ E K+ + R+ ++
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKE-----KV----------KREEVERRVKEDQEEYS 225
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDP-----CKRPTAAEALQHPFFKRCLY 290
+ SE A ++ L + DP C+ A E HPFF+ +
Sbjct: 226 E-----------KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 79/311 (25%), Positives = 146/311 (46%), Gaps = 43/311 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+KY+ +K+G G+ G V+ A++ +G+ VAI+ + +K L + E+ +R+ +PNI
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 62 VKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V + + ++ V E + +L ++ + E + A + + L+++H
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILFKSG 176
HRD+K +N+L+ G++K+ DFG +I P ++R VGT ++ APE++ +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y KVD+W++G + E++ P + + +Y I + G+P +
Sbjct: 193 -YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL-------------- 236
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLR 296
Q P+ LSA+ + + D KR +A E LQH F K P
Sbjct: 237 -QNPE----KLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFLK---IAKPLSS 281
Query: 297 STPAVAATRRG 307
TP +AA +
Sbjct: 282 LTPLIAAAKEA 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 40/309 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E + + +LG G+FG V++A NK +G + A K ++ E + E++ L NHP I
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
VK+ G ++ + E C + +M + + +E ++ Q+ L Y+H
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFGL-AREIDAFPPYTERVGTRWYQAPEIL----FK 174
HRDLK N+L++ G IK+ADFG+ A+ + +GT ++ APE++ K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
Y K D+W++G + E+ P + + KI PT+
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLSQ---------- 237
Query: 235 INYQFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293
PS S + + +++ P RP+AA+ L+HPF P
Sbjct: 238 -----------------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP 280
Query: 294 HLRSTPAVA 302
LR A A
Sbjct: 281 -LRELVAEA 288
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 72/242 (29%), Positives = 124/242 (51%), Gaps = 20/242 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KKLG+G FG VW +S +V A+K LK + L E ++ L H +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAF-LEEANLMKTLQHDKL 63
Query: 62 VKVKELIVEKGNVFFVFECM-QCNLYQLMEA----KKQKQQLFSESAVKAWLFQVFRGLD 116
V++ ++ ++ ++ + E M + +L +++ K +L SA Q+ G+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA------QIAEGMA 117
Query: 117 YMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPEIL 172
Y+ ++ Y HRDL+ N+LVS+ + KIADFGLAR I+ YT R G ++ + APE +
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAI 176
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPL-FQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
G ++ K D+W+ G ++ E++ + + + G +D M + P M++ D L
Sbjct: 177 -NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235
Query: 232 AM 233
M
Sbjct: 236 IM 237
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 26/199 (13%)
Query: 8 KKLGSGSFGCV----WQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
K+LGSG FG V W+A K VAIKA+ + E+ + E K + KL+HP +V+
Sbjct: 10 KELGSGQFGVVHLGKWRAQIK-----VAIKAINEGAMSEEDF-IEEAKVMMKLSHPKLVQ 63
Query: 64 VKELIVEKGNVFFVFECMQ--CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+ + ++ ++ V E M+ C L L +Q+Q S+ + + V G++Y+ +
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREI--DAFPPYTERVGTRW---YQAPEILFKS 175
+ HRDL N LVS G +K++DFG+ R + D YT G ++ + PE+ F
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEV-FNF 175
Query: 176 GLYSSKVDMWAMGAIMAEL 194
YSSK D+W+ G +M E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-21
Identities = 80/307 (26%), Positives = 135/307 (43%), Gaps = 62/307 (20%)
Query: 4 YSLTKKLGSGSFGCVW---QAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
+ L + LG+G++G V+ + +G++ A+K LKK+ +K + R+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQ----- 56
Query: 61 IVKVKELIVEKGNVFFV--FECMQCN--LYQLME--------AKKQKQQLFSESAVKAWL 108
V E + + F V Q + L+ +++ +++ F+ES V+ ++
Sbjct: 57 ---VLEAV--RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 109 FQVFRGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTERV----GT 163
++ LD++HQ G +RD+K EN LL S+G + + DFGL++E ER GT
Sbjct: 112 AEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFCGT 169
Query: 164 RWYQAPEIL-FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM 222
Y APE++ SG + VD W++G + ELL F E + +I
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS-------- 221
Query: 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR---PTAAEA 279
R+ + FP + S +A + I+ L DP KR A E
Sbjct: 222 -------RRILKSKPPFP-----------KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 280 LQHPFFK 286
HPFF+
Sbjct: 264 KNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-21
Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 2 EKYSLTKKLGSGSFGCV----WQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN 57
+ + K+LG+G FG V W+ ++ VAIK +K+ E + E K + KL+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG--QYD---VAIKMIKEGSMSEDEF-IEEAKVMMKLS 57
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQ--CNLYQLMEAKK--QKQQLFSESAVKAWLFQVFR 113
H +V++ + ++ ++ V E M C L L E K Q QL V
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE------MCKDVCE 111
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRW---YQAP 169
G+ Y+ + + HRDL N LV QG +K++DFGL+R + YT VG+++ + P
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPP 170
Query: 170 EILFKSGLYSSKVDMWAMGAIMAEL 194
E+L S +SSK D+WA G +M E+
Sbjct: 171 EVLLYSK-FSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSYSREKCLNLREVKCLRKLNHPNIVKVKE 66
K+G GS G V A K SG++VA+K L+K RE N EV +R H N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN--EVVIMRDYQHENVVEMYN 84
Query: 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126
+ ++ V E ++ + + +E + A V + L +H QG HR
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 127 DLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSGLYSSKVDM 184
D+K +++L++ G +K++DFG ++ P VGT ++ APE++ + Y +VD+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDI 199
Query: 185 WAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244
W++G ++ E++ P + M I D+ L+ ++ P L G
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPKLKNLHKVS---PSLKG 248
Query: 245 VNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
++ L DP +R TAAE L+HPF +
Sbjct: 249 ----------------FLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 84/288 (29%), Positives = 134/288 (46%), Gaps = 38/288 (13%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
Y L +++GSG++G V++A N H+GE+ A+K +K + L +E+ +++ H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 64 V--KELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
L EK ++ CM+ C L + L SE + + +GL Y+H
Sbjct: 71 YFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPL-SELQIAYVCRETLQGLAYLHS 124
Query: 121 QGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEI--LFKSG 176
+G HRD+K N LL G +K+ADFG+A +I A +GT ++ APE+ + K+G
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y+ D+WA+G EL +P M+ + + M N
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP---------PMFDLHPMRALFLMSK----------SN 225
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+Q P+L S N ++ + +P KRPTA L H F
Sbjct: 226 FQPPKLKD------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 81/310 (26%), Positives = 141/310 (45%), Gaps = 54/310 (17%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALK---KSYSREKCLNLREVKCLRKLNHPNIVKV 64
+LG+G+ G V + +++ SG ++A K + K R + + RE+K L + N P IV
Sbjct: 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQII--RELKVLHECNSPYIVGF 64
Query: 65 KELIVEKGNVFFVFECMQC-NLYQLM-EAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ- 121
G + E M +L Q++ +A + + + + ++ V RGL Y+ ++
Sbjct: 65 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-----VLRGLTYLREKH 119
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYS 179
HRD+KP N+LV S+G IK+ DFG++ + ID+ VGTR Y +PE L + Y+
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH-YT 176
Query: 180 SKVDMWAMGAIMAELLLFR------------PLFQGTDEADQMYKICSVLGSPTMDSWAD 227
+ D+W++G + E+ + R +F + + + DS
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS--- 233
Query: 228 GLRQAMAI--------NYQFPQLSGVNLSALMPSA--SEDAINLIESLCSWDPCKRPTAA 277
+ MAI N P+L PS S++ + ++ +P +R
Sbjct: 234 --PRPMAIFELLDYIVNEPPPKL---------PSGAFSDEFQDFVDKCLKKNPKERADLK 282
Query: 278 EALQHPFFKR 287
E +HPF KR
Sbjct: 283 ELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 16/203 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
E L KKLG+G FG VW A NKH+ VA+K +K + L E ++ L H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAF-LAEANVMKTLQHDK 62
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKK-QKQQLFSESAVKAWLFQVFRGLDYM 118
+VK+ +V K ++ + E M +L +++ + KQ L A Q+ G+ ++
Sbjct: 63 LVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA---QIAEGMAFI 118
Query: 119 HQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPEILFK 174
Q+ Y HRDL+ N+LVS + KIADFGLAR I+ YT R G ++ + APE +
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAI-N 176
Query: 175 SGLYSSKVDMWAMGAIMAELLLF 197
G ++ K D+W+ G ++ E++ +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTY 199
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCL----RKLN----HP 59
K LG GSFG V+ A K + + AIKALKK + L +V+C R L+ HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 60 NIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+ + K N+FFV E + ++ + K F + ++ GL +
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQF 111
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKS 175
+H +G +RDLK +N+L+ + G IKIADFG+ +E + GT Y APEIL
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKI 213
Y++ VD W+ G ++ E+L+ + F G DE + I
Sbjct: 172 K-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKAL-KKSYSREK----CLNLREVKCLRKLNHPNIV 62
K +G GSFG V A K G A+K L KK+ ++K + R V L+ L HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 63 KVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ ++FV + + + L Q+++ F E + + +V + Y+H
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHL-----QRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 121 QGYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLY 178
+RDLKPEN+L+ SQG + + DFGL +E ++ + GT Y APE+L K Y
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-Y 173
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY 211
VD W +GA++ E+L P F D QMY
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 88/295 (29%), Positives = 131/295 (44%), Gaps = 61/295 (20%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-NKHSGEV--VAIKALKKSYS---REKCLNLREVKCLRK 55
E +L + +G G FG V+Q V E VA+K K S REK L +E +R+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL--QEAYIMRQ 63
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEA----KKQKQQLFSESAVKAWLFQV 111
+HP+IVK+ +I E V+ V E L L E + K L S + + +Q+
Sbjct: 64 FDHPHIVKLIGVITEN-PVWIVME-----LAPLGELRSYLQVNKYSLDLASLIL-YSYQL 116
Query: 112 FRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVG---TRWYQ 167
L Y+ + + HRD+ N+LV S +K+ DFGL+R ++ Y G +W
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW-M 175
Query: 168 APE-ILFKSGLYSSKVDMWAMGAIMAELLLF--RPLFQGTDEADQMYKICSVLGSPTMDS 224
APE I F+ ++S D+W G M E+L+ +P FQG D + +I
Sbjct: 176 APESINFRR--FTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRI----------- 221
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLC-SWDPCKRPTAAE 278
+G R M P L +LM + C ++DP KRP E
Sbjct: 222 -ENGERLPM------PPNCPPTLYSLM------------TKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E + + +LG G+FG V++A NK +G + A K + E + E+ L +HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
VK+ + + N++ + E C + +M + ++ +E ++ Q L+Y+H+
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGL-AREIDAFPPYTERVGTRWYQAPEILF----K 174
HRDLK N+L + G IK+ADFG+ A+ +GT ++ APE++ K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRP 199
Y K D+W++G + E+ P
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 84/290 (28%), Positives = 126/290 (43%), Gaps = 48/290 (16%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNHPNIVK 63
K +G GSFG V A +K + A+K L+K EK + L+ + HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 64 VKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+ ++FV + + Y L Q+++ F E + + ++ L Y+H
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYS 179
+RDLKPEN+L+ SQG I + DFGL +E I+ + GT Y APE+L K Y
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP-YD 174
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
VD W +GA++ E+L P F + A +MY ++L P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYD--NILNKPLQ----------------- 214
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA----EALQHPFF 285
L P+ + A +L+E L D KR A E H FF
Sbjct: 215 ----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-20
Identities = 87/294 (29%), Positives = 135/294 (45%), Gaps = 56/294 (19%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCL----RKL----NHPNI 61
LG GSFG V A K SG + A+K LKK + L +V+C R L NHP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKK----DVILQDDDVECTMTEKRILSLARNHPFL 58
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
++ +FFV E + N LM QK + F E+ + + ++ L ++H +
Sbjct: 59 TQLYCCFQTPDRLFFVMEFV--NGGDLM-FHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 122 GYFHRDLKPENLLVS-QGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYS 179
G +RDLK +N+L+ +G K+ADFG+ +E I + GT Y APEIL + LY
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL-QEMLYG 174
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
VD WAMG ++ E+L F+ +E D I
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-------------------------- 208
Query: 240 PQLSGVNLSALMPS-ASEDAINLIESLCSWDPCKRPTAAE------ALQHPFFK 286
+N + P+ S+DA++++++ + +P R + L+HPFFK
Sbjct: 209 -----LNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 81/330 (24%), Positives = 137/330 (41%), Gaps = 82/330 (24%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLR-EVKCLRKLNHPNIVKV 64
K +G G+FG V + + A+K L+K+ R + +++ E L + ++ +VK+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+K N++FV + + +M + +F E + ++ ++ ++ +H+ G+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGG--DMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 125 HRDLKPENLLVSQ-GTIKIADFGL-----------------------------AREIDAF 154
HRD+KP+N+L+ + G IK+ DFGL EID
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 155 PPYT-ER--------------VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRP 199
ER VGT Y APE+L ++G Y+ D W++G I+ E+L+ +P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQP 242
Query: 200 LFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAI 259
F A+ K+ +W + I Q L S +A
Sbjct: 243 PFLADTPAETQLKVI---------NW----ETTLHIPSQ------AKL-------SREAS 276
Query: 260 NLIESLCSWDPCKR---PTAAEALQHPFFK 286
+LI LC R A E HPFFK
Sbjct: 277 DLILRLCC-GAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-20
Identities = 85/291 (29%), Positives = 135/291 (46%), Gaps = 51/291 (17%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCL----RKL----NHP 59
K LG GSFG V A K GE A+KALKK + L +V+C R L +P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKK----DVVLIDDDVECTMVEKRVLALAWENP 56
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+ + K ++FFV E + K + L+ + A ++ GL ++H
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAA---EIVCGLQFLH 113
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGL 177
+G +RDLK +N+++ + G IKIADFG+ +E + + GT Y APEIL GL
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL--QGL 171
Query: 178 -YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y+ VD W+ G ++ E+L+ + F G DE D++++ V +P W
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTPHYPRW----------- 218
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ-HPFFK 286
++++ +++E L DP +R ++ HPFFK
Sbjct: 219 -----------------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (225), Expect = 7e-20
Identities = 71/243 (29%), Positives = 109/243 (44%), Gaps = 35/243 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----SREKCLNLREVKCLRKL 56
+ +Y + KK+G+G FG V+ +K + E KA+ SY REK + EV +R+L
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMREL 69
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLF---SESAVKAWLFQVFR 113
H NIV+ + + K N C+ L ++ ++F E A+ Q+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 114 GLDYMHQ-------QGYFHRDLKPENLLVSQGT------------------IKIADFGLA 148
L Y H + HRDLKP+N+ +S G KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 149 REIDAFPPYTERVGTRWYQAPEILF-KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA 207
+ I VGT +Y +PE+L ++ Y K DMWA+G I+ EL + F +
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 208 DQM 210
Q+
Sbjct: 250 SQL 252
|
Length = 1021 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 8e-20
Identities = 77/308 (25%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
+ L + +G G++G V++A +K +G++VAIK + E+ + E LRK NHPN
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE-EYNILRKYSNHPN 64
Query: 61 IVKV------KELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
I K ++ V E C ++ L++ ++K + E + L + R
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124
Query: 114 GLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTER---VGTRWYQAP 169
GL Y+H+ HRD+K +N LL +K+ DFG++ ++D+ R +GT ++ AP
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRNTFIGTPYWMAP 182
Query: 170 E-ILFKSGL---YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ-----MYKIC----SV 216
E I Y ++ D+W++G EL +P D ++KI
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-----CDMHPMRALFKIPRNPPPT 237
Query: 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA 276
L SP +W S+ + I + +RP
Sbjct: 238 LKSPE--NW-----------------------------SKKFNDFISECLIKNYEQRPFM 266
Query: 277 AEALQHPF 284
E L+HPF
Sbjct: 267 EELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 65/235 (27%), Positives = 112/235 (47%), Gaps = 44/235 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR-------EVKCLR 54
+ K +G+G+FG V ++ S A+K + + + L+ E + L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP----EVIRLKQEQHVHNEKRVLK 56
Query: 55 KLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESAVKA 106
+++HP I+++ F E Q LY LME + + FS S
Sbjct: 57 EVSHPFIIRL-----------FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF 105
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERV---- 161
+ ++ L+Y+H + +RDLKPEN+L+ +G IK+ DFG A+++ +R
Sbjct: 106 YASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLC 159
Query: 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICS 215
GT Y APE++ G ++ VD WA+G ++ E+L+ P F D +Y KI +
Sbjct: 160 GTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILA 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 34/202 (16%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV 69
+G G FG V + G+ VA+K LK + + L E + L HPN+V++ +++
Sbjct: 14 IGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAF-LAEASVMTTLRHPNLVQLLGVVL 70
Query: 70 EKGNVFFVFECM-QCNLYQLMEAK------KQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ ++ V E M + +L + ++ +Q F+ V G++Y+ ++
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFA--------LDVCEGMEYLEEKN 122
Query: 123 YFHRDLKPENLLVS-QGTIKIADFGLARE------IDAFPPYTERVGTRWYQAPEILFKS 175
+ HRDL N+LVS K++DFGLA+E P +W APE L +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP-------VKW-TAPEAL-RE 173
Query: 176 GLYSSKVDMWAMGAIMAELLLF 197
+S+K D+W+ G ++ E+ F
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 74/315 (23%), Positives = 125/315 (39%), Gaps = 53/315 (16%)
Query: 9 KLGSGSFGCVWQAVNKH--SGEVVAIKALK-KSYSREKCLNL-REVKCLRKLNHPNIVKV 64
+G + + KH + +VA+K + S S+E L +E+ R+L HPNI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 65 KELIVEKGNVFFVFECM---QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+ ++ V M C L+ K + E A+ L V LDY+H +
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCE--DLL--KTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLARE----------IDAFPPYTERVGTRWYQAPE 170
G+ HR +K ++L+S G + ++ + + FP + + W +PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN-LPWL-SPE 178
Query: 171 ILFKSGL-YSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMY--KI---------CSVL 217
+L ++ Y+ K D++++G EL P F+ A QM K+ S
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVP-FKDM-PATQMLLEKVRGTVPCLLDKSTY 236
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSAL-MPSA---SEDAINLIESLCSWDPCKR 273
DS + N ++ P SE +E DP R
Sbjct: 237 -PLYEDS---------MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 274 PTAAEALQHPFFKRC 288
P+A++ L H FFK+C
Sbjct: 287 PSASQLLNHSFFKQC 301
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 84/347 (24%), Positives = 140/347 (40%), Gaps = 100/347 (28%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLR-EVKCLRKLNH 58
E + K +G G+FG V K +G++ A+K L KS + +++ +++ E L + +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESAVKAWLFQ 110
P +V + ++ F+ Q LY +ME K FSE + ++ +
Sbjct: 61 PWVVSL----------YYSFQDAQ-YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE 109
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA----------------REIDA 153
++ +H+ G+ HRD+KP+N+L+ + G IK++DFGL+ +
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 154 FPPYTER--------------------------------VGTRWYQAPEILFKSGLYSSK 181
R VGT Y APEI + G Y +
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQE 228
Query: 182 VDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241
D W++GAIM E L+ P F + + KI +W + L FP
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKII---------NWRETL--------YFPD 271
Query: 242 LSGVNLSALMPSASEDAINLIESL-CSWDP-CKRPTAAEALQHPFFK 286
++LS +A +LI L + + R A E HPFF+
Sbjct: 272 --DIHLSV-------EAEDLIRRLITNAENRLGRGGAHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 62/193 (32%), Positives = 106/193 (54%), Gaps = 13/193 (6%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKE 66
+K+G G+FG V++ V K + EV A+K + + + K L+E + L++ +HPNIVK+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126
+ V+K ++ V E + L +K+K +L + ++ L G++Y+ + HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSL-LTFLRKKKNRLTVKKLLQMSL-DAAAGMEYLESKNCIHR 117
Query: 127 DLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTR-----WYQAPEILFKSGLYSS 180
DL N LV + +KI+DFG++RE + YT G + W APE L G Y+S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKW-TAPEAL-NYGRYTS 174
Query: 181 KVDMWAMGAIMAE 193
+ D+W+ G ++ E
Sbjct: 175 ESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNH---P 59
Y + +G G++G V++ + +G VVA+K + + ++ REV L +L P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 60 NIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI K ++ ++ + E ++ LM+A +E + + +V L Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-----IAEKYISVIIREVLVALKYI 117
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP-PYTERVGTRWYQAPEILFKSG 176
H+ G HRD+K N+LV+ G +K+ DFG+A ++ + VGT ++ APE++ +
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKI 213
Y +K D+W++G + E+ P + D M I
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 85/303 (28%), Positives = 148/303 (48%), Gaps = 50/303 (16%)
Query: 4 YSLTKKLGSGSFGCVW--QAVNKH-SGEVVAIKALKKSYSREKCLNLREVKCLRK-LNH- 58
+ L K LG+G++G V+ + V+ H SG++ A+K LKK+ +K + R+ L H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 59 ---PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
P +V + + + + + N +L Q+++ F E V+ + ++ L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYI--NGGELFTHLSQRER-FKEQEVQIYSGEIVLAL 118
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV----GTRWYQAPE 170
+++H+ G +RD+K EN+L+ S G + + DFGL++E ER GT Y AP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE--DEVERAYSFCGTIEYMAPD 176
Query: 171 ILF-KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
I+ G + VD W+MG +M ELL F T + ++ +S A+
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF--TVDGEK-------------NSQAEIS 221
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEAL-QHPF 284
R+ + +PQ +SAL A ++I+ L DP KR P+ A+ + +HPF
Sbjct: 222 RRILKSEPPYPQ----EMSAL-------AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
Query: 285 FKR 287
F++
Sbjct: 271 FQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 36/230 (15%)
Query: 6 LTKKLGSGSFGCVWQA-----VNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHP 59
L ++LG G+FG V+ ++ E+VA+K LK++ S + + RE + L H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 60 NIVKVKELIVEKGNVFFVFECMQ---CNLY--------QLMEAKKQKQQLFSESAVKAWL 108
NIVK + E VFE M+ N + +++ + S +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTE---RVG-- 162
Q+ G+ Y+ Q + HRDL N LV + KI DFG++R++ YT RVG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-----YTTDYYRVGGH 183
Query: 163 ----TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF--RPLFQGTDE 206
RW I++ ++++ D+W+ G ++ E+ + +P + ++E
Sbjct: 184 TMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 8 KKLGSGSFGCVWQAVNKHS-GEV--VAIKALKKSYSREKCLN--LREVKCLRKLNHPNIV 62
KKLG GSFG V + S G+V VA+K LK S ++ L+E + L+H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEA-KKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
++ +V + V E L L++ +K F S + + Q+ G+ Y+ +
Sbjct: 60 RLYG-VVLTHPLMMVTEL--APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY-----TERVGTRWYQAPEILFKS 175
+ HRDL N+L+ S +KI DFGL R + + +V W APE L ++
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC-APESL-RT 174
Query: 176 GLYSSKVDMWAMGAIMAELLLF 197
+S D+W G + E+ +
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTY 196
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 53/293 (18%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE----KCLNLREVKCLRKLNHPN-IVKV 64
LG GSFG V A K + E+ AIK LKK + +C + E + L + P + ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC-TMVEKRVLALQDKPPFLTQL 66
Query: 65 KELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
++FV E + +Y + + K F E + ++ GL ++H++G
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFLHRRG 121
Query: 123 YFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV--GTRWYQAPEILFKSGLYS 179
+RDLK +N+++ S+G IKIADFG+ +E T R GT Y APEI+ Y
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFCGTPDYIAPEIIAYQP-YG 179
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
VD WA G ++ E+L +P F G DE D++++ M N +
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ------------------SIMEHNVSY 220
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEAL-QHPFFKR 287
P+ S S++A+++ + L + P KR P + +H FF+R
Sbjct: 221 PK-----------SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVN---KHSGEV--VAIKALK-KSYSREKCLNLREVKCLRK 55
S K LG+G+FG V +A S V VA+K LK ++S E+ + E+K +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 56 L-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
L NH NIV + G + + E C +L + K++ + + ++ +QV +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES--FLTLEDLLSFSYQVAK 152
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAP 169
G+ ++ + HRDL N+L++ G I KI DFGLAR+I Y + R + AP
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 170 EILFKSGLYSSKVDMWAMGAIMAEL 194
E +F + +Y+ + D+W+ G ++ E+
Sbjct: 213 ESIF-NCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 4e-19
Identities = 73/287 (25%), Positives = 129/287 (44%), Gaps = 40/287 (13%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNH-PNIVKVKEL 67
+GSG+ G V++ K +G V+A+K ++++ ++E+ L ++ + K + P IVK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 68 IVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHR 126
+ +VF E M L +L K+ Q E + + + L Y+ + G HR
Sbjct: 83 FITDSDVFICMELMSTCLDKL---LKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR 139
Query: 127 DLKPENLLV-SQGTIKIADFGLA-REIDAFPPYTERVGTRWYQAPEIL---FKSGLYSSK 181
D+KP N+L+ + G +K+ DFG++ R +D+ T G Y APE + + Y +
Sbjct: 140 DVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSAGCAAYMAPERIDPPDPNPKYDIR 198
Query: 182 VDMWAMGAIMAELLLFRPLFQGTD-EADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
D+W++G + EL + ++ E + + KI + + P
Sbjct: 199 ADVWSLGISLVELATGQFPYKNCKTEFEVLTKI---------------------LQEEPP 237
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
L S D + ++ + D KRP E LQHPF +R
Sbjct: 238 SLPPNE------GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKV 64
++ KLG G +G V++ V K VA+K LK+ + L+E ++++ HPN+V++
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKEIKHPNLVQL 67
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ + + + E M L ++ +Q + + Q+ ++Y+ ++ +
Sbjct: 68 LGVCTREPPFYIITEFM-TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 125 HRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPEILFKSGLYSS 180
HRDL N LV + + K+ADFGL+R + YT G ++ + APE L +S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESL-AYNKFSI 184
Query: 181 KVDMWAMGAIMAEL 194
K D+WA G ++ E+
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 84/311 (27%), Positives = 138/311 (44%), Gaps = 59/311 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYS-REKCLNLREVKCLRKLNHP 59
+KY +++ LGSG+ G V A GE A+K + + S +K EV CL +
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91
Query: 60 NIVKVKELIVEKG-----NVFFVFECMQC----NLYQLMEAKKQKQQLFSESAVKAWLFQ 110
+IVK E +K NV + + +L Q ++++ + + F E Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 111 VFRGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTERV-------- 161
V + ++H + HRD+K N LL S G +K+ DFG ++ Y V
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM------YAATVSDDVGRTF 205
Query: 162 -GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220
GT +Y APEI ++ YS K DM+++G ++ ELL + F G + + M+K
Sbjct: 206 CGTPYYVAPEI-WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK-------- 256
Query: 221 TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280
L+G L PS S + ++ +L S DP +RP++++ L
Sbjct: 257 --------------------TLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
Query: 281 QHPFFKRCLYV 291
P K L++
Sbjct: 296 NMPICK--LFI 304
|
Length = 496 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-19
Identities = 67/243 (27%), Positives = 123/243 (50%), Gaps = 33/243 (13%)
Query: 10 LGSGSFGCVWQAVNKHSGE---VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVK 65
+G+G FG V + K G+ VAIK LK Y+ +++ L E + + +HPNI+ ++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 66 ELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
++ + V + E M+ L + +Q F+ + L + G+ Y+ + Y
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 125 HRDLKPENLLVSQGTI-KIADFGLAREID---AFPPYTERVG----TRWYQAPE-ILFKS 175
HRDL N+LV+ + K++DFGL+R ++ + P YT +G RW APE I ++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEAIAYRK 187
Query: 176 GLYSSKVDMWAMGAIMAELLLF--RPLFQGTDE-----ADQMYKICSVLGSPT------M 222
++S D+W+ G +M E++ + RP + +++ +Q Y++ + PT +
Sbjct: 188 --FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLML 245
Query: 223 DSW 225
D W
Sbjct: 246 DCW 248
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 8 KKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSREKCLN-LREVKCLRKLNHPNIV 62
K LGSG+FG V++ V GE VAIK L++ S + L E + ++HP++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
++ + + V + + M L L++ + + + W Q+ +G+ Y+ ++
Sbjct: 73 RLLGICLSS-QVQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 123 YFHRDLKPENLLV-SQGTIKIADFGLAREIDA----FPPYTERVGTRWYQAPEILFKSGL 177
HRDL N+LV + +KI DFGLA+ +D + +V +W A E + +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESILH-RI 187
Query: 178 YSSKVDMWAMGAIMAELLLF 197
Y+ K D+W+ G + EL+ F
Sbjct: 188 YTHKSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 70/245 (28%), Positives = 121/245 (49%), Gaps = 29/245 (11%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ K +G+G FG V K G+ VAIK LK Y+ ++ + L E + + +HPN
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
I+ ++ ++ + V V E M+ K Q F+ + L + G+ Y+
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYLSD 124
Query: 121 QGYFHRDLKPENLLVSQGTI-KIADFGLAR--EIDAFPPYTERVG---TRWYQAPE-ILF 173
GY HRDL N+LV+ + K++DFGL+R E D YT R G RW APE I +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAY 183
Query: 174 KSGLYSSKVDMWAMGAIMAELLLF--RPLFQGTDE-----ADQMYKICSVLGSPT----- 221
+ ++S D+W+ G +M E++ + RP ++ +++ ++ Y++ + + P
Sbjct: 184 RK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL 241
Query: 222 -MDSW 225
+D W
Sbjct: 242 MLDCW 246
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLNHPNIVKVKE 66
LG G FG V + +G++ A K L+K +++ + L E + L K+N +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 67 LIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K + V M + ++Y + F E + ++ GL+ +H++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FEEERALFYAAEILCGLEDLHRE 121
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RDLKPEN+L+ G I+I+D GLA +I RVGT Y APE+L + Y+
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQRYTL 180
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
D W +G ++ E++ + F+G E + ++ + L + +F
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV-----------LETEEVYSAKF- 228
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDP-----CKRPTAAEALQHPFFK 286
SE+A ++ + L + DP C+ A E +HPFF+
Sbjct: 229 --------------SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVKVKE 66
+LG G++G V++ +++ +G +A+K ++ K N + E+ L K P IV
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFH 125
+G V+ E M + A + E ++ + V +GL ++ ++ H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 126 RDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL-----FKSGLYS 179
RD+KP N+LV G +K+ DFG++ + A T +G + Y APE + ++ Y+
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERIKSGGPNQNPTYT 185
Query: 180 SKVDMWAMGAIMAELLLFR---PLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
+ D+W++G + E+ L R P + Q+ I G P
Sbjct: 186 VQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP---------------- 227
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
P L S+DA + + + P +RPT A+ L+HP+ +
Sbjct: 228 ---PTLP--------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KKLG+G FG VW + +V A+K LK + L E + ++KL H +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESF-LEEAQIMKKLRHDKL 63
Query: 62 VKVKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQ----QLFSESAVKAWLFQVFRGLD 116
V++ ++ E+ ++ V E M + +L ++ + + L +A QV G+
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA------QVAAGMA 116
Query: 117 YMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPEIL 172
Y+ + Y HRDL+ N+LV G + KIADFGLAR I+ YT R G ++ + APE
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAA 175
Query: 173 FKSGLYSSKVDMWAMGAIMAELL 195
G ++ K D+W+ G ++ EL+
Sbjct: 176 L-YGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 9 KLGSGSFGCVWQAVNKHSGEV--VAIKALKKSYSREKCLN---LREVKCLRKLNHPNIVK 63
+LGSG+FGCV + V K + VAIK LK EK + +RE + + +L++P IV+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 64 VKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ + E + V E L + + KK + + S V + QV G+ Y+ +
Sbjct: 60 MIGV-CEAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGKN 115
Query: 123 YFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPP-YTERVGTRW---YQAPE-ILFKSG 176
+ HRDL N LLV+Q KI+DFGL++ + A Y R +W + APE I F+
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK- 174
Query: 177 LYSSKVDMWAMGAIMAELLLF 197
+SS+ D+W+ G M E +
Sbjct: 175 -FSSRSDVWSYGITMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 59/297 (19%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV 69
+G G FG V+ +G++ A+K L K K + +++ + L LN ++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETL-ALNE----RIMLSLV 51
Query: 70 EKGNVFFVFECMQ---------CNLYQLMEAKKQKQQL-----FSESAVKAWLFQVFRGL 115
G+ F+ CM + LM L FSE+ ++ + ++ GL
Sbjct: 52 STGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGL 110
Query: 116 DYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
++MH + +RDLKP N+L+ + G ++I+D GLA + P+ VGT Y APE+L K
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 169
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
Y S D +++G ++ +LL F+ D+ +D R +
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------EID------RMTLT 213
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDP-----CKRPTAAEALQHPFFK 286
+ + P S S + +L+E L D C A E +HPFF+
Sbjct: 214 MAVELPD-----------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKV 64
K LG G+FG V K +G A+K L+K E + E + L+ HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 65 KELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
K + FV E + L ++++F+E + + ++ L+Y+H +
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 123 YFHRDLKPENLLVSQ-GTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RD+K ENL++ + G IKI DFGL +E I GT Y APE+L + Y
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYGR 174
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTD 205
VD W +G +M E++ R F D
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 5 SLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYSREKCLN-LREVKCLRKLNH 58
+L + LG G+FG V++ + + VA+K L +S S + + L E + K NH
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 59 PNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLF---QVFRG 114
NIV++ + E+ F + E M +L + + + + S +K LF V +G
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 115 LDYMHQQGYFHRDLKPEN-LLVSQG---TIKIADFGLAREIDAFPPYTERVGTR------ 164
Y+ + + HRD+ N LL +G KIADFG+AR+I Y R G R
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY--RKGGRAMLPIK 186
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
W PE F G+++SK D+W+ G ++ E+
Sbjct: 187 W-MPPEA-FLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKH--SGEV---VAIKALKKSYS-REKCLNLREVKCLR 54
EK +L ++LG GSFG V++ + K GE VAIK + ++ S RE+ L E ++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64
Query: 55 KLNHPNIVKVKELIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKA--W 107
+ N ++V++ ++ V E M + L + L + K
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 108 LFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI---DAFPPYTER-VG 162
++ G+ Y+ + + HRDL N +V++ T+KI DFG+ R+I D + + +
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYK 212
RW APE L K G++++K D+W+ G ++ E+ A+Q Y+
Sbjct: 185 VRW-MAPESL-KDGVFTTKSDVWSFGVVLWEMATL---------AEQPYQ 223
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-18
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 24/200 (12%)
Query: 8 KKLGSGSFGCVWQAV--NKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVK 63
+LGSG+FG V + + K S + VA+K LK + + LRE +++L++P IV+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKK--QKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+ I E + V E L +L K QK + +E + + QV G+ Y+ +
Sbjct: 61 MIG-ICEAESWMLVME-----LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 122 GYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTERVGT-----RWYQAPEIL--F 173
+ HRDL N LLV+Q KI+DFGL++ + A Y + +WY APE + +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNYY 173
Query: 174 KSGLYSSKVDMWAMGAIMAE 193
K +SSK D+W+ G +M E
Sbjct: 174 K---FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-18
Identities = 61/199 (30%), Positives = 110/199 (55%), Gaps = 12/199 (6%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
++K +L + +G G FG V Q +++G+ VA+K +K + + L E + KL+H N
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAFLE--ETAVMTKLHHKN 60
Query: 61 IVKVKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+V++ +I+ G ++ V E M + NL + + + + L S + + V G++Y+
Sbjct: 61 LVRLLGVILHNG-LYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ HRDL N+LVS+ G K++DFGLAR + + ++ +W APE L K +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKW-TAPEAL-KHKKF 174
Query: 179 SSKVDMWAMGAIMAELLLF 197
SSK D+W+ G ++ E+ +
Sbjct: 175 SSKSDVWSYGVLLWEVFSY 193
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-18
Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 80/306 (26%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIK----------ALKKSYSREKCLNLREVKCLRKLNHP 59
LG G++G V+ + + G+++A+K A +K Y + + EV L+ L H
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQ----EEVDLLKSLKHV 62
Query: 60 NIVKVKELIVEKGNVFFVFECMQ-CNLYQLME--------AKKQKQQLFSESAVKAWLFQ 110
NIV+ ++ C+ + ME + + E + Q
Sbjct: 63 NIVQ------------YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ 110
Query: 111 VFRGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREI---DAFPPYTERV----G 162
+ G+ Y+H HRD+K N +L+ G IK+ DFG AR + ++ + G
Sbjct: 111 ILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM 222
T ++ APE++ +SG Y K D+W++G + E+ +P D M+ I + G
Sbjct: 171 TPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG---- 225
Query: 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSA----SEDAINLIESLCSWDPCKRPTAAE 278
LMP S AI+ + S + D +RP+A +
Sbjct: 226 ---------------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ 258
Query: 279 ALQHPF 284
L+H F
Sbjct: 259 LLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 49/291 (16%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKV 64
K LG G+FG V K +G A+K LKK E L E + L+ HP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 65 KELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH-QQ 121
K + FV E + L ++++FSE + + ++ LDY+H ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYS 179
+RDLK ENL++ + G IKI DFGL +E I GT Y APE+L + Y
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL-EDNDYG 174
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
VD W +G +M E++ R F D ++++++ + +F
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI------------------LMEEIRF 215
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFF 285
P+ + S +A +L+ L DP +R A E +QH FF
Sbjct: 216 PR-----------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 81/320 (25%), Positives = 142/320 (44%), Gaps = 59/320 (18%)
Query: 4 YSLTKKLGSGSFGCVW---QAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK-LNH- 58
+ L K LG+G++G V+ + +G++ A+K L+K+ +K + + R L H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 59 ---PNIVKVKELIVEKGNVFFVFEC-----MQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
P +V + + + + + M +LYQ + FSE V+ + +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--------RDNFSEDEVRFYSGE 113
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV----GTRW 165
+ L+++H+ G +RD+K EN+L+ S+G + + DFGL++E ER GT
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF--LSEEKERTYSFCGTIE 171
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225
Y APEI+ G + VD W++G ++ ELL F T E ++ ++
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF--TLEGER-------------NTQ 216
Query: 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEALQ 281
++ R+ + + FP +A +L+ L DP KR P A ++
Sbjct: 217 SEVSRRILKCDPPFP-----------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265
Query: 282 -HPFFKRCLYVPPHLRSTPA 300
HPFFK + LR
Sbjct: 266 EHPFFKGLDWEALALRKVNP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-18
Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKAL---KKSYSREKCLNLREVKCLRKLNHPNIVKV 64
LG+G+ G V + + +G V+A K + KS R++ L RE++ + + P IV
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQIL--RELQIMHECRSPYIVSF 68
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ + N+ E M C ++ +K + V GL Y++
Sbjct: 69 YGAFLNENNICMCMEFMDCGS---LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125
Query: 125 -HRDLKPENLLV-SQGTIKIADFGLAREI-----DAFPPYTERVGTRWYQAPEILFKSGL 177
HRD+KP N+LV S+G IK+ DFG++ E+ D F VGT Y +PE + + G
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF------VGTSTYMSPERI-QGGK 178
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y+ K D+W++G + EL L + F ++ D G D L+Q +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDD--------GQDDPMGILDLLQQ--IVQE 228
Query: 238 QFPQLSGVNLSALMPSA--SEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
P+L PS+ ED + +++ DP +RPT + P F
Sbjct: 229 PPPRL---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 29/221 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGE---VVAIKALKKSYSREKCLNLREVKCLR 54
++ L K LG G FG V +A ++K + VA+K LK + + + +L L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 55 KL--NHPNIVKVKELIVEKGNVFFVFECM-QCNLYQLMEAK------------KQKQQLF 99
KL H NI+ + + ++G ++ + E + NL + + A+ K ++
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 100 SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAR---EIDAFP 155
S + + +QV RG++Y+ + HRDL N+LV++ + KIADFGLAR +ID +
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 156 PYTE-RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+ R+ +W APE LF +Y+ + D+W+ G +M E+
Sbjct: 192 KTSNGRLPVKW-MAPEALFDR-VYTHQSDVWSFGILMWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 40/211 (18%)
Query: 8 KKLGSGSFG----CVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
++LG G+FG C + + ++GEVVA+K L+ S + RE++ L+ L H NIVK
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLME----------AKKQKQQLFSESAVK-AWLFQVF 112
K + G + NL +ME +K +++L + A Q+
Sbjct: 70 YKGVCYSAG---------RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS--QIC 118
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTR------- 164
+G++Y+ + Y HRDL N+LV S+ +KI DFGL + + P E R
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL---PQDKEYYKVREPGESPI 175
Query: 165 -WYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
WY APE L +S +S D+W+ G ++ EL
Sbjct: 176 FWY-APESLTES-KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 86/335 (25%), Positives = 141/335 (42%), Gaps = 74/335 (22%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLR-EVKCLRKLNHPNIVKV 64
K +G G+FG V K +G + A+K L+K+ +E+ ++R E L + + +VK+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+K N++ + E + + KK SE A + ++ + +D +HQ G+
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQLGFI 123
Query: 125 HRDLKPENLLV-SQGTIKIADFGLA------------REIDAFPPYT------------- 158
HRD+KP+NLL+ ++G +K++DFGL R + PP
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 159 -----------ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA 207
VGT Y APE+ ++G Y+ D W++G IM E+L+ P F
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 208 DQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLC- 266
+ K+ +W + L FP + SE A +LI C
Sbjct: 243 ETYRKVM---------NWKETL--------VFPPEVPI---------SEKAKDLILRFCT 276
Query: 267 -SWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTPA 300
S + E HPFF+ + H+R PA
Sbjct: 277 DSENRIGSNGVEEIKSHPFFEGVDW--GHIRERPA 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-17
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KLG G FG VW + V AIK LK + L+E + ++KL H +
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF-LQEAQVMKKLRHEKL 63
Query: 62 VKVKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ ++ E+ ++ V E M + +L + K + + + Q+ G+ Y+ +
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 121 QGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPEILFKSG 176
Y HRDL+ N+LV + + K+ADFGLAR I+ YT R G ++ + APE G
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAAL-YG 178
Query: 177 LYSSKVDMWAMGAIMAEL 194
++ K D+W+ G ++ EL
Sbjct: 179 RFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 12/200 (6%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
M++ L + +G G FG V + + G VA+K +K + + L E + +L H N
Sbjct: 5 MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQAFL--AEASVMTQLRHSN 60
Query: 61 IVKVKELIVE-KGNVFFVFECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
+V++ +IVE KG ++ V E M + +L + ++ + + + + V ++Y+
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL 118
Query: 119 HQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
+ HRDL N+LVS+ + K++DFGL +E + T ++ +W APE L +
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEAL-REKK 175
Query: 178 YSSKVDMWAMGAIMAELLLF 197
+S+K D+W+ G ++ E+ F
Sbjct: 176 FSTKSDVWSFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 29/221 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGE---VVAIKALKKSYSREKCLNL-REVKCL 53
+K +L K LG G FG V A ++K + VA+K LK + + +L E++ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 54 RKL-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVK------ 105
+ + H NI+ + + G ++ + E + NL + + A++ +S +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 106 ------AWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYT 158
+ +QV RG++Y+ Q HRDL N+LV++ + KIADFGLAR+++ Y
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194
Query: 159 E----RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+ R+ +W APE LF +Y+ + D+W+ G +M E+
Sbjct: 195 KTTNGRLPVKW-MAPEALFDR-VYTHQSDVWSFGVLMWEIF 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 8 KKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYSREKCLN-LREVKCLRKLNHPNIVK 63
K +G+G FG V++ + K G VAIK LK Y+ ++ + L E + + +H NI++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
++ ++ + + E M+ L + + FS + L + G+ Y+ Y
Sbjct: 71 LEGVVTKFKPAMIITEYMENG--ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 124 FHRDLKPENLLV-SQGTIKIADFGLAREIDAFP--PYTE---RVGTRWYQAPE-ILFKSG 176
HRDL N+LV S K++DFGL+R ++ P YT ++ RW APE I ++
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPEAIAYRK- 186
Query: 177 LYSSKVDMWAMGAIMAELLLF--RPLFQ 202
++S D+W+ G +M E++ F RP +
Sbjct: 187 -FTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 17/218 (7%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE----KCLNLREVKCLRKLNHP 59
++ LG GSFG V A K + E+ AIK LKK + +C + + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 60 NIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+ ++ ++FV E + +YQ+ + + F E + ++ GL +
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFF 116
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV--GTRWYQAPEILFK 174
+H +G +RDLK +N+++ S+G IKIADFG+ +E + + T + GT Y APEI+
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYK 212
Y VD WA G ++ E+L + F+G DE D++++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 70/245 (28%), Positives = 115/245 (46%), Gaps = 54/245 (22%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E + K +G G+FG V K +G V A+K L+K+ EK + ++ R + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDI----L 55
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESAVKAWLFQVFR 113
V+ L V K +F+ F+ + NLY +ME K+ +E + ++ +
Sbjct: 56 VEADSLWVVK--MFYSFQ-DKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLA------------REIDAFPP--YT 158
+D +HQ G+ HRD+KP+NLL+ S+G +K++DFGL R ++ P +T
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 159 ----------------------ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL 196
VGT Y APE+ ++G Y+ D W++G IM E+L+
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLI 231
Query: 197 FRPLF 201
P F
Sbjct: 232 GYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 45/214 (21%)
Query: 8 KKLGSGSFGCV----WQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPNIV 62
+ LG G FG V + N +GE+VA+K LK+ ++ +E+ L+ L H NIV
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 63 KVKELIVEKGN--VFFVFECM------------QCNLYQLMEAKKQKQQLFSESAVKAWL 108
K K E+G + + E + + NL QL+ LF++
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL--------LFAQ------- 114
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTR--- 164
Q+ G+ Y+H Q Y HRDL N+L+ + +KI DFGLA+ + Y RV
Sbjct: 115 -QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGDS 172
Query: 165 ---WYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
WY A E L K +S D+W+ G + ELL
Sbjct: 173 PVFWY-AVECL-KENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 70/231 (30%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK---KSYSREKCLNLREVKCLRKLNH 58
+ + +LG+G+ G V + +K SG ++A K + K R + + RE++ L + N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNS 62
Query: 59 PNIVKVKELIVEKGNVFFVFECMQC-NLYQLM-EAKKQKQQLFSESAVKAWLFQVFRGLD 116
P IV G + E M +L Q++ EAK+ +++ + ++ V RGL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-----VLRGLA 117
Query: 117 YMHQQ-GYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILF 173
Y+ ++ HRD+KP N+LV S+G IK+ DFG++ + ID+ VGTR Y +PE L
Sbjct: 118 YLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL- 174
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
+ YS + D+W+MG + EL + R D + + ++ G P +D
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDG 221
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 81/317 (25%), Positives = 137/317 (43%), Gaps = 59/317 (18%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV 69
+G G FG V+ +G++ A+K L K K + +++ + L LN ++ +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETL-ALNE----RIMLSLV 51
Query: 70 EKGNVFFVFECMQ---------CNLYQLMEAKK-----QKQQLFSESAVKAWLFQVFRGL 115
G+ F+ CM C + LM + +FSE ++ + ++ GL
Sbjct: 52 STGDCPFIV-CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGL 110
Query: 116 DYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
++MH + +RDLKP N+L+ + G ++I+D GLA + P+ VGT Y APE+L K
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 169
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
Y S D +++G ++ +LL F+ D+ +D R +
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------EID------RMTLT 213
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFFKRCL 289
+N + P S S + +L+E L D KR A E +H FFK
Sbjct: 214 VNVELPD-----------SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262
Query: 290 YVPPHLRSTPAVAATRR 306
+ +L+ P R
Sbjct: 263 WQQVYLQKYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 75/272 (27%), Positives = 114/272 (41%), Gaps = 51/272 (18%)
Query: 28 EVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQ 87
E V K + + R+ E+ CL +H IVK + + + E
Sbjct: 94 EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153
Query: 88 LMEAKKQKQQL-FSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENL-LVSQGTIKIADF 145
++ K+ L F E V +Q+ LD +H + HRDLK N+ L+ G IK+ DF
Sbjct: 154 KQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF 213
Query: 146 GLAREIDAFPPYTERV---------GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL- 195
G +++ Y++ V GT +Y APE L++ YS K DMW++G I+ ELL
Sbjct: 214 GFSKQ------YSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLT 266
Query: 196 LFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ-FPQLSGVNLSALMPSA 254
L RP F+G + + M +Q + Y FP + AL+
Sbjct: 267 LHRP-FKGPSQREIM-------------------QQVLYGKYDPFPCPVSSGMKALL--- 303
Query: 255 SEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ L S +P RPT + L F K
Sbjct: 304 --------DPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 29/247 (11%)
Query: 1 MEKYSLTKKLGSGSFGCVW-----QAVNKHSGEVVAIKALKKSYSREKCLNLR-EVKCLR 54
+ ++LG G+FG V+ + S VAIK LK++ + R E + +
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 55 KLNHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESA---VKAWL-- 108
L HPNIV + + ++ +FE +L++ + + +ES VK+ L
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 109 -------FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREI---DAFPPY 157
Q+ G++Y+ + HRDL N LV +G T+KI+DFGL+R+I D +
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 158 TERV-GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF--RPLFQ-GTDEADQMYKI 213
++ + RW IL+ G ++++ D+W+ G ++ E+ + +P + E +M +
Sbjct: 184 SKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
Query: 214 CSVLGSP 220
+L P
Sbjct: 242 RQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRK---LNHPNIVK 63
+G G+FG V+Q K + + A+K L K +E + E L + P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 64 VKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+K +++ V + M + L QK+ FSE K ++ ++ L+++H+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL-----QKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAR-EIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
+RDLKPEN+L+ + G I + DFGL++ + GT Y APE+L Y+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 180 SKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYK-IC 214
VD W++G ++ E+ + P + ++ QMY+ I
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFY--AEDTQQMYRNIA 210
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 74/303 (24%), Positives = 127/303 (41%), Gaps = 65/303 (21%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKE 66
+LG G+ G V + K++G + A+K + + + K + LRE++ + P IVK
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI-LRELEINKSCKSPYIVKYYG 66
Query: 67 LIVEKGNVFFVFECMQCNLYQLME----------AKKQKQQ--LFSESAVKAWLFQVFRG 114
+++ ++ ME KK K++ E + V +G
Sbjct: 67 AFLDES---------SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 115 LDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF 173
L Y+H + HRD+KP N+L++ +G +K+ DFG++ E+ T GT +Y APE +
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERI- 175
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+ YS D+W++G + E+ R F +G
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPFP-----------------------PEGEPPLG 212
Query: 234 AI-------NYQFPQLS---GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
I N P+L G + SE+ + I+ DP +RPT + L+HP
Sbjct: 213 PIELLSYIVNMPNPELKDEPGNGI-----KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267
Query: 284 FFK 286
+ K
Sbjct: 268 WIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 32/229 (13%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLN 57
M++Y + + +G G G V+ A + VA+K +++ S L LRE K L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSE----SAVKAWL---F 109
HP IV V + + V++ ++ L L+++ QK+ L E ++V A+L
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA------REIDAFPPYTER-- 160
++ ++Y+H +G HRDLKP+N+L+ G + I D+G A E ER
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 161 -----------VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFR 198
VGT Y APE L S D++A+G I+ ++L
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLS 228
|
Length = 932 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 9e-17
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIV 62
+ + + +G G++G V++ NK G + A+K L ++ + E L+ L NHPN+V
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE-AEYNILQSLPNHPNVV 82
Query: 63 KVKELIVEK-----GNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
K + + G ++ V E C ++ +L++ Q E+ + L+ GL
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 117 YMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEIL-- 172
++H HRD+K N LL ++G +K+ DFG++ ++ VGT ++ APE++
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 173 ---FKSGLYSSKVDMWAMGAIMAEL 194
+ Y ++ D+W++G EL
Sbjct: 203 EQQYDYS-YDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 26 SGEVVAIKALKKSYSREKCLNLR---EVKCLRKLNHPNIVK-VKELIVEKGNVFFVFECM 81
+G VAIK L+ E+ R E +L HPNIV + G +F VFE
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE-- 59
Query: 82 QCNLYQLMEAKKQKQQLFSESAVKA-----WLFQVFRGLDYMHQQGYFHRDLKPENLLVS 136
+ + ++ L ++ A+ A + QV L H QG HRDLKP+N++VS
Sbjct: 60 ------YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 137 QGTI----KIADFGL------AREIDA--FPPYTERVGTRWYQAPEILFKSGLYSSKVDM 184
Q + K+ DFG+ R+ D TE +GT Y APE L + + D+
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDL 172
Query: 185 WAMGAIMAELLLFRPLFQGTDEADQMYK 212
+A G I E L + + QG A+ +Y+
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLNHPNIVKVKE 66
LG G FG V + +G++ A K L+K +++ + L E + L K+N +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 67 LIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K + V M + ++Y + EA F E + ++ GL+ +HQ+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAG------FEEGRAVFYAAEICCGLEDLHQE 121
Query: 122 GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RDLKPEN+L+ G I+I+D GLA + RVGT Y APE++ K+ Y+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNERYTF 180
Query: 181 KVDMWAMGAIMAELLLFRPLFQ 202
D WA+G ++ E++ + FQ
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 38/227 (16%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSG-----EVVAIKALKKSYSREKCLNL-REVKCLRKL 56
L K LG G FG V +A VA+K LK++ S + +L E L+++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCNLYQ--LMEAKK------------QKQQLFS-- 100
NHP+++K+ + G + + E + + L E++K L +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 101 ESAVK-------AWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREI- 151
E A+ AW Q+ RG+ Y+ + HRDL N+LV++G KI+DFGL+R++
Sbjct: 121 ERALTMGDLISFAW--QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 152 --DAFPPYTE-RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
D++ ++ R+ +W A E LF +Y+++ D+W+ G ++ E++
Sbjct: 179 EEDSYVKRSKGRIPVKW-MAIESLFDH-IYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 61/192 (31%), Positives = 82/192 (42%), Gaps = 48/192 (25%)
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAR---------------EIDAFPPYT 158
L+Y+H G HRDLKP+NLL+ S G IK+ DFGL++ E D
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 159 ERV-GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
++V GT Y APE++ + G Y VD WAMG I+ E L+ F G + ++ S
Sbjct: 174 KQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD- 231
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR---P 274
W +G AL DA +LI L +P +R
Sbjct: 232 ----DIEWPEG------------------DEALPA----DAQDLISRLLRQNPLERLGTG 265
Query: 275 TAAEALQHPFFK 286
A E QH FF
Sbjct: 266 GAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 85/302 (28%), Positives = 142/302 (47%), Gaps = 35/302 (11%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALK---KSYSREKCLNLREVKCLRKLNHPNIVKVK 65
+LG+G+ G V++ +K SG ++A K + K R + + RE++ L + N P IV
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFY 69
Query: 66 ELIVEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-G 122
G + E M +L Q L +A + +Q+ + ++ V +GL Y+ ++
Sbjct: 70 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-----VIKGLTYLREKHK 124
Query: 123 YFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
HRD+KP N+LV S+G IK+ DFG++ + ID+ VGTR Y +PE L + YS
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QGTHYSV 181
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTD--EADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
+ D+W+MG + E+ + R D E + M+ C V G P +
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG-CPVEGDPAESETSPR---------- 230
Query: 239 FPQLSGVNLSALMPSASEDA--INLIESLCSWDPCKRPTAAEALQ-HPFFKRCLYVPPHL 295
P+ G LS+ P + L++ + + P K P+ + F +CL P
Sbjct: 231 -PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289
Query: 296 RS 297
R+
Sbjct: 290 RA 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KLG G FG VW + +V AIK LK + L+E + ++KL H +
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAF-LQEAQIMKKLRHDKL 63
Query: 62 VKVKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQ----QLFSESAVKAWLFQVFRGLD 116
V + ++ E+ ++ V E M + +L ++ K QL +A Q+ G+
Sbjct: 64 VPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA------QIADGMA 116
Query: 117 YMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTRW---YQAPEIL 172
Y+ + Y HRDL+ N+LV + KIADFGLAR I+ YT R G ++ + APE
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAA 175
Query: 173 FKSGLYSSKVDMWAMGAIMAELL 195
G ++ K D+W+ G ++ EL+
Sbjct: 176 L-YGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 10 LGSGSFGCVWQA-----VNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPNIVK 63
+G G+FG V+QA + +VA+K LK+ S + + RE + + +HPNIVK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 64 VKELIVEKGNVFFVFECMQ----------CNLYQLMEAKKQKQQLFSESAVKAWL----- 108
+ + + +FE M + L
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 109 ----FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPY----TE 159
QV G+ Y+ ++ + HRDL N LV + +KIADFGL+R I + Y +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF--RPLFQGTDE 206
+ RW I + Y+++ D+WA G ++ E+ + +P + E
Sbjct: 193 AIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 6 LTKKLGSGSFGCVWQA-----VNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
L ++LG G+FG V+ A + +VA+K LK + + RE + L L H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLF---------Q 110
IVK + VE + VFE M+ +L + + A L +E A L Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVG------T 163
+ G+ Y+ Q + HRDL N LV + +KI DFG++R++ + Y RVG
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY--RVGGHTMLPI 186
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF--RPLFQ 202
RW I+++ ++++ D+W++G ++ E+ + +P +Q
Sbjct: 187 RWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 73/296 (24%), Positives = 122/296 (41%), Gaps = 59/296 (19%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALK---------KSYSREKCLNLREVKCLRKLNH 58
K LG G+FG V+ + +G +A K ++ K S +C E++ L+ L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQH 63
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQL-----FSESAVKAWLFQVFR 113
IV+ + ++ + M K QL +ES + + Q+
Sbjct: 64 ERIVQYYGCLRDRAEKTLTI------FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE 117
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAF----PPYTERVGTRWYQA 168
G+ Y+H HRD+K N+L S G +K+ DFG ++ + GT ++ +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PE++ G Y K D+W++G + E+L +P + E + M I + PT
Sbjct: 178 PEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPT------- 226
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
N Q P SE A + + + + RP+A E L+HPF
Sbjct: 227 -------NPQLPS-----------HISEHARDFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 52/192 (27%), Positives = 104/192 (54%), Gaps = 10/192 (5%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKE 66
+++G G+FG V+ + VA+K+ +++ + K L+E + L++ +HPNIV++
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126
+ +K ++ V E +Q + + + +L + ++ + G++Y+ + HR
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTF-LRTEGPRLKVKELIQM-VENAAAGMEYLESKHCIHR 118
Query: 127 DLKPENLLVSQ-GTIKIADFGLARE----IDAFPPYTERVGTRWYQAPEILFKSGLYSSK 181
DL N LV++ +KI+DFG++RE + A +++ +W APE L G YSS+
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL-NYGRYSSE 176
Query: 182 VDMWAMGAIMAE 193
D+W+ G ++ E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 78/307 (25%), Positives = 134/307 (43%), Gaps = 42/307 (13%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
+++ + L GS GCV+++ + + V +KA + S + E + LR+L+HP ++
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASS------VHEARLLRRLSHPAVLA 224
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+ ++ V G V + +LY + A+ + L +AV Q+ +DY+H +G
Sbjct: 225 LLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVAR---QLLSAIDYIHGEGI 281
Query: 124 FHRDLKPENLLVSQ-GTIKIADFG---LAREIDAFPPYTERVGTRWYQAPEILFKSGLYS 179
HRD+K EN+LV+ I + DFG AR + P + GT APE+L Y+
Sbjct: 282 IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL-AGDPYT 340
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
VD+W+ G ++ E + D+ P +RQA +F
Sbjct: 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDER--------RPYDAQILRIIRQAQVHVDEF 392
Query: 240 PQLSGVNLSALMPSASE--------------------DAINLIESLCSWDPCKRPTAAEA 279
PQ +G L + + D L+ ++D +RP+AAE
Sbjct: 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452
Query: 280 LQHPFFK 286
L+ P F+
Sbjct: 453 LRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 10 LGSGSFGCVWQAVNKHSGE-----VVAIKALKKSYSREKCLNL-REVKCLRKLNHPNIVK 63
LG G FG V+ A K E +V +KAL+K+ RE+ RKL+H N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 64 VKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQ-----KQQLFSESAVKAWLFQVFRGLDY 117
+ L E + + E +L Q + A K K S A Q+ G+D+
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREI---DAFPPYTERVGTRWYQAPEILF 173
+ + HRDL N LV SQ +K++ L++++ + + + RW APE +
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL-APEAVQ 191
Query: 174 KSGLYSSKVDMWAMGAIMAEL 194
+ +S+K D+W+ G +M E+
Sbjct: 192 E-DDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-16
Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 57/301 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL-----KKSYSREKCLNLREVKCLRKL 56
+ L K LG G+FG V+ + +G +A+K + + S+E E++ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 57 NHPNIVKVKELI---VEKGNVFFVFECMQCNLYQLMEAKKQKQQL-----FSESAVKAWL 108
H IV+ + EK FV + M K QL +E+ + +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFV---------EYMPGGSIKDQLKAYGALTENVTRRYT 112
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAF----PPYTERVGT 163
Q+ +G+ Y+H HRD+K N+L S G +K+ DFG ++ I GT
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223
++ +PE++ G Y K D+W++ + E+L +P + E + M I + PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIATQPTKP 228
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
DG+ S+ + ++ + + +RPTA L+HP
Sbjct: 229 MLPDGV-------------------------SDACRDFLKQIFVEEK-RRPTAEFLLRHP 262
Query: 284 F 284
F
Sbjct: 263 F 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 29/221 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEVVAIKALK--KSYSREKCLN--LREVKCL 53
++ L K LG G FG V A ++K V A+K KS + EK L+ + E++ +
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 54 RKL-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKK------------QKQQLF 99
+ + H NI+ + + G ++ + E + NL + + A++ ++
Sbjct: 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 100 SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYT 158
S + + +QV RG++Y+ + HRDL N+LV++ + KIADFGLAR+I Y
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 159 E----RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+ R+ +W APE LF +Y+ + D+W+ G ++ E+
Sbjct: 198 KTTNGRLPVKW-MAPEALFDR-IYTHQSDVWSFGVLLWEIF 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 59/189 (31%), Positives = 101/189 (53%), Gaps = 10/189 (5%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELI 68
LG G+FG V++ K V A+K K+ +E K L E + L++ +HPNIVK+ +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 69 VEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL 128
++ ++ V E + + L +K+K +L ++ VK + G+ Y+ + HRDL
Sbjct: 62 TQRQPIYIVMELVPGGDF-LSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIHRDL 119
Query: 129 KPENLLVSQGTI-KIADFGLAREIDA---FPPYTERVGTRWYQAPEILFKSGLYSSKVDM 184
N LV + + KI+DFG++R+ D +++ +W APE L G YSS+ D+
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPEAL-NYGRYSSESDV 177
Query: 185 WAMGAIMAE 193
W+ G ++ E
Sbjct: 178 WSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-----NHPNIVKV 64
+G GS+ V K + + A+K +KK + ++ V+ + + NHP +V +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ +FFV E + N LM Q+Q+ E + + ++ L+Y+H++G
Sbjct: 62 HSCFQTESRLFFVIEYV--NGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 125 HRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYSSKV 182
+RDLK +N+L+ S+G IK+ D+G+ +E + + GT Y APEIL + Y V
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSV 177
Query: 183 DMWAMGAIMAELLLFRPLFQ---GTDEADQ 209
D WA+G +M E++ R F +D DQ
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 72/296 (24%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
+ + + + +G G++G V++ +NK +G A+K L + ++ + E L+ L +HPN
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE-AEYNILKALSDHPN 76
Query: 61 IVKV-----KELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+VK K+ + ++ V E C ++ L++ ++ + E + L + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 115 LDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFP-PYTERVGTRWYQAPEIL 172
L ++H HRD+K N LL ++G +K+ DFG++ ++ + VGT ++ APE++
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 173 F----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
Y ++ D+W++G EL P ++KI PT
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-PPPT------- 248
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
L Q P+L S + + I + D KRPT ++ LQH F
Sbjct: 249 LHQ--------PEL-----------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 31/224 (13%)
Query: 6 LTKKLGSGSFGCVWQA-----VNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
L ++LG G+FG V+ A +VA+KALK + RE + L L H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLMEA---------KKQKQQLFSESAVKAWLF- 109
IVK + + + VFE M+ +L + + A Q +Q E + L
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 110 --QVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVG---- 162
Q+ G+ Y+ Q + HRDL N LV +KI DFG++R++ + Y RVG
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY--RVGGHTM 186
Query: 163 --TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF--RPLFQ 202
RW I+++ ++++ D+W+ G I+ E+ + +P FQ
Sbjct: 187 LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQ 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 71/289 (24%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNH-PNIVKVKEL 67
+G G+FG V + ++K SG ++A+K ++ +E+ L ++ + + + P IVK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 68 IVEKGNVFFVFECMQC---NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GY 123
+ +G+ + E M Y+ + + + E + + L+Y+ ++
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEV--LKSVIPEEILGKIAVATVKALNYLKEELKI 129
Query: 124 FHRDLKPENLLVSQ-GTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGL--YS 179
HRD+KP N+L+ + G IK+ DFG++ + +D+ T G R Y APE + S Y
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARDGYD 188
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
+ D+W++G + E+ + + + DQ+ ++ V G P
Sbjct: 189 VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV--VKGDP------------------ 228
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
P LS ++ S +N I D KRP E L+HPF K
Sbjct: 229 -PILS----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 36/241 (14%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK---------KSYSREKCLNLREVKCLR 54
+ L K LG G+FG V+ + +G +A+K ++ K + +C E++ L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLK 59
Query: 55 KLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQ---KQQL-----FSESAVKA 106
L H IV+ + + M+ L ME K QL +E+ +
Sbjct: 60 NLLHERIVQYYG---------CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK 110
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAF----PPYTERV 161
+ Q+ G+ Y+H HRD+K N+L S G +K+ DFG ++ +
Sbjct: 111 YTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT 221
GT ++ +PE++ G Y K D+W++G + E+L +P + + ++KI + +P
Sbjct: 171 GTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV 229
Query: 222 M 222
+
Sbjct: 230 L 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 29/224 (12%)
Query: 3 KYSLTKKLGSGSFGCVWQA----VNK---HSGEVVAIKALKKSYSREKCLNL-REVKCLR 54
+ +L K LG G FG V A ++K + VA+K LK + + +L E++ ++
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 55 KL-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVK------- 105
+ H NI+ + + G ++ + E + NL + + A++ +S K
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 106 -----AWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTE 159
+ +QV RG++Y+ Q HRDL N+LV++ + KIADFGLAR++ Y +
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 160 ----RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRP 199
R+ +W APE LF +Y+ + D+W+ G ++ E+
Sbjct: 193 TTNGRLPVKW-MAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGG 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 92/344 (26%), Positives = 146/344 (42%), Gaps = 52/344 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK---SYSREKCLNLREVKCLRKLNH 58
E Y + K +G G+FG V +K S +V A+K L K + E + N
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 59 PNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
P +V++ + ++ V E M +L LM E K + +V LD
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLALDA 157
Query: 118 MHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID--AFPPYTERVGTRWYQAPEILFK 174
+H G HRD+KP+N+L+ + G +K+ADFG ++D VGT Y +PE+L K
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL-K 216
Query: 175 S----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
S G Y + D W++G + E+L+ D + S++G +++ +
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLV----------GDTPFYADSLVG-----TYSKIMD 261
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRC 288
++N FP+ + S+ A NLI + + + R E QHPFFK
Sbjct: 262 HKNSLN--FPEDVEI---------SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
Query: 289 LYVPPHLRST--PAVAATRRGMLKQQGDRI-----DAEALPYPK 325
+ ++R T P V + D I D E P PK
Sbjct: 311 QWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPK 354
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSG-EVVAIKALKKS-YSREKCLN--LREVKCLRKLN 57
E ++ + LG+GSFG V A K+ VAIK +KS ++K ++ E K L +N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HP V + ++ ++ V E + + + K+ F + Q+ +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFE 145
Query: 117 YMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Y+ +RDLKPENLL+ + G IK+ DFG A+ +D YT GT Y APEIL
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT-LCGTPEYIAPEILLNV 203
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLF 201
G + D W +G + E+L+ P F
Sbjct: 204 G-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 30/223 (13%)
Query: 6 LTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
L +LG G+FG V+ A + +VA+KALK++ + RE + L L H +
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAW-----------L 108
IV+ + E + VFE M+ +L + + + ++ + A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVG----- 162
Q+ G+ Y+ + HRDL N LV QG +KI DFG++R+I + Y RVG
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY--RVGGRTML 186
Query: 163 -TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF--RPLFQ 202
RW IL++ ++++ D+W+ G ++ E+ + +P +Q
Sbjct: 187 PIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 59/297 (19%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLNHPNIVKVKE 66
LG G FG V + +G++ A K L+K +++ + L E + L K+N +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 67 LIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K + V M + ++Y + F E + ++ GL+ + ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FDEQRAIFYAAELCCGLEDLQRE 121
Query: 122 GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS 180
+RDLKPEN+L+ +G I+I+D GLA +I RVGT Y APE++ + Y+
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NNEKYTF 180
Query: 181 KVDMWAMGAIMAELLLFRPLFQ------GTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
D W +G ++ E++ + F+ +E D+ ++ + +++
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR--RVKE-----DQEEYSEKF----- 228
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDP-----CKRPTAAEALQHPFFK 286
SEDA ++ L + +P C+ AA QHP FK
Sbjct: 229 --------------------SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 51/205 (24%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH-PNIV 62
+ L + +G+G++G V++ + +G++ AIK + + E+ + +E+ L+K +H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK-QEINMLKKYSHHRNIA 66
Query: 63 KVKELIVEKG------NVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
++K ++ V E C ++ L+ K K E + ++ RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124
Query: 116 DYMHQQGYFHRDLKPENLLVSQGT-IKIADFGLAREID-AFPPYTERVGTRWYQAPEILF 173
++HQ HRD+K +N+L+++ +K+ DFG++ ++D +GT ++ APE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 174 ----KSGLYSSKVDMWAMGAIMAEL 194
Y K D+W++G E+
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 53/211 (25%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRK 55
EK +++++LG GSFG V++ + K VAIK + ++ S RE+ L E +++
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQQ------LFSESAVKAWL 108
N ++V++ ++ + + E M + +L + + + + + S +
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTE----RVGT 163
++ G+ Y++ + HRDL N +V++ T+KI DFG+ R+I Y + +
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
RW +PE L K G++++ D+W+ G ++ E+
Sbjct: 186 RW-MSPESL-KDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 87/344 (25%), Positives = 140/344 (40%), Gaps = 52/344 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK---SYSREKCLNLREVKCLRKLNH 58
E Y + K +G G+FG V +K + +V A+K L K + E + N
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 59 PNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
P +V++ + ++ V E M +L LM E + + +V LD
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDA 157
Query: 118 MHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFK 174
+H G+ HRD+KP+N+L+ + G +K+ADFG ++ + VGT Y +PE+L K
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL-K 216
Query: 175 S----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
S G Y + D W++G + E+L+ F KI + S T
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--------- 267
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRC 288
FP + + S++A NLI + + + R E +H FFK
Sbjct: 268 --------FPDDNDI---------SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
Query: 289 LYVPPHLRST--PAVAATRRGMLKQ-----QGDRIDAEALPYPK 325
+ LR T P V + + D+ + E P PK
Sbjct: 311 QWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPIPK 354
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-----NHPNIVKV 64
+G GS+ V K + + A+K +KK + ++ V+ + + NHP +V +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-EDIDWVQTEKHVFETASNHPFLVGL 61
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ +FFV E + + LM +++++L E A + + ++ L+++H++G
Sbjct: 62 HSCFQTESRLFFVIEFV--SGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNFLHERGII 118
Query: 125 HRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYSSKV 182
+RDLK +N+L+ ++G IK+ D+G+ +E I + GT Y APEIL + Y V
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSV 177
Query: 183 DMWAMGAIMAELLLFRPLFQ---GTDEADQ 209
D WA+G +M E++ R F +D DQ
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 81/303 (26%), Positives = 128/303 (42%), Gaps = 53/303 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + + K +G G+FG V K++G+V A+K L K + L E C R+ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREERDVLV 56
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLME----------AKKQKQQLFSESAVKAWLFQV 111
+ I N+ + F+ + NLY +M+ K + +L E + +L ++
Sbjct: 57 NGDRRWIT---NLHYAFQ-DENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEM 111
Query: 112 FRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFG--LAREIDAFPPYTERVGTRWYQA 168
+D +HQ GY HRD+KP+N+L+ G I++ADFG L D VGT Y +
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 169 PEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
PEIL G Y + D W++G M E+L F + KI
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI----------- 220
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESL-CSWDP-CKRPTAAEALQH 282
+N++ + SE+A +LI L CS + R + H
Sbjct: 221 ----------MNHK----EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266
Query: 283 PFF 285
PFF
Sbjct: 267 PFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 82/301 (27%), Positives = 130/301 (43%), Gaps = 49/301 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK-----L 56
E + + K +G G+FG V K++ +V A+K L K + L E C R+ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW----EMLKRAETACFREERDVLV 56
Query: 57 NHPN--IVKVKELIVEKGNVFFVFEC-MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N N I + ++ N++ V + + +L L+ + + E + +L ++
Sbjct: 57 NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEMVI 113
Query: 114 GLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI--DAFPPYTERVGTRWYQAPE 170
+D +HQ Y HRD+KP+N+L+ G I++ADFG ++ D + VGT Y +PE
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 171 ILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
IL G Y + D W++G M E+L F + KI +
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESL-CSWDPCKRPTAAEAL-QHPF 284
+QFP A + SEDA +LI L CS + E QHPF
Sbjct: 223 ------HKERFQFP--------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268
Query: 285 F 285
F
Sbjct: 269 F 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 26/214 (12%)
Query: 8 KKLGSGSFGCVWQA----VNKHSGEVVAIKALKKSYSREKCLNLR-EVKCLRKLNHPNIV 62
++LG +FG +++ ++VAIK LK + ++ + E + +L+HPNIV
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 63 KVKELIVEKGNVFFVFECM-QCNLYQLMEAKKQKQQLFSES----AVKAWL--------- 108
+ ++ ++ V +FE + Q +L++ + + + S VK+ L
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGT---- 163
Q+ G++Y+ + H+DL N+L+ Q +KI+D GL+REI + Y + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF 197
RW I++ G +SS D+W+ G ++ E+ F
Sbjct: 191 RWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 50/205 (24%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH-PNIV 62
+ L + +G+G++G V++ + +G++ AIK + + E+ + L E+ L+K +H NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL-EINMLKKYSHHRNIA 76
Query: 63 KVKELIVEKG------NVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
++K ++ V E C ++ L+ K K E + ++ RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGL 134
Query: 116 DYMHQQGYFHRDLKPENLLVSQGT-IKIADFGLAREID-AFPPYTERVGTRWYQAPEILF 173
++H HRD+K +N+L+++ +K+ DFG++ ++D +GT ++ APE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 174 ----KSGLYSSKVDMWAMGAIMAEL 194
Y + D+W++G E+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 82/334 (24%), Positives = 139/334 (41%), Gaps = 86/334 (25%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLR-EVKCLRKLNHPNIVKV 64
K LG G+FG V A + + A+K L+K R + +++ E L + ++ +V++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 65 KELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+K N++FV + + ++ L+ + +F E + ++ ++ ++ +H+ G+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL----IRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 124 FHRDLKPENLLVSQ-GTIKIADFGL----------------------------------- 147
HRD+KP+N+L+ + G IK+ DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 148 AREIDAFPPYTER-------------VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
R D P R VGT Y APE+L ++G Y+ D W++G I+ E+
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM 241
Query: 195 LLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSA 254
L+ +P F + K+ +W L PQ + L P A
Sbjct: 242 LVGQPPFLAQTPLETQMKVI---------NWQTSLHIP-------PQ------AKLSPEA 279
Query: 255 SEDAINLIESLCSW--DPCKRPTAAEALQHPFFK 286
S+ LI LC D + A E HPFFK
Sbjct: 280 SD----LIIKLCRGPEDRLGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 35/235 (14%)
Query: 5 SLTKKLGSGSFG----CVWQAVNKHSGE------------VVAIKALKKSYSREKCLN-L 47
+ +KLG G FG C + + K + +VA+K L++ ++ + L
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 48 REVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAV-- 104
+E+K + +L PNI+++ + + + + E M+ +L Q + + ++ V
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 105 -----KAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYT 158
Q+ G+ Y+ + HRDL N LV + TIKIADFG++R + + Y
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 159 ER----VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF---RPLFQGTDE 206
+ + RW IL G +++ D+WA G + E+L +P Q +DE
Sbjct: 188 IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 71/265 (26%), Positives = 113/265 (42%), Gaps = 75/265 (28%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-----NKHSGEVVAIKALKK--SYSREKCLNLREVKCLR 54
++ L K LG G+FG V QA S VA+K LK+ + S K L + E+K L
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKAL-MTELKILI 65
Query: 55 KL-NHPNIVKVKELIVEKGNVFFVF--ECMQCNLYQLMEAKKQ----------------- 94
+ +H N+V + + G V C NL + +K++
Sbjct: 66 HIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQ 125
Query: 95 ----KQQLFS-----ESAVKAWL-------------------------------FQVFRG 114
KQ+L S SA ++ FQV RG
Sbjct: 126 KEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARG 185
Query: 115 LDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE----RVGTRWYQAP 169
++++ + HRDL N+L+S+ +KI DFGLAR+I P Y R+ +W AP
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW-MAP 244
Query: 170 EILFKSGLYSSKVDMWAMGAIMAEL 194
E +F +Y+++ D+W+ G ++ E+
Sbjct: 245 ESIFDK-VYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKAL-KKSYSREKCLN--LREVKCLRKLNHPNIVKVKE 66
LG G FG V + +G++ A K L KK + K + E + L K++ IV +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 67 LIVEKGNVFFVFECM-----QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
K ++ V M + ++Y + E F E + Q+ GL+++HQ+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG----FPEPRACFYTAQIISGLEHLHQR 116
Query: 122 GYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTE-RVGTRWYQAPEILFKSGLYS 179
+RDLKPEN LL + G ++I+D GLA E+ T+ GT + APE+L + Y
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL-QGEEYD 175
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDE 206
VD +A+G + E++ R F+ E
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 81/314 (25%), Positives = 129/314 (41%), Gaps = 49/314 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL------KKSYSREKCLNLREVKCLRK 55
E + + K +G G+FG V +K S +V A+K L K+S + E +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS---DSAFFWEERDIMAH 99
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
N IV++ + ++ V E M +L LM E + + +V
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLA 154
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDA--FPPYTERVGTRWYQAPEI 171
LD +H G+ HRD+KP+N+L+ G +K+ADFG ++DA VGT Y +PE+
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214
Query: 172 LFK---SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
L G Y + D W++G + E+L+ F KI MD
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI--------MDH---- 262
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFK 286
+ ++ FP S+ A +LI + + + R E HPFFK
Sbjct: 263 -KNSL----TFPD---------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
Query: 287 RCLYVPPHLRSTPA 300
+ ++R T A
Sbjct: 309 NDQWTFDNIRETVA 322
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 50/168 (29%), Positives = 86/168 (51%), Gaps = 9/168 (5%)
Query: 49 EVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLM--EAKKQKQQLFSESAVKA 106
E+ L +LNH NI+K++E++ + N + + + +LY M EA K + + +A
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT-RA 271
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAR--EIDAFPPYTERVGT 163
+ Q+ ++Y+H + HRD+K EN+ ++ G I + DFG A E + VGT
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL--FRPLFQGTDEADQ 209
+PEIL G Y D+W+ G I+ ++L F P+ G + +
Sbjct: 332 VATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 23/161 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-------REVKCL 53
+E++ + K + G+FG V+ K++ ++ A+K +KK+ K N+ R+ L
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK--NMVHQVQAERDALAL 60
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLF----SESAVKAWLF 109
K P IV + + NV+ V E Y + K ++ E AVK ++
Sbjct: 61 SK--SPFIVHLYYSLQSANNVYLVME------YLIGGDVKSLLHIYGYFDEEMAVK-YIS 111
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAR 149
+V LDY+H+ G HRDLKP+N+L+S +G IK+ DFGL++
Sbjct: 112 EVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 56/213 (26%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 4 YSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKK----SYSREKCLNLREVKCLRKL 56
++L + LG G FG V +A K S + VA+K LK S E+ L RE C+++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFL--REAACMKEF 58
Query: 57 NHPNIVKVKELIVE---KGNV---FFVFECMQ---CNLYQLMEAKKQKQQLFSESAVKAW 107
+HPN++K+ + + KG + + M+ + + LM ++ + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 108 LFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTE----RVG 162
+ + G++Y+ + + HRDL N ++++ T+ +ADFGL+++I + Y + ++
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+W A E L +Y++ D+WA G M E++
Sbjct: 179 VKWL-ALESL-ADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 59/273 (21%)
Query: 23 NKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80
+ + + +K L+KS YSRE+ + PN+V + + IV + +VF V +
Sbjct: 14 DTRTQQTFILKGLRKSSEYSRER-------LTIIPHCVPNMVCLHKYIVSEDSVFLVLQH 66
Query: 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138
+ L+ + K E VK W ++ LD +H++G RDL P N+L+ G
Sbjct: 67 AEGGKLWSHI----SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG 122
Query: 139 TIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFR 198
I++ F E++ Y APE+ S + D W++GAI+ ELL
Sbjct: 123 HIQLTYFSRWSEVE--DSCDGEAVENMYCAPEVGGISEE-TEACDWWSLGAILFELL--- 176
Query: 199 PLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPS-ASED 257
G ++ G+ +N +P SE+
Sbjct: 177 ------------------TGKTLVECHPSGINTHTTLN--------------IPEWVSEE 204
Query: 258 AINLIESLCSWDPCKRPTAAEA-----LQHPFF 285
A +L++ L ++P +R A A HPFF
Sbjct: 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 51/246 (20%)
Query: 2 EKYSLTKKLGSGSFG--------------CVWQAVNKHSGEV--VAIKALKKSYSREKCL 45
+ + +KLG G FG A N ++ VA+K L+ S +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAR 63
Query: 46 N--LREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSE 101
L+EVK L +L+ PNI ++ + + + E M N L Q + QK +
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYM-ENGDLNQFL----QKHVAETS 118
Query: 102 SAVKAWLF-----------QVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAR 149
Q+ G+ Y+ + HRDL N LV + TIKIADFG++R
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 150 EIDAFPPYTERVG------TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF---RPL 200
+ + Y RV RW +L G +++K D+WA G + E+L +P
Sbjct: 179 NLYSSDYY--RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 201 FQGTDE 206
TD+
Sbjct: 235 EHLTDQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKH--SGEV---VAIKALKKSYS-REKCLNLREVKCLRK 55
EK +L ++LG GSFG V++ + GE VA+K + +S S RE+ L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECM----------------QCNLYQLMEAKKQKQQLF 99
++V++ ++ + V E M + N + ++ Q+
Sbjct: 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 100 SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYT 158
+E A G+ Y++ + + HRDL N +V+ T+KI DFG+ R+I Y
Sbjct: 126 AEIA---------DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 159 E----RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+ + RW APE L K G++++ DMW+ G ++ E+
Sbjct: 177 KGGKGLLPVRW-MAPESL-KDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 10 LGSGSFGCVWQAVNKHSGEVV--AIKALKKSYSREKCLNLR-EVKCLRKLN-HPNIVKVK 65
+G G+FG V +A K G + AIK +K+ S++ + E++ L KL HPNI+ +
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 66 ELIVEKGNVFFVFE-CMQCNLYQLMEAKK------------QKQQLFSESAVKAWLFQVF 112
+G ++ E NL + + S + + V
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTE-RVGTRWYQAPE 170
RG+DY+ Q+ + HRDL N+LV + + KIADFGL+R + + T R+ RW A E
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW-MAIE 193
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELL 195
L S +Y++ D+W+ G ++ E++
Sbjct: 194 SLNYS-VYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 80/348 (22%), Positives = 147/348 (42%), Gaps = 87/348 (25%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLR-EVKCLRKLNHPNIVKV 64
K LG G+FG V A + + A+K L+K +R + +++ E L + ++ +VK+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 65 KELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+K N++FV + + ++ L+ + ++F E + ++ ++ ++ +H+ G+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL----IRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 124 FHRDLKPENLLVS-QGTIKIADFGLAREI-----------------DAFPPYT------- 158
HRD+KP+N+L+ G IK+ DFGL D+ P
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 159 ----------ERVGTRWYQ--------------APEILFKSGLYSSKVDMWAMGAIMAEL 194
E+ T+ +Q APE+L + G Y+ D W++G I+ E+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEM 241
Query: 195 LLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSA 254
L+ +P F + K+ +W + L P V LS
Sbjct: 242 LVGQPPFLAPTPTETQLKVI---------NWENTL--------HIP--PQVKLSP----- 277
Query: 255 SEDAINLIESLC--SWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTPA 300
+A++LI LC + + R A + HPFF + +R+ PA
Sbjct: 278 --EAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF-SSDIRTQPA 322
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH--- 58
+ + + K +G G+FG V KH+ + A+K L K + L E C R+ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW----EMLKRAETACFREERNVLV 56
Query: 59 ----PNIVKVKELIVEKGNVFFVFEC-MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
I + ++ ++ V + + +L L+ + + E + ++ ++
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYIAEMVL 113
Query: 114 GLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFG--LAREIDAFPPYTERVGTRWYQAPE 170
+ +HQ Y HRD+KP+N+L+ G I++ADFG L D + VGT Y +PE
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 171 IL--FKSGL--YSSKVDMWAMGAIMAELL 195
IL + G+ Y + D W++G M E+L
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 6 LTKKLGSGSFG----CVWQAVNKHSGE----------VVAIKALKKSYSREKCLN-LREV 50
L +KLG G FG C + + + GE +VA+K L+ ++ + L+E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 51 KCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQL--------FSE 101
K + +L +PNI+++ + V + + E M+ +L Q + ++ + S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 102 SAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTER 160
+ + Q+ G+ Y+ + HRDL N LV TIKIADFG++R + + Y +
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 161 ----VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+ RW IL G +++ D+WA G + E+
Sbjct: 189 GRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 43/240 (17%)
Query: 8 KKLGSGSFGCVWQA----------------VNKHSGEVVAIKALKKSYSREKCLN-LREV 50
+KLG G FG V V K +VA+K L+ ++ + L+EV
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 51 KCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKK-------------QKQ 96
K L +L PNI+++ + V++ + + E M+ +L Q + +
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 97 QL--FSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDA 153
L S S++ Q+ G+ Y+ + HRDL N LV + TIKIADFG++R + A
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 154 FPPYTER----VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF---RPLFQGTDE 206
Y + + RW IL G +++ D+WA G + E+L+ +P + TDE
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH--------PNI 61
+G GS+ V K + ++ A+K +KK + ++ ++ H P +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----EDIDWVQTEKHVFEQASSNPFL 58
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V + +F V E + N LM Q+Q+ E + + ++ L+++H++
Sbjct: 59 VGLHSCFQTTSRLFLVIEYV--NGGDLM-FHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLARE-IDAFPPYTERVGTRWYQAPEILFKSGLYS 179
G +RDLK +N+L+ G IK+ D+G+ +E + + GT Y APEIL + Y
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL-RGEEYG 174
Query: 180 SKVDMWAMGAIMAELLLFRPLF 201
VD WA+G +M E++ R F
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 8 KKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSREKCLN-LREVKCLRKLNHPNIV 62
K LGSG+FG V++ + GE VAIK L+++ S + L E + +++P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
++ I V + + M L++ ++ + + W Q+ +G++Y+ ++
Sbjct: 73 RLLG-ICLTSTVQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 123 YFHRDLKPENLLV-SQGTIKIADFGLAREIDA----FPPYTERVGTRWYQAPEILFKSGL 177
HRDL N+LV + +KI DFGLA+ + A + +V +W IL +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI-- 187
Query: 178 YSSKVDMWAMGAIMAELLLF 197
Y+ + D+W+ G + EL+ F
Sbjct: 188 YTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 33/91 (36%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGTRW-- 165
FQV RG++++ + HRDL N+L+S+ +KI DFGLAR+I P Y + R
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 166 -YQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+ APE +F +Y+++ D+W+ G ++ E+
Sbjct: 241 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 7/92 (7%)
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE----RVGT 163
FQV +G++++ + HRDL N+L+S+ +KI DFGLAR+I P Y R+
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+W APE +F +Y+ + D+W+ G ++ E+
Sbjct: 246 KW-MAPETIFDR-VYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 71/312 (22%), Positives = 126/312 (40%), Gaps = 55/312 (17%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV 62
+Y++ L GS G V+ KH G+ K + K+ + K RE+ L+ ++H I+
Sbjct: 93 QYNILSSLTPGSEGEVFVCT-KH-GDEQRKKVIVKAVTGGKTPG-REIDILKTISHRAII 149
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQ---KQQLFSESAVKAWLFQVFRGLDYMH 119
+ K V V +C+L+ ++ +Q + + ++ L Y+H
Sbjct: 150 NLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR-------RLLEALAYLH 202
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER----VGTRWYQAPEILFK 174
+G HRD+K EN+ + + + DFG A ++DA P T + GT +PE+L
Sbjct: 203 GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH-PDTPQCYGWSGTLETNSPELL-A 260
Query: 175 SGLYSSKVDMWAMGAIMAELLLFR-PLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
Y +K D+W+ G ++ E+ + LF + S + + M
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLFG--------------KQVKSSSSQLRSIIRCM 306
Query: 234 AIN-YQFPQLSGVNLSALMPSASE-------------------DAINLIESLCSWDPCKR 273
++ +FPQ NL + D LI + ++D R
Sbjct: 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFR 366
Query: 274 PTAAEALQHPFF 285
P+A + L P F
Sbjct: 367 PSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 50/200 (25%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVV----AIKALKKSYSREKCLN-LREVKCLRKLNHPNIV 62
K LGSG+FG V++ + GE V AIK L ++ + + + E + ++HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
++ + + + V + M L++ + + + W Q+ +G+ Y+ ++
Sbjct: 73 RLLGVCLSP-TIQLVTQLMPHGC--LLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 123 YFHRDLKPENLLV-SQGTIKIADFGLAREIDA----FPPYTERVGTRWYQAPEILFKSGL 177
HRDL N+LV S +KI DFGLAR ++ + ++ +W I ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-- 187
Query: 178 YSSKVDMWAMGAIMAELLLF 197
++ + D+W+ G + EL+ F
Sbjct: 188 FTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
+S+ + G+ G + ++ + E V IKA ++ + E LR +NHP+I++
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGT------ATEAHILRAINHPSIIQ 147
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+K + + +LY + AK+ + + A V R + Y+H+
Sbjct: 148 LKGTFTYNKFTCLILPRYKTDLYCYLAAKRN----IAICDILAIERSVLRAIQYLHENRI 203
Query: 124 FHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP------PYTERVGTRWYQAPEILFKSG 176
HRD+K EN+ ++ G + + DFG A FP Y GT APE+L +
Sbjct: 204 IHRDIKAENIFINHPGDVCLGDFGAA----CFPVDINANKYYGWAGTIATNAPELLARDP 259
Query: 177 LYSSKVDMWAMGAIMAEL 194
Y VD+W+ G ++ E+
Sbjct: 260 -YGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 85/347 (24%), Positives = 149/347 (42%), Gaps = 59/347 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK--SYSREKCLNLREVKCLRKLNHP 59
+++ + LG G+FG V +A ++ E A+K ++ Y+R+ + ++ ++ +R+ +
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188
Query: 60 N---IVKVKELIV-EKGNVFFVF-ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+ ++K++ E G++ V + C L +M K FS + +FQ
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIM-----KHGPFSHRHLAQIIFQTGVA 243
Query: 115 LDYMHQQGYF-HRDLKPENLLVSQGT-----------------IKIADFGLAREIDAFPP 156
LDY H + + H DLKPEN+L+ ++I D G D
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHS 301
Query: 157 YTERVGTRWYQAPEILFKSG-LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICS 215
T V TR Y++PE++ G +YS+ DMW+MG I+ EL + L+ D + ++ +
Sbjct: 302 RTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359
Query: 216 VLGSPTMDSWAD--GLRQAMAINYQFPQLSG----------VNLSALMPSASEDAI-NLI 262
LG + WA G +A + QL + +D + +LI
Sbjct: 360 TLGRLPSE-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418
Query: 263 ESLCSWDPCKRPTAAEALQHP----FFKRCLYVPPH------LRSTP 299
L +D KR A + HP ++ C P + LR TP
Sbjct: 419 YGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRPTP 465
|
Length = 467 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVA---IKALKKSYS-REKCLNLREVKCLRKLNHPNIVK 63
++G+G FG V H G A +K L+ S + E+ L L+EV+ R+LNHPN+++
Sbjct: 1 DEIGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLF----QVFRGLDYMH 119
+E V E C L L + + + ++ A K L +V GL ++H
Sbjct: 60 CLGQCIESIPYLLVLEF--CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 120 QQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTER---------VGTRWYQAP 169
Q + H DL N L + ++KI D+GL A Y E V RW AP
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGL-----ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 170 EIL--FKSGLYSSKV----DMWAMGAIMAEL 194
E++ L ++W++G M EL
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEV----VAIKALKKSYSREKCLNLRE-VKCLRKLNHPNIV 62
K LGSG FG V + + G+ VAIK ++ R+ + + + + L+H IV
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
++ I ++ V + L L++ +Q + + W Q+ +G+ Y+ +
Sbjct: 73 RLLG-ICPGASLQLVTQLSP--LGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 123 YFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPP------YTE-RVGTRWYQAPEILFK 174
HR+L N LL S ++IADFG+A D P Y+E + +W ILF
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVA---DLLYPDDKKYFYSEHKTPIKWMALESILF- 185
Query: 175 SGLYSSKVDMWAMGAIMAELLLF 197
G Y+ + D+W+ G + E++ +
Sbjct: 186 -GRYTHQSDVWSYGVTVWEMMSY 207
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 37/219 (16%)
Query: 100 SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGL----------- 147
SE+ + LF RGL+Y+HQ GY HR++K ++L+S G + ++ GL
Sbjct: 99 SEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQ 156
Query: 148 -AREIDAFPPYTERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGT 204
A+ + FP ++ V W +PE+L + G Y+ K D++++G EL R FQ
Sbjct: 157 KAKVVYDFPQFSTSV-LPWL-SPELLRQDLYG-YNVKSDIYSVGITACELATGRVPFQDM 213
Query: 205 DEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSA---------- 254
+ + +D ++ N Q SG+ S +
Sbjct: 214 LRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR 273
Query: 255 -------SEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
S NL+E DP KRP+A+ L H FFK
Sbjct: 274 TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 35/95 (36%), Positives = 58/95 (61%), Gaps = 7/95 (7%)
Query: 106 AWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGT- 163
++ +QV RG++++ + HRDL N+L++QG I KI DFGLAR+I Y + T
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 164 ---RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+W APE +F + LY++ D+W+ G ++ E+
Sbjct: 301 LPVKW-MAPESIFDN-LYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 8 KKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSREKCLN-LREVKCLRKLNHPNIV 62
K LGSG+FG V++ + GE VAIK L+++ S + L E + + P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
++ + + V V + M L++ ++ + + W Q+ +G+ Y+ +
Sbjct: 73 RLLGICL-TSTVQLVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 123 YFHRDLKPENLLVSQGT-IKIADFGLAR--EIDAFPPYTE--RVGTRWYQAPEILFKSGL 177
HRDL N+LV +KI DFGLAR +ID + + +V +W IL +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR-- 187
Query: 178 YSSKVDMWAMGAIMAELLLF 197
++ + D+W+ G + EL+ F
Sbjct: 188 FTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 10 LGSGSFGCVWQAVNKHSGEVV--AIKALKKSYSREKCLNLR-EVKCLRKL-NHPNIVKVK 65
+G G+FG V +A+ K G + AIK LK+ S + E++ L KL +HPNI+ +
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 66 ELIVEKGNVFFVFE-CMQCNLYQLMEAKK--------QKQQLFSESAVKAWLFQ----VF 112
+G ++ E NL + + K+ + + L Q V
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTE-RVGTRWYQAPE 170
G+ Y+ ++ + HRDL N+LV + KIADFGL+R + + T R+ RW A E
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW-MAIE 188
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELL 195
L S +Y++K D+W+ G ++ E++
Sbjct: 189 SLNYS-VYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELI 68
LG G+ G V++A + + ++A+K + + E + + E++ L K + P I+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 69 VEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL 128
+ + E M L +K + + AV V +GL Y+ HRD+
Sbjct: 69 FVENRISICTEFMDGG--SLDVYRKIPEHVLGRIAVA-----VVKGLTYLWSLKILHRDV 121
Query: 129 KPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG-LYSSKVDMWA 186
KP N+LV ++G +K+ DFG++ ++ T VGT Y APE + SG Y D+W+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-YVGTNAYMAPERI--SGEQYGIHSDVWS 178
Query: 187 MGAIMAELLLFR---PLFQG 203
+G EL L R P Q
Sbjct: 179 LGISFMELALGRFPYPQIQK 198
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 10 LGSGSFGCVWQAVNKHSGEVV--AIKALKKSYSREKCLNLR-EVKCLRKL-NHPNIVKVK 65
+G G+FG V +A K G + AIK +K+ S++ + E++ L KL +HPNI+ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 66 ELIVEKGNVFFVFE-CMQCNLYQLMEAKK--QKQQLFSESAVKAWLF---QVFR------ 113
+G ++ E NL + + + F+ + A Q+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 114 -GLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTE-RVGTRWYQAPE 170
G+DY+ Q+ + HRDL N+LV + KIADFGL+R + + T R+ RW
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 182
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELL 195
+ + +Y++ D+W+ G ++ E++
Sbjct: 183 LNYS--VYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 46/209 (22%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEV--VAIKALKKSYSREKCLN--LREVKCLRKLNHPN 60
+L K LG G FG V + + VA+K +K + + L E C+++ +HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 61 IVKVKELIVEKGN-------VFFVFECMQCNLYQLMEAKK---QKQQLFSESAVKAWLFQ 110
++++ + ++ V + +L+ + + Q L ++ VK ++
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTD 120
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTE----RVGTRW 165
+ G++Y+ + + HRDL N ++++ + +ADFGL+++I Y + ++ +W
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+ + +Y++K D+W+ G M E+
Sbjct: 181 IAIESLADR--VYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 7/92 (7%)
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPY----TERVGT 163
+QV +G+ ++ + HRDL N+L++ G I KI DFGLAR+I Y R+
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+W APE +F +Y+ + D+W+ G ++ E+
Sbjct: 281 KW-MAPESIFNC-VYTFESDVWSYGILLWEIF 310
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 51/202 (25%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 10 LGSGSFGCVWQA--VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRKLNHPNIVKVK 65
+G G FGCV+ ++ ++ A+K+L + E+ L+E ++ +HPN++ +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 66 ELIVEK-GNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWL---FQVFRGLDYMHQ 120
+ + G+ V M+ +L + ++ VK + QV +G++Y+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYLAS 116
Query: 121 QGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYT------ERVGTRWYQAPEILF 173
+ + HRDL N ++ + T+K+ADFGLAR+I Y+ ++ +W A E L
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW-MALESL- 174
Query: 174 KSGLYSSKVDMWAMGAIMAELL 195
++ +++K D+W+ G ++ EL+
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 13/109 (11%)
Query: 98 LFSESAVKAWL------FQVFRGLDYMHQQGYFHRDLKPENLLVSQGT-IKIADFGLARE 150
L +ES +++ +QV G++++ + HRDL N+L+ +G +KI DFGLAR+
Sbjct: 229 LINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 151 IDAFPPYTERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
I Y + T +W APE +F + LY++ D+W+ G ++ E+
Sbjct: 289 IMRDSNYISKGSTFLPLKW-MAPESIFNN-LYTTLSDVWSFGILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 22/200 (11%)
Query: 13 GSFGCVWQAVNKH----SGEVVAIKALKKSYSREKC-LNLREVKCLRKLNHPNIVKVKEL 67
G+FG ++ + E V +K +K S + L L+E L L+H NI+ + +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 68 IVEKGNVFFVFECMQC--NLYQLM----EAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+E G FV NL + + Q S + Q+ G+ Y+H++
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVG------TRWYQAPEILFK 174
G H+D+ N ++ + +KI D L+R D FP +G +W A E L
Sbjct: 137 GVIHKDIAARNCVIDEELQVKITDNALSR--DLFPMDYHCLGDNENRPVKW-MALESLVN 193
Query: 175 SGLYSSKVDMWAMGAIMAEL 194
YSS D+W+ G ++ EL
Sbjct: 194 K-EYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 12/204 (5%)
Query: 5 SLTKKLGSGSFG---CVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ + LG+G FG + VAI L+ S ++ L E L + +H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV+++ +I + V E M K + Q + L + G+ Y+ +
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSE 125
Query: 121 QGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPYTERVGTR--WYQAPEILFKSGL 177
GY H+ L +LV+ + KI+ F +E + YT G + APE + +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI-QYHH 184
Query: 178 YSSKVDMWAMGAIMAELLLF--RP 199
+SS D+W+ G +M E++ + RP
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEV---VAIKALK--KSYSREKCLNLREVKCLRKLNHP 59
L K LG G FG V + VA+K +K E L E C++ +HP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 60 NIVKVKELIVEKGNV------FFVFECMQ---CNLYQL-MEAKKQKQQLFSESAVKAWLF 109
N++K+ + E ++ + M+ + + L ++L ++ +K ++
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FMV 120
Query: 110 QVFRGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTE----RVGTR 164
+ G++Y+ + + HRDL N +L T+ +ADFGL+++I + Y + ++ +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
W A E L +Y+SK D+WA G M E+
Sbjct: 181 WI-AIESL-ADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 76/305 (24%), Positives = 123/305 (40%), Gaps = 55/305 (18%)
Query: 24 KHSGEVVAIKALKKSYSREKCLN------LREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77
K +GE V ++ + + E C N E+ + NHPNIV + + ++ V
Sbjct: 22 KPTGEYVTVRRI----NLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77
Query: 78 FECMQCNLYQLMEAKKQKQQLF----SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENL 133
M AK F SE A+ L V + LDY+H GY HR +K ++
Sbjct: 78 TSFMAYG-----SAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 132
Query: 134 LVS-QGTIKIADFGL------------AREIDAFPPYTERVGTRWYQAPEILFKSGL--Y 178
L+S G + ++ GL R + FP Y+ +V W +PE+L + L Y
Sbjct: 133 LISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKV-LPWL-SPEVL-QQNLQGY 187
Query: 179 SSKVDMWAMGAIMAEL----LLFR--PLFQGTDEA---------DQMYKICSVLGSPTMD 223
+K D++++G EL + F+ P Q E D L
Sbjct: 188 DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSR 247
Query: 224 SWAD-GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
S A+ GL ++ ++ P + + S + +E +P RP+A+ L H
Sbjct: 248 SGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307
Query: 283 PFFKR 287
FFK+
Sbjct: 308 SFFKQ 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQGTI-KIADFGLAREIDAFPPY----TERVGT 163
QV +G+D++ + HRD+ N+L++ G + KI DFGLAR+I Y R+
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+W APE +F +Y+ + D+W+ G ++ E+
Sbjct: 279 KW-MAPESIFDC-VYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 9e-09
Identities = 39/144 (27%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
++PN +K+ + + + ++ +L+ L+ +K+ SE+ VK + Q+ L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEAL 122
Query: 116 DYMHQQGYFHRDLKPENLL--VSQGTIKIADFGLAREIDAFPPYTERV--GTRWYQAPEI 171
+ +H+ H D+K EN+L ++ I + D+GL + I T GT Y +PE
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEK 177
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
+ K Y D WA+G + ELL
Sbjct: 178 I-KGHNYDVSFDWWAVGVLTYELL 200
|
Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 8 KKLGSGSFGCVWQA--VNKHSGE---VVAIKALKKSYSREKCLNLREVKCLR-KLNHPNI 61
++LG FG V++ GE VAIK LK + +R +L HPNI
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFS---ESAVKAWL--------- 108
V + ++ ++ + +F C +L++ + + + S + VK+ L
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY----TERVGT 163
Q+ G++++ H+DL N+LV + +KI+D GL RE+ A Y +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF 197
RW I++ G +S D+W+ G ++ E+ +
Sbjct: 191 RWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 8 KKLGSGSFGCVW--QAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKV 64
K++G+G FG V + + ++ V +K L+ S S +E+ L E + R L H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 65 KELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSE-SAVKAWLFQVFRGLDYMHQQG 122
E V E C +L + + ++ + + + + ++ ++ GL ++H+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 123 YFHRDLKPEN-LLVSQGTIKIADFGLA----REIDAFPPYTERVGTRWYQAPEIL--FKS 175
+ H DL N LL + T+KI D+GL+ +E P V RW APE++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHG 179
Query: 176 GLY----SSKVDMWAMGAIMAELLLF--RPLFQGTDEADQMYKI 213
L + + ++W++G + EL +P +DE Y +
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 8 KKLGSGSFGCVW--QAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKV 64
+++G+G FG V + V +K LK + S +E+ L++ R L HPNI++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESA---VKAWLFQVFRGLDYMHQQ 121
VE VFE C L L Q+Q S ++ ++ G+ +MH+
Sbjct: 61 LGQCVEAIPYLLVFE--YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118
Query: 122 GYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTER---------VGTRWYQAPEI 171
+ H DL N L S T+K+ D+G+ Y E V RW APE+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI-----GPSRYKEDYIETEDDKCVPLRWL-APEL 172
Query: 172 L--FKSGLYSSK----VDMWAMGAIMAELL 195
+ F GL +++ ++WA+G + EL
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 24/48 (50%), Positives = 32/48 (66%), Gaps = 1/48 (2%)
Query: 102 SAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLA 148
+ +K + QV GL +H+ G HRD+KPENLLV+ G +KI DFG A
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 40/200 (20%)
Query: 2 EKYSLTKKLGSGSFGCVWQA--VNKHS---GEVVAIKALKKSYSR-EKCLNLREVKCLRK 55
+ + L KKLG G+FG V++A VNK S G+ V KA Y E +N R +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA--TEYGAVEIWMNERVRRACPN 189
Query: 56 LNHPNIVKVKELIVEKGN----VFFVFECMQCNLYQLMEAK-----------KQKQQLFS 100
+ E + K + + +E + L LM++K + Q L
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEG-ESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248
Query: 101 ESAVKAWLFQ-VFR----GLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDA 153
+ + Q + R LD +H G HRD+KP+N++ S+ G+ KI D G A ++
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL-- 306
Query: 154 FPPYTERVGTRWYQAPEILF 173
RVG Y E L
Sbjct: 307 ------RVGIN-YIPKEFLL 319
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 39/128 (30%), Positives = 52/128 (40%), Gaps = 29/128 (22%)
Query: 159 ERV-GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
ER+ GT Y APE+L + VD WA+G + E L P F DE Q ++L
Sbjct: 538 ERILGTPDYLAPELLLGKP-HGPAVDWWALGVCLFEFLTGIPPFN--DETPQQV-FQNIL 593
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA 277
W +G + +++N Q N IE L + DP KR
Sbjct: 594 NRDI--PWPEG-EEKLSVNAQ---------------------NAIEILLTMDPTKRAGLK 629
Query: 278 EALQHPFF 285
E QHP F
Sbjct: 630 ELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 20/50 (40%), Positives = 28/50 (56%), Gaps = 8/50 (16%)
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREID 152
V+A+L Q+ R G+FH D P N+LV S G I + DFG+ +D
Sbjct: 274 VRAFLRQLLRD-------GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316
|
Length = 517 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 14/32 (43%), Positives = 19/32 (59%)
Query: 118 MHQQGYFHRDLKPENLLVSQGTIKIADFGLAR 149
+H G H DL N+++S G I + DFGLA
Sbjct: 111 LHSAGIIHGDLTTSNMILSGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 13/32 (40%), Positives = 18/32 (56%)
Query: 118 MHQQGYFHRDLKPENLLVSQGTIKIADFGLAR 149
+H+ G H DL N+++S G I DFGL
Sbjct: 108 LHKAGIVHGDLTTSNIILSGGRIYFIDFGLGE 139
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.14 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.09 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.93 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.74 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.05 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.95 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.93 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.9 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.7 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.66 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.62 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.44 | |
| PLN02236 | 344 | choline kinase | 97.21 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.19 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.17 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.13 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.12 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.98 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.71 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.69 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.61 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.16 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.74 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.06 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.7 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.64 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.59 |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-69 Score=475.08 Aligned_cols=288 Identities=58% Similarity=1.045 Sum_probs=274.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc-cchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECC-eEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS-YSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKG-NVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~-~~~iv 77 (356)
|+||.++++||.|+||.||+|+.+.+|..||||.+++. ...++...+||+..|++|+ ||||+++.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 68999999999999999999999999999999999765 3556667789999999998 999999999999887 99999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~~ 156 (356)
||||+++|++++..+ +.+|++..++.|++||++||+|+|.+|+.|||+||+|||+. ...+||+|||+|+.+.+.++
T Consensus 89 fE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 999999999998754 66799999999999999999999999999999999999998 78999999999999999999
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
++..+.|.+|+|||++++.+.|+.+.|||++|||++|+.+-++.|.+.++.|++++|+..+|+|....|..+.......+
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 291 (356)
+++|...+..+..+.+..+.++.++|.+||.|||.+||||.|+|+||||+.....
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 9999999999999999999999999999999999999999999999999865444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-63 Score=433.76 Aligned_cols=258 Identities=35% Similarity=0.526 Sum_probs=218.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 74 (356)
+.|.+.+.||.|+||.|-+|.++.||+.||||+++++... ......+|+++|++|+|||||+++++|...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4688999999999999999999999999999999875321 122346899999999999999999999999999
Q ss_pred EEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC----cEEEeccccee
Q 036550 75 FFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG----TIKIADFGLAR 149 (356)
Q Consensus 75 ~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----~~kL~Dfg~a~ 149 (356)
||||||++|+ |++.+- .++.+.|...+.+++||+.|+.|||++||+||||||+|||++.. .+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999875 666554 34458999999999999999999999999999999999999754 79999999999
Q ss_pred ecCCCCCCccccccccccChHHHhhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccchH
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSG--LYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD-QMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 226 (356)
..++..-..+.||||.|.|||++.+.+ .+..++|||||||++|-+++|.+||....... ...+|..+--.+.+
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p---- 403 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP---- 403 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC----
Confidence 998888888999999999999997654 34558899999999999999999999775544 44444332211122
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..+..+|.++++||.+||..||++|||++|+|+||||+...
T Consensus 404 ----------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 404 ----------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ----------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 22347899999999999999999999999999999998644
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-62 Score=436.00 Aligned_cols=282 Identities=38% Similarity=0.688 Sum_probs=247.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~iv 77 (356)
+.|+.+++||+|+||.||+|++..||+.||+|.++... ........+||.||++|+||||+++.+...+. +.+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 56889999999999999999999999999999998765 33344557999999999999999999998876 799999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC--C
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA--F 154 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~--~ 154 (356)
+|||+.+|..++.. .+-.|++.++++|+.||+.||+|||++||+|||||.+||||++ |.+||+|||+|+.... .
T Consensus 197 FeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999998888763 2334999999999999999999999999999999999999976 8999999999996654 3
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
..++..+-|.+|+|||.+++...|+.++|+||+|||+.||+.|++.|++.++.+++.+|+..+|+|....|. ..+....
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~ 352 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHA 352 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcc
Confidence 467888999999999999999999999999999999999999999999999999999999999999999998 3333333
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..++-...-...+......++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 33333333334455557789999999999999999999999999999999943
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-63 Score=414.54 Aligned_cols=285 Identities=34% Similarity=0.596 Sum_probs=248.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
|++|+.+.++|+|+||.||+|+++.||+.||||.+..+.++ -.+-.++||++|++|+|+|+|.++++|.....+++|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 79999999999999999999999999999999998665432 2344589999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-CCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-AFPP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~~~~ 156 (356)
||++.++++.+....+ .+++..++.+++|++.|+.|||++++|||||||+|||++. |.+||||||+|+.+. ....
T Consensus 81 E~~dhTvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 9999998888875543 3899999999999999999999999999999999999986 899999999999887 5567
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
++..+.|.+|+|||.+.++..|+.++||||+||++.||++|.+.|.+.++.++++.|...+|...+....-.......--
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 88899999999999999988899999999999999999999999999999999999999998776655433333333334
Q ss_pred ccCCCcc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLS-GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+|... ..++..-.+.++.-+.||+++||..||.+|++.+|+|.||||.+.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 4455432 233444456788899999999999999999999999999999653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=440.94 Aligned_cols=250 Identities=36% Similarity=0.615 Sum_probs=224.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccc---cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS---YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+|...+.||+|+|++||.+++..+|+.||+|++.+. .....+...+||++.+.|+|||||+++++|++.+++|||+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 599999999999999999999999999999999764 23445667899999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceeecCCC-CC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~~-~~ 156 (356)
+|.- +|..++. +.++++|.+++.+++||+.||.|||+++|+|||||..|++++++ ++||+|||+|+.+... ..
T Consensus 99 LC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 99 LCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred ecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 8875 5555554 44559999999999999999999999999999999999999987 9999999999998754 56
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
..+.||||.|+|||++.+.+ ++..+||||+|||+|.|++|+|||+..+..+++.+|... .
T Consensus 175 k~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------------~ 234 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------------E 234 (592)
T ss_pred cceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------------------C
Confidence 67899999999999998666 899999999999999999999999999988888887542 4
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
|.+|. .+|.++++||.+||+.||.+|||++++|.|+||+.
T Consensus 235 Y~~P~-----------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 235 YSMPS-----------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ccccc-----------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 45554 67999999999999999999999999999999954
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-61 Score=410.73 Aligned_cols=285 Identities=40% Similarity=0.684 Sum_probs=253.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~i 76 (356)
++.|+.+.+|++|+||.||+|+++.|++.||+|.++.....+ ....++||.+|.+++|||||.+..+.... +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467999999999999999999999999999999998764322 12337999999999999999999988644 68999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
||||++.+|..++.... ++|...+++.++.|++.||+|||.+.|+||||||+|+|+++ |.+||+|||+|+.+++.
T Consensus 155 VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99999999999987544 56999999999999999999999999999999999999975 89999999999998765
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.+++..+-|.+|+|||.+++...|+.++|+||+|||+.||++++|.|.+..+.+++.+|+..+|.|....|.....-...
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 45777889999999999999999999999999999999999999999999999999999999999999999887766655
Q ss_pred hcccCCCcccccccccCCC--CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPS--ASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+.+++...-..+...++. ++....+|++.+|.+||.+|.||+|+|+|.||.+.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 5677776555555444444 55999999999999999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-61 Score=396.98 Aligned_cols=281 Identities=42% Similarity=0.761 Sum_probs=251.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|...++||+|.||.||+|++..||+.||||.++.....+ ....++||..|+.++|+||+.++++|.+.+.+.+|+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 579999999999999999999999999999999997764332 345589999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCCC-
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPP- 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~~- 156 (356)
||++.+|...+. .+...++...++.|+.+++.||+|||++.|+||||||.|+|++ +|.+||+|||+|+.......
T Consensus 81 Efm~tdLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 999999998886 3455699999999999999999999999999999999999997 58999999999998876443
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.+..+-|.+|+|||.+.+.+.|+..+||||.|||+.||+.|.|.|.+.++.+++..|+..+|+|..+.|.+........+
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 33448999999999999999999999999999999999999999999999999999999999999999998876555545
Q ss_pred cc-CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQ-FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
++ +|. .....+++..+.++.||+.+||..||.+|+|+.|+|+|+||++
T Consensus 238 ~~~~P~---~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPK---PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCC---CccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 54 333 2333477889999999999999999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-61 Score=415.51 Aligned_cols=290 Identities=31% Similarity=0.487 Sum_probs=240.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++++.||+|+||+||+++.+.|++.||+|++++.. ..+......|..+|.+++||+||+++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 68999999999999999999999999999999998764 234455678999999999999999999999999999999
Q ss_pred EeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec-CCCC
Q 036550 79 ECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI-DAFP 155 (356)
Q Consensus 79 e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~-~~~~ 155 (356)
||+.|+ |+..+ .+.+.|+|..++.|+.+|+.||.|||++|||||||||+|||+++ |+++|+|||+|+.. ....
T Consensus 105 d~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred eccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999885 55554 44455999999999999999999999999999999999999985 99999999999854 4445
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
...+.|||+.|||||++.+.+ |+.++|+||||+++|+|++|.+||.+.+......+|...-
T Consensus 181 ~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------------ 241 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------------ 241 (357)
T ss_pred ccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------------------
Confidence 566789999999999998886 9999999999999999999999999999888877775431
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC----CHHHHhcCCCCCCCCCCCCCCCC-Ccchhhccccccc
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP----TAAEALQHPFFKRCLYVPPHLRS-TPAVAATRRGMLK 310 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 310 (356)
.......++.+++++++++|..||++|. ++.++.+||||....|.....+. .|+..+...+...
T Consensus 242 -----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~ 310 (357)
T KOG0598|consen 242 -----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLED 310 (357)
T ss_pred -----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccc
Confidence 1111224799999999999999999996 68999999999999887655554 3444444444444
Q ss_pred ccccccCcCCCCCcc
Q 036550 311 QQGDRIDAEALPYPK 325 (356)
Q Consensus 311 ~~~~~~~~~~~~~~~ 325 (356)
..+........++..
T Consensus 311 ~~~Fd~eft~~~~~~ 325 (357)
T KOG0598|consen 311 TSNFDNEFTSYTVDY 325 (357)
T ss_pred cccccHHHHhccccC
Confidence 444444444443333
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-59 Score=417.59 Aligned_cols=258 Identities=34% Similarity=0.568 Sum_probs=226.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
.+|.+++.||+|+|++|++|+++.+++.||||++.+..- .......+|-.+|.+| +||.|++++..|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 589999999999999999999999999999999987642 2233446789999999 899999999999999999999
Q ss_pred EEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 78 FECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 78 ~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
+||++ |.|+++|.+. +.|++..++.++.||+.||+|||++|||||||||+|||+++ +++||+|||.|+.+...
T Consensus 153 Le~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99987 5688888654 44999999999999999999999999999999999999975 79999999999876431
Q ss_pred -------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036550 155 -------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT 221 (356)
Q Consensus 155 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (356)
....+++||..|.+||++. ++..++.+|||+||||+|+|+.|.|||.+.++-..+.+|+..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l----- 302 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL----- 302 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-----
Confidence 1114579999999999984 455899999999999999999999999999998888887553
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPH 294 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~ 294 (356)
.|.||. ++++.+.+||+++|..||.+|+|+++|.+||||.+..|....
T Consensus 303 --------------~y~fp~-----------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 303 --------------DYEFPE-----------GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred --------------cccCCC-----------CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 555554 788999999999999999999999999999999998887533
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-59 Score=388.76 Aligned_cols=260 Identities=33% Similarity=0.520 Sum_probs=231.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++.+.||.|+||+|.+++++.+|..||+|++.+..- ...+...+|.++|+.+.||+++++++.+.+.+++|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 5789999999999999999999999999999999987642 3334457899999999999999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||++|+ ++.+++ +.++|++..++.++.||+.||+|||+++|++|||||+|||++. |.+||+|||+|+.+...
T Consensus 123 meyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999875 777764 3445999999999999999999999999999999999999986 89999999999998763
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
..+.||||.|+|||++...+ |+.++|+|||||++|||+.|.+||...+....+.+|+..
T Consensus 198 -T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------------- 256 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------------- 256 (355)
T ss_pred -EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------------
Confidence 56789999999999996666 999999999999999999999999999998888888653
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYVPPHLRS 297 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~~~~~~ 297 (356)
++.||. .+++++++||.++|+.|-++|. ...++.+||||++..|.....+.
T Consensus 257 ~v~fP~-----------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ 312 (355)
T KOG0616|consen 257 KVKFPS-----------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRK 312 (355)
T ss_pred cccCCc-----------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhcc
Confidence 556665 6799999999999999999994 67899999999999887655554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-58 Score=412.84 Aligned_cols=271 Identities=33% Similarity=0.555 Sum_probs=229.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++++.||+|+||.||+|+.+.||..||+|++++.. ..+......|-.+|...++|+||+++..|.+.+++|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 578999999999999999999999999999999998874 23334456799999999999999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC--
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-- 153 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-- 153 (356)
|||++|+ +..++. +.+.|++..++.++.+++.|++.+|+.|+|||||||+|+||+. |++||+|||+|+-+..
T Consensus 220 MEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999886 444443 4456999999999999999999999999999999999999986 9999999999853210
Q ss_pred ----------------------CC----CC--------------------ccccccccccChHHHhhCCCCCCchhHHHH
Q 036550 154 ----------------------FP----PY--------------------TERVGTRWYQAPEILFKSGLYSSKVDMWAM 187 (356)
Q Consensus 154 ----------------------~~----~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 187 (356)
.. .. ...+|||.|+||||+++.+ |+..+|+|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHH
Confidence 00 00 1237999999999999888 9999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccC
Q 036550 188 GAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCS 267 (356)
Q Consensus 188 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 267 (356)
|||+|||+.|.|||.+.++.+...+|.... ..+.+|... ..++++.|||.+||.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-----------------~~l~fP~~~---------~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWR-----------------ETLKFPEEV---------DLSDEAKDLITRLLC 428 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-----------------hhccCCCcC---------cccHHHHHHHHHHhc
Confidence 999999999999999999999998887632 224444432 568999999999999
Q ss_pred CCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCcchhh
Q 036550 268 WDPCKRPT---AAEALQHPFFKRCLYVPPHLRSTPAVAA 303 (356)
Q Consensus 268 ~dP~~Rpt---~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 303 (356)
||.+|.. ++||.+||||++..|.......+|-++.
T Consensus 429 -d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~ 466 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQ 466 (550)
T ss_pred -CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCC
Confidence 9999985 9999999999999998776666444433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-58 Score=398.49 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=215.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe-EEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGN-VFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~iv~e 79 (356)
++.+.++.||+|+.|+||+|+|+.|++.+|+|++..... .....+.+|+++++..+|||||++|+.|.+++. ++|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 356778999999999999999999999999999965543 344566899999999999999999999999994 999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
||+|+.++.+.... +.++|.....++.++++||.|||+ ++||||||||+|||++. |.+||||||.+..+.+. ..
T Consensus 159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 99987666655432 459999999999999999999995 99999999999999975 89999999999888664 55
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGT-----DEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.+++||..|||||.+.+.. |+.++||||||++++|+.+|+.||... +..+.+..|+.. |+
T Consensus 235 ~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---pp----------- 299 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---PP----------- 299 (364)
T ss_pred ccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---CC-----------
Confidence 7889999999999997665 999999999999999999999999875 233344333321 11
Q ss_pred hhhcccCCCcccccccccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMP-SASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
+.++. .+|+++++||..||++||.+|||+.|+++|||+++..
T Consensus 300 ---------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 300 ---------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ---------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 12223 4899999999999999999999999999999998643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-58 Score=393.29 Aligned_cols=287 Identities=38% Similarity=0.738 Sum_probs=251.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCC-eeEEeEEEEECC-----
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPN-IVKVKELIVEKG----- 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~----- 72 (356)
|+.|..+++||+|+||+||+|+++.+|+.||+|.++..... ......+|+.+|+.++|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35688899999999999999999999999999999776443 3345589999999999999 999999998877
Q ss_pred -eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 73 -NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 73 -~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
.+++||||+.-+|..++.........++...++.+++||+.||+|||+++|+||||||+|||+++ |.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 89999999999999998866543244788999999999999999999999999999999999986 8999999999987
Q ss_pred cC-CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 151 ID-AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 151 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.. ....++..++|.+|.|||++++...|+...||||+|||++||+++++.|.+..+.+++.+|+..+|.|....|....
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 76 44457788999999999999999889999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhhcccCCCcc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINYQFPQLS-GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... ..+..++.+. ...+....+..+++..+++.+||+.+|.+|.|+..+|.||||...
T Consensus 250 ~~~-~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 250 SLP-DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccc-cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 322 2333555554 556666667777899999999999999999999999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=392.09 Aligned_cols=282 Identities=39% Similarity=0.662 Sum_probs=247.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccc--ccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-----CCeEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK--SYSREKCLNLREVKCLRKLNHPNIVKVKELIVE-----KGNVF 75 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 75 (356)
+|...+.||+|+||.|+.+.++.+|+.||+|.+.. ..........+|+.+|+.++|+||+.+.+++.. -..+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 46667999999999999999999999999999974 334455666899999999999999999999865 35799
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA- 153 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~- 153 (356)
+|+|+|+.+|...+.. ++.+++..+..+++||+.||+|+|+.+|+||||||+|++++. -.+||||||+|+....
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 9999998888888753 344999999999999999999999999999999999999986 4899999999998864
Q ss_pred --CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh-h
Q 036550 154 --FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL-R 230 (356)
Q Consensus 154 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~ 230 (356)
....+..+.|.+|.|||+++....|+.+.||||+|||+.||++|++.|.+.+..+++..|...+|+|..+.+.... .
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 3445778999999999999998889999999999999999999999999999999999999999999766654332 1
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......+.|...+.++...++..++.+.+|+.+||..||.+|+|++|+|+||||...
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 2223344577888888889999999999999999999999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-58 Score=393.33 Aligned_cols=280 Identities=36% Similarity=0.652 Sum_probs=248.4
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--C---eEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK--G---NVFFV 77 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~---~~~iv 77 (356)
.|.-.+.+|.|+||.||+|....+++.||||.+-.+.. ...+|+.+|+.++|||||++..+|... . +..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 37778999999999999999999999999999855432 335699999999999999999988743 2 45699
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~ 155 (356)
|||++.+|++.+......+..++.-.++-+++||++||.|||+.||+||||||+|||++. |.+||||||.|+.+....
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 999999999999877666777999999999999999999999999999999999999975 799999999999998888
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
+..+...|..|+|||.+.+...|+.+.||||.||++.||+-|++.|.+.+..+++..|+..+|.|..+......... .
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y--~ 258 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY--T 258 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc--c
Confidence 88889999999999999999999999999999999999999999999999999999999999999987765443222 2
Q ss_pred cccCCCcccccccc-cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSA-LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+|......+.. .....++++.+|+.++|..+|.+|.++.|+|+||||...
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 56677776666655 667899999999999999999999999999999999763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-57 Score=391.75 Aligned_cols=256 Identities=30% Similarity=0.523 Sum_probs=222.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc--cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+.+|.+.+.||+|+||+||+|+++.++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++.+++++|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999999776 3445566789999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-------CcEEEecccceee
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-------GTIKIADFGLARE 150 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-------~~~kL~Dfg~a~~ 150 (356)
|||.| +|.+++..+. .++|.+++.++.||+.||++||+++||||||||+|||++. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99985 6777776443 4999999999999999999999999999999999999964 2589999999999
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
+.+.....+.||+|.|||||++.... |+.|+|+||+|+|+|++++|++||...+..+.+..+...-
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~------------- 230 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN------------- 230 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-------------
Confidence 99877778899999999999996555 9999999999999999999999999998888766443211
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+......+....+++...|..+|.+|.+..+-+.|+++...
T Consensus 231 --------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 231 --------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred --------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 11112223567778899999999999999999999999998653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-58 Score=374.54 Aligned_cols=257 Identities=35% Similarity=0.563 Sum_probs=224.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc--cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
|+|++.+.||+|.|+.|+++.+..+|+.+|+|++... .....+.+.+|+++.+.|+|||||++++.+.+.+..|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5799999999999999999999999999999998543 33455677899999999999999999999999999999999
Q ss_pred eccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCC
Q 036550 80 CMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~ 154 (356)
++.|+ +...|-.+ ..++|..+-.+++||++||.|||.+||||||+||+|+++.. --+||+|||+|..+++.
T Consensus 91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99985 55444433 34899999999999999999999999999999999999953 37999999999999877
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+|||.|||||++.++. |+.++|||+.|||||-|+.|.+||.+.+....+.+|...
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g------------------ 227 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG------------------ 227 (355)
T ss_pred cccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc------------------
Confidence 6677889999999999997776 999999999999999999999999998888888777554
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.++++. ..++.+++++++|+++||..||.+|+|+.|+|+|||+.+..
T Consensus 228 -~yd~~~-------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 228 -AYDYPS-------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred -ccCCCC-------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 333332 23457899999999999999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=397.12 Aligned_cols=253 Identities=34% Similarity=0.552 Sum_probs=221.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc----cc-hHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS----YS-REKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~ 75 (356)
.+|.+.+.||+|+||+|++|.+..+++.||+|++.+. .. .......+|+.+++.+. ||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 5899999999999999999999999999999987664 11 22334458999999998 999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeec-
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREI- 151 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~- 151 (356)
+||||+.| .|++.+.. .+++.|..++.+++||+.|++|||++||+||||||+|||++. +++||+|||++...
T Consensus 97 ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999987 67777754 445899999999999999999999999999999999999986 69999999999988
Q ss_pred CCCCCCccccccccccChHHHhhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSG-LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.......+.|||+.|+|||++.+.. +.+.++||||+||+||.|++|..||...+....+.+|..
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--------------- 237 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--------------- 237 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc---------------
Confidence 4556678899999999999998877 667999999999999999999999999777766666533
Q ss_pred hhhhhcccCCCcccccccccCCCC-CHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+.+|. .+ |+++++|+.+||..||.+|+|+.+++.||||+..
T Consensus 238 ----~~~~~p~-----------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 238 ----GEFKIPS-----------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred ----CCccCCC-----------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 2333443 34 9999999999999999999999999999999973
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-56 Score=400.97 Aligned_cols=253 Identities=29% Similarity=0.534 Sum_probs=224.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
..|....+||+|+.|.||.|+...+++.||+|.+........+.+.+|+.+|+..+|+|||.+++.|...+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888999999999999999999999999999998887777788899999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC-CCc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+|+ |.+.+... .++|.++..+++++++||+|||.+||+|||||.+|||++ +|.+||+|||+|..+.... ...
T Consensus 353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 975 55555432 289999999999999999999999999999999999997 5899999999999886544 567
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
+.+|||+|||||++.... |++++||||||+|+.||+-|.|||-..++...++.|... |.|..
T Consensus 428 TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l---------------- 489 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL---------------- 489 (550)
T ss_pred cccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc----------------
Confidence 889999999999996655 999999999999999999999999998888888777553 22221
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...+.+|+.+++|+.+||..||.+|+++.|||+||||+.
T Consensus 490 ----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 ----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 222478999999999999999999999999999999954
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=386.77 Aligned_cols=282 Identities=35% Similarity=0.655 Sum_probs=237.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
|++|.+.+.||.|+||+||+|++..+++.||+|+++.... .......+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 6899999999999999999999999999999999865432 223345789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~ 157 (356)
|+.|++.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++...... ...
T Consensus 84 ~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 84 YLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 9999988776532 334789999999999999999999999999999999999975 79999999999765432 223
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+....|...........+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 34578999999999877666899999999999999999999999999988888889998999888888654433222333
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.++...........+.++.++++||++||.+||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 344433333333445788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-55 Score=402.29 Aligned_cols=280 Identities=34% Similarity=0.579 Sum_probs=232.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-C-----CCeeEEeEEEEECCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-H-----PNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~iv~~~~~~~~~~~~~i 76 (356)
+|.|.+.||+|+||+|.+|.+..|++.||||++++... -......|+.+|..|+ | -|+|+++++|...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 68999999999999999999999999999999976532 2334467999999996 4 389999999999999999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC---CcEEEecccceeecCC
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDA 153 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~kL~Dfg~a~~~~~ 153 (356)
|+|.+.-+|++++....-. .|+...++.++.||+.||.+||+.||||+||||+|||+.+ ..+||+|||.|+....
T Consensus 266 VfELL~~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eehhhhhhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 9999999999999765443 4999999999999999999999999999999999999964 5999999999987664
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
. .+ +.+.+..|+|||++++.+ |+.+.||||||||++||++|.|.|.+.++.+++..|+..+|.|+...+..+.+...
T Consensus 344 ~-vy-tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 344 R-VY-TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred c-ce-eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 2 23 789999999999999987 99999999999999999999999999999999999999999988766644433211
Q ss_pred hh-c-ccCCC--------------------------c----ccccccccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 234 AI-N-YQFPQ--------------------------L----SGVNLSALMP-SASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 234 ~~-~-~~~~~--------------------------~----~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
.. . ..++. . ....+....+ .....+.+||++||.+||.+|+|+.++|
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 10 0 00010 0 0011111122 3345689999999999999999999999
Q ss_pred cCCCCCCC
Q 036550 281 QHPFFKRC 288 (356)
Q Consensus 281 ~hp~~~~~ 288 (356)
+||||...
T Consensus 501 ~Hpfl~~~ 508 (586)
T KOG0667|consen 501 NHPFLTGT 508 (586)
T ss_pred cCcccccc
Confidence 99999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-55 Score=400.35 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=227.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
=|++++.||.|+.|.|-+|++..||+.+|||++.+.. ......+.+||-+|+.+.||||+++++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 3789999999999999999999999999999997652 2223445789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+.| .|++++.. .++++|.+++++++||+.|+.|||..+|+||||||+|+|++. +++||+|||+|..-....-.
T Consensus 93 yv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 93 YVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred ecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 9986 58888754 345999999999999999999999999999999999999985 68999999999988777788
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
.+.||+|.|.|||++.+..+.+.++||||+|||||.|++|..||++.+-...+.++..+ .|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-------------------~f 229 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-------------------VF 229 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------------------cc
Confidence 89999999999999999998999999999999999999999999988777777666543 22
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVP 292 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 292 (356)
..| ..+|+++.+||++||..||++|.|.+||++|||+..+...+
T Consensus 230 ~MP-----------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 230 EMP-----------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred cCC-----------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 222 37899999999999999999999999999999998875544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=395.65 Aligned_cols=253 Identities=34% Similarity=0.550 Sum_probs=221.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
|++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.... +-..+.+|++++++++|||||.++++|+...++|+|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 79999999999999999999999999999999999876543 3455689999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP- 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~- 156 (356)
||+.|+|..++... +.++|+.++.++.|++.||.|||+++|.|||+||.|||++. |.+|+||||+|+.++....
T Consensus 81 e~a~g~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 81 EYAVGDLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhhhhHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 99999999888643 33999999999999999999999999999999999999986 6999999999998876433
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.+...|||.|||||++.+. .|+..+|+||||||+||+++|+|||....-......|..- |
T Consensus 157 ltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~---------------- 216 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P---------------- 216 (808)
T ss_pred eeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C----------------
Confidence 3455799999999999754 5999999999999999999999999877655555544321 1
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+...|..+.+|++.+|.+||.+|.|..+++.|||.++.
T Consensus 217 -----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 217 -----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred -----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 11123679999999999999999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-56 Score=370.09 Aligned_cols=246 Identities=30% Similarity=0.522 Sum_probs=210.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc--cchHHhhhHHHHHHHHhCCCCCeeEEeE-EEEECC-eEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKE-LIVEKG-NVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~-~~~~~~-~~~iv 77 (356)
.+|.|.++||+|+||+||++++..+|..||.|.++.. ...+......|+.+|++|+|||||++++ .|..+. -++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4599999999999999999999999999999998754 3445566789999999999999999998 454444 48999
Q ss_pred EEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh--CC--cccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 78 FECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ--QG--YFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 78 ~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~--ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
|||++ |+|...+...+...+.++|.++|.++.|++.||..||+ .. |+||||||.||+++. |.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99987 57888888888888889999999999999999999999 44 999999999999975 89999999999988
Q ss_pred CCCCCC-ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 152 DAFPPY-TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 152 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.+.... .+.+|||.||+||++...+ |+.++||||+||++|||+.-.+||.+.+..+...+|.+.- .|+.+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~p------- 249 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPLP------- 249 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCCc-------
Confidence 765443 4678999999999997776 9999999999999999999999999997777666665431 11111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA 276 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 276 (356)
....|.++..+|..|+..||..||+.
T Consensus 250 --------------------~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 --------------------DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --------------------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 02568999999999999999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-55 Score=400.32 Aligned_cols=282 Identities=31% Similarity=0.463 Sum_probs=237.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+++.||+|+||+|+++..+.+++.||||++++.. .++.+....|.+|+... +||.++.++.+|...+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 578999999999999999999999999999999998874 34445557788888877 59999999999999999999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-CC
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-AF 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~~ 154 (356)
||||+.|+. ++ .....+.|++..++.|+.+++.||+|||++||||||||.+|||++. |++||+|||+++..- ..
T Consensus 447 vmey~~Ggd--m~--~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGD--LM--HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCc--EE--EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 999999984 21 2233355999999999999999999999999999999999999985 999999999998764 45
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
...++.||||.|||||++.+.. |+.++|+|||||++|||+.|.+||.+.++++.+..|..
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------------------- 582 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------------------- 582 (694)
T ss_pred CccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------------
Confidence 5678899999999999996665 99999999999999999999999999999998887754
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCC-Ccchhhccccc
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYVPPHLRS-TPAVAATRRGM 308 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~~~~~~-~~~~~~~~~~~ 308 (356)
....+|. .+|.++.++++++|.+||++|.. +++|.+||||+...|.....+. .|+..+..++.
T Consensus 583 d~~~yP~-----------~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 583 DEVRYPR-----------FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred CCCCCCC-----------cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 2333443 57999999999999999999996 5889999999999887654443 45555555555
Q ss_pred ccccccccC
Q 036550 309 LKQQGDRID 317 (356)
Q Consensus 309 ~~~~~~~~~ 317 (356)
.+.++...+
T Consensus 652 ~D~snFd~e 660 (694)
T KOG0694|consen 652 EDVSNFDEE 660 (694)
T ss_pred hhhcccchh
Confidence 554444433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=377.15 Aligned_cols=284 Identities=35% Similarity=0.580 Sum_probs=224.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.++||+|+||+||+|++..+++.||+|++...... ......+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 6899999999999999999999999999999998754322 223457899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
+.+++.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++...... ....
T Consensus 85 ~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 85 VHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred CCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 999988877532 345899999999999999999999999999999999999975 79999999998765432 2234
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE-ADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+..+ .+.+..+....+.+....|............
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 567899999999987766689999999999999999999999987643 4556666666677766555432211100000
Q ss_pred cCCCcccccccccC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALM--PSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+.......+.... ...++.+.+|+.+||+.||++|||+.|+|+||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 01111111111111 1346789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=395.23 Aligned_cols=281 Identities=32% Similarity=0.558 Sum_probs=232.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK--------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~ 73 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 47999999999999999999999999999999885532 2235799999999999999999887432 25
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeec
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREI 151 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~ 151 (356)
+++||||+++++.+.+.........+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|...
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 7799999999998888766556677999999999999999999999999999999999999974 36999999999877
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
..........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+.++...++.|....+......
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 301 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchh
Confidence 65555556789999999999877666899999999999999999999999999888899999988888876655432211
Q ss_pred hhhhcccCCCcccccccc-cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSA-LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.....++......+.. ++...+.++++||.+||..||.+|||+.|+|+||||...
T Consensus 302 --~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 302 --YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred --hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 1122333332222222 233578899999999999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=372.97 Aligned_cols=256 Identities=33% Similarity=0.534 Sum_probs=210.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC--eEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKG--NVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~iv~e~ 80 (356)
+|...+.||+|+||+||++.+..+|+..|+|.+..........+.+|+.+|++++|||||++++...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 5788999999999999999999999999999987764444556789999999999999999999855444 68999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCC----
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDA---- 153 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~---- 153 (356)
+.| +|.+++.... +.++|..++.+.+||++||+|||++||+||||||+|||++. +.+||+|||.+.....
T Consensus 98 ~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 986 6777765432 15999999999999999999999999999999999999987 6999999999987763
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGT-DEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
........||+.|||||++......+.++|||||||++.||+||++||... ...+....+....
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------------- 239 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------------- 239 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------------
Confidence 122345789999999999975332345999999999999999999999873 3333333332110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..+.++..+|.++++||.+||..||++||||+++|+|||.+...
T Consensus 240 -------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 -------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11234457899999999999999999999999999999997643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=374.87 Aligned_cols=285 Identities=35% Similarity=0.657 Sum_probs=239.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
|++|.+.++||+|+||+||+|++..+++.||+|.+..... .......+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 6789999999999999999999999999999999875432 222345689999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~ 157 (356)
|+++++.+.+... +..+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++....... ..
T Consensus 85 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 9999888776532 334799999999999999999999999999999999999975 799999999987654322 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+....+....+.+....|...........+
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 34578999999999877666899999999999999999999999999888888889999998888888665443333344
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.++...........+.++.++++||.+||..||.+|||+.|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 455444333334445789999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=379.22 Aligned_cols=255 Identities=38% Similarity=0.572 Sum_probs=225.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv 77 (356)
+.|.+.+.||.|.||.||+|+++.||+.+|+|++.+.... +.....+|+.+|+++. |||||.++++|++.+.+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 4699999999999999999999999999999999876443 3356789999999998 99999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-----CcEEEecccceeec
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-----GTIKIADFGLAREI 151 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----~~~kL~Dfg~a~~~ 151 (356)
||++.| .|++.+... .++|..+..++.|++.++.|||+.||+||||||+|+|+.. +.+|++|||++...
T Consensus 115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999985 588887655 2999999999999999999999999999999999999942 37999999999998
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.........+||+.|+|||++.... |+..+||||+||++|.|++|.+||.+.+.......+...--.+..+.
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~------- 261 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP------- 261 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC-------
Confidence 8766778889999999999996554 99999999999999999999999999998877776655433333333
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
++.+|..+++||++||..||.+|+|+.++|+|||++..
T Consensus 262 -------------------w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 262 -------------------WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred -------------------ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 35779999999999999999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-54 Score=355.40 Aligned_cols=256 Identities=34% Similarity=0.526 Sum_probs=224.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--------HHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--------EKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.-.+.||.|..++|-+|.++.+|+.+|+|++...... -.+...+|+.+|+++ .||||+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3577788999999999999999999999999998543211 122335799999998 7999999999999999
Q ss_pred eEEEEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceee
Q 036550 73 NVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLARE 150 (356)
Q Consensus 73 ~~~iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~ 150 (356)
.+++|+|.++ |.|++++..... ++|...+.+++|+++|++|||.++||||||||+|||++++ ++||+|||+|+.
T Consensus 97 F~FlVFdl~prGELFDyLts~Vt----lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVT----LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhee----ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999886 679999976544 8999999999999999999999999999999999999875 999999999999
Q ss_pred cCCCCCCccccccccccChHHHh-----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccch
Q 036550 151 IDAFPPYTERVGTRWYQAPEILF-----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (356)
+.........||||+|+|||.+. +...|+..+|+|++|||+|.|+.|.+||-.....-.+..|+.+.-.+..+.|
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 99988889999999999999973 3355899999999999999999999999988777777777766555555555
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
. ++|.+.+|||.+||+.||++|.|++|+|+||||..
T Consensus 253 a--------------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 A--------------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred h--------------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 4 56889999999999999999999999999999954
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=365.40 Aligned_cols=265 Identities=29% Similarity=0.444 Sum_probs=220.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHH-hhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++...||.|..++||+|+...++..||||++.....+.. ..+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 689999999999999999999999999999999987655444 5668899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCCC--
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPP-- 156 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~~-- 156 (356)
|.| ++++.+...-..+ ++|..+..++++++.||.|||.+|.||||||+.|||++ +|.|||+|||.+..+.+...
T Consensus 106 Ma~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 985 6778777655544 99999999999999999999999999999999999997 58999999999876643211
Q ss_pred ---CccccccccccChHHHh-hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 157 ---YTERVGTRWYQAPEILF-KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 157 ---~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
....+||++|||||++. ....|+.|+||||||++..||.+|..||....+...+....+ +.|+.... ...
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~t-~~~--- 257 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLLT-SGL--- 257 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCccc-ccC---
Confidence 14568999999999954 445699999999999999999999999999888766544332 33332110 000
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.....+.++..++.+|..||+.||++|||++++|+|+||+..
T Consensus 258 --------------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 258 --------------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred --------------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 001113567799999999999999999999999999999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=371.66 Aligned_cols=256 Identities=34% Similarity=0.520 Sum_probs=214.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--------------HHhhhHHHHHHHHhCCCCCeeEEeE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--------------EKCLNLREVKCLRKLNHPNIVKVKE 66 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~hp~iv~~~~ 66 (356)
|++|++.+.||+|.||.|-+|++..+++.||||++.+.... ..+...+||.+|++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 57899999999999999999999999999999999764211 1235578999999999999999999
Q ss_pred EEEEC--CeEEEEEEeccCCHHHHHHHHHhhccc-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEE
Q 036550 67 LIVEK--GNVFFVFECMQCNLYQLMEAKKQKQQL-FSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKI 142 (356)
Q Consensus 67 ~~~~~--~~~~iv~e~~~g~l~~~~~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL 142 (356)
+..+. +.+|||+||+..+-... . ....+ +++.+++.|+++++.||+|||.+|||||||||+|+|+++ |.+||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w---~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKW---C-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred eecCcccCceEEEEEeccCCcccc---C-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 98764 78999999998652222 2 22334 899999999999999999999999999999999999975 89999
Q ss_pred ecccceeecC------CCCCCccccccccccChHHHhhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036550 143 ADFGLAREID------AFPPYTERVGTRWYQAPEILFKS---GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKI 213 (356)
Q Consensus 143 ~Dfg~a~~~~------~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 213 (356)
+|||.+.... ........+|||.|+|||...+. ...+.+.||||+||+||.|+.|+.||.+....+.+.+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 9999998662 22233456899999999999773 34578999999999999999999999999988888888
Q ss_pred HHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 214 CSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...- ..||.. +.+...+++||.+||.+||++|.++.++..|||....
T Consensus 332 vn~p-------------------L~fP~~---------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 332 VNDP-------------------LEFPEN---------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hcCc-------------------ccCCCc---------ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 6531 122221 2568899999999999999999999999999999764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=363.50 Aligned_cols=259 Identities=31% Similarity=0.473 Sum_probs=219.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHh---hhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKC---LNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+.|++++.||.|.-|+||+|+...++..+|+|++.+..-.... ....|-+||+.++||.++++|+.|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 5688999999999999999999999999999999876433222 3356999999999999999999999999999999
Q ss_pred EeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCC---
Q 036550 79 ECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA--- 153 (356)
Q Consensus 79 e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~--- 153 (356)
|||.|+ |..+.++ +.++.|++..++.|+.+++.||+|||-.|||+|||||+||||- +|++.|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999876 5444433 3455699999999999999999999999999999999999995 58999999998743210
Q ss_pred --------------------------------C----------------------CCCccccccccccChHHHhhCCCCC
Q 036550 154 --------------------------------F----------------------PPYTERVGTRWYQAPEILFKSGLYS 179 (356)
Q Consensus 154 --------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 179 (356)
. ......+||-.|+|||++.+.+ .+
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-Hg 313 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HG 313 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CC
Confidence 0 0112347999999999998887 89
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHH
Q 036550 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAI 259 (356)
Q Consensus 180 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 259 (356)
.++|+|+|||.+|||+.|..||.+.+..+++.+|+..- ..||.. +.++..++
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-------------------l~Fp~~---------~~vs~~ak 365 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-------------------LKFPEE---------PEVSSAAK 365 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-------------------CcCCCC---------CcchhHHH
Confidence 99999999999999999999999999999988886532 223322 25688999
Q ss_pred HHHHHccCCCCCCCCC----HHHHhcCCCCCCCCCC
Q 036550 260 NLIESLCSWDPCKRPT----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 260 ~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~ 291 (356)
|||+++|.+||++|.. |+||.+||||++..|.
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 9999999999999998 9999999999999887
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=367.06 Aligned_cols=280 Identities=34% Similarity=0.603 Sum_probs=223.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++..... .......+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 589999999999999999999999999999999875432 223455789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--C
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--P 156 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~ 156 (356)
|+.+++.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9999877765432 345899999999999999999999999999999999999975 789999999998764322 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....|++.|+|||++.+.. ++.++|||||||++|+|++|++||...+..+....+....+..+...+...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred ccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 23457899999999996655 89999999999999999999999998887777777766666555443332211111111
Q ss_pred ccCCCcc--cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 237 YQFPQLS--GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 237 ~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..++... ..........+|.++.+||++||+.||++|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1111110 001112234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=366.56 Aligned_cols=278 Identities=34% Similarity=0.635 Sum_probs=224.3
Q ss_pred CCceeecccccCCceEEEEEEEcC-CCcEEEEEEcccccch--HHhhhHHHHHHHHhC---CCCCeeEEeEEEEE-----
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-SGEVVAIKALKKSYSR--EKCLNLREVKCLRKL---NHPNIVKVKELIVE----- 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~----- 70 (356)
++|++.+.||+|+||+||+|++.. +++.||+|++...... ......+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999854 5788999988654322 223345677777665 69999999999852
Q ss_pred CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 71 KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 71 ~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
...+++||||+++++.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 45689999999999888876432 234899999999999999999999999999999999999975 799999999998
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+....+.+..+....+.+....|....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 776544445667999999999986554 8999999999999999999999999999888999998888877766664432
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
... ...+.......+....+.++..+.+|+.+||+.||++|||+.++|+||||
T Consensus 238 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALP---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccc---chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 211 01111112222333445788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-53 Score=341.96 Aligned_cols=253 Identities=30% Similarity=0.509 Sum_probs=222.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++++.||+|.||.||+|+.+.++-.||+|++.+.. ......+.+|+++-+.|+||||++++++|.++...|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 578999999999999999999999999999999997753 22234557899999999999999999999999999999
Q ss_pred EEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC
Q 036550 78 FECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~ 155 (356)
+||.. |.++..+... ....|++...+.++.|++.||.|||.++|+||||||+|+|++ +|.+||+|||.+.... ..
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SN 177 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CC
Confidence 99987 5677776532 344599999999999999999999999999999999999997 5899999999987766 45
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
...+.|||..|.+||...+.. ++..+|+|++|++.||++.|.+||......+.+.+|...
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------------------- 237 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------------------- 237 (281)
T ss_pred CceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------------------
Confidence 567899999999999997666 899999999999999999999999998888888777543
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.+.+| ..++.++.|+|.+||..+|.+|.+..|++.|||...
T Consensus 238 ~~~~p-----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 238 DLKFP-----------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cccCC-----------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 23333 378999999999999999999999999999999853
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=325.53 Aligned_cols=283 Identities=35% Similarity=0.668 Sum_probs=242.9
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
|++|...++||+|.||+||++++..+++.||+|.++.....+ ....++||-+++.++|.|||+++++.+.+..+.+|+
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 678999999999999999999999999999999997764332 356689999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-C
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-P 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~ 156 (356)
||+...|..++. .-++.++.+.++.++.|++.||.|+|++++.|||+||+|+|++. |.+||+|||+++..+-.- -
T Consensus 81 e~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 81 EFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 999988776665 34556899999999999999999999999999999999999975 899999999998776432 3
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
++..+-|.+|.+|.++.+.+.|+.+.|+||.|||+.|+.. |.|.|.+.+..+++.+|+..+|.|..+.|........-
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy- 236 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY- 236 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC-
Confidence 4566789999999999999999999999999999999976 88999999999999999999999999999754321110
Q ss_pred cccCCCc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQL-SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+|.. ....+..+.+.++...+++++++|.-+|.+|.+++++++||||.+.
T Consensus 237 -k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 -KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 111111 1223455567788889999999999999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=365.50 Aligned_cols=285 Identities=35% Similarity=0.651 Sum_probs=237.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+++|.+.++||.|+||.||+|.+..+++.||+|.+..... .......+|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5789999999999999999999999999999999865432 223345689999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~ 157 (356)
|+++++.+.+... ...+++..++.++.||+.||.|||++||+|+||||+||++++ +.++|+|||++....... ..
T Consensus 85 ~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 85 YLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred ccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 9999888776532 334899999999999999999999999999999999999975 699999999987654322 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+...++.+....|............
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 34567899999999877666889999999999999999999999998888888888888888888777655443333333
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.++......+......+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 444433333334445789999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-51 Score=374.49 Aligned_cols=281 Identities=33% Similarity=0.524 Sum_probs=223.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKG------ 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 72 (356)
+++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999986542 223345578999999999999999999986543
Q ss_pred eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 73 NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 73 ~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
.+|+||||+++++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 5799999999997776531 2789999999999999999999999999999999999975 79999999999866
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...++.+....+......
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 5444445568999999999996655 899999999999999999999999998888888888887777665443322111
Q ss_pred hhhhcccCCCccccc------------ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVN------------LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+...... ........+.++++||.+||..||++|||+.|+|+||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 111111111111110 011122357789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=369.75 Aligned_cols=254 Identities=30% Similarity=0.531 Sum_probs=230.2
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|.+.+.||+|.|+.|-+|++..||..||||++.+..- -....+.+|++.|+.++|||||++|++...+..+|+|+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 8889999999999999999999999999999987643 33445678999999999999999999999999999999987
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCCCCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
.| +|+++|.++.. .+.|+.+++|++||+.|+.|||+..+|||||||+|+.+-+ |-+||+|||++-.+......+
T Consensus 100 D~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred CCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 65 79999986643 3899999999999999999999999999999999998854 899999999999998888899
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
+.||+..|.|||+++++.+..+++||||||||||.|.+|++||+..++.+.+-.|+ ..+|.
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-------------------DCKYt 237 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-------------------DCKYT 237 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-------------------ccccc
Confidence 99999999999999999988889999999999999999999999999988877764 34566
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.|. .+|.++++||.+||..||.+|.|.++|..|+|++....
T Consensus 238 vPs-----------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 238 VPS-----------HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred Cch-----------hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 654 78999999999999999999999999999999987544
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=370.55 Aligned_cols=283 Identities=36% Similarity=0.645 Sum_probs=223.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNVF 75 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 75 (356)
+|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999986432 22334567899999999999999999988643 3589
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+||||+++++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999988877753 334899999999999999999999999999999999999975 79999999999765322
Q ss_pred C----CCccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 155 P----PYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 155 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+.+....+....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 12345799999999998652 458999999999999999999999999988877777777777776655443221
Q ss_pred hhhhhhc-ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 230 RQAMAIN-YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
....... ...............+..++.+.+++.+||+.||++|||++++++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 1100000 00111111222233346788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=348.18 Aligned_cols=258 Identities=32% Similarity=0.483 Sum_probs=214.6
Q ss_pred CCceee-cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEE----CCeEE
Q 036550 2 EKYSLT-KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVE----KGNVF 75 (356)
Q Consensus 2 ~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~~~ 75 (356)
++|.+. ++||-|-.|.|-.|.++.||+.+|+|++.-. ....+|+++.-.. .|||||.++++|++ ...+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 678776 7899999999999999999999999997533 3346788877665 69999999999864 36788
Q ss_pred EEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceee
Q 036550 76 FVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLARE 150 (356)
Q Consensus 76 iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~ 150 (356)
+|||+++|+ |+..+..+. .+.|+|.++..|++||..|+.|||+.+|.||||||+|+|... -.+||+|||+|+.
T Consensus 136 iVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 999999875 777765543 345999999999999999999999999999999999999964 3799999999998
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCccchH
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA----DQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 226 (356)
........+.|-||.|.|||++- ...|+..+|+||+||++|.|++|.|||.+.... ....+|....-.++.+.|
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW- 291 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW- 291 (400)
T ss_pred cCCCccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH-
Confidence 88777778899999999999984 444999999999999999999999999876532 333444443333333333
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 293 (356)
..+|.+++++|+++|..+|++|.|++++++|||+.+....|.
T Consensus 292 -------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 292 -------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred -------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 357899999999999999999999999999999988665543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=370.44 Aligned_cols=281 Identities=32% Similarity=0.504 Sum_probs=224.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------C
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK------G 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 72 (356)
+++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999999999999999987542 23334567899999999999999999987543 3
Q ss_pred eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 73 NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 73 ~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
..|+||||+++++.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 5799999999998877632 2789999999999999999999999999999999999975 79999999999876
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....+.+....+......
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 6544445668999999999996655 899999999999999999999999999988888888888777765433322211
Q ss_pred hhhhcccCCCccccc------------ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVN------------LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+...... ........+.++++||.+||..||.+|||+.++|+||||..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 111111111111100 111122346789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=359.00 Aligned_cols=277 Identities=36% Similarity=0.659 Sum_probs=223.9
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhC---CCCCeeEEeEEEEE-----CC
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKL---NHPNIVKVKELIVE-----KG 72 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~-----~~ 72 (356)
+|++.+.||+|+||+||+|++..+++.||+|.+...... ......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 699999999999999999999999999999998754221 122345677777665 79999999998864 34
Q ss_pred eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 73 NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 73 ~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
..+++|||+.+++.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++...
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 689999999998888775432 234899999999999999999999999999999999999975 79999999999877
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||......+.+.++....+.+....|......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 6544445567899999999996655 899999999999999999999999998888888888888777766655432211
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
. ...+............+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus 238 ~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 P---RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred c---ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 11122222233344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=370.65 Aligned_cols=259 Identities=28% Similarity=0.467 Sum_probs=210.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|.+..+++.||+|++.+... .....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999976432 22234567999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99976 56666643 345899999999999999999999999999999999999965 799999999987543210
Q ss_pred -----------------------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036550 156 -----------------------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL 200 (356)
Q Consensus 156 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 200 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCC
Confidence 012357999999999996655 89999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCC---CCCCHH
Q 036550 201 FQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPC---KRPTAA 277 (356)
Q Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rpt~~ 277 (356)
|.+.+..+...++...... ..+|.. ..++++++++|.+|+. +|. .||+++
T Consensus 236 f~~~~~~~~~~~i~~~~~~-----------------~~~p~~---------~~~s~~~~~li~~l~~-~~~~r~~r~~~~ 288 (363)
T cd05628 236 FCSETPQETYKKVMNWKET-----------------LIFPPE---------VPISEKAKDLILRFCC-EWEHRIGAPGVE 288 (363)
T ss_pred CCCCCHHHHHHHHHcCcCc-----------------ccCCCc---------CCCCHHHHHHHHHHcC-ChhhcCCCCCHH
Confidence 9988776666555432111 111111 1468899999999875 444 468999
Q ss_pred HHhcCCCCCCCCCCC
Q 036550 278 EALQHPFFKRCLYVP 292 (356)
Q Consensus 278 e~l~hp~~~~~~~~~ 292 (356)
|+++||||++..|..
T Consensus 289 ei~~hp~f~~~~~~~ 303 (363)
T cd05628 289 EIKTNPFFEGVDWEH 303 (363)
T ss_pred HHhCCCCCCCCCHHH
Confidence 999999999876654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=371.94 Aligned_cols=282 Identities=35% Similarity=0.576 Sum_probs=229.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC-----eEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKG-----NVF 75 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 75 (356)
+|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 58899999999999999999999999999999865422 23345678999999999999999999998776 789
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+||||+.+++.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 999999988877764 2345899999999999999999999999999999999999976 69999999999865432
Q ss_pred --CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 155 --PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+.......
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 222345689999999999876668999999999999999999999999999999999999988888876654433222
Q ss_pred hhhcccCCCcc--cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MAINYQFPQLS--GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......+... ...........++++.+||.+||..||++|||+.++|+||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 11111111110 011112334668999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=365.93 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=213.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||.||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999875421 2234457899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999876 56666643 345899999999999999999999999999999999999965 79999999999876542
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+...
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------------- 230 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------------- 230 (329)
T ss_pred -cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 23467999999999986655 799999999999999999999999877765554443221
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
...+| ..++..+.+||++||..||.+|++ ++++++||||.+..+.
T Consensus 231 ~~~~p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 RLKFP-----------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred CcCCC-----------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 11111 246889999999999999999997 7999999999875443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=362.32 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=213.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 589999999999999999999999999999999865421 23344578999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.+ +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99875 67776643 335899999999999999999999999999999999999975 79999999999876542
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... .
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------------~ 214 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------------K 214 (291)
T ss_pred cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------C
Confidence 23457999999999986655 899999999999999999999999987766555444321 1
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
..+ ...++..+++||++||..||.+|++ ++++++||||+...+.
T Consensus 215 ~~~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 215 LEF-----------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred cCC-----------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 111 2256889999999999999999995 9999999999875554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=367.26 Aligned_cols=281 Identities=32% Similarity=0.520 Sum_probs=223.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------C
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK------G 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 72 (356)
+++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 478999999999999999999999999999999987543 22334557899999999999999999988643 3
Q ss_pred eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 73 NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 73 ~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
..|+||||+++++.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++...
T Consensus 96 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 5799999999988776632 2789999999999999999999999999999999999975 79999999999876
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...++.+..+.+......
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 6544445668999999999996654 899999999999999999999999998888888888777776655443322111
Q ss_pred hhhhcccCCCccccc------------ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVN------------LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+...... ........+.++++||.+||..||++|||+.|+|+||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 111100111111000 011122356789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=370.36 Aligned_cols=276 Identities=24% Similarity=0.341 Sum_probs=213.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||+|++..+++.||+|.... ....+|+.++++++||||+++++++...+..++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 479999999999999999999999999999997532 23468999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--CCCc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--PPYT 158 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--~~~~ 158 (356)
.+++...+... ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|...... ....
T Consensus 166 ~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 166 KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 99888776532 34899999999999999999999999999999999999975 79999999998654321 2233
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCccchHHH---
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD-------EADQMYKICSVLGSPTMDSWADG--- 228 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~--- 228 (356)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ...++..+....+.++.....+.
T Consensus 242 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 242 GWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred cccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 567999999999986654 8999999999999999999997765432 23456666666665543321111
Q ss_pred hhhhhhhcccCCCcc--cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 229 LRQAMAINYQFPQLS--GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
............... ..........++.++.+||.+||.+||.+|||++|+|+||||+..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 111000000000000 000000112457789999999999999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=369.91 Aligned_cols=258 Identities=30% Similarity=0.536 Sum_probs=211.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 58999999999999999999999999999999997542 222334567999999999999999999999999999999
Q ss_pred EeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.|+ |.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999764 6555542 345899999999999999999999999999999999999975 799999999987543211
Q ss_pred --------------------------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC
Q 036550 156 --------------------------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF 197 (356)
Q Consensus 156 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 197 (356)
.....+||+.|+|||++.+.+ ++.++|||||||++|+|++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcC
Confidence 011246999999999986655 89999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC--
Q 036550 198 RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-- 275 (356)
Q Consensus 198 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-- 275 (356)
.+||...+..+....+..... ...++. ...+++++.+||.+||. +|.+|++
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~~~---------~~~~s~~~~~li~~ll~-~p~~R~~~~ 288 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKE-----------------TLQFPD---------EVPLSPEAKDLIKRLCC-EAERRLGNN 288 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCC-----------------ccCCCC---------CCCCCHHHHHHHHHHcc-CHhhcCCCC
Confidence 999998876655544432110 011111 11468999999999996 9999998
Q ss_pred -HHHHhcCCCCCCCCCC
Q 036550 276 -AAEALQHPFFKRCLYV 291 (356)
Q Consensus 276 -~~e~l~hp~~~~~~~~ 291 (356)
+.++++||||+...+.
T Consensus 289 ~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 289 GVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CHHHHhcCCCcCCCCHH
Confidence 9999999999886554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-50 Score=356.14 Aligned_cols=259 Identities=27% Similarity=0.386 Sum_probs=210.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+... .......+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999865421 222345789999999999999999999999999999999
Q ss_pred eccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+.++ |.+.+... ....+++..+..++.||+.||+|||++||+||||||+|||+++ +.++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99864 55454322 2235899999999999999999999999999999999999975 79999999999876554444
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+.......
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 220 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------------- 220 (285)
T ss_pred cCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------------
Confidence 5668999999999996554 8999999999999999999999998765432222221111000
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLY 290 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~ 290 (356)
.......++.++.+|+++||+.||.+||+ ++++++||||.+..+
T Consensus 221 ---------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 221 ---------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred ---------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 01122367899999999999999999997 899999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=363.28 Aligned_cols=249 Identities=31% Similarity=0.467 Sum_probs=206.5
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccCC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCN 84 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g~ 84 (356)
+.||+|+||.||+|.+..+|+.||+|++.+.. ........+|+.++++++||||+++++++...+.+|+||||+.|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987642 223344578999999999999999999999999999999999864
Q ss_pred -HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCcccc
Q 036550 85 -LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTERV 161 (356)
Q Consensus 85 -l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~~ 161 (356)
|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++..... .......+
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 555553 3345899999999999999999999999999999999999965 7999999999875432 22334567
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (356)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ...+
T Consensus 157 gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------------------~~~~-- 214 (323)
T cd05571 157 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------EIRF-- 214 (323)
T ss_pred cCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------CCCC--
Confidence 999999999986554 899999999999999999999999877655444333211 1111
Q ss_pred cccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 242 LSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
+..+++++.+||.+||..||++|| ++.++++||||....+.
T Consensus 215 ---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 215 ---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred ---------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 236789999999999999999999 89999999999876554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=354.35 Aligned_cols=249 Identities=30% Similarity=0.494 Sum_probs=221.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhh---hHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL---NLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
||++.+.||+|.||.|-+|++...|+.||||.+++..-.+..+ +.+||++|+.|+||||+.++.+|++.+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 7999999999999999999999999999999998875444443 3689999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|..+ .|++++..+. .++|.+++.+++||++|+.|||.++++|||||.+|||+++ +++||+|||++-.+....-.
T Consensus 134 YaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 134 YASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred ecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 9875 6999986543 4999999999999999999999999999999999999986 69999999999988887778
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
.++||+|.|.+||++.+..+-++.+|.|||||+||.|..|..||++.+......+|..+ .|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-------------------aY 270 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG-------------------AY 270 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-------------------cc
Confidence 89999999999999988887799999999999999999999999999877666665432 22
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
..| .-+.++.-||+.||..||++|.|++++-.|=|..
T Consensus 271 rEP------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 271 REP------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred cCC------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 222 3466889999999999999999999999998885
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=343.37 Aligned_cols=287 Identities=34% Similarity=0.635 Sum_probs=233.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCC----cEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-CCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG----EVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVE-KGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 74 (356)
..|++++.||+|.||.||+|..+.++ +.||+|.++.... .-....-+|+.+++.++|||++.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 57999999999999999999765544 3789999865522 222344689999999999999999998876 7899
Q ss_pred EEEEEeccCCHHHHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-C----CcEEEecccce
Q 036550 75 FFVFECMQCNLYQLMEAKKQ-KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-Q----GTIKIADFGLA 148 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~----~~~kL~Dfg~a 148 (356)
|+++||.+.+|+..|..++. +...++...++.++.||+.|+.|||++-|+||||||+|||+. + |.+||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99999999999999986543 345689999999999999999999999999999999999994 3 79999999999
Q ss_pred eecCCC----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHH
Q 036550 149 REIDAF----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD---------EADQMYKICS 215 (356)
Q Consensus 149 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~~i~~ 215 (356)
+...+. ......+-|.+|+|||.+++...|+.+.|+|++|||+.||++..|.|.+.. ..+++.+|+.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 887653 122345789999999999999999999999999999999999999997653 3478999999
Q ss_pred HhCCCCccchHHHhhhhhhh----cccCCCcccccccc---cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 216 VLGSPTMDSWADGLRQAMAI----NYQFPQLSGVNLSA---LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+|.|....|.+..+.+.-. .++...+....+.. ..+.-++.+.+|+.+||..||.+|.|++++|+|+||.+.
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 99999999998765433210 11111111211111 123346679999999999999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=368.87 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=208.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 58999999999999999999999999999999986542 122334567999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99965 56666642 345899999999999999999999999999999999999965 799999999986321100
Q ss_pred -----------------------------------------------CCccccccccccChHHHhhCCCCCCchhHHHHH
Q 036550 156 -----------------------------------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMG 188 (356)
Q Consensus 156 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 188 (356)
.....+||+.|+|||++.+.. ++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG 235 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecc
Confidence 001246999999999986654 89999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCC
Q 036550 189 AIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSW 268 (356)
Q Consensus 189 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 268 (356)
|++|+|++|.+||...+..+....+..... ...+|. ...++.++.+||.+||.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRE-----------------TLYFPD---------DIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCC-----------------ccCCCC---------CCCCCHHHHHHHHHHhc-
Confidence 999999999999988776665555432110 011111 11468899999999997
Q ss_pred CCCCC---CCHHHHhcCCCCCCCCCC
Q 036550 269 DPCKR---PTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 269 dP~~R---pt~~e~l~hp~~~~~~~~ 291 (356)
+|.+| +|+.++++||||++..+.
T Consensus 289 ~~~~r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 289 NAENRLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 77775 599999999999876553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=362.25 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=211.9
Q ss_pred CCCceeecccccCCceEEEEEEEcCCC-cEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSG-EVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||.||+|.+..++ ..||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 368999999999999999999876654 789999986542 2223445689999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
||||+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999965 56666643 345899999999999999999999999999999999999965 79999999999876542
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+...
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~------------------ 243 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG------------------ 243 (340)
T ss_pred --cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC------------------
Confidence 23568999999999996655 899999999999999999999999987765555444321
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
... +++.+++.+.++|++||+.||++|+ |++++++||||.+..|.
T Consensus 244 -~~~-----------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 244 -IIY-----------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred -CCC-----------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 111 1235688999999999999999995 89999999999986654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-52 Score=362.72 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=214.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.|.....||+|+||.||+|.+..+++.||+|++..... .+.++..+|+.+|..++++||.++|+.|..+..+|++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 47888999999999999999999999999999987643 44567789999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-Cc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~~ 158 (356)
+|+ +.+++. .+..+.|..+..++++++.||.|||..+.+|||||+.|||+.. |.+||+|||.+..+..... ..
T Consensus 94 ~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 94 GGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred cCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 875 555553 3344689999999999999999999999999999999999975 7999999999988865433 36
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
+++|||.||||||+.+.+ |+.++||||||++.+||.+|.||+....+...+..|
T Consensus 170 tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------------------- 223 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------------------- 223 (467)
T ss_pred cccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------------------
Confidence 889999999999997555 999999999999999999999999877663322211
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
|... .+.+...+|+.+++|+..||..||+.||||.++|+|+|++.
T Consensus 224 -pk~~---PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 224 -PKSA---PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -cCCC---CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 1111 12223377999999999999999999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=366.04 Aligned_cols=259 Identities=27% Similarity=0.487 Sum_probs=208.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
..|.+++.||+|+||+||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999987542 223345678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-- 154 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99976 56666543 345899999999999999999999999999999999999975 79999999987532100
Q ss_pred ----------------------------------------------CCCccccccccccChHHHhhCCCCCCchhHHHHH
Q 036550 155 ----------------------------------------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMG 188 (356)
Q Consensus 155 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 188 (356)
......+||+.|+|||++.+.. ++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG 235 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVG 235 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehh
Confidence 0012347999999999986655 89999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccC-
Q 036550 189 AIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCS- 267 (356)
Q Consensus 189 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~- 267 (356)
|++|+|++|.+||...+..+....+...... ..+|. ...+++++.+||.+||.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~~~---------~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENT-----------------LHIPP---------QVKLSPEAVDLITKLCCS 289 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccc-----------------cCCCC---------CCCCCHHHHHHHHHHccC
Confidence 9999999999999887765554444321110 11111 12568999999999664
Q ss_pred -CCCCCCCCHHHHhcCCCCCCCCCC
Q 036550 268 -WDPCKRPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 268 -~dP~~Rpt~~e~l~hp~~~~~~~~ 291 (356)
.+|..|+++.++++||||++..+.
T Consensus 290 ~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 290 AEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred cccccCCCCHHHHhcCcccCCCChh
Confidence 455569999999999999876554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=350.12 Aligned_cols=281 Identities=36% Similarity=0.728 Sum_probs=229.1
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+|+.++++++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 589999999999999999999999999999998654322 224457899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
+.+++.+.+.... .+..+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||++...... ....
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 9998888775432 2345899999999999999999999999999999999999965 79999999998765432 1223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||++.+...++.++|+|||||++|+|++|++||.+....+....+....+.+....|...... ......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL-PDYKNT 238 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh-HHHHhh
Confidence 3467899999999876666789999999999999999999999998888888778777777766666432211 111222
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
++.............+++++.++|++||..||++|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 22222223333345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=362.99 Aligned_cols=280 Identities=34% Similarity=0.604 Sum_probs=224.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
++|.+.+.||.|+||+||+|.+..+++.||+|++..... .......+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 689999999999999999999999999999999875432 2233456899999999999999999987543 45
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.|++++++++++.+.+. ...+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++....
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 79999999888876653 234899999999999999999999999999999999999975 799999999998765
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.. .....||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+....+.+....+.......
T Consensus 170 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred CC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 42 3456799999999999776668999999999999999999999999888888888887777766554332221111
Q ss_pred hh-hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MA-INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.. .....+......+.......++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 001111111222233334567889999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=361.95 Aligned_cols=255 Identities=31% Similarity=0.561 Sum_probs=226.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc--cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe-EEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGN-VFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~iv 77 (356)
|++|.+++.+|+|+||.+++++++..++.|++|.+... .........+|+.+++++.|||||.+.+.|..++. ++|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 68999999999999999999999999999999998654 34555577899999999999999999999998887 9999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|+|++|+ +.+.+...+ +..|+|+.+..|+.||+.|+.|||+++|+|||||+.||+++. +.|||+|||+|+.+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999875 556655433 566999999999999999999999999999999999999975 688999999999998765
Q ss_pred -CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
...+.+|||.||.||.+.+.. |+.++|||||||++|||++-+++|.+.+......+|+.....|..
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 566789999999999986655 999999999999999999999999999999988888776544333
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...+.+++.+|..||+.+|..||++.++|.+|.+..
T Consensus 228 -----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 -----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 356889999999999999999999999999998863
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=361.65 Aligned_cols=260 Identities=29% Similarity=0.468 Sum_probs=214.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||.||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999876421 23345578999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--c
Confidence 99975 57666642 345899999999999999999999999999999999999975 7999999999976654 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------------- 217 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------------- 217 (333)
T ss_pred cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------------
Confidence 3456799999999999666 48999999999999999999999999887766555443221110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
..|... .....++.++.+||.+||..+|.+||++.++++||||.+..+
T Consensus 218 -~~~~~~-----~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 218 -QRPVYD-----DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred -cCCCCC-----ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 011100 001256899999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=368.26 Aligned_cols=258 Identities=29% Similarity=0.494 Sum_probs=209.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
.+|.++++||+|+||+||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999987643 223345578999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-- 154 (356)
||+.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 81 DYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99976 56666543 245899999999999999999999999999999999999975 79999999997532100
Q ss_pred ----------------------------------------------CCCccccccccccChHHHhhCCCCCCchhHHHHH
Q 036550 155 ----------------------------------------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMG 188 (356)
Q Consensus 155 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 188 (356)
......+||+.|+|||++.+.. ++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG 235 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVG 235 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEech
Confidence 0012347999999999997655 89999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCC
Q 036550 189 AIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSW 268 (356)
Q Consensus 189 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 268 (356)
|++|+|++|.+||...+..+....+...... ..+|. ...+++++.++|.+|+ .
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTS-----------------LHIPP---------QAKLSPEASDLIIKLC-R 288 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCC-----------------cCCCC---------cccCCHHHHHHHHHHc-c
Confidence 9999999999999987766555444321111 11111 1257899999999987 5
Q ss_pred CCCCCCC---HHHHhcCCCCCCCCCC
Q 036550 269 DPCKRPT---AAEALQHPFFKRCLYV 291 (356)
Q Consensus 269 dP~~Rpt---~~e~l~hp~~~~~~~~ 291 (356)
||.+|++ ++++++||||+...+.
T Consensus 289 ~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 289 GPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred CHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999997 9999999999886554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=356.17 Aligned_cols=277 Identities=31% Similarity=0.601 Sum_probs=213.8
Q ss_pred ecccccCCceEEEEEEEc--CCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeEEEEEEecc
Q 036550 7 TKKLGSGSFGCVWQAVNK--HSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNVFFVFECMQ 82 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~iv~e~~~ 82 (356)
.++||+|+||+||+|+++ .+++.||+|.+..... .....+|+.++++++||||+++++++.. +...|++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 4678999999865432 2335689999999999999999999864 467899999999
Q ss_pred CCHHHHHHHHHh-----hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-----CCcEEEecccceeecC
Q 036550 83 CNLYQLMEAKKQ-----KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREID 152 (356)
Q Consensus 83 g~l~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-----~~~~kL~Dfg~a~~~~ 152 (356)
+++.+.+..... ....+++..++.++.||+.||+|||++||+||||||+|||+. .+.+||+|||++....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 998888764321 223489999999999999999999999999999999999994 2689999999998764
Q ss_pred CCC----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHhCC
Q 036550 153 AFP----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---------ADQMYKICSVLGS 219 (356)
Q Consensus 153 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~~~ 219 (356)
... ......||+.|+|||++.+...++.++||||+||++|+|++|.+||..... .+++.++...++.
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 321 223467899999999998766689999999999999999999999975432 3567778888888
Q ss_pred CCccchHHHhhhhhhh----cccCCCccccc----ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 220 PTMDSWADGLRQAMAI----NYQFPQLSGVN----LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 220 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+....|.......... .+......... ........+..+.+||++||++||.+|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8777775542211000 00000000000 001112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=353.78 Aligned_cols=285 Identities=39% Similarity=0.681 Sum_probs=232.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~i 76 (356)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 578999999999999999999999999999999986543221 22346799999999999999999998765 56899
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
||||+++++.+.+... ...+++..++.++.||+.||+|||++|++||||||+||++++ +.+||+|||.+......
T Consensus 86 v~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 9999999888887643 245899999999999999999999999999999999999975 79999999999876543
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.......+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+..+....+...++.+....|.+.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 22233456888999999877666899999999999999999999999999998999999888888877776554332222
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+..+......+.......++.+.+||.+||.+||++|||+.++++||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 222222211112222234468999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=364.76 Aligned_cols=259 Identities=33% Similarity=0.553 Sum_probs=215.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.++.|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 589999999999999999999999999999999875421 23345678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99965 676666532 45899999999999999999999999999999999999975 799999999997665432
Q ss_pred -----------------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036550 156 -----------------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE 206 (356)
Q Consensus 156 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 206 (356)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 22345799999999999666 489999999999999999999999998876
Q ss_pred HHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-HHHHhcCCCC
Q 036550 207 ADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-AAEALQHPFF 285 (356)
Q Consensus 207 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~l~hp~~ 285 (356)
.....++..... ...+|. ...+++++.+||.+||. ||.+|++ ++++++||||
T Consensus 236 ~~~~~~i~~~~~-----------------~~~~p~---------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 236 QETYNKIINWKE-----------------SLRFPP---------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred HHHHHHHhccCC-----------------cccCCC---------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 655555433111 111111 11368999999999997 9999999 9999999999
Q ss_pred CCCCCCC
Q 036550 286 KRCLYVP 292 (356)
Q Consensus 286 ~~~~~~~ 292 (356)
+...+..
T Consensus 289 ~~~~~~~ 295 (350)
T cd05573 289 KGIDWEN 295 (350)
T ss_pred CCCCHHH
Confidence 9866543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=355.63 Aligned_cols=248 Identities=30% Similarity=0.471 Sum_probs=205.2
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccCC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCN 84 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g~ 84 (356)
+.||+|+||.||++++..+|+.||+|++.+.. ........+|+.+++.++||||+++++++...+.+|+||||+.|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999987642 223334567999999999999999999999999999999999865
Q ss_pred -HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCcccc
Q 036550 85 -LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTERV 161 (356)
Q Consensus 85 -l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~~ 161 (356)
|...+. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..... ........
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 544443 3345899999999999999999999999999999999999975 7999999999875422 22234467
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (356)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ...+
T Consensus 157 gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------------------~~~~-- 214 (323)
T cd05595 157 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------EIRF-- 214 (323)
T ss_pred CCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CCCC--
Confidence 999999999986554 899999999999999999999999877665544433211 1111
Q ss_pred cccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 242 LSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
+..+++++.++|.+||..||.+|+ ++.++++||||.+..|
T Consensus 215 ---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 215 ---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred ---------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 236789999999999999999998 8999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=359.88 Aligned_cols=260 Identities=31% Similarity=0.488 Sum_probs=214.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++++... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 589999999999999999999999999999999876432 23344568999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99965 666666432 245899999999999999999999999999999999999975 7999999999987654322
Q ss_pred C--ccccccccccChHHHhh-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 157 Y--TERVGTRWYQAPEILFK-----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 157 ~--~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
. ....||+.|+|||++.. ...++.++|||||||++|+|++|..||..........++.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------- 226 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR----------- 226 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 1 23479999999999863 34578999999999999999999999988776665555433210
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 291 (356)
...+|. .+.++.++.+||++||. ||.+|||+.++++||||+...+.
T Consensus 227 ------~~~~~~---------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 227 ------FLKFPE---------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred ------ccCCCC---------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 011111 12568999999999998 99999999999999999876544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=348.80 Aligned_cols=281 Identities=37% Similarity=0.696 Sum_probs=234.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 6999999999999999999999999999999987653 22345567899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PY 157 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~ 157 (356)
++++|.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||.+....... ..
T Consensus 81 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 MPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9778888775432 45899999999999999999999999999999999999975 789999999998765433 23
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....++..|+|||++.+...++.++||||+||++|+|++|.+||...........+....+.+....|............
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 45678999999999876666799999999999999999999999988888888888888888877666554322222223
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
.++......+....+..+..+.+||++||..||++|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 3333333334444567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=346.63 Aligned_cols=278 Identities=43% Similarity=0.843 Sum_probs=228.6
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCC-CCCeeEEeEEEEEC--CeEEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLN-HPNIVKVKELIVEK--GNVFFVFE 79 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~iv~e 79 (356)
|++.++||+|+||.||+|.+..+++.||+|+++... ........+|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 789999999999999999999999999999987643 222233457899999885 99999999999987 89999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCCCCcc
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTE 159 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~~~~~ 159 (356)
|+++++.+.+... ...+++..++.++.||+.||+|||++|++||||+|+||+++++.+||+|||++...........
T Consensus 81 ~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 81 LMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCC
Confidence 9999988876532 2458999999999999999999999999999999999999889999999999987765555555
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..+++.|+|||++...+.++.++|||||||++|+|++|.+||...+..+....+....+.+.... ...........+.+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccccccC
Confidence 67899999999886666678999999999999999999999999888887777777666655433 22221112223344
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+...........+.++..+.++|.+||..||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 4433333444455779999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=362.78 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=213.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999986532 122334568999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 123 EYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99976 56665532 23899999999999999999999999999999999999975 799999999998765322
Q ss_pred -CCccccccccccChHHHhhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKS---GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||...+.......+......
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------------ 265 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS------------ 265 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc------------
Confidence 22356799999999998653 24789999999999999999999999988776655555332110
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~~ 291 (356)
..+|. ...+|.++.+||++||..+|.+ |+|++++++||||+...|.
T Consensus 266 -----~~~~~---------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 266 -----LTFPD---------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred -----CCCCC---------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 11111 1246899999999999999988 9999999999999876554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=372.14 Aligned_cols=279 Identities=24% Similarity=0.362 Sum_probs=212.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC------CCCeeEEeEEEEEC-CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN------HPNIVKVKELIVEK-GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~-~~~ 74 (356)
++|++.+.||+|+||+||+|.+..+++.||||+++.... .......|+.+++.+. |.+++++++++... +++
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 579999999999999999999999999999999865322 1223355777777664 45688999988765 678
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeCC---------------
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQG--------------- 138 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~--------------- 138 (356)
|+||+++++++.+.+... +.+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 208 ~iv~~~~g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEeccCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 999999999988887533 458999999999999999999998 599999999999999753
Q ss_pred --cEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 036550 139 --TIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSV 216 (356)
Q Consensus 139 --~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 216 (356)
.+||+|||.+..... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|++||...+..+.+..+...
T Consensus 284 ~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 499999998764332 234568999999999997665 899999999999999999999999998888888888887
Q ss_pred hCCCCccchHHHh----hhhhhhccc-CCCcccccccc------c-CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 217 LGSPTMDSWADGL----RQAMAINYQ-FPQLSGVNLSA------L-MPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 217 ~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~------~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
++.++........ ......... .+......+.. . ....++.+.+||.+||++||.+|||++|+|+|||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 7776543221110 000000000 00000000000 0 0012567889999999999999999999999999
Q ss_pred CCCC
Q 036550 285 FKRC 288 (356)
Q Consensus 285 ~~~~ 288 (356)
|.+.
T Consensus 441 ~~~~ 444 (467)
T PTZ00284 441 VLKY 444 (467)
T ss_pred cccc
Confidence 9863
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=343.88 Aligned_cols=259 Identities=32% Similarity=0.495 Sum_probs=223.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
|++|..++.||+|.||.|-+|+.+.+++.||+|++++.. ..+....+.|-++|+..+||.+..+...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 688999999999999999999999999999999998763 23334447799999999999999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec-CCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI-DAF 154 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~-~~~ 154 (356)
|||..|+ |+-.+ ++...|+|...+.+...|+.||.|||+++||+||||.+|+|++. |++||+|||+++.- ...
T Consensus 247 MeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 9999886 33333 34455999999999999999999999999999999999999985 89999999999764 344
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
....++||||.|+|||++.... |+.++|+|.+||++|||++|+.||...+....+..|..
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------------------- 382 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------------------- 382 (516)
T ss_pred ceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-------------------
Confidence 5667899999999999996555 99999999999999999999999998887666555532
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYVPPH 294 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~~~ 294 (356)
...+||+ .+|++++.|+..+|..||.+|.. +.|+.+|+||....|....
T Consensus 383 ed~kFPr-----------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~ 436 (516)
T KOG0690|consen 383 EDLKFPR-----------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATY 436 (516)
T ss_pred hhccCCc-----------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHH
Confidence 2445555 78999999999999999999984 8999999999998886543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=356.57 Aligned_cols=248 Identities=33% Similarity=0.492 Sum_probs=204.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC- 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g- 83 (356)
+.||+|+||.||+|++..+++.||+|++.+.. ........+|+.+++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987642 22334557899999999999999999999999999999999976
Q ss_pred CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCcccc
Q 036550 84 NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTERV 161 (356)
Q Consensus 84 ~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~~ 161 (356)
+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..... .......+
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 4555543 2345899999999999999999999999999999999999975 7999999999876432 22234567
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (356)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.. ....
T Consensus 157 gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-------------------~~~~--- 213 (328)
T cd05593 157 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------EDIK--- 213 (328)
T ss_pred CCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-------------------CCcc---
Confidence 999999999986554 89999999999999999999999987765544333211 0111
Q ss_pred cccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 242 LSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
++..++.++.+||++||..||++|+ ++.++++||||....|
T Consensus 214 --------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 214 --------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1236789999999999999999997 8999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=346.78 Aligned_cols=282 Identities=38% Similarity=0.653 Sum_probs=226.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+++|.+.+.||+|++|.||+|.++.+++.||+|.+...... ......+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999999999999999998654322 22345689999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~ 157 (356)
|+.++|.+.+... ...+++..++.++.||+.||.|||++||+|+||||+||++++ +.+||+|||++...... ...
T Consensus 84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9999888776532 235899999999999999999999999999999999999975 79999999998754322 112
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD-EADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.+...++.++||||+||++|+|++|.+||.... ..+....+....+.+....|...........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 234578899999998766668899999999999999999999998766 5566666777777777776655543322222
Q ss_pred ccCCCcccccccccCCCCC--HHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 237 YQFPQLSGVNLSALMPSAS--EDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..++...........+.++ .++.+++.+||..||++|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 3332222222223333445 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=364.67 Aligned_cols=257 Identities=28% Similarity=0.490 Sum_probs=208.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
.+|++.+.||+|+||+||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999865421 22344568999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-- 154 (356)
||+.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|......
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99975 57776643 345899999999999999999999999999999999999975 79999999997532100
Q ss_pred ------------------------------------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHH
Q 036550 155 ------------------------------------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMA 192 (356)
Q Consensus 155 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 192 (356)
......+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvily 235 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILY 235 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceee
Confidence 0011347999999999996655 899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC
Q 036550 193 ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK 272 (356)
Q Consensus 193 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 272 (356)
+|++|.+||......+....+..... ...++. ...+++++.++|.+|+ .+|.+
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~~~---------~~~~s~~~~~li~~l~-~~p~~ 288 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWET-----------------TLHIPS---------QAKLSREASDLILRLC-CGAED 288 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCc-----------------cccCCC---------CCCCCHHHHHHHHHHh-cCHhh
Confidence 99999999998876655444322110 011111 1257899999999977 59999
Q ss_pred CC---CHHHHhcCCCCCCCCC
Q 036550 273 RP---TAAEALQHPFFKRCLY 290 (356)
Q Consensus 273 Rp---t~~e~l~hp~~~~~~~ 290 (356)
|+ |+.++++||||+...+
T Consensus 289 R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 289 RLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred cCCCCCHHHHhCCCCcCCCCH
Confidence 99 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=361.89 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=210.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999987542 222334567999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99976 56666643 345899999999999999999999999999999999999964 799999999986542210
Q ss_pred -----------------------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036550 156 -----------------------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL 200 (356)
Q Consensus 156 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 200 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCC
Confidence 012357999999999986655 89999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC---CHH
Q 036550 201 FQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP---TAA 277 (356)
Q Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ 277 (356)
|...+......++..... ...+|. ...++.+++++|.+|+. ||.+|+ ++.
T Consensus 236 f~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ 288 (360)
T cd05627 236 FCSETPQETYRKVMNWKE-----------------TLVFPP---------EVPISEKAKDLILRFCT-DSENRIGSNGVE 288 (360)
T ss_pred CCCCCHHHHHHHHHcCCC-----------------ceecCC---------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHH
Confidence 998877665555432110 111111 01368899999999874 999998 489
Q ss_pred HHhcCCCCCCCCCCC
Q 036550 278 EALQHPFFKRCLYVP 292 (356)
Q Consensus 278 e~l~hp~~~~~~~~~ 292 (356)
++++||||++..|..
T Consensus 289 ei~~hp~f~~~~~~~ 303 (360)
T cd05627 289 EIKSHPFFEGVDWGH 303 (360)
T ss_pred HHhcCCCCCCCCHHH
Confidence 999999999876654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=359.03 Aligned_cols=258 Identities=31% Similarity=0.450 Sum_probs=211.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986532 222344568999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|........
T Consensus 123 Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 123 EYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99975 57666532 23899999999999999999999999999999999999975 7999999999987653222
Q ss_pred --CccccccccccChHHHhhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 157 --YTERVGTRWYQAPEILFKSG---LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
....+||+.|+|||++.+.. .++.++|+|||||++|+|++|.+||...+......++......
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------ 265 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS------------ 265 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc------------
Confidence 23567999999999996542 3788999999999999999999999988776665555432111
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~ 290 (356)
..+|. ...++..+++++.+||..++.. |+|+.++++||||+...+
T Consensus 266 -----~~~p~---------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 266 -----LNFPE---------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred -----cCCCC---------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 11111 0146889999999999855543 899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=347.30 Aligned_cols=278 Identities=35% Similarity=0.651 Sum_probs=223.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|.+.+.||+|+||.||+|++..+|+.||+|.+...... ......+|+.++++++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 699999999999999999999999999999998654221 123456799999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
+++++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||+++. +.++|+|||++...... ....
T Consensus 81 ~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 99988777653 2345899999999999999999999999999999999999975 79999999998765432 2223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL-FQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |...+..+.+..+...++.+....|......... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 235 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY--K 235 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc--c
Confidence 456789999999987766689999999999999999998877 4555666677777777777766665433221111 1
Q ss_pred cCCCc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQL-SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.++.. ....+....+.++.++.+||++||..||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11111 1111233345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=384.02 Aligned_cols=281 Identities=28% Similarity=0.396 Sum_probs=232.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccc---ccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK---SYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.|++.||+|+||.|.+++++.|++.||+|++++ ....+...+..|-.+|.--+.+.|+.++..|.++.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 589999999999999999999999999999999987 22344556678889998889999999999999999999999
Q ss_pred EeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||++|+ |..++.... .++|..++.|+..|+.||+.||+.|+|||||||+|||++. |++||+|||.|..+.....
T Consensus 155 dY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred ecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 998765 666664332 5999999999999999999999999999999999999985 9999999999988874322
Q ss_pred --CccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 157 --YTERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
....+|||.|++||++... +.|+..+|+||+||++|||+.|..||......+++.+|+...
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk------------- 297 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK------------- 297 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-------------
Confidence 3466899999999998532 568999999999999999999999999999999999997752
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCcchhhcccc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT---AAEALQHPFFKRCLYVPPHLRSTPAVAATRRG 307 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 307 (356)
..+.||.. ..+|.++++||.+++ .+|+.|.+ ++++.+||||.+..|...... .|++.+...+
T Consensus 298 ----~~l~FP~~---------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~-~pP~vPevss 362 (1317)
T KOG0612|consen 298 ----ESLSFPDE---------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRES-VPPVVPEVSS 362 (1317)
T ss_pred ----hhcCCCcc---------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhc-CCCCCCcCCC
Confidence 23444421 258999999999987 48889998 999999999999999432222 3333333444
Q ss_pred ccccccc
Q 036550 308 MLKQQGD 314 (356)
Q Consensus 308 ~~~~~~~ 314 (356)
..+++++
T Consensus 363 d~DTsnF 369 (1317)
T KOG0612|consen 363 DDDTSNF 369 (1317)
T ss_pred CCccccc
Confidence 4444443
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=344.81 Aligned_cols=286 Identities=33% Similarity=0.673 Sum_probs=230.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
|++|.+.+.||+|++|+||+|.+..+|+.||+|.+...... ....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999998654322 2234578999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCC-C
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAF-P 155 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~-~ 155 (356)
||+++++.+.+... ....+++..++.++.||+.||+|||++|++|+||+|+||++++ +.+||+|||++...... .
T Consensus 81 e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99998887776432 2233688999999999999999999999999999999999974 47999999999765432 2
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+..+...++....+.+....|.+...... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD-Y 237 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh-h
Confidence 223456789999999987766689999999999999999999999998888888888877777777666643221111 0
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
...++...........+.+++.+.+++.+||..||++||++.++++||||.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 111222222222233456789999999999999999999999999999998643
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=345.96 Aligned_cols=282 Identities=41% Similarity=0.716 Sum_probs=230.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~i 76 (356)
+++|.+.+.||.|+||.||+|.+..+++.+|+|.++.....+ .....+|+.++++++||||+++++++... +..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999999999999987543222 22346799999999999999999998877 89999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
||||++++|.+.+.... ..+++..++.++.||+.||+|||++|++|+||||+||++++ +.++|+|||++......
T Consensus 84 v~e~~~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999998888776432 25899999999999999999999999999999999999976 79999999999877654
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||......+...++...++.+....|.........
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 33344568899999999876665789999999999999999999999999888888888888888887777654332222
Q ss_pred hcccCCCcccccccccCCC--CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 235 INYQFPQLSGVNLSALMPS--ASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
............+....+. +++.+.++|++||+.||++|||+.|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1111111111111111222 58899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=351.14 Aligned_cols=245 Identities=29% Similarity=0.466 Sum_probs=203.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
||+|+||+||+|++..+++.||+|++.+.. ........+|+.++++++||||+++++++.+.+..|+||||+.| +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986542 22334457899999999999999999999999999999999976 56
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCcccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTERVGT 163 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~~~gt 163 (356)
.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++...... ......+||
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 666543 345899999999999999999999999999999999999965 79999999998754322 223456799
Q ss_pred ccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcc
Q 036550 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLS 243 (356)
Q Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (356)
+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+... ...
T Consensus 157 ~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-------------------~~~----- 211 (312)
T cd05585 157 PEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-------------------PLR----- 211 (312)
T ss_pred cccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-------------------CCC-----
Confidence 9999999996654 899999999999999999999999887665544433211 111
Q ss_pred cccccccCCCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCCCCCCCC
Q 036550 244 GVNLSALMPSASEDAINLIESLCSWDPCKRP---TAAEALQHPFFKRCL 289 (356)
Q Consensus 244 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~ 289 (356)
++..+++++.+||.+||..||.+|| ++.++++||||.+..
T Consensus 212 ------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 212 ------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 1236789999999999999999997 589999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=352.33 Aligned_cols=251 Identities=31% Similarity=0.466 Sum_probs=205.3
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHH---HhCCCCCeeEEeEEEEECCeEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCL---RKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
|++.+.||+|+||.||+|.+..+++.||+|++++.. ......+.+|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999987542 12223445566554 566899999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-C
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-F 154 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~ 154 (356)
|||+.|+ |...+. ...+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++..... .
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999875 433332 235899999999999999999999999999999999999975 7999999999875432 2
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------------ 216 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------------ 216 (324)
T ss_pred CcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------
Confidence 2234567999999999986554 899999999999999999999999988766655444321
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
... .+..++..+.++|.+||..||.+|| ++.++++||||....+
T Consensus 217 -~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 217 -EVR-----------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred -CCC-----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 111 1235689999999999999999999 7999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=350.91 Aligned_cols=262 Identities=29% Similarity=0.444 Sum_probs=210.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||++++..+++.||+|++.+.. ......+.+|+.+++.++|+||+++++++.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999987532 222334567999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99865 67776643 2344899999999999999999999999999999999999964 7999999999977654322
Q ss_pred --CccccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 157 --YTERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.....||+.|+|||++.. ...++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------------ 225 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------------ 225 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 123469999999999863 34478899999999999999999999988776655554432111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~~ 291 (356)
.+.++ .....++..+++||++||..++.. |+++.++++||||.+..|.
T Consensus 226 -----~~~~~--------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 226 -----HFQFP--------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred -----cccCC--------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 01111 112347899999999999654443 7899999999999876554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=347.93 Aligned_cols=246 Identities=30% Similarity=0.432 Sum_probs=203.9
Q ss_pred ceeecccccCCceEEEEEEEcCCCcE-EEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECC-eEEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEV-VAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKG-NVFFVFE 79 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~iv~e 79 (356)
..+.+.||.|+||+||++.+. |+. ||+|++....... ...+.+|+.+|++++|||||+++|++.+.. .+++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 455677999999999999876 455 9999997654222 457789999999999999999999999887 7999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCCeeeeCC--cEEEecccceeecCCC-
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG-YFHRDLKPENLLVSQG--TIKIADFGLAREIDAF- 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~--~~kL~Dfg~a~~~~~~- 154 (356)
|+++ +|.+++... ....++...+..++.||+.|+.|||+++ ||||||||+|||++.. ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9986 566666543 3456999999999999999999999999 9999999999999874 8999999999877653
Q ss_pred CCCccccccccccChHHHhh-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFK-SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
...+...||+.|||||++.+ ...|+.++||||||+++|||+||..||...........+......|.
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------------ 266 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------------ 266 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------------
Confidence 33344789999999999975 35599999999999999999999999999887555544433322222
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
++...++.+..++..|+..||.+||+..+++.
T Consensus 267 ----------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ----------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 12246889999999999999999999988875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=334.79 Aligned_cols=268 Identities=29% Similarity=0.496 Sum_probs=214.1
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccCC-H
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQCN-L 85 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g~-l 85 (356)
+.||+|+|+.|..|....+|..||||++.+..........+|++++... .|+||+.++++|+++..+|+|||-|.|+ +
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 6899999999999999999999999999998777778889999999998 6999999999999999999999988764 6
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecC--------C
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREID--------A 153 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~--------~ 153 (356)
+..|..+. .|+|.++.++..+|+.||+|||.+||.||||||+|||..+ .-+|||||.+..-+. .
T Consensus 164 LshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKRK----HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 66665443 3999999999999999999999999999999999999965 368999999875432 2
Q ss_pred CCCCccccccccccChHHHh----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 154 FPPYTERVGTRWYQAPEILF----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.+...+.+|+..|||||++. ....|+.++|.||||||+|.|++|++||.+....+--+.- |.+=..--.+..
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr----Ge~Cr~CQ~~LF 315 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR----GEVCRVCQNKLF 315 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC----CCccHHHHHHHH
Confidence 23445678999999999973 3356899999999999999999999999876543210000 000000000111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
..+-++.|.||..+ +..+|.+++++|..+|..|+.+|.++.++++|||++.+..
T Consensus 316 esIQEGkYeFPdkd-------WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKD-------WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHhccCCcCChhh-------hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 22233455555422 2367999999999999999999999999999999987643
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=349.72 Aligned_cols=272 Identities=26% Similarity=0.369 Sum_probs=210.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||.||++++..++..||+|++..... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 689999999999999999999999999999999876533 2334567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.| +|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+++ +.+||+|||++...... ..
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 159 (331)
T cd06649 85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159 (331)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cc
Confidence 986 56666543 23489999999999999999999986 6999999999999975 79999999998766432 23
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc----chHHHh----
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD----SWADGL---- 229 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~---- 229 (356)
....|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+ +.+... .+....
T Consensus 160 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccccCCccccCcccc
Confidence 4457999999999986554 899999999999999999999999876654432211 111100 000000
Q ss_pred -------------------hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 -------------------RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......... .........+++++++||.+||.+||++|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNE-----PPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhC-----CCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000000000 00000112468899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=351.60 Aligned_cols=249 Identities=32% Similarity=0.480 Sum_probs=204.6
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccCC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCN 84 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g~ 84 (356)
+.||+|+||+||+|.+..+|+.||+|++.+.. ........+|+.+++.++||||+++++++...+.+|+||||+.|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987642 222344567999999999999999999999999999999999865
Q ss_pred -HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 85 -LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 85 -l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||+++ +.+||+|||++..... .......
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 544443 33458999999999999999999997 89999999999999975 7999999999875432 2233446
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ...+
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-------------------~~~~- 215 (325)
T cd05594 157 CGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------EIRF- 215 (325)
T ss_pred cCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-------------------CCCC-
Confidence 7999999999986554 899999999999999999999999877665444333210 1111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
+..+++++.+||.+||..||++|+ ++.++++||||.+..+.
T Consensus 216 ----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 216 ----------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred ----------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 235789999999999999999997 99999999999875443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=343.65 Aligned_cols=283 Identities=34% Similarity=0.652 Sum_probs=228.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCe-----
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLN-HPNIVKVKELIVEKGN----- 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~----- 73 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5899999999999999999999999999999987654322 2245578999999994 6999999999987665
Q ss_pred EEEEEEeccCCHHHHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceee
Q 036550 74 VFFVFECMQCNLYQLMEAKKQK-QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLARE 150 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~ 150 (356)
.|+||||+.+++.+.+...... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999988887654332 456899999999999999999999999999999999999985 6899999999876
Q ss_pred cCCC-CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 151 IDAF-PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 151 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.... .......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+......++....+.+....|....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 5432 223344678899999998766668999999999999999999999999988888888888777777666654332
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
...... .++...........+.++..+.+||.+||..||++|||+.+++.||||+
T Consensus 241 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWH--EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchh--hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 221111 1222222222333456899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=350.28 Aligned_cols=248 Identities=31% Similarity=0.469 Sum_probs=204.2
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|+++.+++.||+|++.+.. ........+|+.++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987542 22233456788888876 799999999999999999999999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++..... .......
T Consensus 81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence 4555443 2345899999999999999999999999999999999999975 7999999999876432 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+... ...
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-------------------~~~-- 214 (320)
T cd05590 157 CGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------------------EVV-- 214 (320)
T ss_pred ccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------------CCC--
Confidence 7999999999986544 899999999999999999999999988776655544321 111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH------HHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA------AEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~~~~~~~ 290 (356)
.+..++.++.+||++||+.||.+|+++ +++++||||....|
T Consensus 215 ---------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 215 ---------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ---------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 112468899999999999999999998 99999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=349.83 Aligned_cols=254 Identities=30% Similarity=0.454 Sum_probs=209.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCC-CCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNH-PNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~iv~ 78 (356)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+.. .........|+.+++.+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 6999999999999999999999999999999987642 2233445679999999976 46888999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FP 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~ 155 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..... ..
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99976 56555532 334899999999999999999999999999999999999975 7999999999875422 22
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------------- 216 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------------- 216 (324)
T ss_pred ceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 234567999999999996654 899999999999999999999999987766655544321
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-----HHHhcCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA-----AEALQHPFFKRCLYV 291 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~ 291 (356)
... ++..++.++.+++.+||..||.+|+++ .++++||||....|.
T Consensus 217 ~~~-----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 217 NVS-----------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred CCC-----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 111 123578899999999999999999976 899999999876553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=343.73 Aligned_cols=280 Identities=39% Similarity=0.718 Sum_probs=230.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|++.+.||.|++|.||+|++..+++.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 589999999999999999999999999999998654322 223567899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
+.+++.+.+... ....+++..++.++.||+.||+|||+++++|+||+|+||++++ +.+||+|||++...... ....
T Consensus 81 ~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 81 LHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred cccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 988887776543 2345899999999999999999999999999999999999975 79999999998765432 2223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||++.+...++.++|+|||||++|+|++|..||...+..+...++....+.+....|..... .......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-LPDYKPS 237 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-HHHHHhh
Confidence 446788999999887666578899999999999999999999999888888888888888777665543222 2222233
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
++...........+.++..+.++|.+||+.||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 44433333344455788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=345.88 Aligned_cols=277 Identities=32% Similarity=0.597 Sum_probs=213.0
Q ss_pred ecccccCCceEEEEEEEcC--CCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeEEEEEEecc
Q 036550 7 TKKLGSGSFGCVWQAVNKH--SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNVFFVFECMQ 82 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~iv~e~~~ 82 (356)
..+||+|+||+||+|++.. ++..||+|.+..... .....+|+.+++.++||||+++++++.. +...+++|||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999998654 668999999865432 2245689999999999999999998854 567899999999
Q ss_pred CCHHHHHHHHHh-----hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-----CCcEEEecccceeecC
Q 036550 83 CNLYQLMEAKKQ-----KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREID 152 (356)
Q Consensus 83 g~l~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-----~~~~kL~Dfg~a~~~~ 152 (356)
+++.+.+..... ....+++..++.++.||+.||.|||++||+||||||+|||+. .+.+||+|||++....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 998888764321 223489999999999999999999999999999999999993 3689999999998764
Q ss_pred CCC----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHhCC
Q 036550 153 AFP----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---------ADQMYKICSVLGS 219 (356)
Q Consensus 153 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~~~ 219 (356)
... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||..... ..+..++...++.
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence 321 223457899999999997766689999999999999999999999975432 3456677778888
Q ss_pred CCccchHHHhhhhhhh----cccCCCccccc----ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 220 PTMDSWADGLRQAMAI----NYQFPQLSGVN----LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 220 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+....|.+........ .+......... ........+..+.+|+.+||..||.+|||+.|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8777776543221100 00000000000 111122456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=342.83 Aligned_cols=282 Identities=39% Similarity=0.712 Sum_probs=229.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-----HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-----EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 689999999999999999999999999999998765322 223446799999999999999999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
|||+.|+|.+.+.... ..+++..++.++.||++||.|||++||+|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999778887775322 35899999999999999999999999999999999999975 799999999998775432
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||......+...++...++.+....|.........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY- 236 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc-
Confidence 2334467889999999876666899999999999999999999999988887777788777777666655443222111
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..................+..+.+||.+||..||++|||+.++++||||++..
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 237 -VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred -ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 11111122222334456789999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=341.11 Aligned_cols=281 Identities=35% Similarity=0.691 Sum_probs=233.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
+|++.++||.|++|.||+|++..+|+.||+|++...... ......+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 699999999999999999999999999999998765332 2344568999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCcc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTE 159 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~ 159 (356)
++++.+.+..... ...+++..+..++.||+.||+|||++|++||||||+||++++ +.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 DKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred CccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 9988887764332 345899999999999999999999999999999999999975 79999999998765432 22234
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..+++.|++||++.+...++.++|+|||||++|+|++|.+||...+..+...++......+....|.... ........+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPEYKPTF 238 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCchhcccc
Confidence 5678999999998776668899999999999999999999999988888888888888777777665443 222333344
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+...........+..+..+.+++.+||+.||.+||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 4433333344445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=349.38 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=209.9
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+|.+.+.||+|+||+||+|++..+++.||+|++.+... ........|..++..+ +|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 68999999999999999999999999999999876432 2223345678888777 5899999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FP 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~ 155 (356)
||+.+ +|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..... ..
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99975 56555532 344899999999999999999999999999999999999975 7999999999876432 22
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 216 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------------- 216 (323)
T ss_pred ccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 334567999999999996654 899999999999999999999999988776665554321
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYVP 292 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~ 292 (356)
...+ +..++.++.+++.+||+.||++|++ ..++++||||+...|..
T Consensus 217 ~~~~-----------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 217 NVAY-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred CCCC-----------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 1111 2357899999999999999999997 48999999998765543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=351.60 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=205.8
Q ss_pred CceeecccccCCceEEEEEEEc---CCCcEEEEEEccccc----chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSY----SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
+|++.+.||+|+||+||+|++. .+++.||+|++.+.. ........+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999864 478999999986532 12233456799999999 599999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999986 56666543 344899999999999999999999999999999999999965 799999999987653
Q ss_pred CCC--CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 153 AFP--PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+....
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------- 223 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI------------- 223 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-------------
Confidence 322 22345799999999999765557899999999999999999999997543211111111000
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
.... ..+...+++.+.+++.+||..||++|| +++++++||||+...+.
T Consensus 224 --~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 224 --LKCD-----------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred --hcCC-----------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0000 112235789999999999999999999 88999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=341.96 Aligned_cols=255 Identities=26% Similarity=0.351 Sum_probs=203.7
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEcccccchH---HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE---KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
||+|+||+||++.+..+++.||+|.+.+..... ...+..|+.+++.++|+||+++.+++...+..++||||++| +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999986543221 23446799999999999999999999999999999999976 45
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-Ccccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YTERVGT 163 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~~~~~gt 163 (356)
.+.+.........+++..+..++.||+.||.|||++||+||||||+||++++ +.++|+|||++........ .....||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 5555443334456899999999999999999999999999999999999975 7999999999987654322 2345799
Q ss_pred ccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcc
Q 036550 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLS 243 (356)
Q Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (356)
+.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+...... .
T Consensus 161 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~-------- 216 (280)
T cd05608 161 PGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN---------------D-------- 216 (280)
T ss_pred cCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc---------------c--------
Confidence 9999999996654 899999999999999999999999865432211111110000 0
Q ss_pred cccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 244 GVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 244 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
.....+.++..+.+++.+||+.||++|| +++++++||||++..|.
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 217 ---SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 0012235789999999999999999999 88999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=348.51 Aligned_cols=249 Identities=33% Similarity=0.476 Sum_probs=205.3
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||.||+|++..+++.||+|++.+.. .........|..+++.+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999987642 22233456788888866 899999999999999999999999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|...+. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++..... .......
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence 5555553 2344899999999999999999999999999999999999975 7999999999876432 2223456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|++||...+..+....+... ...+
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-------------------~~~~- 215 (321)
T cd05591 157 CGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-------------------DVLY- 215 (321)
T ss_pred ccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------CCCC-
Confidence 7999999999986544 899999999999999999999999988876665554321 1111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCC-------CHHHHhcCCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-------TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-------t~~e~l~hp~~~~~~~~ 291 (356)
+..++.++.++|.+||..||++|+ ++.++++||||....|.
T Consensus 216 ----------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 216 ----------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred ----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 124688999999999999999999 99999999999876554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=354.13 Aligned_cols=276 Identities=25% Similarity=0.402 Sum_probs=207.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.+|.+.+.||+|+||.||+|.+..+++.||+|+..... ...|+.++++++||||+++++++...+..++|||++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 36999999999999999999999999999999854332 356999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER 160 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~ 160 (356)
.+++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++............
T Consensus 140 ~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 9998887753 3345899999999999999999999999999999999999975 79999999999765443344456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCCccchHHHhh
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFR-PLFQGTDE---------ADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.||+.|+|||++.+.. ++.++|||||||++|+|+++. ++|..... ...+..+...++..+.....+...
T Consensus 217 ~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 217 AGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred cccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 7999999999986655 899999999999999999854 44443221 123333444333222111000000
Q ss_pred hhhhhcccCCCcccccc----cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNL----SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
........+........ ......++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00000000000000000 0001256778899999999999999999999999999975
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=361.71 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=222.4
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
-|.|+.-||.|+||.||+|.++.++-..|.|++.-....+-++++-||+||..++||+||++++.|..++.+||+.|||+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 36788999999999999999999999999999987777777888899999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCC-CCCCccc
Q 036550 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 83 g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
|+-.+.+.... +..+++.++..+++|+|.||.|||+++|||||||..|||++ +|.++|+|||.+..... .....++
T Consensus 113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 99777776544 34599999999999999999999999999999999999997 69999999999876543 2344678
Q ss_pred cccccccChHHHh----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 161 VGTRWYQAPEILF----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 161 ~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
+|||+||||||+. .+..|++++||||||++|.+|..+.||-...++...+.+|...- +|.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPT--------------- 254 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPT--------------- 254 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCc---------------
Confidence 9999999999974 45679999999999999999999999999888877766664321 110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+..++..+.||+.+||..||..||+++++|+||||++.
T Consensus 255 -----------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 255 -----------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -----------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 11123678899999999999999999999999999999863
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=349.06 Aligned_cols=281 Identities=32% Similarity=0.528 Sum_probs=221.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. ........+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 68999999999999999999999999999999986532 22334456899999999999999999988643 35
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.|+||||+.+++.+.+.. .+++..+..++.||+.||+|||++||+||||||+||+++. +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 799999999988877642 1789999999999999999999999999999999999975 799999999998776
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.........+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+...++...++.|....+.......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 544444567899999999996655 8999999999999999999999999888888888888877776653322211111
Q ss_pred hhhcccCCCcccccc-------------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 233 MAINYQFPQLSGVNL-------------SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~-------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.......+......+ .......+..+.+||.+||+.||++|||+.|+|+||||..+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 000000110000000 001224567899999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=341.63 Aligned_cols=259 Identities=27% Similarity=0.395 Sum_probs=211.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+|++.+.||+|+||+||++.+..+++.||+|++...... ......+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998654321 22345689999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+.| +|.+.+... ....+++..+..++.|++.||.|||++|++||||||+||++++ +.++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 9976 455555322 2345899999999999999999999999999999999999976 78999999999877554444
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+|++.|+|||++.+.. ++.++||||+||++|+|++|..||.+.........+...... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~- 221 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE---------------DQ- 221 (285)
T ss_pred ccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh---------------cc-
Confidence 5568999999999986544 899999999999999999999999876554333222211100 00
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
......++..+.+|+.+||..||.+|| +++++++||||....+
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 222 ----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred ----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 111235788999999999999999999 9999999999986443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=353.82 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=209.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986532 222344568999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||++| +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 123 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99975 56665532 23899999999999999999999999999999999999975 799999999998765322
Q ss_pred -CCccccccccccChHHHhhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKSG---LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.....+||+.|+|||++.+.. .++.++|||||||++|+|++|.+||...+......++......
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------ 265 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------------ 265 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc------------
Confidence 223567999999999986542 3789999999999999999999999988776665555432111
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~ 290 (356)
..+|. ...++..++++|.+||..++.+ |++++++++||||++..+
T Consensus 266 -----~~~~~---------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 266 -----LTFPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -----ccCCC---------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 11111 1257899999999999844433 789999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=346.96 Aligned_cols=262 Identities=28% Similarity=0.419 Sum_probs=211.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.++||+|+||+||++++..+++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 68999999999999999999999999999999986532 122334567999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99865 677776532 234899999999999999999999999999999999999974 7999999999876543222
Q ss_pred --CccccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 157 --YTERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
....+||+.|+|||++.. ...++.++|||||||++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------- 226 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER----------- 226 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc-----------
Confidence 234579999999999863 345789999999999999999999999988766665555321100
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~~ 291 (356)
..+ +.....++.++.+|+++||..++.. |++++++++||||.+..|.
T Consensus 227 ------~~~--------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 227 ------FQF--------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred ------ccC--------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 011 1112357899999999999665444 6899999999999876554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=362.73 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=214.7
Q ss_pred CceeecccccCCceEEEEEEEcCC-CcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHS-GEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.|.+.+.||+|+||.||+|.+..+ ++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 389999999999999999998877 7889999876655555556678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC---C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP---P 156 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~---~ 156 (356)
.| +|.+.+........++++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||++....... .
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 75 677777655555567999999999999999999999999999999999999975 799999999998765432 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+.....
T Consensus 228 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~------------------ 288 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY------------------ 288 (478)
T ss_pred ccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 3455799999999998655 489999999999999999999999988776655554432110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
......++.++.++|.+||..||++|||+.+++.|||++.
T Consensus 289 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 289 -----------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -----------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 0112356889999999999999999999999999999863
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=349.11 Aligned_cols=248 Identities=32% Similarity=0.495 Sum_probs=200.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHH-HHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVK-CLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|.+..+|+.||+|++.+... ........|.. +++.++||||+++++++...+..|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 479999999999999999999999999865421 22233344544 56778999999999999999999999999986
Q ss_pred C-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 N-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 ~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+ |...+. +...+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..... .......
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence 4 554443 3345899999999999999999999999999999999999975 7999999999875432 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+... .
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-------------------~---- 212 (325)
T cd05604 157 CGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-------------------P---- 212 (325)
T ss_pred cCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-------------------C----
Confidence 7999999999986654 899999999999999999999999887765554443221 0
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA----AEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~~~~~~~ 290 (356)
....+..+..+.++|++||..||.+||++ .++++||||....+
T Consensus 213 -------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 -------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred -------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 01123578899999999999999999976 59999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=347.49 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=200.2
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||.||+|.+..+++.||+|++++... .....+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 479999999999999999999999999976432 2223456799999988 799999999999999999999999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-CCCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-AFPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~~~~~~~~ 160 (356)
+|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.... ........
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence 5555543 2345999999999999999999999999999999999999975 799999999987532 22333456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||......+. +..................+
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~- 224 (329)
T cd05588 157 CGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------PDQNTEDYLFQVILEKQIRI- 224 (329)
T ss_pred cCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCccccccccc----------ccccchHHHHHHHHcCCCCC-
Confidence 8999999999996654 89999999999999999999999964321100 00000000000001111111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCC------HHHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT------AAEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------~~e~l~hp~~~~~~~ 290 (356)
+..++..+.++|++||..||.+|+| ++++++||||....|
T Consensus 225 ----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 225 ----------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred ----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 2357899999999999999999987 799999999987554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=336.42 Aligned_cols=281 Identities=34% Similarity=0.623 Sum_probs=219.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 6899999999999999999999999999999988654321 22345789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~ 157 (356)
|+++++++.+.. ....+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 999987666542 2334899999999999999999999999999999999999975 799999999998775533 23
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....++..|+|||++.+...++.++|+|||||++|+|++|.+||.+....+....+....+........-..........
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34568899999999877666889999999999999999999999988777766666554443322110000000000000
Q ss_pred cCCCc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQL-SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..+.. .........+.++..+.+|+.+||..||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 11110 0111122234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=347.10 Aligned_cols=248 Identities=31% Similarity=0.487 Sum_probs=201.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHH-HHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVK-CLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|++..+|+.||+|++.+... .......+|.. +++.++||||+++++.+.+.+..|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999875421 22233344444 56789999999999999999999999999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|...+. ....+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..... .......
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence 4555553 2345899999999999999999999999999999999999965 7999999999875432 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+... .
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------------~---- 212 (323)
T cd05575 157 CGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-------------------P---- 212 (323)
T ss_pred cCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------C----
Confidence 7999999999986654 899999999999999999999999987765554444321 0
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA----AEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~~~~~~~ 290 (356)
....+.++..+.++|++||+.||.+||++ .++++||||....+
T Consensus 213 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 -------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 01123568999999999999999999987 69999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=346.42 Aligned_cols=249 Identities=33% Similarity=0.548 Sum_probs=203.9
Q ss_pred ecccccCCceEEEEEEEc---CCCcEEEEEEccccc----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++.||+|+||.||+|++. .+++.||+|++.+.. ........+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 478999999987542 1222344679999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~ 156 (356)
|+.| +|.+.+. ..+.+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 81 YLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence 9986 4555553 3345899999999999999999999999999999999999964 79999999998754322 22
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+... .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------------~ 216 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------------K 216 (323)
T ss_pred ccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------C
Confidence 33457999999999986654 789999999999999999999999987765554444321 1
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
. .+++.+++.+.+||++||..||++|| +++++++||||....+
T Consensus 217 ~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 217 L-----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred C-----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1 11235688999999999999999999 8999999999987544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=345.04 Aligned_cols=248 Identities=31% Similarity=0.458 Sum_probs=201.7
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||.||+|+++.+|+.||+|++++.. .........|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999987642 22233446678888754 899999999999999999999999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +.++|+|||++..... .......
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence 55555532 345899999999999999999999999999999999999975 7999999999875322 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ..
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-------------------~~--- 213 (316)
T cd05620 157 CGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-------------------TP--- 213 (316)
T ss_pred CCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CC---
Confidence 7999999999996654 899999999999999999999999877765544333210 01
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-HHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA-AEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-~e~l~hp~~~~~~~ 290 (356)
.....++.++.+||.+||..||++|+++ +++++||||+...+
T Consensus 214 --------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 214 --------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred --------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 1112468899999999999999999997 58889999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=353.82 Aligned_cols=279 Identities=22% Similarity=0.370 Sum_probs=213.4
Q ss_pred CCceeecccccCCceEEEEEEEc--CCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK--HSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.+|.+.+.||+|+||.||+|... .+++.||+|.+.... ...+|+.+++.++||||+++++++...+..|++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 36999999999999999999754 456889999886532 23579999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-- 156 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-- 156 (356)
++.+++.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.++|+|||++........
T Consensus 167 ~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 167 KYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred hcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 99999888773 2345899999999999999999999999999999999999975 7999999999976654322
Q ss_pred -CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 157 -YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD---EADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ....+..+...++..+.....+.....
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 23457999999999986554 8999999999999999999999997654 344555566555543322111110000
Q ss_pred hh--hcccCCCccccccccc--CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 233 MA--INYQFPQLSGVNLSAL--MPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 233 ~~--~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.. ..+..........+.. ...++.++.+||++||..||++|||+.++|+||||....+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 0011111000011111 1245778999999999999999999999999999987543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=342.94 Aligned_cols=283 Identities=35% Similarity=0.640 Sum_probs=222.0
Q ss_pred CceeecccccCCceEEEEEEEcC--CCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKH--SGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVF 75 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 75 (356)
+|.+.++||+|+||.||+|.+.. +++.||+|.+.... ........+|+.+++.++||||+++++++.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 68999999999999999999988 89999999987632 22234457799999999999999999999988 8899
Q ss_pred EEEEeccCCHHHHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-----CcEEEeccccee
Q 036550 76 FVFECMQCNLYQLMEAKKQKQ-QLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-----GTIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----~~~kL~Dfg~a~ 149 (356)
+||||+++++.+.+....... ..+++..++.++.||+.||.|||+++|+||||||+||+++. +.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 999999999888876554433 36899999999999999999999999999999999999964 689999999998
Q ss_pred ecCCCCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHH
Q 036550 150 EIDAFPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---------DQMYKICSV 216 (356)
Q Consensus 150 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~ 216 (356)
....... .....+++.|+|||++.+...++.++|||||||++|+|++|.+||...... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643222 234467899999999877666899999999999999999999999865532 345566677
Q ss_pred hCCCCccchHHHhhhhhhhc----ccCCCcccccc---cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 217 LGSPTMDSWADGLRQAMAIN----YQFPQLSGVNL---SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
++.+....|........... ..........+ .......+..+.+++.+||+.||++|||+.++++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 77666655543222111111 00000000000 01112578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=345.79 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=211.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||++++..+++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986532 222334567899999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99875 566666532 235899999999999999999999999999999999999975 7999999999987654322
Q ss_pred C--ccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 157 Y--TERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 157 ~--~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. ...+||+.|+|||++.+. +.++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------- 226 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER----------- 226 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-----------
Confidence 1 235799999999998642 34788999999999999999999999887766555544321100
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~~ 291 (356)
..+| .....++.++.++|.+||..++.+ |++++++++||||+...|.
T Consensus 227 ------~~~p--------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 227 ------FQFP--------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred ------ccCC--------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 1111 112356899999999999876654 5699999999999876554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=352.41 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=202.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.++||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 468889999999999999999999999999999865433 2334567899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
+.++.+.. ....++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||++...... ....
T Consensus 154 ~~~~~L~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 154 MDGGSLEG-------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred CCCCcccc-------cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 98763321 122578888999999999999999999999999999999975 68999999999876532 2234
Q ss_pred cccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 159 ERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
...||..|+|||++.. ...++.++|||||||++|+|++|+.||......+....+....
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----------------- 289 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----------------- 289 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----------------
Confidence 5679999999998743 2334678999999999999999999998443222111111100
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... .......++.++.+||.+||..||++|||+.|+++||||.+.
T Consensus 290 --~~~-------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 290 --MSQ-------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred --ccC-------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 000 011123678899999999999999999999999999999874
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=346.40 Aligned_cols=248 Identities=31% Similarity=0.473 Sum_probs=201.0
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHH-HHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREV-KCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|++..+++.||+|++.+... ........|. .+++.++||||+++++++...+..|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999875421 1222233343 456788999999999999999999999999987
Q ss_pred C-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 N-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 ~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+ |.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..... .......
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence 4 5555532 344889999999999999999999999999999999999965 7999999999875432 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+... ..
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------------------~~--- 213 (325)
T cd05602 157 CGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-------------------PL--- 213 (325)
T ss_pred cCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------------------Cc---
Confidence 7999999999986654 899999999999999999999999987766655444321 00
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH----HHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA----EALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~~~~~~~ 290 (356)
...+.++..+.++|.+||+.||.+|+++. ++++|+||....|
T Consensus 214 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 214 --------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 11236789999999999999999999875 8999999987554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=344.65 Aligned_cols=248 Identities=31% Similarity=0.492 Sum_probs=203.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|.+..+++.||+|++.+.. ........+|+.+++.+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987642 22233446788888888 799999999999999999999999976
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|...+. ....+++..+..++.||+.||.|||++||+||||||+||++++ +.+||+|||++..... .......
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence 4555443 2345899999999999999999999999999999999999975 7999999999875322 2223345
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+... ...+
T Consensus 157 ~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-------------------~~~~- 215 (318)
T cd05570 157 CGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-------------------EVRY- 215 (318)
T ss_pred ecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------------------CCCC-
Confidence 7999999999996654 899999999999999999999999877765544433211 1111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-----HHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA-----AEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~ 290 (356)
+..++..+.+||++||..||.+|||+ .++++||||....|
T Consensus 216 ----------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 216 ----------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ----------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 23568899999999999999999999 99999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=343.27 Aligned_cols=248 Identities=33% Similarity=0.495 Sum_probs=201.1
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||.||+|.+..+++.||+|++++.. .........|..++..+ +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987542 12223345566777654 899999999999999999999999976
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++..... .......
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence 55555532 345899999999999999999999999999999999999965 7999999999976532 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------------------~---- 212 (316)
T cd05592 157 CGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-------------------R---- 212 (316)
T ss_pred cCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------C----
Confidence 7999999999986654 899999999999999999999999987765555443211 0
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-HHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA-AEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-~e~l~hp~~~~~~~ 290 (356)
..+...++.++.+||.+||..||++||++ .++++||||....|
T Consensus 213 -------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 -------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 01123568899999999999999999986 58889999987544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=340.76 Aligned_cols=282 Identities=34% Similarity=0.573 Sum_probs=219.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKG------ 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 72 (356)
+++|.+.++||+|+||.||+|.+..+++.||+|.+...... ......+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 57899999999999999999999999999999988654322 1223467999999999999999999987543
Q ss_pred --eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 73 --NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 73 --~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
..++||||+++++.+.+.. ....+++.+++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999999988777643 2235899999999999999999999999999999999999975 789999999997
Q ss_pred ecCCCC-----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 150 EIDAFP-----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 150 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
...... ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||...+.......+....+..+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 664321 112346788999999987666578999999999999999999999998887777777777666666555
Q ss_pred hHHHhhhhhhhcccCCCccccccc--ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLS--ALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+.+...........++........ -.....+..+.+||.+||..||.+|||++++|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 443322111111122211110000 0011246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=345.18 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=199.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|++..+++.||+|++.+.. ........+|+.++.++ +||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997642 22233456788888876 899999999999999999999999986
Q ss_pred C-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 N-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 ~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+ |...+. ....+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++..... .......
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence 5 544442 2345899999999999999999999999999999999999975 7999999999875422 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ +..................
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~~~~~~~~~~i~~~~~~-- 223 (329)
T cd05618 157 CGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNTEDYLFQVILEKQIR-- 223 (329)
T ss_pred cCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCC----------cccccHHHHHHHHhcCCCC--
Confidence 7999999999996654 89999999999999999999999963211000 0000000000000111111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCC------HHHHhcCCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT------AAEALQHPFFKRCLYV 291 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------~~e~l~hp~~~~~~~~ 291 (356)
++..++..+.++|++||..||.+|+| +.++++||||+...|.
T Consensus 224 ---------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 224 ---------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred ---------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 22367889999999999999999998 5899999999876553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=370.39 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=212.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~i 76 (356)
+++|.+.+.||+|+||+||+|.+..++..||+|++.... ......+.+|+.+++.++|||||+++++|.+. +.+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 478999999999999999999999999999999987542 23345567899999999999999999988654 57899
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-------CcccccCCCCCeeeeC-----------
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-------GYFHRDLKPENLLVSQ----------- 137 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~ivH~Dlkp~NIll~~----------- 137 (356)
||||+.+ +|.+.+.........+++..++.|+.||+.||.|||+. +||||||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999975 78888776544456699999999999999999999985 4999999999999953
Q ss_pred -------CcEEEecccceeecCCCCCCccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 036550 138 -------GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ 209 (356)
Q Consensus 138 -------~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 209 (356)
+.+||+|||++.............||+.|+|||++.+. ..++.++||||||||+|+|++|..||........
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 24899999999877654444556899999999998653 4478999999999999999999999987665443
Q ss_pred HHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+....... + .. .....+.++.+||..||..+|.+|||+.|+|.|||+...
T Consensus 252 li~~lk~~--p-----------------~l----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 252 LISELKRG--P-----------------DL----------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHhcC--C-----------------CC----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 33222110 0 00 012458899999999999999999999999999999754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=341.86 Aligned_cols=249 Identities=31% Similarity=0.478 Sum_probs=202.5
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHh-CCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRK-LNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|++..+++.||+|+++... .........|..++.. ++||||+++++++.+.+.+++||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999987642 2223344567788876 4999999999999999999999999875
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||++..... .......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence 56665542 334899999999999999999999999999999999999975 7999999999875422 2223456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.||+.|+|||++.+.. ++.++||||+||++|+|++|..||...+..+....+... ...
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-------------------~~~-- 214 (316)
T cd05619 157 CGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-------------------NPC-- 214 (316)
T ss_pred cCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CCC--
Confidence 7999999999986554 899999999999999999999999887765544433210 001
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH-HHhcCCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA-EALQHPFFKRCLYV 291 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~-e~l~hp~~~~~~~~ 291 (356)
....++.++.++|.+||..||++||++. ++++||||....+.
T Consensus 215 ---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 215 ---------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ---------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 1124688999999999999999999996 89999999886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=344.13 Aligned_cols=283 Identities=37% Similarity=0.638 Sum_probs=224.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ........+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 68999999999999999999999999999999986432 22334457899999999999999999987644 3589
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+++||+++++.+.+. ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 999999998776653 234899999999999999999999999999999999999975 69999999998766432
Q ss_pred CC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. .....|++.|+|||++.+...++.++|||||||++|+|++|++||...+.......+...++.+..+.+.....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 21 12346899999999987666689999999999999999999999998887777777777777766655433222
Q ss_pred hhhhhcc-cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 231 QAMAINY-QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
....... ..+......+....+..+.++.+|+.+||+.||++|||+.++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 1111111 1111111122223346788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=341.51 Aligned_cols=281 Identities=24% Similarity=0.380 Sum_probs=209.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.++||+|+||.||++.+..++..+|+|++..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 689999999999999999999999999999999876533 2334567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.| +|.+.+.. ...+++..+..++.|++.||.|||++ +|+|+||||+|||+++ +.+||+|||++...... ..
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 159 (333)
T cd06650 85 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159 (333)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence 975 67776643 33489999999999999999999975 7999999999999975 78999999998765432 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCccchHHHhh---hhh
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSV-LGSPTMDSWADGLR---QAM 233 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~---~~~ 233 (356)
....|++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+... .+.+.......... ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 3457899999999986554 899999999999999999999999876543332211100 00000000000000 000
Q ss_pred -hhc-ccCCC----------cccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 234 -AIN-YQFPQ----------LSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 234 -~~~-~~~~~----------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... ...+. ............++.++.+||.+||+.||++|||+.|++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 00000 00000000112467899999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.93 Aligned_cols=253 Identities=27% Similarity=0.362 Sum_probs=201.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
||+|+||+||++.+..+|+.||+|.+..... ........|+++++.++||||+++++++.+....++||||+.| +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999865321 1223445699999999999999999999999999999999976 55
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTR 164 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~ 164 (356)
.+.+... ....+++..+..++.||+.||+|||++||+||||||+||++++ +.++|+|||++.............|++
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence 5555332 2234889999999999999999999999999999999999975 689999999998776544444567999
Q ss_pred cccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccc
Q 036550 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244 (356)
Q Consensus 165 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (356)
.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+.... ......
T Consensus 159 ~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---------------~~~~~~------ 216 (277)
T cd05607 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT---------------LEDEVK------ 216 (277)
T ss_pred CccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh---------------hccccc------
Confidence 999999986655 8999999999999999999999997654321111111100 000000
Q ss_pred ccccccCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCCCCCCCCC
Q 036550 245 VNLSALMPSASEDAINLIESLCSWDPCKRPTA----AEALQHPFFKRCLY 290 (356)
Q Consensus 245 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~~~~~~~ 290 (356)
.....++.++.+++.+||+.||++||++ ++++.||||+...+
T Consensus 217 ----~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 217 ----FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ----cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0112568899999999999999999999 77889999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=337.01 Aligned_cols=280 Identities=28% Similarity=0.504 Sum_probs=226.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC--CCC----eeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN--HPN----IVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp~----iv~~~~~~~~~~~~~ 75 (356)
+||.++..+|+|+||.|-.+.+..++..||||+++.-. .-.+..+-|+++|+++. .|+ +|.+.++|...++.|
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 58999999999999999999999999999999987643 22344566999999993 232 678888899999999
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC------------------
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ------------------ 137 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------------------ 137 (356)
||+|.++-++++.+.. +.-.+|+...++.+.+||+++++|||+++++|.||||+|||+.+
T Consensus 168 ivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 168 IVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 9999999899999864 34456999999999999999999999999999999999999831
Q ss_pred ---CcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 036550 138 ---GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 138 ---~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 214 (356)
-.++|+|||.|+...... ++.+.|..|.|||++++-+ |+.++||||+||||+||.+|...|+..++.+.+..+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred CCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence 158999999998766533 6678999999999999988 9999999999999999999999999999989888888
Q ss_pred HHhCCCCccchHHHhhhhhhhc--ccCCCcc-----------cccccccCC---CCCHHHHHHHHHccCCCCCCCCCHHH
Q 036550 215 SVLGSPTMDSWADGLRQAMAIN--YQFPQLS-----------GVNLSALMP---SASEDAINLIESLCSWDPCKRPTAAE 278 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----------~~~~~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~e 278 (356)
..+|+++.........+..... .+.+... ..++..... ..-.++.|||++||.+||.+|+|+.|
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 8888777666655433322211 1111111 111111111 12236899999999999999999999
Q ss_pred HhcCCCCCC
Q 036550 279 ALQHPFFKR 287 (356)
Q Consensus 279 ~l~hp~~~~ 287 (356)
+|.||||+.
T Consensus 403 AL~HpFF~~ 411 (415)
T KOG0671|consen 403 ALSHPFFAR 411 (415)
T ss_pred HhcCHHhhc
Confidence 999999985
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=334.89 Aligned_cols=252 Identities=27% Similarity=0.477 Sum_probs=213.6
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
|.++++||+|+||.||+|.++.+|+.+|+|.+.... +-.....|+.+|++++.|++|++|+.|.....+|||||||+.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 678899999999999999999999999999987643 345568899999999999999999999999999999999985
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCC-CCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF-PPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~-~~~~~~ 160 (356)
+..+.++. ++++++|.++..+++.-+.||+|||...-+|||||..|||++ +|..||+|||.|..+.+. ...++.
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 56666543 445699999999999999999999999999999999999996 589999999999877543 455678
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+|||.|||||++..-+ |+.++||||||++..||..|+|||....+...+..| |
T Consensus 190 IGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------------------P 242 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------------------P 242 (502)
T ss_pred ccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------------------c
Confidence 9999999999997776 999999999999999999999999987764433222 1
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+.. -.-+...|.++.||+++||..+|++|-|+.++++|||.++.
T Consensus 243 T~PPPT-F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 243 TKPPPT-FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred CCCCCC-CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 100000 01123568999999999999999999999999999999863
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=333.74 Aligned_cols=255 Identities=38% Similarity=0.645 Sum_probs=208.9
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHh--hhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKC--LNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|++.+.||+|+||+||++.+..+++.||+|++......... ...+|+.++++++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999876543332 2356999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeec-CCCCCCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAFPPYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~-~~~~~~~ 158 (356)
.+ ++.+.+. ....+++..+..++.||+.||++||++|++|+||||+||+++ ++.++|+|||.+... .......
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccc----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 98 7887776 334489999999999999999999999999999999999998 579999999999864 3333445
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||++.....++.++|+||||+++|+|++|..||......+....+.......... ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~ 224 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS------------SSQ 224 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH------------HTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc------------ccc
Confidence 67899999999998635558999999999999999999999999874433333332221110000 000
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
. ....+..+.++|.+||+.||++|||+.++++||||
T Consensus 225 ~-----------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 Q-----------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp S-----------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred c-----------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0 00123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=352.12 Aligned_cols=274 Identities=25% Similarity=0.376 Sum_probs=207.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
..|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+.++++++|+|||++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 369999999999999999999999999999996432 22467999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC---C
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---Y 157 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~---~ 157 (356)
.+++.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++....... .
T Consensus 243 ~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 243 RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 99988877532 235899999999999999999999999999999999999975 7999999999986543211 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCcc--c----
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD-------EADQMYKICSVLGSPTMD--S---- 224 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~--~---- 224 (356)
....||+.|+|||++.+.. ++.++|||||||++|||++|..++.... ...++.++....+..... .
T Consensus 320 ~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 2356999999999996655 8999999999999999999875543221 123444444433321110 0
Q ss_pred -hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 225 -WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+........ .....+......+..+ ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 399 ~l~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRA-ARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhh-hcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000 0011111111111111 246778999999999999999999999999999974
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=334.64 Aligned_cols=281 Identities=35% Similarity=0.589 Sum_probs=216.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH-HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++....... .....+|+.+++.++|+||+++++++.+++..|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 57999999999999999999999999999999986543222 23457899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+.+++.+.+... ...+++..++.++.||+.||.|||++||+|+||||+||+++. +.++|+|||++....... ...
T Consensus 85 ~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 85 MHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred ccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 998887776432 234788899999999999999999999999999999999975 799999999987653321 223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE-ADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+++.|+|||++.+...++.++|+|||||++|+|++|.+||..... .+.+..+....+.|....+............
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 446789999999986655578899999999999999999999986653 3455556555665555544333211100000
Q ss_pred cCCCcccccccccCC--CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMP--SASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.++............ ..+..+.+++.+||..||++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 011000111111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=358.94 Aligned_cols=256 Identities=30% Similarity=0.464 Sum_probs=212.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC-------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKG------- 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 72 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++.... ........+|+.++..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 68999999999999999999999999999999986543 233345578999999999999999988775432
Q ss_pred -eEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 73 -NVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 73 -~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
.+++||||+.+ +|.+.+.........+++..++.++.||+.||+|||+++|+||||||+|||++. +.+||+|||++.
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 36899999875 688877665555667999999999999999999999999999999999999975 799999999997
Q ss_pred ecCCC---CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 150 EIDAF---PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 150 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
..... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+....
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~--------- 261 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR--------- 261 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---------
Confidence 65432 1223567999999999996654 8999999999999999999999998877655544432210
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.....+.+++++.+++.+||..||.+||++.++++|||++.
T Consensus 262 --------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 262 --------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 01122467899999999999999999999999999999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=336.04 Aligned_cols=280 Identities=58% Similarity=1.036 Sum_probs=238.7
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEEec
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|.+.+.||.|++|+||+|....+++.|++|.+..... .+.....+|+..++++. |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999998999999999866533 22233457999999998 999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER 160 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~ 160 (356)
+|++.+.+.... +..+++..+..++.|++.+|.|||++|++|+||+|+||++++ +.++|+|||.+............
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 889888775432 235899999999999999999999999999999999999986 79999999999887665555566
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.++..|+|||++.+...++.++|+||||+++++|++|.+||......+...++...++.+....|.+...........++
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 78999999999876666899999999999999999999999999988899999999999988888776655444444444
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
...........+..+..+.+||++||..||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 444443444444558899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=345.43 Aligned_cols=249 Identities=33% Similarity=0.537 Sum_probs=205.1
Q ss_pred ecccccCCceEEEEEEE---cCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 7 TKKLGSGSFGCVWQAVN---KHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++.||+|+||.||++++ ..+|+.||+|++.+... .......+|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999986 35789999999876432 22334467999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
.+ +|.+.+. +...+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++...... ....
T Consensus 81 ~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 81 RGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 75 5666653 2345899999999999999999999999999999999999975 79999999998765443 2334
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+... ...
T Consensus 157 ~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~-------------------~~~ 216 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-------------------KLG 216 (318)
T ss_pred cccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-------------------CCC
Confidence 567999999999986554 789999999999999999999999987766555444221 111
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLY 290 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~ 290 (356)
.+..+++.+.++|++||+.||++||| +.++++||||....+
T Consensus 217 -----------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 217 -----------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred -----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 12356899999999999999999999 788999999987644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=342.58 Aligned_cols=281 Identities=37% Similarity=0.643 Sum_probs=227.6
Q ss_pred CCcee-ecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--------------HhhhHHHHHHHHhCCCCCeeEEeE
Q 036550 2 EKYSL-TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--------------KCLNLREVKCLRKLNHPNIVKVKE 66 (356)
Q Consensus 2 ~~y~~-~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hp~iv~~~~ 66 (356)
++|.. .+.||.|+||+||+|.+..+++.||+|++....... .....+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 57765 577999999999999999999999999986543221 113568999999999999999999
Q ss_pred EEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecc
Q 036550 67 LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADF 145 (356)
Q Consensus 67 ~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Df 145 (356)
++...+..+++|||+.|++.+.+.. ...+++..+..++.||+.||+|||++||+|+||+|+||++++ +.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999998887753 234899999999999999999999999999999999999975 69999999
Q ss_pred cceeecCC---------------CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036550 146 GLAREIDA---------------FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQM 210 (356)
Q Consensus 146 g~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 210 (356)
|.+..... ........+++.|+|||.+.+...++.++|+|||||++|+|++|.+||...+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99976541 111223457888999999876666799999999999999999999999999988888
Q ss_pred HHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+....+.+....|........... +............+..+.++.++|.+||+.+|++|||++++|.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccc--cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 88888888887776654432111111 11111122223334668899999999999999999999999999999865
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.68 Aligned_cols=279 Identities=38% Similarity=0.746 Sum_probs=228.0
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|++.+.||.|++|.||+|.+..+|..||+|++...... ....+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999999999999998754322 2234578999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCcc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTE 159 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~ 159 (356)
++++.+.+..... ..+++..+..++.|++.||+|||+++++||||+|+||++++ +.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 9888887754321 34899999999999999999999999999999999999975 79999999998765432 22233
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+......++....+.+....|..... .......+
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 237 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS-LPDYKPTF 237 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh-chhhhhhc
Confidence 46788999999886665578999999999999999999999998888888888888777776665543211 11222233
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+...........+.++..+.++|.+||+.||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 3333333344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=339.55 Aligned_cols=282 Identities=37% Similarity=0.683 Sum_probs=223.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEEC-------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEK------- 71 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------- 71 (356)
+++|.+.++||.|+||.||+|.+..+++.||+|++......+ .....+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999999999999999986543221 23456899999999999999999987543
Q ss_pred -CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 72 -GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 72 -~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
..+++|+||+.+++...+.. ....+++..++.++.||++||.|||++||+|+||||+||++++ +.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999999987776653 2335899999999999999999999999999999999999975 799999999987
Q ss_pred ecCCCCC------------CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 036550 150 EIDAFPP------------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217 (356)
Q Consensus 150 ~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 217 (356)
....... .+...+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 6543211 1233578889999998766668999999999999999999999999988888888888888
Q ss_pred CCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+.+....|.....................+.......++.+.+||.+||..||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 87776666543222211110111111111222234567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=334.99 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=207.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.|++.+.||+|+||+||++.+..+++.||+|.+.+.... ......+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 488899999999999999999999999999998654221 22345679999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+.| +|.+.+.... ...+++..+..++.|++.||.|||++||+||||||+||++++ +.++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 9976 5666654322 234899999999999999999999999999999999999975 79999999999876544444
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....|++.|+|||++.+.. ++.++|+||+||++|+|++|.+||.................. ..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------------~~- 221 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------------VQ- 221 (285)
T ss_pred cCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------------hh-
Confidence 4567999999999986554 899999999999999999999999865432111111000000 00
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~ 288 (356)
......+++++.+|+.+||+.||++||| ++|+++||||++.
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 222 ----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0112356889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=340.47 Aligned_cols=254 Identities=30% Similarity=0.467 Sum_probs=208.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+|.+.+.||+|+||+||+|.+..+|+.||+|++.+.. .........|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999987642 222334567888888885 577888999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-C
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-P 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~ 155 (356)
||+.| +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++...... .
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99976 5655553 2345899999999999999999999999999999999999975 79999999998764322 2
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------------- 216 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------------- 216 (323)
T ss_pred cccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 233457999999999986554 899999999999999999999999987766555544321
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
...+ +..++.++.+++.+||..||.+|++ .+++++||||....|.
T Consensus 217 ~~~~-----------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 217 NVSY-----------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred CCCC-----------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 1111 2356889999999999999999997 5799999999986654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=342.43 Aligned_cols=282 Identities=34% Similarity=0.578 Sum_probs=217.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC----------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK---------- 71 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---------- 71 (356)
.+|.+.+.||.|+||.||+|.+..+|+.||+|.+............+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5899999999999999999999999999999998765554555667899999999999999999876543
Q ss_pred ----CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecc
Q 036550 72 ----GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADF 145 (356)
Q Consensus 72 ----~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Df 145 (356)
...|+||||+++++.+.+. ...+++..++.++.||+.||.|||++||+||||||+||+++. +.++|+||
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 3579999999988776653 234899999999999999999999999999999999999973 47899999
Q ss_pred cceeecCCCCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036550 146 GLAREIDAFPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT 221 (356)
Q Consensus 146 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (356)
|.+........ .....++..|+|||++.+...++.++|||||||++|+|++|..||...+..+....+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99976543211 12346788999999986656688999999999999999999999998877666665554433322
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+..........................+.++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 2222111111000000000111111223345688999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=346.22 Aligned_cols=248 Identities=28% Similarity=0.469 Sum_probs=200.5
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC---CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL---NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
||+|+||+||+|++..+++.||+|++.+... ........|..++..+ +||||+++++.+.+.+.+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999865422 1222334566676655 699999999999999999999999876
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..... .......
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence 5555553 3345899999999999999999999999999999999999975 7999999999875432 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+... ...++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~~ 217 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-------------------KVRFP 217 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------------------CCCCC
Confidence 79999999999976666899999999999999999999999887665544443211 11111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCC----CHHHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRP----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----t~~e~l~hp~~~~~~~ 290 (356)
. ..+++++.+||++||..||.+|| ++.++++||||....+
T Consensus 218 ~----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 218 K----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred C----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 1 24688999999999999999998 7999999999987543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=323.72 Aligned_cols=284 Identities=33% Similarity=0.581 Sum_probs=235.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--------C
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVE--------K 71 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------~ 71 (356)
..|....+||+|.||.||+|+.+.+|+.||+|++....+ .-....++|+.+|..|+|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 457788999999999999999999999999998754322 223455899999999999999999887752 3
Q ss_pred CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 72 GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 72 ~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
..+|+||++++.+|..++... ...|+..++..++.+++.||.|+|++.|+|||+||+|+|++. |.+||+|||+++.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 468999999999988887533 234899999999999999999999999999999999999986 8999999999965
Q ss_pred cCC-----CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccch
Q 036550 151 IDA-----FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 151 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (356)
... .+.++..+-|.+|++||.+++...|+++.|||..|||+.+|+++.+.|++..+..++..|...+|+...+.|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 532 234566778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhhhhhcccCCCccccccccc---C--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSAL---M--PSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+......-.....+.........+ . -.-.+++.+|+.+||..||.+|++++++|+|.||...
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 8765544433333332211111111 1 1235689999999999999999999999999999753
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=349.28 Aligned_cols=250 Identities=33% Similarity=0.539 Sum_probs=218.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
|.-++-||.|+||.||-|++..|.+.||||.+..+.. ..-.+++.|+..|+++.|||++.+.++|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5567899999999999999999999999999875533 2334668899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE 159 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~ 159 (356)
|-|+-.|++...+ +++.+..+..|..+.++||.|||+.+.||||||..|||+++ |.|||+|||.|.... +..+
T Consensus 108 ClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PAns 181 (948)
T KOG0577|consen 108 CLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PANS 181 (948)
T ss_pred HhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---chhc
Confidence 9999888887554 45899999999999999999999999999999999999976 899999999987765 3467
Q ss_pred ccccccccChHHHh--hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 160 RVGTRWYQAPEILF--KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 160 ~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
++|||+||||||++ ..+.|+-++||||||++..||..-+||+...+....++.|...-. |...
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-PtLq-------------- 246 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PTLQ-------------- 246 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CCCC--------------
Confidence 89999999999985 346799999999999999999999999998888888887765321 1111
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.+.+|..+++|+.+||+.-|.+|||.+++|.|+|...
T Consensus 247 -------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 247 -------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred -------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1356889999999999999999999999999999965
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=342.43 Aligned_cols=283 Identities=36% Similarity=0.667 Sum_probs=228.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE----CCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVE----KGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 579999999999999999999999999999999875432 223445679999999999999999998753 35789
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+||||++|++.+.+. ....+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++......
T Consensus 85 lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 999999988777664 2344899999999999999999999999999999999999975 79999999999766432
Q ss_pred CC-----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 155 PP-----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 155 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.. .....|+..|+|||.+.+...++.++|||||||++|+|++|++||...+.......+....+.++...+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 1244789999999998665568999999999999999999999999988888888888888877766554332
Q ss_pred hhhhh-hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMA-INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..... ....++......+....+..+.++.++|++||+.||++|||++++++||||.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 22111 111223333333334445679999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=333.45 Aligned_cols=279 Identities=44% Similarity=0.829 Sum_probs=234.7
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|.+.+.||.|++|.||+|.+..+++.+++|.+...... ......+|+.++++++|+||+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 78889999999999999999999999999998655332 3345678999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCcc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYTE 159 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~~ 159 (356)
++++.+.+... ...+++..+..++.||+.||.|||+++|+|+||||+||++++ +.++|+|||.+....... ....
T Consensus 81 ~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 99887776543 245899999999999999999999999999999999999986 799999999998776543 3334
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..++..|+|||.+.+...++.++|+|||||++|+|++|++||...+..+...++...++.+....|.............+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 56888999999987765689999999999999999999999999888888888888888777666655544333334444
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+...........+.++.++.+||.+||..||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 4444444444556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=352.30 Aligned_cols=249 Identities=31% Similarity=0.507 Sum_probs=213.0
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CHHH
Q 036550 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQ 87 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~ 87 (356)
.||+|.||+||-|+|..|....|||.+....++..+-+..||.+.+.|.|.|||+++|.+..++++-|.||-++| +|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 589999999999999999999999999888777777888999999999999999999999999999999998876 4666
Q ss_pred HHHHHHhhcccC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCCCC-ccccc
Q 036550 88 LMEAKKQKQQLF--SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPY-TERVG 162 (356)
Q Consensus 88 ~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~~~-~~~~g 162 (356)
++. .+.+++ +|.++..+.+||++||.|||++.|||||||-+|+|++. |.+||+|||.++.+....+. .++.|
T Consensus 662 LLr---skWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 662 LLR---SKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHH---hccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 655 455667 89999999999999999999999999999999999985 99999999999988765553 46789
Q ss_pred cccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 163 TRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD-QMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 163 t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
|..|||||++... ..|+.++|||||||++.||.||+|||-...... .+.++- .|+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG---------------------myK-- 795 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG---------------------MYK-- 795 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc---------------------cee--
Confidence 9999999999644 459999999999999999999999997654322 222211 111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+.++..+|.++++||.+|+..||..||++.++|..||++..
T Consensus 796 -----vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 796 -----VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -----cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1223345789999999999999999999999999999999864
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=336.09 Aligned_cols=282 Identities=35% Similarity=0.656 Sum_probs=223.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKG------ 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 72 (356)
+++|++.+.||+|+||+||+|.++.+|+.||+|+++..... ......+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46899999999999999999999999999999998654322 2234567999999999999999999987654
Q ss_pred ----eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 73 ----NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 73 ----~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
.+++++||+++++...+... ...+++..++.++.||+.||+|||++||+|+||||+||++++ +.+||+|||.
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 79999999999877776532 335899999999999999999999999999999999999976 6999999999
Q ss_pred eeecCCCC--CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccch
Q 036550 148 AREIDAFP--PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 148 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (356)
+....... ......++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+....|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 98765432 2233456888999999876656789999999999999999999999988888888888887777766655
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.+..........+...............++..+.+++.+||..||++|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 433211110000000000011122234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=339.15 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=200.6
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|.+..+++.||+|++.+... .....+.+|+.++.++ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976532 2233456899999888 699999999999999999999999976
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++..... .......
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence 4555543 2345999999999999999999999999999999999999975 7999999999876422 2233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE------ADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .+....... .
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------------~ 217 (327)
T cd05617 157 CGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------------E 217 (327)
T ss_pred cCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------------h
Confidence 8999999999986554 89999999999999999999999964321 111111110 0
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC------HHHHhcCCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT------AAEALQHPFFKRCLYV 291 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------~~e~l~hp~~~~~~~~ 291 (356)
.... .+..++..+.++|.+||..||.+|++ .+++++||||....|.
T Consensus 218 ~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 218 KPIR-----------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred CCCC-----------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 0111 12357889999999999999999998 5799999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=332.01 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=208.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHH-HHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKC-LRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|++.+.||+|+||.||++.+..+|+.||+|.++.... ........|+.+ ++.++||||+++++++..++..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 589999999999999999999999999999999876532 233344456554 666799999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|++|++.+.+.........+++..++.++.||+.||+|||++ +++||||||+||+++. +.+||+|||++.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999998888876544556799999999999999999999998 9999999999999975 79999999999876543333
Q ss_pred ccccccccccChHHHhhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 158 TERVGTRWYQAPEILFKS---GLYSSKVDMWAMGAIMAELLLFRPLFQGTD-EADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
....++..|+|||++.+. ..++.++|+|||||++|+|++|..||.... ..+....+....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 224 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---------------- 224 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC----------------
Confidence 445789999999988542 336889999999999999999999997532 222222221100
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...++ ...+|.++.++|.+||..+|.+|||+.++++||||...
T Consensus 225 --~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 225 --SPQLP----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --CCCCC----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00000 12468899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=334.21 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=210.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||.|+||.||+|.+..+++.|++|++..........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46999999999999999999999999999999987765555566778999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCC-CCCcc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF-PPYTE 159 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~-~~~~~ 159 (356)
+|+....+... ....+++..++.++.||+.+|.|||++|++||||||+||+++ ++.++|+|||++...... .....
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 88654433222 223489999999999999999999999999999999999997 579999999998764332 22234
Q ss_pred ccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 160 RVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
..+++.|+|||++.+ ...++.++|+|||||++|+|++|.+||...+......++... ..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-------------- 232 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EP-------------- 232 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CC--------------
Confidence 568899999998852 334688999999999999999999999876654433332111 00
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
+ .......++.++.++|.+||..||++||+++++++||||....
T Consensus 233 ----~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 233 ----P------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ----c------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 0011235678999999999999999999999999999997644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=341.93 Aligned_cols=283 Identities=37% Similarity=0.645 Sum_probs=224.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 74 (356)
++|.+.+.||+|+||+||+|++..+++.||+|.+.... ........+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 58999999999999999999999999999999986542 22233456799999999999999999987644 358
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
|+++||+++++.+.+.. ...+++..++.++.||+.||.|||+++++|+||||+||+++. +.+||+|||++.....
T Consensus 85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999999988777642 345899999999999999999999999999999999999975 7999999999987654
Q ss_pred C-CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 154 F-PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .......++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+.......+....+.+....+.......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3 222345688999999998765558999999999999999999999999887777777777777766655442111100
Q ss_pred hh-hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MA-INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.. .....+...........+.+++++.+||++||+.||++|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 000111111122223345789999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=340.11 Aligned_cols=248 Identities=30% Similarity=0.453 Sum_probs=199.7
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHH-HHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREV-KCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|++..+++.||+|++.+... .......+|. .+++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999865421 2222334444 467889999999999999999999999999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-CCCCccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-FPPYTER 160 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~~~~~~~ 160 (356)
+|...+. ....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++..... .......
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence 4554443 2345899999999999999999999999999999999999975 7999999999875422 2223456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+... ..
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------------------~~--- 213 (321)
T cd05603 157 CGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-------------------PL--- 213 (321)
T ss_pred cCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------------CC---
Confidence 7999999999986554 899999999999999999999999887765544443211 01
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA----AEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~~~~~~~ 290 (356)
...+..+..+.++|.+||+.||.+|+++ .++++|+||....+
T Consensus 214 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 214 --------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred --------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 1123568899999999999999999975 59999999986544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=331.76 Aligned_cols=281 Identities=35% Similarity=0.634 Sum_probs=219.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 5899999999999999999999989999999998654322 23445789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~ 157 (356)
|+.+++.+.+.. ....+++..++.++.||+.||.|||+.|++|+||+|+||++++ +.++|+|||++...... ...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 999876655432 2234899999999999999999999999999999999999975 68999999998876432 223
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....++..|+|||++.+...++.++|||||||++|+|++|.+||......+...++....+...................
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568999999999876666789999999999999999999999888776766666655544322111000000000011
Q ss_pred cCCCcc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLS-GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..+... ........+.++..+.+|+.+||..||++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 111110 111122345778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=331.86 Aligned_cols=279 Identities=39% Similarity=0.709 Sum_probs=225.2
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFFVFE 79 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~iv~e 79 (356)
|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999999999999997663 22334567899999999999999999999988 89999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--C
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--P 156 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~ 156 (356)
|+++++.+.+... ...+++..++.++.||+.||+|||++|++|+||+|+||++++ +.++|+|||.+....... .
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9998877776532 245899999999999999999999999999999999999975 799999999998775533 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....++..|+|||.+.+...++.++|||||||++|+|++|..||...+.......+....+.+....|...........
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 33456788999999876665689999999999999999999999999888888888888777777666644322111111
Q ss_pred ccCCCcccccccccCCC-CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 237 YQFPQLSGVNLSALMPS-ASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..........+...... .+..+.+++++||..||++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11111111111112223 48899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=331.73 Aligned_cols=281 Identities=40% Similarity=0.665 Sum_probs=222.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 589999999999999999999999999999999865432 223456789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--C
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--P 156 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~ 156 (356)
|+++++.+.+.. +...+++..+..++.||+.||.|||++|++|+||+|+||++++ +.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 999987766543 2344899999999999999999999999999999999999975 799999999998765543 3
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....++..|+|||++.+...++.++|+||||+++|+|++|.+||......+....+...++......+...........
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 34567889999999997764689999999999999999999999998887777777666655544432221111000000
Q ss_pred ccCCCcc-cccc-cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 237 YQFPQLS-GVNL-SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 237 ~~~~~~~-~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..++... .... ......++.++.+||++||..||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0111100 0000 11223458999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=330.11 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=210.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.|++.+.||+|+||+||++.+..+++.||+|.+..... .......+|+.+++.++|+||+++++.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999865432 222345789999999999999999999999999999999
Q ss_pred eccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+.++ +.+.+... ....+++..+..++.|++.||.|||++||+||||||+||++++ +.++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99875 55554332 2235899999999999999999999999999999999999975 68999999999776544444
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+........
T Consensus 159 ~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------------- 221 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------------- 221 (285)
T ss_pred cCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------------
Confidence 5567999999999986554 89999999999999999999999987665433333222111000
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~ 288 (356)
......++..+.+|+.+||+.||++||| +.++++|+||...
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 222 ----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0112356889999999999999999999 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=341.75 Aligned_cols=282 Identities=40% Similarity=0.679 Sum_probs=231.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC-----eEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKG-----NVF 75 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 75 (356)
+|.+.+.||.|++|.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999999999999999987653 333456678999999999999999999988765 789
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
++|||+++++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++++ +.++|+|||.+......
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999999887777642 236899999999999999999999999999999999999975 79999999999887654
Q ss_pred C----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 P----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. ......+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+..+....+....+.+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 3 234556899999999987764689999999999999999999999999998888888888888777665542111
Q ss_pred hh-hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QA-MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.. .......+......+....+.++.++.+||.+||+.||.+|||++++++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 11 11111122222333344455689999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=325.87 Aligned_cols=251 Identities=25% Similarity=0.459 Sum_probs=207.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-----hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-----REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999999999999999865421 122345779999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
++||+.| ++.+.+.. ...+++..++.++.|++.||.|||++|++|+||+|+||++++ +.++|+|||.+......
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999976 56666543 234899999999999999999999999999999999999976 79999999998765432
Q ss_pred CCC----ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PPY----TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
... ....++..|+|||++.+.. ++.++|||||||++|+|++|++||...+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------ 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT------------ 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC------------
Confidence 111 2356888999999986655 89999999999999999999999987655444333221100
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.......++..+.++|.+||..+|.+|||+.++++||||
T Consensus 225 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 ----------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 011223678899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=346.76 Aligned_cols=263 Identities=27% Similarity=0.473 Sum_probs=232.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
.++.++..||-|+||.|=++........+|+|++++.. ....+....|-++|..+..|+||++|..|.++.++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 46778899999999999999877666679999998763 444556678999999999999999999999999999999
Q ss_pred E-eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 E-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e-~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
| |++|.++..+..+ +.|++.+++.++.++++|++|||++|||+|||||+|.+++. |-+||.|||+|+.+.....
T Consensus 500 EaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9 6778888888543 44999999999999999999999999999999999999975 8999999999999999999
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
..++||||.|.|||++++.+ .+.++|.||||+++|||++|.|||++.++...+..|.+... .
T Consensus 576 TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----------------~ 637 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----------------K 637 (732)
T ss_pred eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----------------h
Confidence 99999999999999998877 89999999999999999999999999999999988876532 2
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYVPPHLRS 297 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~~~~~~ 297 (356)
+.+| ..++..+.+||+++++.+|.+|.. +.++-+|-||.+..|.-...+.
T Consensus 638 i~~P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~ 692 (732)
T KOG0614|consen 638 IEFP-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRT 692 (732)
T ss_pred hhcc-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhcc
Confidence 2333 367889999999999999999986 8999999999999988665554
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=334.08 Aligned_cols=265 Identities=31% Similarity=0.499 Sum_probs=215.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|.+...... ....+.+|+++++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 5899999999999999999999999999999998765322 3345678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+... .+..+++..++.++.||+.||+|||++|++|+||||+||+++. +.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99876 676665432 2345899999999999999999999999999999999999974 7999999999865432111
Q ss_pred ------------------------------CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036550 157 ------------------------------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE 206 (356)
Q Consensus 157 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 206 (356)
.....|+..|+|||++.+.. ++.++|||||||++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11346888999999986554 79999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC----HHHHhcC
Q 036550 207 ADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT----AAEALQH 282 (356)
Q Consensus 207 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~e~l~h 282 (356)
...+..+... ...++. ....+..+.++|.+||..||++||| ++++|+|
T Consensus 238 ~~~~~~~~~~-------------------~~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETFSNILKK-------------------EVTFPG---------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHhcC-------------------CccCCC---------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 6555443211 001111 1136889999999999999999999 9999999
Q ss_pred CCCCCCCCCCCCCCC
Q 036550 283 PFFKRCLYVPPHLRS 297 (356)
Q Consensus 283 p~~~~~~~~~~~~~~ 297 (356)
|||++..|......+
T Consensus 290 ~~~~~~~~~~~~~~~ 304 (316)
T cd05574 290 PFFRGVNWALIRHTT 304 (316)
T ss_pred chhhcCChhhcccCC
Confidence 999987665444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=342.54 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=217.3
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccCCH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCNL 85 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g~l 85 (356)
+.||.|.||+||-|.++++|+.||||++.+.. ......+.+|+.||+.++||.||.+...|+..+.++.|||-+.|+.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 78999999999999999999999999997653 2334566789999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCCCCCcccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAFPPYTERV 161 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~~~~~~~~ 161 (356)
++.|.... .+.+++...+.++.||+.||.|||-++|+|+||||+|||+.+ -.+||||||+|+.+++..-..+.+
T Consensus 650 LEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 650 LEMILSSE--KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred HHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 98887543 345999999999999999999999999999999999999975 389999999999999877777889
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (356)
|||.|+|||++.+.+ |...-|+||+|||+|--++|..||....+ ...+|...-...+..+|
T Consensus 728 GTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW---------------- 788 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPW---------------- 788 (888)
T ss_pred CCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCch----------------
Confidence 999999999997766 99999999999999999999999986543 22333322222333333
Q ss_pred cccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 242 LSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.++++.++|||..+|+..=.+|.|++..|.|||+++.
T Consensus 789 ----------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 789 ----------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ----------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 4789999999999999999999999999999999864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=335.88 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=218.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++.|+..+.||+|+||.||-|+-+.||+.||.|.+.+.. .......++|..+|++++.+.||.+-..|+..+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356889999999999999999999999999999886542 22234557899999999999999999999999999999
Q ss_pred EEeccCCHHHH-HHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQCNLYQL-MEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~l~~~-~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
+..|+|+-+.+ |.... +..|+|..++.++.+|+.||++||+.+||+|||||+|||+|+ |+++|+|+|+|..+....
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999873322 22222 135999999999999999999999999999999999999987 899999999999999888
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
+....+||.+|||||++.+.. |+.+.|+|||||++|+|+.|..||...........+-. .....
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---------------r~~~~ 405 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---------------RTLED 405 (591)
T ss_pred ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---------------HHhcc
Confidence 888889999999999996665 99999999999999999999999986654332222111 11111
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
.. .+...+|++++++.+.+|..||++|. +++++.+||||+...|.
T Consensus 406 ~~-----------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 406 PE-----------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred hh-----------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 11 22347899999999999999999998 57899999999987764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=330.07 Aligned_cols=278 Identities=38% Similarity=0.751 Sum_probs=234.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|++.+.||+|.+|.||+|.+..+++.||+|++.... ........+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 778899999999999999999999999999987653 222345567999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCcc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYTE 159 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~~ 159 (356)
++++.+.+.... ..+++..+..++.|++.||.|||++||+||||+|+||++++ +.++|+|||.+....... ....
T Consensus 81 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred CcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 999888886542 34899999999999999999999999999999999999976 799999999987765432 3334
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..++..|+|||.+.+...++.++|+|||||++|+|++|.+||...+..+...++...++.+....|....... .....+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTF 236 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-cccccc
Confidence 4567889999998766568999999999999999999999999998888888898888888877776554332 333444
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+...........+..+..+.++|.+||..||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 4444444444455678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=329.38 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=211.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||.|+||+||++.+..++..||+|++..........+.+|+.++++++||||+++++.+...+..|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 57999999999999999999998899999999987665555566778999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+++ +.+.+.. ....+++..++.++.|++.||.|||++||+|+||||+||+++. +.++|+|||.+....... ...
T Consensus 85 ~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 85 DGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred CCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 875 5555432 2345899999999999999999999999999999999999974 799999999887654322 223
Q ss_pred cccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 159 ERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
...+++.|+|||++.. ...++.++|+|||||++|+|++|.+||...+......++.... +
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-------------- 225 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--P-------------- 225 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--C--------------
Confidence 4568999999999853 2346789999999999999999999998776544433332110 0
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+. ......++.++.++|.+||..||.+|||+.++++||||.+.
T Consensus 226 -----~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 -----PT------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----CC------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 01123568899999999999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=335.90 Aligned_cols=278 Identities=22% Similarity=0.308 Sum_probs=203.1
Q ss_pred eecccccC--CceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 6 LTKKLGSG--SFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 6 ~~~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
+.+.||+| +|++||++.++.+|+.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 57889999 789999999999999999999876432 22345567999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC---
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--- 156 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--- 156 (356)
.+ ++.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. +.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 86 5666664332 234899999999999999999999999999999999999975 7999999987544321110
Q ss_pred -----CccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc-cch---H
Q 036550 157 -----YTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM-DSW---A 226 (356)
Q Consensus 157 -----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~---~ 226 (356)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||.............. +..+. ... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 1123567889999999654 3489999999999999999999999986654433322211 11000 000 0
Q ss_pred -HHhh---------hhhhhcc----cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 227 -DGLR---------QAMAINY----QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 227 -~~~~---------~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+... ....... ..+.............+++.+.+||.+||+.||++|||++++++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0000 0000000 00000011111223356889999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=338.91 Aligned_cols=255 Identities=28% Similarity=0.501 Sum_probs=199.4
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcc-ccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~-~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.|+++++||.|+.+.||++.....+ .||+|.+. ... .....-+.+|+..|.+| .|.+||+++++-..++.+|||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 5999999999999999999866544 45555543 322 23344567899999999 59999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCCC---
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPP--- 156 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~~--- 156 (356)
|-+.+|...+.++.. ..+.-.++.|..||+.|+.++|.+||||.||||.|+|+-+|.+||+|||.|..+.....
T Consensus 441 ~Gd~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 441 CGDIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cccccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCcccccee
Confidence 999999888865432 23434889999999999999999999999999999999999999999999988765322
Q ss_pred CccccccccccChHHHhhCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 157 YTERVGTRWYQAPEILFKSG----------LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
..+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..... ...++ .....|.
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl-~aI~~P~----- 589 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKL-HAITDPN----- 589 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHH-HhhcCCC-----
Confidence 24568999999999996432 156789999999999999999999985432 11111 1111110
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
-.+.||... -..++.++++.||.+||.+|||+.++|+|||++-
T Consensus 590 --------~~Iefp~~~----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 590 --------HEIEFPDIP----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred --------ccccccCCC----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 012233221 1234999999999999999999999999999975
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=329.30 Aligned_cols=255 Identities=28% Similarity=0.508 Sum_probs=210.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||.|+||+||++.+..+++.|++|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 57999999999999999999999999999999987655555556688999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-Cc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~~ 158 (356)
.++ |...+. ...+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 875 444442 224899999999999999999999999999999999999974 7999999999876644322 23
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... ..+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------------- 234 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------------- 234 (296)
T ss_pred CcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------------
Confidence 457899999999986544 789999999999999999999999887765443332211 0000
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
......+++.+.++|++||..||++|||+.++++||||..+.
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 235 ---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 011235788999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=326.20 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=209.4
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
-|++.+.||.|+||.||++.+..++..+++|.+..........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 37889999999999999999999999999999876655555566789999999999999999999999999999999998
Q ss_pred CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCccc
Q 036550 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTER 160 (356)
Q Consensus 83 g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~~ 160 (356)
++....+.. ....++++..+..++.||+.||.|||+.|++||||||+||+++. +.++|+|||++...... ......
T Consensus 86 ~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 86 GGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred CCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 764433322 12345899999999999999999999999999999999999975 79999999998765432 222345
Q ss_pred cccccccChHHHh----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 161 VGTRWYQAPEILF----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 161 ~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.+++.|+|||++. ....++.++|+||+||++|+|++|.+||...+.......+......
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 226 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP----------------- 226 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-----------------
Confidence 7899999999974 2334778999999999999999999999887665544443221100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......++.++.+||.+||..||.+|||++++++||||...
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 ----------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 001112468899999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=310.45 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=208.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~i 76 (356)
+||++.+.||+|+|+-||++....+++.||+|++.....++.+..++|++..++++|||+++++++...+ ...|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 6899999999999999999999999999999999888777788889999999999999999998876433 35899
Q ss_pred EEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 77 VFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 77 v~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+++|.. |++.+.+.....++..++|.++..|+.+|++||++||+.. ++||||||.|||+++ +.++|.|||.++...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence 999654 7799999988888888999999999999999999999999 999999999999987 899999999987653
Q ss_pred CC----------CCCccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 036550 153 AF----------PPYTERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220 (356)
Q Consensus 153 ~~----------~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 220 (356)
-. ........|..|+|||.+.- ....+.++|||||||++|.|+.|..||...- ...++-
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~GgSl 251 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGGSL 251 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCCeE
Confidence 21 11122347889999998732 2336889999999999999999999996321 111111
Q ss_pred CccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 221 TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
... ....++.+|+.. .+|..+.++|++||+.||.+||++.+++.+
T Consensus 252 aLA--------v~n~q~s~P~~~---------~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 ALA--------VQNAQISIPNSS---------RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEe--------eeccccccCCCC---------CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000 011134445432 479999999999999999999999999875
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=326.84 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=204.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 579999999999999999999999999999999865532 3334567899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE 159 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~ 159 (356)
++++..+.. ..+++..+..++.|++.||.|||++||+|+||||+||+++. +.++|+|||++...... ....
T Consensus 81 ~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~ 152 (279)
T cd06619 81 MDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKT 152 (279)
T ss_pred CCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccC
Confidence 998755432 12789999999999999999999999999999999999975 79999999999876543 2344
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQM---YKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
..|+..|+|||++.+.. ++.++|+|||||++|+|++|..||......... ........ .
T Consensus 153 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------~ 214 (279)
T cd06619 153 YVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-----------------D 214 (279)
T ss_pred CCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-----------------c
Confidence 68999999999986554 899999999999999999999999753321100 00000000 0
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+. ......++++.+++.+||..||++||+++++++||||...
T Consensus 215 ~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 215 EDPPV-------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred cCCCC-------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00000 0112467899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=329.76 Aligned_cols=255 Identities=27% Similarity=0.490 Sum_probs=209.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||.|+||.||++.+..+++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57999999999999999999999999999999997665555566788999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-Cc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~~ 158 (356)
++ ++.+.+.. ..+++..+..++.|++.||.|||+.|++||||||+||+++. +.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 76 45555432 23789999999999999999999999999999999999975 7999999999887644322 23
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...+.......+.. .+.+
T Consensus 174 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~------------------ 233 (297)
T cd06656 174 TMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP------------------ 233 (297)
T ss_pred cccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC------------------
Confidence 45789999999998654 478999999999999999999999977654332211110 0000
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.......++..+.+|+.+||..||++||++.++++||||....
T Consensus 234 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 234 --------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred --------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 0011235678899999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=327.91 Aligned_cols=253 Identities=32% Similarity=0.484 Sum_probs=212.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||.||++.+..+++.||+|++.+... .......+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 589999999999999999999999999999999865421 22345678999999999999999999999999999999
Q ss_pred Eec-cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~-~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+ +++|.+.+... ..+++..+..++.||+.||.|||++|++|+||+|+||++++ +.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999 45777776533 45899999999999999999999999999999999999975 79999999999876543
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~ 214 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-------------------K 214 (290)
T ss_pred CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------C
Confidence 3445789999999998655 4789999999999999999999999877754444333211 0
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
. .+...++..+.++|.+||..||.+|+ +++++++||||....|.
T Consensus 215 ~-----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 215 V-----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred c-----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 1 11235688999999999999999999 99999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=337.27 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=196.2
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC-Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEK-GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~~ 73 (356)
++|++.++||+|+||.||+|.+ ..+++.||+|++..... .....+.+|+.+++.+ +||||+++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 6899999999999999999975 34567899999875432 3344567899999999 899999999988754 46
Q ss_pred EEEEEEeccC-CHHHHHHHHHhh---------------------------------------------------------
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQK--------------------------------------------------------- 95 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~--------------------------------------------------------- 95 (356)
++++|||+.+ +|.+.+......
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 8999999975 677776542210
Q ss_pred -cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC---CccccccccccChH
Q 036550 96 -QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPE 170 (356)
Q Consensus 96 -~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 170 (356)
..++++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++........ .....+++.|+|||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 234788899999999999999999999999999999999975 7999999999986543221 12334568899999
Q ss_pred HHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccc
Q 036550 171 ILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSA 249 (356)
Q Consensus 171 ~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
++.+.. ++.++|||||||++|+|++ |.+||......+.......... ...
T Consensus 247 ~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~ 297 (338)
T cd05102 247 SIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT----------------------------RMR 297 (338)
T ss_pred HhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC----------------------------CCC
Confidence 986554 8999999999999999997 9999987654333222211000 001
Q ss_pred cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 250 LMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 250 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.....++.+.+++.+||..||.+|||+.++++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12356889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=327.96 Aligned_cols=254 Identities=27% Similarity=0.483 Sum_probs=209.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.+|.+.+.||+|+||.||++.+..+++.||+|.+..........+.+|+.+++.++|+||+++++.+......|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 58999999999999999999999999999999987765555566788999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
.| +|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||++++ +.++|+|||++....... ...
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 76 56665532 23789999999999999999999999999999999999975 689999999987654322 223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||...........+... +.+
T Consensus 175 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------------ 234 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP------------------ 234 (296)
T ss_pred cccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC------------------
Confidence 457899999999986544 789999999999999999999999876654332222110 000
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......++..+.+++.+||..||++|||+.++++||||...
T Consensus 235 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 235 --------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred --------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 001123567899999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=324.44 Aligned_cols=254 Identities=29% Similarity=0.504 Sum_probs=205.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||+|++..+++.||+|+++...........+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57999999999999999999999999999999987665444455678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
++ +|.+.+.. .+.+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... ....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 86 56666542 335899999999999999999999999999999999999975 79999999998766432 2223
Q ss_pred cccccccccChHHHh--hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILF--KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...|++.|+|||++. ....++.++|+|||||++|+|++|.+||............... .
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-------------------~ 225 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-------------------N 225 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-------------------C
Confidence 457999999999974 2344788999999999999999999999765543322221110 0
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
...+.. .....++..+.++|.+||..||++|||++++++|||
T Consensus 226 ~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 FQPPKL------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCCcc------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000000 001145788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=332.95 Aligned_cols=282 Identities=36% Similarity=0.638 Sum_probs=223.9
Q ss_pred CceeecccccCCceEEEEEEEcCC--CcEEEEEEcccccch--HHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC----Ce
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHS--GEVVAIKALKKSYSR--EKCLNLREVKCLRKL-NHPNIVKVKELIVEK----GN 73 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~----~~ 73 (356)
+|.+.+.||+|+||.||++.+..+ +..||+|.+...... ......+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 689999999999999999999888 899999998653222 234457899999999 599999999875432 46
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.++++++++++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||.+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999999988877742 345899999999999999999999999999999999999975 789999999998654
Q ss_pred CCC-----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 153 AFP-----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 153 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
... ......|++.|+|||++.+...++.++||||+||++|+|++|.+||...+.......+...++.++...+..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 321 123347899999999987655689999999999999999999999999888888888888888777654433
Q ss_pred Hhhhhhh-hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 228 GLRQAMA-INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
....... ............+....+..+..+.+|+.+||+.||++|||+.+++.||||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 2221110 001111111222233345678999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=323.28 Aligned_cols=252 Identities=29% Similarity=0.504 Sum_probs=210.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||.|++|.||+|.+..+++.||+|++.... ......+.+|+.+++.++|+||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 58999999999999999999999999999999987653 23334567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~ 157 (356)
+.+ ++.+.+... .+++..++.++.|++.||.|||+++++|+||+|+||++++ +.++|+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 876 566665432 5899999999999999999999999999999999999975 79999999999887654 233
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||...+.......+.... .
T Consensus 156 ~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~------------------ 215 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-P------------------ 215 (274)
T ss_pred ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-C------------------
Confidence 4557889999999996655 8999999999999999999999998766443332221110 0
Q ss_pred cCCCcccccccccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMP-SASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+ .... .++..+.+++.+||..||++|||++++++||||++.
T Consensus 216 --~--------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 216 --P--------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred --C--------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0 0011 268899999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=323.75 Aligned_cols=254 Identities=29% Similarity=0.477 Sum_probs=204.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||.||+|.+..+++.||+|++............+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 57999999999999999999999999999999987654444455678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
++ +|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||++++ +.++|+|||++....... ...
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 86 56665542 345899999999999999999999999999999999999975 689999999998764322 223
Q ss_pred cccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...|++.|+|||.+.. ...++.++|+||+||++|+|++|.+||...........+... .
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------~ 225 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------------N 225 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------------C
Confidence 4578999999998742 334678999999999999999999999755432221111000 0
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
+..+.. .....++..+.+|+++||..||++|||++++++|+|
T Consensus 226 ~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 226 FQPPKL------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCCCC------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 011256889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=335.78 Aligned_cols=280 Identities=35% Similarity=0.628 Sum_probs=223.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGN------ 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------ 73 (356)
++|.+.+.||+|++|.||+|++..+++.||+|++.... ........+|+.++++++||||+++++++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 57999999999999999999999999999999986542 2223445689999999999999999988766554
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.++|+||++++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||++++ +.++|+|||++....
T Consensus 95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 899999998888887653 34899999999999999999999999999999999999975 799999999998765
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.. .....++..|+|||++.+...++.++|||||||++|+|++|+.||...........+....+.++...+.......
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 42 3445788999999998765557899999999999999999999999888877777777776655543332211110
Q ss_pred h-hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 M-AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
. ......+.............++..+.+||.+||..||++|||+.++++||||.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0 0001111111122223334568999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=333.34 Aligned_cols=280 Identities=36% Similarity=0.655 Sum_probs=220.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------e
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKG------N 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------~ 73 (356)
++|.+.+.||+|+||.||++.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 6899999999999999999999999999999998653222 2334578999999999999999999987553 4
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+++||||+++++.+.+. ...+++..++.++.||+.||+|||++||+||||||+||++++ +.++|+|||++....
T Consensus 95 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 68999999877776653 234899999999999999999999999999999999999974 799999999987664
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.. .....+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+.......+....+.++.. +.......
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 246 (343)
T cd07880 170 SE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSE 246 (343)
T ss_pred cC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HHHhhcch
Confidence 32 2345678999999998765558899999999999999999999999888777766666654443322 22211110
Q ss_pred hh--hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 233 MA--INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.. .....+...........+.+++.+.++|.+||..||++|||+.++++||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00 0011222222223334457889999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=320.12 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=210.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||.|+||+||+|.+..++..+|+|++..... .....+.+|+.+++.++|+||+++++.+...+..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 689999999999999999999988999999999865432 3445668899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC-
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY- 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~- 157 (356)
+.| ++.+.+.... ....+++..++.++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 976 5666654322 1245899999999999999999999999999999999999975 69999999998766543221
Q ss_pred ----ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 158 ----TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 158 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
....|+..|+|||++.....++.++|+|||||++|+|++|..||...+......+..... +.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------ 225 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PP------------ 225 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--CC------------
Confidence 334689999999998766468999999999999999999999998766544433332210 00
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.++. ......++..+.+++.+||..||++|||+.++++||||
T Consensus 226 ----~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 ----SLET------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----CcCC------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000 00123678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=339.24 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=221.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
..|.+.++||.|.|++|.++++..++..||||++.+..-+. ...+.+|+.+|..++|||||+++.+.+.+..+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 46999999999999999999999999999999998874332 2346789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~~~~~ 157 (356)
|..+ .+++++... +...+..++.++.|+++|++|||+++|||||||.+|||++.+ ++||+|||++..+......
T Consensus 136 ya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 136 YASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred eccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence 9875 577777543 337789999999999999999999999999999999999986 5999999999999888888
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
.+.||++.|.|||++.+..+.++.+|+||+|+++|.|++|..||++.+-.+...+ ....++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-------------------vl~gk~ 272 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-------------------VLRGKY 272 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch-------------------heeeee
Confidence 8999999999999999988889999999999999999999999998765433222 123345
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
+.|. -++.++.++|+++|..+|.+|++.+++..|.|.....
T Consensus 273 rIp~-----------~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 273 RIPF-----------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred cccc-----------eeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 5544 5688999999999999999999999999999997543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=332.31 Aligned_cols=280 Identities=34% Similarity=0.598 Sum_probs=219.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 689999999999999999999999999999999875432 2234556899999999999999999988643 35
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.|++++++++++.+.+.. ..+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++....
T Consensus 97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 789999998888776532 24899999999999999999999999999999999999975 799999999987654
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. ......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+....+.+....+.......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 172 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred c--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 3 22345789999999998765568899999999999999999999998887777777777766655544432221110
Q ss_pred hhh-cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MAI-NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... ....+..............++++.+||.+||..||.+|||+.++++||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 00111111111222223568899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=322.22 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=203.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC------CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEK------GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~------~~~ 74 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++..... ......+|+.+++++ +|+||+++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 368999999999999999999999999999999865532 234567899999998 799999999998753 468
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
|++|||+++ +|.+.+... ....+++..+..++.|++.||+|||+++|+|+||||+||++++ +.++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999986 566666432 2345899999999999999999999999999999999999975 689999999998664
Q ss_pred CC-CCCccccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 153 AF-PPYTERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
.. .......|++.|+|||++.+ ...++.++|+||+||++|+|++|..||...........+...
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~----------- 231 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----------- 231 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-----------
Confidence 32 22345678999999999853 234788999999999999999999999765543332221100
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.. .......++..+.+|+.+||..||.+|||+.++++||||
T Consensus 232 ----------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 ----------PA-------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------CC-------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 001112567899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=316.59 Aligned_cols=251 Identities=29% Similarity=0.523 Sum_probs=206.1
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-CCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE-KGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~iv~e 79 (356)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ........+|+.++++++|+|++++++.+.. ++.++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999999999999986543 2333456789999999999999999998764 456899999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-C
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-P 156 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~ 156 (356)
|+++ ++.+.+... ....+++.+++.++.|++.||++||++|++|+||||+||++++ +.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 9875 566666532 3345899999999999999999999999999999999999975 789999999998764322 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....+++.|+|||++.+.. ++.++|+|||||++++|++|..||...+.......+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------------ 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------------ 219 (257)
T ss_pred cccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence 33456899999999986554 88999999999999999999999987765544433322110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.......++++.+++.+||+.||++|||+.++++||||
T Consensus 220 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=333.13 Aligned_cols=279 Identities=38% Similarity=0.649 Sum_probs=219.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.... ....+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999999999999999998654222 223457899999999999999999998754 35
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+++|+||+..++.... +..+++..+..++.|++.||+|||++|++||||||+||+++. +.++|+|||++....
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6999999987655432 234899999999999999999999999999999999999975 799999999987654
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. ......+++.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+....+ +.....
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (342)
T cd07879 169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV-QKLEDK 245 (342)
T ss_pred C--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH-HHhccc
Confidence 3 2234578899999999876555889999999999999999999999988877777777776665443322 211111
Q ss_pred hhhc--ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 233 MAIN--YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 233 ~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.... ...+......+....+..+..+.+||.+||+.||.+|||+++++.||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 1100 11122122223333456788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=351.43 Aligned_cols=285 Identities=25% Similarity=0.363 Sum_probs=201.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCC-cEEEEE--------------Eccc---ccchHHhhhHHHHHHHHhCCCCCeeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG-EVVAIK--------------ALKK---SYSREKCLNLREVKCLRKLNHPNIVK 63 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~-~~vavK--------------~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~ 63 (356)
++|++++.||+|+||+||+|..+... ..++.| .+.+ ........+.+|+.+|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 68999999999999999998764322 222222 1111 11122344578999999999999999
Q ss_pred EeEEEEECCeEEEEEEeccCCHHHHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEE
Q 036550 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQ-KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIK 141 (356)
Q Consensus 64 ~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~k 141 (356)
+++++.+.+..|++++++.+++++.+..... .........++.++.||+.||+|||++||+||||||+|||++. +.+|
T Consensus 228 l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999998887653221 1122446778899999999999999999999999999999975 7999
Q ss_pred EecccceeecCCCCC--CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCC-CCCCC--ChHHHHHHHHHH
Q 036550 142 IADFGLAREIDAFPP--YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRP-LFQGT--DEADQMYKICSV 216 (356)
Q Consensus 142 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~--~~~~~~~~i~~~ 216 (356)
|+|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.. ||... .....+.++...
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 999999987654322 22457999999999997655 8999999999999999999875 44432 334455555544
Q ss_pred hCCCCccchHHHhhhhhhh--cccCCCccccccccc--CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 217 LGSPTMDSWADGLRQAMAI--NYQFPQLSGVNLSAL--MPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.+....+ +.+........ ...+... ......+ ...++.++.++|.+||.+||.+|||+.|+|+||||....
T Consensus 387 ~~~~~~~-~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 387 LSVCDEE-FPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred cccChhh-cCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 4322211 11110000000 0000000 0000000 124677899999999999999999999999999998643
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=326.00 Aligned_cols=260 Identities=25% Similarity=0.466 Sum_probs=208.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 589999999999999999999999999999998865422 2334567899999999999999999999999999999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.|+ +..++.. ......+++..+..++.||+.||.|||+ .||+|+||||+||+++. +.++|+|||.+...... ..
T Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 158 (286)
T cd06622 81 MDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA 158 (286)
T ss_pred cCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence 9875 5444432 2223358999999999999999999997 59999999999999975 68999999998766432 22
Q ss_pred ccccccccccChHHHhhCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 158 TERVGTRWYQAPEILFKSG-----LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
....+++.|+|||++.+.. .++.++|+|||||++|+|++|..||...........+.......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 226 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD------------ 226 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC------------
Confidence 3456889999999985432 25789999999999999999999997655433322221111100
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.....+.++.++.+||.+||..+|++||++.++++||||....
T Consensus 227 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 227 --------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred --------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 0112235789999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=332.62 Aligned_cols=282 Identities=38% Similarity=0.718 Sum_probs=224.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC--CeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKL-NHPNIVKVKELIVEK--GNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~i 76 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ........+|+.+++++ +||||+++++++... ...|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 68999999999999999999999899999999885432 22333456799999999 999999999998654 46899
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
||||++++|...+... .+++..++.++.||+.||+|||++||+|+||||+||++++ +.+||+|||.+.......
T Consensus 87 v~e~~~~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYMETDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EecccccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 9999999887776432 5889999999999999999999999999999999999975 799999999987664321
Q ss_pred ------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 156 ------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
......|+..|+|||++.+...++.++|+|||||++|+|++|++||......+...++....+.+....+....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 22334689999999998766668899999999999999999999999888888888887777766554443222
Q ss_pred hhhhhhcc-cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINY-QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........ ..+...........+.++.++.++|.+||+.||++|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 11111111 111122222333445689999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=326.04 Aligned_cols=282 Identities=31% Similarity=0.498 Sum_probs=218.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-----C---CCeeEEeEEEEEC--
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-----H---PNIVKVKELIVEK-- 71 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~iv~~~~~~~~~-- 71 (356)
.||.+.++||.|.|++||+|.|..+.+.||+|+++.. ..-.+..+.||.+|+++. | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 4899999999999999999999999999999987643 333445678999999882 3 3699999999754
Q ss_pred --CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeCC----------
Q 036550 72 --GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQG---------- 138 (356)
Q Consensus 72 --~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~---------- 138 (356)
.++|||+|+++.+|+.+|.....++ ++...++.|++||+.||.|||. .||||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 5899999999999999998766555 8899999999999999999996 599999999999998200
Q ss_pred -------------c------------------------------------------------------------------
Q 036550 139 -------------T------------------------------------------------------------------ 139 (356)
Q Consensus 139 -------------~------------------------------------------------------------------ 139 (356)
.
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------EE
Q 036550 140 ------------------------------------------------------------------------------IK 141 (356)
Q Consensus 140 ------------------------------------------------------------------------------~k 141 (356)
+|
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 45
Q ss_pred EecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHH
Q 036550 142 IADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGT------DEADQMYKICS 215 (356)
Q Consensus 142 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~ 215 (356)
|+|||.|++... .++..+.|..|+||||+++.+ |++.+||||++||+|||+||...|... .+++.++.|+.
T Consensus 395 IaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E 471 (590)
T KOG1290|consen 395 IADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME 471 (590)
T ss_pred Eeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence 566666555442 445567899999999999988 999999999999999999999999643 35788999999
Q ss_pred HhCCCCccchHHHhhhhhhhcc--c---CCCcccccc-------cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 216 VLGSPTMDSWADGLRQAMAINY--Q---FPQLSGVNL-------SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
++|..+......+.-.....+. . ..+.....+ -.+......++.+|+.-||+.+|++||||.++|+||
T Consensus 472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP 551 (590)
T KOG1290|consen 472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP 551 (590)
T ss_pred HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence 9998776544322111111110 0 000111110 011123356789999999999999999999999999
Q ss_pred CCCCCC
Q 036550 284 FFKRCL 289 (356)
Q Consensus 284 ~~~~~~ 289 (356)
|+....
T Consensus 552 wLn~~~ 557 (590)
T KOG1290|consen 552 WLNPVA 557 (590)
T ss_pred cccCCC
Confidence 998653
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=318.04 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=208.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||.|+||.||+|.+..+++.+++|++..........+.+|+.++++++||||+++++++.+.+.+|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 68999999999999999999999999999999997765555566788999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+++ +.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+||++++ +.++|+|||++....... ...
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 875 55544322 245899999999999999999999999999999999999975 689999999987665422 223
Q ss_pred cccccccccChHHHhhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILFKS--GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||...+.......+......+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~---------------- 223 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP---------------- 223 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------------
Confidence 45788999999998654 247889999999999999999999998776544433322110000
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
+. .......+.++.+|+.+||..||.+|||+.+++.|+|
T Consensus 224 ---~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 ---PK------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---cc------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 0011245778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=325.60 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=209.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|...+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 578888999999999999999999999999999876432 33445678999999996 9999999999999999999999
Q ss_pred eccCCHHHHHHHH-HhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 80 CMQCNLYQLMEAK-KQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 80 ~~~g~l~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
|+++++.++.... ......+++..+..++.|++.||+|||+. +++||||||+||+++. +.++|+|||++........
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 9998876655432 22335689999999999999999999975 9999999999999975 7899999999976654433
Q ss_pred CccccccccccChHHHhhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKS--GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.....|+..|+|||++.+. ..++.++|||||||++|+|++|.+||..... ....+........
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~------------- 228 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP------------- 228 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-------------
Confidence 3455789999999998665 3589999999999999999999999976542 1111111110000
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+.. .......++.++.+|+.+||..||++|||+.++++||||...
T Consensus 229 -----~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 229 -----PIL----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -----CcC----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 000 001112578899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=326.56 Aligned_cols=274 Identities=25% Similarity=0.360 Sum_probs=208.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||.||++.+..++..+|+|.+...... ....+.+|++++++++||||+++++++.+++.++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 5899999999999999999999999999999998754332 234467899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
++| +|.+.+... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++ +.++|+|||++...... ..
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cc
Confidence 976 666666432 458999999999999999999997 59999999999999975 68999999998765432 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CCcc-------------
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGS-PTMD------------- 223 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~------------- 223 (356)
....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..... .+...... ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCc
Confidence 3467899999999985544 889999999999999999999999766533322 22111100 0000
Q ss_pred -chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 224 -SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+...........-.. ........++.++.+|+.+||..||++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEP------PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCC------CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0000000000000000 0000112368899999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=316.39 Aligned_cols=251 Identities=28% Similarity=0.463 Sum_probs=210.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6999999999999999999999999999999986542 23345567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~~~ 157 (356)
++| +|.+.+... ....+++..+..++.|++.+|.|||++|++|+||+|+||++++ +.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 976 677777543 2344899999999999999999999999999999999999975 36899999999887665444
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------------- 218 (256)
T cd08220 159 YTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------------- 218 (256)
T ss_pred cccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------------
Confidence 4567899999999986544 78999999999999999999999987766554443322110
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
......++.++.+++.+||..||++|||+.|+++||||
T Consensus 219 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ----------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 01123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=314.62 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=209.4
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccc--cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 589999999999999999999999999999998643 233455667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-C
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-Y 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~ 157 (356)
+.| +|.+.+... ....+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 865 677776543 2345899999999999999999999999999999999999986 7999999999887654322 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....|++.|+|||++.+.. ++.++|+|||||++++|++|..||...+.......+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 217 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------------- 217 (256)
T ss_pred hccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence 3456889999999986654 8899999999999999999999998877555444332210
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+ ......++..+.+++.+||..+|++||++.++++|||+
T Consensus 218 -~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 -F--------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -C--------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0 01112567899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.10 Aligned_cols=276 Identities=37% Similarity=0.683 Sum_probs=218.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhC---CCCCeeEEeEEEEECCe-----
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKL---NHPNIVKVKELIVEKGN----- 73 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~----- 73 (356)
|++.+.||.|+||.||+|.++.+++.||+|++...... ......+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999989999999998754322 123345677777665 69999999999988776
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.+++|||+.+++.+.+..... ..+++..++.++.||+.||.|||+++++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhcccCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999999988887754322 24899999999999999999999999999999999999975 799999999998876
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.........++..|+|||++.+.. ++.++|+|||||++|+|++|.+||......+...++......+....|......
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL- 236 (287)
T ss_pred CCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc-
Confidence 544444556889999999986654 889999999999999999999999998888888887776655443333211100
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
....++...........+.++..+.++|.+||..||++||++.++++||||
T Consensus 237 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 --PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred --chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001111111222233334667899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=321.11 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=206.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC-----CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEK-----GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-----~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+..+++.+|+|++..... ......+|+.+++++ +|||++++++++... +..+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 679999999999999999999999999999999865432 234456799999998 899999999998753 3689
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
+||||++| +|.+.+......+..+++..++.++.|++.||.|||++|++|+||||+||++++ +.+||+|||++.....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999976 677776654445566899999999999999999999999999999999999975 6899999999876543
Q ss_pred CC-CCccccccccccChHHHhhCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 154 FP-PYTERVGTRWYQAPEILFKSG----LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.. ......|+..|+|||++.... .++.++|||||||++|+|++|++||...........+... +.
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~------- 250 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP------- 250 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC-------
Confidence 22 123456889999999985432 2678999999999999999999999876654443332211 00
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
+. .......+..+.++|.+||..||++||++.++++||||+
T Consensus 251 -----------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 -----------PT------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -----------CC------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 001124577899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=329.81 Aligned_cols=243 Identities=29% Similarity=0.465 Sum_probs=203.4
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc-
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ- 82 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~- 82 (356)
+.+++.||+|.||.||+|.+.. ...||+|.++.... ....+.+|+.+|++|+|+|||++++++..++.+|||||||.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 4568999999999999998874 34699999876532 33456799999999999999999999999999999999998
Q ss_pred CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcccc
Q 036550 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERV 161 (356)
Q Consensus 83 g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~ 161 (356)
|+|.+++.. ..+..+...+...++.||++|++||+++++|||||-..||||++ ..+||+|||+|+...+. .+....
T Consensus 286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASE 362 (468)
T ss_pred CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeecC
Confidence 678888875 34455899999999999999999999999999999999999987 58999999999955432 222222
Q ss_pred ---ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 162 ---GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 162 ---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
-..-|.|||++.... ++.++|||||||+|+||+| |+.||...+..+.+..+..+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy-------------------- 421 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY-------------------- 421 (468)
T ss_pred CCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--------------------
Confidence 345599999996555 9999999999999999998 899999999888887775543
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+.|+ ++.+|+++.+++..|+..+|++|||.+.+..
T Consensus 422 Rlp~---------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 422 RLPR---------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred cCCC---------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 3333 2367999999999999999999999986653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=307.76 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=211.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++...+.-||.|+.|+||+++.+.+|...|||.+.+.. ..+...++..+.++... ++|+||+++++|..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34567788999999999999999999999999997654 33444556677777665 49999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
.|.--...++. .-.++++|..+-++...++.||.||.. +||+|||+||+|||+++ |++||||||.+-.+.+....
T Consensus 172 lMs~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 172 LMSTCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 88654444443 234569999999999999999999986 58999999999999987 89999999999888777777
Q ss_pred ccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 158 TERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTD-EADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
+...|-+.|||||.+.- ...|+.++||||||++++||.||..||.+.+ +.+.+.++... .|+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP------------- 313 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP------------- 313 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC-------------
Confidence 78899999999999843 2458999999999999999999999998753 44555555441 111
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......++|+++.+|+..||+.|+.+||.-.++|+|||+...
T Consensus 314 ------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 ------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 111122589999999999999999999999999999999754
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=319.24 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=207.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC------eE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKG------NV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~------~~ 74 (356)
++|++.+.||+|++|.||+|.+..+++.|++|++..... ....+.+|+.+++++ +|+||+++++++.... .+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 689999999999999999999998999999999876543 335567899999999 7999999999997644 48
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+++|||+.+ +|.+.+.........+++..++.++.|++.||.|||++|++|+||+|+||++++ +.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 999999986 566666554434566899999999999999999999999999999999999974 789999999987654
Q ss_pred CC-CCCccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 153 AF-PPYTERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
.. .......|++.|+|||++... ..++.++|||||||++|+|++|.+||...........+... +.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~------ 235 (275)
T cd06608 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP------ 235 (275)
T ss_pred cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC------
Confidence 32 222345689999999998532 34678999999999999999999999866544443332211 00
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+. .......+..+.+||.+||..||++|||+.++++|||+
T Consensus 236 ------------~~------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 ------------PT------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ------------CC------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00 00012367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.02 Aligned_cols=249 Identities=31% Similarity=0.567 Sum_probs=203.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGN 73 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 73 (356)
+|.+.+.||.|++|.||+|.+..+++.||+|.+...... ....+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999989999999988654221 11345689999999999999999999999999
Q ss_pred EEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
.+++|||+++ +|.+.+.. ...+++..+..++.|++.||+|||++|++||||+|+||++++ +.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999976 56666643 245899999999999999999999999999999999999975 68999999998766
Q ss_pred CCCC-------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 152 DAFP-------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 152 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
.... ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-------- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc--------
Confidence 4211 112345889999999986544 788999999999999999999999876554333322110
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
........++..+.++|++||+.||.+||++.++++||||
T Consensus 228 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ---------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0011223568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=320.98 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=204.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEE-----ECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIV-----EKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~-----~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +||||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 689999999999999999999999999999998765432 234456799999999 7999999999874 346789
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
+||||++| +|.+.+.........+++..++.++.|++.||.|||+++++||||||+||++++ +.++|+|||++.....
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 99999976 576766544444556899999999999999999999999999999999999975 6899999999987643
Q ss_pred CC-CCccccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 154 FP-PYTERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.. ......|++.|+|||++.. ...++.++|+||+||++|+|++|..||...........+...
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~------------ 244 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN------------ 244 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc------------
Confidence 22 2234568999999999743 234788999999999999999999999876543332211100
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..+. .......+.++.+++.+||+.||++|||+.++++|+||
T Consensus 245 ---------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 ---------PPPT------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ---------CCCc------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000 00112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=346.77 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=204.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEE-EEE---C---CeE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKEL-IVE---K---GNV 74 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~-~~~---~---~~~ 74 (356)
+++|.+.|.+|+|+.||+|++...|..||+|++-..+...-....+||.+|++|+ |+|||.+++. ... . -.+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 4688999999999999999999888999999987776666677789999999996 9999999993 321 1 257
Q ss_pred EEEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC-CcEEEecccceee
Q 036550 75 FFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 75 ~iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
+++||||. |+|.+++..+...+ |+|.+|++|++|+++|+.+||... |||||||-+|||++. |+.||||||.|+-
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 89999999 68999998776655 999999999999999999999998 999999999999975 7899999999875
Q ss_pred cCCCCCC----------ccccccccccChHHHh--hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 036550 151 IDAFPPY----------TERVGTRWYQAPEILF--KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLG 218 (356)
Q Consensus 151 ~~~~~~~----------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 218 (356)
....... -....|+.|+|||++. +....+.|+|||+|||+||.|+....||.......
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------- 265 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------- 265 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----------
Confidence 4322211 1124799999999974 33447899999999999999999999998764322
Q ss_pred CCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 219 SPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
+...+|.||.. +..+..+++||+.||+.||.+||++.|++.+
T Consensus 266 -------------Ilng~Y~~P~~---------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 266 -------------ILNGNYSFPPF---------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -------------EEeccccCCCC---------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 23346677654 3679999999999999999999999998875
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=315.61 Aligned_cols=251 Identities=28% Similarity=0.531 Sum_probs=206.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||.|+||.||+|.+..+++.|++|.+..... ...+.+|+.++++++||||+++++.+.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 689999999999999999999998899999999865532 456788999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
++ +|.+.+.. ....+++..++.++.|++.||.|||+++++|+||+|+||++++ +.++|+|||++....... ...
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 86 56666542 2345899999999999999999999999999999999999975 789999999998765433 223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...++..|+|||++.+.. ++.++|||||||++|+|++|.+||...........+... .
T Consensus 158 ~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~ 215 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---------------------P 215 (256)
T ss_pred cccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---------------------C
Confidence 445889999999986554 899999999999999999999999876543332211100 0
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.+ .......++..+.++|.+||..||++|||+.++|+||||
T Consensus 216 ~~------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 PP------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CC------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 000112467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=325.29 Aligned_cols=253 Identities=28% Similarity=0.499 Sum_probs=206.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
.|....+||+|+||.||++.+..++..||+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 45667889999999999999999999999999876555555667889999999999999999999999999999999998
Q ss_pred CC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCcc
Q 036550 83 CN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTE 159 (356)
Q Consensus 83 g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~ 159 (356)
++ +.+.+. ...+++..+..++.||+.||.|||++||+||||||+||++++ +.++|+|||++...... .....
T Consensus 103 ~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 103 GGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 75 444432 224899999999999999999999999999999999999975 79999999998755332 22234
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+...... ..
T Consensus 178 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~ 238 (292)
T cd06658 178 LVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP------------------RV 238 (292)
T ss_pred eecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------cc
Confidence 57899999999985544 889999999999999999999999876654443332211100 00
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......+..+.+++.+||..||++|||++++++||||...
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 239 ---------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred ---------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 0012468899999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=325.59 Aligned_cols=280 Identities=35% Similarity=0.623 Sum_probs=220.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-CCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE-KGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~iv~ 78 (356)
++|.+.+.||.|+||.||+|.+..+++.||+|.+.+.. ......+.+|+.+++.++||||+++++++.. ....++++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 58999999999999999999999999999999876432 2223455689999999999999999999875 56789999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
||+++++.+.+. ...+++..+..++.||+.||.|||++||+|+||+|+||++++ +.++|+|||.+..... ..
T Consensus 90 e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~ 162 (328)
T cd07856 90 ELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QM 162 (328)
T ss_pred ehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--Cc
Confidence 999888776653 234789999999999999999999999999999999999975 6899999999876543 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh-hhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA-MAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~ 236 (356)
....+++.|+|||++.+...++.++|+|||||++|+|++|.+||...........+...++.++...+....... ....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 345678899999988665568999999999999999999999999888766666666666666543332111100 0000
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+...........+.++..+.++|.+||+.+|++|||+++++.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 1111111222223334678999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.93 Aligned_cols=251 Identities=31% Similarity=0.522 Sum_probs=210.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|++.+.||.|+||.||.+++..+++.+++|.+.... ......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999876542 23344567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~ 157 (356)
+.+ +|.+.+.... ...+++..+..++.|++.+|.|||++|++|+||+|+||++++ +.+||+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 975 6777765432 345899999999999999999999999999999999999975 689999999998765433 23
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||......+....+.... .
T Consensus 159 ~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------------- 218 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--Y----------------- 218 (256)
T ss_pred cccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--C-----------------
Confidence 3457899999999986655 7889999999999999999999998877665555443210 0
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
......++.++.+++.+||..||.+|||+.++++|||+
T Consensus 219 ----------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 219 ----------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ----------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 01113568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=320.42 Aligned_cols=253 Identities=23% Similarity=0.422 Sum_probs=202.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEE------CCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVE------KGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~------~~~~ 74 (356)
.+|++.+.||.|+||+||+|.+..+++.||+|++.... .....+..|+.+++++ +|+||+++++++.. .+..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 46899999999999999999999999999999986543 2334567799999998 79999999999853 4678
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
|++|||+++ ++.+.+... ....+++..+..++.||+.||.|||++||+|+||+|+||++++ +.++|+|||++....
T Consensus 95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 999999986 566666532 2344889999999999999999999999999999999999975 789999999987654
Q ss_pred CC-CCCccccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 153 AF-PPYTERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
.. .......|++.|+|||++.. ...++.++|+|||||++|+|++|.+||...........+... .
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~------- 242 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------- 242 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C-------
Confidence 32 22344678999999999853 234788999999999999999999999765543322211100 0
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
........++.++.+||++||..||.+|||+.|+|+||||
T Consensus 243 ------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0001112568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=323.56 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=208.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 468999999999999999999999999999998864322 22345678999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
||+.|++.+.+... ...+++..+..++.||+.||.|||++||+|+||+|+||++++ +.++|+|||++......
T Consensus 95 e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 99999988776533 235899999999999999999999999999999999999975 79999999998765432
Q ss_pred ccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 158 TERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
....+++.|+|||++.+ ...++.++||||||+++|+|++|.+||...+.......+... ..
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~---------------- 231 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DS---------------- 231 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CC----------------
Confidence 34578899999998742 345888999999999999999999999877655443332110 00
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+. ......+..+.++|.+||..||++||++.+++.||||...
T Consensus 232 ----~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 ----PT-------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ----CC-------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00 0012357889999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=323.62 Aligned_cols=254 Identities=27% Similarity=0.462 Sum_probs=207.4
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
|....+||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++..++..++++||+.+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 55667899999999999999999999999998765444455667899999999999999999999999999999999987
Q ss_pred C-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCccc
Q 036550 84 N-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTER 160 (356)
Q Consensus 84 ~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~~ 160 (356)
+ +.+.+. ...+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... ......
T Consensus 103 ~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 103 GALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 5 444332 234899999999999999999999999999999999999975 79999999998755432 222345
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.|+..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+... ...
T Consensus 178 ~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~----------------- 235 (297)
T cd06659 178 VGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPP----------------- 235 (297)
T ss_pred ecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----CCC-----------------
Confidence 7899999999986554 899999999999999999999999877655544332110 000
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.......++..+.++|.+||..+|++||+++++++||||.++..
T Consensus 236 ------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 ------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred ------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00112356889999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=313.57 Aligned_cols=253 Identities=30% Similarity=0.514 Sum_probs=209.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~iv~ 78 (356)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 6999999999999999999999999999999986542 2334456789999999999999999998764 45689999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH-----hCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH-----QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
||+++ +|.+.+.........+++..++.++.||+.||.||| +.+++|+||+|+||++++ +.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99875 677777665555667999999999999999999999 999999999999999976 79999999999877
Q ss_pred CCCCC-CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 152 DAFPP-YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 152 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
..... .....+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 225 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-------------- 225 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--------------
Confidence 65443 34457899999999986544 889999999999999999999999887644433322111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.........+..+.+++.+||..+|++|||+.++++|||+
T Consensus 226 ---------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ---------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0111223568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=316.65 Aligned_cols=254 Identities=25% Similarity=0.474 Sum_probs=203.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+|+..+.||+|+||.||++.+..+++.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58899999999999999999999999999999865321 123456789999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C-cEEEecccceeecCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G-TIKIADFGLAREIDA 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~-~~kL~Dfg~a~~~~~ 153 (356)
|+||+.| +|.+.+.. ..++++..+..++.||+.||.|||++|++|+||+|+||+++. + .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999886 46555532 345899999999999999999999999999999999999965 3 699999999877653
Q ss_pred CCC-----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 154 FPP-----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 154 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--------- 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---------
Confidence 211 1234688999999998654 4899999999999999999999999755432222221111000
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
.........+++++.+++.+||..||++|||+.++++||||+
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ----------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000112235688999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=313.15 Aligned_cols=251 Identities=31% Similarity=0.562 Sum_probs=208.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|++.+.||+|+||+||++.+..+|+.||+|.+.... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999986432 23344667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-C
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-Y 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~ 157 (356)
+.+ ++.+.+... ....+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||.+........ .
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 875 677766532 2234789999999999999999999999999999999999975 7999999999987654322 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~------------------- 218 (256)
T cd08218 159 RTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY------------------- 218 (256)
T ss_pred hhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-------------------
Confidence 2346889999999985544 78899999999999999999999987766655544422110
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
......++.++.++|.+||+.+|++||++.++++||||
T Consensus 219 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 ----------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ----------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 01123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=320.77 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=207.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||.||++.+..+++.|++|.+..... .....+.+|+.+++.++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 579999999999999999999999999999999876532 22345568999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-- 154 (356)
||+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||++++ +.++|+|||++......
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99986 56666532 245899999999999999999999999999999999999975 69999999988632100
Q ss_pred --------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 036550 155 --------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220 (356)
Q Consensus 155 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 220 (356)
.......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+....+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~--- 232 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD--- 232 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---
Confidence 0011235788999999986554 8999999999999999999999998766554444332210
Q ss_pred CccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCCCCCCCCCC
Q 036550 221 TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT---AAEALQHPFFKRCLYV 291 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~ 291 (356)
...+. .....+.++.++|.+||..||++||+ +.++++||||....+.
T Consensus 233 ----------------~~~~~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 233 ----------------IEWPE--------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred ----------------cCCCC--------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 01111 11246889999999999999999998 7999999999775443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=312.31 Aligned_cols=251 Identities=31% Similarity=0.547 Sum_probs=207.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-----hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-----REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+|+..+.||+|+||+||+|.+..+++.|++|.+..... .....+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 68899999999999999999998999999999865431 2334567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
+||+++ ++.+.+.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++. +.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999976 56666542 334899999999999999999999999999999999999964 799999999988765544
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......+++.|+|||.+.....++.++|+|||||++|+|++|.+||...........+....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------------ 218 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK------------------ 218 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc------------------
Confidence 34456789999999998554447899999999999999999999998766433333221100
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
........+++.+.+++.+||..+|.+|||+.+++.|||+
T Consensus 219 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 ----------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0111223568899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=314.74 Aligned_cols=251 Identities=27% Similarity=0.489 Sum_probs=200.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 74 (356)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 37999999999999999999999999999999886432 1223456789999999999999999998875 3678
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++++||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+++|+|+||||+||++++ +.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 899999976 56666642 234899999999999999999999999999999999999975 689999999987654
Q ss_pred CC----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AF----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.. .......++..|+|||.+.+.. ++.++|+||+||++|+|++|++||...........+... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~------- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT------- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC-------
Confidence 31 1122345888999999986544 889999999999999999999999876544333222110 00
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
.......+++.+.+++ +||..+|++|||++|+++||||+
T Consensus 227 ------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0111224678889999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=313.86 Aligned_cols=250 Identities=27% Similarity=0.478 Sum_probs=202.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+|.+.+.||.|+||+||+|.+. +++.+|+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 6899999999999999999864 788999998864321 122345789999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
++||+.| +|.+.+.. ...+++..+..++.|++.||+|||+.+|+|+||+|+||++++ +.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999976 56666532 234899999999999999999999999999999999999974 79999999998754311
Q ss_pred -------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 155 -------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 155 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
.......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 225 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--------- 225 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC---------
Confidence 1123456899999999986554 78999999999999999999999987654433322211100
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
........++.++.+||++||..+|.+||++.++++||||
T Consensus 226 ------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 226 ------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0111234678899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=316.51 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=206.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 579999999999999999999999999999999876543 3344567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+++ +|.+.+.... ..+++..+..++.|++.||+|||+ .|++|+||||+||++++ +.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 994 6776665332 458999999999999999999999 99999999999999976 68999999998766432221
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE-----ADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
...++..|+|||.+.+. .++.++|+|||||++|+|++|..||..... .+....+.. ..
T Consensus 158 -~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~------------ 220 (265)
T cd06605 158 -TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EP------------ 220 (265)
T ss_pred -cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CC------------
Confidence 26788999999998655 589999999999999999999999975521 111111110 00
Q ss_pred hhhcccCCCcccccccccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMP-SASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
. ..... .++.++.++|.+||..||++|||+.+++.||||+..
T Consensus 221 ------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 ------P--------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ------C--------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 0 00111 268899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.25 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=197.8
Q ss_pred CCceeecccccCCceEEEEEEEcC----------------CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH----------------SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKV 64 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~ 64 (356)
++|.+.++||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 479999999999999999997532 345799999876533 334456789999999999999999
Q ss_pred eEEEEECCeEEEEEEeccC-CHHHHHHHHHh---------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 036550 65 KELIVEKGNVFFVFECMQC-NLYQLMEAKKQ---------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL 128 (356)
Q Consensus 65 ~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 128 (356)
++++.+.+..++||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||++||+||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl 164 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 9999999999999999875 67777654221 1123678889999999999999999999999999
Q ss_pred CCCCeeeeC-CcEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q 036550 129 KPENLLVSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL--FRPLFQ 202 (356)
Q Consensus 129 kp~NIll~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~ 202 (356)
||+|||+++ +.+||+|||++........ .....++..|+|||++.... ++.++|||||||++|+|++ +..||.
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 999999976 6899999999986643221 12234578899999986554 8999999999999999986 567888
Q ss_pred CCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 203 GTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..+..+....+......... .......+.++..+.+++.+||..||.+|||+.++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 244 ELTDEQVIENAGEFFRDQGR----------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cCCHHHHHHHHHHHhhhccc----------------------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 76655444333221110000 0000112356889999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=334.01 Aligned_cols=241 Identities=30% Similarity=0.498 Sum_probs=201.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+.|.+...+|.|+|+.|-.+.+..+++.+++|++.+.. .+..+|+.++... +||||+++++++.+..+.|+|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 56888999999999999999999999999999997762 2334577666665 799999999999999999999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee--eCCcEEEecccceeecCCCCCC
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV--SQGTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.|+ +++.+.... .....+..|+++|+.|+.|||++|||||||||+|||+ +.|+++|+|||+++..... .
T Consensus 398 l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 398 LDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence 9886 334433222 2337888899999999999999999999999999999 3579999999999887654 4
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.+.+-|..|.|||++...+ |+.++||||||++||+|++|..||...... +.+.++ +.+..
T Consensus 471 ~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~-------------- 531 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKF-------------- 531 (612)
T ss_pred cccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcc--------------
Confidence 4568899999999997555 999999999999999999999999977655 333222 22211
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
...+|.++++||+.||+.||.+|+++.+++.||||.
T Consensus 532 --------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 532 --------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred --------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 136899999999999999999999999999999993
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=312.52 Aligned_cols=248 Identities=30% Similarity=0.479 Sum_probs=203.5
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
||.|++|.||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++.+.+++..++++||+.+ +|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999999999999999875432 2334567899999999999999999999999999999999865 67
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTR 164 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~ 164 (356)
.+.+.. ...+++..+..++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++.............+++
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence 776643 234899999999999999999999999999999999999965 799999999998776543334457899
Q ss_pred cccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCc
Q 036550 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD--EADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242 (356)
Q Consensus 165 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (356)
.|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .......+..... ..
T Consensus 157 ~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~----- 213 (262)
T cd05572 157 EYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-----------------KL----- 213 (262)
T ss_pred CccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------CC-----
Confidence 999999986544 8999999999999999999999998766 3333322221000 01
Q ss_pred ccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 036550 243 SGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLY 290 (356)
Q Consensus 243 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~ 290 (356)
..+...+.++.++|.+||..||++||+ +.|+++||||++..|
T Consensus 214 ------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 214 ------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 111244789999999999999999999 999999999987544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.75 Aligned_cols=252 Identities=25% Similarity=0.495 Sum_probs=201.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--Ce
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GN 73 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 73 (356)
.++|.+.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 368999999999999999999999999999999875432 12234557899999999999999999988764 56
Q ss_pred EEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
++++|||++| +|.+.+.. ...+++..+..++.|++.||.|||+++++|+||||+||++++ +.++|+|||.+...
T Consensus 81 ~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8899999976 56666542 234789999999999999999999999999999999999975 79999999998765
Q ss_pred CCC----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 152 DAF----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 152 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
... .......++..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+. ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~----- 227 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN----- 227 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC-----
Confidence 321 1223356889999999986644 8999999999999999999999998665443332221 11100
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
...+...+..+.++|++|+. +|++||+++++++|||+.
T Consensus 228 --------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 --------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 11123567889999999994 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=329.77 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=197.6
Q ss_pred CCceeecccccCCceEEEEEEEcCC-----CcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-----GEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||.||+|++..+ +..||+|++..... .....+.+|+.+++.+ +|+||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4699999999999999999986543 35799999976533 3344567899999999 899999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh-----------------------------------------------------------
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ----------------------------------------------------------- 94 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~----------------------------------------------------------- 94 (356)
++||||+.+ +|.+.+.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999875 67777654321
Q ss_pred -------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC---cccccc
Q 036550 95 -------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY---TERVGT 163 (356)
Q Consensus 95 -------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~---~~~~gt 163 (356)
...++++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......... ....++
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 1124788999999999999999999999999999999999986 68999999999876433221 122355
Q ss_pred ccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCc
Q 036550 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242 (356)
Q Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (356)
+.|+|||++.+.. ++.++|||||||++|+|++ |..||..................+
T Consensus 278 ~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~---------------------- 334 (374)
T cd05106 278 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM---------------------- 334 (374)
T ss_pred cceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc----------------------
Confidence 6799999986544 8999999999999999997 999998765443333322211000
Q ss_pred ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 243 SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 243 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++++.+++.+||..||.+|||+.++++
T Consensus 335 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 ------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011245789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=297.29 Aligned_cols=278 Identities=28% Similarity=0.567 Sum_probs=225.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEEC--CeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEK--GNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~iv 77 (356)
.++|++.+++|+|.|+.||.|++..+++.++||+++.-. .....+|+.+|+.|. ||||++++++..+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 478999999999999999999999999999999987642 345678999999995 99999999999865 456799
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~ 155 (356)
+||+...-+..+. ..++.-.++.++.+++.||.|||++||.|||+||.|++++. ..++|+|+|+|.......
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999876444432 12788899999999999999999999999999999999986 589999999999998888
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLF-QGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.++..+.+..|-.||.+...+.|+.+-|+|||||++..|+.-+.|| .+.+..+++.+|...+|......+..-..-...
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 8888899999999999988888999999999999999999987665 567788999999999887654444221111110
Q ss_pred hccc--CCCccccccccc-----CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQ--FPQLSGVNLSAL-----MPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~--~~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..+. ..+.+...+..+ ..-.++++.||+.++|..|.++|+|+.|++.||||..
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 0000 001111111111 1235799999999999999999999999999999964
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.96 Aligned_cols=253 Identities=34% Similarity=0.597 Sum_probs=213.1
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|.+.+.||.|+||.||++.+..++..|++|++..... .......+|+++++.++|||++++.+.+...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 69999999999999999999999999999999876533 4445667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~ 157 (356)
+++ +|.+.+.........+++..+..++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 986 677777654433466999999999999999999999999999999999999986 799999999998765543 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....|++.|+|||.+.+.. ++.++|+||+|+++++|++|..||...+............
T Consensus 161 ~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 219 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------------- 219 (258)
T ss_pred cceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--------------------
Confidence 3457899999999886554 8899999999999999999999998776544443332110
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
...+....+..+.+++.+||..+|++|||+.++|+||||
T Consensus 220 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 111223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=315.23 Aligned_cols=249 Identities=30% Similarity=0.513 Sum_probs=207.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+|.+.+.||.|+||.||+|.+..+++.||+|++.+... .....+.+|++++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 69999999999999999999999999999999875431 234556789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+.| +|.+.+.. ..++++..+..++.||++||.|||++|++|+||+|+||++++ +.++|+|||.+.........
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 9976 45555533 245899999999999999999999999999999999999975 79999999999877654444
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA--DQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... +........
T Consensus 157 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 216 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------------- 216 (258)
T ss_pred cccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-------------------
Confidence 4567899999999986555 899999999999999999999999876642 211111100
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH--HHHhcCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA--AEALQHPFF 285 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~~ 285 (356)
.....+...+..+.++|.+||..||.+||++ +|+++||||
T Consensus 217 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011223567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=311.06 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=202.1
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
......||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++|+||+++++++..++..++++||+.+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 33456899999999999999999999999998776666666778999999999999999999999999999999999875
Q ss_pred -CHHHHHHHHHhhcccC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCCC-C
Q 036550 84 -NLYQLMEAKKQKQQLF--SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPP-Y 157 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~~-~ 157 (356)
+|.+.+.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. +.++|+|||.+........ .
T Consensus 90 ~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 90 GSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 6766665321 234 88889999999999999999999999999999999964 6899999999876643222 2
Q ss_pred ccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|.+||................
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 227 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF------------------- 227 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-------------------
Confidence 334689999999998543 237889999999999999999999997543321111000000
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.........+++++.+|+.+||..+|++|||+.+++.||||
T Consensus 228 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 --------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00111223578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=310.68 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=204.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 578999999999999999999999999999999875422 23334567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
+||+++ ++.+++.........+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999986 677776655444556899999999999999999999999999999999999975 689999999988765422
Q ss_pred C-CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 156 P-YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
. .....|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...... ..........+.++
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 227 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------------ 227 (267)
T ss_pred HHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------------
Confidence 2 22346889999999986655 789999999999999999999999654321 11111111111111
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+..+.+++.+||..+|++|||+.++++.
T Consensus 228 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 ---------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ---------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0112457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=314.52 Aligned_cols=248 Identities=29% Similarity=0.453 Sum_probs=194.5
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHH---hCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLR---KLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
.||+|+||.||++.+..+++.||+|.+.+... .......+|..+++ ..+||||+.+++.+...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999865422 12223344544443 3479999999999999999999999998
Q ss_pred CC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccc
Q 036550 83 CN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER 160 (356)
Q Consensus 83 g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~ 160 (356)
|+ |.+.+. ....+++..+..++.||+.||.|||+++|+|+||||+||++++ +.++|+|||++....... ....
T Consensus 81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 155 (279)
T cd05633 81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS 155 (279)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCc
Confidence 65 555543 2345899999999999999999999999999999999999965 799999999987664432 2345
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ--MYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
.|++.|+|||.+.+...++.++|+||+||++|+|++|..||........ ..... ....
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------------~~~~-- 215 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------LTVN-- 215 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh------------------hcCC--
Confidence 7999999999986555589999999999999999999999976432211 11110 0000
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
..+.+.++.++.++|.+||..||++|+ |++++++||||++..+
T Consensus 216 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 216 ---------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred ---------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 112236789999999999999999999 6999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=313.86 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=205.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~iv~ 78 (356)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|+++++.++||||+++++++.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 579999999999999999999999999999999876533 3345567899999999999999999988654 4789999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||++| +|.+.+.........+++..+..++.||+.||.|||+.|++|+||+|+||++++ +.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99976 676666554445566899999999999999999999999999999999999975 689999999987654322
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCccchHHHhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE-----ADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|..||..... .+....+.. ....
T Consensus 160 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~-------- 226 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNP-------- 226 (287)
T ss_pred cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCch--------
Confidence 1245678899999998554 489999999999999999999999986532 111111100 0000
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+. ........++.+.+|+.+||..||++|||+.|++.||||...
T Consensus 227 ------~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 227 ------ELKD-----EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ------hhcc-----CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 0000 000001346789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=314.41 Aligned_cols=254 Identities=27% Similarity=0.482 Sum_probs=207.4
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
+|...+.||+|++|.||++.+..+++.+++|.+..........+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 45667899999999999999999999999999865544445556789999999999999999999999999999999997
Q ss_pred C-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCcc
Q 036550 83 C-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYTE 159 (356)
Q Consensus 83 g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~~ 159 (356)
| +|.+.+.. ..+++..+..++.||+.||.|||++|++||||+|+||++++ +.++|+|||.+....... ....
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 6 56665543 34899999999999999999999999999999999999975 799999999887554322 2234
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... ..+.
T Consensus 175 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~------------------ 234 (285)
T cd06648 175 LVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK------------------ 234 (285)
T ss_pred ccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC------------------
Confidence 56899999999986544 899999999999999999999999876654444333211 0000
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
......++..+.+|+++||..||++|||+.++++||||+.+.
T Consensus 235 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 235 --------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred --------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 000124678999999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.17 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=198.0
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|++.+.||+|+||+||+|.+ ..++..||+|+++... ......+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 3467789999986543 23345567899999999 899999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh-----------------------------------------------------------
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ----------------------------------------------------------- 94 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~----------------------------------------------------------- 94 (356)
++||||+.| +|.+.+.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999875 57777653211
Q ss_pred ------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC---c
Q 036550 95 ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY---T 158 (356)
Q Consensus 95 ------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~---~ 158 (356)
....+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++......... .
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 1124788899999999999999999999999999999999986 58999999999876543221 1
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...++..|+|||++.+.. ++.++|||||||++|+|++ |.+||..........+..... .
T Consensus 275 ~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------~ 334 (375)
T cd05104 275 NARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-------------------Y 334 (375)
T ss_pred CCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-------------------c
Confidence 223456799999986554 8999999999999999998 899998765443333322110 0
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.. ..+...+.++.+++.+||..||++|||+.++++.
T Consensus 335 ~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 335 RM---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred cC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00 0112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=312.30 Aligned_cols=255 Identities=29% Similarity=0.503 Sum_probs=203.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch----------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECC
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR----------EKCLNLREVKCLRKLNHPNIVKVKELIVEKG 72 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 72 (356)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... ..+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999999999999987542111 1124467999999999999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
..++||||+.| +|.+.+... ..+++..++.++.||+.||.|||+++++|+||+|+||++++ +.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 99999999876 566665432 45899999999999999999999999999999999999975 7999999999876
Q ss_pred cCCCC---CCccccccccccChHHHhhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 151 IDAFP---PYTERVGTRWYQAPEILFKSG-LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 151 ~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
..... ......|+..|+|||++.... .++.++|+||||+++|++++|..||...........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA------- 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC-------
Confidence 54321 123346889999999986543 4789999999999999999999999765543333222111000
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..++ ......++..+.++|.+||..+|++|||+.++++||||
T Consensus 231 ----------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 ----------PPIP-------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------CcCC-------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 11223568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=309.35 Aligned_cols=248 Identities=30% Similarity=0.516 Sum_probs=205.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
+|++.+.||+|+||.||++.+..+++.||+|.++... ........+|+.+++.++|+||+++++.+.+.+.+|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 6999999999999999999999999999999986532 333445678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-Cc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~~ 158 (356)
++ ++.+.+.. .....+++..++.++.||+.||.|||++||+|+||||+||++++ +.++|+|||.+........ ..
T Consensus 81 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 75 56666543 23445899999999999999999999999999999999999975 7999999999987654322 23
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...|++.|+|||++.+.. ++.++|+||||+++|+|++|.+||...+.......+.....
T Consensus 159 ~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 217 (255)
T cd08219 159 TYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-------------------- 217 (255)
T ss_pred cccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC--------------------
Confidence 456899999999986554 89999999999999999999999987766554443322110
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++..+.+||.+||..||++|||+.++++-
T Consensus 218 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 ---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01123567889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=314.26 Aligned_cols=238 Identities=19% Similarity=0.254 Sum_probs=194.0
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccchH---HhhhHHHHHHHHhCCCCCeeEEeEEEEE----CCeEEEEEEe
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE---KCLNLREVKCLRKLNHPNIVKVKELIVE----KGNVFFVFEC 80 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~iv~e~ 80 (356)
..||+|++|.||+|.. +|+.||+|.++...... ...+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999976 68999999997654322 3455689999999999999999999877 3578999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.|+ |.+.+.. ...+++.....++.|++.||.|||+. +++||||||+||++++ +.+||+|||++.......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9875 6666643 23488999999999999999999984 9999999999999975 799999999987654422
Q ss_pred ccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....|++.|+|||++.+. ..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 242 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--------------- 242 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC---------------
Confidence 345789999999998652 4589999999999999999999999998776655544432211110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.....++.+.+++.+||+.||++|||+.++++
T Consensus 243 -------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 -------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11246889999999999999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=329.94 Aligned_cols=257 Identities=28% Similarity=0.536 Sum_probs=208.9
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
|..++.||-|+||.|.+++...|...||+|.+++.+. +.......|-.||..-+++.||++|..|.+.+++|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 6788999999999999999999999999999977542 2222335688999999999999999999999999999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecC------
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREID------ 152 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~------ 152 (356)
++|+ +..++. +.+.|.|..++.|+.++..|+++.|..|+|||||||+||||+ +|++||+|||+|+-+.
T Consensus 711 IPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 711 IPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9876 444443 344599999999999999999999999999999999999998 5899999999996321
Q ss_pred ---CC-----------------CC-----------------CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHH
Q 036550 153 ---AF-----------------PP-----------------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195 (356)
Q Consensus 153 ---~~-----------------~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 195 (356)
+. .. .-..+||+.|+|||++.+.+ |+..+|+||.|||||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHh
Confidence 00 00 01237999999999998877 899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-
Q 036550 196 LFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP- 274 (356)
Q Consensus 196 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 274 (356)
.|++||......+...++.. |...+ .++ ....+|+++.++|.+++ .+++.|.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~n---------w~~~l--------~~~---------~~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVIN---------WRNFL--------HIP---------YQGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred hCCCCccCCCCCcceeeeee---------hhhcc--------ccc---------cccccCHHHHHHHHHHh-cChhhhhc
Confidence 99999998877666555432 22111 111 12367999999999966 5788887
Q ss_pred --CHHHHhcCCCCCCCCCCC
Q 036550 275 --TAAEALQHPFFKRCLYVP 292 (356)
Q Consensus 275 --t~~e~l~hp~~~~~~~~~ 292 (356)
.++|+.+||||+...+..
T Consensus 919 kng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred ccchhhhhcCccccccchHh
Confidence 478899999999988766
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=317.37 Aligned_cols=252 Identities=30% Similarity=0.511 Sum_probs=207.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.|...++||+|+||+||+|.+..+++.|++|++..... .....+.+|+.+++.++|||++++++++.+.+..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 35667889999999999999999999999999865322 223455789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
|+.|++.+.+... ..++++..+..++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++..... ..
T Consensus 102 ~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~ 175 (313)
T cd06633 102 YCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---AN 175 (313)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CC
Confidence 9999988776532 345899999999999999999999999999999999999975 7899999999865432 23
Q ss_pred cccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...|+..|+|||++.. ...++.++|+|||||++|+|++|.+||...+.......+.... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~----------------- 237 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S----------------- 237 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C-----------------
Confidence 4578999999999853 3457889999999999999999999998776555544432210 0
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+. ...+.++..+.+|+.+||+.+|.+||++.++++||||...
T Consensus 238 ---~~-------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 238 ---PT-------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ---CC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00 0112457789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=309.73 Aligned_cols=253 Identities=32% Similarity=0.501 Sum_probs=209.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+..+++++|+||+++++++...+..+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 579999999999999999999999999999999876644 3345667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+++ +|.+.+... ..+++..+..++.||+.||.|||+ +|++|+||+|+||+++. +.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 984 677666533 458999999999999999999999 99999999999999965 78999999999877543332
Q ss_pred -ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 158 -TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---ADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 158 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||..... .+....+...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------------- 218 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----------------- 218 (264)
T ss_pred ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-----------------
Confidence 245688999999998554 589999999999999999999999987642 2222211100
Q ss_pred hhcccCCCcccccccccCCC-CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPS-ASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........ ++..+.++|.+||..+|++|||+.++++||||+..
T Consensus 219 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 219 ------------PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ------------CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 00111123 68899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=313.58 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=206.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.|...++||.|+||.||+|.+..++..||+|++.... ......+.+|+.+++.+.||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5888999999999999999999999999999987543 233455678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+| +|.+.+.. ..+++..+..++.|++.||+|||+++++|+||+|+||++++ +.++|+|||++....... ...
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 76 56665532 34899999999999999999999999999999999999975 689999999997765432 223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...++..|+|||++.+.. ++.++|+|||||++|+|++|.+||...........+...
T Consensus 160 ~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------------- 216 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN---------------------- 216 (277)
T ss_pred cccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC----------------------
Confidence 346888999999986554 799999999999999999999999876554333221100
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........++..+.+++.+||..+|++||++.++++||||...
T Consensus 217 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 217 -------NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -------CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0011123467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=311.17 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=197.8
Q ss_pred CCceeecccccCCceEEEEEEEc---CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+|+||.||+|.+. ..+..||+|.++.... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46999999999999999999765 4567899999876533 2334567899999999999999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||++++ |.+.+.. ....+++..++.++.||+.||+|||++|++||||||+||++++ +.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999875 4445432 2235899999999999999999999999999999999999975 689999999876543221
Q ss_pred CCc--cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 PYT--ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 ~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
... ...++..|+|||++.+.. ++.++|||||||++|++++ |.+||......+....+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------------- 226 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-------------- 226 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------------
Confidence 111 223567899999986654 8999999999999999775 9999988776555444322110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. ..+..++..+.+++.+||..+|.+|||++++++
T Consensus 227 ------~---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 ------L---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------C---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0 112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=313.91 Aligned_cols=252 Identities=31% Similarity=0.409 Sum_probs=202.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
||+|+||+||+|.+..+|+.||+|++.+.. ......+.+|+.+++.++||||+++++.+...+..|+||||+.+ +|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999999999999999986532 12233446799999999999999999999999999999999986 56
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTR 164 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~ 164 (356)
.+.+.... ...+++..+..++.|++.||.|||++|++||||+|+||++++ +.++|+|||.+.............++.
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence 66664322 235899999999999999999999999999999999999975 799999999987665433444557888
Q ss_pred cccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccc
Q 036550 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244 (356)
Q Consensus 165 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (356)
.|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+.... ..
T Consensus 159 ~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~------ 212 (277)
T cd05577 159 GYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-------------------LE------ 212 (277)
T ss_pred CcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-------------------cc------
Confidence 999999986655 8999999999999999999999997665321111111100 00
Q ss_pred ccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 245 VNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 245 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
......+.+++.+.++|.+||+.||++|| ++.++++||||.+..|
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 00112235689999999999999999999 8999999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=312.76 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=205.9
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCC---CCCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLN---HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~iv~ 78 (356)
.|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5889999999999999999999999999999987543 233445678999999986 999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+.. ..+++..+..++.||+.||.|||+.||+|+||+|+||++++ +.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99976 55555432 25899999999999999999999999999999999999975 799999999998765432
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......|+..|+|||.+.+...++.++|+|||||++|+|++|.+||...........+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------------- 217 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------------- 217 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------------
Confidence 2234578999999999866555789999999999999999999999876543322111000
Q ss_pred cccCCCcccccccccC-CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALM-PSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+ .+. ...+.++.+++.+||..||++||++.++++||||++.
T Consensus 218 --~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 --KPP--------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred --CCC--------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 000 011 1367899999999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.03 Aligned_cols=255 Identities=28% Similarity=0.492 Sum_probs=208.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||++.+..+++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 58999999999999999999998899999999987655555566788999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
.+ ++.+.+.. ..+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++....... ...
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 76 56555532 23789999999999999999999999999999999999975 689999999887654332 223
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||.+.+. .++.++|+|||||++|++++|.+||...+.......+.. .+.+
T Consensus 174 ~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~------------------ 233 (293)
T cd06647 174 TMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP------------------ 233 (293)
T ss_pred cccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC------------------
Confidence 34688999999998654 478999999999999999999999987655433221110 0000
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.......++..+.+++++||..+|++||++.+++.||||+...
T Consensus 234 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 234 --------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred --------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 0011224678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=308.91 Aligned_cols=252 Identities=31% Similarity=0.547 Sum_probs=204.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
||.+.+.||+|+||.||++.+..+++.|++|.+...... ....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 699999999999999999999989999999998765443 455667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC-
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY- 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~- 157 (356)
+.+ +|.+.+.. ...+++..++.++.|++.||.|||++|++|+||+|+||++++ +.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 886 56665542 334789999999999999999999999999999999999976 68999999998876543221
Q ss_pred ----ccccccccccChHHHhhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCccchHHHhh
Q 036550 158 ----TERVGTRWYQAPEILFKSG--LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ-MYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 158 ----~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 230 (356)
....+++.|+|||++.+.. .++.++|||||||++|++++|..||........ ...+.. ...+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------- 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---------- 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC----------
Confidence 1346789999999985443 278899999999999999999999976543222 222111 0000
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.+|. ...++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 226 -------~~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -------PIPD---------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -------CCCc---------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0111 12458899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=316.35 Aligned_cols=252 Identities=30% Similarity=0.485 Sum_probs=208.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.|...+.||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778899999999999999999999999999986542 2223456789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
|+.|++.+.+... ..++++..+..++.||+.||.|||++||+||||+|+||++++ +.++|+|||++..... ..
T Consensus 106 ~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~ 179 (317)
T cd06635 106 YCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---AN 179 (317)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cc
Confidence 9999887776532 345899999999999999999999999999999999999975 7999999998875443 23
Q ss_pred cccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...|++.|+|||.+.. .+.++.++|+|||||++|+|++|.+||...........+......+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 243 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------------- 243 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC----------------
Confidence 4578999999999853 3457899999999999999999999998766555444443211100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......++.+.+++.+||+.+|.+||++.++++|+|+...
T Consensus 244 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 ------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0112467889999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=318.34 Aligned_cols=252 Identities=28% Similarity=0.467 Sum_probs=205.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+.|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35888899999999999999999999999999987543 23344567899999999999999999999999999999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-C
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-Y 157 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~ 157 (356)
++++ +.+.+. ...+++..++.++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9864 555442 234899999999999999999999999999999999999975 7899999999876654321 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||...........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------------- 216 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------------- 216 (277)
T ss_pred hcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------------
Confidence 2346889999999986554 889999999999999999999999765443322211000
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.........+.++.++|.+||..+|++|||+.++++||||...
T Consensus 217 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 217 --------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred --------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0011123567889999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=313.95 Aligned_cols=263 Identities=27% Similarity=0.382 Sum_probs=204.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||+||++.+..+++.||+|++..... .....+.+|+++++.++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 579999999999999999999999999999998865432 3345667899999999999999999999999999999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
++++ |.+.+. ..+.+++..++.++.|++.||.|||+ .+++|+||||+||++++ +.++|+|||++...... ..
T Consensus 85 ~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 85 MDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IA 159 (284)
T ss_pred CCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-cc
Confidence 9875 444443 23458999999999999999999997 69999999999999975 68999999998765332 12
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....|+..|+|||++.+. .++.++|+|||||++|+|++|..||........... ....+.+....... .
T Consensus 160 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~--~ 228 (284)
T cd06620 160 DTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DPMGILDLLQQIVQ--E 228 (284)
T ss_pred CccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hhhHHHHHHHHHhh--c
Confidence 345789999999998655 489999999999999999999999986544211000 00000000000000 0
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..+. .....++..+.+|+.+||..||++|||+.|+++|+||.+
T Consensus 229 ~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 229 PPPR-------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred cCCC-------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000 000136788999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=315.39 Aligned_cols=252 Identities=31% Similarity=0.489 Sum_probs=206.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.|...+.||+|+||+||+|++..++..||+|.+.... ......+.+|+.+++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 5778899999999999999999999999999986432 2223345689999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
|+.|++.+.+... ...+++..+..++.|++.||.|||+++++||||+|+||++++ +.++|+|||++...... .
T Consensus 96 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~ 169 (308)
T cd06634 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169 (308)
T ss_pred ccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---c
Confidence 9999887776532 345899999999999999999999999999999999999975 78999999998765432 3
Q ss_pred cccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+.......+.....
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------------ 231 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------------ 231 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC------------------
Confidence 4568899999999853 34478899999999999999999999977654443333221100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+. ......+..+.+||.+||..+|.+||+++++++|||+...
T Consensus 232 ---~~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 232 ---PA-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---CC-------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00 0112567889999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=343.43 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=198.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
|++|++.++||+|+||.||+|++..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 6899999999999999999999999999999999875422 2234567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHh-------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccce
Q 036550 78 FECMQC-NLYQLMEAKKQ-------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA 148 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a 148 (356)
|||++| +|.+.+..... ....++...+..++.||+.||+|||++||+||||||+||+++. +.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999976 56666653221 1223566788899999999999999999999999999999975 79999999999
Q ss_pred eecCCC-------------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 036550 149 REIDAF-------------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ 209 (356)
Q Consensus 149 ~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 209 (356)
...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765210 0111246999999999986655 89999999999999999999999987544332
Q ss_pred HHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.... ....+. . ......+++.+.+++.+||..||++|++..+.+.
T Consensus 240 ~~~~--~i~~P~------------------------~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRD--VILSPI------------------------E-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhh--hccChh------------------------h-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2110 000000 0 0001256889999999999999999987665554
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=312.17 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=203.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCC-----cEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSG-----EVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 74 (356)
+++|++.+.||+|+||.||+|.+...+ ..||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357999999999999999999876554 68999998754332 334567899999999999999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcE
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTI 140 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~ 140 (356)
+++|||+.+ +|.+.+..... ....+++..++.++.||+.||.|||++|++|+||||+||++++ +.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 999999875 67777754321 1144889999999999999999999999999999999999976 689
Q ss_pred EEecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036550 141 KIADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSV 216 (356)
Q Consensus 141 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 216 (356)
+|+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997654321 223446788999999986554 8999999999999999998 99999887765554433221
Q ss_pred hCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .......+++++.+++.+||+.||.+||++.+++++
T Consensus 243 ~-----------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 243 Q-----------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred C-----------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 001123678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=311.77 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=201.2
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.+.||+|+||+||++.+ ..++..+|+|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4689999999999999999975 23456799999877655555667889999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHH---------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecc
Q 036550 77 VFECMQC-NLYQLMEAKK---------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADF 145 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Df 145 (356)
+|||+.+ +|.+++.... .....+++..++.++.||+.||+|||++|++||||||+||++++ +.++|+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence 9999875 6777765332 12234899999999999999999999999999999999999975 78999999
Q ss_pred cceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 036550 146 GLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPT 221 (356)
Q Consensus 146 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (356)
|++........ .....+++.|+|||++.+. .++.++|+|||||++|+|++ |.+||......+....+.....
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~--- 240 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--- 240 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc---
Confidence 99976543221 1223457789999998654 48999999999999999998 9999987776554444322100
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......+.++.+++.+||+.||.+|||+.++++
T Consensus 241 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 --------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0011246789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=303.31 Aligned_cols=251 Identities=31% Similarity=0.563 Sum_probs=208.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
+|.+.+.||.|++|.||++.+..+++.+++|++..........+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 58999999999999999999998999999999977655455667889999999999999999999999999999999998
Q ss_pred C-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccc
Q 036550 83 C-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER 160 (356)
Q Consensus 83 g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~ 160 (356)
| +|.+.+.... ..+++..+..++.|++.||.+||++|++||||+|+||++++ +.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 5 5666654321 45899999999999999999999999999999999999975 68999999999877654333456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+........... ..+. .+
T Consensus 158 ~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-----------------~~ 218 (253)
T cd05122 158 VGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-----------------LR 218 (253)
T ss_pred ecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC-----------------cC
Confidence 7899999999986554 789999999999999999999999877544433332210 0000 00
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
....++..+.++|.+||..||++|||+.++++|||
T Consensus 219 ---------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 219 ---------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00124789999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=309.30 Aligned_cols=253 Identities=32% Similarity=0.542 Sum_probs=205.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+|.+.+.||+|+||.||++.+..++..+++|+++... ........+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998887777777765421 12223445789999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCC-
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~- 155 (356)
+||+.+ ++.+.+.........+++..++.++.|++.||.|||++|++|+||+|+||+++++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcc
Confidence 999876 566666654445566999999999999999999999999999999999999999999999999987764322
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...
T Consensus 161 ~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~------------------- 220 (260)
T cd08222 161 LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG------------------- 220 (260)
T ss_pred cccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------------------
Confidence 223456889999999885544 788999999999999999999999766544433332110
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
........++.++.++|.+||..||++||++.++++||||
T Consensus 221 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 221 ----------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0011123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=310.41 Aligned_cols=251 Identities=28% Similarity=0.423 Sum_probs=195.4
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHH---HHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREV---KCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
.||+|+||.||+|.+..+++.||+|++.+... ........|. ..++...||||+++++.+.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999865421 1111223333 34455689999999999999999999999998
Q ss_pred CC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccc
Q 036550 83 CN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTER 160 (356)
Q Consensus 83 g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~ 160 (356)
|+ |.+.+. ....+++..++.++.|++.||.|||+++|+||||||+||++++ +.++|+|||++....... ....
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 155 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS 155 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCc
Confidence 75 444442 2345899999999999999999999999999999999999965 799999999987654322 2345
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.|+..|+|||++.+...++.++||||+||++|+|++|..||............ ... ...
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~---------------~~~----- 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMT---------------LTM----- 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHh---------------hcc-----
Confidence 79999999999875545889999999999999999999999866322111100 000 000
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
....+...+.++.+++.+||..||.+|| ++.++++||||....+.
T Consensus 215 ------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 215 ------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred ------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 0112235689999999999999999999 99999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=307.43 Aligned_cols=251 Identities=33% Similarity=0.603 Sum_probs=206.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|.+.+.||.|+||.||++.+..+|..||+|.+.... ......+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 6899999999999999999999999999999986542 12334557899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC--cEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG--TIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.+ +|.+.+... ....+++..+..++.|++.||.|||+++++|+||||+||+++++ .++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 976 666666432 22347999999999999999999999999999999999999764 4799999998776543222
Q ss_pred -ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 -TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....|++.|+|||++.+.. ++.++|+|||||++++|++|..||...+.......+....
T Consensus 159 ~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 218 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------- 218 (257)
T ss_pred ccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------------
Confidence 2346899999999885544 8899999999999999999999998766554443322110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.....+..+.++.++|.+||..+|++|||+.++++||||
T Consensus 219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 011123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=311.09 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=202.0
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+. .+++.||+|.+...... ....+.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 57999999999999999999874 34688999998766544 3456788999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHH----------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEe
Q 036550 76 FVFECMQC-NLYQLMEAKK----------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIA 143 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~ 143 (356)
++|||+.| +|.+.+.... .....+++..+..++.||+.||.|||++|++||||||+||+++. +.++|+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 99999875 6777765432 12244789999999999999999999999999999999999965 799999
Q ss_pred cccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 036550 144 DFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGS 219 (356)
Q Consensus 144 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 219 (356)
|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~-- 241 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR-- 241 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--
Confidence 9999876533211 12334678899999986554 8999999999999999998 999998776655443332110
Q ss_pred CCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 220 PTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
........+..+.+++.+||..||++|||+.|+++
T Consensus 242 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 ---------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred ---------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00111356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.69 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=203.7
Q ss_pred CCceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|..+. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 589999999999999999997542 356899998865432 22334578999999999999999999999999999
Q ss_pred EEEEecc-CCHHHHHHHHHhh------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 76 FVFECMQ-CNLYQLMEAKKQK------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
+||||+. |+|.+.+...... ....+...+..++.||+.||.|||+++|+||||||+||++++ +.++|+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence 9999987 5677777643211 123567788999999999999999999999999999999975 6999999999
Q ss_pred eeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+........ .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||......+....+... +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~---- 239 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GY---- 239 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC----
Confidence 876543211 12234567899999986544 8999999999999999998 78999877665544333211 00
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc------CCCCCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ------HPFFKRCLY 290 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~~~~ 290 (356)
.......++.+.+++.+||+.||++|||+.++++ ||||.+..|
T Consensus 240 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 240 ------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 0111245789999999999999999999999987 999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=312.24 Aligned_cols=253 Identities=27% Similarity=0.460 Sum_probs=204.5
Q ss_pred eeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccCC
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCN 84 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g~ 84 (356)
....+||+|+||.||++.+..+++.||+|.+..........+.+|+.+++.++|+||+++++.+...+..+++|||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 33468999999999999999999999999986554445556788999999999999999999999999999999999875
Q ss_pred HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCccccc
Q 036550 85 LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYTERVG 162 (356)
Q Consensus 85 l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~~~~g 162 (356)
.+..+.. ...+++..++.++.|++.||+|||++|++|+||+|+||++++ +.++|+|||++....... ......|
T Consensus 103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 3333321 234899999999999999999999999999999999999975 689999999987664322 2234568
Q ss_pred cccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCc
Q 036550 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242 (356)
Q Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (356)
++.|+|||.+.+. .++.++|+||+||++|+|++|.+||...........+...... .+
T Consensus 179 ~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~------------------~~--- 236 (292)
T cd06657 179 TPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------------KL--- 236 (292)
T ss_pred CccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc------------------cc---
Confidence 9999999988544 4789999999999999999999999876654443322111000 00
Q ss_pred ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 243 SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 243 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.....++..+.+++.+||..||.+||++.++++||||....
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 237 ------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 01124688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=313.56 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=204.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|.+.+.||.|+||.||+|.+..+++.||+|.++.... .......+|+.++.+. .||||+++++++.+....|++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4689999999999999999999999999999999876432 2333445677766666 5999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+++.+.+++... ...+++..+..++.||+.||+|||+ .||+||||+|+||++++ +.+||+|||++........
T Consensus 94 e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99988777665432 2368999999999999999999997 59999999999999975 6999999999877654444
Q ss_pred CccccccccccChHHHhhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCccchHHHhhhh
Q 036550 157 YTERVGTRWYQAPEILFKS---GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.....+++.|+|||.+.+. +.++.++|||||||++|+|++|+.||...... +.+..+.... .
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 236 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-P------------- 236 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-C-------------
Confidence 4445688899999998543 23788999999999999999999999764322 2222221110 0
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...+ ....++.++.+|+.+||..||.+|||+.++++||||..
T Consensus 237 ----~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 237 ----PSLP---------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ----CCCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0000 01146789999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.55 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=194.6
Q ss_pred CCceeeccc--ccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKL--GSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~i--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.....+ +||||+++++.+...+..|+||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 467777777 99999999999999999999999986543221 133333323 7999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C-cEEEecccceeecCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G-TIKIADFGLAREIDAFP 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~-~~kL~Dfg~a~~~~~~~ 155 (356)
||++| +|.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++. + .++|+|||.+......
T Consensus 89 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 89 DYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99875 677776432 25899999999999999999999999999999999999976 4 7999999998876542
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCccchHHHhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ-MYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
....++..|+|||++.+.. ++.++|+||+||++|+|++|..||........ ...+.....
T Consensus 164 --~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 224 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ---------------- 224 (267)
T ss_pred --ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc----------------
Confidence 2346899999999996655 89999999999999999999999985543321 111111000
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-HHHHhcCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-AAEALQHPFFK 286 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~l~hp~~~ 286 (356)
......+..++.+.+||.+||+.||.+|++ ++++|+||||.
T Consensus 225 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 225 -----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred -----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 001112357899999999999999999996 69999999996
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=316.82 Aligned_cols=260 Identities=30% Similarity=0.453 Sum_probs=218.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
.+|.++..||+|+||.|-++..+.+.+.||||++++.-- .+.+-.+.|-++|... +-|.+++++.+|..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 368889999999999999999999999999999988632 2222335688888777 578899999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecC-CCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREID-AFP 155 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~-~~~ 155 (356)
|||+.|+ .+..+.+.-+.|-|..+..++.+|+-||-+||++||++||||.+|||++ +|++||+|||+++.-- ...
T Consensus 429 MEyvnGG---DLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGG---DLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCc---hhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 9999987 2223334445589999999999999999999999999999999999997 5999999999997642 334
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
...+.||||.|+|||++. ...|+.++|+||+||+||||+.|++||.+.++.+....|...
T Consensus 506 TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------------- 565 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------------- 565 (683)
T ss_pred ceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------------
Confidence 456789999999999985 445999999999999999999999999999999988887553
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-----HHHhcCCCCCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA-----AEALQHPFFKRCLYVPPHL 295 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~~~~~ 295 (356)
+..+| +.+|.++.++.+.+|...|.+|... .++-.||||....|.-...
T Consensus 566 nvsyP-----------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~ 619 (683)
T KOG0696|consen 566 NVSYP-----------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER 619 (683)
T ss_pred cCcCc-----------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence 33333 4789999999999999999999854 6888999999888764433
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=306.24 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=201.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.+|.+.++||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++..++.++++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35889999999999999999999999999999987543 33445678999999999999999999999999999999998
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY-- 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~-- 157 (356)
++ +|.+.+... ....+++..++.++.|++.||+|||++|++||||||+||++++ +.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 75 677666432 2334899999999999999999999999999999999999965 78999999999876543211
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------------- 222 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------------- 222 (263)
T ss_pred CCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------------
Confidence 1223456799999886554 8899999999999999998 999998776554433332110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .......+.++.+++.+||..||++|||+.++++.
T Consensus 223 -~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 -R---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred -C---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0 01123568999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=302.79 Aligned_cols=250 Identities=32% Similarity=0.547 Sum_probs=208.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~iv~ 78 (356)
+|.+.+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+.++++++||||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58999999999999999999999999999999876543 3445667899999999999999999999988 8999999
Q ss_pred Eecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+. +++.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||++++ +.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9995 46666665332 5899999999999999999999999999999999999986 7999999999988766543
Q ss_pred ---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCccchHHHhhhh
Q 036550 157 ---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 157 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...... .....+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS----------------- 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----------------
Confidence 34567899999999986555 899999999999999999999999876621 11111100
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
...........+..+.+||.+||..||++||++.++++||||
T Consensus 219 -----------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -----------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -----------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 001112233568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.35 Aligned_cols=252 Identities=29% Similarity=0.528 Sum_probs=210.1
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ........+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 6999999999999999999999999999999987543 23344557899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
+++ +|.+.+.........+++..+..++.|++.||.|||++|++|+||+|+||++++ +.+||+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 865 677777655444566899999999999999999999999999999999999976 68999999999776554 333
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+... .
T Consensus 160 ~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~ 217 (256)
T cd08530 160 TQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------------K 217 (256)
T ss_pred cccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------------C
Confidence 45689999999998554 4788999999999999999999999887755433332111 0
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
........+.++.+++.+||..+|.+|||+.++++||++
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 --------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 111223568899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.94 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=197.3
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHH-HhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCL-RKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||.|+||.||+|.+..+++.||+|++.+.... .......|..++ ...+|+|++++++++...+..|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 6799999999999999999999999998764321 112233444444 445899999999999999999999999976
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcccc
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERV 161 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~ 161 (356)
+|.+++.. ...+++..+..++.||+.||.|||+++++|+||+|+||++++ +.++|+|||++..... .....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 154 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFV 154 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCC
Confidence 56555532 345899999999999999999999999999999999999975 7999999999876543 23456
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (356)
+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||...+.......+.... ..++.
T Consensus 155 ~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~ 214 (260)
T cd05611 155 GTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-------------------INWPE 214 (260)
T ss_pred CCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-------------------cCCCC
Confidence 889999999986655 8999999999999999999999998776655443332210 00000
Q ss_pred cccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCCCCCCCCC
Q 036550 242 LSGVNLSALMPSASEDAINLIESLCSWDPCKRPT---AAEALQHPFFKRCLY 290 (356)
Q Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~ 290 (356)
.....+++++.+++.+||..||++||| ++|+++||||++..|
T Consensus 215 -------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 215 -------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 111256899999999999999999995 589999999987544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=308.27 Aligned_cols=248 Identities=33% Similarity=0.539 Sum_probs=203.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
||.|+||.||++.+..+|+.|++|++..... .......+|++++++++||||+++++.+...+..|+++||+.| +|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6999999999999999999999999876533 2344567899999999999999999999999999999999976 66
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC---------
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--------- 155 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--------- 155 (356)
.+.+... ..+++..+..++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++.......
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 6666432 25899999999999999999999999999999999999975 799999999987553321
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 216 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG------------------- 216 (265)
T ss_pred cccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 223446888999999986655 889999999999999999999999887765554443221
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH---HHHhcCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA---AEALQHPFFKRCLY 290 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~~~~~~~ 290 (356)
....+. ...++..+.+|+.+||+.+|.+|||+ .++|+||||++..|
T Consensus 217 ~~~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 217 KIEWPE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred CcCCCc---------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 011111 01248899999999999999999999 99999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.40 Aligned_cols=252 Identities=27% Similarity=0.506 Sum_probs=203.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||.|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 578999999999999999999999999999999876532 22334567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+.........+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999986 677777654444556899999999999999999999999999999999999975 789999999987664432
Q ss_pred C-CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 P-YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA--DQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .....++..|+|||++.+.. ++.++|+||||+++|+|++|..||...... .....+..
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 222 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ----------------- 222 (267)
T ss_pred cccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-----------------
Confidence 2 23457899999999986554 789999999999999999999999755432 11111100
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...+. ......+..+.+++.+||..||++|||+.++++
T Consensus 223 ----~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 223 ----CDYPP-------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----CCCCC-------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00010 011246889999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=313.87 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=197.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcE--EEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEV--VAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||.||+|.+..++.. +|+|.+.... ......+.+|+.++.++ +||||+++++++.+.+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46899999999999999999998877764 5777665432 23334567899999999 89999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEE
Q 036550 77 VFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKI 142 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL 142 (356)
+|||+.+ +|.+.+..... ....+++..++.++.||+.||+|||++|++||||||+|||+++ +.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 9999874 67777754321 1235889999999999999999999999999999999999965 79999
Q ss_pred ecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 036550 143 ADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPT 221 (356)
Q Consensus 143 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (356)
+|||++.............++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----- 239 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 239 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-----
Confidence 999998643322122222346679999988554 48999999999999999998 99999876654443322110
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
... ......+.++.+++.+||+.+|++||++++++.+
T Consensus 240 ---------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ---------------YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ---------------CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0112467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=318.74 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=196.2
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC-Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEK-GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~~ 73 (356)
++|++.+.||+|+||.||+|.+. .+++.||+|+++.... .....+.+|+.+++++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 58999999999999999999743 3458899999875432 2234557899999999 899999999987654 67
Q ss_pred EEEEEEeccC-CHHHHHHHHHh---------------------------------------------------------h
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQ---------------------------------------------------------K 95 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~---------------------------------------------------------~ 95 (356)
++++|||+.+ +|.+.+..... .
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8899999986 56666643211 1
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC---CccccccccccChHH
Q 036550 96 QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEI 171 (356)
Q Consensus 96 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~ 171 (356)
...+++..+..++.||+.||+|||++||+||||||+|||+++ +.++|+|||++..+..... .....++..|+|||+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 235899999999999999999999999999999999999985 7899999999987643221 123345678999999
Q ss_pred HhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccccccccc
Q 036550 172 LFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSAL 250 (356)
Q Consensus 172 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
+.+.. ++.++|||||||++|+|++ |..||......+.+......... ...
T Consensus 247 ~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~ 297 (337)
T cd05054 247 IFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR----------------------------MRA 297 (337)
T ss_pred hcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC----------------------------CCC
Confidence 86655 8999999999999999998 99999865443332222111000 001
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 251 MPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 251 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....++++.+++.+||+.+|++||++.++++|
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=307.98 Aligned_cols=250 Identities=28% Similarity=0.484 Sum_probs=204.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 7888999999999999999999999999999865432 233456789999999999999999999999999999999998
Q ss_pred CC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCcc
Q 036550 83 CN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYTE 159 (356)
Q Consensus 83 g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~~ 159 (356)
++ +.+.+. ...+++..+..++.|++.|+.+||++|++|+||+|+||++++ +.++|+|||++....... ....
T Consensus 86 ~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 86 GGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 74 555543 234899999999999999999999999999999999999975 689999999987665432 1233
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccC
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (356)
..++..|+|||.+.+. ..+.++|+|||||++|+|++|..||...........+... .
T Consensus 161 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~--------------------- 217 (277)
T cd06641 161 FVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N--------------------- 217 (277)
T ss_pred ccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C---------------------
Confidence 4688899999988554 4788999999999999999999999876544333322110 0
Q ss_pred CCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......++.++.+++.+||..+|.+||++.++++||||.+.
T Consensus 218 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 218 -------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred -------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 011123568899999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=306.97 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=201.3
Q ss_pred CCceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 478999999999999999999877 788999999875433 33445788999999999999999999999889999
Q ss_pred EEEEeccC-CHHHHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC----cEEEecccc
Q 036550 76 FVFECMQC-NLYQLMEAKKQ---KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG----TIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----~~kL~Dfg~ 147 (356)
++|||+.| +|.+++..... ....+++..+..++.||+.||+|||+++++|+||||+||++++. .+||+|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 99999865 67777765431 11248999999999999999999999999999999999999752 599999999
Q ss_pred eeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+........ ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||...........+... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~---- 239 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR---- 239 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc----
Confidence 987633211 11223456899999996555 8999999999999999997 99999877655443322111 00
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++..+.+++.+||+.||++|||+.++++|
T Consensus 240 ------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 ------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=307.43 Aligned_cols=252 Identities=20% Similarity=0.352 Sum_probs=200.7
Q ss_pred CCCceeecccccCCceEEEEEEE----cCCCcEEEEEEcccccchH-HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVN----KHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
+++|++.+.||+|+||+||+|.. ..++..||+|.+....... ...+.+|+.+++.++||||+++++++...+..|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 46799999999999999999985 3456789999987544332 345678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHh-------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcE
Q 036550 76 FVFECMQC-NLYQLMEAKKQ-------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTI 140 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~ 140 (356)
++|||+.+ +|.+.+..... ....+++..+..++.||+.||.|||++|++||||||+||++++ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 99999975 67776643211 1234788999999999999999999999999999999999976 689
Q ss_pred EEecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036550 141 KIADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSV 216 (356)
Q Consensus 141 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 216 (356)
||+|||++....... ......++..|+|||++.+.. ++.++|+|||||++|+|++ |.+||.+.........+...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997654321 122344677899999986554 8999999999999999998 99999876654443333211
Q ss_pred hCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .......++..+.+++.+||+.||++||++.+++++
T Consensus 243 ~-----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 243 Q-----------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred C-----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0 011223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=306.54 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=198.4
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|++.+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 57999999999999999999864 2457899999865432 33445678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhh------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 76 FVFECMQC-NLYQLMEAKKQK------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
+||||+.+ +|.+.+...... ...++...+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||+
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 99999875 677776542211 123577889999999999999999999999999999999975 7999999999
Q ss_pred eeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~------ 238 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG------ 238 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC------
Confidence 876543211 12234578899999986544 8999999999999999999 789998776654443332110
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
........+..+.+++.+||+.||++|||+.+++++
T Consensus 239 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 -----------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred -----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=324.52 Aligned_cols=249 Identities=30% Similarity=0.462 Sum_probs=202.9
Q ss_pred eeecccccCCceEEEEEEEcCCCcEEEEEEcccc----cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe--EEEEE
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS----YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGN--VFFVF 78 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~iv~ 78 (356)
+....||+|+|-+||+|.|..+|..||--.++.. .....+.+..|+.+|+.|+||||+++++++.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3457899999999999999999999885443321 22333567889999999999999999999987654 78999
Q ss_pred Eecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC--CcEEEecccceeecCC
Q 036550 79 ECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ--GTIKIADFGLAREIDA 153 (356)
Q Consensus 79 e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~ 153 (356)
|.+. |+|..++.+++. ++...++.|++||+.||.|||++. |+|||||-+||+|+. |.|||+|+|+|+....
T Consensus 123 EL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9776 567777654443 899999999999999999999986 999999999999975 8999999999998765
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.. ....+|||.|||||+.. . .|+..+||||||..+.||.|+..||..-....++++.+...-.|
T Consensus 199 s~-aksvIGTPEFMAPEmYE-E-~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP------------- 262 (632)
T KOG0584|consen 199 SH-AKSVIGTPEFMAPEMYE-E-NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP------------- 262 (632)
T ss_pred cc-cceeccCccccChHHHh-h-hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH-------------
Confidence 33 34479999999999985 3 39999999999999999999999998766655555544322111
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+.+.-.+++++||.+||.. .++|+|+.|+|+||||+..
T Consensus 263 --------------~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 263 --------------AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --------------HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 111223368999999999999 9999999999999999874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.98 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=204.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.++||.|+||.||+|.+.. ++.+|+|++............+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 468999999999999999999887 8899999998766555666788999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-Cc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~~ 158 (356)
++ +|.+.+... .+..+++..++.++.||+.||.|||++|++|+||||+||++++ +.+||+|||.+........ ..
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 76 777777542 2345899999999999999999999999999999999999975 6999999999976643211 12
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 163 ~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 223 (261)
T cd05148 163 DKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------------ 223 (261)
T ss_pred CCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC------------------
Confidence 33456789999998554 48999999999999999998 89999877765555444321110
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++.+.+++.+||+.||++|||+.++++
T Consensus 224 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.55 Aligned_cols=276 Identities=22% Similarity=0.301 Sum_probs=199.4
Q ss_pred ecccccC--CceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 7 TKKLGSG--SFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 7 ~~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
...||.| +||+||++.+..+|+.||+|++..... .....+.+|+.+++.++||||++++++|...+..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 999999999999999999999875432 223455789999999999999999999999999999999988
Q ss_pred C-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-C--
Q 036550 83 C-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-Y-- 157 (356)
Q Consensus 83 g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~-- 157 (356)
+ ++.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++. +.++++||+.+........ .
T Consensus 83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 83 YGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 6 6666665432 234899999999999999999999999999999999999974 7999999986543321100 0
Q ss_pred -----ccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH---
Q 036550 158 -----TERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG--- 228 (356)
Q Consensus 158 -----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--- 228 (356)
....++..|+|||++.+. ..++.++|||||||++|+|++|.+||...........+.. .+....+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 237 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK---GPPYSPLDITTFP 237 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc---CCCCCCccccccc
Confidence 112345679999998654 3478999999999999999999999987765444333322 1111111000
Q ss_pred --hhhhhhhcccCC--------------Cc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 229 --LRQAMAINYQFP--------------QL-SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 229 --~~~~~~~~~~~~--------------~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
............ .. ...........++..+.+|+++||..||++|||+.++|+||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000000000000 00 000001112346788999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=303.21 Aligned_cols=246 Identities=25% Similarity=0.418 Sum_probs=199.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++.+.+.+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 68999999999999999999865 567799998765432 3456678999999999999999999999999999999998
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.+ +|.+.+... ....+++..+..++.|++.||+|||+++++|+||||+||++++ +.++|+|||.+........ .
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 64 677776543 2344889999999999999999999999999999999999976 6899999999987654221 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------- 221 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY------------------- 221 (261)
T ss_pred CCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 2234567899999985544 8899999999999999998 999998776655544432211
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..+ ....++.++.+++.+||..||++|||++++++
T Consensus 222 -~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 222 -RMP---------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -CCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111 11256889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.64 Aligned_cols=279 Identities=21% Similarity=0.299 Sum_probs=197.5
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccc--cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.+.+|. +|.||++++..+++.||+|++... .......+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3344444 455666666779999999998765 233445667899999999999999999999999999999999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-----
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP----- 156 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~----- 156 (356)
++.+++... ....+++..++.++.|++.||+|||+++|+||||||+||++++ +.+||+|||.+........
T Consensus 84 ~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 466665533 2234899999999999999999999999999999999999975 8999999998875532211
Q ss_pred ---CccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc--cchHHHhh
Q 036550 157 ---YTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM--DSWADGLR 230 (356)
Q Consensus 157 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ 230 (356)
.....++..|+|||++... ..++.++|+||+||++|+|++|..||..................... ..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 1234577889999998653 34789999999999999999999999876654433222111100000 00000000
Q ss_pred hhhhh--cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QAMAI--NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..... ....+.............++.++.+|+.+||..||++|||+.++|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00000 00000000001111223456789999999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=307.92 Aligned_cols=255 Identities=30% Similarity=0.528 Sum_probs=210.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
+.|.+.+.||+|++|.||+|.+..++..|++|++..... ....+.+|+++++.++|+|++++++.+...+..|+++||+
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 468899999999999999999998999999999876544 3455678999999999999999999999999999999999
Q ss_pred c-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 82 Q-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+ ++|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++....... ...
T Consensus 98 ~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 98 DGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred CCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 8 57777776432 35899999999999999999999999999999999999975 799999999887654321 123
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... ..+.
T Consensus 175 ~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~----------------- 235 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP----------------- 235 (286)
T ss_pred cccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC-----------------
Confidence 345788999999986554 899999999999999999999999877655443333211 0000
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......++..+.+||.+||+.+|.+|||+.++++||||.+.
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 ---------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ---------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00012367899999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=302.66 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=215.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHH---hhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+++.||+|+|++|-+++.++|.+.||+|++++...++. .....|..+...- +||.+|.++.+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 5789999999999999999999999999999999988644333 3446677777766 79999999999999999999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeec-CCC
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAF 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~-~~~ 154 (356)
|.||++|+- +..+.+++..++|+.++.+...|+.||.|||++||++||||.+|+|++ +|++||+|+|+++.- ...
T Consensus 329 vieyv~ggd---lmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcc---eeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999999872 222223444599999999999999999999999999999999999997 599999999999865 344
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCccchHH
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGT-------DEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
...+++||||.|.|||++.+.. |+.++|+|+|||++|||+.|+.||+-- +.++.+.++
T Consensus 406 d~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-------------- 470 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-------------- 470 (593)
T ss_pred cccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------------
Confidence 5567899999999999997776 999999999999999999999999621 112222222
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC------CHHHHhcCCCCCCCCCCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP------TAAEALQHPFFKRCLYVPPH 294 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------t~~e~l~hp~~~~~~~~~~~ 294 (356)
..+.+++.|+ .+|-.+..+++..|.+||.+|. ...++..|+||....|....
T Consensus 471 ----ilekqiripr-----------slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 471 ----ILEKQIRIPR-----------SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred ----Hhhhcccccc-----------eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 1233444554 5677888999999999999997 47899999999988776433
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=302.61 Aligned_cols=252 Identities=28% Similarity=0.532 Sum_probs=203.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||.||+|.+..+|+.||+|.++... ......+.+|+.++++++|+|++++++++...+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 478999999999999999999999999999999886432 22344567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+++ +|.+.+.........+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999985 677777654444556899999999999999999999999999999999999974 799999999987654322
Q ss_pred -CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA--DQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...... +....+...
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 223 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---------------- 223 (267)
T ss_pred cccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------------
Confidence 223456889999999986554 899999999999999999999999654321 111111100
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.++. ...+.++..+.++|.+||..+|++|||+.++++
T Consensus 224 -----~~~~-------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 -----DYPP-------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----CCCC-------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 001256789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=309.62 Aligned_cols=249 Identities=34% Similarity=0.568 Sum_probs=206.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||.|+||.||+|.+..+++.||+|++.+.. ........+|+.+++++. ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 58999999999999999999999999999999987632 223345678999999998 99999999999999999999
Q ss_pred EEec-cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~-~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
||++ +++|.+.+.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999 5577777643 235999999999999999999999999999999999999975 799999999987654322
Q ss_pred ---------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 036550 156 ---------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 156 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 214 (356)
......++..|+|||++.... ++.++|+|||||+++++++|..||...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 112345789999999986544 8899999999999999999999999776544333322
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCCCC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA----AEALQHPFF 285 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~~ 285 (356)
. ....+ +..+++.+.+||.+||+.||++|||+ +++++||||
T Consensus 236 ~-------------------~~~~~-----------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 K-------------------LEYSF-----------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred h-------------------cCCCC-----------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 1 11111 23568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=298.91 Aligned_cols=249 Identities=32% Similarity=0.584 Sum_probs=209.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+|.+.+.||+|++|.||++.+..+++.|++|.+..... .....+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 68999999999999999999999999999999876643 3445667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-C
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-Y 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~ 157 (356)
+.+ +|.+.+... ..+++..+..++.|++.||.+||++||+||||+|+||+++. +.++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 986 566665432 45899999999999999999999999999999999999976 7999999999987765332 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...
T Consensus 157 ~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 214 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------------- 214 (254)
T ss_pred cccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---------------------
Confidence 3456899999999986555 889999999999999999999999876644333322110
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
......+.++..+.+++.+||..+|++|||+.+++.||||
T Consensus 215 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 --------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0111223668899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=309.45 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=199.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCc--EEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGE--VVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
.++|.+.+.||+|+||.||+|.+..++. .+++|.++... ......+.+|+.+++++ +||||+++++++...+..++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 4789999999999999999999877664 47888876432 23344567899999999 79999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEE
Q 036550 77 VFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKI 142 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL 142 (356)
++||+++ +|.+.+..... ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 9999874 67777754221 1134889999999999999999999999999999999999975 68999
Q ss_pred ecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 036550 143 ADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPT 221 (356)
Q Consensus 143 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (356)
+|||++..............+..|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~--- 236 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 236 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---
Confidence 9999986443221222223356799999886544 8999999999999999997 9999987766554443321100
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++..+.+|+.+||..||.+|||++++++.
T Consensus 237 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 --------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123568899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.07 Aligned_cols=282 Identities=26% Similarity=0.438 Sum_probs=229.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCC------CCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH------PNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------p~iv~~~~~~~~~~~~~ 75 (356)
.+|.|....|+|-||+|..|.+...|..||||+|.+...- ...-+.|+++|++|.. -|.++++..|.+.+++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 4799999999999999999999999999999999876322 2334789999999952 47899999999999999
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC--cEEEecccceeecCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG--TIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~kL~Dfg~a~~~~~ 153 (356)
+|||.+.-+|.+++...... -.+....++.|+.|++.||..|...||+|.||||+|||++++ .+||||||.|...+.
T Consensus 511 lVFE~LslNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 511 LVFEPLSLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred EEehhhhchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence 99999999999999876543 347889999999999999999999999999999999999874 899999999988776
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh--hh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL--RQ 231 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~ 231 (356)
. ..+.+.-+..|.|||++++-. |++..|+||+||+||||.||+..|.+....+++...+...|.++..+...+. .+
T Consensus 590 n-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 590 N-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred c-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 4 345667788899999998887 9999999999999999999999999999999999888888888776664332 11
Q ss_pred hhhhcccCC-----Cccccc-----------------------ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 232 AMAINYQFP-----QLSGVN-----------------------LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 232 ~~~~~~~~~-----~~~~~~-----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
.+..+..|- ...... ++.-....-.++.+|+.+||..||++|.|+.|+|+||
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 111111111 000000 0000111234689999999999999999999999999
Q ss_pred CCCC
Q 036550 284 FFKR 287 (356)
Q Consensus 284 ~~~~ 287 (356)
||+.
T Consensus 748 Fi~~ 751 (752)
T KOG0670|consen 748 FITE 751 (752)
T ss_pred cccC
Confidence 9974
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=301.58 Aligned_cols=250 Identities=26% Similarity=0.489 Sum_probs=201.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 74 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875321 22334567899999999999999999998764 568
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++++||+.| +|.+.+.. ...+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999876 56666542 234889999999999999999999999999999999999975 689999999997654
Q ss_pred CC----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AF----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.. .......++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||..........++. ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~------ 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK------ 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC------
Confidence 21 1123456899999999986654 7899999999999999999999998765444333221 11110
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
...+..+++.+.++|.+||. +|..|||+.+++.|||.
T Consensus 228 -------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 -------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 11234678999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=305.11 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=201.3
Q ss_pred CCceeecccccCCceEEEEEEEcCC-----CcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-----GEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 6899999999999999999987643 48899999865532 33445678999999999999999999999999999
Q ss_pred EEEEecc-CCHHHHHHHHHh------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 76 FVFECMQ-CNLYQLMEAKKQ------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
+||||+. |+|.+.+..... ....+++..+..++.||+.||.|||+++++|+||||+||++++ +.+||+|||+
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence 9999986 577777754322 1234788899999999999999999999999999999999975 7999999999
Q ss_pred eeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+....... ......++..|+|||.+.+.. ++.++|||||||++|++++ |.+||...+.......+... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~---- 239 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH---- 239 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC----
Confidence 87654322 123345678999999985544 8999999999999999998 99999877655544333210 00
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...+...+..+.+++.+||..+|++|||+.++++.
T Consensus 240 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 240 ------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01122458899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=308.01 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=200.6
Q ss_pred CCceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccchH-HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
.+|++.+.||+|+||.||+|.+.. +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 568999999999999999998754 35789999987554332 345678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHH------------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEE
Q 036550 76 FVFECMQC-NLYQLMEAKK------------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIK 141 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~k 141 (356)
+++||+.+ ++.+.+.... .....+++..+..++.|++.||.|||++||+||||||+||++++ +.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999875 5666664221 11234788999999999999999999999999999999999975 6899
Q ss_pred EecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 036550 142 IADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVL 217 (356)
Q Consensus 142 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 217 (356)
|+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999876543221 12334678899999986555 8999999999999999998 889998876655544443211
Q ss_pred CCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .......+..+.+++.+||+.+|.+||++.++++.
T Consensus 244 ~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 V-----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred c-----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 0 01123678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=301.52 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=202.2
Q ss_pred cccccCCceEEEEEEEcCC---CcEEEEEEcccccchH-HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec-c
Q 036550 8 KKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM-Q 82 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~-~ 82 (356)
+.||+|+||.||+|.+... +..|++|++....... ...+.+|+.+++.++|+||+++++++.+.+..+++|||+ +
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999998866 8999999997765433 456678999999999999999999999999999999999 4
Q ss_pred CCHHHHHHHHHhh-----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 83 CNLYQLMEAKKQK-----QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 83 g~l~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
++|.+.+...... ...+++..++.++.||+.||+|||++|++|+||||+||++++ +.++|+|||.+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 6777777654211 356899999999999999999999999999999999999987 899999999998775432
Q ss_pred --CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 --PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......+++.|+|||.+... .++.++|||||||++|+|++ |..||......+....+....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------- 224 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------------- 224 (262)
T ss_pred cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 22345678899999998665 48999999999999999999 699998876655444332210
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.......++.++.+++.+||..||++|||+.+++++
T Consensus 225 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=321.34 Aligned_cols=235 Identities=27% Similarity=0.450 Sum_probs=198.0
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
++-||.|+.|.||+|+.. ++.||||.++.- ...+|.-|++|+||||+.+.++|.....+|||||||.. -|
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 567999999999999654 789999987432 23578999999999999999999999999999999985 57
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTR 164 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~ 164 (356)
++.+. .+..++......|..+|+.|+.|||.+.|||||||.-||||+. +.+||+|||.++.+.+......++||.
T Consensus 200 ~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 200 YEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred HHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence 77764 4455899999999999999999999999999999999999975 799999999999888777777899999
Q ss_pred cccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccc
Q 036550 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244 (356)
Q Consensus 165 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (356)
.|||||++.+.. .+.++|||||||+||||+||..||..-+...+++-+-. .
T Consensus 276 aWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs----------------------------N 326 (904)
T KOG4721|consen 276 AWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS----------------------------N 326 (904)
T ss_pred hhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccC----------------------------C
Confidence 999999996655 89999999999999999999999987664433221100 0
Q ss_pred ccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 245 VNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 245 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
.-....+..+++.++=||+.||.-.|..||+..++|.|-
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 001222346788999999999999999999999999983
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=302.01 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=197.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||++..+. +..+|+|.+..... ....+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 579999999999999999998764 56799998765432 2345678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY-- 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~-- 157 (356)
.+ +|.+.+... ...+++..+..++.|++.||.|||++||+|+||||+||++++ +.+||+|||.+.........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 75 566665432 234899999999999999999999999999999999999975 68999999998765432211
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.+.. ++.++|+|||||++|+|++ |++||...+..+....+......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------- 220 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------------- 220 (256)
T ss_pred CCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------------
Confidence 1223566899999986544 8999999999999999999 89999887765555444321100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+..+.+++.+||..||++|||++++++
T Consensus 221 ------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011235778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=318.54 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=196.6
Q ss_pred CCceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++++. ||||+++++++.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 568899999999999999998643 345799999975433 33456788999999996 99999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh-----------------------------------------------------------
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ----------------------------------------------------------- 94 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~----------------------------------------------------------- 94 (356)
|+||||+.+ +|.+.+.....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 999999875 67776654321
Q ss_pred ---------------------------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcE
Q 036550 95 ---------------------------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTI 140 (356)
Q Consensus 95 ---------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~ 140 (356)
....+++..+..++.||+.||+|||+++|+||||||+|||+++ +.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence 0124788889999999999999999999999999999999986 589
Q ss_pred EEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036550 141 KIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSV 216 (356)
Q Consensus 141 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 216 (356)
||+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...............
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~ 355 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence 9999999986643222 12335678899999986554 8999999999999999997 99999865433332222111
Q ss_pred hCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. ... .....++.++.+++.+||..||++|||+.++.+
T Consensus 356 ~-------------------~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 356 G-------------------YRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred C-------------------CCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 0 000 111356889999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=338.65 Aligned_cols=145 Identities=31% Similarity=0.542 Sum_probs=127.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
|++|.+.++||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+++|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999987542 22234567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
|||+.| +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999965 67776643 234899999999999999999999999999999999999975 799999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=304.46 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=200.8
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.++||+|+||.||++... .++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46889999999999999999743 3567899999877665666677899999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHh-----------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEe
Q 036550 77 VFECMQC-NLYQLMEAKKQ-----------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIA 143 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~ 143 (356)
+|||+.+ +|.+.+..... ....+++..++.++.||+.||+|||++|++||||||+||++++ +.+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEEC
Confidence 9999875 67777654321 0124789999999999999999999999999999999999975 689999
Q ss_pred cccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 036550 144 DFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGS 219 (356)
Q Consensus 144 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 219 (356)
|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+.....
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 242 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE- 242 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc-
Confidence 9999876543221 12234567899999986655 8999999999999999998 9999987666554433321100
Q ss_pred CCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 220 PTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+++.+.+++.+||+.||++||++.++++
T Consensus 243 ----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 243 ----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0111256889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=300.32 Aligned_cols=246 Identities=26% Similarity=0.364 Sum_probs=197.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||++.+.. +..+|+|.+..... ....+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 579999999999999999997654 45699998875432 2345678999999999999999999999989999999998
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY-- 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~-- 157 (356)
.+ ++.+.+... ...+++..++.++.||+.||.|||++|++|+||||+||++++ +.+||+|||.+.........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 76 566665432 225899999999999999999999999999999999999975 68999999998766432211
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 159 ~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 220 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------------- 220 (256)
T ss_pred CCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------------
Confidence 1223567799999986544 8899999999999999998 99999877765544444221110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+..+.+++.+||..||.+|||+.+++++
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112357899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.20 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=198.2
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||.||++.+ ..++..||+|+++.... .....+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4789999999999999999975 33556899999876533 3334567899999999 799999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+++|||+.+ +|.+.+... ....+++.++..++.||+.||+|||+++|+|+||||+||++++ +.++|+|||++....
T Consensus 115 ~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999875 677766432 2233899999999999999999999999999999999999976 589999999997654
Q ss_pred CCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.... .....+++.|+|||++.+.. ++.++||||+||++|+|++ |.+||......+..........
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~---------- 261 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY---------- 261 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC----------
Confidence 3221 11234578899999986554 8999999999999999998 9999987765444333322100
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. .......+..+.+++.+||..+|++|||+.++++
T Consensus 262 ---------~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 ---------R---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 0011245789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=299.34 Aligned_cols=241 Identities=23% Similarity=0.382 Sum_probs=191.5
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+.+ +|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 479999999999999999999999998765432 3344567899999999999999999999999999999999876 56
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC---cccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY---TERV 161 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~---~~~~ 161 (356)
.+.+.. ....+++..++.++.|++.||.|||++|++||||||+||++++ +.+||+|||++......... ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 666542 2335899999999999999999999999999999999999975 68999999998765432111 1112
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||...........+.....
T Consensus 158 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------------- 214 (252)
T cd05084 158 IPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------------- 214 (252)
T ss_pred CceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----------------------
Confidence 345699999985544 8999999999999999997 8999976655433322211100
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......+..+.+++.+||..||++|||+.++++
T Consensus 215 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 -------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112256889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=320.45 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=200.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+..+..+||+|.||+||+|++.. .||||+++...- ...+.+.+|+.++++-+|.||+-+.|++...+. .||+.+
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 45678999999999999999875 499999976542 344567899999999999999999999988877 889999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC---CCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID---AFP 155 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~---~~~ 155 (356)
|+| +|+..+.....+ |...+.+.|++||++|+.|||.++|||+|||..||++.+ +.|||+|||+++.-. ...
T Consensus 469 CeGsSLY~hlHv~etk---fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETK---FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhh---hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 998 588887755433 899999999999999999999999999999999999977 899999999986532 233
Q ss_pred CCccccccccccChHHHhhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKS--GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
......|...|||||++... ..|++.+|||||||++|||++|..||...+....+..+-.+...|.
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd------------ 613 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD------------ 613 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc------------
Confidence 44556788999999999643 4589999999999999999999999994444333333322211111
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+.......+.++++|+..|+.+++++||...+||.
T Consensus 614 -------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 -------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12222356779999999999999999999999987
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=310.37 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=195.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcE----EEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV----VAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
.+|++.+.||+|+||+||+|.+..++.. ||+|+++.... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 5799999999999999999998766654 89999875432 3345567899999999999999999998765 4678
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+++|+.+ ++.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 8888765 677776532 234889999999999999999999999999999999999976 68999999999876543
Q ss_pred CCC---ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PPY---TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
... ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.. .+.....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~------------ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGE------------ 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCC------------
Confidence 221 1223467899999986554 8999999999999999997 99999876554432 2221110
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+ ..+..+.++.+++.+||..||++|||+.+++.+
T Consensus 229 -------~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 229 -------RLP---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -------CCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001 112457789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.10 Aligned_cols=245 Identities=26% Similarity=0.401 Sum_probs=195.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.++||+|+||+||+|.+..+ ..||+|++...... ...+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC-HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 5799999999999999999988765 45999998764332 245678999999999999999999874 45679999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY-- 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~-- 157 (356)
.+ ++.+.+... ....+++..+..++.|++.||+|||+++++|+||||+||++++ +.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 86 677776532 2334789999999999999999999999999999999999975 68999999999876543221
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||+..+.. ++.++|+|||||++|+|++ |.+||...........+....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------------- 220 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------------- 220 (262)
T ss_pred cCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------------
Confidence 1234667899999885554 8999999999999999999 889998776555443332110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.. .....++..+.+++.+||..||++|||+.++++
T Consensus 221 -~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 221 -RM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -CC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 011356889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=306.81 Aligned_cols=251 Identities=25% Similarity=0.440 Sum_probs=199.6
Q ss_pred CCceeecccccCCceEEEEEEEcCC-----CcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-----GEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||.||++.+... ...+|+|.+..... .....+.+|+.+++++ +|+||+++++++...+.+
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 5799999999999999999987643 37899999876432 2334567899999999 899999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHH------------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcE
Q 036550 75 FFVFECMQC-NLYQLMEAKK------------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTI 140 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~ 140 (356)
+++|||+.+ +|.+.+.... .....+++..+..++.||+.||.|||+++|+||||||+||++++ +.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence 999999865 6777765321 22345899999999999999999999999999999999999975 789
Q ss_pred EEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036550 141 KIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSV 216 (356)
Q Consensus 141 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 216 (356)
||+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+...
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 250 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999987654221 12223457799999985544 8999999999999999997 99999877655544333211
Q ss_pred hCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. . .......+..+.+|+.+||..||++|||+.+++++
T Consensus 251 ~--------------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 251 Y--------------------R---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred C--------------------c---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0 0 01112567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=300.48 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=198.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|++|.||+|.+. +++.||+|.++.... ....+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 57999999999999999999875 457899999876533 2345678999999999999999999999999999999999
Q ss_pred -cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--
Q 036550 82 -QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY-- 157 (356)
Q Consensus 82 -~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~-- 157 (356)
+++|.+.+.... +..+++..+..++.|++.||.+||++|++||||||+||++++ +.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 467777765432 345899999999999999999999999999999999999975 78999999999877532211
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....+..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.........+.....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------ 222 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------------ 222 (261)
T ss_pred CCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 1112345799999885544 8999999999999999999 9999987766554443322110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. ......+..+.+++.+||+.+|.+||++.++++
T Consensus 223 --~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 --M---------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --C---------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0 111256789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=305.46 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=200.6
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46899999999999999999753 3456799999876655555667889999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEE
Q 036550 77 VFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKI 142 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL 142 (356)
||||+.+ +|.+.+..... ....+++..++.++.||+.||+|||++||+||||||+||++++ +.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEE
Confidence 9999865 67777654321 1234789999999999999999999999999999999999975 68999
Q ss_pred ecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036550 143 ADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLG 218 (356)
Q Consensus 143 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 218 (356)
+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~- 242 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR- 242 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-
Confidence 9999997654321 122345678899999986554 8999999999999999998 999998776654433321100
Q ss_pred CCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 219 SPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
........+..+.+++.+||..||++|||+.++++
T Consensus 243 ----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 243 ----------------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred ----------------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 00111245789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.68 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=199.2
Q ss_pred CCceeecccccCCceEEEEEEEcCC---CcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||+||+|.+..+ ...||+|.+...... ....+.+|+.+++.++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5799999999999999999988654 458999998765433 344567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
|||+.+ +|.+.+... ...+++..+..++.|++.||.|||+++|+|+||||+||++++ +.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999976 676666532 235899999999999999999999999999999999999976 68999999999877521
Q ss_pred CCCc--cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 155 PPYT--ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 155 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.... ...++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...........+....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------------- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 1111 223457899999986544 8999999999999999998 999997766554433332210
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+ .....+..+.+++.+||+.+|++||++.+++++
T Consensus 226 ------~~~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 ------RLP---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 112568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=300.66 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=195.3
Q ss_pred ceeecccccCCceEEEEEEEcCC---CcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe-----
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGN----- 73 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----- 73 (356)
|.+.+.||+|+||.||+|....+ +..||+|.++... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 4789999987543 2233456789999999999999999998865543
Q ss_pred -EEEEEEeccC-CHHHHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccce
Q 036550 74 -VFFVFECMQC-NLYQLMEAKKQ--KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA 148 (356)
Q Consensus 74 -~~iv~e~~~g-~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a 148 (356)
.+++|||+.+ ++...+..... ....+++..+..++.||+.||.|||+++++||||||+||++++ +.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 7999999875 56666644321 2235899999999999999999999999999999999999976 69999999999
Q ss_pred eecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 149 REIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 149 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------- 232 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN------- 232 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 87643221 112345678999998854 448999999999999999999 899998766554433332110
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.......++..+.+++.+||+.||++|||+.+++++
T Consensus 233 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 ----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=304.53 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=200.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCC----------------cEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG----------------EVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKV 64 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~ 64 (356)
++|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 58999999999999999999876544 5689999876543 334456789999999999999999
Q ss_pred eEEEEECCeEEEEEEeccC-CHHHHHHHHHh-------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee
Q 036550 65 KELIVEKGNVFFVFECMQC-NLYQLMEAKKQ-------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS 136 (356)
Q Consensus 65 ~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 136 (356)
++++..++..+++||++.+ +|.+.+..... ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence 9999999999999999875 67777654321 112589999999999999999999999999999999999997
Q ss_pred C-CcEEEecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHH
Q 036550 137 Q-GTIKIADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL--FRPLFQGTDEADQM 210 (356)
Q Consensus 137 ~-~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~ 210 (356)
+ +.++|+|||++....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+.+
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 6 699999999987654321 122345678899999986544 8999999999999999998 77888776655544
Q ss_pred HHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
............ ..........+.++.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 244 ENAGHFFRDDGR----------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHhccccccc----------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 433221111000 0000112356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=295.40 Aligned_cols=277 Identities=34% Similarity=0.514 Sum_probs=226.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
.||.-++.+|.|+- .|.-|.|.-+++.||+|.+..... .......+|..++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47888999999999 888899999999999998755432 2234457899999999999999999998643 46
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+|+|||+|..++-..+... ++-.++..++.|++.|++|||+.||+||||||+||++.. ..+||.|||+|..-+
T Consensus 96 ~y~v~e~m~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILME------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 8999999999998887622 678899999999999999999999999999999999975 699999999998776
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
..-..+..+.|..|.|||++.+.+ |...+||||+||++.||++|...|.+.+..++..++...+|.|.+.-..+.....
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 655667789999999999999988 9999999999999999999999999999999999999999998765543332211
Q ss_pred hhhccc------------CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 233 MAINYQ------------FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 233 ~~~~~~------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
...-.. ||...-.....-.+.-+..+++++.+||..||++|.|++++|+|||++
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111001 111111111111223456799999999999999999999999999998
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=298.09 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=195.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.++||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC-HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 68999999999999999999876 5667999998764332 345678999999999999999999875 45689999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.+ +|.+.+... ....+++..++.++.|++.||.|||++|++|+||||+||++++ +.++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 75 677766532 2334899999999999999999999999999999999999976 5899999999987644221 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||...+..+....+....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------------- 220 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------------- 220 (260)
T ss_pred cCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 1223556799999885544 8899999999999999999 899998776655444432210
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.. ......+..+.+|+.+||..||++|||+.++++
T Consensus 221 -~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 -RM---------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -CC---------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=306.34 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=198.5
Q ss_pred CCceeecccccCCceEEEEEEEcC-------CCcEEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-------SGEVVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999998643 23579999987643 23334567899999999 7999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
..|+||||+++ +|.+.+..... ....++..++..++.||+.||+|||++|++||||||+||++++ +
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 99999999875 67777765322 1134888999999999999999999999999999999999975 7
Q ss_pred cEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||.+........ .....+++.|+|||++.+.. ++.++|+|||||++|+|++ |.+||...+..+....+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 899999999876543211 11223457899999986554 8999999999999999998 889998766544333321
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
... ........+.++.+++.+||..+|++|||+.+++++
T Consensus 257 ~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 257 EGH-----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCC-----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 110 001123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.68 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=197.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.+|++.+.||+|+||.||++.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC-HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 46899999999999999999876 4668999998654322 234678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc-
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT- 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~- 158 (356)
+| +|.+.+... ...+++..+..++.||+.||+|||++|++||||||+||++++ +.+||+|||++....+.....
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 75 577766532 235899999999999999999999999999999999999975 789999999987664322111
Q ss_pred -cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 -ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 -~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...++..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||...+..+....+.....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 219 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------------ 219 (256)
T ss_pred CCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------------
Confidence 122345799999986554 8999999999999999998 8999987766554433321100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. ......+..+.+++.+||..+|++|||+.++++.
T Consensus 220 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 --L---------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 1112468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=298.80 Aligned_cols=239 Identities=19% Similarity=0.254 Sum_probs=186.9
Q ss_pred cccccCCceEEEEEEEcC------------CCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 8 KKLGSGSFGCVWQAVNKH------------SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
+.||+|+||+||+|.... ....|++|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 23358999877655444556678999999999999999999999998999
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C-------cEEEecccc
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G-------TIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~-------~~kL~Dfg~ 147 (356)
++|||++++..+.+.. .....+++..++.++.||+.||+|||+++|+||||||+|||++. + .++++|||+
T Consensus 81 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 81 MVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999998765444322 22345899999999999999999999999999999999999964 2 389999999
Q ss_pred eeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 148 AREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
+...... ....++..|+|||++.....++.++|||||||++|+|+ +|..||......+... ....
T Consensus 159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~---------- 224 (262)
T cd05077 159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG---------- 224 (262)
T ss_pred CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc----------
Confidence 8765432 23467889999999865566899999999999999997 5888887654332211 1000
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
... .....+.++.+++.+||+.||.+||++.+++++
T Consensus 225 ---------~~~-----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 ---------QCM-----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---------Ccc-----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 011345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.87 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=194.2
Q ss_pred ceeecccccCCceEEEEEEEcCCCc--EEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGE--VVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
|.+.+.||+|+||.||+|.+..++. .||+|.++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999999877765 69999886542 33345567899999999999999999976432 35
Q ss_pred EEEEEEeccC-CHHHHHHHHH--hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 74 VFFVFECMQC-NLYQLMEAKK--QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
.+++|||+.+ ++.+.+.... .....+++..+..++.||+.||+|||+++|+||||||+|||+++ +.++|+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999975 5666554322 12344899999999999999999999999999999999999975 689999999998
Q ss_pred ecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccch
Q 036550 150 EIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 150 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (356)
....... .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...........+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~------ 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-R------ 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-C------
Confidence 7643221 12234677899999986544 8999999999999999999 899998766544433332110 0
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....+..+..+.++|.+||..||++|||+.+++++
T Consensus 233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 ----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=301.44 Aligned_cols=249 Identities=26% Similarity=0.428 Sum_probs=196.6
Q ss_pred CceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 336799998875543 233456789999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHh--------------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee
Q 036550 77 VFECMQC-NLYQLMEAKKQ--------------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV 135 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 135 (356)
++||+.+ +|.+.+..... ....+++..+..++.|++.||+|||+++++||||||+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 9999885 67666653211 12347899999999999999999999999999999999999
Q ss_pred eC-CcEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 036550 136 SQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQM 210 (356)
Q Consensus 136 ~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 210 (356)
++ +.+||+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.......
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 75 6899999999876533221 12234567899999985544 8999999999999999998 99999876654433
Q ss_pred HHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..+... +.. ......+.++.+|+.+||+.||++||++.++++
T Consensus 240 ~~~~~~--------------------~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTG--------------------YRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCC--------------------CCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 322111 000 011356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=348.01 Aligned_cols=253 Identities=30% Similarity=0.502 Sum_probs=208.1
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
|+....+||.|.||.||.|.+..||...|+|-++-.... ......+|..++..++|||+|+++++-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 456678999999999999999999999999988655433 223446899999999999999999999999999999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC---
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--- 155 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--- 155 (356)
|.|+ |.+++. .++-.+|...+.+..|++.|+.|||+.|||||||||+||+++. |.+|++|||.|..+.+..
T Consensus 1316 C~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1316 CEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred hccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9875 555543 3334788888999999999999999999999999999999975 799999999998886542
Q ss_pred --CCccccccccccChHHHhhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 --PYTERVGTRWYQAPEILFKSG--LYSSKVDMWAMGAIMAELLLFRPLFQGTDE-ADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 --~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
......||+.|||||++.+.+ ...-++|||||||++.||+||+.||...+. ...++.+..+ ..
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g-h~----------- 1459 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG-HK----------- 1459 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-CC-----------
Confidence 223557999999999997653 367789999999999999999999986654 3444433221 11
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+.++..+|++.++||.+||..||++|+++.|+|+|.|-+.+
T Consensus 1460 -----------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1460 -----------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -----------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 22233689999999999999999999999999999997654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=302.54 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=203.4
Q ss_pred CceeecccccCCceEEEEEEEc---CCCcEEEEEEcccccc----hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYS----REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
+|++.+.||.|+||.||+|.+. .+|+.||+|++..... .......+|+.+++.+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 4789999999865321 2234456799999999 699999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++||||+.+ +|.+.+.. ...+++..+..++.||+.||.|||++|++||||+|+|||+++ +.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999986 56666543 344899999999999999999999999999999999999965 799999999987664
Q ss_pred CCC--CCccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 153 AFP--PYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK---------- 226 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc----------
Confidence 322 22345689999999998643 34678999999999999999999999754332221111111000
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
. .....+.+++.+.+++.+||..||++|| +++++++||||+...|
T Consensus 227 -----~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 227 -----S-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred -----c-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0 0011235688999999999999999997 8999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=297.08 Aligned_cols=251 Identities=29% Similarity=0.508 Sum_probs=203.0
Q ss_pred CceeecccccCCceEEEEEEEcC-CCcEEEEEEccccc----------chHHhhhHHHHHHHHh-CCCCCeeEEeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKH-SGEVVAIKALKKSY----------SREKCLNLREVKCLRK-LNHPNIVKVKELIVE 70 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~ 70 (356)
.|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 78899999875321 1122334678888875 799999999999999
Q ss_pred CCeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 71 KGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 71 ~~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
.+..+++|||+.| ++.+.+.........+++..++.++.|++.||.|||+ .+++|+||+|+||++++ +.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999876 6777776544555669999999999999999999996 78999999999999975 6899999999
Q ss_pred eeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 148 AREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
+.............|+..|+|||.+.+.. ++.++|+||||+++|+|++|.+||...+.......+......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 232 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP------- 232 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-------
Confidence 98766544445567899999999996544 8999999999999999999999998766544443332211100
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....+++.+.+++.+||+.||++||++.|+.++
T Consensus 233 ---------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 ---------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ---------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0012467899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=295.82 Aligned_cols=241 Identities=35% Similarity=0.553 Sum_probs=200.4
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec-cCCH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM-QCNL 85 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~-~g~l 85 (356)
||.|+||.||++.+..+++.||+|++.+.... ......+|+.+++.++||||+++++.+..++..+++||++ +++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 79999999999999989999999998765322 3345578999999999999999999999999999999999 5577
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCcccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTERVGT 163 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~~~gt 163 (356)
.+.+... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++ +.++|+|||.+...... .......++
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 7776532 34899999999999999999999999999999999999975 69999999999876543 223455789
Q ss_pred ccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcc
Q 036550 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLS 243 (356)
Q Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (356)
..|+|||.+.+.. .+.++|+||||+++|++++|..||...+.......+.. ...
T Consensus 157 ~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------------------~~~------ 210 (250)
T cd05123 157 PEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-------------------DPL------ 210 (250)
T ss_pred ccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-------------------CCC------
Confidence 9999999986554 78899999999999999999999987765443333321 011
Q ss_pred cccccccCCCCCHHHHHHHHHccCCCCCCCCCH---HHHhcCCCC
Q 036550 244 GVNLSALMPSASEDAINLIESLCSWDPCKRPTA---AEALQHPFF 285 (356)
Q Consensus 244 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~---~e~l~hp~~ 285 (356)
......+..+.+++++||..||++|||+ +++++||||
T Consensus 211 -----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 -----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1122458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=299.91 Aligned_cols=238 Identities=17% Similarity=0.238 Sum_probs=186.1
Q ss_pred ccccCCceEEEEEEEcCC------------------------CcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEE
Q 036550 9 KLGSGSFGCVWQAVNKHS------------------------GEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKV 64 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 64 (356)
.||+|+||.||+|....+ ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999974321 24589998876544444566789999999999999999
Q ss_pred eEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-------
Q 036550 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ------- 137 (356)
Q Consensus 65 ~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------- 137 (356)
++++...+..++||||++++.++.+... ....+++..+..++.||+.||+|||++||+||||||+|||+++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999997644433322 2345899999999999999999999999999999999999964
Q ss_pred -CcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHH
Q 036550 138 -GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICS 215 (356)
Q Consensus 138 -~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~ 215 (356)
+.+|++|||.+...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+... ...
T Consensus 160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~ 235 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE 235 (274)
T ss_pred cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence 24899999987654322 23467888999999876566899999999999999994 6999998665433211 111
Q ss_pred HhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. ....+ ...++.+.++|.+||..+|++|||+.+++++
T Consensus 236 ~-------------------~~~~~-----------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 236 K-------------------KHRLP-----------EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred h-------------------ccCCC-----------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 0 00111 1345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=296.66 Aligned_cols=245 Identities=26% Similarity=0.410 Sum_probs=196.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 57999999999999999999865 577899999875543 2345678999999999999999999874 45789999998
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.+ +|.+.+... .+..+++..+..++.|++.||+|||++|++|+||||+||++++ +.++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 65 677776532 2345899999999999999999999999999999999999976 6899999999977653211 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.... ++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 161 ~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 222 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------------- 222 (260)
T ss_pred cCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----------------
Confidence 2234567899999885544 8899999999999999998 99999877665544433211100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+.++.+++.+||..+|++|||++++++
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 ------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=301.91 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=197.0
Q ss_pred CCceeecccccCCceEEEEEEEcC----------------CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH----------------SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKV 64 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~ 64 (356)
++|++.++||+|+||+||++.+.. ++..||+|++..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999986432 345799999875532 334566789999999999999999
Q ss_pred eEEEEECCeEEEEEEeccC-CHHHHHHHHHhh-------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee
Q 036550 65 KELIVEKGNVFFVFECMQC-NLYQLMEAKKQK-------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS 136 (356)
Q Consensus 65 ~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 136 (356)
++++...+..+++|||+.+ +|.+.+...... ...+++.++..++.||+.||+|||++|++|+||||+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 9999999999999999875 677777543211 12377889999999999999999999999999999999997
Q ss_pred C-CcEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHH
Q 036550 137 Q-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL--FRPLFQGTDEADQM 210 (356)
Q Consensus 137 ~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~ 210 (356)
+ +.++|+|||++........ .....++..|+|||+..+.. ++.++|+|||||++|+|++ |..||......+..
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 5 7899999999876543221 11233467899999886654 8999999999999999998 77899876654443
Q ss_pred HHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......... ...... .....++..+.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~-------------~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 244 ENTGEFFRDQ-------------GRQVYL---------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHhhc-------------cccccC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3221110000 000000 111246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=295.27 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=189.7
Q ss_pred cccccCCceEEEEEEE--cCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVN--KHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||.||+|.+ ..++..+|+|+++.... .....+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3699999999999964 45788999999865432 23345678999999999999999999875 4567899999886
Q ss_pred C-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC----C
Q 036550 84 N-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP----Y 157 (356)
Q Consensus 84 ~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~----~ 157 (356)
+ |.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||++++ +.+||+|||++........ .
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 4 6666542 234899999999999999999999999999999999999976 5899999999987654322 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||.+.. ..++.++|+|||||++|+|++ |.+||......+....+.....
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~------------------ 216 (257)
T cd05116 156 THGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER------------------ 216 (257)
T ss_pred CCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------------------
Confidence 12234678999998854 448899999999999999998 9999987766555444322100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...+..+++++.++|.+||+.||++||++.+|..
T Consensus 217 -----------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 -----------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0112357899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.23 Aligned_cols=245 Identities=33% Similarity=0.500 Sum_probs=194.2
Q ss_pred eeecccccCCceEEEEEEEc----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 5 SLTKKLGSGSFGCVWQAVNK----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.+.+.||.|+||.||+|... ..+..|+||.++.... .....+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999887 4567899999965433 335677899999999999999999999998888999999
Q ss_pred ecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-
Q 036550 80 CMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP- 156 (356)
Q Consensus 80 ~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~- 156 (356)
|+. |+|.+.+... ....+++..+..++.||+.||.|||+++++|++|+++||++++ +.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 997 5788887654 2344899999999999999999999999999999999999985 7999999999987732211
Q ss_pred --CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 157 --YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.........|+|||.+.... ++.++||||||+++||+++ |..||...+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---------------
T ss_pred cccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc---------------
Confidence 12345778899999986665 8999999999999999999 7899988876665554422110
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++..+.+++..||..||.+|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1112356889999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=295.36 Aligned_cols=243 Identities=24% Similarity=0.413 Sum_probs=195.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEE-ECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV-EKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~iv~e 79 (356)
+++|.+.+.||+|+||.||++... |..||+|.++.... ...+.+|+.++++++|+|++++++++. ..+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 468999999999999999999654 78899999865432 345678999999999999999999764 4567899999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+++ +|.+.+... ....+++..+..++.||+.||+|||++|++||||||+||++++ +.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 81 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9975 677776532 2234789999999999999999999999999999999999975 789999999987654422
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 217 (256)
T cd05082 157 DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------ 217 (256)
T ss_pred CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence 2334567899999985544 8899999999999999997 9999987665444433321100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
....+..++.+.+++.+||..||++|||+.++++
T Consensus 218 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 -----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=299.42 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=192.6
Q ss_pred CCc-eeecccccCCceEEEEEE----EcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--Ce
Q 036550 2 EKY-SLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK--GN 73 (356)
Q Consensus 2 ~~y-~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 73 (356)
+|| .+.+.||+|+||+||++. ...++..||+|++..... .....+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 567 999999999999998865 345788999999876533 2344567899999999999999999987653 46
Q ss_pred EEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
.+++|||+.+ ++.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||++++ +.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 8999999886 45555532 23899999999999999999999999999999999999975 68999999999876
Q ss_pred CCCCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCccchH
Q 036550 152 DAFPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL-GSPTMDSWA 226 (356)
Q Consensus 152 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 226 (356)
..... .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||....... ....... +......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhh
Confidence 54221 12234567799999886544 8999999999999999999999987544211 1111000 000000000
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+. ..... ........+..+.+++.+||..||++|||++++++
T Consensus 235 ~~----~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 EL----LERGM---------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hh----hhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00000 01123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=298.66 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=195.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc----EEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.++||+|+||+||+|.+..+++ .||+|++..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 578999999999999999999877776 489999865433 3344567899999999999999999998754 5678
Q ss_pred EEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
++||++ |++.+.+... ...+++..+..++.||+.||.|||+++|+||||||+|||+++ +.+||+|||++......
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 999887 4677666432 234899999999999999999999999999999999999965 78999999999876533
Q ss_pred CCC---ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PPY---TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
... ....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||...........+.. ...+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~---------- 230 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL---------- 230 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC----------
Confidence 221 1223567899999986554 8999999999999999998 9999987655443322211 1000
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+.++.+++.+||..||++||++.+++..
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 231 ------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112467899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=295.06 Aligned_cols=243 Identities=25% Similarity=0.425 Sum_probs=198.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 57999999999999999999764 78999999876544 3456678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE 159 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~ 159 (356)
++ +|.+.+.... ...+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||.+....... ..
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~~ 158 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DS 158 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--cc
Confidence 85 6777665322 224899999999999999999999999999999999999975 789999999998764322 23
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
..++..|+|||.+... .++.++|+|||||++|+|++ |..||......+....+... +.
T Consensus 159 ~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------------~~ 217 (256)
T cd05039 159 GKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--------------------YR 217 (256)
T ss_pred CCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC--------------------CC
Confidence 3456679999998654 48899999999999999997 99999877655443332110 00
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......++.+.++|.+||..+|++|||+.++++
T Consensus 218 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 218 ---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0112356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=312.11 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=198.4
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccch-HHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.++||+|+||.||+|++. .+++.||+|+++..... ....+.+|+.+|.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46788899999999999999854 35578999999765332 2345678999999997 99999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh-----------------------------------------------------------
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ----------------------------------------------------------- 94 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~----------------------------------------------------------- 94 (356)
++||||+.+ +|.+.+.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999875 67777754221
Q ss_pred -----------------------------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 95 -----------------------------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 95 -----------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
....+++..++.++.||+.||+|||+++++||||||+|||+++ +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 1123677888999999999999999999999999999999986 6
Q ss_pred cEEEecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||++....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+......
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence 89999999998653221 122345778899999986544 8999999999999999998 899998765544433322
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... . ...+..++.++.+++.+|+..+|.+||++.++++.
T Consensus 356 ~~~~-------------------~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 356 KRGY-------------------R---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcCC-------------------C---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1100 0 01123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.01 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=197.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc---EEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
.+|++.+.||+|+||.||+|.+..+++ .||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 579999999999999999999877664 69999987653 23345667899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+++ +|.+.+... ...+++..++.++.|++.||.|||++|++|+||||+||++++ +.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999986 455555432 334899999999999999999999999999999999999975 699999999987654322
Q ss_pred CC---cccc---ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 156 PY---TERV---GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 156 ~~---~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.. .... .+..|+|||.+.+.. ++.++|||||||++|++++ |..||...+..+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~----------- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY----------- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 11 1111 245799999986544 8999999999999999886 999998776555444332110
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+ .....+..+.+++.+||..+|++||++.++++.
T Consensus 229 ---------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 229 ---------RLP---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred ---------cCC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 112567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=295.66 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=199.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
.++|.+.++||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.++++++|+||+++++++......+++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 368999999999999999999876 457899999876433 234567899999999999999999999988999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-- 156 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-- 156 (356)
+.+ +|.+.+... .+..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||.+........
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 875 677776542 2234899999999999999999999999999999999999965 7999999999987653211
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....++..|+|||.+.+.. ++.++|+|||||++|+|++ |+.||.+.........+......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------------- 223 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---------------- 223 (261)
T ss_pred hhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 11223456899999986554 8999999999999999998 99999877665555444321110
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+..+.+++.+||..||++||+++++++
T Consensus 224 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 -------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=301.51 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=197.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCC--------------cEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG--------------EVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKE 66 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~ 66 (356)
++|++.+.||+|+||.||+|++..++ ..||+|.++.... .....+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 48999999999999999999875432 3599999876533 23345678999999999999999999
Q ss_pred EEEECCeEEEEEEeccC-CHHHHHHHHHh--------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC
Q 036550 67 LIVEKGNVFFVFECMQC-NLYQLMEAKKQ--------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ 137 (356)
Q Consensus 67 ~~~~~~~~~iv~e~~~g-~l~~~~~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 137 (356)
++...+..++||||+.+ +|.+.+..... ....+++..+..++.|++.||+|||++|++|+||||+||++++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 99999999999999876 57666643211 1123688899999999999999999999999999999999975
Q ss_pred -CcEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHH
Q 036550 138 -GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL--FRPLFQGTDEADQMY 211 (356)
Q Consensus 138 -~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~ 211 (356)
+.+||+|||++........ .....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||......+...
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 5899999999876543221 12234567899999986554 8999999999999999988 678888766555444
Q ss_pred HHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 212 KICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.+........ ... .....+..+..+.+|+.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~~~--------------~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 244 NTGEFFRNQG--------------RQI--------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHhhhhcc--------------ccc--------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3322110000 000 00112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=300.42 Aligned_cols=238 Identities=19% Similarity=0.260 Sum_probs=188.3
Q ss_pred cccccCCceEEEEEEEcCCCc-------EEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 8 KKLGSGSFGCVWQAVNKHSGE-------VVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+.||.|+||+||+|.+..++. .||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998865544 4888887665444455667899999999999999999999999999999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC---------cEEEecccceee
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG---------TIKIADFGLARE 150 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---------~~kL~Dfg~a~~ 150 (356)
+.++ |.+.+... ...+++..+..++.||+.||.|||++||+||||||+||++++. .++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9875 55555432 2348999999999999999999999999999999999999652 279999999866
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
... .....++..|+|||++.+...++.++|||||||++|+|++| .+||...+........ .
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~-------------- 219 (258)
T cd05078 158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-E-------------- 219 (258)
T ss_pred cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-H--------------
Confidence 543 23356888999999997656689999999999999999998 4666655443322111 0
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... ++...+.++.+++.+||+.||++|||++++++.
T Consensus 220 -----~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 -----DRHQ-----------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----cccc-----------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0011 112456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=294.69 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=195.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|++|.||+|.+..+ ..+|+|.+..... ....+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 5799999999999999999987655 4599998765432 2345678999999999999999998875 45678999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.+ +|.+.+... ....+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 86 677777542 2334789999999999999999999999999999999999975 6899999999977643221 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||...+.. ++.++|+|||||++|+|++ |..||......+....+.....
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------ 221 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------------------ 221 (260)
T ss_pred CCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 2234567899999885544 8999999999999999999 9999987766554443322100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. ......+..+.+++.+||..||++||+++++++
T Consensus 222 --~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 --M---------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --C---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 111256789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=303.14 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=197.9
Q ss_pred CCceeecccccCCceEEEEEEEc-------CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-------HSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||.||+|.+. ..+..||+|.++.... .....+.+|+.+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57899999999999999999763 2345799999875433 3334567899999999 6999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
..+++|||+.+ +|.+++..... ....+++..+..++.||+.||.|||++|++||||||+||++++ +
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 99999999875 67777754321 1234889999999999999999999999999999999999975 7
Q ss_pred cEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||.+........ .....++..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999976643211 1122345679999998654 48999999999999999999 899998776655444332
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
... .......++.++.+++.+||..||++|||+.++++
T Consensus 251 ~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 251 EGH-----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred cCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 110 00112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=299.49 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=198.7
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|++.+.||+|+||.||+|.+. .++..||+|++...... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 57999999999999999999874 36789999998765432 3345678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHh------------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee
Q 036550 76 FVFECMQC-NLYQLMEAKKQ------------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS 136 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 136 (356)
++|||+++ +|.+.+..... ....+++..+..++.||+.||+|||+++++||||||+||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 99999885 67777753211 112478889999999999999999999999999999999996
Q ss_pred C-CcEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 036550 137 Q-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMY 211 (356)
Q Consensus 137 ~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 211 (356)
+ +.++|+|||++........ ......+..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+....+...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5 7999999999876543211 12234567799999986554 8999999999999999997 888997766555443
Q ss_pred HHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 212 KICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.+.... ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 244 YVRDGN-----------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 332100 00112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.85 Aligned_cols=246 Identities=29% Similarity=0.467 Sum_probs=200.2
Q ss_pred ceeecccccCCceEEEEEEEcCCC----cEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSG----EVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+.+.+.||.|+||.||++.+..++ ..||+|++...... ....+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999998766 89999999766543 4556678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.+ ++.+.+..... ..+++..+..++.||+.||++||++|++|+||||+||++++ +.++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99876 67666654322 11899999999999999999999999999999999999986 5899999999987754322
Q ss_pred Cc--cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 157 YT--ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 157 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.. ...+++.|+|||.+. ...++.++|+|||||++|+|++ |.+||...+.......+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 222 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------------- 222 (258)
T ss_pred cccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 22 123678999999984 4558999999999999999998 8899987665555444322100
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......+.++.+++.+||..||++|||+.++++
T Consensus 223 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 --------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0111246889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=296.20 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=197.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCC---cEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG---EVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+|+||.||+|.+..++ ..+|+|.++.... .....+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 47999999999999999999886544 3799999876432 2344667899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+++ +|.+.+... ...+++.++..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999976 566666432 245899999999999999999999999999999999999965 689999999998765432
Q ss_pred CC----ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 PY----TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. ....++..|+|||.+.+.. ++.++|+|||||++|++++ |..||......+....+....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------------- 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------------- 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-------------
Confidence 11 1122356899999986544 8999999999999999886 999998776554443332211
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..+ .....+..+.+++.+||+.+|.+||++.++++
T Consensus 227 -------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 -------RLP---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------cCC---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011 11246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=297.53 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=199.8
Q ss_pred CCceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|++.+.||+|+||+||+|+.+. +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 579999999999999999999754 3567999988665433 3455678999999999999999999999989999
Q ss_pred EEEEeccC-CHHHHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccce
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQ-----QLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA 148 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a 148 (356)
+||||+.+ +|.+.+....... ..+++..+..++.||+.||+|||+++|+||||||+||+++. +.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 99999985 6777765433111 15899999999999999999999999999999999999975 78999999998
Q ss_pred eecCCC--CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccch
Q 036550 149 REIDAF--PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 149 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (356)
...... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--------- 234 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--------- 234 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC---------
Confidence 654321 1223345678899999886554 7899999999999999998 88899766554433332110
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... .....++..+.+++.+||..||++|||+.+++++
T Consensus 235 ----------~~~~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 ----------KLEL---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ----------CcCC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000 0112568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=324.02 Aligned_cols=265 Identities=29% Similarity=0.444 Sum_probs=198.9
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------eEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKG------NVFF 76 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------~~~i 76 (356)
+...+.||+|+||.||+++++.+|+.||||.+++.. ....+..-+|+++|++++|+|||+++++-+... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345688999999999999999999999999997754 233444468999999999999999999866443 5679
Q ss_pred EEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC---C--cEEEecccceee
Q 036550 77 VFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ---G--TIKIADFGLARE 150 (356)
Q Consensus 77 v~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~--~~kL~Dfg~a~~ 150 (356)
+||||.|+ |...+. ...+...++|.+++.++.++..||.|||++|||||||||.||++-. | .-||+|||.|+.
T Consensus 95 vmEyC~gGsL~~~L~-~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLN-SPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEeecCCCcHHHHhc-CcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999875 555544 4445556999999999999999999999999999999999999843 3 579999999999
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCccchH
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA----DQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 226 (356)
+++.....+.+||+.|.+||++...+.|+.-+|.|||||++|+..||..||...... +..+.+...-.....-...
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 999999999999999999999987677999999999999999999999999755432 2333332221111000000
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP 274 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 274 (356)
........+...+|.. ..+....-..+-..+..+|.++|.+|.
T Consensus 254 ~~eNgpv~~s~~lP~p-----~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQP-----NHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cccCCceeeeccCCCc-----ccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0000111222222221 111122334566788999999999999
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=302.16 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=199.4
Q ss_pred CCceeecccccCCceEEEEEEEc-------CCCcEEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-------HSGEVVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||.||+|++. .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 57899999999999999999752 234579999987543 23345567899999999 8999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
..+++|||+.+ +|.+.+..... ....++...+..++.||+.||.|||++|++||||||+||++++ +
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 99999999975 67777754321 1234788899999999999999999999999999999999975 7
Q ss_pred cEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||.+........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 899999999987654221 22234567899999986544 8999999999999999998 889998776655444332
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... .......+..+.+|+.+||..+|++|||+.++++.
T Consensus 254 ~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 254 EGHR-----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCCc-----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1100 00112568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.75 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=197.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc---EEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|...+.||+|+||.||+|.+..++. .+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468999999999999999999876654 79999987653 23345567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+++ +|.+.+.. ....+++..+..++.|++.||+|||++|++|+||||+||++++ +.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999986 45555532 2345899999999999999999999999999999999999975 689999999987664322
Q ss_pred CC--c--cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 PY--T--ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~~--~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. . ....+..|+|||++.... ++.++|+|||||++|+|++ |..||......+....+......
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~----------- 229 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL----------- 229 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC-----------
Confidence 11 1 112345799999986544 7999999999999999997 99999877665554444321110
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+ .....+..+.+++.+|+..+|++||++.++++
T Consensus 230 ---------~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 230 ---------P---------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---------C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 01245789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=296.35 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=191.0
Q ss_pred cccccCCceEEEEEEEcCCCc--EEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEecc-
Q 036550 8 KKLGSGSFGCVWQAVNKHSGE--VVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQ- 82 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~- 82 (356)
+.||+|+||.||+|.+..++. .+++|.+.... ......+.+|+.+++++ +||||+++++++...+..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999988775 46888876533 23344567899999999 89999999999999999999999987
Q ss_pred CCHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 83 CNLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 83 g~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
|+|.+.+..... ....+++..++.++.|++.||+|||++|++||||||+||++++ +.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 467777754321 1234789999999999999999999999999999999999975 799999999986
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.............+..|+|||++... .++.++|+|||||++|+|++ |..||...+..+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------------ 227 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------------ 227 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------------
Confidence 43322111222346679999988554 48999999999999999997 99999876654443332110
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+.. ......+.++.+++.+|+..||.+|||+.++++
T Consensus 228 --------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 --------YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --------CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 011246789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=308.55 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=193.8
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC-Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEK-GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~~ 73 (356)
++|++.+.||+|+||+||+|.+ ..+++.||+|+++.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5899999999999999999984 35678999999876433 2334567899999999 689999999988654 56
Q ss_pred EEEEEEeccC-CHHHHHHHHHh----------------------------------------------------------
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQ---------------------------------------------------------- 94 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~---------------------------------------------------------- 94 (356)
.+++|||+++ +|.+.+.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999975 57766653210
Q ss_pred -----hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC---Ccccccccc
Q 036550 95 -----KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---YTERVGTRW 165 (356)
Q Consensus 95 -----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~ 165 (356)
....++...+..++.||+.||+|||++||+||||||+||++++ +.+||+|||++........ .....++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0123688889999999999999999999999999999999975 7999999999876533221 112335677
Q ss_pred ccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccc
Q 036550 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244 (356)
Q Consensus 166 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (356)
|+|||++.+.. ++.++|||||||++|+|++ |..||.................. .
T Consensus 247 y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~------- 301 (343)
T cd05103 247 WMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----------------M------- 301 (343)
T ss_pred eECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-----------------C-------
Confidence 99999986554 8999999999999999997 99999765433222221110000 0
Q ss_pred ccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 245 VNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 245 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++++.+++.+||..||++|||+.++++|
T Consensus 302 ----~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.16 Aligned_cols=242 Identities=25% Similarity=0.362 Sum_probs=194.9
Q ss_pred cccccCCceEEEEEEEcC-CCc--EEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc-
Q 036550 8 KKLGSGSFGCVWQAVNKH-SGE--VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ- 82 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~- 82 (356)
+.||+|++|.||+|.+.. +++ .||+|.+..... .....+.+|+.++++++||||+++++.+.. ...+++|||+.
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998865 333 699999987655 445567789999999999999999999988 88999999986
Q ss_pred CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC----C
Q 036550 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP----Y 157 (356)
Q Consensus 83 g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~----~ 157 (356)
++|.+.+..... ..+++..++.++.|++.||+|||++|++|+||||+||+++. +.+||+|||++........ .
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 567777654321 45899999999999999999999999999999999999975 7999999999987654211 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE------------------ 218 (257)
T ss_pred cCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence 1235678899999885544 8999999999999999998 9999987766655444422100
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. .......+..+.+++.+||..+|++|||+.++++
T Consensus 219 -~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 -R---------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -c---------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 0011246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=304.83 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=198.8
Q ss_pred CCceeecccccCCceEEEEEEEcCC-------CcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-------GEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
.+|.+.+.||+|+||.||+|++... +..||+|.+..... .....+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 3699999999999999999986432 24799998875432 2344567899999999 7999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
..++++||+++ +|.+.+..... ....++...+..++.||+.||.|||++|++||||||+||++++ +
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 99999999875 67777754321 1234788889999999999999999999999999999999974 7
Q ss_pred cEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999987654321 12223456799999986554 8899999999999999998 889998876655544332
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... .......+.++.+++.+||..+|.+|||+.+++++
T Consensus 251 ~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 251 EGHR-----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred cCCC-----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1100 01112567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.46 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=195.3
Q ss_pred CCceeecccccCCceEEEEEE----EcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 75 (356)
++|++.+.||+|+||+||+|. +..+++.||+|.+..........+.+|+.+++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 468999999999999999997 456788999999876655555567889999999999999999998754 35689
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
+||||+.+ +|.+.+... ...+++..+..++.||+.||.|||++||+||||||+||++++ +.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 99999964 677776432 234899999999999999999999999999999999999975 7899999999987643
Q ss_pred CCCC----ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc-cchHHH
Q 036550 154 FPPY----TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM-DSWADG 228 (356)
Q Consensus 154 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 228 (356)
.... ....++..|+|||++.+.. ++.++|||||||++|+|++|..++...... .... .+.... ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~ 234 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM----MGNDKQGQMIVYH 234 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh----cccccccccchHH
Confidence 2221 1122345699999986544 899999999999999999998776543321 1100 010000 011111
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
........... .....++.++.+|+.+||..+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 235 LIELLKNNGRL---------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHHhcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 11111111111 1224678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.01 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=197.5
Q ss_pred CCceeecccccCCceEEEEEEEcC----CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-CCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH----SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVE-KGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 579999999999999999999875 368899998865432 334456789999999999999999998765 46788
Q ss_pred EEEEecc-CCHHHHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 76 FVFECMQ-CNLYQLMEAKKQK----QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
++++|+. +++.+.+...... +..+++..+..++.||+.||+|||+++++|+||||+||++++ +.+||+|||+++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 9999987 5677776543222 145899999999999999999999999999999999999965 799999999997
Q ss_pred ecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccch
Q 036550 150 EIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 150 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (356)
.+..... .....++..|+|||++.+.. ++.++|||||||++|++++ |.+||...+..+....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------- 235 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG--------- 235 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---------
Confidence 6532211 12234577899999986554 8999999999999999999 99999876654433222110
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+..+ ....+++++.+++.+||..||++|||+.++++
T Consensus 236 -----------~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 -----------YRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -----------CCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 11245789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=292.37 Aligned_cols=260 Identities=25% Similarity=0.416 Sum_probs=206.2
Q ss_pred eeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHh-CCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRK-LNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
+-+..||.|+||+|++..++.+|+..|||.++.... .++..++.|.....+ -++||||+++|....++..||.||.|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 345789999999999999999999999999976643 455566667665544 479999999999999999999999998
Q ss_pred CCHHHHHHH-HHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcc
Q 036550 83 CNLYQLMEA-KKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE 159 (356)
Q Consensus 83 g~l~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~ 159 (356)
-++..+... ...+...++|..+-.+....+.||.||.. ..|||||+||+|||++. |.+||||||.+-.+.+.-..+.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence 876554432 22234458999999999999999999985 58999999999999986 9999999999987765444456
Q ss_pred ccccccccChHHHhhCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 160 RVGTRWYQAPEILFKSGL-YSSKVDMWAMGAIMAELLLFRPLFQGTDE-ADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
..|-..|||||.+..... |+.++|+||||+++||+.||+.||..-+. .+++..+.. |.|+.-.
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~------------- 291 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILL------------- 291 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeec-------------
Confidence 689999999999965543 89999999999999999999999986443 233333322 1111100
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
++. -.-.+|..+..||..||.+|-+.||...+++++||+...
T Consensus 292 -~~~--------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 292 -FDK--------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -Ccc--------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 000 001578899999999999999999999999999999754
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=291.48 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=190.1
Q ss_pred cccccCCceEEEEEEEcCCC---cEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNKHSG---EVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
++||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++. .+..+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 57999999999999876555 7899999876543 23445678999999999999999999876 4567999999875
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc---
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT--- 158 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~--- 158 (356)
+|.+.+... ..+++..+..++.|++.||+|||+++++|+||||+||++++ +.+||+|||.+..........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 677776532 25899999999999999999999999999999999999975 789999999998764332211
Q ss_pred -cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 -ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 -~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
...++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-R----------------- 216 (257)
T ss_pred cCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c-----------------
Confidence 112346799999985544 8999999999999999998 999998776654443332210 0
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++..+.+++.+||..||++|||+.++++
T Consensus 217 -----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.33 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=191.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc----EEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++.+.||+|+||+||+|.+..+++ .+++|.+..... .....+..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 579999999999999999999887776 477777754322 22234567888899999999999999875 455678
Q ss_pred EEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
++||+. |+|.+.+... ...+++..+..++.||+.||.|||++|++||||||+||++++ +.+||+|||.+......
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 899876 5777776532 345899999999999999999999999999999999999976 68999999999865432
Q ss_pred C---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 P---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+ .....+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~---------- 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERL---------- 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC----------
Confidence 1 122345677899999986554 8999999999999999998 99999876554332221 110000
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+..+.+++.+|+..||++|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001134678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.66 Aligned_cols=240 Identities=26% Similarity=0.419 Sum_probs=192.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
++||+|+||.||+|.+.. ++.||+|.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||+.| ++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999887 999999998765443 445667899999999999999999999999999999999875 56
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC---cccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY---TERV 161 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~---~~~~ 161 (356)
.+.+.. ....+++..+..++.|++.||+|||+++++||||||+||++++ +.++|+|||++......... ....
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 666543 2335789999999999999999999999999999999999975 78999999998765422111 1123
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+.... ..
T Consensus 157 ~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------------------~~- 214 (251)
T cd05041 157 IPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------------------RM- 214 (251)
T ss_pred ceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------------------CC-
Confidence 45679999998554 48999999999999999999 889998766544333322110 00
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+.++.+++.+||..+|.+|||+.++++
T Consensus 215 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 --------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011256789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=330.98 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=194.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC---------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK--------- 71 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------- 71 (356)
.+|+.++.||+|+||.||+|+++-+|+.||||.+....+ .......+|+.+|++|+|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 467888999999999999999999999999999976542 2334557899999999999999997653110
Q ss_pred --------------------------------------------------------------------------------
Q 036550 72 -------------------------------------------------------------------------------- 71 (356)
Q Consensus 72 -------------------------------------------------------------------------------- 71 (356)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC
Q 036550 72 ------------------------------GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121 (356)
Q Consensus 72 ------------------------------~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 121 (356)
-.+||-||||+-.++..+........ ....++++++||++||.|+|+.
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC
Confidence 01688899999887766654333111 4778899999999999999999
Q ss_pred CcccccCCCCCeeeeC-CcEEEecccceeecC-------------------CCCCCccccccccccChHHHhhCC--CCC
Q 036550 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREID-------------------AFPPYTERVGTRWYQAPEILFKSG--LYS 179 (356)
Q Consensus 122 ~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~~~ 179 (356)
|||||||||.||++++ +.|||+|||+|+... +....+..+||.-|+|||++.+.. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 9999999999999986 799999999998621 112346678999999999997665 699
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHH
Q 036550 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAI 259 (356)
Q Consensus 180 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 259 (356)
.++||||||+|+|||+. ||...-+... +...+..+ .+|.. ..++...-+.-.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~---iL~~LR~g-----------------~iP~~-----~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERAS---ILTNLRKG-----------------SIPEP-----ADFFDPEHPEEA 848 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHH---HHHhcccC-----------------CCCCC-----cccccccchHHH
Confidence 99999999999999994 4664433221 11111111 11111 111122334567
Q ss_pred HHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 260 NLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 260 ~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
.+|+.||+.||++||||.|+|++.||-
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 899999999999999999999999986
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.43 Aligned_cols=253 Identities=17% Similarity=0.265 Sum_probs=185.5
Q ss_pred CCceeecccccCCceEEEEEEEcCC---CcEEEEEEcccccchH--H---------hhhHHHHHHHHhCCCCCeeEEeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSYSRE--K---------CLNLREVKCLRKLNHPNIVKVKEL 67 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~hp~iv~~~~~ 67 (356)
++|.+.+.||+|+||+||+|.+..+ +..+|+|+........ . .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998877 6778888643322110 0 011223445566789999999997
Q ss_pred EEECC----eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEE
Q 036550 68 IVEKG----NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKI 142 (356)
Q Consensus 68 ~~~~~----~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL 142 (356)
+.... ..+++++++..++.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++. +.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 66543 44788888877776665432 23678889999999999999999999999999999999975 79999
Q ss_pred ecccceeecCCC--------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 036550 143 ADFGLAREIDAF--------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 143 ~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 214 (356)
+|||+|+..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.............
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999765321 1112346999999999986554 8999999999999999999999998774322211111
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.. +........... .+..++.+.++++.|+..+|++||+..++++
T Consensus 247 ~~----------~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KC----------DFIKRLHEGKIK------------IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HH----------HHHHHhhhhhhc------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00 000000000111 1245789999999999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=299.04 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=201.1
Q ss_pred CceeecccccCCceEEEEEEEc---CCCcEEEEEEcccccc----hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYS----REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
+|.+.+.||+|++|.||++.+. .+++.||+|++.+... .....+.+|+.+++++ +||||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 4678999999865421 2223456799999999 699999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++||||+.+ +|.+.+.. ...+++..++.++.|++.+|.|||+.+++||||+|+||+++. +.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999986 56655542 245899999999999999999999999999999999999975 689999999987654
Q ss_pred CCCC--CccccccccccChHHHhhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 153 AFPP--YTERVGTRWYQAPEILFKSG-LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 153 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.... .....|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~------------ 224 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI------------ 224 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH------------
Confidence 3221 12346899999999985432 36789999999999999999999997543221111111100
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC---HHHHhcCCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT---AAEALQHPFFKRCLYV 291 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~ 291 (356)
.... ......++..+.+++.+||+.||++||| +.++|+||||+...|.
T Consensus 225 ---~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 225 ---LKSK-----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ---HccC-----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 0000 1112356889999999999999999998 5778999999987653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=305.72 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=194.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC-eEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKG-NVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~iv~e~ 80 (356)
++|.-...||+|+||.||+|.-.. |..||||.+..........+.+|+.++.+++|||+|+++|+|.+.+ ..++|+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 456777899999999999998654 4899999887654431334899999999999999999999999988 59999999
Q ss_pred cc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCCeeeeC-CcEEEecccceeecCC-C
Q 036550 81 MQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG---YFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-F 154 (356)
Q Consensus 81 ~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~ 154 (356)
+. |+|.+.+...... +++|....+|+.++++||+|||... ||||||||+|||+|+ .++||+|||+|..... .
T Consensus 154 m~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred cCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 98 6787777643222 6899999999999999999999854 999999999999995 6999999999976654 3
Q ss_pred CCCccc-cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH-HHHhCCCCccchHHHhh
Q 036550 155 PPYTER-VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA--DQMYKI-CSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i-~~~~~~~~~~~~~~~~~ 230 (356)
...... .||.+|+|||.+.. +..+.++|||||||++.||++|+.+.+..... ..+... ...+...
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---------- 300 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---------- 300 (361)
T ss_pred cceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc----------
Confidence 333333 89999999999865 55899999999999999999999888754311 111111 0000000
Q ss_pred hhhhhcccCCCccccccc--ccCC-CCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLS--ALMP-SASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~--~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.+.......+. .... ..-..+..+...|++.+|.+||++.|+++
T Consensus 301 -------~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 -------KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -------chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11111111110 0000 11234778899999999999999999754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.26 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=196.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
.++|.+.++||+|+||.||++.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 378999999999999999999865 45669999887543 234456789999999999999999999887 778999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-- 156 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-- 156 (356)
+++ ++.+.+... ....+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||.+........
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 975 777777542 2344788999999999999999999999999999999999976 6999999999976643221
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....++..|+|||++... .++.++|+|||||++|++++ |..||...+..+....+.....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------- 221 (260)
T cd05073 160 REGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------------- 221 (260)
T ss_pred ccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------------
Confidence 1123456779999998554 48999999999999999998 9999987765554433321100
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. ......+.++.+++.+||+.||++||++.++++
T Consensus 222 ---~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 ---M---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---C---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 111356889999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=289.86 Aligned_cols=239 Identities=26% Similarity=0.363 Sum_probs=188.0
Q ss_pred ccccCCceEEEEEEEc--CCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-C
Q 036550 9 KLGSGSFGCVWQAVNK--HSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-N 84 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 84 (356)
.||+|+||.||+|.+. .++..||+|++...... ....+.+|+.++++++||||+++++++. .+..++||||+++ +
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999765 45667999998765432 2345678999999999999999999875 4578999999976 5
Q ss_pred HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC----Ccc
Q 036550 85 LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP----YTE 159 (356)
Q Consensus 85 l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~----~~~ 159 (356)
|.+.+.. ....+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++........ ...
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 6655542 2345899999999999999999999999999999999999976 6899999999876543221 111
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
..+++.|+|||++.... ++.++|||||||++|++++ |..||......+....+.... .
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------------- 216 (257)
T cd05115 158 GKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------------- 216 (257)
T ss_pred CCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C-------------------
Confidence 22357899999986544 8999999999999999996 999998776655443332210 0
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......++++.+++.+||..||++||++.++.+
T Consensus 217 ---------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=292.92 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=196.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc----EEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.+.||+|+||+||+|.++.+|. .||+|........ ....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 579999999999999999999876665 5899988765432 33456789999999999999999999887 78899
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+|||+.+ +|.+.+... ...+++..+..++.||+.||+|||++|++|+||||+||++++ +.+||+|||.+......
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999875 676666432 334899999999999999999999999999999999999965 79999999999876533
Q ss_pred CCCc---cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PPYT---ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.... ...++..|+|||.+... .++.++|+|||||++|++++ |..||......+....+... ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---------- 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERL---------- 230 (279)
T ss_pred ccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCC----------
Confidence 2211 12235679999988544 48999999999999999998 99999887665544333221 000
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+..+.+++.+||..||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111245778999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=292.41 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=196.2
Q ss_pred CCceeecccccCCceEEEEEEEcCC---CcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||.||+|.+..+ ...||+|...... ......+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4689999999999999999987544 3569999887654 3344566789999999999999999998875 457899
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+... ...+++..+..++.||+.||+|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 999875 576766432 234899999999999999999999999999999999999976 789999999998765432
Q ss_pred CC--ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 PY--TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.. ....++..|+|||.+... .++.++|||||||++|+|++ |..||......+....+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------------- 226 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-------------- 226 (270)
T ss_pred ceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc--------------
Confidence 21 122345679999988554 48999999999999999986 9999988776554433321100
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....+..+..+.+++.+|+..+|++|||+.++++.
T Consensus 227 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 227 ---------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123568899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=288.70 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=196.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.+|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+++++.++|||++++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 57899999999999999999875 4678999998754332 335678999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.++ |.+.+.. ....+++..++.++.|++.||+|||+++++|+||||+||+++. +.++|+|||.+........ .
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 864 5555442 2234789999999999999999999999999999999999975 6899999999886643221 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||...........+....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------- 218 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF------------------- 218 (256)
T ss_pred CCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-------------------
Confidence 1223567899999986544 8899999999999999998 999998776555443332110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.. ......+..+.+|+.+||..+|++|||+.+++++
T Consensus 219 -~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 -RL---------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -CC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00 0012357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=290.09 Aligned_cols=279 Identities=32% Similarity=0.574 Sum_probs=223.5
Q ss_pred eeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeEEEE
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNVFFV 77 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~iv 77 (356)
+-.+.||.|+||.||.+.|..+|+.||+|.+..-..+ ......+|+.+|..++|.|++..+++..-. ..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3458999999999999999999999999988654322 234457899999999999999998887543 346777
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceeecCCC--
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAF-- 154 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~~-- 154 (356)
+|.+..+|...+- ..+.++.+.++-+++||+.||+|||+.+|.||||||.|+|++.+ .+||||||+++.....
T Consensus 136 TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 7877776665553 44569999999999999999999999999999999999999887 8999999999876432
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
...+..+-|-.|.|||.+.+...|+.++||||.|||+.||+..+..|+..++.+++..|...+|+|..+.+.....-...
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 33445578999999999999999999999999999999999999999999999999999999999998877544332222
Q ss_pred hccc----CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQ----FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
-..+ -|......-..-......+...++.++|..||.+|.+.++++.|+++.+
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1111 1111111001111234557899999999999999999999999999965
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=291.10 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=189.0
Q ss_pred cccccCCceEEEEEEEc--CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-
Q 036550 8 KKLGSGSFGCVWQAVNK--HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC- 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g- 83 (356)
+.||+|+||.||+|... .++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999754 3567899998876543 2334567899999999999999999999999999999999985
Q ss_pred CHHHHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC---Cc
Q 036550 84 NLYQLMEAKKQ-KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---YT 158 (356)
Q Consensus 84 ~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~---~~ 158 (356)
+|.+.+..... .....++..+..++.|++.||+|||+++++|+||||+||+++. +.+||+|||.+........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 67777754332 2234677888899999999999999999999999999999976 6899999999875433211 12
Q ss_pred cccccccccChHHHhhCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 159 ERVGTRWYQAPEILFKSG------LYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
...++..|+|||++.+.. .++.++|||||||++|+|++ |.+||......+.........
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------- 226 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ-------------- 226 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc--------------
Confidence 345788899999985321 25789999999999999996 999998765544332211100
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
....+ .+......+..+.+++..|+ .+|++|||+++++.
T Consensus 227 ----~~~~~------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 227 ----QLKLP------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ----cCCCC------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000 01112246788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=294.85 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=193.3
Q ss_pred ceeecccccCCceEEEEEEE----cCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVN----KHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFF 76 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~i 76 (356)
|.+.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 78999999999999999974 45788999999875532 2334567899999999999999999998775 57899
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
||||++| +|.+.+... ...+++..+..++.||+.||+|||++|++||||||+||++++ +.++|+|||++......
T Consensus 86 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 86 IMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 9999975 566665432 234899999999999999999999999999999999999975 68999999999876443
Q ss_pred CC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. .....++..|+|||++.+.. ++.++|||||||++|+|+++..|+..... ... ...+............
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhcccccccccHHHHH
Confidence 21 12345677899999986554 88999999999999999998776543211 110 1111111111000000
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
........ ......++..+.+|+.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000 11123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=286.65 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=191.2
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||+.+ ++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47999999999999864 6889999998765432 234567899999999999999999999999999999999875 56
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--ccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY--TERVG 162 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~--~~~~g 162 (356)
.+.+.. ....+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++......... ....+
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 555532 2234789999999999999999999999999999999999975 68999999998765432111 12234
Q ss_pred cccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCC
Q 036550 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241 (356)
Q Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (356)
+..|+|||++.+. .++.++|||||||++|++++ |..||...........+.....
T Consensus 157 ~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 212 (250)
T cd05085 157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------- 212 (250)
T ss_pred cccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 6679999998554 48899999999999999998 9999987765544333321100
Q ss_pred cccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 242 LSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++..+.+++.+||..+|++|||+.++++.
T Consensus 213 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 213 ------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 01123568899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=292.08 Aligned_cols=244 Identities=27% Similarity=0.435 Sum_probs=192.7
Q ss_pred cccccCCceEEEEEEEcCCC------cEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 8 KKLGSGSFGCVWQAVNKHSG------EVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+.||+|+||.||+|.+.... +.+|+|.+.+... .....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46999999999999876443 7899998865432 3345567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC------cEEEecccceee
Q 036550 81 MQC-NLYQLMEAKKQ---KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG------TIKIADFGLARE 150 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~------~~kL~Dfg~a~~ 150 (356)
+.+ +|.+.+..... ....+++..+..++.||+.||.|||+++++|+||||+||+++.+ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 875 67777754322 12347889999999999999999999999999999999999763 699999999876
Q ss_pred cCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 151 IDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 151 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
..... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~-------- 230 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G-------- 230 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--------
Confidence 54321 112334577899999986544 8999999999999999998 99999876655443332110 0
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. .......+..+.+++.+||..+|++||++.++++
T Consensus 231 ---------~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ---------R-----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------c-----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 0111356789999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=290.43 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=189.2
Q ss_pred cccccCCceEEEEEEEcC--CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-
Q 036550 8 KKLGSGSFGCVWQAVNKH--SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC- 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g- 83 (356)
+.||+|+||.||+|.... ....+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999996432 445789998765433 2334567899999999999999999999999999999999985
Q ss_pred CHHHHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC---CCc
Q 036550 84 NLYQLMEAKKQ-KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP---PYT 158 (356)
Q Consensus 84 ~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~---~~~ 158 (356)
+|.+.+..... .....++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 67777654332 1233578888999999999999999999999999999999975 699999999986543221 112
Q ss_pred cccccccccChHHHhhC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 159 ERVGTRWYQAPEILFKS------GLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
...+++.|+|||++... ..++.++|||||||++|+|++ |.+||......+.+..+......
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------------ 228 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI------------ 228 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc------------
Confidence 33467789999998532 346889999999999999999 78999877665544443322110
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..+ .+......+..+.+++..|+ .||++|||++++++
T Consensus 229 ------~~~------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 ------KLP------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------cCC------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000 01122357888999999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=289.50 Aligned_cols=241 Identities=27% Similarity=0.413 Sum_probs=193.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||++. .+++.||+|.+..... ...+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 579999999999999999985 5788999999865432 34567899999999999999999998655 479999998
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE 159 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~ 159 (356)
.+ +|.+.+.... ...+++..+..++.|++.||.|||++|++||||||+||+++. +.++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCC
Confidence 75 7777765432 234799999999999999999999999999999999999975 78999999998765432 223
Q ss_pred ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...+..|+|||.+.+. .++.++|+|||||++|+|++ |.+||......+....+.... .
T Consensus 157 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------------~ 215 (254)
T cd05083 157 SKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------------------R 215 (254)
T ss_pred CCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC--------------------C
Confidence 3456789999988554 48899999999999999997 999998776544433322110 0
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++..+.+++.+||..+|.+||++.+++.
T Consensus 216 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ---------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.52 Aligned_cols=227 Identities=27% Similarity=0.417 Sum_probs=183.3
Q ss_pred CCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CHHHHHHH
Q 036550 13 GSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEA 91 (356)
Q Consensus 13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~ 91 (356)
|.+|.||+|++..+++.||+|.+..... ..+|...+....||||+++++++.+.+..+++|||+.| +|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999999999999999876532 22345555566799999999999999999999999986 67777653
Q ss_pred HHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccccccccccChH
Q 036550 92 KKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPE 170 (356)
Q Consensus 92 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 170 (356)
. ..+++..+..++.|++.||+|||++||+||||||+||+++. +.++|+|||.+...... .....++..|+|||
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE 152 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPE 152 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCc
Confidence 3 34899999999999999999999999999999999999975 78999999988665542 23345678899999
Q ss_pred HHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccccccccc
Q 036550 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSAL 250 (356)
Q Consensus 171 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
.+.+.. ++.++|+||+||++|+|++|..||........ ..... ..
T Consensus 153 ~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------------~~~~~-----------~~ 197 (237)
T cd05576 153 VGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------------THTTL-----------NI 197 (237)
T ss_pred ccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------------ccccc-----------CC
Confidence 875444 78999999999999999999988754321000 00000 11
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCH-----HHHhcCCCC
Q 036550 251 MPSASEDAINLIESLCSWDPCKRPTA-----AEALQHPFF 285 (356)
Q Consensus 251 ~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~ 285 (356)
++.++..+.++|.+||+.||++|+|+ +++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 23568899999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=288.90 Aligned_cols=235 Identities=21% Similarity=0.297 Sum_probs=184.8
Q ss_pred cccccCCceEEEEEEEcCCC----------cEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 8 KKLGSGSFGCVWQAVNKHSG----------EVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999998776 35888877654332 4566789999999999999999999888 778999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC--------cEEEecccce
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG--------TIKIADFGLA 148 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--------~~kL~Dfg~a 148 (356)
|||+.++ |.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++.. .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999865 555554322 258999999999999999999999999999999999999753 5999999999
Q ss_pred eecCCCCCCccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 149 REIDAFPPYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||..............
T Consensus 156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----------- 221 (259)
T cd05037 156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----------- 221 (259)
T ss_pred ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-----------
Confidence 87654 2234577889999998665 358999999999999999999 5788876543222111100
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
....+ ......+.+++.+||..+|++|||+.++++
T Consensus 222 ---------~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 ---------QHRLP-----------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ---------CCCCC-----------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 112378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=316.64 Aligned_cols=248 Identities=26% Similarity=0.427 Sum_probs=208.4
Q ss_pred CceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+.++.+.||+|+||+||+|+-.. ....||||.++...+. .+.++.+|++++..++|||||+++|+|..++.+|+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 45678999999999999997432 3467999999877666 77889999999999999999999999999999999
Q ss_pred EEEecc-CCHHHHHHHHHh------hcc----cCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEec
Q 036550 77 VFECMQ-CNLYQLMEAKKQ------KQQ----LFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIAD 144 (356)
Q Consensus 77 v~e~~~-g~l~~~~~~~~~------~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~D 144 (356)
|+|||. |+|.+++..... .+. +++..+...|+.||+.|++||-++.+|||||-..|+||+++ .|||+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecc
Confidence 999998 678888875432 122 28899999999999999999999999999999999999986 899999
Q ss_pred ccceeecCCCCCCc---cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 036550 145 FGLAREIDAFPPYT---ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSP 220 (356)
Q Consensus 145 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 220 (356)
||+++..-...-+. ...-...|||||.++-++ ++.++||||+||+|||+++ |..||.+....+.+..+..+
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g---- 721 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG---- 721 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC----
Confidence 99998763321111 223456799999997666 9999999999999999998 89999999888887766432
Q ss_pred CccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 221 TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
.+...+...+.++.+|+..|++.+|++||+++||=
T Consensus 722 -------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 -------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred -------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 12334457899999999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.99 Aligned_cols=247 Identities=27% Similarity=0.434 Sum_probs=199.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCc---E-EEEEEcccc---cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGE---V-VAIKALKKS---YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
+-.+.++||+|+||.||+|.-+..+. . ||+|..+.. .......+.+|+++|+.++|||||+++|+..++..++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 44567999999999999998765422 3 899998752 2445567789999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~ 153 (356)
+|||++.| +|.+.+.... ..++..+...++.+.+.||+|||+++++||||-..|+|++.+ .+||+|||++.....
T Consensus 238 ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 99999987 5777765433 248999999999999999999999999999999999999985 569999999876542
Q ss_pred CCCCccc-cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 154 FPPYTER-VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 154 ~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
....... --...|+|||.+... .|++++||||+||++||+++ |..||.+....+...++....
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~-------------- 379 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG-------------- 379 (474)
T ss_pred eeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 2222212 245679999999554 79999999999999999998 889999999887777773321
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+..+ .+...+..+..++.+|+..||+.|||+.++.+
T Consensus 380 -----~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 380 -----YRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -----ccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1111 11255788999999999999999999988865
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.81 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=188.9
Q ss_pred cccccCCceEEEEEEEcCC--CcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-
Q 036550 8 KKLGSGSFGCVWQAVNKHS--GEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC- 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g- 83 (356)
+.||+|+||+||++....+ ...+++|.+..... .....+.+|+.+++.++||||+++++.+.+....|+||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 4699999999999975433 34567777655432 3445678899999999999999999999999999999999985
Q ss_pred CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC---CCCcc
Q 036550 84 NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF---PPYTE 159 (356)
Q Consensus 84 ~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~---~~~~~ 159 (356)
+|.+.+.........+++..++.++.||+.||+|||+++++||||||+|||++. +.++|+|||++...... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 677777654333344678888999999999999999999999999999999975 79999999987643221 11234
Q ss_pred ccccccccChHHHhhC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 160 RVGTRWYQAPEILFKS------GLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
..++..|+|||++... ..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------------- 227 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------------- 227 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------------
Confidence 5688999999987432 125778999999999999997 57888877665554443321110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..+ .+.....+++.+.+++..|+ .+|++|||++++++
T Consensus 228 -----~~~------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 -----KLF------KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----ccC------CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000 01122356889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.66 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=212.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEE-----CCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVE-----KGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-----~~~~~ 75 (356)
+.+++...||.|.+|.||+++++.+++..|+|+.....+. .+....|.++|+.+ +|||++.++++|.. ++.+|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4588999999999999999999999999999998766433 34456688889887 79999999999863 47899
Q ss_pred EEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 76 FVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
+|||||+|+ ..|++.... +..+.|..+..|++.++.||.+||++.++|||||-.|||+++ +.+||+|||.+..++.
T Consensus 98 LVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 999999865 666665443 677999999999999999999999999999999999999975 8999999999988865
Q ss_pred C-CCCccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 154 F-PPYTERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
. ....+.+|||.||||||+.-. ..|+..+|+||||++..||.-|.||+-...+...+..|-. .|+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPP------- 245 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP------- 245 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCC-------
Confidence 4 345678999999999998543 3478899999999999999999999988877665544311 000
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+-..-++..+.++.+||..||..|-.+||+..++|+|||.++
T Consensus 246 -----------------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 246 -----------------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -----------------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 011123467899999999999999999999999999999984
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.56 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=184.9
Q ss_pred cccccCCceEEEEEEEcC---CCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEE-ECCeEEEEEEecc
Q 036550 8 KKLGSGSFGCVWQAVNKH---SGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIV-EKGNVFFVFECMQ 82 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~iv~e~~~ 82 (356)
+.||+|+||+||+|.+.. .+..||+|.+.... ......+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34679999886433 233455678999999999999999999765 4566889999987
Q ss_pred C-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-----
Q 036550 83 C-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP----- 155 (356)
Q Consensus 83 g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~----- 155 (356)
+ ++.+.+... ....++..+..++.||+.||.|||+++++||||||+|||+++ +.+||+|||++.......
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 5 666666432 223577888899999999999999999999999999999975 699999999987653311
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~------------------ 218 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG------------------ 218 (262)
T ss_pred ccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC------------------
Confidence 112334577899999986554 8999999999999999999 56777765544433222110
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+ ......+..+.+++.+||..+|++||++.++++.
T Consensus 219 ---~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 219 ---RRL--------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ---CCC--------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 0112457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.15 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=207.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHH-----hhhHHHHHHHHhCCCCCeeEEeEEEE-ECCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREK-----CLNLREVKCLRKLNHPNIVKVKELIV-EKGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~-----~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~ 73 (356)
+||-++..||+|+|+.||+|.|...++.||+|+-.... ..+. ....+|.+|.+.|+||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 57999999999999999999999999999999864332 2222 22357999999999999999999997 5578
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC----CcEEEecccc
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ----GTIKIADFGL 147 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~----~~~kL~Dfg~ 147 (356)
+|.|+||++|+-+++.. ...+.++|.+++.|+.||+.||.||.... |||-||||.|||+-+ |.+||+|||+
T Consensus 543 FCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 99999999998665543 33445999999999999999999999875 999999999999955 6899999999
Q ss_pred eeecCCCC--------CCccccccccccChHHHhhC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 036550 148 AREIDAFP--------PYTERVGTRWYQAPEILFKS---GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSV 216 (356)
Q Consensus 148 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 216 (356)
++.+++.. ..+...||.+|++||.+.-. ...+.++||||+|||+|..+.|+.||........+..-
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe--- 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE--- 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh---
Confidence 99886432 22455799999999997432 45788999999999999999999999876432221110
Q ss_pred hCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
..-..+...+||.. +.++.++++||++||.+.-+.|..+.++-.||||.
T Consensus 697 ------------NTIlkAtEVqFP~K---------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 697 ------------NTILKATEVQFPPK---------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred ------------hchhcceeccCCCC---------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 00112233455543 46799999999999999999999999999999995
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.13 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=193.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc----EEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++.+.||+|+||.||+|.+..+|. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 578999999999999999999887776 478888765433 2233467899999999999999999998654 4678
Q ss_pred EEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
++||+. |++.+.+... ...+++..+..++.||+.||.|||++||+|+||||+||++++ +.+||+|||++......
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 899887 4677766432 234889999999999999999999999999999999999965 78999999999866432
Q ss_pred CC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+........ +.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~------------ 228 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGE------------ 228 (303)
T ss_pred ccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCC------------
Confidence 22 12234577899999986554 8999999999999999997 899998765433222 211100
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+ ..+..+..+.+++.+|+..+|++||++.++++.
T Consensus 229 -------~~~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 229 -------RLP---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -------CCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 112457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=314.42 Aligned_cols=277 Identities=21% Similarity=0.277 Sum_probs=181.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCC----CcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEE------EEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHS----GEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKEL------IVE 70 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~------~~~ 70 (356)
.++|.+.+.||+|+||.||+|++..+ +..||+|.+......+. ..+| .++...+.+++.+... ...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~--~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI--WMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH--HHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 36899999999999999999999988 89999998764322111 1111 1122222222222111 235
Q ss_pred CCeEEEEEEeccC-CHHHHHHHHHh----------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCe
Q 036550 71 KGNVFFVFECMQC-NLYQLMEAKKQ----------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENL 133 (356)
Q Consensus 71 ~~~~~iv~e~~~g-~l~~~~~~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 133 (356)
.+..++|+||+++ +|.+++..... .+....+..+..++.||+.||+|||+++|+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 5688999999986 46666643210 001123456778999999999999999999999999999
Q ss_pred eeeC--CcEEEecccceeecCCC--CCCccccccccccChHHHhhCC---------------------CCCCchhHHHHH
Q 036550 134 LVSQ--GTIKIADFGLAREIDAF--PPYTERVGTRWYQAPEILFKSG---------------------LYSSKVDMWAMG 188 (356)
Q Consensus 134 ll~~--~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwslG 188 (356)
|+++ +.+||+|||+|..+... ......++++.|+|||.+.... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9974 68999999999865432 2234568999999999764322 134456999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCC
Q 036550 189 AIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSW 268 (356)
Q Consensus 189 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 268 (356)
|++|+|+++..++. +....+.++....+. ....|....... ... ...............+.+||.+||+.
T Consensus 367 viL~el~~~~~~~~--~~~~~~~~~l~~~~~-~~~~~~~~~~~~------~~~-~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 367 LIFLQMAFPNLRSD--SNLIQFNRQLKRNDY-DLVAWRKLVEPR------ASP-DLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHhCcCCCc--hHHHHHHHHHHhcCC-cHHHHHHhhccc------cch-hhhhhhhhccccchHHHHHHHHHccC
Confidence 99999998665543 333344444333222 112222111100 000 00000011122345677999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCCC
Q 036550 269 DPCKRPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 269 dP~~Rpt~~e~l~hp~~~~~~~~ 291 (356)
||++|||+.++|+||||++....
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCCcc
Confidence 99999999999999999875543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=285.06 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=191.6
Q ss_pred ceeecccccCCceEEEEEEEc---CCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------
Q 036550 4 YSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKG------ 72 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 72 (356)
|.+.+.||+|+||.||+|.+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 357899999986542 223445678999999999999999999886532
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccce
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ--KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA 148 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a 148 (356)
..+++++|+.+ ++.+.+..... ....++...++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 24678888875 55555543221 1224789999999999999999999999999999999999975 69999999998
Q ss_pred eecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 149 REIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 149 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
....... ......+++.|++||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~----- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NR----- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-Cc-----
Confidence 8664322 112334567899999985554 7899999999999999999 89999877654433332211 00
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.......+..+.+++.+||..+|++|||+.+++++
T Consensus 234 -----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 -----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.71 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=195.9
Q ss_pred CCceeecccccCCceEEEEEEEc----CCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK----HSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 74 (356)
++|.+.+.||+|+||.||+|... .+++.||+|++...... ....+.+|+.+++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46888999999999999999854 35889999998766543 34567889999999999999999999887 5678
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+++|||+.+ ++.+.+.... ..+++..+..++.||+.||+|||++|++|+||||+||+++. +.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999965 6777765332 24899999999999999999999999999999999999975 689999999998765
Q ss_pred CCCCC----ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AFPPY----TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
..... ....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||......... ..+..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~ 234 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-----MIGIAQGQMIVTR 234 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhcc-----ccccccccccHHH
Confidence 32211 1223456799999986554 899999999999999999999998654321100 0000000000000
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...........+ .....+.++.+++.+||..||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 235 LLELLKEGERLP---------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHcCCcCC---------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111111111 11245789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=287.94 Aligned_cols=278 Identities=28% Similarity=0.471 Sum_probs=214.8
Q ss_pred CCceeecccccCCceEEEEEEEcC---CCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH---SGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
+.|.++.+||+|+|++||++.+.. .++.||+|.+....... ...+|+++|..+ .+.||+++.+++..++...+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~--ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS--RILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch--HHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 468899999999999999999877 78999999987654433 367899999999 699999999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCC--
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDA-- 153 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~-- 153 (356)
+||++..-...+... ++...++.+++.++.||.++|.+|||||||||+|+|.+. ++-.|+|||+|.....
T Consensus 114 lp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 999998644444321 778899999999999999999999999999999999985 7999999999862110
Q ss_pred -------------------------------C------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHH
Q 036550 154 -------------------------------F------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAI 190 (356)
Q Consensus 154 -------------------------------~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 190 (356)
. .......||++|.|||++.+.+.-+.++||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 000123699999999999999888999999999999
Q ss_pred HHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCccchHHHhhh-----------hhhhcccCCCcc----------ccccc
Q 036550 191 MAELLLFRPLFQ-GTDEADQMYKICSVLGSPTMDSWADGLRQ-----------AMAINYQFPQLS----------GVNLS 248 (356)
Q Consensus 191 l~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~----------~~~~~ 248 (356)
+..++++..||- ..++.+.+..+...+|.......+..... ..+....|.... .....
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 999999998865 45666777777766665433222211111 000111111110 01122
Q ss_pred ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 249 ALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 249 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...+..+..+.+|+.+||..||.+|.|++++|+||||..
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 223456678999999999999999999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.83 Aligned_cols=249 Identities=26% Similarity=0.444 Sum_probs=203.0
Q ss_pred CceeecccccCCceEEEEEEEcCC-C----cEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHS-G----EVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+-.+.+.||+|+||.||.|.-... | ..||+|.+.+.. ..+..++++|+.+|++++|||||+++|++.+.+..+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 346789999999999999986542 2 349999997764 4556788999999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 77 VFECMQC-NLYQLMEAKKQ---KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
++|||.| +|..+++..+. ....++......++.||+.|+.||+++++|||||-..|+|++. ..+||+|||+|+.+
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 9999986 57777764411 1344899999999999999999999999999999999999986 68999999999955
Q ss_pred CCCCCCcc---ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 152 DAFPPYTE---RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 152 ~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
-...-+.. ..-...|||||.+.. +.++.++|||||||++||++| |..||...+..+.+....... .
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R-------- 922 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R-------- 922 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c--------
Confidence 43222211 122356999999965 569999999999999999998 899999998877765443321 1
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...++.++..+.+++..|++.+|++||+...+++
T Consensus 923 --------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 --------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1112367888999999999999999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=307.67 Aligned_cols=246 Identities=30% Similarity=0.444 Sum_probs=192.7
Q ss_pred ecccccCCceE-EEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEeccCC
Q 036550 7 TKKLGSGSFGC-VWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECMQCN 84 (356)
Q Consensus 7 ~~~ig~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~~g~ 84 (356)
.+.+|.|+.|+ ||+|. ..|+.||||.+-.. ......+||..|+.- +|||||++++.-.+++..||..|.|.++
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhh
Confidence 46789999986 69995 45889999987443 223457899999987 6999999999999999999999999999
Q ss_pred HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC------CcEEEecccceeecCCC----
Q 036550 85 LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ------GTIKIADFGLAREIDAF---- 154 (356)
Q Consensus 85 l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------~~~kL~Dfg~a~~~~~~---- 154 (356)
|.+++...............+.++.|++.||++||+.+||||||||+||||+. .+++|+|||+++.+...
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 99999864111111111456788999999999999999999999999999964 38999999999988643
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......||.+|+|||++.... -..++|||||||++|+.++| ..||...-..+ .+|..
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~------------------ 727 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT------------------ 727 (903)
T ss_pred hcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc------------------
Confidence 2345567999999999997766 57799999999999999886 89998654322 12211
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.++. +..+.+....++.+||.+|+..+|..||+|.++|.||+|-.
T Consensus 728 -~~~~--------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 728 -GNYT--------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -Cccc--------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 1111 11111222228999999999999999999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=271.89 Aligned_cols=241 Identities=41% Similarity=0.686 Sum_probs=197.8
Q ss_pred CceEEEEEEEcCCCcEEEEEEcccccchH-HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CHHHHHHH
Q 036550 14 SFGCVWQAVNKHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEA 91 (356)
Q Consensus 14 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~ 91 (356)
+||.||+|.+..+++.+|+|++....... ...+.+|+..+++++|+||+++++++......++++|++++ +|.+.+..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999899999999987654433 56678899999999999999999999999999999999988 77776643
Q ss_pred HHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCccccccccccChH
Q 036550 92 KKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPE 170 (356)
Q Consensus 92 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 170 (356)
.. .+++..+..++.+++.++.+||+.+++|+||+|+||++++ +.++|+|||.+.............++..|++||
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 22 2799999999999999999999999999999999999976 699999999998877654555677899999999
Q ss_pred HHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccccccccc
Q 036550 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSAL 250 (356)
Q Consensus 171 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
.+.+.. ++.++|+||||+++++|++|..||.................. ... ..
T Consensus 157 ~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~--------~~ 209 (244)
T smart00220 157 VLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP------------------PFP--------PP 209 (244)
T ss_pred HHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC------------------CCc--------cc
Confidence 986544 788999999999999999999999874333332222111000 000 00
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 251 MPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 251 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
...++.++.+++.+||..||++||++.++++||||
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 01167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=294.58 Aligned_cols=269 Identities=23% Similarity=0.360 Sum_probs=184.6
Q ss_pred CCceeecccccCCceEEEEEEEc----------------CCCcEEEEEEcccccchHHh--------------hhHHHHH
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK----------------HSGEVVAIKALKKSYSREKC--------------LNLREVK 51 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E~~ 51 (356)
++|++.++||+|+||+||+|... ..++.||||.+......... ....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999999752 24567999998654322111 2234777
Q ss_pred HHHhCCCCCe-----eEEeEEEEE--------CCeEEEEEEeccC-CHHHHHHHHHh--------------------hcc
Q 036550 52 CLRKLNHPNI-----VKVKELIVE--------KGNVFFVFECMQC-NLYQLMEAKKQ--------------------KQQ 97 (356)
Q Consensus 52 ~l~~l~hp~i-----v~~~~~~~~--------~~~~~iv~e~~~g-~l~~~~~~~~~--------------------~~~ 97 (356)
++.+++|.++ ++++++|.. .+..|+||||+++ +|.+.+..... ...
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7778876654 566666642 3568999999986 56666642110 012
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcc--ccccccccChHHHhh
Q 036550 98 LFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE--RVGTRWYQAPEILFK 174 (356)
Q Consensus 98 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~~~ 174 (356)
.+++..++.++.|++.+|.|||+++|+||||||+|||++. +.+||+|||++........... ..+|+.|+|||++..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 2467789999999999999999999999999999999975 7999999999976543322222 235899999999854
Q ss_pred CCC-------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 175 SGL-------------------Y--SSKVDMWAMGAIMAELLLFRP-LFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 175 ~~~-------------------~--~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
... | ..+.|+||+||++|+|++|.. ||..........+.. ......|.. .
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~~~r~----~ 456 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLNRWRM----Y 456 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHHHHHh----h
Confidence 321 1 124799999999999999875 775432111100000 000011110 0
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCC---CCCCCHHHHhcCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDP---CKRPTAAEALQHPFFKR 287 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rpt~~e~l~hp~~~~ 287 (356)
....+.++ .....++.+.+|+.+||..+| .+|+|++|+|+||||..
T Consensus 457 ~~~~~~~~---------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 457 KGQKYDFS---------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccCCCcc---------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11112222 234678999999999999766 68999999999999964
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.05 Aligned_cols=243 Identities=26% Similarity=0.460 Sum_probs=197.9
Q ss_pred eeecccccCCceEEEEEEEcC----CCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 5 SLTKKLGSGSFGCVWQAVNKH----SGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
...++||+|.||.||.|.... ..--||||..+.+. ....+.++.|+.+|+.++||||++++|++.+. ..|||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 446899999999999997543 23459999988743 34567789999999999999999999999765 5799999
Q ss_pred ecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
.+. |.|..++.... ..++..+...+++||+.||.|||++.+|||||-..|||+.. .-+||+|||+++.+.+..-+
T Consensus 471 L~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 776 66888876543 34889999999999999999999999999999999999976 57999999999998876555
Q ss_pred cccccc--ccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 158 TERVGT--RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 158 ~~~~gt--~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
....|. .-|||||.+ +...++.++|||.|||.+||++. |..||.+-...+.+..+.+
T Consensus 548 kaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn------------------- 607 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN------------------- 607 (974)
T ss_pred hccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-------------------
Confidence 544443 459999988 44558999999999999999876 9999998766555433322
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++.+++.+..++.+|+.++|.+||...++..
T Consensus 608 ----------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 ----------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ----------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 1223345688999999999999999999998877654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=299.53 Aligned_cols=257 Identities=30% Similarity=0.491 Sum_probs=218.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.++.++|.|+||.||+++++.+++..|+|+++.....+..-..+|+-+++..+|||||.+++.+...+.+||+|||+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 68999999999999999999999999999999999887777667788999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCcc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTE 159 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~~ 159 (356)
+|+.++.+. .-.++++|.++..+.+..+.||+|||+.|=+|||||-.|||+++ |.+||.|||.+..++.. .....
T Consensus 95 gggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 95 GGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred CCCccccee---eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 987665554 34567999999999999999999999999999999999999975 89999999998877543 44567
Q ss_pred ccccccccChHHH--hhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCccchHHHhhhhhhhc
Q 036550 160 RVGTRWYQAPEIL--FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICS-VLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 160 ~~gt~~y~aPE~~--~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~ 236 (356)
++|||.|||||+. ...+.|...+|||++|+...|+-.-++|.....+...+..+.+ .+.+|..+.
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD------------ 239 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD------------ 239 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC------------
Confidence 8999999999995 3455699999999999999999988888766655544443322 222222111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
....++.+.+|++.+|..+|.+|||++.+|.|||...
T Consensus 240 --------------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 240 --------------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1256889999999999999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=249.67 Aligned_cols=211 Identities=25% Similarity=0.442 Sum_probs=180.1
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEec
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
...+..||+|++|.|-+.++..+|...|+|.+...- .++....++|+.+..+. .+|++|.+++.+..++.+||.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 344678999999999999999999999999987653 34455567888877665 7999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeee-CCcEEEecccceeecCCCCCCcc
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTE 159 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~~~~~ 159 (356)
.-++..+......+++.++|..+-+++..+++||.|||++ .++|||+||+|||++ +|++|+||||.+-.+.+.-..+.
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 9998888877778888999999999999999999999976 899999999999998 48999999999988766544455
Q ss_pred ccccccccChHHHhh---CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH
Q 036550 160 RVGTRWYQAPEILFK---SGLYSSKVDMWAMGAIMAELLLFRPLFQGT-DEADQMYKIC 214 (356)
Q Consensus 160 ~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~ 214 (356)
..|.-.|||||.+.. ...|+.++||||||++++||.+++.||..- ++.+++.++.
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 678899999999843 335899999999999999999999999754 4455555554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=280.15 Aligned_cols=244 Identities=27% Similarity=0.447 Sum_probs=202.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc-
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ- 82 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~- 82 (356)
..+..+||-|.||.||.+.+++..-.||||.++.+ .-+...++.|+.+|+.++|||+|+++++|..+..+|||+|||.
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 34568999999999999999999999999998655 4556778999999999999999999999999999999999876
Q ss_pred CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceeecCCCCCCcccc
Q 036550 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERV 161 (356)
Q Consensus 83 g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~~~~~~~~~ 161 (356)
|+|+++++...+. .++.-....++.||..|++||..+++|||||-..|.|+.++ .+|++|||+++.+... .++...
T Consensus 348 GNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceeccc
Confidence 7899998765432 37777888999999999999999999999999999999985 6899999999988653 344444
Q ss_pred c---cccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 162 G---TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 162 g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
| ..-|.|||-+.- ..++.++|||+|||+|||+.| |-.||.+.+....+..+... |
T Consensus 425 GAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--------------------y 483 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--------------------Y 483 (1157)
T ss_pred CccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------------c
Confidence 4 456999998844 448999999999999999988 78999988765544433222 1
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+.. -+.++++.+.+|++.|++|+|++||+..|+-+
T Consensus 484 RM~---------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 484 RMD---------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ccc---------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 111 12377999999999999999999999888743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.63 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=203.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
+..+.++||+|-||.|.+|.-. .+..||+|+++..... ....+.+||.+|.+|+||||+.++++|..++.+++|+||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4568899999999999999644 3689999999877543 3477889999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY-- 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~-- 157 (356)
+. +|.+++..+.... ........++.||+.|++||.+.++|||||.+.|+|++. .++||+|||+++.+-...-+
T Consensus 618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 84 5667766542221 233445569999999999999999999999999999986 69999999999866433222
Q ss_pred -ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 158 -TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL--LFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 158 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
...+-...|||||.+...+ ++.++|+|+||+++||++ +...||....+++...+....+..+....
T Consensus 696 qgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~---------- 764 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV---------- 764 (807)
T ss_pred ecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce----------
Confidence 2234567899999998777 899999999999999985 57899998888777766655443332221
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
....++.++..+.+++.+|++.+-.+|||.+++-.
T Consensus 765 ------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 ------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 12223467889999999999999999999999843
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=282.06 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=206.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCC---cEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG---EVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++..+.+.||+|.||.|++|.+...+ -.||||+++..... .-.++++|+.+|.+|+|+|++++||+..+ ..+.||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34567799999999999999987533 46999999776544 55678999999999999999999999987 678899
Q ss_pred EEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
||.+. |+|++.+.. .....|.....-.|+.||+.|+.||.++++|||||-..|+|+.. ..+||||||+.+.++...
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99887 578888876 34556888899999999999999999999999999999999965 799999999999987665
Q ss_pred CCcccc----ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 PYTERV----GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~~~~~~----gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.+.... -...|.|||.+...+ ++.++|+|++||++|||++ |..||.+......+.+|-..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-------------- 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-------------- 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--------------
Confidence 543322 345699999996555 8999999999999999998 78999998887777665311
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.....++.+|.++.+++..|+..+|++|||...|.+.-++
T Consensus 332 ---------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 ---------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ---------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 1112234679999999999999999999999988654444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=276.88 Aligned_cols=197 Identities=29% Similarity=0.468 Sum_probs=173.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHh--------hhHHHHHHHHhCC---CCCeeEEeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKC--------LNLREVKCLRKLN---HPNIVKVKELIVE 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~E~~~l~~l~---hp~iv~~~~~~~~ 70 (356)
.+|...+.+|+|+||.|++|.++.+...|++|.+.+..--... ..-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 3689999999999999999999999999999999875321111 1235999999997 9999999999999
Q ss_pred CCeEEEEEEeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 71 KGNVFFVFECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 71 ~~~~~iv~e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
++++|++||-.+. +|+++|..+.+ ++|..++.|+.|++.|+++||+.||||||||-+|+.++. |-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999997654 68888876655 999999999999999999999999999999999999975 8999999998
Q ss_pred eeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036550 148 AREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQG 203 (356)
Q Consensus 148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 203 (356)
|....+ .++..++||..|.|||++.+.++.+...|||+||+++|.+..-..||..
T Consensus 717 aa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 876554 4667889999999999999988889999999999999999988888753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=280.10 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=208.1
Q ss_pred ceeecccccCCceEEEEEEEcCCC---cEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSG---EVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
..|.+.||.|.||.|++|+-+..| ..||||.++.... ..+.+++.|+.||-+++||||+++.++......++||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 467899999999999999987766 4699999987754 456688999999999999999999999999999999999
Q ss_pred ecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceeecCCCCC-
Q 036550 80 CMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPP- 156 (356)
Q Consensus 80 ~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~~~~- 156 (356)
||+ |+|..+++.+ .+.|+..++.-+++.|+.|++||-+.|.|||||-..|||++.+ .+|++|||+++.+.+..+
T Consensus 711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 998 4566665533 2448999999999999999999999999999999999999876 899999999998865442
Q ss_pred -Cccccc--cccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 157 -YTERVG--TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 157 -~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
+++.-| ...|.|||.+.-.+ ++.++|+||+|+++||.++ |..||-.....+.+..|.....-|++.
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm--------- 857 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM--------- 857 (996)
T ss_pred cccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC---------
Confidence 222223 35699999996555 8999999999999999887 899999888888888776654433322
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
+++..+.+|+..|+++|-.+||...||+++
T Consensus 858 --------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 858 --------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 568899999999999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.59 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=181.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
.|...+.||+|+||.||+|.+..++..||+|.+...... ...|+.++++++|||||++++++.+.+..|+||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 455667899999999999999999999999998654321 2357899999999999999999999999999999997
Q ss_pred C-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---hCCcccccCCCCCeeeeCC-cEEEecccceeecCCCCCC
Q 036550 83 C-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH---QQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 83 g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~~~~~ 157 (356)
+ +|.+.+. .+++..+..++.||+.||+||| +.+|+||||||+||+++.+ ..++. ||.+..... .
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~ 835 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---D 835 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---C
Confidence 5 5666653 1789999999999999999999 6799999999999999864 44543 555433221 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh-CCCCccchHHHhhhhhhh
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVL-GSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ 235 (356)
....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .......... .......|.
T Consensus 836 ~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 905 (968)
T PLN00113 836 TKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI--------- 905 (968)
T ss_pred CCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee---------
Confidence 2346889999999986544 899999999999999999999999543211 0111111000 000000000
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.+..... .........++.+++.+|++.||++|||+.|+++.
T Consensus 906 ---~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 906 ---DPSIRGD--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---CccccCC--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000 00001123467899999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=252.35 Aligned_cols=186 Identities=31% Similarity=0.446 Sum_probs=152.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHh--CCCCCeeEEeEEEEECC----eEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK--LNHPNIVKVKELIVEKG----NVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~~----~~~ 75 (356)
+...+.+.||+|.||.||+|. -+++.||||++... +...+.+|-+|.+. ++|+||+++++.-+... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345678899999999999994 55799999998653 34456677777765 58999999999876554 899
Q ss_pred EEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCCeeee-CCcEEEec
Q 036550 76 FVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ---------GYFHRDLKPENLLVS-QGTIKIAD 144 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivH~Dlkp~NIll~-~~~~kL~D 144 (356)
+|++|.+ |+|.+++..+. +++....+++..|++||+|||+- .|+|||||..|||+. ++...|+|
T Consensus 285 LVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999765 78999986543 89999999999999999999963 599999999999995 67999999
Q ss_pred ccceeecCCCCC---CccccccccccChHHHhhCCCCC-----CchhHHHHHHHHHHHHhC
Q 036550 145 FGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYS-----SKVDMWAMGAIMAELLLF 197 (356)
Q Consensus 145 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g 197 (356)
||+|..+....+ .-..+||..|||||++.+.-... .+.||||+|.+++||++-
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 999988764322 23468999999999997654333 358999999999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=270.72 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=195.9
Q ss_pred ceeecccccCCceEEEEEEEc----C---CCcEEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNK----H---SGEVVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~----~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
..+.+.||+|+||+|++|.-. . ....||+|..+... ..+...+..|+.+|+.+ +|+||+.+++++...+.+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 356679999999999999632 1 25679999987654 34566778999999999 699999999999999999
Q ss_pred EEEEEecc-CCHHHHHHHHH---hhc---------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cE
Q 036550 75 FFVFECMQ-CNLYQLMEAKK---QKQ---------QLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TI 140 (356)
Q Consensus 75 ~iv~e~~~-g~l~~~~~~~~---~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~ 140 (356)
++|+||+. |+|.+++...+ ... ..++......++.||+.|++||+++.++||||-..|||+.++ .+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEE
Confidence 99999987 67888887655 100 238899999999999999999999999999999999999886 89
Q ss_pred EEecccceeecCCCCCCcc--ccc--cccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHH
Q 036550 141 KIADFGLAREIDAFPPYTE--RVG--TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTD-EADQMYKIC 214 (356)
Q Consensus 141 kL~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~~~~~~i~ 214 (356)
||+|||+|+.......+.. ..+ ...|||||.+.. ..|+.++||||+|+++||+++ |..||.+.. ..+....+.
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~ 536 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK 536 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence 9999999997655444332 222 234999999966 569999999999999999998 889998754 333322221
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.+ .. ...+...+.++.++++.|++.+|++||+..++..
T Consensus 537 ~G-~r----------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 537 EG-NR----------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cC-CC----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 11 00 1112356899999999999999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=229.10 Aligned_cols=210 Identities=41% Similarity=0.698 Sum_probs=180.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc-CCHHH
Q 036550 10 LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQ 87 (356)
Q Consensus 10 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~-g~l~~ 87 (356)
||+|++|.||++.+..+++.+++|++...... ....+.+|+..++.+.|++|+++++++......++++|+++ +++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998765432 23556789999999999999999999999899999999999 56777
Q ss_pred HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCC-CCccccccc
Q 036550 88 LMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFP-PYTERVGTR 164 (356)
Q Consensus 88 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~-~~~~~~gt~ 164 (356)
.+.... ..++...++.++.+++.+|.+||++|++|+||+|.||++++ +.++|+|||.+....... ......+..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 665321 34899999999999999999999999999999999999987 799999999998765432 123456889
Q ss_pred cccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccc
Q 036550 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSG 244 (356)
Q Consensus 165 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (356)
.|++||.+.....++.+.|+|++|+++++|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------- 187 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------- 187 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------------
Confidence 999999986553588999999999999998
Q ss_pred ccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 245 VNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 245 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
..+.+++.+|+..||++||++.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1467999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=239.41 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=194.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEE-EEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKEL-IVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~-~~~~~~~~iv~e 79 (356)
|.|.|.+.+|+|.||.+-+|+++.+++.+++|.+.+... ...++.+|..---.| .|.||+.-+++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 679999999999999999999999999999999977644 344566776554445 58999987775 667788999999
Q ss_pred ecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC---CcEEEecccceeecCCCC
Q 036550 80 CMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 80 ~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~kL~Dfg~a~~~~~~~ 155 (356)
|++ |+|.+.+.. ..+.|...+.++.|+++|+.|||++++||||||.+|||+-+ -++||||||..+..+..-
T Consensus 103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 988 455555432 23889999999999999999999999999999999999943 499999999988766532
Q ss_pred CCccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCccchHHHhh
Q 036550 156 PYTERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ-MYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. ..-.+..|.+||+.... -...+.+|+|.||+++|.+++|.+||+.....+. +.+... +..
T Consensus 178 ~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~------------w~~ 243 (378)
T KOG1345|consen 178 K--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ------------WLK 243 (378)
T ss_pred h--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH------------Hhc
Confidence 2 22356779999987532 1257789999999999999999999996543332 222222 111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCC---CCHHHHhcCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR---PTAAEALQHPFFK 286 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~e~l~hp~~~ 286 (356)
. .....+..+..+|+.+..+.++-|..+|++| .++..-...-|..
T Consensus 244 r-----------k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 244 R-----------KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred c-----------cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 1 1113344456789999999999999999999 6666666677764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=259.30 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=195.3
Q ss_pred eeecccccCCceEEEEEEEcCCCc----EEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+..+.||.|+||+||+|.+.-.|+ +||+|++.... ......+++|+.+|.+++|||++++++++..+. +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 456899999999999998865554 68888876543 334556789999999999999999999997765 778999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-C
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-P 156 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~ 156 (356)
|+++ .|.++++.++. .+.......|..||++|+.|||.++++||||-..|||+.. +.+|++|||+++.+.... .
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9885 68888876443 4788999999999999999999999999999999999976 799999999998875432 2
Q ss_pred Ccccc--ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 157 YTERV--GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 157 ~~~~~--gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
+.... -.+.|||=|.+.... |+.++||||+||++||++| |..|+.+....+....+...
T Consensus 855 y~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g----------------- 916 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG----------------- 916 (1177)
T ss_pred ccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-----------------
Confidence 22222 356699999886554 9999999999999999988 89999988766654333211
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.+ ...++..+-++.-++.+||..|+..||+++++-.
T Consensus 917 -----------eR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 -----------ER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -----------cc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 01 1223467889999999999999999999888754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=239.91 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=177.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHh--CCCCCeeEEeEEEEEC----CeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK--LNHPNIVKVKELIVEK----GNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~----~~~~i 76 (356)
+..+.+.||+|.||.||+|+++ |+.||||++.... +....+|.++++. |+|+||+.+++.-..+ ..+|+
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 4578899999999999999876 8899999986543 3334566666665 5999999999874322 36899
Q ss_pred EEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCCeeee-CCcEEEeccc
Q 036550 77 VFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ--------GYFHRDLKPENLLVS-QGTIKIADFG 146 (356)
Q Consensus 77 v~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~-~~~~kL~Dfg 146 (356)
|++|.+ |+|+|++.. ..++.+...+++..++.||++||.. .|.|||||..|||+. +|.+.|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999887 789999864 3389999999999999999999953 499999999999996 4799999999
Q ss_pred ceeecCCC-----CCCccccccccccChHHHhhCCC-----CCCchhHHHHHHHHHHHHh----------CCCCCCCCCh
Q 036550 147 LAREIDAF-----PPYTERVGTRWYQAPEILFKSGL-----YSSKVDMWAMGAIMAELLL----------FRPLFQGTDE 206 (356)
Q Consensus 147 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~----------g~~pf~~~~~ 206 (356)
+|...... ...+..+||-.|||||++...-. .-..+||||||.++||+.. -++||..--+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99766543 23356799999999999843311 1125899999999999975 2577764322
Q ss_pred ----HHHHHHHH--HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 207 ----ADQMYKIC--SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 207 ----~~~~~~i~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
.+.+.+++ +.+.+..+..|.. ...-..+..+++.|+..||..|.|+-.+.
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s------------------------~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKS------------------------DPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCccccc------------------------CHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 12222211 1111112222211 01123567889999999999999986653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=228.31 Aligned_cols=201 Identities=40% Similarity=0.670 Sum_probs=172.3
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
|.+.+.||.|++|+||++.+..+++.+|+|.+...... ....+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999988999999999876544 55667789999999999999999999998899999999998
Q ss_pred C-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CCc
Q 036550 83 C-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PYT 158 (356)
Q Consensus 83 g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~~ 158 (356)
+ +|.+.+..... .+++..+..++.+++.+|.+||+++++|+||+|.||+++. +.++|+|||.+....... ...
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 8 77776653221 1789999999999999999999999999999999999986 799999999998776543 334
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChH
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQG-TDEA 207 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~ 207 (356)
...++..|++||.+.+...++.++|+|+||+++++|++|++||.. .+..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 567888999999984444477899999999999999999999977 4443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=280.58 Aligned_cols=198 Identities=18% Similarity=0.269 Sum_probs=145.8
Q ss_pred hCCC-CCeeEEeEEE-------EECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 036550 55 KLNH-PNIVKVKELI-------VEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126 (356)
Q Consensus 55 ~l~h-p~iv~~~~~~-------~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 126 (356)
.+.| +||++++++| ...+.+++++||++++|.+.+.. ....+++..++.+++||+.||.|||++||+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 3445 5777777776 23356788899999999988853 23458999999999999999999999999999
Q ss_pred cCCCCCeeeeC--------------------CcEEEecccceeecCCCC-----------------CCccccccccccCh
Q 036550 127 DLKPENLLVSQ--------------------GTIKIADFGLAREIDAFP-----------------PYTERVGTRWYQAP 169 (356)
Q Consensus 127 Dlkp~NIll~~--------------------~~~kL~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aP 169 (356)
||||+|||++. +.+|++|||+++...... .....+||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999942 356777777765421100 01124689999999
Q ss_pred HHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccc
Q 036550 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSA 249 (356)
Q Consensus 170 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
|++.+.. |+.++|||||||++|||++|.+|+..... ....+.... .+..
T Consensus 185 E~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~---------------------~~~~------- 233 (793)
T PLN00181 185 EEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV---------------------LPPQ------- 233 (793)
T ss_pred hhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh---------------------cChh-------
Confidence 9987665 89999999999999999999988753221 111111100 0000
Q ss_pred cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 250 LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 250 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.....+...+++.+||..||.+|||+.|+|+||||.+
T Consensus 234 -~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 234 -ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred -hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 0012456778999999999999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=210.06 Aligned_cols=165 Identities=20% Similarity=0.280 Sum_probs=124.3
Q ss_pred CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCcccc
Q 036550 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERV 161 (356)
Q Consensus 83 g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~ 161 (356)
|+|.+.+..+ +..+++..++.++.||+.||+|||+++ ||+|||+++ +.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~ 65 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSR 65 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCC
Confidence 5677777532 345999999999999999999999999 999999975 68888 9998876542 236
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD-QMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+..........
T Consensus 66 g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------- 127 (176)
T smart00750 66 VDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR----------------- 127 (176)
T ss_pred CcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc-----------------
Confidence 899999999996655 8999999999999999999999997654322 222222111100000
Q ss_pred CcccccccccCCCCCH--HHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 241 QLSGVNLSALMPSASE--DAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~--~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
. ......++. ++.+++.+||..||.+|||+.++++|+|+.
T Consensus 128 --~----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 --D----RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --c----cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0 000012233 699999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=214.67 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=192.9
Q ss_pred CCceeecccccCCceEEEEEEEcCC-----CcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-----GEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEK-GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 74 (356)
+|++..-.+-+|.||.||.|.++.. .+.|-+|.++...+. +...++.|...+..+.|||+..+.+++..+ ...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 3566777889999999999976543 344667777655433 234457899999999999999999988654 566
Q ss_pred EEEEEecc-CCHHHHHHHHH----hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccce
Q 036550 75 FFVFECMQ-CNLYQLMEAKK----QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA 148 (356)
Q Consensus 75 ~iv~e~~~-g~l~~~~~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a 148 (356)
+.++.+++ |+|..++...+ ...+.++-.+...++.|+..|++|||++||||.||-..|.++++ -.+||+|=.++
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence 77888877 57777776332 22344777788889999999999999999999999999999988 59999999999
Q ss_pred eecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 149 REIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 149 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
+.+-...- ....-....||+||.+.... |+.++|+|||||++|||+| |+.||...++.+....+.++
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-------- 514 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-------- 514 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc--------
Confidence 87643111 01123456799999996655 9999999999999999998 89999999887765554332
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
++..+ +-.+++++..++.-|+..+|++||+.+|+..
T Consensus 515 ------------yRlaQ---------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ------------YRLAQ---------PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------ceecC---------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11111 1267999999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=215.60 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=191.9
Q ss_pred CceeecccccCCceEEEEEEEcCCC-cEEEEEEcccccchHHhhhHHHHHHHHhCC----CCCeeEEeEEE-EECCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSG-EVVAIKALKKSYSREKCLNLREVKCLRKLN----HPNIVKVKELI-VEKGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~~~~~~-~~~~~~~i 76 (356)
+|.+.++||+|+||.||+|.+..++ ..+|+|+...........+..|+.++..+. .+++..+++.. ..++.-|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999988774 689999876543332224567888888886 36899999999 57788999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC------CcEEEeccccee-
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ------GTIKIADFGLAR- 149 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------~~~kL~Dfg~a~- 149 (356)
||+.++.+|.++..... .+.|+..++..++.|++.+|++||+.|++||||||+|++++. ..+.|.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99999999999875544 456999999999999999999999999999999999999964 359999999998
Q ss_pred -ecC-CC----C---C-CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 036550 150 -EID-AF----P---P-YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGS 219 (356)
Q Consensus 150 -~~~-~~----~---~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 219 (356)
... .. . . .....||..|.++.+..+.. .+.+.|+||++.++.+++.|..||..................
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 321 11 0 1 12345999999999987666 799999999999999999999999776543322222111000
Q ss_pred CCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 220 PTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .... .....+.++.++...+-..+...+|....+...
T Consensus 256 ~-----------------~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 L-----------------LTDR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred h-----------------cccc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0 0000 112345677777777777888889987666544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=245.41 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=195.5
Q ss_pred eeecccccCCceEEEEEEEcCCCcEEEEEEccc---ccchHHh---hhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK---SYSREKC---LNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~---~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
.-...+|.|++|.|+.+........++.|.... ....+.. ....|..+-..++|||++.....+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 346789999999998888777776666665431 1111111 1345777777889999988777766655555559
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC---
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--- 154 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--- 154 (356)
||++++|+..+... ..++...+.+++.|++.|++|+|+.||.|||+||+|+++.. |.+||+|||.+......
T Consensus 401 E~~~~Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccHHHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999888777643 34889999999999999999999999999999999999986 59999999998765322
Q ss_pred --CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 155 --PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......+|+..|+|||++.+..+.....||||.|+++..|.+|+.||......+....-
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------------------- 537 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------------------- 537 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------------------
Confidence 22345689999999999988876667899999999999999999999876554432100
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..+............+...++...+.+|.+||++||.+|.|+++|++.+||+...
T Consensus 538 --~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 538 --NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred --hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 0011111111122233346678899999999999999999999999999998754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=195.31 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=170.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
.+|.++++||.|+||.+|+|....+|..||||+-+.... ...+..|..+.+.|. ...|..+..+..+..+-.+||+.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 479999999999999999999999999999998544322 234567999999996 46788888888888899999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCC--
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~-- 154 (356)
.+.+|.+++....++ |+..++.-++-|++.-++|+|.++++||||||+|+|+.- +.+.|+|||+|+...+.
T Consensus 93 LGPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 93 LGPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred cCccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 999999998765443 899999999999999999999999999999999999964 58999999999876432
Q ss_pred ------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 036550 155 ------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ 209 (356)
Q Consensus 155 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 209 (356)
.......||..|.+--...+.. .+...|+=|+|.++.++.-|..||++......
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 2223457999999988776554 57889999999999999999999998765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=229.03 Aligned_cols=240 Identities=30% Similarity=0.463 Sum_probs=193.7
Q ss_pred ccccCCceEEEEEEE---cCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEEecc
Q 036550 9 KLGSGSFGCVWQAVN---KHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
.+|+|+||.|++++. ...|..||+|+.++.... .......|-.++...+ ||.+|+++..++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999999863 345778999998765321 1112345778888886 9999999999999999999999998
Q ss_pred CC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCCCCccc
Q 036550 83 CN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER 160 (356)
Q Consensus 83 g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~~~~~~ 160 (356)
|+ ++..+ .....+.+..++.+...++-+++++|+.+|+|||+|++||+++ +|++++.|||.++..-+... .
T Consensus 81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---~ 153 (612)
T KOG0603|consen 81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---A 153 (612)
T ss_pred cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---c
Confidence 85 33332 3444489999999999999999999999999999999999997 58999999999987654332 2
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
|||..|||||++. + ...++|.||+|++.|+|++|..||.. +...+|.... .-.
T Consensus 154 cgt~eymApEI~~--g-h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-------------------~~~- 206 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--G-HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-------------------LEM- 206 (612)
T ss_pred ccchhhhhhHhhh--c-cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-------------------cCC-
Confidence 9999999999985 3 78899999999999999999999997 4444443311 111
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYVP 292 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~ 292 (356)
+..++..+.+++..++..+|..|.. +.++++|+||+...|..
T Consensus 207 ----------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 207 ----------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred ----------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence 1256889999999999999999985 58999999999888773
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=216.25 Aligned_cols=171 Identities=22% Similarity=0.283 Sum_probs=128.5
Q ss_pred CCCceeecccccCCceEEEEEEEcC-CCcEEEEEEcccc-----cchHHhhhHHHHHHHHhCCCCCeeE-EeEEEEECCe
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKH-SGEVVAIKALKKS-----YSREKCLNLREVKCLRKLNHPNIVK-VKELIVEKGN 73 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~-~~~~~~~~~~ 73 (356)
+++|.+.+.||+|+||+||+|++.. +++.||+|++... .......+.+|+++|++++|+|+++ +++ .+.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence 4689999999999999999999876 6788899986533 1223445689999999999999985 443 256
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCCeeeeC-CcEEEecccceeec
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL-KPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl-kp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
.|+||||+.|+.+..+. . .. ...++.|++++|.|||++||+|||| ||+|||++. +.+||+|||+|...
T Consensus 93 ~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 79999999886443221 0 11 1467899999999999999999999 999999964 68999999999866
Q ss_pred CCCC---------CCccccccccccChHHHhhCC-----CCCCchhHH
Q 036550 152 DAFP---------PYTERVGTRWYQAPEILFKSG-----LYSSKVDMW 185 (356)
Q Consensus 152 ~~~~---------~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Diw 185 (356)
.... ......+++.|+|||.+.... ..+..+|-|
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 4322 113446788899999874321 123446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-26 Score=204.85 Aligned_cols=259 Identities=35% Similarity=0.556 Sum_probs=200.0
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCC-CeeEEeEEEEECCeEEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHP-NIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~iv~e 79 (356)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999887 78999998766443 355667899999999988 79999999987788899999
Q ss_pred eccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC--cEEEecccceeecCCCC-
Q 036550 80 CMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG--TIKIADFGLAREIDAFP- 155 (356)
Q Consensus 80 ~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~kL~Dfg~a~~~~~~~- 155 (356)
++.+. +.+.+...... ..+++..+..++.|++.++.|+|+.+++|||+||+||+++.. .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99875 44233221110 258999999999999999999999999999999999999864 69999999998654432
Q ss_pred ------CCccccccccccChHHHhhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC-Ccc
Q 036550 156 ------PYTERVGTRWYQAPEILFKS--GLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---ADQMYKICSVLGSP-TMD 223 (356)
Q Consensus 156 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~-~~~ 223 (356)
......|+..|+|||.+.+. ..++...|+||+|++++++++|..||..... .............+ ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 24567899999999999764 4589999999999999999999999887764 33333333222221 000
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.. .. . .. ......+.+++.+++..+|..|.+..+...+++...
T Consensus 238 ~~--------------~~--~--~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 238 PL--------------SP--S--NP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cc--------------Cc--c--cc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 00 00 0 00 122357899999999999999999999999877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=200.75 Aligned_cols=216 Identities=25% Similarity=0.332 Sum_probs=178.1
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.|+|+++||+|+||..+.|.+..+++.||||.-... .++..+..|.+..+.| ..++|..++.+...+-+-.+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 599999999999999999999999999999974332 2334556788888888 5799999998888888888999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC------CcEEEecccceeecCCC-
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ------GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------~~~kL~Dfg~a~~~~~~- 154 (356)
+.+|.|++....+ .|+..++..++.|++.-++|+|++.+|.|||||+|+||.. +.+.++|||+|+...+.
T Consensus 107 GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 9999999886554 4999999999999999999999999999999999999953 58999999999877543
Q ss_pred -------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCccc
Q 036550 155 -------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD---EADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 155 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~ 224 (356)
.......||..||+--..++.. -+.+.|+=|||-++.+.+-|..||++.. ..+.+.+|-......+.+.
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV 262 (449)
T ss_pred ccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence 2234567999999998887776 6889999999999999999999998753 3444555544433333333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=225.56 Aligned_cols=222 Identities=30% Similarity=0.450 Sum_probs=168.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|..++.|..|+||.||+++|+.+.+.+|+|+ ++.. ..++- ++....+|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------------
Confidence 468899999999999999999999999999964 3221 11111 33333455554
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC------
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF------ 154 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~------ 154 (356)
|+-...+. .-++++. +++.+++|||+.||+|||+||+|.+|+. |++|++|||+++.....
T Consensus 136 -gDc~tllk----~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLK----NIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhcc----cCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 32222221 1122332 2377999999999999999999999987 99999999998643210
Q ss_pred ----------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 155 ----------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 155 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
-.....||||.|+|||++...+ |+..+|+|++|+|+|+.+.|..||.+..+++.+...+.-....+..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~- 280 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE- 280 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-
Confidence 0112348999999999998887 9999999999999999999999999999988887766543322222
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC---CHHHHhcCCCCCCCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP---TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~~ 291 (356)
....+++++++|.++|+.+|..|. ++-++.+|+||+...|.
T Consensus 281 --------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 --------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred --------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 236789999999999999999996 57888899999887665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=195.08 Aligned_cols=234 Identities=23% Similarity=0.289 Sum_probs=149.6
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCC----------CCCeeEEeEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLN----------HPNIVKVKELIVE 70 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------hp~iv~~~~~~~~ 70 (356)
+...+.||.|+++.||.+++..||+.+|+|+....... .-+...+|.-....+. |-.++-.++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 46789999999999999999999999999997544321 2222333433333321 2223333333221
Q ss_pred ---------C---C-----eEEEEEEeccCCHHHHHHHHHhhcc---cCCHHHHHHHHHHHHHHHHHHHhCCcccccCCC
Q 036550 71 ---------K---G-----NVFFVFECMQCNLYQLMEAKKQKQQ---LFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKP 130 (356)
Q Consensus 71 ---------~---~-----~~~iv~e~~~g~l~~~~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 130 (356)
. . +.+++|+-+.++|.+++........ .+.......+..|+++.+++||+.|++|+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 1 1 3478888888988887654322221 122333355669999999999999999999999
Q ss_pred CCeeeeC-CcEEEecccceeecCCCCCCccccccccccChHHHhhC-------CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036550 131 ENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS-------GLYSSKVDMWAMGAIMAELLLFRPLFQ 202 (356)
Q Consensus 131 ~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~ 202 (356)
+|++++. |.++|+||+.....+..... ...+..|.+||..... -.++.+.|.|+||+++|.|+||..||.
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999975 89999999988776653221 3455789999987543 236889999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 036550 203 GTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR 273 (356)
Q Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 273 (356)
........ .| .+..+. .++..+++||+.+|++||.+|
T Consensus 252 ~~~~~~~~-------------~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADP-------------EW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTS-------------GG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCccccc-------------cc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 65432110 00 122223 678999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=186.16 Aligned_cols=141 Identities=24% Similarity=0.298 Sum_probs=108.6
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--------------------------HhhhHHHHHHHHhCCCC
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--------------------------KCLNLREVKCLRKLNHP 59 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~hp 59 (356)
+.+.||+|+||+||+|.+. +|+.||+|+++...... .....+|+..+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 3578999999999999987 89999999987542110 01123599999999877
Q ss_pred CeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCCeeeeCC
Q 036550 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM-HQQGYFHRDLKPENLLVSQG 138 (356)
Q Consensus 60 ~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dlkp~NIll~~~ 138 (356)
++.....+.. .+ .+|||||++|+.+.... .....+++..+..++.|++.+|.++ |+.||+||||||+|||++++
T Consensus 80 ~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~ 154 (190)
T cd05147 80 GIPCPEPILL-KS-HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDG 154 (190)
T ss_pred CCCCCcEEEe-cC-CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECC
Confidence 7644333222 22 38999999986332211 1224589999999999999999999 79999999999999999999
Q ss_pred cEEEecccceeecC
Q 036550 139 TIKIADFGLAREID 152 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~ 152 (356)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=194.93 Aligned_cols=192 Identities=26% Similarity=0.351 Sum_probs=146.6
Q ss_pred CCCCeeEEeEEEEE---------------------------CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHH
Q 036550 57 NHPNIVKVKELIVE---------------------------KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLF 109 (356)
Q Consensus 57 ~hp~iv~~~~~~~~---------------------------~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~ 109 (356)
+|||||++.++|.+ ...+|+||.....+|.+++-.+. .+....+-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-----CchHHHHHHHH
Confidence 59999999988753 23589999988899888875332 67888899999
Q ss_pred HHHHHHHHHHhCCcccccCCCCCeeee--C-C--cEEEecccceeecCCC-------CCCccccccccccChHHHhhCCC
Q 036550 110 QVFRGLDYMHQQGYFHRDLKPENLLVS--Q-G--TIKIADFGLAREIDAF-------PPYTERVGTRWYQAPEILFKSGL 177 (356)
Q Consensus 110 qi~~aL~~LH~~~ivH~Dlkp~NIll~--~-~--~~kL~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~ 177 (356)
|+++|+.|||.+||.|||+|.+|||+. + + .++|+|||.+-..... .......|...-||||+......
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999993 3 2 7899999987544321 12234457888999999854321
Q ss_pred -----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCC
Q 036550 178 -----YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMP 252 (356)
Q Consensus 178 -----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
.-.++|.|+.|.+.||+++-..||........ +...+....++.++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------------------~~r~Yqe~qLPalp~ 480 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------------------DTRTYQESQLPALPS 480 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchhee----------------------------chhhhhhhhCCCCcc
Confidence 23479999999999999999999987433211 111122334556667
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCH---HHHhc
Q 036550 253 SASEDAINLIESLCSWDPCKRPTA---AEALQ 281 (356)
Q Consensus 253 ~~s~~~~~li~~~L~~dP~~Rpt~---~e~l~ 281 (356)
.+++.+++++..+|+.||++|+++ ..+|+
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 899999999999999999999984 45554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=186.86 Aligned_cols=168 Identities=13% Similarity=0.113 Sum_probs=127.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhh---------hHHHHHHHHhCCCCCeeEEeEEEEEC-
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL---------NLREVKCLRKLNHPNIVKVKELIVEK- 71 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hp~iv~~~~~~~~~- 71 (356)
.+|++.+.+|.|+||.||++.+ ++..+|+|++.......... +.+|+..+.++.|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4799999999999999999754 46689999997554333322 46899999999999999999886643
Q ss_pred -------CeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEe
Q 036550 72 -------GNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIA 143 (356)
Q Consensus 72 -------~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~ 143 (356)
+..+++|||++|. |.+.. .+++. ...+++.+|..||+.|++|||+||+||+++++.++|+
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~li 176 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP--------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRII 176 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh--------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEE
Confidence 3578999999985 43331 13332 4569999999999999999999999999987559999
Q ss_pred cccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHH
Q 036550 144 DFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195 (356)
Q Consensus 144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 195 (356)
|||.+......... ...++... |+.++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~-----------d~~vler~-y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK-----------DRIDLERH-YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH-----------HHHHHHhH-hcccccccceeEeehHHH
Confidence 99987654321111 01233333 678999999999987554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=177.58 Aligned_cols=141 Identities=23% Similarity=0.261 Sum_probs=110.7
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--------------------------HhhhHHHHHHHHhCCCC
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--------------------------KCLNLREVKCLRKLNHP 59 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~hp 59 (356)
+.+.||+|+||+||+|.+. +|+.||+|+++...... .....+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4578999999999999987 89999999987642100 11224689999999999
Q ss_pred CeeEEeEEEEECCeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC
Q 036550 60 NIVKVKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ 137 (356)
Q Consensus 60 ~iv~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~ 137 (356)
++.....+.... .++||||++|+ +..... ....+++..+..++.|++.++.++|+ +||+||||||+||++++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHD 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEEC
Confidence 875444443332 48999999986 222211 12347888999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCC
Q 036550 138 GTIKIADFGLAREIDA 153 (356)
Q Consensus 138 ~~~kL~Dfg~a~~~~~ 153 (356)
+.++|+|||+|.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 9999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=214.14 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=178.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-c---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-S---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+|...+-||.+.|=+|.+|++.. |. |++|++-+.. . +.....+.|+. ....++||.+++..+...+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 47788999999999999997763 44 8899875543 1 22233345665 56679999999998888888889999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec--C--C
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI--D--A 153 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~--~--~ 153 (356)
+|+..+|+|.+..+. .+..-+.+-|+.||+.||.-+|..||+|||||.+|||++. +=+.|+||..-+.. . +
T Consensus 101 qyvkhnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHhhhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 999999999885443 3677788889999999999999999999999999999988 67899999876432 1 2
Q ss_pred CCCCc----cccccccccChHHHhhCC----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036550 154 FPPYT----ERVGTRWYQAPEILFKSG----------LYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLG 218 (356)
Q Consensus 154 ~~~~~----~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 218 (356)
+..++ +......|.|||.+.... ...++-||||+||+++||++ |+|||.... +...... +
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~-~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSG-N 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhcc-C
Confidence 22222 223456799999986521 24667899999999999987 789996321 1110000 0
Q ss_pred CCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 219 SPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....+... ..-.+..++++|..|++.||++|.++++.|+-
T Consensus 252 ~~~~e~~L------------------------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLL------------------------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHH------------------------HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00000000 01124578999999999999999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=168.99 Aligned_cols=186 Identities=19% Similarity=0.144 Sum_probs=136.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH----HhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE----KCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~ 78 (356)
..+...|++|+||+|+++.. .+..++.+.+.....-. ...+.+|+++|++|. |+++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999998854 67788877765543311 124578999999995 5889999886 3469999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL-KPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl-kp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.|..+... .+.. ...++.|++.+|+++|++||+|||| ||+|||++. |.++|+|||+|........
T Consensus 78 eyI~G~~L~~~---------~~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQR---------PPRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhh---------hhhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99988643211 1111 2357889999999999999999999 799999964 7899999999986554321
Q ss_pred C----c----------cccccccccChHHHhhCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 036550 157 Y----T----------ERVGTRWYQAPEILFKSGLYS-SKVDMWAMGAIMAELLLFRPLFQGTD 205 (356)
Q Consensus 157 ~----~----------~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~ 205 (356)
. . ....++.|++|+.-.--...+ ...++++.|+.+|.++|+..++-+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1 0 112588899998753332233 56788899999999999998876544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=167.51 Aligned_cols=135 Identities=19% Similarity=0.210 Sum_probs=105.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-----CCCCeeEEeEEEEECC---eEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-----NHPNIVKVKELIVEKG---NVF 75 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~---~~~ 75 (356)
+.-.+.||+|+||.||. +..++.. +||++............+|+.+++.+ +||||++++++++.+. .++
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34457899999999995 6767665 69988765444455678999999999 5799999999998873 434
Q ss_pred -EEEEecc---CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHH-HHHHhCCcccccCCCCCeeeeC-----CcEEEecc
Q 036550 76 -FVFECMQ---CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL-DYMHQQGYFHRDLKPENLLVSQ-----GTIKIADF 145 (356)
Q Consensus 76 -iv~e~~~---g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~ivH~Dlkp~NIll~~-----~~~kL~Df 145 (356)
+|+||.+ |+|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++. +.++|+||
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 7899855 578888743 126666 35688888888 9999999999999999999963 37999995
Q ss_pred cce
Q 036550 146 GLA 148 (356)
Q Consensus 146 g~a 148 (356)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=195.48 Aligned_cols=189 Identities=23% Similarity=0.402 Sum_probs=153.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC---CCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN---HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+.|.|.+.||+|+||+||+|.+.. |+.||+|+-+.....+-. --.+++.+|+ -+.|..+...+...+.-++|+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 578999999999999999999877 999999987665433321 1233445555 345666666666677788999
Q ss_pred Eecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--------CcEEEeccccee
Q 036550 79 ECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--------GTIKIADFGLAR 149 (356)
Q Consensus 79 e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--------~~~kL~Dfg~a~ 149 (356)
||.+ |+|++++. ..+.+++..+..+..||+..++.||..+||||||||+|.|+.. -.++|+|||.+.
T Consensus 774 ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9987 57888875 4555899999999999999999999999999999999999942 279999999997
Q ss_pred ecC---CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCC
Q 036550 150 EID---AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRP 199 (356)
Q Consensus 150 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 199 (356)
.+. +...+...++|-.+-.+|+..+.. |++.+|.|.|+.+++-|+.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 764 334456678999999999986665 9999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=166.83 Aligned_cols=239 Identities=20% Similarity=0.273 Sum_probs=181.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+..+.-+|.+...|..|++++..+ .+++|++.... .+...++..|.-.|+-+.||||+.+++.|....++.++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 445677899999999999998744 46677765442 23334567788999999999999999999999999999999
Q ss_pred cc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeCC---cEEEecccceeecCCC
Q 036550 81 MQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQG---TIKIADFGLAREIDAF 154 (356)
Q Consensus 81 ~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~---~~kL~Dfg~a~~~~~~ 154 (356)
|+ |+|+..+... .+-.++..++.+++.+|+.|++|||+.. |..--|....++++++ ++-.+|--++...
T Consensus 269 mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred ccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 98 5788887543 3334678889999999999999999875 4455688889999875 5666665554322
Q ss_pred CCCccccccccccChHHHhhCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGL--YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
....-.|.||+||.+.+... .-.++|+|||+++++||.|...||..-.+.+.-.++.--
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale---------------- 404 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE---------------- 404 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----------------
Confidence 22356789999999965432 245799999999999999999999987765543332110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA 279 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 279 (356)
.. ...+++++|+....|+.-|+..||.+||....+
T Consensus 405 -gl-----------rv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 405 -GL-----------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred -cc-----------cccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 00 123446889999999999999999999987665
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=168.88 Aligned_cols=143 Identities=19% Similarity=0.230 Sum_probs=109.6
Q ss_pred ceeecccccCCceEEEEEE-EcCCCcEEEEEEcccccch------------------------HHhhhHHHHHHHHhCCC
Q 036550 4 YSLTKKLGSGSFGCVWQAV-NKHSGEVVAIKALKKSYSR------------------------EKCLNLREVKCLRKLNH 58 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 58 (356)
|.+.+.||+|+||.||+|. +..+|+.||+|++...... ......+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7789999999999999998 6778999999998654210 01223579999999975
Q ss_pred C--CeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCCeee
Q 036550 59 P--NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG-YFHRDLKPENLLV 135 (356)
Q Consensus 59 p--~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll 135 (356)
. .++++++. . ..++||||++|....... .....+....+..++.||+.+|++||++| |+||||||+||++
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 3 34444442 2 348999999995332211 11223566778899999999999999999 9999999999999
Q ss_pred eCCcEEEecccceeecCC
Q 036550 136 SQGTIKIADFGLAREIDA 153 (356)
Q Consensus 136 ~~~~~kL~Dfg~a~~~~~ 153 (356)
+++.++|+|||.|...+.
T Consensus 183 ~~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 HDGKVVIIDVSQSVELDH 200 (237)
T ss_pred ECCCEEEEEChhhhccCC
Confidence 988999999999875543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-22 Score=178.80 Aligned_cols=178 Identities=30% Similarity=0.450 Sum_probs=130.9
Q ss_pred CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 72 GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 72 ~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
.++||.|+++.-+.+..+..++......+......++.|+..|++| +|.+|+|+||.||++.. +.+||+|||+.+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3688999988865444443334444556888899999999999999 99999999999999965 5799999999998
Q ss_pred cCCCC-------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 036550 151 IDAFP-------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTM 222 (356)
Q Consensus 151 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (356)
..... ..+...||..||+||.+.+.. |+.++||||||+|++||+. -...|..... +..+-. +..++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~--g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRD--GIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhc--CCCCh
Confidence 87655 456778999999999997766 9999999999999999997 3333321111 100100 00000
Q ss_pred cchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
..| .-.+.-..|+.+||...|.+||++.+.--|+|.
T Consensus 480 ~~~---------------------------~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 480 EFL---------------------------QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHh---------------------------hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 000 113456689999999999999987777777765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=153.76 Aligned_cols=134 Identities=21% Similarity=0.237 Sum_probs=108.6
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccc--------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++.||+|++|.||+|.+ +|..+++|+...... .......+|+.++..+.|++++....++.+.+..+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999976 677899997643221 11234567999999999999887777777778889999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceee
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLARE 150 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~ 150 (356)
||++| ++.+.+.. ... ....++.+++.+|.++|+.|++|+|++|+|||++++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~-------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINS-------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHh-------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 99987 45555432 122 778899999999999999999999999999999989999999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-22 Score=189.72 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=198.5
Q ss_pred CCceeecccccCCceEEEEEEEc-CCCcEEEEEEccccc--chHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-HSGEVVAIKALKKSY--SREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv 77 (356)
..|.+.+.||+|+|+.|-++... .+...+|.|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 36889999999999999988764 344567777665443 222223344777777776 99999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCCeeeeC-C-cEEEecccceeecCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH-QQGYFHRDLKPENLLVSQ-G-TIKIADFGLAREIDA 153 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~-~-~~kL~Dfg~a~~~~~ 153 (356)
+++..|+ +++.+. .......+...+..++.|+..++.|+| ..++.|+||||+|.+++. + .+++.|||+|+....
T Consensus 100 ~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9997664 444442 111113677888899999999999999 999999999999999976 5 799999999987755
Q ss_pred -C---CCCccccc-cccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 154 -F---PPYTERVG-TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 154 -~---~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
. ......+| ++.|+|||...+.....+..|+||+|+++..+++|..|+......+..+. .|
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-----------~~--- 243 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-----------SW--- 243 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-----------ee---
Confidence 2 22234578 99999999998866678999999999999999999999987655432110 00
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...........+..++....+++.++|..+|..|.+.+++-.+||+..
T Consensus 244 -----------~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 244 -----------KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------cccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000011112334578899999999999999999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.8e-19 Score=147.52 Aligned_cols=130 Identities=19% Similarity=0.263 Sum_probs=100.5
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEccccc-c-------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-S-------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
.||+|+||.||++. .++..+++|+..... . .......+|+++++.+.|+++.....++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999997 357889999854321 1 1123446799999999888765555555566777999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeec
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREI 151 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~ 151 (356)
++|. +.+.+.... . .++.|++.+|.+||+.|++|+|++|.||+++++.++++|||.+...
T Consensus 79 ~~g~~l~~~~~~~~--------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcH--------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcCC
Confidence 9875 444432110 0 7889999999999999999999999999999999999999988654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=148.92 Aligned_cols=136 Identities=21% Similarity=0.223 Sum_probs=103.8
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch----------------------HHhhhHHHHHHHHhCCCCC-
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR----------------------EKCLNLREVKCLRKLNHPN- 60 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp~- 60 (356)
|.+.+.||+|+||.||++... +|+.||+|++...... ......+|+.++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788999999999999999875 7999999987543210 0112456888899887774
Q ss_pred -eeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CC
Q 036550 61 -IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QG 138 (356)
Q Consensus 61 -iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~ 138 (356)
++..++ .+..+++|||++|.....+. .......++.+|+.++.++|+.||+||||||+||+++ ++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~---------~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVR---------VLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcc---------ccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444443 24558999999986333221 1134567889999999999999999999999999997 47
Q ss_pred cEEEecccceeecCC
Q 036550 139 TIKIADFGLAREIDA 153 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~ 153 (356)
.++|+|||.+.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999866554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=168.42 Aligned_cols=134 Identities=19% Similarity=0.206 Sum_probs=105.3
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEc-cccc-c------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL-KKSY-S------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~-~~~~-~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
|...+.||+|+||+||++.+... .+++|+. .+.. . .....+.+|+++++.++|++++....++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 45678999999999999976543 3444432 2111 1 11234578999999999999988877777777789
Q ss_pred EEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeec
Q 036550 76 FVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREI 151 (356)
Q Consensus 76 iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~ 151 (356)
+||||++|. |.+.+. ....++.|++.+|.+||+.|++||||||+|||++++.++|+|||++...
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCcccccC
Confidence 999999875 544442 3467899999999999999999999999999998899999999998654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=144.20 Aligned_cols=137 Identities=23% Similarity=0.306 Sum_probs=98.6
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--Hhh----------------------hHHHHHHHHhCCCC--
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCL----------------------NLREVKCLRKLNHP-- 59 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~hp-- 59 (356)
+.+.||+|+||+||+|.+. +|+.||+|++....... ... ...|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999877 79999999986532111 000 12456666666433
Q ss_pred CeeEEeEEEEECCeEEEEEEeccCCHH--HHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeee
Q 036550 60 NIVKVKELIVEKGNVFFVFECMQCNLY--QLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVS 136 (356)
Q Consensus 60 ~iv~~~~~~~~~~~~~iv~e~~~g~l~--~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~ 136 (356)
.+.+.+++ ...+++|||++|+.. ..+.... . ...++.++.+++.++.++|. .||+|+||||+||+++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 24444443 245899999998311 1111110 1 16678899999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCC
Q 036550 137 QGTIKIADFGLAREIDA 153 (356)
Q Consensus 137 ~~~~kL~Dfg~a~~~~~ 153 (356)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=160.04 Aligned_cols=203 Identities=21% Similarity=0.313 Sum_probs=151.7
Q ss_pred HHhCCCCCeeEEeEEEEECCeEEEEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCc-ccccCCC
Q 036550 53 LRKLNHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY-FHRDLKP 130 (356)
Q Consensus 53 l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-vH~Dlkp 130 (356)
|+.+.|.|+.++++.+.++...++|.+|+. |+|.+.+.. ....++.-....++++|+.||.|+|+-.| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence 457899999999999999999999999887 677777764 23337888888999999999999998876 9999999
Q ss_pred CCeeeeCC-cEEEecccceeecCC---CCCCccccccccccChHHHhhCCC------CCCchhHHHHHHHHHHHHhCCCC
Q 036550 131 ENLLVSQG-TIKIADFGLAREIDA---FPPYTERVGTRWYQAPEILFKSGL------YSSKVDMWAMGAIMAELLLFRPL 200 (356)
Q Consensus 131 ~NIll~~~-~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~ll~g~~p 200 (356)
.|.+++.. .+||+|||+...... ........-..-|.|||.+..... .+.++||||+|++++|+++-..|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999875 999999999876642 111122234566999999866421 36679999999999999999999
Q ss_pred CCCCCh----HHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH
Q 036550 201 FQGTDE----ADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA 276 (356)
Q Consensus 201 f~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 276 (356)
|..... .+...++......+..+.... .....+++..+++.|+..+|.+||++
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~-----------------------~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIEL-----------------------LNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhh-----------------------hhhcchHHHHHHHHhcccChhhCccH
Confidence 986432 233333332111111111100 01345589999999999999999999
Q ss_pred HHHhc
Q 036550 277 AEALQ 281 (356)
Q Consensus 277 ~e~l~ 281 (356)
+++-.
T Consensus 215 ~~i~~ 219 (484)
T KOG1023|consen 215 EQIRS 219 (484)
T ss_pred HHHHh
Confidence 88754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=128.77 Aligned_cols=131 Identities=24% Similarity=0.201 Sum_probs=107.7
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCC--CCeeEEeEEEEECCeEEEEEEeccC
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH--PNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.+.||.|.++.||++.... ..+++|....... ...+.+|+.+++.+.+ .++++++.++...+..+++|||+.|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 56889999999999998753 7899999866543 3456789999999976 5899999888877889999999987
Q ss_pred CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 84 NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ---GYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 84 ~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
.....+ +......++.+++++|.++|.. +++|+|++|+||++++ +.++++|||.+..
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 633221 4455667889999999999985 7999999999999987 8999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=136.57 Aligned_cols=132 Identities=19% Similarity=0.325 Sum_probs=97.4
Q ss_pred cccc-cCCceEEEEEEEcCCCcEEEEEEccccc-------------chHHhhhHHHHHHHHhCCCCCe--eEEeEEEEEC
Q 036550 8 KKLG-SGSFGCVWQAVNKHSGEVVAIKALKKSY-------------SREKCLNLREVKCLRKLNHPNI--VKVKELIVEK 71 (356)
Q Consensus 8 ~~ig-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~i--v~~~~~~~~~ 71 (356)
..|| .|+.|+||.+... +..++||.+.... ........+|+++++.+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 8888899988653 7789999875321 0122345779999999988775 6677664432
Q ss_pred -C---eEEEEEEeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEec
Q 036550 72 -G---NVFFVFECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIAD 144 (356)
Q Consensus 72 -~---~~~iv~e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~D 144 (356)
+ ..++|||+++| ++.+.+.. ..+++.. +.||+.+|.+||++||+|+||||+|||++. +.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999986 45555432 2355543 578999999999999999999999999975 6899999
Q ss_pred ccceee
Q 036550 145 FGLARE 150 (356)
Q Consensus 145 fg~a~~ 150 (356)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.4e-17 Score=150.10 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=191.8
Q ss_pred Cceeeccccc--CCceEEEEEEE--cCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEE
Q 036550 3 KYSLTKKLGS--GSFGCVWQAVN--KHSGEVVAIKALKKSYS--REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 3 ~y~~~~~ig~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 75 (356)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... .....-.+|+.-..++ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556788999 99999999988 88899999998443322 2222335677777777 4999999999999999999
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHH----HHHHHHhCCcccccCCCCCeeeeC--CcEEEeccccee
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR----GLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~ 149 (356)
+-+|+++..+..... .....+++..++..+.+... ||.++|+.+++|-|+||+||+..+ ...+++|||+..
T Consensus 195 iqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 999999977666554 33444889999999999999 999999999999999999999965 589999999999
Q ss_pred ecCCCCCC-cc-----ccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCC
Q 036550 150 EIDAFPPY-TE-----RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGT--DEADQMYKICSVLGSPT 221 (356)
Q Consensus 150 ~~~~~~~~-~~-----~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~ 221 (356)
.+++..-. .. .-|..-|++||+. .+.++...|++++|.++.+..++..++... +.........
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------- 342 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------- 342 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------
Confidence 88764321 11 2577889999987 344899999999999999999887665543 2211111100
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.-..+....+..+...+..|++.+|..|++++.+++|++...
T Consensus 343 ------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 ------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 001112355677778999999999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-17 Score=160.47 Aligned_cols=263 Identities=23% Similarity=0.273 Sum_probs=194.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+.+.+.+.+..|+++.++.+....+|...+.|+...... .+......+-.++-...+|.++.....+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 567788899999999999998888888777776543321 11111122222222334566666655555667889999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-- 154 (356)
+|.+| ++...+. .....+++..+.++..+.+++++||+..+.|+|++|.|++... ++.+++|||.....+..
T Consensus 884 ~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhh----cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99876 4444443 2334678888999999999999999999999999999999864 89999999843322100
Q ss_pred ------------------------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036550 155 ------------------------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGT 204 (356)
Q Consensus 155 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 204 (356)
.......||+.|.+||.+.+.. .+..+|+|++|+++++.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0112336899999999998776 789999999999999999999999998
Q ss_pred ChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH---HHhc
Q 036550 205 DEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA---EALQ 281 (356)
Q Consensus 205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~---e~l~ 281 (356)
........|....- .++.-....+..+.+++..+|..+|.+|.++. ++-.
T Consensus 1039 tpq~~f~ni~~~~~---------------------------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~ 1091 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDI---------------------------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKG 1091 (1205)
T ss_pred chhhhhhccccCCC---------------------------CCCCCccccChhhhhhhhhhhccCchhccCccccccccc
Confidence 88776655543211 12222336788999999999999999999887 8999
Q ss_pred CCCCCCCCCCCCCCC
Q 036550 282 HPFFKRCLYVPPHLR 296 (356)
Q Consensus 282 hp~~~~~~~~~~~~~ 296 (356)
||||+...|.+....
T Consensus 1092 ~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1092 HPFFQDVDWENLALQ 1106 (1205)
T ss_pred CCccCCCCccccccc
Confidence 999998887764443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.9e-15 Score=121.25 Aligned_cols=141 Identities=17% Similarity=0.203 Sum_probs=102.5
Q ss_pred eecccccCCceEEEEEEEcC------CCcEEEEEEccccc----------------------chHHhhh----HHHHHHH
Q 036550 6 LTKKLGSGSFGCVWQAVNKH------SGEVVAIKALKKSY----------------------SREKCLN----LREVKCL 53 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l 53 (356)
+...||.|--+.||.|.... .+..+|+|+.+... .+..... .+|++.|
T Consensus 1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 35689999999999997653 35789999864310 0011112 3799999
Q ss_pred HhCCC--CCeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCC
Q 036550 54 RKLNH--PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM-HQQGYFHRDLKP 130 (356)
Q Consensus 54 ~~l~h--p~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dlkp 130 (356)
+++.. -++++++++ ..-++||||++++..-.-. -+...+++.....+..+++.+|..| |+.|+|||||++
T Consensus 81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 99843 456666654 3458999999874111100 1112256667778889999999998 899999999999
Q ss_pred CCeeeeCCcEEEecccceeecCC
Q 036550 131 ENLLVSQGTIKIADFGLAREIDA 153 (356)
Q Consensus 131 ~NIll~~~~~kL~Dfg~a~~~~~ 153 (356)
.|||+.++.+.|+|||.+...+.
T Consensus 154 ~NIL~~~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWHDGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEECCcEEEEECCCceeCCC
Confidence 99999999999999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-13 Score=129.54 Aligned_cols=169 Identities=24% Similarity=0.420 Sum_probs=127.5
Q ss_pred EE-EEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhc
Q 036550 18 VW-QAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQ 96 (356)
Q Consensus 18 V~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~ 96 (356)
+| .|..+.++.+|.++..+...........+-+.-|+.++||||+++++.++.++..|+|+|.+.. +...+..
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~----- 100 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE----- 100 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHH-----
Confidence 45 4666788999999988776552233446678889999999999999999999999999997643 2233332
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-CccccccccccChHHHh
Q 036550 97 QLFSESAVKAWLFQVFRGLDYMH-QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YTERVGTRWYQAPEILF 173 (356)
Q Consensus 97 ~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~ 173 (356)
++...+.-.+.||+.||.||| +.+++|++|.-+.|+++. |..||++|-.+........ .....---.|..|+.+.
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 346677788999999999997 678999999999999986 8999999999876654332 11122233366776542
Q ss_pred hCCCCCCchhHHHHHHHHHHHHhC
Q 036550 174 KSGLYSSKVDMWAMGAIMAELLLF 197 (356)
Q Consensus 174 ~~~~~~~~~DiwslG~il~~ll~g 197 (356)
.. .-..|.|-|||++++++.|
T Consensus 179 ~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc---ccchhhhhHHHHHHHHhCc
Confidence 21 2456999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-14 Score=116.46 Aligned_cols=127 Identities=14% Similarity=0.114 Sum_probs=94.3
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-eEEeEEEEECCeEEEEEEeccCCH
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-VKVKELIVEKGNVFFVFECMQCNL 85 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~iv~e~~~g~l 85 (356)
++.|+.|.++.||++... ++.|++|+...... ......+|+.+++.+.+.++ ++++.+. ....++|||+++|..
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 467899999999999754 77899998755432 12334679999998865444 4455443 334579999999863
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCc-----ccccCCCCCeeeeCCcEEEeccccee
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY-----FHRDLKPENLLVSQGTIKIADFGLAR 149 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-----vH~Dlkp~NIll~~~~~kL~Dfg~a~ 149 (356)
.... ......++.++..+|..||+.++ +|+|++|.||+++++.++++|||.+.
T Consensus 78 l~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE-----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred cccc-----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 2211 01123456899999999999985 99999999999998899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-14 Score=133.41 Aligned_cols=248 Identities=21% Similarity=0.245 Sum_probs=183.0
Q ss_pred CCceeecccccCCceEEEEEEEc-CCCcEEEEEEcccccchH--HhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-HSGEVVAIKALKKSYSRE--KCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
-+|..+..||.|.|+.|+.+... .++..|++|.+.+..... ...-+.|+.+...+ .|.++++.+..+......|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 36788899999999999998754 678889999887654322 23336788777777 588999988888777777888
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~~ 155 (356)
.||+.+....+-. .....+.+...+.+..|++.++.++|++.++|+|+||+||++.. +..+++|||..+.+.-.
T Consensus 345 ~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 345 LEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred hhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 8999775443332 22233889999999999999999999999999999999999976 78999999988753221
Q ss_pred CCcccccccccc-ChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 156 PYTERVGTRWYQ-APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 156 ~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.....+.-.+. ..|++.....+..++|++|||..+.+.++|.+.-........ +.
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~-------------------- 476 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IR-------------------- 476 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---ee--------------------
Confidence 11223444455 366666666689999999999999999998765443222110 00
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.......+..+.++..+.+.+...++..|+.+.++..|.-|..
T Consensus 477 ----------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 477 ----------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ----------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0001111244578889999999999999999999999987754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=129.87 Aligned_cols=139 Identities=25% Similarity=0.332 Sum_probs=92.0
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccchH----------------------------------------HhhhH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE----------------------------------------KCLNL 47 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 47 (356)
+.||.|++|+||+|+.+ +|+.||||+.+...... +-++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999865 78999999976542110 01223
Q ss_pred HHHHHHHhC----CCCCeeEEeEEEE-ECCeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHH-HHHHHHh
Q 036550 48 REVKCLRKL----NHPNIVKVKELIV-EKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFR-GLDYMHQ 120 (356)
Q Consensus 48 ~E~~~l~~l----~hp~iv~~~~~~~-~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~ 120 (356)
+|+..+.++ ++.+-+.+-.++. ..+..++||||++|. +.+..... ..+ .. ...++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~-~~~--~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD-EAG--LD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH-hcC--CC---HHHHHHHHHHHHHHHHHh
Confidence 456555554 2333333333332 234568999999885 44433221 111 22 2345555555 4678899
Q ss_pred CCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
.|++|+|++|.||++++ |.++|+|||++..++.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999964 7999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-14 Score=136.66 Aligned_cols=143 Identities=26% Similarity=0.399 Sum_probs=95.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH----------------------------------H-----
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE----------------------------------K----- 43 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------~----- 43 (356)
.|+. +.||.|++|+||+|+.+.+|+.||||++++.-... .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 78999999999999998889999999987541100 0
Q ss_pred -hhhHHHHHHHHhC----CCCCeeEEeEEEEE-CCeEEEEEEeccCC-HHHHH--HHHHhhcccCCHHHHHHHHHHHHHH
Q 036550 44 -CLNLREVKCLRKL----NHPNIVKVKELIVE-KGNVFFVFECMQCN-LYQLM--EAKKQKQQLFSESAVKAWLFQVFRG 114 (356)
Q Consensus 44 -~~~~~E~~~l~~l----~hp~iv~~~~~~~~-~~~~~iv~e~~~g~-l~~~~--~~~~~~~~~l~~~~~~~i~~qi~~a 114 (356)
-++.+|+..+.++ .+.+.+.+-.++.+ ....++||||+.|. +.+.. .........+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 1123455444444 24444544444433 45678999999985 43321 11111111355666666666665
Q ss_pred HHHHHhCCcccccCCCCCeeeeC-C----cEEEecccceeecCC
Q 036550 115 LDYMHQQGYFHRDLKPENLLVSQ-G----TIKIADFGLAREIDA 153 (356)
Q Consensus 115 L~~LH~~~ivH~Dlkp~NIll~~-~----~~kL~Dfg~a~~~~~ 153 (356)
..|++|+|++|.||+++. | .++++|||++..++.
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 589999999999999975 4 899999999987754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-12 Score=104.50 Aligned_cols=131 Identities=24% Similarity=0.312 Sum_probs=95.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEE-cccccchH-------HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKA-LKKSYSRE-------KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~-~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
..+++|+-+.++.+.. -|..+++|. +.|..... .....+|+.+++++.--.|....=+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4688999999999955 355577775 33332111 1233579999999865555444445566777889999
Q ss_pred eccCCHHH-HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeec
Q 036550 80 CMQCNLYQ-LMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREI 151 (356)
Q Consensus 80 ~~~g~l~~-~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~ 151 (356)
|++|.+.. .+... ...+++.+=.-+.-||.+||+|+||.++||+++.+.+.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCccccc
Confidence 99997554 43221 135667777788899999999999999999999999999999998643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.3e-12 Score=115.17 Aligned_cols=214 Identities=19% Similarity=0.270 Sum_probs=156.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEE----ECCeEEEEEEeccC--CHHH
Q 036550 14 SFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV----EKGNVFFVFECMQC--NLYQ 87 (356)
Q Consensus 14 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~~~iv~e~~~g--~l~~ 87 (356)
...+.|+|....+|..|++|++.-...........-+++++++.|+|+|++.++|. .+..+++|++|.++ +|++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34578999999999999999984332222222234678899999999999999886 34678999999886 5766
Q ss_pred HHHHHH-----------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC-cEEEecccceeecCCCC
Q 036550 88 LMEAKK-----------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFP 155 (356)
Q Consensus 88 ~~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~kL~Dfg~a~~~~~~~ 155 (356)
...... ..+...+|..+|.++.||..||.++|+.|+..+-|.|.+||++.. +++|+..|....+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 653221 223347899999999999999999999999999999999999876 99999999876665433
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCCccchHHHhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL-FQGTDEADQ-MYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.+| +.+ -.+-|.=.||.+++.|.||..- +........ +..|
T Consensus 448 -----------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------------------- 490 (655)
T KOG3741|consen 448 -----------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------------------- 490 (655)
T ss_pred -----------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh--------------------
Confidence 111 211 2345889999999999999543 222222222 1111
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....|.+++++|.-+...++++ -++.+++.+
T Consensus 491 -----------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 -----------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -----------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1256889999999999988887 677777764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.2e-13 Score=116.33 Aligned_cols=197 Identities=21% Similarity=0.297 Sum_probs=137.1
Q ss_pred HHhCCCCCeeEEeEEEEEC-----CeEEEEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Q 036550 53 LRKLNHPNIVKVKELIVEK-----GNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YF 124 (356)
Q Consensus 53 l~~l~hp~iv~~~~~~~~~-----~~~~iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 124 (356)
|-.+.|.|||+++.++.+. ....++.||+. |++...++.-...+..+....-++|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3345699999999987644 45788999997 5677777766666777889999999999999999999885 99
Q ss_pred cccCCCCCeeeeCC-cEEEecccceeecC------CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC
Q 036550 125 HRDLKPENLLVSQG-TIKIADFGLAREID------AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF 197 (356)
Q Consensus 125 H~Dlkp~NIll~~~-~~kL~Dfg~a~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 197 (356)
|+++.-+.|++..+ -+|+ |-+.-.... .........+-++|.|||.-...+ ...++|||++|....+|..|
T Consensus 201 hgnlTc~tifiq~ngLIki-g~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKI-GSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cCCcchhheeecCCceEEe-cccCccccchhhhhhhHhhhhccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHh
Confidence 99999999999864 4444 333211111 011122335678899999643333 56789999999999999877
Q ss_pred CCC-CCCCCh---HHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCC
Q 036550 198 RPL-FQGTDE---ADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR 273 (356)
Q Consensus 198 ~~p-f~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 273 (356)
..- -.+... .+...+.... -...--++++.+||.-.|..|
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~------------------------------------len~lqr~~i~kcl~~eP~~r 322 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIG------------------------------------LENGLQRGSITKCLEGEPNGR 322 (458)
T ss_pred eeccCCCcceeehhhhhhhheee------------------------------------ccCccccCcCcccccCCCCCC
Confidence 533 222111 1111111000 011223578999999999999
Q ss_pred CCHHHHhcCCCCCC
Q 036550 274 PTAAEALQHPFFKR 287 (356)
Q Consensus 274 pt~~e~l~hp~~~~ 287 (356)
|++.+++.||-+-+
T Consensus 323 p~ar~llfHpllfe 336 (458)
T KOG1266|consen 323 PDARLLLFHPLLFE 336 (458)
T ss_pred cchhhhhcCceeee
Confidence 99999999998754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.8e-11 Score=95.82 Aligned_cols=142 Identities=18% Similarity=0.225 Sum_probs=101.3
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEc-ccccc-------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKAL-KKSYS-------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
....|-+|+-+.|+++.+ .|+.+.||.- .+... -......+|+++|.++.--.|....=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 356788999999999954 5888888853 22211 1122335799999988654554444456666667899
Q ss_pred EEeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C---cEEEecccceeec
Q 036550 78 FECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G---TIKIADFGLAREI 151 (356)
Q Consensus 78 ~e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~---~~kL~Dfg~a~~~ 151 (356)
|||.+| ++.+.+....... ........++++|-+.+.-||.++|||+||..+||++.. | .+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999999 6667765443321 223333788999999999999999999999999999954 2 5699999987543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-11 Score=98.17 Aligned_cols=127 Identities=24% Similarity=0.353 Sum_probs=81.8
Q ss_pred EEEEEEEcCCCcEEEEEEccccc-------------ch-------------HHhhhHHHHHHHHhCCCC--CeeEEeEEE
Q 036550 17 CVWQAVNKHSGEVVAIKALKKSY-------------SR-------------EKCLNLREVKCLRKLNHP--NIVKVKELI 68 (356)
Q Consensus 17 ~V~~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~hp--~iv~~~~~~ 68 (356)
.||.|... .|..+|+|+.+... .+ ......+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999764 57799999864320 00 112335699999999755 466666442
Q ss_pred EECCeEEEEEEecc--CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHH-HHhCCcccccCCCCCeeeeCCcEEEecc
Q 036550 69 VEKGNVFFVFECMQ--CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY-MHQQGYFHRDLKPENLLVSQGTIKIADF 145 (356)
Q Consensus 69 ~~~~~~~iv~e~~~--g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~ivH~Dlkp~NIll~~~~~kL~Df 145 (356)
. -++||||++ |.....+.... ++......++.+++..+.. +|+.||+||||.+.|||++++.+.++||
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf 150 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDF 150 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--G
T ss_pred --C--CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEec
Confidence 2 379999999 64333332211 2234556778888885555 5899999999999999999999999999
Q ss_pred cceeecCC
Q 036550 146 GLAREIDA 153 (356)
Q Consensus 146 g~a~~~~~ 153 (356)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 99977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=99.26 Aligned_cols=137 Identities=20% Similarity=0.252 Sum_probs=95.0
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCC--CCeeEEeEEEEEC---CeEEEEEEec
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNH--PNIVKVKELIVEK---GNVFFVFECM 81 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~---~~~~iv~e~~ 81 (356)
+.|+.|.++.||++.... |+.+++|+...... .......+|+.+++.+.+ .++++++.+.... +..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999997643 67899999765432 123455789999999965 3456777766543 3668999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ---------------------------------------- 120 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 120 (356)
+|. +.+.+.. ..+++.....++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 885 2221100 124555555556666666666653
Q ss_pred ----------------CCcccccCCCCCeeeeC--C-cEEEecccceee
Q 036550 121 ----------------QGYFHRDLKPENLLVSQ--G-TIKIADFGLARE 150 (356)
Q Consensus 121 ----------------~~ivH~Dlkp~NIll~~--~-~~kL~Dfg~a~~ 150 (356)
..++|+|+.|.||+++. + .+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34699999999999977 4 578999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-09 Score=95.89 Aligned_cols=254 Identities=15% Similarity=0.123 Sum_probs=155.9
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEE----E--EECC-eEEEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKEL----I--VEKG-NVFFV 77 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~----~--~~~~-~~~iv 77 (356)
..+.||+|+-+.+|..-.- + ..+.|++.......+.. -+..|... .||-+-.-+.+ . -+.+ .+-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4678999999999977432 2 23567776654322221 22233333 56644331111 1 1222 26788
Q ss_pred EEeccCC--HHHHHH--HHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 78 FECMQCN--LYQLME--AKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 78 ~e~~~g~--l~~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
|..+.|- ...+.. .+++......+....++.+.|+.+.+.||+.|.+-+|+.++|+|+++ +.+.|.|-..-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence 8877762 332221 11222233678889999999999999999999999999999999976 689999877665555
Q ss_pred CCCCCccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 153 AFPPYTERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
+...+.-.+|.+.|.+||.-.-. -.-+...|.|.||+++|+++.| +.||.+.... .+.......
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~-----------~~ap~p~E~ 237 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI-----------SDAPNPLET 237 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc-----------CCCCCcchh
Confidence 55555667899999999974311 1135678999999999999886 8999865321 111111100
Q ss_pred Hhhh---hhhhcccCCCcccccccccCCCCCHHHHHHHHHccC--CCCCCCCCHH
Q 036550 228 GLRQ---AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCS--WDPCKRPTAA 277 (356)
Q Consensus 228 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dP~~Rpt~~ 277 (356)
.+.. ....+ +-+.....+..-.+.-+++.+..+..+|+. .++.-|||++
T Consensus 238 ~Ia~g~f~ya~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 238 DIAHGRFAYASD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhhcceeeechh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 0000 00000 111112222222234567889999999985 3477899864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.9e-11 Score=115.34 Aligned_cols=153 Identities=19% Similarity=0.282 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-----CCc-----cccccccccChHHHhhCC
Q 036550 109 FQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-----PYT-----ERVGTRWYQAPEILFKSG 176 (356)
Q Consensus 109 ~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-----~~~-----~~~gt~~y~aPE~~~~~~ 176 (356)
.+...|+.|+|+ .++||++|.|++|.++. +.+||+.|+++....... .+. .......|.|||.+.. .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 344489999995 58999999999999986 689999999987665421 111 1135677999999976 4
Q ss_pred CCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCC
Q 036550 177 LYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSAS 255 (356)
Q Consensus 177 ~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 255 (356)
..+.++|+||+||++|.+. .|+..+...........-...+ ..........++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~--------------------------~~~~~~~s~~~p 238 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL--------------------------NAGAFGYSNNLP 238 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc--------------------------ccccccccccCc
Confidence 4899999999999999998 5666666554322221111100 011112225789
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 256 EDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 256 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.++++=+.++|..++..||++.+++..|||.+.
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 999999999999999999999999999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=4e-09 Score=92.23 Aligned_cols=131 Identities=15% Similarity=0.065 Sum_probs=90.5
Q ss_pred eEEEEEEEcCCCcEEEEEEcccccchH-----------HhhhHHHHHHHHhCCCCCe--eEEeEEEEE-----CCeEEEE
Q 036550 16 GCVWQAVNKHSGEVVAIKALKKSYSRE-----------KCLNLREVKCLRKLNHPNI--VKVKELIVE-----KGNVFFV 77 (356)
Q Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hp~i--v~~~~~~~~-----~~~~~iv 77 (356)
..|.++. -.|+.|.||......... .....+|...+.+|..-+| +..+++.+. ....++|
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3455553 357789999764332111 1135678888888743333 334444433 2346899
Q ss_pred EEeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--------CcEEEecccc
Q 036550 78 FECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--------GTIKIADFGL 147 (356)
Q Consensus 78 ~e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--------~~~kL~Dfg~ 147 (356)
||++++ ++.+++.... ....++.....++.++...+.-||.+||+|+|+++.|||++. ..+.|+||+.
T Consensus 114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999998 4666654221 123567778899999999999999999999999999999963 4899999998
Q ss_pred eee
Q 036550 148 ARE 150 (356)
Q Consensus 148 a~~ 150 (356)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-09 Score=92.33 Aligned_cols=137 Identities=21% Similarity=0.261 Sum_probs=100.0
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc----------------------chHHhhhHHHHHHHHhCCCC--
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----------------------SREKCLNLREVKCLRKLNHP-- 59 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~hp-- 59 (356)
+.++.+||.|--|.||.|.+. .|.++|+|.-+... .-......+|.++|+.|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356789999999999999877 68899999743210 01123346799999999655
Q ss_pred CeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 60 ~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
.+++.+++ +.-.+|||+..|..+.-+. ++......++..|++-+.-+-..|+||+|+++-||++++ |
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 67776653 4557999999985222111 234455566777777777777999999999999999986 5
Q ss_pred cEEEecccceeecCC
Q 036550 139 TIKIADFGLAREIDA 153 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~ 153 (356)
.++++||-.+...+.
T Consensus 240 ~~~vIDwPQ~v~~~h 254 (304)
T COG0478 240 DIVVIDWPQAVPISH 254 (304)
T ss_pred CEEEEeCcccccCCC
Confidence 999999998866543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.8e-11 Score=110.19 Aligned_cols=244 Identities=15% Similarity=0.098 Sum_probs=172.1
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC-eeEEeEEEEECCeEEEEEEecc
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN-IVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
|....-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+..++..++.++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 445566789999999999887766655 6766544 22344899999999999 6777777777788999999987
Q ss_pred CC--HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCCCCccc
Q 036550 83 CN--LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTER 160 (356)
Q Consensus 83 g~--l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~~~~~~ 160 (356)
++ ....... ..-.+.+-+...+.+.-..+|+++|+..=+|+| ||+.+++..++.||+....+.......+.
T Consensus 318 ~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 318 TGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred CCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccC
Confidence 65 1111110 000133444555667778899999998888998 99999999999999999888776556778
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-ccchHHHhhhhhhhcccC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT-MDSWADGLRQAMAINYQF 239 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (356)
.+++.++|||+...+. +....|.|++|+-..++.-|.+|-..... ....+ +..+ .....+.
T Consensus 391 ~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~----g~~p~s~~L~~~----------- 452 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMI----GNGPNSPMLTDK----------- 452 (829)
T ss_pred CCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCC----CCCCCccccchh-----------
Confidence 8999999999986555 88899999999988888888877654211 00000 0000 0000000
Q ss_pred CCcccccccccCCCCCHHHH-HHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 240 PQLSGVNLSALMPSASEDAI-NLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~s~~~~-~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
...++... ++...|+..-|..|+....++-|.+|.+|..
T Consensus 453 ------------~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 453 ------------SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ------------hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 01111122 5788899999999999999999999998743
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.8e-08 Score=84.03 Aligned_cols=102 Identities=22% Similarity=0.314 Sum_probs=76.4
Q ss_pred hhHHHHHHHHhCCCC--CeeEEeEEEEEC----CeEEEEEEeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHH
Q 036550 45 LNLREVKCLRKLNHP--NIVKVKELIVEK----GNVFFVFECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116 (356)
Q Consensus 45 ~~~~E~~~l~~l~hp--~iv~~~~~~~~~----~~~~iv~e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 116 (356)
...+|...+..|..- .+++.+++.+.. ...++|+|+++| +|.+.+..... .+......++.++...+.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence 446788877777432 244555555442 245899999987 46666543222 566778899999999999
Q ss_pred HHHhCCcccccCCCCCeeeeCC----cEEEecccceee
Q 036550 117 YMHQQGYFHRDLKPENLLVSQG----TIKIADFGLARE 150 (356)
Q Consensus 117 ~LH~~~ivH~Dlkp~NIll~~~----~~kL~Dfg~a~~ 150 (356)
-||++||+|+|+++.|||++.+ .+.|+||+-+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999875 599999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.3e-08 Score=81.27 Aligned_cols=133 Identities=18% Similarity=0.250 Sum_probs=85.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhh---------HHHHHHHHhCC---CCCeeEEeEEEE-
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---------LREVKCLRKLN---HPNIVKVKELIV- 69 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---hp~iv~~~~~~~- 69 (356)
+|.+.+.+-......|.+. ..+|+.+++|..+.........+ .+++..+.++. ......++.+.+
T Consensus 32 ~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 4666666666666666665 45678899998765433222211 23444444442 222333222222
Q ss_pred ----ECCeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEec
Q 036550 70 ----EKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIAD 144 (356)
Q Consensus 70 ----~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~D 144 (356)
.....+++|||++|- +.+... +++ .+...|.+++.-+|+.|++|+|..|.|++++++.+++.|
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID 177 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIID 177 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEE
Confidence 234567899999995 333221 333 234567788999999999999999999999999999999
Q ss_pred cccee
Q 036550 145 FGLAR 149 (356)
Q Consensus 145 fg~a~ 149 (356)
|+...
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.4e-08 Score=82.10 Aligned_cols=139 Identities=22% Similarity=0.224 Sum_probs=96.1
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchH------------------------HhhhHHHHHHHHhCC--CCC
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE------------------------KCLNLREVKCLRKLN--HPN 60 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~--hp~ 60 (356)
...|..|--+.||+|.. .++..+|+|+++...... ......|..-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 45777888889999965 468899999975431110 112245788888774 344
Q ss_pred eeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeCCc
Q 036550 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQGT 139 (356)
Q Consensus 61 iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~ 139 (356)
+++.+.+. +-.+||||++... ...-.-+.-++....+..+..++++.+.-|-. .++||+||+.=|||+.++.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~ 204 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGE 204 (268)
T ss_pred CCCceeec----CCeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCe
Confidence 55555554 2379999997541 00000111113444677888889998888877 9999999999999999999
Q ss_pred EEEecccceeecCC
Q 036550 140 IKIADFGLAREIDA 153 (356)
Q Consensus 140 ~kL~Dfg~a~~~~~ 153 (356)
+.++|||.|.....
T Consensus 205 p~iID~~QaV~~~h 218 (268)
T COG1718 205 PYIIDVSQAVTIDH 218 (268)
T ss_pred EEEEECccccccCC
Confidence 99999999976653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.6e-08 Score=93.43 Aligned_cols=139 Identities=24% Similarity=0.375 Sum_probs=86.2
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccch----------------------------------------HHhhhH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR----------------------------------------EKCLNL 47 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~ 47 (356)
..|+.++-|+||+|+-+. |+.||||+.+..-.. .+-++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578899999999999775 999999997653100 111223
Q ss_pred HHHHHHHhC----C-CCCeeEEeEEE-EECCeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh
Q 036550 48 REVKCLRKL----N-HPNIVKVKELI-VEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120 (356)
Q Consensus 48 ~E~~~l~~l----~-hp~iv~~~~~~-~~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 120 (356)
+|+.-+.++ + .+++ .+=.++ +..+.-.++|||+.|- +.+..... . ..++...+...+.++ -+.-+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-~--~g~d~k~ia~~~~~~--f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-S--AGIDRKELAELLVRA--FLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH-h--cCCCHHHHHHHHHHH--HHHHHHh
Confidence 466666655 2 3333 333333 2345568999999994 43332221 1 113422222221111 1122334
Q ss_pred CCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
.|+.|.|..|.||+++. |++.+.|||+...++.
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 89999999999999975 7999999999877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.6e-07 Score=76.86 Aligned_cols=136 Identities=16% Similarity=0.149 Sum_probs=94.5
Q ss_pred ccCCceEEEEEEEcCCCcEEEEEEccccc------chHHhhhHHHHHHHHhCCCC--CeeEEeEEEEE--C--CeEEEEE
Q 036550 11 GSGSFGCVWQAVNKHSGEVVAIKALKKSY------SREKCLNLREVKCLRKLNHP--NIVKVKELIVE--K--GNVFFVF 78 (356)
Q Consensus 11 g~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hp--~iv~~~~~~~~--~--~~~~iv~ 78 (356)
|+|+.|.|+.... .|+.|=+|...... ......+.+|+..++.|..- .++++...... . -..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5689999998753 34467788764221 11345668899999888432 24444422111 1 2467999
Q ss_pred EeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCc--EEEecccceee
Q 036550 79 ECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGT--IKIADFGLARE 150 (356)
Q Consensus 79 e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~--~kL~Dfg~a~~ 150 (356)
|-++| +|.+.+.... ..+.++.....++.++...+.-||+.|+.|+|+.+.||+++ +|. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98885 5666653221 12356777789999999999999999999999999999996 565 99999986643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-07 Score=80.51 Aligned_cols=136 Identities=14% Similarity=0.135 Sum_probs=82.6
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC--eeEEeEEEEECCeEEEEEEeccCCH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN--IVKVKELIVEKGNVFFVFECMQCNL 85 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~~~~~~~~~iv~e~~~g~l 85 (356)
..||.|..+.||+. .+..+++|....... .....+|.++++.+..-. +.+++++..+.+...+|||+++|.-
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 244678998765432 233578999999885433 5677888777888889999999841
Q ss_pred --H--------------HHHHHH---Hhhc--ccCCHHH-HHHHHH----------HHHHH-HHHHH----hCCcccccC
Q 036550 86 --Y--------------QLMEAK---KQKQ--QLFSESA-VKAWLF----------QVFRG-LDYMH----QQGYFHRDL 128 (356)
Q Consensus 86 --~--------------~~~~~~---~~~~--~~l~~~~-~~~i~~----------qi~~a-L~~LH----~~~ivH~Dl 128 (356)
. ..+... .... ....... ...+.. .+... ..+|. ...++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1 111110 0000 0001000 001100 01111 12222 124789999
Q ss_pred CCCCeeeeCCcEEEeccccee
Q 036550 129 KPENLLVSQGTIKIADFGLAR 149 (356)
Q Consensus 129 kp~NIll~~~~~kL~Dfg~a~ 149 (356)
.|.||+++++.+.++||+.+.
T Consensus 161 ~~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCCcEEEechhcC
Confidence 999999988669999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.4e-06 Score=75.06 Aligned_cols=74 Identities=16% Similarity=0.200 Sum_probs=52.1
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCC--CeeEEeEEEE---ECCeEEEEEEec
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHP--NIVKVKELIV---EKGNVFFVFECM 81 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~~~~~~~---~~~~~~iv~e~~ 81 (356)
++.|+.|..+.||++.... ..+++|..... .......+|..+++.+... .+.+++.... .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4678999999999997664 48899987554 3445566788888887433 3556666443 334678999999
Q ss_pred cCC
Q 036550 82 QCN 84 (356)
Q Consensus 82 ~g~ 84 (356)
+|.
T Consensus 78 ~g~ 80 (239)
T PF01636_consen 78 PGR 80 (239)
T ss_dssp SSE
T ss_pred ccc
Confidence 885
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.8e-07 Score=89.68 Aligned_cols=196 Identities=19% Similarity=0.234 Sum_probs=133.2
Q ss_pred HHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE----EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC
Q 036550 47 LREVKCLRKLNHPNIVKVKELIVEKGNVFFVF----ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121 (356)
Q Consensus 47 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~----e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 121 (356)
.-|+..+.++.|+|++.++.+-.......+++ +++.+ ++...+. .-..++..+++.+..++++||.++|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34677778889999999988865543322333 34443 3444432 334489999999999999999999999
Q ss_pred CcccccCCCCCe---ee-eCCcEEEe--cccceeecCCCCCCccccccccccChHHHhhCCCCCC--chhHHHHHHHHHH
Q 036550 122 GYFHRDLKPENL---LV-SQGTIKIA--DFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS--KVDMWAMGAIMAE 193 (356)
Q Consensus 122 ~ivH~Dlkp~NI---ll-~~~~~kL~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~il~~ 193 (356)
...|.-+..+-. -. .++.+..+ ||+.+..............+..+.++|...... +.. ..|+|++|.....
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHHHhh
Confidence 665555444421 11 12455666 999888777655555556777888888774332 333 3699999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCC-HHHHHHHHHccCCCCCC
Q 036550 194 LLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSAS-EDAINLIESLCSWDPCK 272 (356)
Q Consensus 194 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~~~~li~~~L~~dP~~ 272 (356)
+..|..+-........ +.+..+ ....+++.+|+.-++++
T Consensus 385 ~~~~~~i~~~~~~~~~----------------------------------------~l~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPVS----------------------------------------LLDVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhcCcccccccchhh----------------------------------------hhccccchhhhhhhhhhcchhhhh
Confidence 9887655332211000 001112 16788999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 036550 273 RPTAAEALQHPFFKR 287 (356)
Q Consensus 273 Rpt~~e~l~hp~~~~ 287 (356)
|+++.+++.|+|...
T Consensus 425 Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRF 439 (1351)
T ss_pred ccchhhhhhchhccc
Confidence 999999999999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.5e-07 Score=84.73 Aligned_cols=135 Identities=21% Similarity=0.316 Sum_probs=85.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccch-------------------------------------HHhhhHHHH
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-------------------------------------EKCLNLREV 50 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~ 50 (356)
+.||.-+.|+||+|+-+. |+.||||+-+..-.. .+-++.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999775 999999996543111 011223344
Q ss_pred HHHHhC----CCCC------eeEEeEEEEECCeEEEEEEeccCC-H--HHHHHHHHhhcccCCHHHHHHHHHHHHHHH-H
Q 036550 51 KCLRKL----NHPN------IVKVKELIVEKGNVFFVFECMQCN-L--YQLMEAKKQKQQLFSESAVKAWLFQVFRGL-D 116 (356)
Q Consensus 51 ~~l~~l----~hp~------iv~~~~~~~~~~~~~iv~e~~~g~-l--~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL-~ 116 (356)
+-..+. .|-+ |++++..+ ...-.++|||++|. + .+.+... + ++...+.. .+.++. +
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---g--i~~~~i~~---~l~~~~~~ 315 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---G--ISPHDILN---KLVEAYLE 315 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---C--CCHHHHHH---HHHHHHHH
Confidence 433332 3444 44444333 34568999999983 2 2333222 1 45544333 333322 2
Q ss_pred HHHhCCcccccCCCCCeeee-----CCcEEEecccceeecCC
Q 036550 117 YMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDA 153 (356)
Q Consensus 117 ~LH~~~ivH~Dlkp~NIll~-----~~~~kL~Dfg~a~~~~~ 153 (356)
-+=..|++|+|=.|.||++. ++.+.+-|||+...+..
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 23357899999999999998 35899999999876654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.9e-06 Score=73.79 Aligned_cols=71 Identities=15% Similarity=0.153 Sum_probs=50.0
Q ss_pred ccccCCc-eEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEEeccCC
Q 036550 9 KLGSGSF-GCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFECMQCN 84 (356)
Q Consensus 9 ~ig~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e~~~g~ 84 (356)
.|..|.+ +.||++... +..+.+|+..... .....+|+.+++.+. +--+++++++....+..++||++++|.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 3445555 789999643 4678889875432 234567888888883 445667888777767789999999885
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1e-06 Score=70.49 Aligned_cols=128 Identities=23% Similarity=0.239 Sum_probs=91.0
Q ss_pred eeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCee-EEeEEEEECCeEEEEEEeccC
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV-KVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~~~iv~e~~~g 83 (356)
.+.+.||+|.+|.||++.+. |..+|+|+-+.++ ....+..|+++|..+.--++. +++.+-. .++.|||..|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 45688999999999999765 6689999865543 345667899999998766654 3443322 2455999999
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCC--CCeeeeCCcEEEecccceeec
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKP--ENLLVSQGTIKIADFGLAREI 151 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp--~NIll~~~~~kL~Dfg~a~~~ 151 (356)
.|.+.... .+ ++-+..+++..--|-..||-|+.|.- .||+++++.+.|+||..|+.-
T Consensus 97 ~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG-------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc-------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 44443221 01 22344566666667788999999984 578888889999999998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=66.56 Aligned_cols=125 Identities=22% Similarity=0.320 Sum_probs=87.7
Q ss_pred CCceeecccccCCc-eEEEEEEEcCCCcEEEEEEccc---c--------cc----------hHHhhhHHHHHHHHhCC--
Q 036550 2 EKYSLTKKLGSGSF-GCVWQAVNKHSGEVVAIKALKK---S--------YS----------REKCLNLREVKCLRKLN-- 57 (356)
Q Consensus 2 ~~y~~~~~ig~G~~-g~V~~~~~~~~~~~vavK~~~~---~--------~~----------~~~~~~~~E~~~l~~l~-- 57 (356)
++++.++.||.|.- |.||++. .+|+.||+|+... . .. .-...+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46788999999999 9999995 4688999999321 0 00 11123356777777763
Q ss_pred -CCCe--eEEeEEEEEC------------------CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHH
Q 036550 58 -HPNI--VKVKELIVEK------------------GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116 (356)
Q Consensus 58 -hp~i--v~~~~~~~~~------------------~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 116 (356)
+.++ |+++|+..-. ....||.||+...- .++... +.+|++-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 4556 8999987322 12357888776552 123333 567888889
Q ss_pred HHHhCCcccccCCCCCeeeeCCcEEEecccce
Q 036550 117 YMHQQGYFHRDLKPENLLVSQGTIKIADFGLA 148 (356)
Q Consensus 117 ~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a 148 (356)
.+|..||+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc----CCEEEecccC
Confidence 999999999999999987 5578899864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.4e-06 Score=82.75 Aligned_cols=78 Identities=19% Similarity=0.312 Sum_probs=56.1
Q ss_pred ecccccCCceEEEEEEEcCCC--cEEEEEEcccccc-hHHhhhHHHHHHHHhCC-CCCe--eEEeEEEEEC---CeEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSG--EVVAIKALKKSYS-REKCLNLREVKCLRKLN-HPNI--VKVKELIVEK---GNVFFV 77 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~i--v~~~~~~~~~---~~~~iv 77 (356)
.+.++.|.+..+|+......+ ..+++|+...... .......+|+.+|+.+. |+++ ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998765432 4677887644321 22345678999999995 6654 7788877654 567899
Q ss_pred EEeccCC
Q 036550 78 FECMQCN 84 (356)
Q Consensus 78 ~e~~~g~ 84 (356)
|||++|.
T Consensus 123 ME~v~G~ 129 (822)
T PLN02876 123 MEYLEGR 129 (822)
T ss_pred EEecCCc
Confidence 9999885
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.7e-05 Score=64.09 Aligned_cols=128 Identities=18% Similarity=0.281 Sum_probs=88.3
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEccccc----------------chHHhhhHHHHHHHHhCC------CCCeeEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----------------SREKCLNLREVKCLRKLN------HPNIVKV 64 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hp~iv~~ 64 (356)
...||+|+.-.||.- .. +...+||+..... ........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 467999999999954 43 4456899987654 112234456666666555 7899999
Q ss_pred eEEEEECCeEEEEEEecc---C----CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC
Q 036550 65 KELIVEKGNVFFVFECMQ---C----NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ 137 (356)
Q Consensus 65 ~~~~~~~~~~~iv~e~~~---g----~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 137 (356)
+|+.+.+....+|+|.+. | +|.+++. .+.+++ .. ...+-+-.+||-+++|+.+|++|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 999999988899999552 3 3444442 223555 33 334445567889999999999999999953
Q ss_pred ---C--cEEEec-cc
Q 036550 138 ---G--TIKIAD-FG 146 (356)
Q Consensus 138 ---~--~~kL~D-fg 146 (356)
+ .+.|+| ||
T Consensus 154 ~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLG 168 (199)
T ss_pred cCCCceEEEEEeCCC
Confidence 2 577777 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.15 E-value=1e-05 Score=70.94 Aligned_cols=136 Identities=17% Similarity=0.220 Sum_probs=78.0
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-eEEeEEEEECCeEEEEEEeccCCHHH
Q 036550 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-VKVKELIVEKGNVFFVFECMQCNLYQ 87 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~iv~e~~~g~l~~ 87 (356)
.+..|-.+.+|++. .++..+++|+.......-.....+|..+++.+....+ .+++... . -++||||++|...+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 46678889999986 4567888997654322211234678899988854333 3444332 2 26899999884221
Q ss_pred -----------HHHHH---Hh----hcccCCH-HHHHHHHHHH---------HHHHHHHHh--------CCcccccCCCC
Q 036550 88 -----------LMEAK---KQ----KQQLFSE-SAVKAWLFQV---------FRGLDYMHQ--------QGYFHRDLKPE 131 (356)
Q Consensus 88 -----------~~~~~---~~----~~~~l~~-~~~~~i~~qi---------~~aL~~LH~--------~~ivH~Dlkp~ 131 (356)
.+... .. ...+++. ..+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 11110 00 0111111 1222222221 111222222 24899999999
Q ss_pred CeeeeCCcEEEecccceee
Q 036550 132 NLLVSQGTIKIADFGLARE 150 (356)
Q Consensus 132 NIll~~~~~kL~Dfg~a~~ 150 (356)
||+++++.+.|+||..|..
T Consensus 157 Nil~~~~~~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQGLKLIDWEYASD 175 (256)
T ss_pred cEEEeCCCCEEEeccccCc
Confidence 9999987799999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.4e-05 Score=69.05 Aligned_cols=69 Identities=10% Similarity=0.079 Sum_probs=43.0
Q ss_pred cccccCCce-EEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCC---CeeEEeEEEEEC---CeEEEEEEe
Q 036550 8 KKLGSGSFG-CVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHP---NIVKVKELIVEK---GNVFFVFEC 80 (356)
Q Consensus 8 ~~ig~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~~~~~~~~~---~~~~iv~e~ 80 (356)
+.|+.|+.. .||+. +..+++|+..... ......+|+.+++.+... .+..+++..... +..+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 567777776 59976 2357788755422 233567899999887532 344444443322 245889999
Q ss_pred ccC
Q 036550 81 MQC 83 (356)
Q Consensus 81 ~~g 83 (356)
+.|
T Consensus 76 i~G 78 (235)
T cd05155 76 LEG 78 (235)
T ss_pred ecC
Confidence 887
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00012 Score=67.60 Aligned_cols=75 Identities=16% Similarity=0.182 Sum_probs=51.5
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEccccc-------chHHhhhHHHHHHHHhCC---CCCeeEEeEEEEECCeEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-------SREKCLNLREVKCLRKLN---HPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~i 76 (356)
.+.||.|.+..||++.....++.|+||.-.... .........|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 467999999999999986544689999853211 112233456888888762 3457777766 4456789
Q ss_pred EEEeccC
Q 036550 77 VFECMQC 83 (356)
Q Consensus 77 v~e~~~g 83 (356)
|||++++
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999865
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.1e-05 Score=67.38 Aligned_cols=142 Identities=25% Similarity=0.314 Sum_probs=97.1
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccc----------------------cchH----HhhhHHHHHHHHhCCCC
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS----------------------YSRE----KCLNLREVKCLRKLNHP 59 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~----------------------~~~~----~~~~~~E~~~l~~l~hp 59 (356)
+-.+|..|--+.||.|... +|..+|||+++-+ ..+. ......|++-|.+++.-
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4578888999999999754 6788999986532 0111 12234588888888655
Q ss_pred CeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCCeeeeCC
Q 036550 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM-HQQGYFHRDLKPENLLVSQG 138 (356)
Q Consensus 60 ~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dlkp~NIll~~~ 138 (356)
.|...--+.. ..-.+||++++..-+-. -.-+...++...+..+-.|++.-+.-| |..++||.||+--|+|+-+|
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG 301 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG 301 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC
Confidence 5432211111 12378999998642211 112333477778888878877777655 46799999999999999999
Q ss_pred cEEEecccceeecCC
Q 036550 139 TIKIADFGLAREIDA 153 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~ 153 (356)
.+.++|-+.+.....
T Consensus 302 ~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEEccccccCCC
Confidence 999999998865543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.8e-05 Score=67.17 Aligned_cols=138 Identities=12% Similarity=0.005 Sum_probs=79.6
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCC--CeeEEeEE------EEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHP--NIVKVKEL------IVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~~~~~------~~~~~~~~iv~ 78 (356)
.+.|..|....+|++.. .+..+++|+.... .......|+.+++.+.+. .+++++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 56778888889999853 3457899987642 223455688888877432 24444332 23446678999
Q ss_pred EeccCCHHH-----HH-------H---HHHhh-ccc-----C-CHHH--H--------HHHHHHHHHHHHHHHh------
Q 036550 79 ECMQCNLYQ-----LM-------E---AKKQK-QQL-----F-SESA--V--------KAWLFQVFRGLDYMHQ------ 120 (356)
Q Consensus 79 e~~~g~l~~-----~~-------~---~~~~~-~~~-----l-~~~~--~--------~~i~~qi~~aL~~LH~------ 120 (356)
++++|...+ .. . ..... ... . .... . ......+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 999874211 11 0 00000 000 0 0000 0 0011112334444443
Q ss_pred -CCcccccCCCCCeeeeCCcE-EEeccccee
Q 036550 121 -QGYFHRDLKPENLLVSQGTI-KIADFGLAR 149 (356)
Q Consensus 121 -~~ivH~Dlkp~NIll~~~~~-kL~Dfg~a~ 149 (356)
.+++|+|+.|.||+++++.+ .|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 47999999999999998765 799999774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00015 Score=62.47 Aligned_cols=73 Identities=14% Similarity=0.127 Sum_probs=47.3
Q ss_pred ecccccCCceEEEEEEEcC-CCcEEEEEEcccccchHHhhhHHHHHHHHhCCC-CCeeEEeEEEEECCeEEEEEEeccCC
Q 036550 7 TKKLGSGSFGCVWQAVNKH-SGEVVAIKALKKSYSREKCLNLREVKCLRKLNH-PNIVKVKELIVEKGNVFFVFECMQCN 84 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~iv~e~~~g~ 84 (356)
++.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+.. .-.+++++.+. + .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 4678889999999996443 356788997654321 11233578888988853 33455554432 2 3799999873
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00056 Score=61.97 Aligned_cols=139 Identities=13% Similarity=0.097 Sum_probs=74.2
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC--eeEEeE------EEEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN--IVKVKE------LIVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~------~~~~~~~~~iv~ 78 (356)
.+.|+.|...++|++... +..+++|+.. ... ......|+.+++.|...+ +.+++. +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~--~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLT--AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec-cCC--hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 356777888899998643 3368899875 211 222334556665553111 333332 123356788999
Q ss_pred EeccCCH------------HHHHHHHHhhcccC--------C--H-HH------------HHHHHHH-HHHHHHHHH---
Q 036550 79 ECMQCNL------------YQLMEAKKQKQQLF--------S--E-SA------------VKAWLFQ-VFRGLDYMH--- 119 (356)
Q Consensus 79 e~~~g~l------------~~~~~~~~~~~~~l--------~--~-~~------------~~~i~~q-i~~aL~~LH--- 119 (356)
+|++|.. ...+...-.....+ . . .. ....+.+ +-..++.+.
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 9998841 11111000000001 0 0 00 0111111 111222322
Q ss_pred ----hCCcccccCCCCCeeeeCCcE-EEecccceee
Q 036550 120 ----QQGYFHRDLKPENLLVSQGTI-KIADFGLARE 150 (356)
Q Consensus 120 ----~~~ivH~Dlkp~NIll~~~~~-kL~Dfg~a~~ 150 (356)
..++||+|+.|.||+++++.+ -|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 248999999999999998776 7999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00032 Score=63.16 Aligned_cols=139 Identities=17% Similarity=0.121 Sum_probs=77.3
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC--eeEEeEE------EEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN--IVKVKEL------IVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~------~~~~~~~~iv~ 78 (356)
.+.++.|....+|++.. ++..+++|+...... ......|+++++.|...+ +++++.. ....+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 56777888889999853 234578898755322 223345677777763222 3444332 12346678999
Q ss_pred EeccCCH-----HHH-------HHHHHhhcccCCH--------H---H--HH----------HHHHHHHHHHHHHHh---
Q 036550 79 ECMQCNL-----YQL-------MEAKKQKQQLFSE--------S---A--VK----------AWLFQVFRGLDYMHQ--- 120 (356)
Q Consensus 79 e~~~g~l-----~~~-------~~~~~~~~~~l~~--------~---~--~~----------~i~~qi~~aL~~LH~--- 120 (356)
+|++|.. ... +...-.....++. . . .. .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9988731 111 1100000000100 0 0 00 011123334555542
Q ss_pred ----CCcccccCCCCCeeeeCCc-EEEeccccee
Q 036550 121 ----QGYFHRDLKPENLLVSQGT-IKIADFGLAR 149 (356)
Q Consensus 121 ----~~ivH~Dlkp~NIll~~~~-~kL~Dfg~a~ 149 (356)
.+++|+|+.+.||+++++. ..|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 6899999999999998765 5799999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=3.1e-05 Score=68.09 Aligned_cols=134 Identities=15% Similarity=0.211 Sum_probs=92.2
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-----------------h-----HHhhhHHHHHHHHhCC-CCC
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-----------------R-----EKCLNLREVKCLRKLN-HPN 60 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------~-----~~~~~~~E~~~l~~l~-hp~ 60 (356)
|.++..||-|.-+.||.+-+. .|++.++|.-+.... . ..-...+|...|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567899999999999999865 588889996432110 0 1122346888888884 332
Q ss_pred -eeEEeEEEEECCeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-C
Q 036550 61 -IVKVKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-Q 137 (356)
Q Consensus 61 -iv~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~ 137 (356)
+++.++ .+..++|||++.|- +... . ....+..+...++.-+.-|-++|+||+|..--||++. +
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v-~---------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQV-R---------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeee-e---------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence 444444 34568999988773 2222 1 1122334556677777888999999999999999997 5
Q ss_pred CcEEEecccceeecC
Q 036550 138 GTIKIADFGLAREID 152 (356)
Q Consensus 138 ~~~kL~Dfg~a~~~~ 152 (356)
+.++++||-......
T Consensus 239 ~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTS 253 (465)
T ss_pred CCEEEeechHhhccC
Confidence 789999999775544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=5.4e-06 Score=85.48 Aligned_cols=253 Identities=12% Similarity=-0.003 Sum_probs=158.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 74 (356)
+.|++.=-+|-|..+..-..+.+. ..+.+|+.+..+ +...+....|..-++...|+++.....-... ....
T Consensus 1229 e~~EV~l~i~~~~~~R~k~Lr~ki--d~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee 1306 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFRNKWLRSKI--DWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEE 1306 (2724)
T ss_pred hhhheeeecccceeeccchHhhhh--ceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHH
Confidence 344555455555554332222221 235566654322 2223333445556666789988776655432 2455
Q ss_pred EEEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCCeeeeC-CcEEEecccc
Q 036550 75 FFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG-----YFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 75 ~iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
|..++++. |.+++.+.+...+..++...-+.....+.+.+..-+|+.. .+|+++|+.|.++.. -+++++++|+
T Consensus 1307 ~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gL 1386 (2724)
T KOG1826|consen 1307 YIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGL 1386 (2724)
T ss_pred HHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccc
Confidence 77888766 5688888776666666777777776666677777777542 789999999999865 5899999999
Q ss_pred eeec-CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 148 AREI-DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 148 a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
.+.. ..........+++.|++|+....-. ++.++|+|+.|+-+|....|..+|-..... +.+. ...
T Consensus 1387 dKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs~~n~~fi~flq~-----~Lkg---iid---- 1453 (2724)
T KOG1826|consen 1387 DKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRSDGNAYFIFFLQP-----ALKG---IID---- 1453 (2724)
T ss_pred ccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHhcccHHHHHHHHH-----HHcC---ccc----
Confidence 9833 2223334567899999999875555 677799999999999999888877422111 1110 000
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
+..+ .....-.|.++......+|-+.-..||.-...+.-+.|.
T Consensus 1454 ---------n~tf--------~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1454 ---------NHTF--------FSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ---------cccc--------ccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 0000 011112244555566666667777899988888877774
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00037 Score=65.03 Aligned_cols=173 Identities=20% Similarity=0.260 Sum_probs=109.3
Q ss_pred hhhHHHHHHHHhCCCCCeeEEeEEEEEC-CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC
Q 036550 44 CLNLREVKCLRKLNHPNIVKVKELIVEK-GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122 (356)
Q Consensus 44 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 122 (356)
...+....+++.+.|+|...++++-... ....+|+|+++-++.+....+.... . +++ .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~~--~----------s~~-------~~~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLKD--E----------SLL-------AHG 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcccch--h----------hhc-------ccc
Confidence 3456678889999999999999886533 4578999999999998876433110 0 111 222
Q ss_pred cccccCCCCCeeeeCCcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036550 123 YFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQ 202 (356)
Q Consensus 123 ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 202 (356)
+.| - +.++.+| -+++.. |- ..++++||||+|.++.++..|...+.
T Consensus 88 ~~~-----~------~~~~~td-~~~t~~-----------------~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 88 VLH-----L------NIIYITD-HFLTKY-----------------PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred cce-----e------hhhhccc-cccccC-----------------CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 222 1 2233333 111100 00 01248999999999999999998887
Q ss_pred CCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 203 GTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....+....+......+....... ... . ..-.++....++..+|+-..|..||...++.++
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a-~e~--~---------------~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~ 194 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTA-MEH--L---------------IQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR 194 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHH-HHH--H---------------HHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence 7666666555544433222111100 000 0 001346678899999999999999999999999
Q ss_pred CCCCCC
Q 036550 283 PFFKRC 288 (356)
Q Consensus 283 p~~~~~ 288 (356)
+-|.+.
T Consensus 195 ~i~~ev 200 (725)
T KOG1093|consen 195 CSFTEV 200 (725)
T ss_pred ccHHHH
Confidence 999764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00023 Score=59.06 Aligned_cols=100 Identities=20% Similarity=0.247 Sum_probs=75.1
Q ss_pred HHHHHHHhCCC-CCeeEEeEEEEECCeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh---CC
Q 036550 48 REVKCLRKLNH-PNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ---QG 122 (356)
Q Consensus 48 ~E~~~l~~l~h-p~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 122 (356)
+|.-+++.+.+ +++++++|+| ++ +++.||.+. ++++.. ........-++....+++.++++.+++|+. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 48888999965 6999999998 33 567898884 332110 000011125889999999999999999998 45
Q ss_pred cccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 123 YFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 123 ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+.-.|++|+|+-+++ +++|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 889999999999876 699999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0004 Score=62.40 Aligned_cols=73 Identities=15% Similarity=0.117 Sum_probs=46.7
Q ss_pred ecccccCCceEEEEEEEcC------CCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC-eeEEeEEEEECCeEEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKH------SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN-IVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~iv~e 79 (356)
++.+..|-...||++.... +++.|++|+..... .......+|..+++.+...+ ..++++++. + .+|++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence 4567778888999997543 25789999865542 22234567888888885333 345555543 2 35788
Q ss_pred eccCC
Q 036550 80 CMQCN 84 (356)
Q Consensus 80 ~~~g~ 84 (356)
|++|.
T Consensus 78 ~i~G~ 82 (302)
T cd05156 78 FIPSR 82 (302)
T ss_pred eeCCC
Confidence 88773
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0023 Score=58.05 Aligned_cols=73 Identities=12% Similarity=0.153 Sum_probs=45.8
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEccccc-------chHHhhhHHHHHHHHhCC--CC-CeeEEeEEEEECCeEEEEE
Q 036550 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-------SREKCLNLREVKCLRKLN--HP-NIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~--hp-~iv~~~~~~~~~~~~~iv~ 78 (356)
.||.|...-||++.+...++.|+||.-.... .-......-|.+.|+... .| .+++++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 5799999999999976444689999743211 111122245777777663 34 4455543 3455567899
Q ss_pred EeccC
Q 036550 79 ECMQC 83 (356)
Q Consensus 79 e~~~g 83 (356)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0025 Score=58.28 Aligned_cols=138 Identities=17% Similarity=0.238 Sum_probs=77.9
Q ss_pred ecccccCCceEEEEEEEcC----CCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-eEEeEEEEECCeEEEEEEec
Q 036550 7 TKKLGSGSFGCVWQAVNKH----SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-VKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~iv~e~~ 81 (356)
+..|..|-.-.+|++.... +++.|++|+..... ....+..+|..+++.+..-++ .++++.+.. + .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence 4566668888999986432 34689999876542 222233678999888854333 455665532 2 478888
Q ss_pred cCCHHH-----------HHHHHHh---h----cc--cCCHHHHHHHHHHHH-----------------HHHHHH----H-
Q 036550 82 QCNLYQ-----------LMEAKKQ---K----QQ--LFSESAVKAWLFQVF-----------------RGLDYM----H- 119 (356)
Q Consensus 82 ~g~l~~-----------~~~~~~~---~----~~--~l~~~~~~~i~~qi~-----------------~aL~~L----H- 119 (356)
+|...+ .+..... . .. +.....+..++.++. ..+..| .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 763211 1100000 0 00 111233333332221 111111 1
Q ss_pred ---hCCcccccCCCCCeeeeC--CcEEEeccccee
Q 036550 120 ---QQGYFHRDLKPENLLVSQ--GTIKIADFGLAR 149 (356)
Q Consensus 120 ---~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~ 149 (356)
...++|+|+++.|||+++ +.+.|+||..|.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 235899999999999975 479999999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0073 Score=55.88 Aligned_cols=74 Identities=16% Similarity=0.153 Sum_probs=48.8
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccc-------hHHhhhHHHHHHHHhCC---CCCeeEEeEEEEECCeEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-------REKCLNLREVKCLRKLN---HPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~ 75 (356)
..+.||.|....||++.+. +..|+||.-..... -.......|++.|+.+. ..++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3568899999999999763 45689997542110 01222244677776653 247888887775 4457
Q ss_pred EEEEeccC
Q 036550 76 FVFECMQC 83 (356)
Q Consensus 76 iv~e~~~g 83 (356)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999966
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0031 Score=57.96 Aligned_cols=75 Identities=17% Similarity=0.152 Sum_probs=48.0
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEccccc------chHHhhhHHHHHHHHhCC--CC-CeeEEeEEEEECCeEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY------SREKCLNLREVKCLRKLN--HP-NIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--hp-~iv~~~~~~~~~~~~~iv 77 (356)
.+.||-|.-.-||++.+...++.|+||.-.... .-......-|.+.|+... .| ++++++. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 578899999999999885446779999743211 111222345778887763 34 4555553 345556788
Q ss_pred EEeccC
Q 036550 78 FECMQC 83 (356)
Q Consensus 78 ~e~~~g 83 (356)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 887753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.018 Score=51.93 Aligned_cols=29 Identities=24% Similarity=0.582 Sum_probs=26.3
Q ss_pred CCcccccCCCCCeeeeCCcEEEeccccee
Q 036550 121 QGYFHRDLKPENLLVSQGTIKIADFGLAR 149 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~ 149 (356)
.+++|+|+.+.||+++++.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence 57899999999999998899999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0036 Score=55.40 Aligned_cols=29 Identities=24% Similarity=0.454 Sum_probs=24.6
Q ss_pred CcccccCCCCCeeeeC-Cc-EEEecccceee
Q 036550 122 GYFHRDLKPENLLVSQ-GT-IKIADFGLARE 150 (356)
Q Consensus 122 ~ivH~Dlkp~NIll~~-~~-~kL~Dfg~a~~ 150 (356)
.++|+|+.|.|||+++ +. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987 65 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0028 Score=57.66 Aligned_cols=73 Identities=11% Similarity=0.189 Sum_probs=45.6
Q ss_pred ecccccCCceEEEEEEEcCC---CcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-eEEeEEEEECCeEEEEEEecc
Q 036550 7 TKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-VKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~iv~e~~~ 82 (356)
++.|..|-...+|++..... +..|++|+...... ...+..+|..+++.+..-++ +++++++. .+ +|.+|+.
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence 45566688889999864432 34788998755422 22334578999988865444 45565552 22 4778877
Q ss_pred CC
Q 036550 83 CN 84 (356)
Q Consensus 83 g~ 84 (356)
|.
T Consensus 94 g~ 95 (330)
T PLN02421 94 AR 95 (330)
T ss_pred CC
Confidence 64
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0072 Score=54.09 Aligned_cols=75 Identities=13% Similarity=0.160 Sum_probs=44.9
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEccc--ccchHHhhhHHHHHHHHhCCC--CCeeEEeEEEEECC--eEEEEEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKK--SYSREKCLNLREVKCLRKLNH--PNIVKVKELIVEKG--NVFFVFE 79 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~--~~~iv~e 79 (356)
+++.+..|..-.+|...+. ++.+++. ... ..........+|..+++.+.- --+...+++|.++. ..|.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344444444556665443 7778888 321 122333444678888888742 33455666666554 6799999
Q ss_pred eccC
Q 036550 80 CMQC 83 (356)
Q Consensus 80 ~~~g 83 (356)
++.|
T Consensus 106 ~veG 109 (321)
T COG3173 106 WVEG 109 (321)
T ss_pred Eecc
Confidence 9988
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.015 Score=53.93 Aligned_cols=29 Identities=31% Similarity=0.312 Sum_probs=26.2
Q ss_pred CCcccccCCCCCeeeeCCcEEEeccccee
Q 036550 121 QGYFHRDLKPENLLVSQGTIKIADFGLAR 149 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~ 149 (356)
..++|.|+-+.||+.+++.+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEecccc
Confidence 46799999999999999999999999774
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0081 Score=53.77 Aligned_cols=103 Identities=12% Similarity=0.108 Sum_probs=69.7
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCC---CCeeEEeEEEEE---CCeEEEEEEe
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH---PNIVKVKELIVE---KGNVFFVFEC 80 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~~~~~~~~---~~~~~iv~e~ 80 (356)
.+.||.|..+.||..... ++ .+.+|..+.. .....+..|+..|+.+.. -.++++++++.+ .+..++|||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDS-QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcC-CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 568999999999998543 23 4677874321 123466789999998843 367888887754 3668999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 121 (356)
++|...... ..+......+..+++.+|.-||+.
T Consensus 95 i~G~~~~~~--------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 95 LRGVSVEAP--------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred cCCEecCCC--------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 988522110 023344556667788888888874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.024 Score=51.09 Aligned_cols=29 Identities=17% Similarity=0.102 Sum_probs=25.5
Q ss_pred CcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 122 GYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 122 ~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
++||+|+.++|||+++ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 7999999999999965 5899999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.045 Score=49.72 Aligned_cols=28 Identities=29% Similarity=0.316 Sum_probs=24.2
Q ss_pred CCcccccCCCCCeeeeCCcEEEeccccee
Q 036550 121 QGYFHRDLKPENLLVSQGTIKIADFGLAR 149 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~ 149 (356)
.++||+|+.+.|||+++ .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWRD-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhccccC-CcEEEeCCCCC
Confidence 46899999999999964 68899999764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0095 Score=53.70 Aligned_cols=102 Identities=14% Similarity=0.283 Sum_probs=69.4
Q ss_pred CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeCCcEEEecccceee
Q 036550 72 GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQGTIKIADFGLARE 150 (356)
Q Consensus 72 ~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~ 150 (356)
.+.|++|++-++++...- .-..+++..++++.+..++-+..+ .+-|||+.-.|||+++|++-|+||-+++.
T Consensus 299 ~y~yl~~kdhgt~is~ik--------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDHGTPISIIK--------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecCCceeeeee--------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeec
Confidence 467788888777643221 135677888999998888887765 58999999999999999999999999984
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHH
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAM 187 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 187 (356)
-.... .+.....--|-.+.|. .+..-+||-+
T Consensus 371 ~~~q~----~isy~rldhp~lF~G~--dd~QFeIYrl 401 (488)
T COG5072 371 SYSQG----IISYNRLDHPDLFNGV--DDYQFEIYRL 401 (488)
T ss_pred ccCCc----eeeccccCchhhhcCc--cceeeeHHHH
Confidence 33211 1222223334444433 3556677654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.1 Score=46.36 Aligned_cols=74 Identities=15% Similarity=0.184 Sum_probs=47.3
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC---CCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL---NHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
-.+.++.|....+|+.. .+++.+.+|+-.. .....+..|++-|+.| ..-.+++++++....+..++||||++
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 45778899999999986 6788899998652 2234556788777777 34457788888887777799999976
Q ss_pred CC
Q 036550 83 CN 84 (356)
Q Consensus 83 g~ 84 (356)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 43
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.21 Score=47.36 Aligned_cols=74 Identities=12% Similarity=0.083 Sum_probs=45.6
Q ss_pred eecccccCCceEEEEEEEcC--------CCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCee-EEeEEEEECCeEEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKH--------SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV-KVKELIVEKGNVFF 76 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~~~i 76 (356)
-++.|..|-.-.+|++.... .++.|.+++...... .-.+..+|..+++.+..-+|- ++++.+. + +.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-ELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-ceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CE
Confidence 45677778888899986442 156788998755432 112345688888887544443 4555442 2 45
Q ss_pred EEEeccCC
Q 036550 77 VFECMQCN 84 (356)
Q Consensus 77 v~e~~~g~ 84 (356)
|.+|++|.
T Consensus 184 I~efi~g~ 191 (442)
T PTZ00296 184 IEEWLYGD 191 (442)
T ss_pred EEEeeCCc
Confidence 67888764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.41 Score=50.42 Aligned_cols=30 Identities=33% Similarity=0.460 Sum_probs=25.2
Q ss_pred CCcccccCCCCCeeeeCC---cEE-Eecccceee
Q 036550 121 QGYFHRDLKPENLLVSQG---TIK-IADFGLARE 150 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~~---~~k-L~Dfg~a~~ 150 (356)
.++||+|+.+.|||++.+ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 579999999999999865 555 999998754
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.019 Score=47.29 Aligned_cols=30 Identities=23% Similarity=0.377 Sum_probs=26.4
Q ss_pred CcccccCCCCCeeeeCCcEEEecccceeec
Q 036550 122 GYFHRDLKPENLLVSQGTIKIADFGLAREI 151 (356)
Q Consensus 122 ~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~ 151 (356)
-.+|+|+.|.||+++++.++|+||+.|...
T Consensus 78 ~p~H~D~~~~N~~~~~~~~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASGLRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCCEEEEeCCcccCC
Confidence 369999999999999988999999988643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.15 Score=43.04 Aligned_cols=85 Identities=16% Similarity=0.261 Sum_probs=54.9
Q ss_pred hhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh--C
Q 036550 44 CLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ--Q 121 (356)
Q Consensus 44 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~ 121 (356)
..+.++.+++++++ .|+++.-= +.-.+-+|.|.|..-- . .... ++.-=+.+|.-.|+ .
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~--i----------~~~N----~i~agi~~L~~fH~~~~ 162 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK--I----------NFSN----FITAGIKDLMDFHSENQ 162 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--c----------chhH----HHHHhHHHHHHhhccCC
Confidence 34467888888775 56666521 2334568889764320 0 1111 11112456777884 4
Q ss_pred CcccccCCCCCeeeeC-CcEEEecccce
Q 036550 122 GYFHRDLKPENLLVSQ-GTIKIADFGLA 148 (356)
Q Consensus 122 ~ivH~Dlkp~NIll~~-~~~kL~Dfg~a 148 (356)
+.+|||-.|+||+-+. |.+||.|-+..
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhhh
Confidence 6999999999999986 89999998854
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.11 Score=47.71 Aligned_cols=56 Identities=21% Similarity=0.235 Sum_probs=36.4
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHH-HHhCCcccccCCCCCeee
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY-MHQQGYFHRDLKPENLLV 135 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~ivH~Dlkp~NIll 135 (356)
.++=+|+.| ++...+... ..+|...+.++.-...||-- +---+++|.|+.|.||++
T Consensus 321 vl~E~~~~Gl~v~~~v~~~-----~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVli 378 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK-----SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLI 378 (565)
T ss_pred eeeeeccccccHHhhhhcc-----cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEE
Confidence 344447766 444444322 24566666666666666643 445689999999999998
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.1 Score=46.57 Aligned_cols=136 Identities=22% Similarity=0.222 Sum_probs=89.0
Q ss_pred eecccccCCceEEEEEEEc-------C---CCcEEEEEEccccc-------------c-----------hHHhh--hHHH
Q 036550 6 LTKKLGSGSFGCVWQAVNK-------H---SGEVVAIKALKKSY-------------S-----------REKCL--NLRE 49 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~-------~---~~~~vavK~~~~~~-------------~-----------~~~~~--~~~E 49 (356)
|..+|..|.-+.|+-|.-- . .-+.+|||+++-.. - +..-. ..+|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 4578889999999888421 1 22468999864210 0 00001 1234
Q ss_pred HHHHHhC-----CCCCeeEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH-HhCCc
Q 036550 50 VKCLRKL-----NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM-HQQGY 123 (356)
Q Consensus 50 ~~~l~~l-----~hp~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~i 123 (356)
..-|.++ .+|-+|.+.. -.+||-+++.. .+..-+-+.-.++....+..-.|+..++.-| |..-+
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~L 405 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLL 405 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHHHHhhhe
Confidence 4444443 5788877753 35888888753 1111111223378888888888888888665 56789
Q ss_pred ccccCCCCCeeeeCCcEEEecccceeec
Q 036550 124 FHRDLKPENLLVSQGTIKIADFGLAREI 151 (356)
Q Consensus 124 vH~Dlkp~NIll~~~~~kL~Dfg~a~~~ 151 (356)
||-|++--|+|+..|.+.++|...+...
T Consensus 406 VHADlSEyN~Lw~~gKvw~IDVsQsvep 433 (531)
T KOG2269|consen 406 VHADLSEYNLLWTPGKVWVIDVSQSVEP 433 (531)
T ss_pred eecchhhhhheecCCceEEEechhccCC
Confidence 9999999999999999999999877543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 356 | ||||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-57 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-57 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-57 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-57 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-57 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-57 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-57 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-57 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-57 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-57 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-57 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-57 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-57 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-57 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-57 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-56 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-56 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-56 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-56 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-56 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-56 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-56 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-56 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-56 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-56 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-56 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-56 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-56 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-56 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-56 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-56 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-56 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-56 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-56 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-55 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-52 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-51 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-51 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-48 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-47 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-47 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-47 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-46 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-46 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-46 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-45 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-45 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-45 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-45 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-45 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-45 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-45 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-45 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-45 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-45 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-45 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-45 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-45 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-45 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-45 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-45 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-45 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-45 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-45 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-45 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-45 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-45 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-45 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-44 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-44 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-44 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-44 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-44 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-44 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-44 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-44 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-44 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-44 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-44 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-44 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-44 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-44 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-44 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-44 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-44 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-44 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-44 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-44 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-44 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-44 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-44 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-44 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-44 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-44 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-44 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-44 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-43 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-43 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-43 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-43 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-43 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-43 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-42 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-42 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-42 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-42 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-42 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-42 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-42 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-42 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-42 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-42 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-42 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-42 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-42 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-42 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-42 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-42 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-42 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-42 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-42 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-42 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-42 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-42 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-42 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-41 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-41 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-41 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-41 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-41 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-41 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-41 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-41 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-41 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-41 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-41 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-41 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-41 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-41 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-41 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-41 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-41 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-41 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-41 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-41 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-41 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-41 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-41 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-41 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-41 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-41 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-41 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-41 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-41 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-41 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-41 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-41 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-41 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-41 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-40 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-40 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-40 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-40 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-40 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-40 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-40 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-40 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-39 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-39 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-38 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-38 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-38 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-38 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-37 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-36 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-36 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-35 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-35 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-35 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-35 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-35 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-34 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-34 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-34 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-34 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-34 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-34 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-34 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-34 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-34 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-34 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-34 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-34 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-34 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-34 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-34 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-34 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-34 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-34 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-34 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-33 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-33 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-33 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-33 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-33 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-33 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-33 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-33 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-32 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-32 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-32 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-32 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-32 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-32 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-32 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-32 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-31 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-31 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-31 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-30 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-30 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-30 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-30 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-30 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-30 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-30 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-30 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-30 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-30 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-30 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-29 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-29 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-29 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-29 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-29 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-28 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-28 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-28 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-28 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-28 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-28 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-28 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-28 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-28 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-28 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-28 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-27 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-27 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-27 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-27 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-27 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-27 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-27 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-27 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-27 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-26 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-26 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-26 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-26 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-26 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-26 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-26 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-26 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-26 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-26 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-26 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-26 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-26 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-26 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-25 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-25 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-25 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-25 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-25 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-25 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-24 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-24 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-24 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-24 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-23 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-23 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-23 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-23 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-23 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-23 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-23 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-23 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-22 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-22 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-22 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-22 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-22 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-22 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-22 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-21 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-21 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-21 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-20 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-20 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-20 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-20 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-20 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-19 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-19 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-19 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-19 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-19 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-19 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-19 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-19 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-18 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-18 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-17 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-17 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-17 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-13 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 7e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-12 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-12 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-12 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-12 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-10 |
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-125
Identities = 96/313 (30%), Positives = 153/313 (48%), Gaps = 9/313 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
MEKY K+G GS+G V++ N+ +G++VAIK +S K + LRE++ L++L H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
PN+V + E+ K + VFE + ++ ++ E VK+ +Q + +++
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFC 118
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSG 176
H+ HRD+KPEN+L++ IK+ DFG AR + Y + V TRWY++PE+L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y VD+WA+G + AELL PL+ G + DQ+Y I LG
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 237 YQFPQLSGV-NLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHL 295
+ P + L P+ S A+ L++ DP +R T + L HP+F+ + L
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN-IREIEDL 297
Query: 296 RSTPAVAATRRGM 308
A
Sbjct: 298 AKEHDKPAENLYF 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-121
Identities = 100/291 (34%), Positives = 150/291 (51%), Gaps = 8/291 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
MEKY +G GS+G V + NK +G +VAIK +S + K + +RE+K L++L H
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
N+V + E+ +K + VFE + + +E V+ +LFQ+ G+ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFC 140
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSG 176
H HRD+KPEN+LVS G +K+ DFG AR + Y + V TRWY+APE+L
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y VD+WA+G ++ E+ + PLF G + DQ+Y I LG+ + +
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 237 YQFPQLS-GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ P++ L P SE I+L + DP KRP AE L H FF+
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-117
Identities = 98/294 (33%), Positives = 159/294 (54%), Gaps = 15/294 (5%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
Y+ TK +G+GSFG V+QA SGE+VAIK + ++K RE++ +RKL+H NI
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 109
Query: 62 VKVKELIVEKGNVF------FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
V+++ G V + + +Y++ + +Q VK +++Q+FR L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 116 DYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF 173
Y+H G HRD+KP+NLL+ +K+ DFG A+++ P + +R+Y+APE++F
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 229
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+ Y+S +D+W+ G ++AELLL +P+F G DQ+ +I VLG+PT + +
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289
Query: 234 AINYQFPQLSGVNLS-ALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
++FPQ+ + P +AI L L + P R T EA H FF
Sbjct: 290 --EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-114
Identities = 101/295 (34%), Positives = 159/295 (53%), Gaps = 16/295 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
Y+ K +G+GSFG V+QA S EV A+KK ++K RE++ +R + HPN
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEV----AIKKVL-QDKRFKNRELQIMRIVKHPN 93
Query: 61 IVKVKELIVEKGN------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+V +K G+ + V E + +Y+ + +Q +K +++Q+ R
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 115 LDYMHQQGYFHRDLKPENLLV--SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
L Y+H G HRD+KP+NLL+ G +K+ DFG A+ + A P + +R+Y+APE++
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELI 213
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
F + Y++ +D+W+ G +MAEL+ +PLF G DQ+ +I VLG+P+ +
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273
Query: 233 MAINYQFPQLSGVNLS-ALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
M ++FPQ+ S P DAI+LI L + P R TA EAL HPFF
Sbjct: 274 M--EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-110
Identities = 103/293 (35%), Positives = 165/293 (56%), Gaps = 15/293 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
MEKY +K+G G++G V++A N GE A+K ++ E +RE+ L++L H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIVK+ ++I K + VFE + +L +L++ + K++L Q+ G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYC 116
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF----PPYTERVGTRWYQAPEILF 173
H + HRDLKP+NLL++ +G +KIADFGLAR AF YT + T WY+AP++L
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR---AFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
S YS+ +D+W++G I AE++ PLF G EADQ+ +I +LG+P +W + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP-NVTELP 232
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ F + + + E I+L+ + DP +R TA +AL+H +FK
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-110
Identities = 108/295 (36%), Positives = 169/295 (57%), Gaps = 16/295 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-----CLNLREVKCLRK 55
++Y LG G F V++A +K++ ++VAIK +K + E LRE+K L++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
L+HPNI+ + + K N+ VF+ M+ +L +++ + S +KA++ +GL
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGL 125
Query: 116 DYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILF 173
+Y+HQ HRDLKP NLL+ G +K+ADFGLA+ YT +V TRWY+APE+LF
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD--GLRQ 231
+ +Y VDMWA+G I+AELLL P G + DQ+ +I LG+PT + W D L
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ F G+ L + +A +D ++LI+ L ++PC R TA +AL+ +F
Sbjct: 246 YV----TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 322 bits (829), Expect = e-110
Identities = 107/302 (35%), Positives = 177/302 (58%), Gaps = 17/302 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
MEKY +K+G G++G V++A + G +VA+K ++ E +RE+ L++L+H
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
PNIV + ++I + + VFE M+ +L ++++ K +S +K +L+Q+ RG+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHC 135
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF----PPYTERVGTRWYQAPEILF 173
HQ HRDLKP+NLL++ G +K+ADFGLAR AF YT V T WY+AP++L
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLAR---AFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
S YS+ VD+W++G I AE++ +PLF G + DQ+ KI S+LG+P W +
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293
F S+++P ++ I+L+ ++ +DP KR +A +A+ HP+FK + P
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD---LDP 309
Query: 294 HL 295
+
Sbjct: 310 QI 311
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-110
Identities = 106/317 (33%), Positives = 172/317 (54%), Gaps = 10/317 (3%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLN 57
ME Y KLG G++ V++ +K + +VA+K ++ E+ C +REV L+ L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLK 58
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
H NIV + ++I + ++ VFE + +L Q ++ + + VK +LFQ+ RGL Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNIINMHNVKLFLFQLLRGLAY 115
Query: 118 MHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKS 175
H+Q HRDLKP+NLL++ +G +K+ADFGLAR Y V T WY+ P+IL S
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
YS+++DMW +G I E+ RPLF G+ +Q++ I +LG+PT ++W L
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHL 295
Y +P+ L + P D +L+ L ++ R +A +A++HPFF L
Sbjct: 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKL 295
Query: 296 RSTPAVAATRRGMLKQQ 312
T ++ A + L+++
Sbjct: 296 PDTTSIFALKEIQLQKE 312
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = e-107
Identities = 102/294 (34%), Positives = 168/294 (57%), Gaps = 15/294 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
M+KY +K+G G++G V++A N+ + E+VA+K ++ E LRE+ L++L H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIV++ +++ + VFE +L + ++ VK++LFQ+ +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFC 117
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF----PPYTERVGTRWYQAPEILF 173
H + HRDLKP+NLL++ G +K+A+FGLAR AF Y+ V T WY+ P++LF
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLAR---AFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 174 KSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
+ LYS+ +DMW+ G I AEL RPLF G D DQ+ +I +LG+PT + W + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SMTKL 233
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ +L ++P + +L+++L +P +R +A EALQHP+F
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-106
Identities = 102/299 (34%), Positives = 167/299 (55%), Gaps = 21/299 (7%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
+++Y KLG G++G V++A++ + E VAIK ++ + E +REV L++L H
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI+++K +I + +FE + +L + M+ S +K++L+Q+ G+++
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD----VSMRVIKSFLYQLINGVNFC 148
Query: 119 HQQGYFHRDLKPENLLVS------QGTIKIADFGLAREIDAF----PPYTERVGTRWYQA 168
H + HRDLKP+NLL+S +KI DFGLAR AF +T + T WY+
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR---AFGIPIRQFTHEIITLWYRP 205
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PEIL S YS+ VD+W++ I AE+L+ PLF G E DQ++KI VLG P +W G
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP-G 264
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ FP+ G L ++ + ++ ++L+ ++ DP KR +A AL+HP+F
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-106
Identities = 91/314 (28%), Positives = 167/314 (53%), Gaps = 22/314 (7%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLN 57
++ +KLG+G++ V++ +NK +G VA+K +K E+ +RE+ +++L
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTAIREISLMKELK 61
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAK--KQKQQLFSESAVKAWLFQVFRGL 115
H NIV++ ++I + + VFE M +L + M+++ + + VK + +Q+ +GL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 116 DYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF----PPYTERVGTRWYQAPE 170
+ H+ HRDLKP+NLL++ +G +K+ DFGLAR AF ++ V T WY+AP+
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR---AFGIPVNTFSSEVVTLWYRAPD 178
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+L S YS+ +D+W+ G I+AE++ +PLF GT++ +Q+ I ++G+P W +
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP-SVT 237
Query: 231 QAMAINYQFPQLSGVNLS-----ALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
+ N Q +L + ++ + L +P R +A +AL HP+F
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297
Query: 286 KRCLYVPPHLRSTP 299
Y + +
Sbjct: 298 -AEYYHHASMGGSR 310
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-106
Identities = 102/302 (33%), Positives = 156/302 (51%), Gaps = 24/302 (7%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-----LREVKCLRK 55
+Y ++G G++G V++A + HSG VA+K+++ +REV LR+
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 56 LN---HPNIVKVKELIVEKGN-----VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAW 107
L HPN+V++ ++ V VFE + +L ++ K +K
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDL 125
Query: 108 LFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWY 166
+ Q RGLD++H HRDLKPEN+LV+ GT+K+ADFGLAR T V T WY
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
+APE+L +S Y++ VDMW++G I AE+ +PLF G EADQ+ KI ++G P D W
Sbjct: 186 RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 227 D--GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
L FP + +++P E L+ + +++P KR +A ALQH +
Sbjct: 245 RDVSLP-----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 285 FK 286
Sbjct: 300 LH 301
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-103
Identities = 87/307 (28%), Positives = 157/307 (51%), Gaps = 30/307 (9%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKA--LKKSY-SREKCLNLREVKCLRKLN 57
M+++ + + G G+FG V K +G VAIK + +RE L+ ++ L L+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 58 HPNIVKVKELIVEKGNVFF-------VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
HPNIV+++ G V E + L++ ++Q +K +LFQ
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 111 VFRGLDYMHQQ--GYFHRDLKPENLLV--SQGTIKIADFGLAREIDAFPPYTERVGTRWY 166
+ R + +H HRD+KP N+LV + GT+K+ DFG A+++ P + +R+Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
+APE++F + Y++ VD+W++G I AE++L P+F+G + A Q+++I VLG P+ +
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL- 256
Query: 227 DGLRQAMAINY---QFPQLSGVNLS----ALMPSASEDAINLIESLCSWDPCKRPTAAEA 279
+ + ++ G+ S +++A +L+ +L + P +R EA
Sbjct: 257 ----RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 280 LQHPFFK 286
L HP+F
Sbjct: 313 LCHPYFD 319
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-102
Identities = 97/298 (32%), Positives = 158/298 (53%), Gaps = 18/298 (6%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVN-KHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLN 57
++Y ++G G++G V++A + K+ G VA+K ++ E +REV LR L
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 58 ---HPNIVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLF 109
HPN+V++ ++ + + VFE + +L ++ K + +K +F
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMF 127
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQA 168
Q+ RGLD++H HRDLKP+N+LV+ G IK+ADFGLAR T V T WY+A
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PE+L +S Y++ VD+W++G I AE+ +PLF+G+ + DQ+ KI V+G P + W
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-R 245
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
F S + + E +L+ +++P KR +A AL HP+F+
Sbjct: 246 DVALP--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-100
Identities = 93/304 (30%), Positives = 151/304 (49%), Gaps = 21/304 (6%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNH 58
+ KY K+G G+FG V++A ++ +G+ VA+K + +E LRE+K L+ L H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 59 PNIVKVKELIVEK--------GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
N+V + E+ K G+++ VF+ + +L L+ K F+ S +K +
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQM 132
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREID-----AFPPYTERVGTR 164
+ GL Y+H+ HRD+K N+L++ G +K+ADFGLAR YT RV T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
WY+ PE+L Y +D+W G IMAE+ P+ QG E Q+ I + GS T +
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPS--ASEDAINLIESLCSWDPCKRPTAAEALQH 282
W + + + + + + + A++LI+ L DP +R + +AL H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 283 PFFK 286
FF
Sbjct: 313 DFFW 316
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-100
Identities = 89/305 (29%), Positives = 161/305 (52%), Gaps = 25/305 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-----------LREV 50
Y++ + + SGS+G V V+ G VAIK + + S + +N LRE+
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 51 KCLRKLNHPNIVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVK 105
+ L +HPNI+ ++++ V ++ V E M+ +L Q++ ++ + S ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---HDQRIVISPQHIQ 137
Query: 106 AWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTR 164
+++ + GL +H+ G HRDL P N+L+ I I DF LARE A T V R
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
WY+APE++ + ++ VDMW+ G +MAE+ + LF+G+ +Q+ KI V+G+P ++
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 225 WADGLRQAMAINY---QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
A +Y + +A++P+A A++LI + ++P +R + +AL+
Sbjct: 258 V-VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 282 HPFFK 286
HP+F+
Sbjct: 317 HPYFE 321
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 1e-99
Identities = 100/305 (32%), Positives = 156/305 (51%), Gaps = 25/305 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL-NLREVKCLRKLNHPN 60
+ L LG G++G V A +K +GE+VAIK ++ L LRE+K L+ H N
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 61 IVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
I+ + + V+ + E MQ +L++++ Q+ S+ ++ +++Q R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSDDHIQYFIYQTLRAV 125
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY-----------TERVGT 163
+H HRDLKP NLL+ S +K+ DFGLAR ID E V T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223
RWY+APE++ S YS +D+W+ G I+AEL L RP+F G D Q+ I ++G+P D
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 224 SWADGLRQAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ + A Y P L + P + I+L++ + +DP KR TA EAL+
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 282 HPFFK 286
HP+ +
Sbjct: 306 HPYLQ 310
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 6e-98
Identities = 87/329 (26%), Positives = 164/329 (49%), Gaps = 53/329 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
+KYSL K LG+GSFG V + + SG+ A+K + + + RE+ ++ L+H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK----NRELDIMKVLDHVN 61
Query: 61 IVKVKELIVEKGN--------------------------------------VFFVFECMQ 82
I+K+ + G+ + + E +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV--SQGTI 140
L++++++ + + + + +++Q+FR + ++H G HRD+KP+NLLV T+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 141 KIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL 200
K+ DFG A+++ P + +R+Y+APE++ + Y+ +D+W++G + EL+L +PL
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241
Query: 201 FQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY---QFPQLSGVNLSALMPSAS-E 256
F G DQ+ +I ++G+PT + M +Y +FP L + ++P +
Sbjct: 242 FSGETSIDQLVRIIQIMGTPTKEQM-----IRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296
Query: 257 DAINLIESLCSWDPCKRPTAAEALQHPFF 285
AI+L+E + ++P R EA+ HPFF
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 9e-97
Identities = 106/296 (35%), Positives = 157/296 (53%), Gaps = 20/296 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
+ Y +GSG++G V A++K SGE VAIK L + + E RE+ L+ + H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 60 NIVKVKELIVEKGN------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ + + V MQ +L ++M + SE ++ ++Q+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM-----GLKF-SEEKIQYLVYQMLK 137
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H G HRDLKP NL V +KI DFGLAR D T V TRWY+APE++
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVI 195
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y+ VD+W++G IMAE+L + LF+G D DQ+ +I V G P + L
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV-QKLNDK 254
Query: 233 MAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A +Y PQ + + L P AS A +L+E + D KR TAA+AL HPFF+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 2e-96
Identities = 102/298 (34%), Positives = 164/298 (55%), Gaps = 19/298 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL-NLREVKCLRKLNHPN 60
+Y+ +G G++G V A + + VAIK + + C LRE+K L + H N
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 61 IVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
I+ + ++I + +V+ V + M+ +LY+L+ K Q S + +L+Q+ RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGL 141
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY----TERVGTRWYQAPE 170
Y+H HRDLKP NLL+ + +KI DFGLAR D + TE V TRWY+APE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
I+ S Y+ +D+W++G I+AE+L RP+F G DQ+ I +LGSP+ + + +
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCII 260
Query: 231 QAMAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A NY P + V + L P+A A++L++ + +++P KR +AL HP+ +
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-96
Identities = 97/308 (31%), Positives = 151/308 (49%), Gaps = 29/308 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CL-NLREVKCLRKLNHP 59
+Y K LG G G V+ AV+ + VAIK K + + LRE+K +R+L+H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 60 NIVKVKELIVEKGN--------------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVK 105
NIVKV E++ G+ V+ V E M+ +L ++ +Q E +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL-----EQGPLLEEHAR 123
Query: 106 AWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG--TIKIADFGLAREIDAFPPY----TE 159
+++Q+ RGL Y+H HRDLKP NL ++ +KI DFGLAR +D + +E
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGS 219
+ T+WY++P +L Y+ +DMWA G I AE+L + LF G E +QM I +
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 220 PTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA 279
+ + L L+ L+P S +A++ +E + ++ P R TA EA
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 280 LQHPFFKR 287
L HP+
Sbjct: 304 LSHPYMSI 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 6e-95
Identities = 79/300 (26%), Positives = 147/300 (49%), Gaps = 24/300 (8%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHP 59
+ Y L +KLG G + V++A+N + E V +K LK ++ RE+K L L P
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91
Query: 60 NIVKVKELI---VEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
NI+ + +++ V + + QL Q ++ ++ +++++ + LD
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALD 144
Query: 117 YMHQQGYFHRDLKPENLLV--SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
Y H G HRD+KP N+++ +++ D+GLA Y RV +R+++ PE+L
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 175 SGLYSSKVDMWAMGAIMAELLLFR-PLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+Y +DMW++G ++A ++ + P F G D DQ+ +I VLG+ + + D +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 234 AINY--QFPQLSGVNLSALMPS-----ASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ + S + S S +A++ ++ L +D R TA EA++HP+F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 2e-94
Identities = 101/296 (34%), Positives = 161/296 (54%), Gaps = 19/296 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
Y + +GSG++G V AV+ +G VAIK L + + E RE++ L+ + H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 60 NIVKVKELIVEKGN------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ + V M +L +LM K + E ++ ++Q+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 139
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H G HRDLKP NL V +KI DFGLAR+ D T V TRWY+APE++
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVI 197
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y+ VD+W++G IMAE++ + LF+G+D DQ+ +I V G+P + L+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV-QRLQSD 256
Query: 233 MAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A NY P+L + ++++ +AS A+NL+E + D +R TA EAL HP+F+
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 3e-94
Identities = 99/296 (33%), Positives = 153/296 (51%), Gaps = 19/296 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CL-NLREVKCLRKLNHP 59
E+Y +GSG++G V A + +G VA+K L + + RE++ L+ + H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 60 NIVKVKELIVEKGN------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ + V+ V M +L ++ K Q ++ V+ ++Q+ R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILR 143
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H HRDLKP NL V +KI DFGLAR T V TRWY+APEI+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIM 201
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y+ VD+W++G IMAELL R LF GTD DQ+ I ++G+P + +
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL-KKISSE 260
Query: 233 MAINY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A NY Q+ +N + + A+ A++L+E + D KR TAA+AL H +F
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 9e-93
Identities = 105/355 (29%), Positives = 165/355 (46%), Gaps = 74/355 (20%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CL-NLREVKCLRKLNHP 59
++Y + +G+GS+G V +A +K VVAIK + + + C LRE+ L +LNH
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 60 NIVKVKELIVEKGNVFF-----VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
++VKV ++++ K F V E + +L + +E +K L+ + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF----RTPVYLTELHIKTLLYNLLVG 168
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP----------------- 156
+ Y+H G HRDLKP N LV ++K+ DFGLAR +D
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 157 -----------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-------- 197
T V TRWY+APE++ Y+ +D+W++G I AELL
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 198 ---RPLFQGTD--------------------EADQMYKICSVLGSPTMDSWADGLRQAMA 234
PLF G+ DQ+ I ++LG+P+ + + L + A
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI-EALEKEDA 347
Query: 235 INY--QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
Y FP+ G +L+ P++S DAI+L++ + ++P KR T E L HPFFK
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-91
Identities = 87/313 (27%), Positives = 148/313 (47%), Gaps = 37/313 (11%)
Query: 9 KLGSGSFGCVWQAVNKH--SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKE 66
K+G G++G V++A K + A+K ++ + RE+ LR+L HPN++ +++
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQK 85
Query: 67 LIVEKGN--VFFVFECMQCNLYQLMEAKKQ-----KQQLFSESAVKAWLFQVFRGLDYMH 119
+ + + V+ +F+ + +L+ +++ + K VK+ L+Q+ G+ Y+H
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 120 QQGYFHRDLKPENLLVS-----QGTIKIADFGLARE----IDAFPPYTERVGTRWYQAPE 170
HRDLKP N+LV +G +KIAD G AR + V T WY+APE
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---------ADQMYKICSVLGSPT 221
+L + Y+ +D+WA+G I AELL P+F E DQ+ +I +V+G P
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 265
Query: 222 MDSW--------ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR 273
W L + N + A +L++ L + DP KR
Sbjct: 266 DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325
Query: 274 PTAAEALQHPFFK 286
T+ +A+Q P+F
Sbjct: 326 ITSEQAMQDPYFL 338
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 6e-90
Identities = 100/347 (28%), Positives = 161/347 (46%), Gaps = 66/347 (19%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CL-NLREVKCLRKLNHP 59
+ Y + +G GS+G V+ A +K++ + VAIK + + + C LRE+ L +L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 60 NIVKVKELIVEKGN-----VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
I+++ +LI+ ++ V E +L +L + +E +K L+ + G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF----KTPIFLTEEHIKTILYNLLLG 141
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY---------------- 157
+++H+ G HRDLKP N L+ ++K+ DFGLAR I++
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 158 -------TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-----------FRP 199
T V TRWY+APE++ Y+ +D+W+ G I AELL P
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 200 LFQGT-----------------DEADQMYKICSVLGSPTMDSWADGLRQAMAINY--QFP 240
LF G+ DQ+ I +++G+PT D + + I Y FP
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL-KNINKPEVIKYIKLFP 320
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+NL PS S+D INL+ES+ ++P KR T +AL HP+ K
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 1e-87
Identities = 96/309 (31%), Positives = 148/309 (47%), Gaps = 32/309 (10%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CL-NLREVKCLRKLNH 58
+++Y K +GSG+ G V A + VAIK L + + + RE+ ++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 59 PNIVKVKELIV------EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
NI+ + + E +V+ V E M NL Q++ + +L + L+Q+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMEL-DHERMSYLLYQML 137
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171
G+ ++H G HRDLKP N++V S T+KI DFGLAR T V TR+Y+APE+
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ G Y VD+W++G IM E++ LF GTD DQ K+ LG+P + Q
Sbjct: 198 ILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK--LQ 254
Query: 232 AMAINY--QFPQLSGVNLSALMPSA------------SEDAINLIESLCSWDPCKRPTAA 277
Y P+ +G + L P + A +L+ + D KR +
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 278 EALQHPFFK 286
EALQHP+
Sbjct: 315 EALQHPYIN 323
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-87
Identities = 90/331 (27%), Positives = 166/331 (50%), Gaps = 52/331 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CL-NLREVKCLRKLN-H 58
KY L KKLG G++G VW+++++ +GEVVA+K + ++ RE+ L +L+ H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 59 PNIVKVKELIVEKGN--VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
NIV + ++ + V+ VF+ M+ +L+ ++ + + + ++Q+ + +
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI-----RANILEPVHKQYVVYQLIKVIK 123
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY------------------ 157
Y+H G HRD+KP N+L+ ++ +K+ADFGL+R
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 158 ----TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKI 213
T+ V TRWY+APEIL S Y+ +DMW++G I+ E+L +P+F G+ +Q+ +I
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 214 CSVLGSPTMDSWADGLRQAMAINY--QFPQLSGVNLSAL----------------MPSAS 255
V+ P+ + + ++ A + + S +
Sbjct: 244 IGVIDFPSNEDV-ESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 256 EDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
E+A++L++ L ++P KR +A +AL+HPF
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-86
Identities = 92/306 (30%), Positives = 144/306 (47%), Gaps = 28/306 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-CL-NLREVKCLRKLNHP 59
++Y K +GSG+ G V A + VAIK L + + + RE+ ++ +NH
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 60 NIVKVKELIVEKGN------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
NI+ + + + V+ V E M NL Q++ Q + L+Q+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 175
Query: 114 GLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
G+ ++H G HRDLKP N++V S T+KI DFGLAR T V TR+Y+APE++
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
G Y VD+W++G IM E++ + LF G D DQ K+ LG+P +
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 233 MAINYQFPQLSGVNLSALMPSA------------SEDAINLIESLCSWDPCKRPTAAEAL 280
P+ +G+ L P + + A +L+ + DP KR + +AL
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 281 QHPFFK 286
QHP+
Sbjct: 355 QHPYIN 360
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 9e-75
Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 39/322 (12%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
MEKY +K+G GSFG + G IK + S K REV L + H
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 59 PNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
PNIV+ +E E G+++ V + C +L++ + QK LF E + W Q+ L +
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 118 MHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTE-RVGTRWYQAPEILFKS 175
+H + HRD+K +N L GT+++ DFG+AR +++ +GT +Y +PEI
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
Y++K D+WA+G ++ EL + F+ + + KI
Sbjct: 201 P-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII--------------------- 238
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL--YVPP 293
+ FP +S S D +L+ L +P RP+ L+ F + + ++ P
Sbjct: 239 SGSFPPVS--------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
Query: 294 HLRSTPAVAATRRGMLKQQGDR 315
L + T Q
Sbjct: 291 QLIAEEFCLKTFSKFGSQPIPA 312
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 1e-74
Identities = 73/313 (23%), Positives = 117/313 (37%), Gaps = 56/313 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ LG G+FG V +A N AIK ++ + + + L EV L LNH +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI-LSEVMLLASLNHQYV 64
Query: 62 VKVKELIVEKGNVFFVFECMQ--CNLYQLME---------AKKQKQQLFSESAVKAWLFQ 110
V+ +E+ N ++ L+ ME + Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 111 VFRGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPY------------ 157
+ L Y+H QG HRDLKP N + +KI DFGLA+ +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 158 ---TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214
T +GT Y A E+L +G Y+ K+DM+++G I E++ P G + + + K+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL- 241
Query: 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP 274
+++ +FP + + +I L DP KRP
Sbjct: 242 ------------------RSVSIEFP-------PDFDDNKMKVEKKIIRLLIDHDPNKRP 276
Query: 275 TAAEALQHPFFKR 287
A L +
Sbjct: 277 GARTLLNSGWLPV 289
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 6e-72
Identities = 66/305 (21%), Positives = 124/305 (40%), Gaps = 51/305 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
YS+ K++GSG V+Q +N+ ++ AIK + + + L+ E+ L KL
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 59 PN--IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+ I+++ + + ++ V EC +L ++ KK K++ + +
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 141
Query: 117 YMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILF 173
+HQ G H DLKP N L+ G +K+ DFG+A ++ + VGT Y PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 174 KSGL----------YSSKVDMWAMGAIMAELLLFRPLFQG-TDEADQMYKICSVLGSPTM 222
S K D+W++G I+ + + FQ ++ +++ I
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP------ 255
Query: 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
+FP +D ++++ DP +R + E L H
Sbjct: 256 -----------NHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293
Query: 283 PFFKR 287
P+ +
Sbjct: 294 PYVQI 298
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-71
Identities = 71/304 (23%), Positives = 126/304 (41%), Gaps = 26/304 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL-KKSYSREKCLNLREVKCLRKLNHPN 60
+ L+ LG G+ V++ +K +G++ AIK S+ R + +RE + L+KLNH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 61 IVKVKELI--VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
IVK+ + + + E C +LY ++E + ES L V G+++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 118 MHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
+ + G HR++KP N++ Q K+ DFG ARE++ + GT Y P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 173 FKSGL-------YSSKVDMWAMGAIMAELLL----FRPLFQGTDEADQMYKICSVLGSPT 221
++ L Y + VD+W++G FRP + MYKI + G P+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ I++ +LS ++ ++ D K +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 282 HPFF 285
Sbjct: 303 ETSD 306
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 8e-71
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 40/291 (13%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKL-N 57
+ + +LG GS+G V++ +K G + A+K + +++ L EV K+
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP V++++ E G ++ E +L Q + E+ V +L L +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 118 MHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
+H QG H D+KP N+ + G K+ DFGL E+ + G Y APE+L G
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QG 230
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y + D++++G + E+ L + Q +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELP---HGGEGW--------------------QQLRQG 267
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
Y P+ + S + +++ + DP R TA L P ++
Sbjct: 268 YLPPEFT--------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-70
Identities = 73/299 (24%), Positives = 129/299 (43%), Gaps = 42/299 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
E Y + +G+GS+G + K G+++ K L E + EV LR+L H
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 59 PNIVKVKELIVEKGN--VFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
PNIV+ + I+++ N ++ V E C +L ++ +++Q E V + Q+ L
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 116 DYMHQQGYF-----HRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTE-RVGTRWYQA 168
H++ HRDLKP N L + +K+ DFGLAR ++ + + VGT +Y +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PE + Y+ K D+W++G ++ EL P F + + KI
Sbjct: 185 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------------ 231
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+F ++ S++ +I + + RP+ E L++P
Sbjct: 232 ---------KFRRIP--------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 5e-70
Identities = 99/341 (29%), Positives = 167/341 (48%), Gaps = 42/341 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHP 59
E+Y++ LG GSFG V + ++ + + A+K + K+ +++ LREV+ L+KL+HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 60 NIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI+K+ E++ + + + V E L+ + +K+ FSE + QVF G+ YM
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYM 137
Query: 119 HQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
H+ HRDLKPEN+L+ IKI DFGL+ +R+GT +Y APE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
+ Y K D+W+ G I+ LL P F G +E D + ++
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------------------ET 236
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPH 294
Y F + S+DA +LI + ++ P R TA + L+HP+ ++ P
Sbjct: 237 GKYAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
Query: 295 LRSTPAVAATRRGMLK-QQGDRIDAEALPYPKIVKQLSPLD 334
+ P++ + + + Q ++ AL Y + +L+ LD
Sbjct: 290 ISDLPSLESAMTNIRQFQAEKKLAQAALLY--MASKLTTLD 328
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-69
Identities = 66/304 (21%), Positives = 124/304 (40%), Gaps = 51/304 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
YS+ K++GSG V+Q +N+ ++ AIK + + + L+ E+ L KL
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 60 N--IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
+ I+++ + + ++ V EC +L ++ KK K++ + +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHT 123
Query: 118 MHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEIL-- 172
+HQ G H DLKP N L+ G +K+ DFG+A ++ + VGT Y PE +
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 173 --------FKSGLYSSKVDMWAMGAIMAELLLFRPLFQG-TDEADQMYKICSVLGSPTMD 223
S K D+W++G I+ + + FQ ++ +++ I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-------- 235
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
+FP +D ++++ DP +R + E L HP
Sbjct: 236 ---------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275
Query: 284 FFKR 287
+ +
Sbjct: 276 YVQI 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-69
Identities = 74/306 (24%), Positives = 119/306 (38%), Gaps = 61/306 (19%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
+ + +GSG FG V++A ++ G+ IK +K + EK REVK L KL+H N
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAE--REVKALAKLDHVN 65
Query: 61 IVKVKELIVE----------------KGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESA 103
IV +F E C + L Q + +K++ + +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVL 123
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTERVG 162
Q+ +G+DY+H + +RDLKP N LV +KI DFGL + T G
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPT 221
T Y +PE + Y +VD++A+G I+AELL + F+ + +
Sbjct: 184 TLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLR------- 232
Query: 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ + L++ L S P RP +E L+
Sbjct: 233 --------------DGIIS-----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
Query: 282 HPFFKR 287
+
Sbjct: 268 TLTVWK 273
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-69
Identities = 91/294 (30%), Positives = 148/294 (50%), Gaps = 43/294 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHP 59
E+Y++ LG GSFG V + ++ + + A+K + K+ +++ LREV+ L+KL+HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 60 NIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI+K+ E++ + + + V E L+ + +K+ FSE + QVF G+ YM
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYM 137
Query: 119 HQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
H+ HRDLKPEN+L+ IKI DFGL+ +R+GT +Y APE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS--WADGLRQA 232
+ Y K D+W+ G I+ LL P F G +E D + ++ + G D W
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQW------- 246
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ S+DA +LI + ++ P R TA + L+HP+ +
Sbjct: 247 -------------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 4e-69
Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 35/291 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPN 60
+ + +KLGSG+FG V + SG IK + K S+ + E++ L+ L+HPN
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 61 IVKVKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
I+K+ E+ + N++ V E + L + + + + + + SE V + Q+ L Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 120 QQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Q H+DLKPEN+L IKI DFGLA + T GT Y APE+ +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD 201
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
+ K D+W+ G +M LL F GT + K P L
Sbjct: 202 --VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--KEPNYAVECRPL------ 251
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ A++L++ + + DP +RP+AA+ L H +FK
Sbjct: 252 -------------------TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-69
Identities = 101/344 (29%), Positives = 153/344 (44%), Gaps = 47/344 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHP 59
E Y KKLGSG++G V +K + AIK ++K+ + L EV L+ L+HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 60 NIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI+K+ + +K N + V E L+ + + + F+E + QV G+ Y+
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYL 152
Query: 119 HQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
H+ HRDLKPENLL+ IKI DFGL+ + ER+GT +Y APE+L K
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK 212
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
Y K D+W++G I+ LL P F G + + + K+
Sbjct: 213 K--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------------------EK 251
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPH 294
Y F S + SE A +LI+ + +D +R +A +AL+HP+ K
Sbjct: 252 GKYTFD-------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304
Query: 295 LRSTPAVAATRRGM--------LKQQGDRIDAEALPYPKIVKQL 330
P++A M L Q A L + K+L
Sbjct: 305 GIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKEL 348
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-68
Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 66/323 (20%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK---KSYSREKCLNLREVKCLRKLN 57
+ + + LG G FG V++A NK AIK ++ + +REK + REVK L KL
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM--REVKALAKLE 61
Query: 58 HPNIVKVKELIVEKGN------------VFFVFE-CMQCNLYQLMEAKKQKQQLFSESAV 104
HP IV+ +EK ++ + C + NL M + ++ S
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVC 120
Query: 105 KAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID----------- 152
Q+ ++++H +G HRDLKP N+ + +K+ DFGL +D
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 153 --AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQM 210
A+ +T +VGT+ Y +PE + + YS KVD++++G I+ ELL P + +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL--YPFSTQMERVRTL 237
Query: 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDP 270
+ N +FP L +++ + S P
Sbjct: 238 TDVR---------------------NLKFPPLF--------TQKYPCEYVMVQDMLSPSP 268
Query: 271 CKRPTAAEALQHPFFKRCLYVPP 293
+RP A +++ F+ L P
Sbjct: 269 MERPEAINIIENAVFED-LDFPG 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-68
Identities = 91/294 (30%), Positives = 141/294 (47%), Gaps = 40/294 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNL-REVKCLRKLNH 58
++Y + LG GSFG V +K +G+ A+K + K + +L REV+ L++L+H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 59 PNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
PNI+K+ E +KG + V E L+ + ++K+ FSE + QV G+ Y
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITY 141
Query: 118 MHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF 173
MH+ HRDLKPENLL+ I+I DFGL+ +A +++GT +Y APE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+ Y K D+W+ G I+ LL P F G +E D + K+
Sbjct: 202 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------------------E 240
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
Y F SE A +LI + ++ P R +A +AL H + +
Sbjct: 241 KGKYTFE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-68
Identities = 91/306 (29%), Positives = 148/306 (48%), Gaps = 40/306 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKLNHP 59
+ Y + ++LG G+F V + V+K +G A K + +R+ RE + RKL HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 60 NIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIV++ + I E+ + VF+ + L++ + A++ +SE+ + Q+ + Y
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYC 121
Query: 119 HQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
H G HR+LKPENLL++ +K+ADFGLA E++ + GT Y +PE+L K
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
YS VD+WA G I+ LL+ P F D+ +I A
Sbjct: 182 DP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------------------KA 221
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP- 293
Y +P S + + +A +LI+S+ + +P KR TA +AL+ P+ V
Sbjct: 222 GAYDYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274
Query: 294 -HLRST 298
H + T
Sbjct: 275 IHRQDT 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-67
Identities = 79/289 (27%), Positives = 128/289 (44%), Gaps = 35/289 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ Y+L +G GS+G V AV K + A K + K + + +E++ ++ L+HPNI
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+++ E + +++ V E C +L E K+ F ES + V + Y H+
Sbjct: 69 IRLYETFEDNTDIYLVMEL--CTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKL 125
Query: 122 GYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
HRDLKPEN L +K+ DFGLA +VGT +Y +P++L
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-- 183
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y + D W+ G +M LL P F +++ M KI +
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------------------REGTF 224
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
FP + S A +LI L + P +R T+ +AL+H +F+
Sbjct: 225 TFP-------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-67
Identities = 65/305 (21%), Positives = 123/305 (40%), Gaps = 51/305 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
YS+ K++GSG V+Q +N+ ++ AIK + + + L+ E+ L KL
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 59 PN--IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+ I+++ + + ++ V EC +L ++ KK K++ + +
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 169
Query: 117 YMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILF 173
+HQ G H DLKP N L+ G +K+ DFG+A ++ + VG Y PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 174 KSGL----------YSSKVDMWAMGAIMAELLLFRPLFQG-TDEADQMYKICSVLGSPTM 222
S K D+W++G I+ + + FQ ++ +++ I
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------- 282
Query: 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
+FP +D ++++ DP +R + E L H
Sbjct: 283 ----------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321
Query: 283 PFFKR 287
P+ +
Sbjct: 322 PYVQI 326
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-67
Identities = 71/301 (23%), Positives = 126/301 (41%), Gaps = 26/301 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL-KKSYSREKCLNLREVKCLRKLNHPN 60
+ L+ LG G+ V++ +K +G++ AIK S+ R + +RE + L+KLNH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 61 IVKVKELI--VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
IVK+ + + + E C +LY ++E + ES L V G+++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 118 MHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
+ + G HR++KP N++ Q K+ DFG ARE++ + GT Y P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 173 FKSGL-------YSSKVDMWAMGAIMAELLL----FRPLFQGTDEADQMYKICSVLGSPT 221
++ L Y + VD+W++G FRP + MYKI + G P+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ I++ +LS ++ ++ D K +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 282 H 282
Sbjct: 303 E 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-66
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 50/304 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-------------LR 48
E Y +KLGSG++G V K+ AIK +KKS + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 49 EVKCLRKLNHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAW 107
E+ L+ L+HPNI+K+ ++ +K + V E L++ + + + F E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANI 151
Query: 108 LFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGT 163
+ Q+ G+ Y+H+ HRD+KPEN+L+ IKI DFGL+ +R+GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223
+Y APE+L K Y+ K D+W+ G IM LL P F G ++ D + K+
Sbjct: 212 AYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---------- 259
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
Y F + S++A LI+ + ++D KR TA EAL
Sbjct: 260 ---------EKGKYYFD-------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303
Query: 284 FFKR 287
+ K+
Sbjct: 304 WIKK 307
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-66
Identities = 88/292 (30%), Positives = 144/292 (49%), Gaps = 38/292 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHP 59
+ Y + ++LG G+F V + V+K +G A K + +R+ RE + RKL HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 60 NIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIV++ + I E+ + VF+ + L++ + A++ +SE+ + Q+ + Y
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYC 144
Query: 119 HQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
H G HR+LKPENLL++ +K+ADFGLA E++ + GT Y +PE+L K
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
YS VD+WA G I+ LL+ P F D+ +I A
Sbjct: 205 DP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------------------KA 244
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
Y +P S + + +A +LI+S+ + +P KR TA +AL+ P+
Sbjct: 245 GAYDYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-66
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 32/288 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ Y + ++LGSG+FG V + V K +G V K + Y +K E+ + +L+HP +
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+ + + +K + + E + +L + + SE+ V ++ Q GL +MH+
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 122 GYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
H D+KPEN++ ++KI DFGLA +++ T + APEI+ +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-V 227
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
DMWA+G + LL F G D+ + + + +++
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------------DWE 268
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
F S S +A + I++L +P KR T +AL+HP+ K
Sbjct: 269 FD-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-66
Identities = 77/310 (24%), Positives = 128/310 (41%), Gaps = 41/310 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-----LREVKCLRKL 56
+ Y L + +G G F V + +N+ +G+ A+K + + RE L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
HP+IV++ E G ++ VFE M +L + + ++SE+ ++ Q+ L
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 116 DYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREI-DAFPPYTERVGTRWYQAPE 170
Y H HRD+KP +L++ +K+ FG+A ++ ++ RVGT + APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
++ + Y VD+W G I+ LL F GT E ++
Sbjct: 204 VVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKE-----RL---------------FE 242
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290
+ Y+ SE A +L+ + DP +R T EAL HP+ K
Sbjct: 243 GIIKGKYKMN-------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295
Query: 291 VP--PHLRST 298
HL T
Sbjct: 296 YAYKIHLPET 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-66
Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 43/299 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--------LREVKCL 53
++Y ++K LGSG+ G V A + + + VAI+ + K E++ L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
+KLNHP I+K+K + + + V E M+ +L + ++ E+ K + +Q+
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--ELFDKVVGNKR-LKEATCKLYFYQMLL 250
Query: 114 GLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ Y+H+ G HRDLKPEN+L+S IKI DFG ++ + GT Y AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 170 EILFKSGL--YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
E+L G Y+ VD W++G I+ L P F +
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD--------------- 355
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
Q + Y F + SE A++L++ L DP R T EAL+HP+ +
Sbjct: 356 ---QITSGKYNFI-------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-66
Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 37/295 (12%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK---KSYSREKCLNLREVKCLRKLN 57
+ + + KK+G G F V++A G VA+K ++ ++ + ++E+ L++LN
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HPN++K +E + V E +L ++++ K++++L E V + Q+ L+
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 117 YMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTE-RVGTRWYQAPEILFK 174
+MH + HRD+KP N + + G +K+ D GL R + VGT +Y +PE + +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQG--TDEADQMYKICSVLGSPTMDSWADGLRQA 232
+G Y+ K D+W++G ++ E+ + F G + KI
Sbjct: 211 NG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---------------- 253
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+P L + SE+ L+ + DP KRP
Sbjct: 254 -----DYPPLPSDHY-------SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-66
Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 37/290 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + + LGSG+F V+ + +G++ A+K +KKS + E+ L+K+ H NI
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V ++++ + + V + L+ + + ++E + QV + Y+H+
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGV----YTEKDASLVIQQVLSAVKYLHE 124
Query: 121 QGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
G HRDLKPENLL I I DFGL++ ++ + GT Y APE+L +
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS VD W++G I LL P F E+ KI
Sbjct: 184 -YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI-------------------KEGY 223
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
Y+F S SE A + I L DP +R T +AL HP+
Sbjct: 224 YEFE-------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-66
Identities = 91/322 (28%), Positives = 135/322 (41%), Gaps = 63/322 (19%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIK-----ALKKSYSREKCLNLREVKCLRK 55
+Y + LG G F ++ + + EV A K L K + REK E+ R
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRS 71
Query: 56 LNHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
L H ++V + VF V E C + +L +L + +K +E + +L Q+ G
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLG 127
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV----GTRWYQAP 169
Y+H+ HRDLK NL + +KI DFGLA +++ ER GT Y AP
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAP 184
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWADG 228
E+L K G +S +VD+W++G IM LL+ +P F+ T + Y +I
Sbjct: 185 EVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN------------ 230
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK-- 286
Y P + A +LI+ + DP RPT E L FF
Sbjct: 231 -------EYSIP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272
Query: 287 --------RCLYVPPHLRSTPA 300
CL +PP P+
Sbjct: 273 YIPARLPITCLTIPPRFSIAPS 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-65
Identities = 74/290 (25%), Positives = 122/290 (42%), Gaps = 34/290 (11%)
Query: 2 EKYSLTKK--LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHP 59
Y+++K LG G FG V + +G +A K +K ++K E+ + +L+H
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
N++++ + K ++ V E + +L + + +E ++ Q+ G+ +MH
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGG--ELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 120 QQGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
Q H DLKPEN+L IKI DFGLAR GT + APE++
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
S DMW++G I LL F G ++A+ + I +A
Sbjct: 265 -VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI-------------------LACR 304
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ SE+A I L + R +A+EAL+HP+
Sbjct: 305 WDLE-------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-65
Identities = 81/297 (27%), Positives = 131/297 (44%), Gaps = 43/297 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLRK 55
+ Y + ++LGSG F V + K +G+ A K +KK REV LR+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+ HPNI+ + ++ K +V + E + L+ + K+ +E +L Q+ G
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES----LTEDEATQFLKQILDG 120
Query: 115 LDYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ Y+H + H DLKPEN+++ IK+ DFG+A +I+A + GT + AP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
EI+ + DMW++G I LL F G + + + I
Sbjct: 181 EIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNI---------------- 223
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A+NY F + SE A + I L DP +R T A++L+H + K
Sbjct: 224 ---SAVNYDFD-------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 5e-65
Identities = 87/332 (26%), Positives = 138/332 (41%), Gaps = 46/332 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLRK 55
+ Y ++LGSG F V + K +G A K +KK ++ REV L++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+ HPN++ + E+ K +V + E + L+ + K+ +E +L Q+ G
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNG 126
Query: 115 LDYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ Y+H H DLKPEN+++ + IKI DFGLA +ID + GT + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
EI+ + DMW++G I LL F G + + + +
Sbjct: 187 EIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV---------------- 229
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289
A+NY+F + S A + I L DP KR T ++LQHP+ K
Sbjct: 230 ---SAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 290 YVPPHLRSTPAVAATRRGMLKQQGDRIDAEAL 321
R AV + K+ R +
Sbjct: 280 TQQALSRKASAVNMEK---FKKFAARKKSNNG 308
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-65
Identities = 81/316 (25%), Positives = 132/316 (41%), Gaps = 43/316 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLRK 55
+ Y + ++LGSG F V + K +G A K +KK SR REV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+ H N++ + ++ + +V + E + L+ + K+ SE +++ Q+ G
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDG 127
Query: 115 LDYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
++Y+H + H DLKPEN+++ IK+ DFGLA EI+ + GT + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
EI+ + DMW++G I LL F G + + + I
Sbjct: 188 EIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---------------- 230
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289
+++Y F SE A + I L + KR T EAL+HP+
Sbjct: 231 ---TSVSYDFD-------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 290 YVPPHLRSTPAVAATR 305
+R V
Sbjct: 281 NQQAMVRRESVVNLEN 296
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-64
Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 41/301 (13%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLN 57
+E + + + LG G FG V+ A K S ++A+K L K+ + + REV+ L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HPNI+++ + V+ + E +Y+ + QK F E ++ ++ L
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALS 123
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Y H + HRD+KPENLL+ S G +KIADFG + + GT Y PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGR 182
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
+ KVD+W++G + E L+ +P F+ + +I V
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------------- 222
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHL 295
+ FP +E A +LI L +P +RP E L+HP+ P +
Sbjct: 223 EFTFP-----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271
Query: 296 R 296
+
Sbjct: 272 Q 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-64
Identities = 86/299 (28%), Positives = 137/299 (45%), Gaps = 43/299 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS-------YSREKCLNL-REVKCL 53
++Y ++K LGSG+ G V A + + + VAIK + K + LN+ E++ L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
+KLNHP I+K+K + + + V E M+ +L + ++ E+ K + +Q+
Sbjct: 70 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--ELFDKVVGNKR-LKEATCKLYFYQMLL 125
Query: 114 GLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ Y+H+ G HRDLKPEN+L+S IKI DFG ++ + GT Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 170 EILFKSGL--YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
E+L G Y+ VD W++G I+ L P F +
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD--------------- 230
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
Q + Y F + SE A++L++ L DP R T EAL+HP+ +
Sbjct: 231 ---QITSGKYNFI-------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-64
Identities = 98/339 (28%), Positives = 158/339 (46%), Gaps = 52/339 (15%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK--KSYSREKCLNLREVKCLRKLNH-- 58
+Y + K +G GSFG V +A + + VA+K ++ K + R+ E++ L L
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA---AEEIRILEHLRKQD 154
Query: 59 ----PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
N++ + E + ++ FE + NLY+L+ KK K Q FS V+ + + +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELI--KKNKFQGFSLPLVRKFAHSILQC 212
Query: 115 LDYMHQQGYFHRDLKPENLLVSQG---TIKIADFGLA-REIDAFPPYTERVGTRWYQAPE 170
LD +H+ H DLKPEN+L+ Q IK+ DFG + E Y + +R+Y+APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY---IQSRFYRAPE 269
Query: 171 ILFKSGL-YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP--------- 220
++ G Y +DMW++G I+AELL PL G DE DQ+ + +LG P
Sbjct: 270 VIL--GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 221 ---------------TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDA-----IN 260
T+ + +DG + +L G S +A + ++
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 261 LIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
++ WDP R T +AL+HP+ +R L PP T
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTS 426
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-64
Identities = 79/337 (23%), Positives = 134/337 (39%), Gaps = 77/337 (22%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-----LREVKCLRKL 56
+KY L +G GS+G V A+ + + AIK + K+ R+ EV+ ++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQ---------------------------------- 82
+HPNI ++ E+ ++ + V E
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 83 ---CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS--- 136
+ ++ + E + + Q+F L Y+H QG HRD+KPEN L S
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 137 QGTIKIADFGLAREIDAFPP-----YTERVGTRWYQAPEILFKSGL-YSSKVDMWAMGAI 190
IK+ DFGL++E T + GT ++ APE+L + Y K D W+ G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 191 MAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSAL 250
+ LL+ F G ++AD + ++ + F +
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNK-------------------KLCFE-------NPN 299
Query: 251 MPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
S A +L+ +L + + +R A ALQHP+ +
Sbjct: 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 2e-64
Identities = 73/330 (22%), Positives = 133/330 (40%), Gaps = 32/330 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ Y + ++LG+G+FG V + + +G A K + + +K +E++ + L HP +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V + + + + ++E + +L E + SE ++ QV +GL +MH+
Sbjct: 217 VNLHDAFEDDNEMVMIYEF--MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 122 GYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
Y H DLKPEN++ + +K+ DFGL +D GT + APE+ +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKPV 333
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
DMW++G + LL F G ++ + + + S ++
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------------------DWN 374
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRST 298
+ SED + I L DP R T +AL+HP+ +
Sbjct: 375 MD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427
Query: 299 PAVAATRRGMLKQQGDRIDAEALPYPKIVK 328
+ R +K + D P +I
Sbjct: 428 SSRYTKIRDSIKTKYDAWPEPLPPLGRISN 457
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-64
Identities = 84/316 (26%), Positives = 133/316 (42%), Gaps = 43/316 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLRK 55
+ Y + ++LGSG F V + K +G A K +KK SR REV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+ HPNI+ + ++ + +V + E + L+ + K+ SE +++ Q+ G
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDG 127
Query: 115 LDYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
++Y+H + H DLKPEN+++ IK+ DFGLA EI+ + GT + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
EI+ + DMW++G I LL F G + + + I
Sbjct: 188 EIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---------------- 230
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289
A++Y F SE A + I L + KR T EAL+HP+
Sbjct: 231 ---TAVSYDFD-------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 290 YVPPHLRSTPAVAATR 305
+R V
Sbjct: 281 TQQAMVRRESVVNLEN 296
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-64
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
EKY + + LG G FG V + V S + K +K + + + +E+ L H NI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV-KKEISILNIARHRNI 63
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+ + E + +FE + + E +E + +++ QV L ++H
Sbjct: 64 LHLHESFESMEELVMIFEF--ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 122 GYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
H D++PEN++ TIKI +FG AR++ + Y APE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV-V 180
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
S+ DMW++G ++ LL F + I M Y
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-------------------MNAEYT 221
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
F S +A++ ++ L + R TA+EALQHP+ K+
Sbjct: 222 FD-------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 6e-64
Identities = 76/343 (22%), Positives = 124/343 (36%), Gaps = 63/343 (18%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNI 61
+ LG G+ G + VA+K + REV+ LR+ + HPN+
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNV 80
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
++ ++ + E L + +E QK L Q GL ++H
Sbjct: 81 IRYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 122 GYFHRDLKPENLLV------SQGTIKIADFGLAREID----AFPPYTERVGTRWYQAPEI 171
HRDLKP N+L+ + I+DFGL +++ +F + GT + APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 172 LFKSGL--YSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
L + + VD+++ G + ++ F + + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--------------- 242
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
L A LIE + + DP KRP+A L+HPFF
Sbjct: 243 ------GACSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS- 289
Query: 289 LYVPPHLRSTPAVAATRRGMLKQQGDRIDAEALPYPKIVKQLS 331
+ + DRI+ E+L P IVKQL
Sbjct: 290 -------------LEKQLQFFQDVSDRIEKESLDGP-IVKQLE 318
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 7e-64
Identities = 84/314 (26%), Positives = 130/314 (41%), Gaps = 38/314 (12%)
Query: 2 EKYSLTKK-LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
Y LT K LG G F V Q ++K +G+ A K LKK + C L E+ L
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 59 -PNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
P ++ + E+ + + E ++ L + + SE+ V + Q+ G+
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVY 145
Query: 117 YMHQQGYFHRDLKPENLLV----SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
Y+HQ H DLKP+N+L+ G IKI DFG++R+I E +GT Y APEIL
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL 205
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
++ DMW +G I LL F G D + I
Sbjct: 206 NYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI------------------- 245
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVP 292
+N + S S+ A + I+SL +P KRPTA L H + ++ +
Sbjct: 246 SQVNVDYS-------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298
Query: 293 PHLRSTPAVAATRR 306
+ ++ +
Sbjct: 299 LFHPEETSSSSQTQ 312
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-64
Identities = 87/297 (29%), Positives = 142/297 (47%), Gaps = 47/297 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS----YSREKCLNLREVKCLRKLN 57
E+Y L ++LG G+F V + V +G+ A + +K RE + R L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE--REARICRLLK 68
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HPNIV++ + I E+G+ + +F+ L++ + A++ +SE+ + Q+ +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVL 124
Query: 117 YMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEI 171
+ HQ G HR+LKPENLL++ +K+ADFGLA E++ + GT Y +PE+
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS--WADGL 229
L K Y VD+WA G I+ LL+ P F D+ +I + G+ S W
Sbjct: 185 LRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--GAYDFPSPEW---- 237
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ + +A +LI + + +P KR TAAEAL+HP+
Sbjct: 238 ----------------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-63
Identities = 71/310 (22%), Positives = 118/310 (38%), Gaps = 59/310 (19%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKL-NH 58
++ +K+GSG FG V++ V + G + AIK KK + LREV L H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 59 PNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
++V+ E ++ E C +L + + F E+ +K L QV RGL Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 118 MHQQGYFHRDLKPENLLVSQ--------------------GTIKIADFGLAREIDAFPPY 157
+H H D+KP N+ +S+ KI D G I + P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQ 188
Query: 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
E G + A E+L ++ + K D++A+ + PL DQ ++I
Sbjct: 189 VE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQ-- 242
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA 277
G P++ S++ L++ + DP +RP+A
Sbjct: 243 GRL-------------------PRIPQ--------VLSQEFTELLKVMIHPDPERRPSAM 275
Query: 278 EALQHPFFKR 287
++H
Sbjct: 276 ALVKHSVLLS 285
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-63
Identities = 91/321 (28%), Positives = 134/321 (41%), Gaps = 63/321 (19%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIK-----ALKKSYSREKCLNLREVKCLRK 55
+Y + LG G F ++ + + EV A K L K + REK E+ R
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRS 97
Query: 56 LNHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
L H ++V + VF V E C + +L +L + +K +E + +L Q+ G
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLG 153
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV----GTRWYQAP 169
Y+H+ HRDLK NL + +KI DFGLA +++ ER GT Y AP
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAP 210
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWADG 228
E+L K G +S +VD+W++G IM LL+ +P F+ T + Y +I
Sbjct: 211 EVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN------------ 256
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR- 287
Y P + A +LI+ + DP RPT E L FF
Sbjct: 257 -------EYSIP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
Query: 288 ---------CLYVPPHLRSTP 299
CL +PP P
Sbjct: 299 YIPARLPITCLTIPPRFSIAP 319
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-63
Identities = 64/311 (20%), Positives = 114/311 (36%), Gaps = 45/311 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ Y +KLG G F V H G A+K + +++ RE R NHPNI
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 62 VKVKELIVEKGN----VFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+++ + + + + + L+ +E K K +E + L + RGL+
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 117 YMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE----------RVGTRW 165
+H +GY HRDLKP N+L+ G + D G + + + T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 166 YQAPEI--LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223
Y+APE+ + + + D+W++G ++ ++ + +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--------------- 253
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
D + A+ PQ P S L+ S+ + DP +RP L
Sbjct: 254 ---DSVALAVQNQLSIPQ---------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 284 FFKRCLYVPPH 294
+ H
Sbjct: 302 EALQPPAPGQH 312
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-63
Identities = 86/310 (27%), Positives = 128/310 (41%), Gaps = 61/310 (19%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---------LREVKC 52
E Y + LG G V + ++K + + A+K + + L+EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 53 LRKLN-HPNIVKVKELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESA 103
LRK++ HPNI+++K+ F VF+ LM+ +K SE
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFD--------LMKKGELFDYLTEKVT---LSEKE 125
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVG 162
+ + + + +H+ HRDLKPEN+L+ IK+ DFG + ++D E G
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 185
Query: 163 TRWYQAPEILFKSGL-----YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
T Y APEI+ S Y +VDMW+ G IM LL P F + + I
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---- 241
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA 277
M+ NYQF S S+ +L+ P KR TA
Sbjct: 242 ---------------MSGNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 278 EALQHPFFKR 287
EAL HPFF++
Sbjct: 280 EALAHPFFQQ 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-62
Identities = 76/315 (24%), Positives = 126/315 (40%), Gaps = 59/315 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
K LG GS G V G VA+K + + L E+K L + +HPN
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPN 70
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKK---QKQQLFSESAVKAWLFQVFRGLDY 117
+++ ++ E NL L+E+K + +L E + L Q+ G+ +
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 118 MHQQGYFHRDLKPENLLVS--------------QGTIKIADFGLAREIDA-----FPPYT 158
+H HRDLKP+N+LVS I I+DFGL +++D+
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 159 ERVGTRWYQAPEILFKSGL------YSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMY 211
GT ++APE+L +S + +D+++MG + +L + F D+ +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKYSRES 248
Query: 212 KICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPC 271
I + + ++ S +A +LI + DP
Sbjct: 249 NI-------------------IRGIFSLDEMK----CLHDRSLIAEATDLISQMIDHDPL 285
Query: 272 KRPTAAEALQHPFFK 286
KRPTA + L+HP F
Sbjct: 286 KRPTAMKVLRHPLFW 300
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-62
Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 37/290 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + + +LG G+ V++ K + + A+K LKK+ ++ E+ L +L+HPNI
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNI 110
Query: 62 VKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+K+KE+ + V E L+ + K +SE + Q+ + Y+H+
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLHE 166
Query: 121 QGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
G HRDLKPENLL + +KIADFGL++ ++ GT Y APEIL
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y +VDMW++G I LL F M+ R+ +
Sbjct: 227 -YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------------------RRILNCE 267
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
Y F S S +A +L+ L DP KR T +ALQHP+
Sbjct: 268 YYFI-------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-62
Identities = 81/331 (24%), Positives = 144/331 (43%), Gaps = 48/331 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
+ Y + + +G GS+ + ++K + A+K + KS K E++ L + HPN
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KRDPTEEIEILLRYGQHPN 77
Query: 61 IVKVKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
I+ +K++ + V+ V E M+ L + +K FSE A LF + + ++Y+H
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITKTVEYLH 133
Query: 120 QQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAF-PPYTERVGTRWYQAPEILF 173
QG HRDLKP N+L +I+I DFG A+++ A T + APE+L
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+ G Y + D+W++G ++ +L F + +I L +
Sbjct: 194 RQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEI---------------LARIG 236
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293
+ + S S+ A +L+ + DP +R TAA L+HP+ +P
Sbjct: 237 SGKFSLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289
Query: 294 HLRSTP--------AVAATRRGMLKQQGDRI 316
+ + A+AAT + + Q +
Sbjct: 290 YQLNRQDAPHLVKGAMAATYSALNRNQSPVL 320
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-62
Identities = 84/295 (28%), Positives = 135/295 (45%), Gaps = 44/295 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLN 57
+E + + LG GSF V++A + H+G VAIK + K + + EVK +L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP+I+++ + V+ V E C+ ++ K + + FSE+ + ++ Q+ G+ Y
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEM--CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV---GTRWYQAPEILF 173
+H G HRDL NLL+ IKIADFGLA ++ P+ + GT Y +PEI
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIAT 185
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWADGLRQA 232
+S + + D+W++G + LL+ RP F TD K+
Sbjct: 186 RSA-HGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLNKVVLA---------------- 227
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+Y+ P S +A +LI L +P R + + L HPF R
Sbjct: 228 ---DYEMP-----------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 7e-62
Identities = 84/309 (27%), Positives = 126/309 (40%), Gaps = 60/309 (19%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL--------REVKCL 53
+KY +G G V + V++ +G A+K ++ + R L RE L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 54 RKL-NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLME--------AKKQKQQLFSESAV 104
R++ HP+I+ + + +F VF+ LM +K SE
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFD--------LMRKGELFDYLTEKVA---LSEKET 202
Query: 105 KAWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGT 163
++ + + + ++H HRDLKPEN+L+ I+++DFG + ++ E GT
Sbjct: 203 RSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGT 262
Query: 164 RWYQAPEILFKSGL-----YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLG 218
Y APEIL S Y +VD+WA G I+ LL P F + + I
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI----- 317
Query: 219 SPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE 278
M YQF S S +LI L DP R TA +
Sbjct: 318 --------------MEGQYQFS-------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 279 ALQHPFFKR 287
ALQHPFF+R
Sbjct: 357 ALQHPFFER 365
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-61
Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 43/300 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLN 57
++ + + + LG G FG V+ A K + ++A+K L KS ++ + RE++ L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HPNI+++ ++ ++ + E + LY+ + QK F E ++ ++ L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALH 128
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Y H++ HRD+KPENLL+ +G +KIADFG + + T GT Y PE++
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPEMIEGK 187
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
+ KVD+W G + E L+ P F + +I +V
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------------- 227
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL--YVPP 293
+ +FP P S+ + +LI L + P +R ++HP+ K +PP
Sbjct: 228 DLKFP-----------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-61
Identities = 43/329 (13%), Positives = 85/329 (25%), Gaps = 60/329 (18%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNHP 59
K L + L G V+ + E A+K + +L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 60 NIVKVKELI--------------------------VEKGNVFFVFECMQCNLYQLMEA-- 91
+ + ++ N + +L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 92 -KKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149
+ A+ Q+ R + +G H P+NL + G + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 150 EIDAFPPYTERVGTRWYQAPEILFKSGL-YSSKVDMWAMGAIMAELLLFRPLFQGTDEAD 208
++ Y E L S ++ ++ W +G + + F
Sbjct: 243 KVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 209 QMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSW 268
+ L P DS F + + + LI ++
Sbjct: 301 KGSWKRPSLRVPGTDSL------------AFGSCTPL---------PDFVKTLIGRFLNF 339
Query: 269 DPCKRPTAAEALQHPFFKRCLYVPPHLRS 297
D +R EA++ P F + + + S
Sbjct: 340 DRRRRLLPLEAMETPEFLQ---LQNEISS 365
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-61
Identities = 83/307 (27%), Positives = 137/307 (44%), Gaps = 34/307 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
+ K LG GSF + V+K S + A+K + K +E+ L+ HPN
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQ--KEITALKLCEGHPN 67
Query: 61 IVKVKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IVK+ E+ ++ + F V E + L++ ++ KK FSE+ + ++ + +MH
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH----FSETEASYIMRKLVSAVSHMH 123
Query: 120 QQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAF-PPYTERVGTRWYQAPEILFK 174
G HRDLKPENLL + IKI DFG AR P T Y APE+L +
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
+G Y D+W++G I+ +L + FQ D S T S + +++
Sbjct: 184 NG-YDESCDLWSLGVILYTMLSGQVPFQSHDR------------SLTCTSAVEIMKKIKK 230
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPH 294
++ F + S++A +LI+ L + DP KR + + + + + +
Sbjct: 231 GDFSFE-------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283
Query: 295 LRSTPAV 301
TP +
Sbjct: 284 PLMTPDI 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 6e-61
Identities = 91/335 (27%), Positives = 145/335 (43%), Gaps = 59/335 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK--KSYSREKCLNLREVKCLRKLNHP 59
++Y + +G GSFG V +A ++ E VAIK +K K++ + EV+ L +N
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQIEVRLLELMNKH 110
Query: 60 ------NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
IV +K + + ++ VFE + NLY L+ + + S + + + Q+
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLL--RNTNFRGVSLNLTRKFAQQMCT 168
Query: 114 GLDYMHQQ--GYFHRDLKPENLLVSQG---TIKIADFGLAREIDAFP-PYTERVGTRWYQ 167
L ++ H DLKPEN+L+ IKI DFG + ++ Y + +R+Y+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY---IQSRFYR 225
Query: 168 APEILFKSGL-YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM---- 222
+PE+L G+ Y +DMW++G I+ E+ PLF G +E DQM KI VLG P
Sbjct: 226 SPEVLL--GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
Query: 223 ---------DSWADG---------------------LRQAMAINYQFPQLSGVNLSALMP 252
+ DG L + + P S
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343
Query: 253 SASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ +LI + +DP R ALQH FFK+
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-60
Identities = 84/349 (24%), Positives = 139/349 (39%), Gaps = 46/349 (13%)
Query: 2 EKYSLTKK-LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHP 59
+ Y +T + LG G G V Q NK + E A+K L+ K REV+ + P
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKAR--REVELHWRASQCP 115
Query: 60 NIVKVKE----LIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+IV++ + L + + V EC+ L+ ++ + + F+E + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEA 173
Query: 115 LDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPE 170
+ Y+H HRD+KPENLL + +K+ DFG A+E + T T +Y APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+L Y DMW++G IM LL P F +
Sbjct: 234 VLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------KT 277
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290
+ Y+FP + SE+ LI +L +P +R T E + HP+ +
Sbjct: 278 RIRMGQYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 291 VPPHLRSTPAVA----ATRRGMLKQQGDRIDAEALPYPKI-VKQLSPLD 334
VP T V + ++ + + Y +I +K++
Sbjct: 331 VPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDAS 379
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-60
Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 42/322 (13%)
Query: 2 EKYSLTKK-LGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNLREVKCLRKL-N 57
+ Y L + LG G+ V +N + + A+K ++K + R + REV+ L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQG 69
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
H N++++ E E+ + VFE M+ + + ++ F+E + V LD
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALD 125
Query: 117 YMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREID--------AFPPYTERVGTR 164
++H +G HRDLKPEN+L +KI DF L I + P G+
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 165 WYQAPEILFKSGL----YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220
Y APE++ Y + D+W++G I+ LL P F G +D C
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD-----CGWDRGE 240
Query: 221 TMDSWADGLRQA-MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA 279
+ + L ++ Y+FP S A +LI L D +R +AA+
Sbjct: 241 ACPACQNMLFESIQEGKYEFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
Query: 280 LQHPFFKRCLYVPPHLRSTPAV 301
LQHP+ + C P + TP V
Sbjct: 294 LQHPWVQGC--APENTLPTPMV 313
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 9e-60
Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 20/296 (6%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPNI 61
+ + ++LG+G FG V + +++ +GE VAIK ++ S + E++ ++KLNHPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 62 VKVKELIVEKGNV------FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
V +E+ + E + +L + + + + E ++ L +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSA 133
Query: 115 LDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPE 170
L Y+H+ HRDLKPEN+++ + KI D G A+E+D TE VGT Y APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+L + Y+ VD W+ G + E + F + Q + S D L
Sbjct: 194 LL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDLT 251
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A+ + P + L + ++ + W +R T + F+
Sbjct: 252 GAVKFSSVLPTPNH-----LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-59
Identities = 79/311 (25%), Positives = 126/311 (40%), Gaps = 42/311 (13%)
Query: 2 EKYSLTKK-LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHP 59
+ Y L+K+ LG G G V + ++ +G+ A+K L K +EV + P
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKAR--QEVDHHWQASGGP 82
Query: 60 NIVKVKEL----IVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+IV + ++ K + + ECM+ L+ ++ + + F+E + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA--FTEREAAEIMRDIGTA 140
Query: 115 LDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPE 170
+ ++H HRD+KPENLL + +K+ DFG A+E T +Y APE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPE 199
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+L Y DMW++G IM LL P F + R
Sbjct: 200 VLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---------------KR 243
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290
+ Y FP + SEDA LI L DP +R T + + HP+ + +
Sbjct: 244 RIRLGQYGFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296
Query: 291 VPPHLRSTPAV 301
VP T V
Sbjct: 297 VPQTPLHTARV 307
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-59
Identities = 72/336 (21%), Positives = 135/336 (40%), Gaps = 61/336 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK--KSYSREKCLNLREVKCLRKLNH- 58
+ + +K+G G+FG V + + + A+K ++ K Y+R E L+K+ +
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQND 91
Query: 59 ----PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
NIVK + ++ +FE + +LY+++ + F +K + ++ +
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEII--TRNNYNGFHIEDIKLYCIEILKA 149
Query: 115 LDYMHQQGYFHRDLKPEN-LLVSQG-------------------------TIKIADFGLA 148
L+Y+ + H DLKPEN LL IK+ DFG A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 149 -REIDAFPPYTERVGTRWYQAPEILFKSGL-YSSKVDMWAMGAIMAELLLFRPLFQGTDE 206
+ D + TR Y+APE++ L + DMW+ G ++AEL LF+ +
Sbjct: 210 TFKSDYHGSI---INTRQYRAPEVIL--NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264
Query: 207 ADQMYKICSVLGSPTMDSWADGLRQAM-------AINYQFPQLSGV---------NLSAL 250
+ + + S++ + + + + +P+ + L
Sbjct: 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324
Query: 251 MPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
E + + S+ DP RP+ AE L+H F +
Sbjct: 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 79/350 (22%), Positives = 137/350 (39%), Gaps = 58/350 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-NKHSGEVVAIKALK--KSYSREKCLNLREVKCLRKLNH 58
E+Y + LG G+FG V + + + VA+K ++ Y E+ L+K+
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKE 75
Query: 59 P------NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
V + + G++ FE + N ++ + K+ Q + V+ +Q+
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL--KENNFQPYPLPHVRHMAYQLC 133
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQGT--------------------IKIADFGLA-REI 151
L ++H+ H DLKPEN+L I++ADFG A +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 152 DAFPPYTERVGTRWYQAPEILFKSGL-YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQM 210
+ V TR Y+ PE++ L ++ D+W++G I+ E LFQ + + +
Sbjct: 194 EHHTTI---VATRHYRPPEVIL--ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 211 YKICSVLGSPTMDSWADGLRQAM----AINYQFPQLSGV-------NLSALMPSASED-- 257
+ +LG +Q + + G L + M S +
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 258 -AINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTPAVAATRR 306
+L+ + +DP +R T AEAL HPFF + P RS R
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAG---LTPEERSFHTSRNPSR 355
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-58
Identities = 87/330 (26%), Positives = 141/330 (42%), Gaps = 51/330 (15%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLN--- 57
+Y L +KLG G F VW A + + VA+K ++ + E+K L+++N
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDAD 76
Query: 58 --------HPNIVKVKELIVEKGN----VFFVFECMQCNLYQLMEAKKQKQQLFSESAVK 105
+I+K+ + KG V VFE + NL L+ KK + + VK
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVK 134
Query: 106 AWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVS-------QGTIKIADFGLAREIDAFPPY 157
Q+ GLDYMH++ G H D+KPEN+L+ IKIAD G A D Y
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQG------TDEADQMY 211
T + TR Y++PE+L + + D+W+ ++ EL+ LF+ T + D +
Sbjct: 193 TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 212 KICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVN---------LSALMPSASEDA---I 259
+I +LG +G N + + L+ + ++A
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 260 NLIESLCSWDPCKRPTAAEALQHPFFKRCL 289
+ + + DP KR A + HP+ K L
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-57
Identities = 82/335 (24%), Positives = 137/335 (40%), Gaps = 63/335 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVN-KHSGEVVAIKALK--KSYSREKCLNLREVKCLRKLNH 58
+Y + LG G+FG V + ++ K G VA+K +K Y E++ L LN
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNT 70
Query: 59 P------NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
V++ E G++ VFE + + Y + K+ F ++ +Q+
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFI--KENGFLPFRLDHIRKMAYQIC 128
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQGT--------------------IKIADFGLA-REI 151
+ ++++H H DLKPEN+L Q IK+ DFG A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 152 DAFPPYTERVGTRWYQAPEILFKSGL-YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQM 210
+ V TR Y+APE++ L +S D+W++G I+ E L +F D + +
Sbjct: 189 EHHSTL---VSTRHYRAPEVIL--ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 211 YKICSVLGSPTMDSWADGLRQAMAINY------QFPQLSGV---------NLSALMPSAS 255
+ +LG +++ Y + + S L M S
Sbjct: 244 AMMERILGPLPKHM----IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 256 ED---AINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ +LI+ + +DP KR T EAL+HPFF
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 3e-55
Identities = 72/360 (20%), Positives = 125/360 (34%), Gaps = 108/360 (30%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK---KSYSREKCLNLREVKCLRKLN 57
+ + + +G G FG V++A NK AIK ++ + +REK +REVK L KL
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV--MREVKALAKLE 62
Query: 58 HPNIVKV----------------------------------------------KELIVEK 71
HP IV+ +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 72 GNVFFVFECMQCNLYQLME-----------AKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ LY M+ ++ + Q+ ++++H
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 121 QGYFHRDLKPEN-LLVSQGTIKIADFGLAREID-------------AFPPYTERVGTRWY 166
+G HRDLKP N +K+ DFGL +D A+ +T +VGT+ Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
+PE + + YS KVD++++G I+ ELL + + +
Sbjct: 243 MSPEQIHGNN-YSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVR------------ 287
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
N +FP L +++ + S P +RP A + +++ F+
Sbjct: 288 ---------NLKFPLLF--------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-54
Identities = 58/333 (17%), Positives = 118/333 (35%), Gaps = 58/333 (17%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL------------- 47
+ Y + + L G F + + + A+K +KS +K
Sbjct: 30 INDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 48 ----REVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAK----KQKQQL 98
E++ + + + + + +I V+ ++E M+ ++ + E K
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 99 FSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP 156
+K + V Y+H + HRD+KP N+L+ G +K++DFG + +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 157 YTERVGTRWYQAPEILFKSGLYS-SKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KIC 214
GT + PE Y+ +KVD+W++G + + F +++ I
Sbjct: 208 KG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSA--------SEDAINLIESLC 266
+ N ++P L L S + I+ ++
Sbjct: 267 TK-------------------NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL 307
Query: 267 SWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
+P +R T+ +AL+H + LR
Sbjct: 308 RKNPAERITSEDALKHEWLAD--TNIEDLREFS 338
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 46/334 (13%), Positives = 94/334 (28%), Gaps = 84/334 (25%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL---REVKCLRKL-------- 56
LG +A ++ +GE + + EV LR L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 57 -----------------NHPNIVKVKEL--IVEKGNVFFVFECMQCNLYQLME---AKKQ 94
+++V+ + + FF++ MQ NL E +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 95 KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153
+ A QV R L +H G H L+P ++++ Q G + + F A
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 154 FPPYTERVGTRWYQAPEILFKSGL----------YSSKVDMWAMGAIMAELLLFRPLFQG 203
+R ++ PE+ + + D WA+G ++ +
Sbjct: 259 ---RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 204 TDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIE 263
I ++ + + L+E
Sbjct: 316 DAALGGSEWI-----------------------FRSC-----------KNIPQPVRALLE 341
Query: 264 SLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS 297
+ R +A++ P +++ + L +
Sbjct: 342 GFLRYPKEDRLLPLQAMETPEYEQ---LRTELSA 372
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 51/306 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--------LREVKC 52
+KYS LGSG+FG VW AV+K + V +K +KK E C E+
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 53 LRKLNHPNIVKVKELIVEKGNVFFVFE--CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
L ++ H NI+KV ++ +G V E +L+ ++ + E Q
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQ 138
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ + Y+ + HRD+K EN+++ TIK+ DFG A ++ + GT Y AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
E+L + +++MW++G + L+ F L
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPF-------------------------CEL 233
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289
+ + P S++ ++L+ L P +R T + + P+ + +
Sbjct: 234 EETVEAAIHPP-----------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282
Query: 290 YVPPHL 295
+ +
Sbjct: 283 NLADYT 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-51
Identities = 75/287 (26%), Positives = 118/287 (41%), Gaps = 35/287 (12%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKEL 67
LG G++G V+ + + +AIK + + SR E+ + L H NIV+
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 68 IVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHR 126
E G + E +L L+ +K + +E + + Q+ GL Y+H HR
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 127 DLKPENLLVS--QGTIKIADFGLAREIDAFPPYTER-VGTRWYQAPEILFKSGL-YSSKV 182
D+K +N+L++ G +KI+DFG ++ + P TE GT Y APEI+ K Y
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 183 DMWAMGAIMAELLLFRPLFQGTDEADQ-MYKICSVLGSPTMDSWADGLRQAMAINYQFPQ 241
D+W++G + E+ +P F E M+K+ P + P
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP-----------------EIP- 248
Query: 242 LSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
S S +A I DP KR A + L F K
Sbjct: 249 ----------ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-51
Identities = 77/309 (24%), Positives = 125/309 (40%), Gaps = 60/309 (19%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNI 61
+ + + L G F V++A + SG A+K L + + ++EV ++KL HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 62 VK--------VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
V+ +E + + E + L + ++ K + + S V +Q R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCR 147
Query: 114 GLDYMHQQG--YFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYT------------ 158
+ +MH+Q HRDLK ENLL+S QGTIK+ DFG A I +P Y+
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 159 -ERVGTRWYQAPEI--LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICS 215
R T Y+ PEI L+ + K D+WA+G I+ L + F E +I +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVN 263
Query: 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT 275
Y P + +LI ++ +P +R +
Sbjct: 264 G-------------------KYSIPP---------HDTQYTVFHSLIRAMLQVNPEERLS 295
Query: 276 AAEALQHPF 284
AE +
Sbjct: 296 IAEVVHQLQ 304
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-51
Identities = 66/291 (22%), Positives = 121/291 (41%), Gaps = 45/291 (15%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVK-- 63
++G GSF V++ ++ + VA L+ + E + L+ L HPNIV+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 64 --VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ + K + V E M L + ++ ++ +++W Q+ +GL ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 121 QGYF--HRDLKPENLLVS--QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
+ HRDLK +N+ ++ G++KI D GLA A +GT + APE +++
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPE-MYEEK 205
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y VD++A G M E+ + A Q+Y+ +
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--------------------- 243
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
SGV ++ A + +IE + +R + + L H FF+
Sbjct: 244 ------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-51
Identities = 75/309 (24%), Positives = 136/309 (44%), Gaps = 47/309 (15%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL----REVKCLRKLNH 58
KY + LG GS+G V + ++ + A+K LKK R +E++ LR+L H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 59 PNIVKVKELIV--EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
N++++ +++ EK ++ V E C + +++++ +K+ F + Q+ GL+
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLE 123
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP----YTERVGTRWYQAPEI 171
Y+H QG H+D+KP NLL+ + GT+KI+ G+A + F T G+ +Q PEI
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEI 182
Query: 172 LFKSGLYS-SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+S KVD+W+ G + + F+G + I
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-------------- 228
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290
+Y P +L++ + ++P KR + + QH +F++
Sbjct: 229 -----SYAIP-----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK--K 270
Query: 291 VPPHLRSTP 299
PP P
Sbjct: 271 HPPAEAPVP 279
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-50
Identities = 68/301 (22%), Positives = 112/301 (37%), Gaps = 61/301 (20%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
+ ++ LG G G V Q NK + E A+K L+ REV+ + P+
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPH 72
Query: 61 IVKVKEL----IVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
IV++ ++ + + V EC+ L+ ++ + + F+E + + +
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAI 130
Query: 116 DYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171
Y+H HRD+KPENLL + +K+ DFG A E
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKET 170
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ Y DMW++G IM LL P F + +
Sbjct: 171 TGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------KTR 213
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYV 291
Y+FP + SE+ LI +L +P +R T E + HP+ + V
Sbjct: 214 IRMGQYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266
Query: 292 P 292
P
Sbjct: 267 P 267
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-50
Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 38/295 (12%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPN 60
Y L K +G G+F V A + +G VAIK + K+ L REV+ ++ LNHPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 61 IVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IVK+ E+I + ++ + E ++ + A + E ++ Q+ + Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCH 131
Query: 120 QQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
Q+ HRDLK ENLL+ + IKIADFG + E G Y APE+
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
+VD+W++G I+ L+ F G + + ++ + Y+
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-------------------LRGKYR 232
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293
P S D NL++ +P KR T + ++ +
Sbjct: 233 IP-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-50
Identities = 41/308 (13%), Positives = 100/308 (32%), Gaps = 59/308 (19%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSREKCLNLREVKCLRKL 56
+ + LG G+F V++A + + +K K + E + + ++ L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLM-EAKKQKQQLFSESAVKAWLFQVFRG 114
+K + + V E L + K +++ + V ++ ++
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 115 LDYMHQQGYFHRDLKPENLLV------------SQGTIKIADFGLAREIDAFPP---YTE 159
++ +H H D+KP+N ++ + + D G + ++ FP +T
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 160 RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL-G 218
+ T +Q E+L ++ ++D + + A + +L + K +
Sbjct: 245 KCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMK--VKNEGGECKPEGLFRR 301
Query: 219 SPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE 278
P +D W + + + C + +
Sbjct: 302 LPHLDMWNE---------------------------------FFHVMLNIPDCHHLPSLD 328
Query: 279 ALQHPFFK 286
L+ K
Sbjct: 329 LLRQKLKK 336
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-49
Identities = 67/293 (22%), Positives = 118/293 (40%), Gaps = 37/293 (12%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHP 59
+E + L + LG G++G V AVN+ + E VA+K + + + N+ +E+ + LNH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 60 NIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
N+VK E + E C L+ +E E + + Q+ G+ Y+
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYL 121
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTE---RVGTRWYQAPEILFK 174
H G HRD+KPENLL+ + +KI+DFGLA GT Y APE+L +
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
++ VD+W+ G ++ +L + ++ Q Y
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------------------SDWKE 223
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ + L+ + +P R T + + ++ +
Sbjct: 224 KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 77/304 (25%), Positives = 134/304 (44%), Gaps = 37/304 (12%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
++Y K +GSG+FG +K + E+VA+K +++ + ++ + RE+ R L HPN
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPN 77
Query: 61 IVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV+ KE+I+ ++ + E LY+ + + FSE + + Q+ G+ Y H
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGR---FSEDEARFFFQQLLSGVSYCH 133
Query: 120 QQGYFHRDLKPENLLV---SQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKS 175
HRDLK EN L+ +KI DFG ++ P + VGT Y APE+L +
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRQ 192
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
D+W+ G + +L+ F+ +E K +++ +++
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT---------------IQRILSV 237
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHL 295
Y P + S + +LI + DP R + E H +F + L P L
Sbjct: 238 KYSIPDDIRI---------SPECCHLISRIFVADPATRISIPEIKTHSWFLKNL--PADL 286
Query: 296 RSTP 299
+
Sbjct: 287 MNES 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-48
Identities = 70/308 (22%), Positives = 122/308 (39%), Gaps = 40/308 (12%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHP 59
+E + L + LG G++G V AVN+ + E VA+K + + + N+ +E+ + LNH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 60 NIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
N+VK E + E C L+ +E E + + Q+ G+ Y+
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYL 121
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTE---RVGTRWYQAPEILFK 174
H G HRD+KPENLL+ + +KI+DFGLA GT Y APE+L +
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
++ VD+W+ G ++ +L + ++ Q Y
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------------------SDWKE 223
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL---YV 291
+ + L+ + +P R T + + ++ + L
Sbjct: 224 KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 292 PPHLRSTP 299
P + S
Sbjct: 275 RPRVTSGG 282
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-48
Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 64/317 (20%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL--------------- 47
+Y+L ++G GS+G V A N++ A+K L K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 48 -----------REVKCLRKLNHPNIVKVKELI--VEKGNVFFVFECMQCNLYQLMEAKKQ 94
+E+ L+KL+HPN+VK+ E++ + +++ VFE N +ME
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL--VNQGPVME-VPT 130
Query: 95 KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDA 153
+ L + A + + +G++Y+H Q HRD+KP NLLV G IKIADFG++ E
Sbjct: 131 LKPLSEDQARF-YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 154 FPPYTER-VGTRWYQAPEILF-KSGLYS-SKVDMWAMGAIMAELLLFRPLFQGTDEADQM 210
VGT + APE L ++S +D+WAMG + + + F
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDP 270
KI S + P +ED +LI + +P
Sbjct: 250 SKIKS--QALEFPDQ--------------------------PDIAEDLKDLITRMLDKNP 281
Query: 271 CKRPTAAEALQHPFFKR 287
R E HP+ R
Sbjct: 282 ESRIVVPEIKLHPWVTR 298
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 65/315 (20%), Positives = 118/315 (37%), Gaps = 74/315 (23%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS--YSREKCLNL----REVKCLRKL 56
+Y + LGSG FG V+ + VAIK ++K + N EV L+K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 57 NH--PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLF---------SESAVK 105
+ ++++ + + + +E + Q LF E +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLI-----------LERPEPVQDLFDFITERGALQEELAR 152
Query: 106 AWLFQVFRGLDYMHQQGYFHRDLKPENLLV--SQGTIKIADFGLAREIDAFPP---YTER 160
++ +QV + + H G HRD+K EN+L+ ++G +K+ DFG A YT+
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVYTDF 208
Query: 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSP 220
GTR Y PE + + +W++G ++ +++ F+ + +I
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII------ 256
Query: 221 TMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280
G F S + +LI + P RPT E
Sbjct: 257 ------RG-------QVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQ 292
Query: 281 QHPFFKRCLYVPPHL 295
HP+ + + +P
Sbjct: 293 NHPWMQD-VLLPQET 306
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-47
Identities = 65/319 (20%), Positives = 116/319 (36%), Gaps = 35/319 (10%)
Query: 2 EKYSLTKKLGSG--SFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL--REVKCLRKLN 57
Y L +G G V A K +GE V ++ + + + E+ + N
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HPNIV + + ++ V M + L+ +E A+ L V + LD
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALD 142
Query: 117 YMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA--------FPPYTERVGTRWYQ 167
Y+H GY HR +K ++L+S G + ++ + + V +
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 168 APEILFKSGL-YSSKVDMWAMGAIMA-ELLLFRPLFQGTD----------------EADQ 209
+PE+L ++ Y +K D++++G I A EL F+
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWD 269
+ SP+ GL ++ + P + S + +E +
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321
Query: 270 PCKRPTAAEALQHPFFKRC 288
P RP+A+ L H FFK+
Sbjct: 322 PDARPSASTLLNHSFFKQI 340
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-47
Identities = 76/308 (24%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
E + K LG GSF V A + AIK L+K + +V +
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK----RHIIKENKVPYVTRERDVM 84
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLF 109
+L+HP VK+ + ++F L + +K F E+ + +
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSY--AKNGELLKYI-----RKIGSFDETCTRFYTA 137
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER---VGTRW 165
++ L+Y+H +G HRDLKPEN+L+ I+I DFG A+ + VGT
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDS 224
Y +PE+L + D+WA+G I+ +L+ P F+ +E ++ KI
Sbjct: 198 YVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKI----------- 244
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT------AAE 278
+ + Y FP A +L+E L D KR
Sbjct: 245 --------IKLEYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 285
Query: 279 ALQHPFFK 286
HPFF+
Sbjct: 286 LKAHPFFE 293
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-47
Identities = 61/314 (19%), Positives = 109/314 (34%), Gaps = 49/314 (15%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
+ + ++G GSFG V + +K +G A+K + R + + E+ L+ P
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPR 111
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV + + E V E ++ +L QL++ E +L Q GL+Y+H
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLH 167
Query: 120 QQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPYTER------VGTRWYQAPEI 171
+ H D+K +N+L+S + DFG A + GT + APE+
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ +KVD+W+ +M +L + KI +
Sbjct: 228 VMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPP------- 273
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYV 291
P + PS + I+ +P R +A E +
Sbjct: 274 --------PIRE------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ--- 316
Query: 292 PPHLRSTPAVAATR 305
+P +
Sbjct: 317 EVGGLKSPWKGEYK 330
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-47
Identities = 64/310 (20%), Positives = 109/310 (35%), Gaps = 65/310 (20%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL------REVKCLRKL 56
+Y L LG G FG V+ VAIK + ++ EV L K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 57 N----HPNIVKVKELIVEKGNVFFVFE----CMQCNLYQLMEAKKQKQQLFSESAVKAWL 108
HP ++++ + + V E L+ + K E + +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD--LFDYITEKGP----LGEGPSRCFF 145
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVS--QGTIKIADFGLAREIDAFPP---YTERVGT 163
QV + + H +G HRD+K EN+L+ +G K+ DFG A YT+ GT
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPYTDFDGT 201
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223
R Y PE + + ++ +W++G ++ +++ F
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF---------------------- 239
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283
+ ++ + FP S D LI + P RP+ E L P
Sbjct: 240 ---ERDQEILEAELHFP-----------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285
Query: 284 FFKRCLYVPP 293
+ + P
Sbjct: 286 WMQTPAEDVP 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 80/327 (24%), Positives = 138/327 (42%), Gaps = 58/327 (17%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL---REVKCLRKLNHP 59
Y + + LG GSFG V A + + + VA+K + + ++ +++ RE+ L+ L HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+I+K+ ++I ++ V E L+ + KK+ +E + + Q+ ++Y H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCH 125
Query: 120 QQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV----GTRWYQAPEILFK 174
+ HRDLKPENLL+ +KIADFGL+ + G+ Y APE++
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLS----NIMTDGNFLKTSCGSPNYAAPEVING 181
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
+VD+W+ G ++ +L+ R F + K+ S M +
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPDF--------- 230
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPH 294
S A +LI + DP +R T E + P+F L P +
Sbjct: 231 -------------------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL--PDY 269
Query: 295 LRSTPAVAATRRGMLKQQGDRIDAEAL 321
LR + QG D+ +
Sbjct: 270 LRPME----------EVQGSYADSRIV 286
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 45/340 (13%), Positives = 90/340 (26%), Gaps = 75/340 (22%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-------------------------RE 42
LG +A ++ +GE + + ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 43 KCLNLREVKCLRKLNHPNIVKVKELIVEKG-----NVFFVFECMQCNLYQLMEA---KKQ 94
++LR + + P K+ + +++ + FF++ MQ NL E
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 95 KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153
+ A QV R L +H G H L+P ++++ Q G + + F A
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 154 --FPPYTERVGTRWYQAPEIL----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA 207
P A +L L + D W +G + +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 208 DQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCS 267
I + + L+E
Sbjct: 324 GGSEWI----------------------------FRSC------KNIPQPVRALLEGFLR 349
Query: 268 WDPCKRPTAAEALQHPFFKRCL-YVPPHLRSTPAVAATRR 306
+ R +A++ P +++ + L R
Sbjct: 350 YPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTR 389
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-46
Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 37/302 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHPN 60
+ Y L + +GSG+ V A E VAIK + + L+E++ + + +HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQL----FSESAVKAWLFQVFRGL 115
IV V K ++ V + + ++ +++ K + ES + L +V GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 116 DYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER------VGTRWYQA 168
+Y+H+ G HRD+K N+L+ G+++IADFG++ + T VGT + A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 169 PEILFKSGLYSSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
PE++ + Y K D+W+ G I A EL + + D
Sbjct: 195 PEVMEQVRGYDFKADIWSFG-ITAIELATGAAPYHKYPPMKVLMLT------LQNDP--- 244
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
P L M + +I DP KRPTAAE L+H FF+
Sbjct: 245 ------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
Query: 287 RC 288
+
Sbjct: 293 KA 294
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-45
Identities = 77/300 (25%), Positives = 122/300 (40%), Gaps = 41/300 (13%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL---REVKCLRKLN 57
+ Y L LG G+FG V ++ +G VA+K L + R + RE++ L+
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HP+I+K+ ++I + F V E L+ + K + E + Q+ +D
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGR---VEEMEARRLFQQILSAVD 125
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Y H+ HRDLKPEN+L+ + KIADFGL+ + G+ Y APE++
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
+VD+W+ G I+ LL F KI G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--G----------------- 226
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHL 295
+ P + L+ + DP KR T + +H +FK+ L P +L
Sbjct: 227 VFYIP-----------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL--PSYL 273
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 67/303 (22%), Positives = 123/303 (40%), Gaps = 57/303 (18%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
+ + + + +G GSFG V + ++ A+K + K +KC+ EV+ +
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK----QKCVERNEVRNVFKELQIM 69
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLF 109
+ L HP +V + ++ ++F V + + Y L Q+ F E VK ++
Sbjct: 70 QGLEHPFLVNLWYSFQDEEDMFMVVDLL--LGGDLRYHL-----QQNVHFKEETVKLFIC 122
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQA 168
++ LDY+ Q HRD+KP+N+L+ G + I DF +A + T GT+ Y A
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMA 182
Query: 169 PEILFKSGL--YSSKVDMWAMGAIMAELLLFRPLFQGTDEAD--QMYKICSVLGSPTMDS 224
PE+ YS VD W++G ELL R + ++
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH------------ 230
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ-HP 283
+P + S++ ++L++ L +P +R + +Q P
Sbjct: 231 ------TFETTVVTYP-----------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273
Query: 284 FFK 286
+
Sbjct: 274 YMN 276
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVK 63
+ +K+G+GSFG V +A + G VA+K L + + +N LREV +++L HPNIV
Sbjct: 41 IKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 64 VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ + N+ V E + +LY+L+ ++QL + + V +G++Y+H +
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS-MAYDVAKGMNYLHNRN 157
Query: 123 YF--HRDLKPENLLVSQ-GTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLY 178
HR+LK NLLV + T+K+ DFGL+R F GT + APE+L +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL-RDEPS 216
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
+ K D+++ G I+ EL + + + A + + R
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----------KCKR-------- 257
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
++ + + +IE + +P KRP+ A +
Sbjct: 258 -LEIP--------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-44
Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 38/291 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+KY+ +K+G G+ G V+ A++ +G+ VAI+ + +K L + E+ +R+ +PNI
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V + + ++ V E + +L ++ E + A + + L+++H
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHS 134
Query: 121 QGYFHRDLKPEN-LLVSQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLY 178
HRD+K +N LL G++K+ DFG +I + VGT ++ APE++ + Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-Y 193
Query: 179 SSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
KVD+W++G IMA E++ P + + +Y I T +
Sbjct: 194 GPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLI------ATNGT------------- 233
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
P+L S + + D KR +A E LQH F K
Sbjct: 234 --PELQNPE------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 82/297 (27%), Positives = 127/297 (42%), Gaps = 48/297 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIK--ALKKSYSREKCLNL-REVKCLRKLNH 58
+ +S +++G GSFG V+ A + + EVVAIK + S EK ++ +EV+ L+KL H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
PN ++ + + + + V E + L+E K+ E + A +GL Y+
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYL 170
Query: 119 HQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEI--L 172
H HRD+K N LL G +K+ DFG A + VGT ++ APE+
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILA 224
Query: 173 FKSGLYSSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
G Y KVD+W++G I EL +P + +Y I +S
Sbjct: 225 MDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI------AQNES------- 270
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
P L + S N ++S P RPT+ L+H F R
Sbjct: 271 --------PALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-43
Identities = 78/304 (25%), Positives = 131/304 (43%), Gaps = 63/304 (20%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
++ + + + LG+GSFG V ++H+G A+K LKK E + L++V+ L
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK----EIVVRLKQVEHTNDERLML 60
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLF 109
+ HP I+++ + +F + + L +K Q F K +
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDY--IEGGELFSLL-----RKSQRFPNPVAKFYAA 113
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQA 168
+V L+Y+H + +RDLKPEN+L+ G IKI DFG A+ + YT GT Y A
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYT-LCGTPDYIA 171
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWAD 227
PE++ Y+ +D W+ G ++ E+L F ++ + Y KI +
Sbjct: 172 PEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNA----------- 218
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQH 282
+FP P +ED +L+ L + D +R + H
Sbjct: 219 --------ELRFP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259
Query: 283 PFFK 286
P+FK
Sbjct: 260 PWFK 263
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 73/295 (24%), Positives = 124/295 (42%), Gaps = 56/295 (18%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL----REVKCLRKLNHPNI 61
L + +G G FG V++A G+ VA+KA + + + +E K L HPNI
Sbjct: 11 LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ ++ + +++ N+ V E + L +++ K+ + W Q+ RG++Y+H
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHD 123
Query: 121 QGYF---HRDLKPENLLVSQG---------TIKIADFGLAREIDAFPPYTERVGTRWYQA 168
+ HRDLK N+L+ Q +KI DFGLARE G + A
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMA 182
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PE++ ++ ++S D+W+ G ++ ELL F+G D Y + +
Sbjct: 183 PEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-----------NK 230
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAI-NLIESLCSWDPCKRPTAAEALQH 282
L + I PS + L+E + DP RP+ L
Sbjct: 231 LA--LPI----------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 61/303 (20%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
++++ K LG+GSFG V +K SG A+K L K +K + L++++ L
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----QKVVKLKQIEHTLNEKRIL 95
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN---LYQLMEAKKQKQQLFSESAVKAWLFQ 110
+ +N P +VK++ + N++ V E ++ + ++ FSE + + Q
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEY--VAGGEMFSHL----RRIGRFSEPHARFYAAQ 149
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ +Y+H +RDLKPENLL+ QG I++ DFG A+ + +T GT AP
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RTWT-LCGTPEALAP 207
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWADG 228
EI+ G Y+ VD WA+G ++ E+ P F Q+Y KI S
Sbjct: 208 EIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSG------------ 253
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHP 283
+FP S D +L+ +L D KR + H
Sbjct: 254 -------KVRFP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295
Query: 284 FFK 286
+F
Sbjct: 296 WFA 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-43
Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
++ + + +G G+FG V +A K + VAIK ++ R+ + E++ L ++NHPN
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFI--VELRQLSRVNHPN 62
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IVK+ + V V E + +LY ++ + + A+ W Q +G+ Y+H
Sbjct: 63 IVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS-WCLQCSQGVAYLH 119
Query: 120 Q---QGYFHRDLKPENLLVSQG--TIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK 174
+ HRDLKP NLL+ G +KI DFG A +I T G+ + APE+ F+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEV-FE 176
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
YS K D+++ G I+ E++ R F M + +G R
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----------MWAVHNGTR---- 222
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
P L + + +L+ S DP +RP+ E ++
Sbjct: 223 -----PPLI--------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 24/306 (7%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHP 59
+ + +LG+G+ G V++ +K SG V+A K + +RE++ L + N P
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 60 NIVKVKELIVEKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
IV G + E M L Q++ +K E + V +GL Y+
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 119 HQQGY-FHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
++ HRD+KP N+LV S+G IK+ DFG++ ++ + VGTR Y +PE L +
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH 206
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS + D+W+MG + E+ + R D + + ++ +N
Sbjct: 207 -YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 237 YQ----------FPQLSGV--NLSALMPSA--SEDAINLIESLCSWDPCKRPTAAEALQH 282
F L + +PS S + + + +P +R + + H
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 283 PFFKRC 288
F KR
Sbjct: 326 AFIKRS 331
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 85/326 (26%), Positives = 133/326 (40%), Gaps = 50/326 (15%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL---REVKCLRKLN 57
+ Y L LG G+FG V ++ +G VA+K L + R + RE++ L+
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 58 HPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HP+I+K+ ++I ++F V E L+ + K + E + Q+ G+D
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGR---LDEKESRRLFQQILSGVD 130
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Y H+ HRDLKPEN+L+ + KIADFGL+ + G+ Y APE++
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
+VD+W+ G I+ LL F KIC G
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--G----------------- 231
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHL 295
+ P + I+L++ + DP KR T + +H +FK+ L P +L
Sbjct: 232 IFYTP-----------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL--PKYL 278
Query: 296 RSTPAVAATRRGMLKQQGDRIDAEAL 321
ID EAL
Sbjct: 279 FPEDP---------SYSSTMIDDEAL 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-43
Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 38/291 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
K+G GS G V A KHSG VA+K + + + L EV +R H N+
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ + + ++ + E +Q L ++ + +E + V + L Y+H
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHA 159
Query: 121 QGYFHRDLKPEN-LLVSQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLY 178
QG HRD+K ++ LL G +K++DFG +I P VGT ++ APE++ +S Y
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-Y 218
Query: 179 SSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
+++VD+W++G IM E++ P + M ++
Sbjct: 219 ATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRL------RDSPP------------- 258
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
P+L + S + +E + DP +R TA E L HPF +
Sbjct: 259 --PKLKNSH------KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-43
Identities = 59/311 (18%), Positives = 114/311 (36%), Gaps = 55/311 (17%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVK 63
+ + +G G FG V+ + GEV AI+ + E L REV R+ H N+V
Sbjct: 37 IGELIGKGRFGQVYHG--RWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 64 VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ ++ + + LY ++ K + + ++ +G+ Y+H +G
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 123 YFHRDLKPENLLVSQGTIKIADFGLAREIDAFP------PYTERVGTRWYQAPEILFKSG 176
H+DLK +N+ G + I DFGL + G + APEI+ +
Sbjct: 151 ILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 177 L--------YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
+S D++A+G I EL F+ ++++ G
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM------------GTG 258
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH----PF 284
++ + ++ +++ +++ +RPT + + P
Sbjct: 259 MKPNL-SQIGMG---------------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
Query: 285 FKRCLYVPPHL 295
R L P H
Sbjct: 303 RNRRLSHPGHF 313
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 75/324 (23%), Positives = 145/324 (44%), Gaps = 43/324 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E + + +KLG GS+G V++A++K +G++VAIK + ++ + E+ +++ + P++
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK--EISIMQQCDSPHV 86
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
VK + +++ V E ++ ++ + + +E + L +GL+Y+H
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLHF 143
Query: 121 QGYFHRDLKPEN-LLVSQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLY 178
HRD+K N LL ++G K+ADFG+A ++ D +GT ++ APE++ + G Y
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-Y 202
Query: 179 SSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
+ D+W++G I A E+ +P + ++ I PT
Sbjct: 203 NCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI------PTNPP------------- 242
Query: 238 QFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLR 296
P P S++ + ++ P +R TA + LQHPF +
Sbjct: 243 --PTFRK-------PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA---KGVSI 290
Query: 297 STPAVAATRRGMLKQQGDRIDAEA 320
+ LK+Q + E
Sbjct: 291 LRDLINEAMDVKLKRQESQQREEG 314
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-43
Identities = 63/287 (21%), Positives = 110/287 (38%), Gaps = 48/287 (16%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVK 65
+ LG G FG + ++ +GEV+ +K L + + L+EVK +R L HPN++K
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 66 ELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
++ + + F+ E ++ L ++ K Q S ++ + G+ Y+H
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII--KSMDSQY-PWSQRVSFAKDIASGMAYLHSMNII 130
Query: 125 HRDLKPENLLV-SQGTIKIADFGLAREID---------------AFPPYTERVGTRWYQA 168
HRDL N LV + +ADFGLAR + VG ++ A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PE++ Y KVD+++ G ++ E++ + +
Sbjct: 191 PEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GLNVRGF 239
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT 275
L + P P+ + C DP KRP+
Sbjct: 240 LDRYC------P-----------PNCPPSFFPITVRCCDLDPEKRPS 269
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-43
Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 45/294 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALK-KSYSREKCLNLREVKCLRKLNHPN 60
E ++ +K+G GSFG V++ ++ + +VVAIK + + E +E+ L + + P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+ K ++ ++ + E + + L+E E+ + L ++ +GLDY+H
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLH 136
Query: 120 QQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILFKS 175
+ HRD+K N LL G +K+ADFG+A ++ +R VGT ++ APE++ +S
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 194
Query: 176 GLYSSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
Y SK D+W++G I A EL P ++ I P +
Sbjct: 195 A-YDSKADIWSLG-ITAIELARGEPPHSELHPMKVLFLI------PKNNP---------- 236
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
P L G + S+ +E+ + +P RPTA E L+H F R
Sbjct: 237 -----PTLEG--------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 44/286 (15%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
+ ++ +++GSGSFG V++ K G+V A+K L + + L EV LRK H
Sbjct: 23 DGQITVGQRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 59 PNIVKVKELI--VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
NI+ + + V + + +LY + A + K F + Q RG+
Sbjct: 80 VNILL---FMGYSTAPQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGM 133
Query: 116 DYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF---PPYTERVGTRWYQAPEI 171
DY+H + HRDLK N+ + + T+KI DFGLA E + + + G+ + APE+
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 172 L--FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
+ S YS + D++A G ++ EL+ + + + DQ+
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------------------ 235
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT 275
+ + P +LS + + + L+ +RP+
Sbjct: 236 -EMVGRGSLSP-----DLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 71/295 (24%), Positives = 111/295 (37%), Gaps = 52/295 (17%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-------LREVKCLRKLNH 58
K++G G FG V + VVAIK+L S + REV + LNH
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 59 PNIVKVKELI-VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
PNIVK L + V E + C +LY + K S + + G++
Sbjct: 83 PNIVK---LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIE 136
Query: 117 YMHQQGYF--HRDLKPENLLVSQG------TIKIADFGLAREIDAFPPYTERVGTRWYQA 168
YM Q HRDL+ N+ + K+ADFGL+++ + +G + A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMA 194
Query: 169 PEILF-KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
PE + + Y+ K D ++ I+ +L F ++ I + +
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIR--------EE 245
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
GLR P + N+IE S DP KRP + ++
Sbjct: 246 GLR---------PTIP--------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 41/296 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E + + +LG G+FG V++A NK +G + A K ++ E + E++ L +HP I
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
VK+ G ++ + E + +M + +E ++ Q+ L+++H
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHS 135
Query: 121 QGYFHRDLKPEN-LLVSQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEIL----FK 174
+ HRDLK N L+ +G I++ADFG++ + +GT ++ APE++ K
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 175 SGLYSSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
Y K D+W++G I E+ P + + KI D
Sbjct: 196 DTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI------AKSDP--------- 239
Query: 234 AINYQFPQLSGVNLSALMPSA-SEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
P L PS S + + ++ +P RP+AA+ L+HPF
Sbjct: 240 ------PTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 6e-42
Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 47/300 (15%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----SREKCLNLREVKCLRKL 56
+ + LG G FG V + +G++ A K L+K E L E + L K+
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKV 241
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLFQVF 112
N +V + K + V M N + + Q F E+ + ++
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLM--NGGDLKFHI---YHMGQAGFPEARAVFYAAEIC 296
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171
GL+ +H++ +RDLKPEN+L+ G I+I+D GLA + RVGT Y APE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ Y+ D WA+G ++ E++ + FQ + + ++ R
Sbjct: 357 VKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---------------ERL 400
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFFK 286
+ ++ S A +L L DP +R +A E +HP FK
Sbjct: 401 VKEVPEEYS-----------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 50/288 (17%), Positives = 96/288 (33%), Gaps = 46/288 (15%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIV 62
+ KL G +W+ + G + +K LK + E LR +HPN++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 63 KVKELIVE--KGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
V + + M +LY ++ + + +S + + RG+ ++H
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 120 QQGYF--HRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFK-- 174
L ++++ + T +I+ + + R+ + APE L K
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKP 184
Query: 175 SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234
DMW+ ++ EL+ F + K+ +GLR
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-----------EGLR---- 229
Query: 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
P + P S L++ + DP KRP +
Sbjct: 230 -----PTIP--------PGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-41
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 55/304 (18%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
E Y + K +G G+FG V +K + +V A+K L K + + + +
Sbjct: 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK----FEMIKRSDSAFFWEERDIM 123
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
N P +V++ + ++ V E M +L LM E + + +V
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVV 178
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER--VGTRWYQAP 169
LD +H G+ HRD+KP+N+L+ G +K+ADFG +++ VGT Y +P
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 170 EILFKSG---LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSW 225
E+L G Y + D W++G + E+L+ F Y KI +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMN---------- 287
Query: 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR---PTAAEALQH 282
+ FP + + S++A NLI + + D R E +H
Sbjct: 288 -------HKNSLTFPDDNDI---------SKEAKNLICAFLT-DREVRLGRNGVEEIKRH 330
Query: 283 PFFK 286
FFK
Sbjct: 331 LFFK 334
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 3e-41
Identities = 85/301 (28%), Positives = 131/301 (43%), Gaps = 57/301 (18%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLR------ 54
+E + L K LG GSFG V+ A K + + AIKALKK + L +V+C
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK----DVVLMDDDVECTMVEKRVL 71
Query: 55 --KLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWL 108
HP + + K N+FFV E N +Y + Q F S +
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEY--LNGGDLMYHI-----QSCHKFDLSRATFYA 124
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV-GTRWY 166
++ GL ++H +G +RDLK +N+L+ G IKIADFG+ +E T GT Y
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
APEIL Y+ VD W+ G ++ E+L+ + F G DE ++++ S+
Sbjct: 185 IAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFH--SIRMDNP----- 235
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ-HPFF 285
+P ++A +L+ L +P KR ++ HP F
Sbjct: 236 -----------FYP-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
Query: 286 K 286
+
Sbjct: 274 R 274
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 74/307 (24%), Positives = 124/307 (40%), Gaps = 58/307 (18%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
+ + + LG G FG V+ K +G++ A K L K ++ + + L
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK----KRLKKRKGYQGAMVEKKIL 239
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLF 109
K++ IV + K ++ V M N Y + + F E +
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIM--NGGDIRYHIYNVD-EDNPGFQEPRAIFYTA 296
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTE-RVGTRWYQ 167
Q+ GL+++HQ+ +RDLKPEN+L+ G ++I+D GLA E+ A T+ GT +
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMDS 224
APE+L Y VD +A+G + E++ R F+ E ++ + VL
Sbjct: 357 APELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--RVLEQAV--- 410
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEAL 280
+P S + + E+L DP KR + + L
Sbjct: 411 -------------TYP-----------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446
Query: 281 -QHPFFK 286
HP F+
Sbjct: 447 RTHPLFR 453
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-41
Identities = 84/304 (27%), Positives = 125/304 (41%), Gaps = 60/304 (19%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------- 52
+ K +G GSFG V A +K A+K L+K + L +E K
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQK----KAILKKKEEKHIMSERNVL 92
Query: 53 LRKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWL 108
L+ + HP +V + ++FV + + N Y L Q+++ F E + +
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYI--NGGELFYHL-----QRERCFLEPRARFYA 145
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV-GTRWY 166
++ L Y+H +RDLKPEN+L+ SQG I + DFGL +E T GT Y
Sbjct: 146 AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEY 205
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
APE+L K Y VD W +GA++ E+L P F + +MY ++L P
Sbjct: 206 LAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYD--NILNKPL----- 256
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEALQH 282
Q P+ + A +L+E L D KR E H
Sbjct: 257 -----------QLK-----------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294
Query: 283 PFFK 286
FF
Sbjct: 295 VFFS 298
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-41
Identities = 70/299 (23%), Positives = 113/299 (37%), Gaps = 53/299 (17%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------LRKLNHPN 60
K +G G+F V K +G+V A+K + K L EV C L +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNK----WDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
I ++ ++ ++ V E L+ + + + +L ++ +D +H+
Sbjct: 123 ITQLHFAFQDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 121 QGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER--VGTRWYQAPEILFKSGL 177
GY HRD+KP+N+L+ G I++ADFG ++ A VGT Y +PEIL G
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 178 ------YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMY-KICSVLGSPTMDSWADGLR 230
Y + D WA+G E+ + F + Y KI
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-AETYGKIVH--------------- 284
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR---PTAAEALQHPFFK 286
+ P + E+A + I+ L P R A + HPFF
Sbjct: 285 --YKEHLSLPLVD--------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-40
Identities = 74/304 (24%), Positives = 120/304 (39%), Gaps = 51/304 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
E + + K +G G+FG V K++ +V A+K L K + L E C L
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK----WEMLKRAETACFREERDVL 128
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
+ I + + N++ V + +L L+ + + E + +L ++
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS---KFEDRLPEEMARFYLAEMV 185
Query: 113 RGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER--VGTRWYQAP 169
+D +HQ Y HRD+KP+N+L+ G I++ADFG ++ VGT Y +P
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 170 EIL----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225
EIL G Y + D W++G M E+L F + KI +
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---------- 295
Query: 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR---PTAAEALQH 282
+QFP + SE+A +LI L R + +H
Sbjct: 296 -------HKERFQFPT--------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKH 339
Query: 283 PFFK 286
PFF
Sbjct: 340 PFFS 343
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 78/304 (25%), Positives = 130/304 (42%), Gaps = 60/304 (19%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
M + K LG G+FG V K +G A+K L+K E + EV L
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLF 109
+ HP + +K + FV E N + L ++++F+E + +
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEY--ANGGELFFHL-----SRERVFTEERARFYGA 112
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV-GTRWYQ 167
++ L+Y+H + +RD+K ENL++ G IKI DFGL +E + + GT Y
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
APE+L + Y VD W +G +M E++ R F D +++++ +L
Sbjct: 173 APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFE--LILMEEI------ 222
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEAL-QH 282
+FP + S +A +L+ L DP +R P+ A+ + +H
Sbjct: 223 ----------RFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 283 PFFK 286
FF
Sbjct: 262 RFFL 265
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 66/295 (22%), Positives = 124/295 (42%), Gaps = 36/295 (12%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVK-CLRKLNH 58
+ +LG G++G V + + SG+++A+K ++ + + ++ L ++ +R ++
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
P V + +G+V+ E M +L + + K Q E + + + L+++
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 119 HQQGYF-HRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL---F 173
H + HRD+KP N+L++ G +K+ DFG++ + G + Y APE +
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
YS K D+W++G M EL + DSW +Q
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL---------------------AILRFPYDSWGTPFQQLK 224
Query: 234 AI-NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ PQL S + ++ + +RPT E +QHPFF
Sbjct: 225 QVVEEPSPQLPA-------DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 48/304 (15%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKAL----KKSYSREKCLNLREVKCLRKLNHPNI 61
L + +G G FG VW+ K GE VA+K ++S+ RE E+ L H NI
Sbjct: 46 LQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA-----EIYQTVMLRHENI 98
Query: 62 VK----VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+ + ++ V + + +L+ + + + + GL
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLA 153
Query: 117 YMHQQGYF--------HRDLKPENLLV-SQGTIKIADFGLAREIDAFP-----PYTERVG 162
++H + HRDLK +N+LV GT IAD GLA D+ RVG
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 163 TRWYQAPEIL-----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
T+ Y APE+L K + D++AMG + E+ + ++ Y
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY----- 268
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA 277
D + +R+ + P + S A ++ + R TA
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS---CEALRVMAKIMRECWYANGAARLTAL 325
Query: 278 EALQ 281
+
Sbjct: 326 RIKK 329
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 72/308 (23%), Positives = 129/308 (41%), Gaps = 63/308 (20%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
M +S+ + +G G FG V+ +G++ A+K L K ++ + L
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK----KRIKMKQGETLALNERIML 243
Query: 54 RKLN---HPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKA 106
++ P IV + + F+ + M N Y L + +FSE+ ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLM--NGGDLHYHL-----SQHGVFSEADMRF 296
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRW 165
+ ++ GL++MH + +RDLKP N+L+ G ++I+D GLA + P+ VGT
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHG 355
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD--QMYKICSVLGSPTMD 223
Y APE+L K Y S D +++G ++ +LL F+ D ++ + L
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTLTMAV-- 411
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEA 279
+ P S S + +L+E L D +R A+
Sbjct: 412 --------------ELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 446
Query: 280 L-QHPFFK 286
+ + PFF+
Sbjct: 447 VKESPFFR 454
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 67/296 (22%), Positives = 120/296 (40%), Gaps = 39/296 (13%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKL-NH 58
+ ++GSG+ G VW+ + +G V+A+K +++S ++E+ L ++ + K +
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
P IV+ + +VF E M +L K+ Q E + + + L Y+
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLK---KRMQGPIPERILGKMTVAIVKALYYL 140
Query: 119 HQQ-GYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL---- 172
++ G HRD+KP N+L+ +G IK+ DFG++ + G Y APE +
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
Y + D+W++G + EL G +
Sbjct: 201 PTKPDYDIRADVWSLGISLVEL---------------------ATGQFPYKNCKTDFEVL 239
Query: 233 MAI-NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ + P L G S D + ++ + D KRP + L+H F KR
Sbjct: 240 TKVLQEEPPLLPG------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-40
Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 68/310 (21%)
Query: 1 MEKYSLTKKLGSGSFGCVWQA---VNKHSGEVVAIKALKKSYSREKCLNLREVKC----- 52
E + L + LG G +G V+Q ++G++ A+K LKK+ ++
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN---AKDTAHTKAER 72
Query: 53 --LRKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKA 106
L ++ HP IV + G ++ + E + QL +++ +F E
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEY--LSGGELFMQL-----EREGIFMEDTACF 125
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER----V 161
+L ++ L ++HQ+G +RDLKPEN+++ QG +K+ DFGL +E
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGTVTHTFC 182
Query: 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT 221
GT Y APEIL +SG ++ VD W++GA+M ++L P F G + + KI
Sbjct: 183 GTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK------ 235
Query: 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAA 277
L P P +++A +L++ L + R P A
Sbjct: 236 -----CKLN--------LP-----------PYLTQEARDLLKKLLKRNAASRLGAGPGDA 271
Query: 278 EALQ-HPFFK 286
+Q HPFF+
Sbjct: 272 GEVQAHPFFR 281
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-40
Identities = 69/306 (22%), Positives = 126/306 (41%), Gaps = 57/306 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
+ L + +G+G++G V++ + +G++ AIK + + E+ + +E+ L+K +H N
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI-KQEINMLKKYSHHRN 82
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLME----------AKKQKQQLFSESAVKAWLFQ 110
I ++K M L+ +ME K K E + +
Sbjct: 83 IATYYGAFIKKNP-----PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 111 VFRGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTER---VGTRWY 166
+ RGL ++HQ HRD+K +N LL +K+ DFG++ ++D R +GT ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYW 195
Query: 167 QAPEIL----FKSGLYSSKVDMWAMGAIMA-ELLLFRPLFQGTDEADQMYKICSVLGSPT 221
APE++ Y K D+W++G I A E+ P ++ I P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLI------PR 248
Query: 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ P+L S + IES + +RP + ++
Sbjct: 249 NPA---------------PRLKSKKWSKKF-------QSFIESCLVKNHSQRPATEQLMK 286
Query: 282 HPFFKR 287
HPF +
Sbjct: 287 HPFIRD 292
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 85/304 (27%), Positives = 135/304 (44%), Gaps = 58/304 (19%)
Query: 1 MEKYSLTKKLGSGSFGCVWQA---VNKHSGEVVAIKALKKSY----SREKCLNLREVKCL 53
++ L K LG GSFG V+ + ++ A+K LKK+ R + R++ L
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--L 80
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLF 109
++NHP IVK+ +G ++ + + +L K+ +F+E VK +L
Sbjct: 81 VEVNHPFIVKLHYAFQTEGKLYLILDF--LRGGDLFTRL-----SKEVMFTEEDVKFYLA 133
Query: 110 QVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLARE-IDAFPPYTERVGTRWYQ 167
++ LD++H G +RDLKPEN+L+ +G IK+ DFGL++E ID GT Y
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
APE++ + G ++ D W+ G +M E+L FQG D + M I
Sbjct: 194 APEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-----------A 241
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEALQ-H 282
L P S +A +L+ L +P R P E ++ H
Sbjct: 242 KLG--------MP-----------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282
Query: 283 PFFK 286
FF
Sbjct: 283 SFFS 286
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 77/306 (25%), Positives = 135/306 (44%), Gaps = 63/306 (20%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLR------ 54
+ ++ LG GSFG V + K + E+ A+K LKK + + +V+C
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDDDVECTMVEKRVL 74
Query: 55 --KLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWL 108
P + ++ ++FV E N +Y + Q+ F E +
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEY--VNGGDLMYHI-----QQVGRFKEPHAVFYA 127
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER--VGTRW 165
++ GL ++ +G +RDLK +N+++ S+G IKIADFG+ +E + + T + GT
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPD 186
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225
Y APEI+ Y VD WA G ++ E+L + F+G DE D++++ S++
Sbjct: 187 YIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ--SIMEHNV---- 238
Query: 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEALQ 281
+P S S++A+ + + L + P KR P ++
Sbjct: 239 ------------AYP-----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275
Query: 282 -HPFFK 286
H FF+
Sbjct: 276 EHAFFR 281
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 69/304 (22%), Positives = 117/304 (38%), Gaps = 48/304 (15%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKAL----KKSYSREKCLNLREVKCLRKLNHPNI 61
L + +G G +G VW+ GE VA+K +KS+ RE E+ L H NI
Sbjct: 12 LLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRET-----ELYNTVMLRHENI 64
Query: 62 VK----VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+ ++ + + +LY + + + + + GL
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLA 119
Query: 117 YMHQQGYF--------HRDLKPENLLV-SQGTIKIADFGLAREIDAFP-----PYTERVG 162
++H + + HRDLK +N+LV G IAD GLA RVG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 163 TRWYQAPEIL-----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
T+ Y APE+L +VD+WA G ++ E + R + G E + V
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVVP 238
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA 277
P+ + +R+ + ++ Q P + S ++ L++ +P R TA
Sbjct: 239 NDPSFED----MRKVVCVDQQRPNIPNRWFSDPTLTS---LAKLMKECWYQNPSARLTAL 291
Query: 278 EALQ 281
+
Sbjct: 292 RIKK 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-39
Identities = 70/305 (22%), Positives = 120/305 (39%), Gaps = 50/305 (16%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALK----KSYSREKCLNLREVKCLRKLNHPNI 61
+ K++G G +G VW K GE VA+K S+ RE E+ + H NI
Sbjct: 41 MVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASWFRET-----EIYQTVLMRHENI 93
Query: 62 VK----VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+ + ++ + + + +LY + K ++ + GL
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 117 YMHQQGYF--------HRDLKPENLLV-SQGTIKIADFGLAREIDA-----FPPYTERVG 162
++H + + HRDLK +N+LV GT IAD GLA + + P RVG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 163 TRWYQAPEIL-----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
T+ Y PE+L DM++ G I+ E + R + G E Y++
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIVEE---YQLPYHD 264
Query: 218 GSPTMDSWADGLRQAMAINYQFPQL-SGVNLSALMPSASEDAINLIESLCSWDPCKRPTA 276
P+ S+ D +R+ + I P + + + + L+ + +P R TA
Sbjct: 265 LVPSDPSYED-MREIVCIKKLRPSFPNRWSSDECLRQMGK----LMTECWAHNPASRLTA 319
Query: 277 AEALQ 281
+
Sbjct: 320 LRVKK 324
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-39
Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 34/296 (11%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVK-CLRKLNH 58
E ++G G++G V + V+K SG+++A+K ++ + ++ L ++ +R +
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLM-EAKKQKQQLFSESAVKAWLFQVFRGLDY 117
P IV+ + +G+ + E M + + + E + + L++
Sbjct: 81 PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 118 MHQQGY-FHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
+ + HRD+KP N+L+ G IK+ DFG++ ++ T G R Y APE + S
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 176 GL---YSSKVDMWAMGAIMAELLLFR-PLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
Y + D+W++G + EL R P + DQ+ ++ V G P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDP----------- 247
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
PQLS ++ S IN + + D KRP E L+HPF
Sbjct: 248 --------PQLS----NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 81/309 (26%), Positives = 134/309 (43%), Gaps = 68/309 (22%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLR------ 54
++ + + LG GSFG V A K +G++ A+K LKK + L +V+C
Sbjct: 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK----DVILQDDDVECTMTEKRIL 77
Query: 55 --KLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWL 108
NHP + ++ +FFV E N ++ + QK + F E+ + +
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEF--VNGGDLMFHI-----QKSRRFDEARARFYA 130
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER----VGT 163
++ L ++H +G +RDLK +N+L+ +G K+ADFG+ +E GT
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFCGT 187
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223
Y APEIL + Y VD WAMG ++ E+L F+ +E D +++ ++L
Sbjct: 188 PDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFE--AILNDEV-- 241
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEA 279
+P EDA +++S + +P R E
Sbjct: 242 --------------VYP-----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEH 276
Query: 280 --LQHPFFK 286
L+HPFFK
Sbjct: 277 AILRHPFFK 285
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 83/368 (22%), Positives = 135/368 (36%), Gaps = 91/368 (24%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL----- 56
+Y + +KLG G F VW + + + VA+K + KS L E++ L+ +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDP 95
Query: 57 NHPNIVKVKELIVEKGNVF-----------FVFECMQCNLYQLMEAKKQKQQLFSESAVK 105
N PN +E++V+ + F VFE + +L + + K Q VK
Sbjct: 96 NDPN----REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWI--IKSNYQGLPLPCVK 149
Query: 106 AWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVS---------------------------- 136
+ QV +GLDY+H + H D+KPEN+L+S
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 137 --------------QGTIKIADFGLAREID---AFP---PYTERVGTRWYQAPEILFKSG 176
K A+ + D A +TE + TR Y++ E+L SG
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG 269
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQG------TDEADQMYKICSVLGSPTMDSWADG-- 228
Y++ D+W+ + EL LF+ T + D + I +LG G
Sbjct: 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328
Query: 229 ----------LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE 278
L+ + V + + + + P KR TAAE
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 279 ALQHPFFK 286
L+HP+
Sbjct: 389 CLRHPWLN 396
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-38
Identities = 82/305 (26%), Positives = 127/305 (41%), Gaps = 61/305 (20%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKC-------L 53
M ++ K LG G+FG V K +G A+K LKK K EV L
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----DEVAHTLTENRVL 202
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWLF 109
+ HP + +K + FV E N + L ++++FSE + +
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEY--ANGGELFFHL-----SRERVFSEDRARFYGA 255
Query: 110 QVFRGLDYMH-QQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV-GTRWY 166
++ LDY+H ++ +RDLK ENL++ G IKI DFGL +E + GT Y
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 315
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
APE+L + Y VD W +G +M E++ R F D +++++ +L
Sbjct: 316 LAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFE--LILMEEI----- 366
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PT-AAEALQ 281
+FP + +A +L+ L DP +R A E +Q
Sbjct: 367 -----------RFP-----------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404
Query: 282 HPFFK 286
H FF
Sbjct: 405 HRFFA 409
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 4e-38
Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 61/306 (19%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLR------ 54
+ ++ LG GSFG V + K + E+ A+K LKK + + +V+C
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDDDVECTMVEKRVL 395
Query: 55 --KLNHPNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVKAWL 108
P + ++ ++FV E N +Y + Q+ F E +
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEY--VNGGDLMYHI-----QQVGRFKEPHAVFYA 448
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV-GTRWY 166
++ GL ++ +G +RDLK +N+++ S+G IKIADFG+ +E T+ GT Y
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 508
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
APEI+ Y VD WA G ++ E+L + F+G DE D++++ S++
Sbjct: 509 IAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ--SIMEHNV----- 559
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR----PTAAEALQ- 281
+P S S++A+ + + L + P KR P ++
Sbjct: 560 -----------AYP-----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597
Query: 282 HPFFKR 287
H FF+
Sbjct: 598 HAFFRY 603
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 74/305 (24%), Positives = 135/305 (44%), Gaps = 51/305 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK----- 55
++ + L + +G GS+ V K + + A+K +KK E + ++ ++
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK----ELVNDDEDIDWVQTEKHVF 63
Query: 56 ---LNHPNIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQ 110
NHP +V + + +FFV E + ++ + Q+Q+ E + + +
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAE 118
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER--VGTRWYQ 167
+ L+Y+H++G +RDLK +N+L+ S+G IK+ D+G+ +E P T GT Y
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYI 177
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
APEIL Y VD WA+G +M E++ R F +D + ++
Sbjct: 178 APEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----------NTEDY 226
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQ- 281
+ + + P S S A ++++S + DP +R T +Q
Sbjct: 227 LFQVILEKQIRIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275
Query: 282 HPFFK 286
HPFF+
Sbjct: 276 HPFFR 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 51/305 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK----- 55
++ + L + +G GS+ V K + + A++ +KK E + ++ ++
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK----ELVNDDEDIDWVQTEKHVF 106
Query: 56 ---LNHPNIVKVKELIVEKGNVFFVFECMQCN--LYQLMEAKKQKQQLFSESAVKAWLFQ 110
NHP +V + + +FFV E + ++ + Q+Q+ E + + +
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAE 161
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV--GTRWYQ 167
+ L+Y+H++G +RDLK +N+L+ S+G IK+ D+G+ +E P T GT Y
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYI 220
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
APEIL Y VD WA+G +M E++ R F +D + ++
Sbjct: 221 APEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----------NTEDY 269
Query: 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQ- 281
+ + + P S S A ++++S + DP +R T +Q
Sbjct: 270 LFQVILEKQIRIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318
Query: 282 HPFFK 286
HPFF+
Sbjct: 319 HPFFR 323
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 73/306 (23%), Positives = 120/306 (39%), Gaps = 44/306 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
L + G FGCVW+A E VA+K + N EV L + H NI
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSW-QNEYEVYSLPGMKHENI 80
Query: 62 VK----VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
++ K +++ + + +L + K + S + + + RGL
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLA 135
Query: 117 YMHQQGYF----------HRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY---TERVG 162
Y+H+ HRD+K +N+L+ + T IADFGLA + +A +VG
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 163 TRWYQAPEIL----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLG 218
TR Y APE+L ++DM+AMG ++ EL G + + +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 219 SPTMDSWADGLRQAMAINYQFPQL-SGVNLSALMPSASEDAINLIESLCSW--DPCKRPT 275
P+++ +++ + + P L A M E IE C W D R +
Sbjct: 256 HPSLED----MQEVVVHKKKRPVLRDYWQKHAGMAMLCE----TIEE-C-WDHDAEARLS 305
Query: 276 AAEALQ 281
A +
Sbjct: 306 AGCVGE 311
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSREKCLN-LREVKCLRKLNHP 59
K LGSG+FG V++ + GE VAIK L+++ S + L E + +++P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 60 NIVKVKEL--IVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
++ + L I V + + M L++ ++ + + W Q+ +G++Y
Sbjct: 78 HVCR---LLGICLTSTVQLITQLMP--FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPE-I 171
+ + HRDL N+LV + +KI DFGLA+ + A G +W A E I
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESI 191
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
L +Y+ + D+W+ G + EL+
Sbjct: 192 LH--RIYTHQSDVWSYGVTVWELM 213
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 54/202 (26%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
E L +++G G+FG V+ + +VA+K+ +++ + L+E + L++ +HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV++ + +K ++ V E +Q + + + + +L ++ ++ + G++Y+
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQ-MVGDAAAGMEYLE 230
Query: 120 QQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGT-----RWYQAPEILF 173
+ HRDL N LV++ +KI+DFG++RE Y G +W APE L
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWT-APEAL- 287
Query: 174 KSGLYSSKVDMWAMGAIMAELL 195
G YSS+ D+W+ G ++ E
Sbjct: 288 NYGRYSSESDVWSFGILLWETF 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-35
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 6 LTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ LG G FG V ++GE VA+K+LK + +E++ LR L H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 61 IVKVKELIVEKGN--VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
IVK K + E G + + E + +L + + K K + + Q+ +G+DY
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDY 141
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAPEI 171
+ + Y HRDL N+LV S+ +KI DFGL + I+ YT + WY APE
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APEC 200
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
L + + D+W+ G + ELL
Sbjct: 201 LMQ-SKFYIASDVWSFGVTLHELL 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 74/315 (23%), Positives = 132/315 (41%), Gaps = 70/315 (22%)
Query: 1 MEKYSLTKKLGSGSFGCVWQA---VNKHSGEVVAIKALKKSYSREKCLNLREVKC----- 52
+E + L K LG+G++G V+ +G++ A+K LKK+ +K + +
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK---AKTTEHTRTER 109
Query: 53 --LRKLNH-PNIVKVKELIVEKGNVFFVFECMQCN----LYQLMEAKKQKQQLFSESAVK 105
L + P +V + + + + + N L +++ F+E V+
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDY--INGGELFTHL-----SQRERFTEHEVQ 162
Query: 106 AWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER--VG 162
++ ++ L+++H+ G +RD+K EN+L+ S G + + DFGL++E A G
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 163 TRWYQAPEIL--FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---ADQMY-KICSV 216
T Y AP+I+ SG + VD W++G +M ELL F E ++ +I
Sbjct: 223 TIEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK- 280
Query: 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR--- 273
+P S A +LI+ L DP KR
Sbjct: 281 ----------SEPP--------YP-----------QEMSALAKDLIQRLLMKDPKKRLGC 311
Query: 274 -PTAAEALQ-HPFFK 286
P A+ ++ H FF+
Sbjct: 312 GPRDADEIKEHLFFQ 326
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
++ KLG G +G V++ V K VA+K LK+ + L+E ++++ HPN+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKEIKHPNL 278
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ + + + + E M NL + ++ +Q S + Q+ ++Y+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
+ + HR+L N LV +K+ADFGL+R + YT G +W APE L
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT-APESL-AY 393
Query: 176 GLYSSKVDMWAMGAIMAELL 195
+S K D+WA G ++ E+
Sbjct: 394 NKFSIKSDVWAFGVLLWEIA 413
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 6 LTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
++LG G+FG V ++GEVVA+K L+ S RE++ L+ L H NI
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 62 VKVKELIVEKGN--VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
VK K + G + + E + +L ++ K++ + + Q+ +G++Y+
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 130
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAPEIL 172
+ Y HRDL N+LV ++ +KI DFGL + + + + WY APE L
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESL 189
Query: 173 FKSGLYSSKVDMWAMGAIMAELL 195
+ +S D+W+ G ++ EL
Sbjct: 190 TE-SKFSVASDVWSFGVVLYELF 211
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSREKCLN-LREVKCLRKLNHP 59
K LGSG+FG V++ + GE VAIK L+++ S + L E + +++P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
++ ++ I V + + M L++ ++ + + W Q+ +G++Y+
Sbjct: 78 HVCRL-LGICLTSTVQLITQLMP--FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 120 QQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPE-ILF 173
+ HRDL N+LV + +KI DFGLA+ + A G +W A E IL
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILH 193
Query: 174 KSGLYSSKVDMWAMGAIMAELLLF 197
+Y+ + D+W+ G + EL+ F
Sbjct: 194 --RIYTHQSDVWSYGVTVWELMTF 215
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-34
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 6 LTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+LG G+FG V ++G +VA+K L+ S ++ RE++ L+ L+ I
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 62 VKVKELIVEKGN--VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
VK + + G + V E + L ++ + + S + + Q+ +G++Y+
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAPEIL 172
+ HRDL N+LV S+ +KIADFGLA+ + Y R WY APE L
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESL 202
Query: 173 FKSGLYSSKVDMWAMGAIMAELL 195
++S + D+W+ G ++ EL
Sbjct: 203 S-DNIFSRQSDVWSFGVVLYELF 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-34
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 6 LTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
++LG G+FG V ++GEVVA+K L+ S RE++ L+ L H NI
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 62 VKVKELIVEKGN--VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
VK K + G + + E + +L ++ K++ + + Q+ +G++Y+
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYL 161
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAPEIL 172
+ Y HRDL N+LV ++ +KI DFGL + + Y + WY APE L
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESL 220
Query: 173 FKSGLYSSKVDMWAMGAIMAELL 195
+ +S D+W+ G ++ EL
Sbjct: 221 TE-SKFSVASDVWSFGVVLYELF 242
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 55/318 (17%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKAL----KKSYSREKCLNLREVKCLRKL 56
++ L + +G G +G V++ VA+K ++++ EK + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINEK-----NIYRVPLM 64
Query: 57 NHPNIVK-----VKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQ 110
H NI + + + V E +L + + +
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHS 119
Query: 111 VFRGLDYMHQQGYF---------HRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY--- 157
V RGL Y+H + HRDL N+LV + GT I+DFGL+ +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 158 ------TERVGTRWYQAPEIL------FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD 205
VGT Y APE+L +VDM+A+G I E + R
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE-IFMRCTDLFPG 238
Query: 206 EADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESL 265
E+ Y++ ++ D ++ ++ Q P+ A IE
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFED-MQVLVSREKQRPKFP--EAWKENSLAVRSLKETIED- 294
Query: 266 CSW--DPCKRPTAAEALQ 281
C W D R TA A +
Sbjct: 295 C-WDQDAEARLTAQXAEE 311
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 72/286 (25%), Positives = 108/286 (37%), Gaps = 39/286 (13%)
Query: 6 LTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ LG G FG V N +GE+VA+KALK + +E+ LR L H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 61 IVKVKELIVEKGN--VFFVFECMQC-NLYQ-LMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
I+K K + G + V E + +L L QL + Q+ G+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL------FAQQICEGMA 148
Query: 117 YMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPP-YTERVGT----RWYQAPE 170
Y+H Q Y HRDL N+L+ +KI DFGLA+ + Y R WY APE
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 207
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
L + + D+W+ G + ELL K ++G L
Sbjct: 208 CLKE-YKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLC-SWDPCKRPT 275
+ + + P+ P + + C + RPT
Sbjct: 262 ELLERGERLPR----------PDKCPAEVYHLMKNCWETEASFRPT 297
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 8 KKLGSGSFGCVWQAV-NKHSGEV-VAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVK 63
K+LGSG+FG V + VA+K LK + + L E +++L++P IV+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 64 VKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ I E + V E + L + + Q+ + + + + QV G+ Y+ +
Sbjct: 83 M-IGICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 123 YFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAPE-ILFKS 175
+ HRDL N+L+ +Q KI+DFGL++ + A Y + +WY APE I +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINY-- 194
Query: 176 GLYSSKVDMWAMGAIMAELL 195
+SSK D+W+ G +M E
Sbjct: 195 YKFSSKSDVWSFGVLMWEAF 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 9 KLGSGSFGCVWQAV-NKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRKLNHPNIVKVK 65
+LG G+FG V Q V ++ VAIK LK+ + +RE + + +L++P IV++
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL- 75
Query: 66 ELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ + + V E L++ + K+++ S V L QV G+ Y+ ++ +
Sbjct: 76 IGVCQAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 125 HRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAPE-ILFKSGL 177
HRDL N+L+ ++ KI+DFGL++ + A YT R +WY APE I F
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINF--RK 189
Query: 178 YSSKVDMWAMGAIMAELL 195
+SS+ D+W+ G M E L
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 5 SLTKKLGSGSFGCVWQAV-NKHSGEV--VAIKALKKSYSREKCLN---LREVKCLRKLNH 58
L +KLG GSFG V + + SG+ VA+K LK + +REV + L+H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 59 PNIVKVKEL--IVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
N+++ L +V + V E +L + +K + + + + QV G+
Sbjct: 81 RNLIR---LYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSR-YAVQVAEGM 134
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAP 169
Y+ + + HRDL NLL+ ++ +KI DFGL R + Y + W AP
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-AP 193
Query: 170 E-ILFKSGLYSSKVDMWAMGAIMAELL 195
E + +S D W G + E+
Sbjct: 194 ESLKT--RTFSHASDTWMFGVTLWEMF 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
++ L + +G G FG V + G VA+K +K + + L E + +L H N+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFL--AEASVMTQLRHSNL 76
Query: 62 VKVKELI----VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
V+ L+ EKG ++ V E M +L + + + + + + + V ++
Sbjct: 77 VQ---LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 117 YMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEI 171
Y+ + HRDL N+LVS K++DFGL +E + + +W APE
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWT-APEA 185
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
L + +S+K D+W+ G ++ E+
Sbjct: 186 LRE-KKFSTKSDVWSFGILLWEIY 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
K LGSG FG V + V GE V IK ++ R+ + + L+H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV++ + ++ V + + L L++ +Q + + W Q+ +G+ Y+ +
Sbjct: 77 IVRL-LGLCPGSSLQLVTQYLP--LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 121 QGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
G HR+L N+L+ S +++ADFG+A + +W A E +
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIH-F 191
Query: 176 GLYSSKVDMWAMGAIMAELL 195
G Y+ + D+W+ G + EL+
Sbjct: 192 GKYTHQSDVWSYGVTVWELM 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVK 65
L + +G G FG V + G VA+K +K + + L E + +L H N+V+
Sbjct: 197 LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFL--AEASVMTQLRHSNLVQ-- 250
Query: 66 ELI----VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
L+ EKG ++ V E M +L + + + + + + + V ++Y+
Sbjct: 251 -LLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
+ HRDL N+LVS K++DFGL +E + + +W APE L +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWT-APEALRE- 360
Query: 176 GLYSSKVDMWAMGAIMAELL 195
+S+K D+W+ G ++ E+
Sbjct: 361 KKFSTKSDVWSFGILLWEIY 380
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
++ KLG G +G V++ V K VA+K LK+ + L+E ++++ HPN+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKEIKHPNL 71
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ + + + + E M NL + ++ +Q S + Q+ ++Y+ +
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
+ + HRDL N LV +K+ADFGL+R + YT G +W APE L
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT-APESLAY- 186
Query: 176 GLYSSKVDMWAMGAIMAELL 195
+S K D+WA G ++ E+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-33
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKV 64
+ +++GSG FG V + +V AIK +++ E+ + E + + KL+HP +V++
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDF-IEEAEVMMKLSHPKLVQL 68
Query: 65 KELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+ +E+ + V E M+ L + + ++ LF+ + V G+ Y+ +
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 124 FHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPE-ILFKSGL 177
HRDL N LV IK++DFG+ R + YT GT +W +PE F
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWA-SPEVFSF--SR 181
Query: 178 YSSKVDMWAMGAIMAELL 195
YSSK D+W+ G +M E+
Sbjct: 182 YSSKSDVWSFGVLMWEVF 199
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-33
Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KLG G FG VW + V AIK LK + L+E + ++KL H +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF-LQEAQVMKKLRHEKL 241
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ ++ E+ ++ V E M +L + K + + + Q+ G+ Y+ +
Sbjct: 242 VQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
Y HRDL+ N+LV K+ADFGLAR I+ YT R G +W APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWT-APEAA-LY 355
Query: 176 GLYSSKVDMWAMGAIMAELL 195
G ++ K D+W+ G ++ EL
Sbjct: 356 GRFTIKSDVWSFGILLTELT 375
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV---VAIKALKKSYSREKCLN-LREVKCLRKLN 57
E+ L + +G G FG V Q + VAIK K S L+E +R+ +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP+IVK+ ++ + V+ + E +L + ++ +++ + +Q+ L Y
Sbjct: 75 HPHIVKL-IGVITENPVWIIMELCTLG--ELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPE-I 171
+ + + HRD+ N+LV S +K+ DFGL+R ++ Y + +W APE I
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWM-APESI 189
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
F ++S D+W G M E+L
Sbjct: 190 NF--RRFTSASDVWMFGVCMWEIL 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKH-SGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNI 61
Y + + G G ++ A++++ +G V +K L S E + + + E + L ++ HP+I
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLME------AKKQKQQLFSESAVKAWLFQVFRGL 115
V++ + Y +ME K+ K Q + A+L ++ L
Sbjct: 142 VQIFNFVEHTD------RHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPAL 195
Query: 116 DYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Y+H G + DLKPEN+++++ +K+ D G I++F GT +QAPEI+
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYL---YGTPGFQAPEIV--R 250
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGT 204
+ D++ +G +A L L P G
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGR 279
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEV--VAIKALKKSYSREKCLN-LREVKCLRKLNHPNIVKV 64
+LG G+FG V Q V + + VAIK LK+ + +RE + + +L++P IV++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 65 KELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYF 124
+ + + V E L + K++ S V L QV G+ Y+ ++ +
Sbjct: 402 -IGVCQAEALMLVMEMAG--GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 125 HRDLKPENLLV-SQGTIKIADFGLAREIDAFPP-YTERVGT----RWYQAPE-ILFKSGL 177
HR+L N+L+ ++ KI+DFGL++ + A YT R +WY APE I F
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINF--RK 515
Query: 178 YSSKVDMWAMGAIMAELL 195
+SS+ D+W+ G M E L
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-NKHSGEV--VAIKALKKSYSREKCLN-LREVKCLRKLN 57
E L + LG G FG V++ V H GE VA+K KK + + + E ++ L+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP+IVK+ I+E+ + + E +L ++ + + + Q+ + + Y
Sbjct: 72 HPHIVKL-IGIIEEEPTWIIMELYP--YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPE-I 171
+ HRD+ N+LV S +K+ DFGL+R I+ Y + T +W +PE I
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWM-SPESI 186
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
F +++ D+W M E+L
Sbjct: 187 NF--RRFTTASDVWMFAVCMWEIL 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KKLG+G FG VW A +V A+K +K + L E ++ L H +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAF-LAEANVMKTLQHDKL 245
Query: 62 VKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
VK+ +V K ++ + E M +L + K + + + Q+ G+ ++ Q
Sbjct: 246 VKLHA-VVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
+ Y HRDL+ N+LVS KIADFGLAR I+ YT R G +W APE +
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWT-APEAINF- 359
Query: 176 GLYSSKVDMWAMGAIMAELL 195
G ++ K D+W+ G ++ E++
Sbjct: 360 GSFTIKSDVWSFGILLMEIV 379
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KLG G FG VW + V AIK LK + L+E + ++KL H +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF-LQEAQVMKKLRHEKL 324
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ ++ E+ ++ V E M +L + K + + + Q+ G+ Y+ +
Sbjct: 325 VQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
Y HRDL+ N+LV K+ADFGLAR I+ YT R G +W APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWT-APEAA-LY 438
Query: 176 GLYSSKVDMWAMGAIMAELL 195
G ++ K D+W+ G ++ EL
Sbjct: 439 GRFTIKSDVWSFGILLTELT 458
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E+ +L K+LGSG FG V K +V A+K +K+ E +E + + KL+HP +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEF-FQEAQTMMKLSHPKL 65
Query: 62 VKVKELIVEKGNVFFVFECMQ--CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
VK + ++ ++ V E + C L+ + + S + + V G+ ++
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGC----LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 120 QQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFK 174
+ HRDL N LV +K++DFG+ R + Y VGT +W APE+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWS-APEVFHY 179
Query: 175 SGLYSSKVDMWAMGAIMAELL 195
YSSK D+WA G +M E+
Sbjct: 180 -FKYSSKSDVWAFGILMWEVF 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 6 LTKKLGSGSFGCVWQAV--NKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRKLNHPNI 61
+ K +GSG G V +V VAIKALK Y+ + + L E + + +HPNI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
++++ ++ V E M+ +L + + Q V L V G+ Y+
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVG-MLRGVGAGMRYLSD 169
Query: 121 QGYFHRDLKPENLLV-SQGTIKIADFGLAREI-DAFPPYTERVGT----RWYQAPE-ILF 173
GY HRDL N+LV S K++DFGL+R + D G RW APE I F
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAIAF 228
Query: 174 KSGLYSSKVDMWAMGAIMAELL 195
+SS D+W+ G +M E+L
Sbjct: 229 --RTFSSASDVWSFGVVMWEVL 248
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 65/289 (22%), Positives = 119/289 (41%), Gaps = 47/289 (16%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR---EVKCLRKLNHPN 60
Y + KLG G V+ A + VAIKA+ ++ R EV +L+H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV + ++ E + V E ++ L + + + L ++A+ + Q+ G+ + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAI-NFTNQILDGIKHAH 128
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-YTERV-GTRWYQAPEILFKSG 176
HRD+KP+N+L+ T+KI DFG+A+ + T V GT Y +PE K
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA-KGE 187
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
D++++G ++ E+L+ P F G ++ A++I
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNG-------------------ET-------AVSIA 221
Query: 237 YQ-----FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280
+ P ++ + + + N+I D R + +
Sbjct: 222 IKHIQDSVPNVT----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-32
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV----VAIKALKKSYSREKCLN-LREVKCLRKL 56
+ K +G+G FG V++ + K S VAIK LK Y+ ++ ++ L E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQ--CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+H NI++++ +I + + + E M+ L E + FS + L + G
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAG 159
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREI-DAFPPYTERVGT----RWYQA 168
+ Y+ Y HRDL N+LV S K++DFGL+R + D G RW A
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-A 218
Query: 169 PE-ILFKSGLYSSKVDMWAMGAIMAELL 195
PE I + ++S D+W+ G +M E++
Sbjct: 219 PEAISY--RKFTSASDVWSFGIVMWEVM 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 6 LTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYSREKCLN-LREVKCLRKLNHPNI 61
+ +G G FG V+ + AIK+L + ++ LRE +R LNHPN+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 62 VKVKELI----VEKGNVFFVFECMQC-NLYQLMEAKKQK---QQLFSESAVKAWLFQVFR 113
+ LI +G + M +L Q + + ++ + L S + QV R
Sbjct: 85 LA---LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS------FGLQVAR 135
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGT------RWY 166
G++Y+ +Q + HRDL N ++ + T+K+ADFGLAR+I Y+ + +W
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELL 195
A E L +++K D+W+ G ++ ELL
Sbjct: 196 -ALESLQT-YRFTTKSDVWSFGVLLWELL 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 48/210 (22%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEV---VAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ +G G FGCV+ + A+K+L + + L E ++ +HPN
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 61 IVKVKELI----VEKGNVFFVFECMQC-NLYQLMEAKKQK---QQLFSESAVKAWLFQVF 112
++ L+ +G+ V M+ +L + + + L + QV
Sbjct: 88 VLS---LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVA 138
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREI---DAFPPYTERVGT---RW 165
+G+ Y+ + + HRDL N ++ + T+K+ADFGLAR++ + + + + +W
Sbjct: 139 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
A E L +++K D+W+ G ++ EL+
Sbjct: 199 M-ALESLQT-QKFTTKSDVWSFGVLLWELM 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYSREKCLN-LREVKCLRKLN 57
S+ K +G+G FG V K + VAIK LK Y+ ++ + L E + + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQ--CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
HPNI++++ ++ + V V E M+ L + Q F+ + L + G+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGM 160
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREI-DAFPPYTERVGT----RWYQAP 169
Y+ GY HRDL N+L+ S K++DFGL R + D G RW +P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SP 219
Query: 170 E-ILFKSGLYSSKVDMWAMGAIMAELL 195
E I + ++S D+W+ G ++ E++
Sbjct: 220 EAIAY--RKFTSASDVWSYGIVLWEVM 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + K+LG+G FG V + +V AIK +K+ E + E K + L+H +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEF-IEEAKVMMNLSHEKL 81
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
V++ + ++ +F + E M L + ++ + F + V ++Y+
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 121 QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILFKS 175
+ + HRDL N LV+ QG +K++DFGL+R + YT VG+ RW PE+L
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS-PPEVL-MY 195
Query: 176 GLYSSKVDMWAMGAIMAELL 195
+SSK D+WA G +M E+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIY 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV---VAIKALKKSYSREKCLN-LREVKCLRKLN 57
E+ L + +G G FG V Q + VAIK K S L+E +R+ +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 58 HPNIVKVKELI--VEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
HP+IVK LI + + V+ + E +L + ++ +++ + +Q+ L
Sbjct: 450 HPHIVK---LIGVITENPVWIIMELCTLG--ELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVG---TRWYQAPEI 171
Y+ + + HRD+ N+LV S +K+ DFGL+R ++ Y G +W APE
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APES 563
Query: 172 LFKSGLYSSKVDMWAMGAIMAELL 195
+ ++S D+W G M E+L
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEIL 586
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYSREKCLN--LREVKCLRKL 56
++++L + LG G FG V +A K VA+K LK + LRE C+++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 57 NHPNIVKV------KELIVEKGNVFFVFECMQC-NL--YQLMEAKKQKQQLFSESAVKAW 107
+HP++ K+ + M+ +L + L + + +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 108 LFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGT--- 163
+ + G++Y+ + + HRDL N ++++ T+ +ADFGL+R+I + Y + +
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 164 -RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+W A E L LY+ D+WA G M E++
Sbjct: 203 VKWL-ALESLAD-NLYTVHSDVWAFGVTMWEIM 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV---VAIKALKKSYSREKCLN--LREVKCLRKL 56
L K LG G FG V + K VA+K +K S ++ + L E C++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 57 NHPNIVK-----VKELIVEKGNVFFVFECMQC-NL--YQLMEAKKQKQQLFSESAVKAWL 108
+HPN+++ ++ + M+ +L Y L + + + ++
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGT---- 163
+ G++Y+ + + HRDL N ++ T+ +ADFGL+++I + Y +
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+W A E L +Y+SK D+WA G M E+
Sbjct: 214 KWI-AIESLAD-RVYTSKSDVWAFGVTMWEIA 243
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L ++LG+G FG VW +V A+K+LK+ L E +++L H +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF-LAEANLMKQLQHQRL 70
Query: 62 VKVKELI--VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
V+ L V + ++ + E M+ +L + K + + + Q+ G+ ++
Sbjct: 71 VR---LYAVVTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGT----RWYQAPEILF 173
++ Y HRDL+ N+LVS + KIADFGLAR I+ YT R G +W APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWT-APEAI- 182
Query: 174 KSGLYSSKVDMWAMGAIMAELL 195
G ++ K D+W+ G ++ E++
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIV 204
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 37/211 (17%), Positives = 81/211 (38%), Gaps = 23/211 (10%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV-------VAIKALKKSYSREKCLNLREVKCLR 54
E + LG G+F +++ V + G+ V +K L K++ +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 55 KLNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
KL+H ++V + V V E ++ +L + K+ + + Q+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAA 124
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQ---------GTIKIADFGLAREIDAFPPYTERVGTR 164
+ ++ + H ++ +N+L+ + IK++D G++ + ER+
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--P 182
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
W PE + + D W+ G + E+
Sbjct: 183 WV-PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-31
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 44/290 (15%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR---EVKCLRKLNHPN 60
Y L + LG G V A + VA+K L+ +R+ LR E + LNHP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 61 IVKV----KELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
IV V + + V E + L ++ + + + A+ + + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAI-EVIADACQAL 129
Query: 116 DYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI-DAFPPYTER---VGTRWYQAPE 170
++ HQ G HRD+KP N+++S +K+ DFG+AR I D+ T+ +GT Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+ ++ D++++G ++ E+L P F G DS
Sbjct: 190 QA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTG-------------------DS------ 223
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280
+++ YQ + + SA S D ++ + +P R A +
Sbjct: 224 -PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-31
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 5 SLTKKLGSGSFGCVWQAVNKHSGEV---VAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ +G G FGCV+ + A+K+L + + L E ++ +HPN
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 61 IVKVKELI----VEKGNVFFVFECMQ-CNLYQLMEAKKQK---QQLFSESAVKAWLFQVF 112
++ L+ +G+ V M+ +L + + + L + QV
Sbjct: 152 VLS---LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVA 202
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGT------RW 165
+G+ ++ + + HRDL N ++ + T+K+ADFGLAR++ + T +W
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
A E L +++K D+W+ G ++ EL+
Sbjct: 263 M-ALESLQT-QKFTTKSDVWSFGVLLWELM 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 26/218 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE-----VVAIKALKKSYSREKCLN-LREVKCLRK 55
++LG FG V++ VAIK LK E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQ-------------CNLYQLMEAKKQKQQLFSES 102
L HPN+V + ++ + + +F + + + +
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 103 AVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERV 161
+ Q+ G++Y+ H+DL N+LV +KI+D GL RE+ A Y
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 162 GT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
+ RW APE + G +S D+W+ G ++ E+
Sbjct: 189 NSLLPIRWM-APEAIM-YGKFSIDSDIWSYGVVLWEVF 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 15/217 (6%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR---EVKCLRKLNHPN 60
Y L + +G G G V++A + +VA+K + ++ S + R E + +L P+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+V + + G ++ + +L ++ +++ L AV A + Q+ LD H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAV-AIVRQIGSALDAAH 151
Query: 120 QQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTER---VGTRWYQAPEILFKS 175
G HRD+KPEN+LVS + DFG+A T+ VGT +Y APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPE-RFSE 209
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYK 212
+ + D++A+ ++ E L P +QG D+ M
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGA 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 52/212 (24%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
EK +++++LG GSFG V++ V K E VAIK + ++ S + + L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQLFSESAVK-----AWL 108
N ++V++ ++ + + E M +L L + +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGT---- 163
++ G+ Y++ + HRDL N +V++ T+KI DFG+ R+I Y +
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 164 RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
RW +PE L G++++ D+W+ G ++ E+
Sbjct: 205 RW-MSPESLK-DGVFTTYSDVWSFGVVLWEIA 234
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLNLREVKCLRKL 56
L ++LG G+FG V+ A ++ ++ VA+KALK + RE + L L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQ-------------CNLYQLMEAKKQKQQLFSESA 103
H +IVK + + + VFE M+ + + +Q + S
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVG 162
+ Q+ G+ Y+ Q + HRDL N LV +KI DFG++R++ + Y
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 163 T----RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
T RW PE + ++++ D+W+ G I+ E+
Sbjct: 195 TMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIF 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLNLREVKCLRKL 56
L +LG G+FG V+ A + ++ VA+KALK++ + RE + L L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQC------------NLYQLMEAKKQKQQLFSESAV 104
H +IV+ + E + VFE M+ + L + +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 105 KAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGT 163
A QV G+ Y+ + HRDL N LV QG +KI DFG++R+I + Y T
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 164 ----RWYQAPEILFKSGLYSSKVDMWAMGAIMAELL 195
RW PE + ++++ D+W+ G ++ E+
Sbjct: 221 MLPIRWM-PPESIL-YRKFTTESDVWSFGVVLWEIF 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
+ +L + LG G+FG V++ + + VA+K L + S + L+ L E + K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQ--LFSESAVKAWLFQV 111
NH NIV+ + ++ F + E M +L L E + + Q + + +
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 112 FRGLDYMHQQGYFHRDLKPENLLVSQG----TIKIADFGLAREI---DAFPPYTERVGT- 163
G Y+ + + HRD+ N L++ KI DFG+AR+I Y + G
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCA 205
Query: 164 ----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+W PE + G+++SK D W+ G ++ E+
Sbjct: 206 MLPVKW-MPPEAFME-GIFTSKTDTWSFGVLLWEI 238
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 38/221 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
+ +G G+FG V+QA + + VA+K LK+ S + + RE + +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQLFSESAVKAWL----- 108
++PNIVK+ + + +FE M +L + L S S +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 109 --------------FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDA 153
QV G+ Y+ ++ + HRDL N LV + +KIADFGL+R I +
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 154 FPPYTERVGT------RWYQAPEILFKSGLYSSKVDMWAMG 188
Y + RW PE +F Y+++ D+WA G
Sbjct: 227 ADYY--KADGNDAIPIRWM-PPESIF-YNRYTTESDVWAYG 263
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
+ +L + LG G+FG V++ + + VA+K L + S + L+ L E + K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQ--LFSESAVKAWLFQV 111
NH NIV+ + ++ F + E M +L L E + + Q + + +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 112 FRGLDYMHQQGYFHRDLKPENLLVSQG----TIKIADFGLAREIDAFPPYTE---RVGT- 163
G Y+ + + HRD+ N L++ KI DFG+AR+I Y R G
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGC 245
Query: 164 -----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+W PE + G+++SK D W+ G ++ E+
Sbjct: 246 AMLPVKW-MPPEAFME-GIFTSKTDTWSFGVLLWEI 279
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-NKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRKL-N 57
+G G+FG V +A K + AIK +K+ S++ + E++ L KL +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQC-NL-------------YQLMEAKKQKQQLFSESA 103
HPNI+ + +G ++ E NL A L S+
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVG 162
+ + V RG+DY+ Q+ + HRDL N+LV + KIADFGL+R + Y ++
Sbjct: 145 LH-FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTM 200
Query: 163 T----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
RW A E L +Y++ D+W+ G ++ E+
Sbjct: 201 GRLPVRW-MAIESLN-YSVYTTNSDVWSYGVLLWEI 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
+ L K LG G FG V +A + +G VA+K LK++ S + + L E L++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 56 LNHPNIVKVKELI---VEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQLFSESAVKAWL-- 108
+NHP+++K L + G + + E + +L L E++K +
Sbjct: 83 VNHPHVIK---LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 109 -----------------FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLARE 150
+Q+ +G+ Y+ + HRDL N+LV++G +KI+DFGL+R+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 151 IDAFPPYTERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+ Y +R +W A E LF +Y+++ D+W+ G ++ E+
Sbjct: 200 VYEEDSYVKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEI 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYS-REKCLNLREVKCLRK 55
K LG+G+FG V +A + K + VA+K LK + EK + E+K +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 56 L-NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQLFSESAVKAWL---- 108
L H NIV + G V + E +L L + + + + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 109 -----FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVG 162
QV +G+ ++ + HRD+ N+L++ G KI DFGLAR+I Y +
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 163 T----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+W APE +F +Y+ + D+W+ G ++ E+
Sbjct: 226 ARLPVKW-MAPESIF-DCVYTVQSDVWSYGILLWEI 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 34/222 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
++ L K LG G+FG V +A ++K + VA+K LK+ + + + E+K L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 56 L-NHPNIVKVKELI----VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKA--- 106
+ +H N+V L+ G + + E + NL + +K+ + + +
Sbjct: 87 IGHHLNVVN---LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 107 ---------WLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPP 156
+ FQV +G++++ + HRDL N+L+S+ +KI DFGLAR+I P
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 157 YTERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
Y + +W APE +F +Y+ + D+W+ G ++ E+
Sbjct: 204 YVRKGDARLPLKW-MAPETIF-DRVYTIQSDVWSFGVLLWEI 243
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
+ S K LG+G+FG V +A + K + VA+K LK S + + E+K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 56 L-NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQ-LMEAKKQKQQLFSESAVKA------ 106
L NH NIV + G + E +L L + + A+
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 107 -------WLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYT 158
+ +QV +G+ ++ + HRDL N+L++ G KI DFGLAR+I Y
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 159 ERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+ +W APE +F +Y+ + D+W+ G + EL
Sbjct: 203 VKGNARLPVKW-MAPESIFN-CVYTFESDVWSYGIFLWEL 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGE---VVAIKALKKSYSREKCLN-LREVKCL 53
+K +L K LG G+FG V A ++K + VA+K LK + + + + E++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 54 RKL-NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKA----- 106
+ + H NI+ + + G ++ + E NL + + A++ +S +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 107 -------WLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYT 158
+Q+ RG++Y+ Q HRDL N+LV++ +KIADFGLAR+I+ Y
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 159 ERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+ +W APE LF +Y+ + D+W+ G +M E+
Sbjct: 215 KTTNGRLPVKW-MAPEALF-DRVYTHQSDVWSFGVLMWEI 252
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 18/178 (10%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH-PN 60
+Y L +K+GSGSFG ++ + +GE VAIK + E K + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
I ++ E V E + +L L +K FS V Q+ ++Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 123
Query: 121 QGYFHRDLKPENLLVSQG----TIKIADFGLARE-IDAF----PPYTER---VGTRWY 166
+ + HRD+KP+N L+ G + I DFGLA++ DA PY E GT Y
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV---VAIKALKKSYSREKCLN-LREVKCL 53
++ L K LG G+FG V A ++K VA+K LK + + + + E++ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 54 RKL-NHPNIVKVKELIVEKGNVFFVFECMQC-NL--YQLMEAKKQKQQLFSESAVKAWL- 108
+ + H NI+ + + G ++ + E NL Y + ++ S
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 109 ---------FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYT 158
+QV RG++Y+ + HRDL N+LV++ +KIADFGLAR+I Y
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 159 ERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+ +W APE LF +Y+ + D+W+ G ++ E+
Sbjct: 249 KTTNGRLPVKW-MAPEALF-DRIYTHQSDVWSFGVLLWEI 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGE---VVAIKALKKSYSREKCLN-LREVKCL 53
+K +L K LG G FG V A ++K + VA+K LK + + + + E++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 54 RKL-NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKA----- 106
+ + H NI+ + + G ++ + E NL + + A++ +S +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 107 -------WLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYT 158
+Q+ RG++Y+ Q HRDL N+LV++ +KIADFGLAR+I+ Y
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 159 ERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
+ +W APE LF +Y+ + D+W+ G +M E+
Sbjct: 261 KTTNGRLPVKW-MAPEALF-DRVYTHQSDVWSFGVLMWEI 298
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 20/179 (11%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNI 61
+ + KK+G G+FG + N ++ E VAIK E + ++L + I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
+V V E + +L L + + FS V Q+ ++Y+H +
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT---FSLKTVLMIAIQLISRMEYVHSK 124
Query: 122 GYFHRDLKPENLLVSQG------TIKIADFGLARE-IDAFP----PYTER---VGTRWY 166
+RD+KPEN L+ + I I DF LA+E ID PY E GT Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQA----VNKHSGEV-VAIKALKKSYSREKCLN-LREVKCLRK 55
E K LGSG+FG V A ++K + VA+K LK+ + + E+K + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 56 L-NHPNIVKVKELI---VEKGNVFFVFECMQC-NL----------YQLMEAKKQKQQLFS 100
L +H NIV L+ G ++ +FE +L + E + + Q+
Sbjct: 105 LGSHENIVN---LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 101 ESAVKAWL---------FQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLARE 150
E L +QV +G++++ + HRDL N+LV+ G +KI DFGLAR+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 151 IDAFPPYTERVGT----RWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
I + Y R +W APE LF+ G+Y+ K D+W+ G ++ E+
Sbjct: 222 IMSDSNYVVRGNARLPVKW-MAPESLFE-GIYTIKSDVWSYGILLWEI 267
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 42/310 (13%), Positives = 86/310 (27%), Gaps = 64/310 (20%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNHPN 60
Y L G WQA++ VA+ + + L L +++ P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 61 IVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
+ +V +++ + V E ++ +L ++ + A++A + + D H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIRA-MQSLAAAADAAH 146
Query: 120 QQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ G P + VS G + +A + +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANP------------------------- 181
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
+ D+ +GA + LL+ R G+R +A +
Sbjct: 182 --QDDIRGIGASLYALLVNRWPLPE-----------------------AGVRSGLAPAER 216
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA---EALQHPFFKRCLYVPPHL 295
+ + + + D R + Q V +
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPI 276
Query: 296 RSTPAVAATR 305
P AA R
Sbjct: 277 DEAPVSAAPR 286
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 42/180 (23%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN 60
Y + +++G GSFG +++ N + + VAIK + + E + + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTG 67
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
I V E + V + + +L L++ +K FS V Q+ + +H+
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE 124
Query: 121 QGYFHRDLKPENLLVSQG------TIKIADFGLARE-IDAFP----PYTER---VGTRWY 166
+ +RD+KP+N L+ + I + DFG+ + D PY E+ GT Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 18/178 (10%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPN 60
K+ L +K+GSGSFG ++ N + E VAIK + L E K R L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
I V+ VE V + + +L L +K S V Q+ ++++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
Query: 121 QGYFHRDLKPENLLVSQG----TIKIADFGLARE-IDAFP----PYTER---VGTRWY 166
+ + HRD+KP+N L+ G + I DFGLA++ D PY E GT Y
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 27/170 (15%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV 62
++ L KK+GSG FG ++ A + E A +K Y L E+K +++ + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL-FSELKFYQRVAKKDCI 96
Query: 63 KVKELIVEKGNV-------------------FFVFECMQCNLYQLMEAKKQKQQLFSESA 103
K + + F V E + +L ++ F +S
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKST 152
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIK---IADFGLARE 150
V ++ L+Y+H+ Y H D+K NLL+ +AD+GL+
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 27/171 (15%), Positives = 59/171 (34%), Gaps = 24/171 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSG--------EVVAIK---------ALKKSYSRE-K 43
++ L + G +++A + + ++K + + R K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 44 CLNLREVKCLRKLNHPNIVKVKELIVEKGNV-FFVFECMQCNLYQLMEAKKQKQQLFSES 102
L + + K L I V + F V + +L + + + SE
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSAL--DVSPKHVLSER 159
Query: 103 AVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIK---IADFGLARE 150
+V ++ L+++H+ Y H ++ EN+ V +A +G A
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 36/173 (20%), Positives = 68/173 (39%), Gaps = 30/173 (17%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIK---ALKKSYSREKCLNLREVKCLRKLNHP 59
+ + +G G FGC++ A + +S E V +K S L E+K ++ P
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPL-FTELKFYQRAAKP 93
Query: 60 NIVKVKELIVEKGNV-------------------FFVFECMQCNLYQLMEAKKQKQQLFS 100
++ + + F + + +L ++ EA ++ FS
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR---FS 150
Query: 101 ESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIK---IADFGLARE 150
V ++ L+Y+H+ Y H D+K NLL++ + D+GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.9 bits (201), Expect = 1e-17
Identities = 41/273 (15%), Positives = 84/273 (30%), Gaps = 66/273 (24%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLRK 55
EK +K+G G FG V+Q + H+ + I A++ L E+ ++
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 56 L---------NHPNIVKVKELIVEKG------------------------------NVFF 76
L + + + +G +F
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLV 135
V E + ++ ++ + +L S + K+ L Q+ L + HRDL N+L+
Sbjct: 140 VLEFE----FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 136 -SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
K+ + P +V Y+ + ++
Sbjct: 196 KKTSLKKLHYTLNGKSST-IPSCGLQVSIID------------YTLSRLERDGIVVFCDV 242
Query: 195 LLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227
+ LF G + D + I ++ + W +
Sbjct: 243 SMDEDLFTG--DGDYQFDIYRLMKKENNNRWGE 273
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 40/209 (19%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLR----EVKCLRKLNHPNIVKV 64
K+G G FG V++ + VA+K L + E+K + K H N+V+
Sbjct: 38 KMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE- 94
Query: 65 KELI---VEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKA--W------LFQVFR 113
L+ + ++ V Y M +L W
Sbjct: 95 --LLGFSSDGDDLCLV--------YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN 144
Query: 114 GLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPY-----TERV-GTRWY 166
G++++H+ + HRD+K N LL T KI+DFGLAR A + T R+ GT Y
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQTVMTSRIVGTTAY 201
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELL 195
APE L G + K D+++ G ++ E++
Sbjct: 202 MAPEAL--RGEITPKSDIYSFGVVLLEII 228
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 43/214 (20%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVK 65
+G G FG V++ V + G VA+K S E E++ L HP++V
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEF---ETEIETLSFCRHPHLVS-- 99
Query: 66 ELI---VEKGNVFFVFECMQCN-----LYQLMEAK-----KQKQQLFSESAVKAWLFQVF 112
LI E+ + +++ M+ LY +Q+ ++ +A
Sbjct: 100 -LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA--------- 149
Query: 113 RGLDYMHQQGYFHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPYTE-----RV-GTRW 165
RGL Y+H + HRD+K N LL KI DFG+++ + V GT
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLSTVVKGTLG 206
Query: 166 YQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRP 199
Y PE F G + K D+++ G ++ E+L R
Sbjct: 207 YIDPE-YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 107 WLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG-TIKIADFGLAREIDAFPPYTERVGTR- 164
+ FQV +G++++ + HRDL N+L+S+ +KI DFGLAR+I P Y + R
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 165 ---WYQAPEILFKSGLYSSKVDMWAMGAIMAEL 194
W APE +F +Y+ + D+W+ G ++ E+
Sbjct: 258 PLKW-MAPETIFD-RVYTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 17/145 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRK 55
++ L K LG G+FG V +A + VA+K LK+ + E + E+K L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 56 L-NHPNIVKVKEL-IVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
+ +H N+V + G + + E + NL + +K+ + + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA-----RFR 136
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQ 137
+G DY+ G DLK ++
Sbjct: 137 QGKDYV---GAIPVDLKRRLDSITS 158
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 36/208 (17%)
Query: 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS----REKCLNLREVKCLRKLNHPNIVKV 64
LG G FG V++ G +VA+K LK+ + + EV+ + H N+++
Sbjct: 37 ILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLR- 91
Query: 65 KELI---VEKGNVFFVFECMQCNL---YQLMEAKKQKQQLFSESAVK-----AWLFQVFR 113
L + V+ M N L E + + L + A R
Sbjct: 92 --LRGFCMTPTERLLVYPYM-ANGSVASCLRERPESQPPLDWPKRQRIALGSA------R 142
Query: 114 GLDYMHQQGY---FHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPY-TERV-GTRWYQ 167
GL Y+H HRD+K N LL + + DFGLA+ +D + T V GT +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAELL 195
APE L +G S K D++ G ++ EL+
Sbjct: 203 APEYL-STGKSSEKTDVFGYGVMLLELI 229
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.82 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.31 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.94 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.39 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.05 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-68 Score=471.08 Aligned_cols=257 Identities=30% Similarity=0.480 Sum_probs=224.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ......+.+|+.+|++++|||||+++++|++++++||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999997643 223345688999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-- 154 (356)
||+.| +|.+.+.. .+.++|..++.++.||+.||+|||++||+||||||+|||+++ |.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99986 68888753 345999999999999999999999999999999999999975 79999999999987532
Q ss_pred -CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 155 -PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
....+.+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.++...
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----------------- 249 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL----------------- 249 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------------
T ss_pred cccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2345679999999999997765 899999999999999999999999998888777776542
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE------ALQHPFFKRCLYVPP 293 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------~l~hp~~~~~~~~~~ 293 (356)
.+.+| +.+|+++++||.+||..||++|||++| +++||||++..|...
T Consensus 250 --~~~~p-----------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 250 --EYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp --CCCCC-----------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred --CCCCC-----------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 12222 367999999999999999999999988 589999999877644
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-68 Score=465.60 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=206.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .....+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999976532 2234567899999999999999999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
|||++|+|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||+++ +++||+|||+|+.......
T Consensus 92 mEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 99999999988753 345999999999999999999999999999999999999975 7999999999988776666
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
..+.+||+.|||||++.+..+++.++|||||||++|+|++|++||.+.+.......+... .
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-------------------~ 228 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-------------------V 228 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------------C
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------------C
Confidence 667899999999999987776678999999999999999999999988777666655432 1
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+.+ +..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus 229 ~~~-----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 YTL-----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp CCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCC-----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 112 2357999999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-67 Score=471.69 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=221.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.++||+|+||+||+|+++.+|+.||||++..........+.+|+.+|++++|||||+++++|.+++.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999998766555667789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
.| +|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+|||++. |.+||+|||+|+.+... ....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 87 56666532 34999999999999999999999999999999999999975 89999999999987543 3456
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
+.+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+..... +...
T Consensus 229 ~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~--------------- 291 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLK--------------- 291 (346)
T ss_dssp CCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCS---------------
T ss_pred ccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCC---------------
Confidence 789999999999986555 89999999999999999999999999888777766644211 1111
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+..+|+++++||.+||..||++|||++|+|+||||++.
T Consensus 292 -----------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 292 -----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp -----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 112579999999999999999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-67 Score=476.75 Aligned_cols=256 Identities=31% Similarity=0.549 Sum_probs=216.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
||+|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999997653 334456789999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+... ++..+++..++.|+.||+.||+|||++|||||||||+|||+++ |.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99975 788887543 3445899999999999999999999999999999999999975 799999999998765432
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+.++.....
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------------- 242 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----------------- 242 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----------------
T ss_pred cccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----------------
Confidence 224568999999999997655 89999999999999999999999999988887777754311
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+ .....+|+++.+||.+||..||++|||++|+|+||||++.
T Consensus 243 ----~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 243 ----P--------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp ----C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ----C--------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 1 1223679999999999999999999999999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=474.28 Aligned_cols=283 Identities=34% Similarity=0.614 Sum_probs=241.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE------CCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVE------KGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 73 (356)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999976532 334456789999999999999999999764 367
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+||||||++|+|.+.+. ..+.+++..++.+++||+.||+|||++|||||||||+|||++. |.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 99999999999888874 3456999999999999999999999999999999999999975 799999999998653
Q ss_pred C-----CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 153 A-----FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 153 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
. .....+.+||+.|||||++.+...|+.++||||+|||+|+|++|.+||.+.+..+++..|....+.|+...|..
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 2 22345679999999999998877789999999999999999999999999999999999999999998877654
Q ss_pred Hhhhh-hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 228 GLRQA-MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 228 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..... ......++......+....+.+|+++++||.+||.+||++|||++|+|+||||++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 32221 12223455555556666777899999999999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-65 Score=473.33 Aligned_cols=254 Identities=28% Similarity=0.492 Sum_probs=221.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.++||+|+||+||+|+++.+|+.||||++..........+.+|+.+|+.++|||||+++++|.+++.+||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999998766555667789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
.| +|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+|||++. |.+||+|||+|+.+... ....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 87 56666532 34999999999999999999999999999999999999975 89999999999987543 3456
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
+.+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+..... +..
T Consensus 306 ~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~---------------- 367 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL---------------- 367 (423)
T ss_dssp CCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCC----------------
T ss_pred ccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC----------------
Confidence 789999999999986655 89999999999999999999999999888777766644211 111
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.....+|+++++||.+||..||++|||++|+|+||||++.
T Consensus 368 ----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 ----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1123679999999999999999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-65 Score=455.50 Aligned_cols=255 Identities=31% Similarity=0.499 Sum_probs=212.5
Q ss_pred CCceeecccccCCceEEEEEEEc---CCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++++.||+|+||+||+|++. .+++.||+|++++... .....+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 4688999999976532 223345789999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA- 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~- 153 (356)
||||+.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||+++ |.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999986 68787753 345999999999999999999999999999999999999975 7999999999986543
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.....+.+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.++...
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----------------- 241 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----------------- 241 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred CccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------
Confidence 33445679999999999996655 899999999999999999999999998888877776542
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
.+.+ +..+|+++.+||++||+.||++||| ++|+++||||++..|.
T Consensus 242 --~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 242 --KLGM-----------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp --CCCC-----------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --CCCC-----------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 1111 2367999999999999999999998 5899999999986553
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-64 Score=442.11 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=207.9
Q ss_pred Cc-eeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE----CCeEE
Q 036550 3 KY-SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE----KGNVF 75 (356)
Q Consensus 3 ~y-~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 75 (356)
+| ++.++||+|+||+||+|++..+++.||+|++.... ......+.+|+.+|++++|||||+++++|.+ ++.+|
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 44 67889999999999999999999999999986543 3344567899999999999999999999875 35689
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeee--CCcEEEecccceee
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVS--QGTIKIADFGLARE 150 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~--~~~~kL~Dfg~a~~ 150 (356)
|||||+.| +|.+.+.. ...+++..++.|+.||+.||+|||++| |+||||||+|||++ +|.+||+|||+|+.
T Consensus 106 lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999986 67777753 345999999999999999999999999 99999999999996 47999999999975
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
... ....+.+||+.|||||++.+ + |+.++|||||||++|+|+||.+||........+.+.......|
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------- 248 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred CCC-CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence 443 34456789999999998843 4 8999999999999999999999998766555443332211100
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.......++++.+||.+||..||++|||++|+|+||||++
T Consensus 249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1112356889999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=447.92 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=210.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
+.|.+.++||+|+||+||+|+++.+|+.||||+++... ...+|+.+|+.++|||||++++++.+++.+||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46889999999999999999999999999999997542 2357999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C-cEEEecccceeecCCCC---
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G-TIKIADFGLAREIDAFP--- 155 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~-~~kL~Dfg~a~~~~~~~--- 155 (356)
.| +|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++. | ++||+|||+|+......
T Consensus 133 ~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 85 688877532 45999999999999999999999999999999999999975 5 69999999998765322
Q ss_pred ---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 ---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.....+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+...++... .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~------------- 272 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--P------------- 272 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--C-------------
T ss_pred ceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--C-------------
Confidence 123358999999999997655 899999999999999999999999887766555555431 0
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH-------------hcCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA-------------LQHPFFKR 287 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~-------------l~hp~~~~ 287 (356)
.....+++.+|+++.+||.+||..||.+|||+.|+ |+|||+.+
T Consensus 273 ------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 273 ------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp ------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred ------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 11123345789999999999999999999999997 57999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-62 Score=447.13 Aligned_cols=278 Identities=27% Similarity=0.458 Sum_probs=218.5
Q ss_pred CCceeecccccCCceEEEEEEEc---CCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.++||+|+||+||+|+++ .+++.||+|++.+... .....+|+.+|+.+ +|||||+++++|.+.+++|+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 57999999999999999999875 4678999999866533 23457899999998 699999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAF 154 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~ 154 (356)
|||++| +|.+.+. .+++..++.+++||+.||+|||++||+||||||+|||++. +.+||+|||+|+.....
T Consensus 99 mE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 99 MPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999975 6776652 3899999999999999999999999999999999999975 69999999999765432
Q ss_pred C-----------------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCC-CC
Q 036550 155 P-----------------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQ-GT 204 (356)
Q Consensus 155 ~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~ 204 (356)
. ...+.+||+.|+|||++.+...|+.++||||+|||+|+|++|++||. +.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 22345899999999999887779999999999999999999999985 55
Q ss_pred ChHHHHHHHHHHhCCCCccchHHHhhhh-------------------hhhcccCCCcc-----cccccccCCCCCHHHHH
Q 036550 205 DEADQMYKICSVLGSPTMDSWADGLRQA-------------------MAINYQFPQLS-----GVNLSALMPSASEDAIN 260 (356)
Q Consensus 205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~-----~~~~~~~~~~~s~~~~~ 260 (356)
++.+++..|...+|.+....+....... .......|... .......+..+|++++|
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 6778888888888765433332221111 11111111110 01112234578999999
Q ss_pred HHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 261 LIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 261 li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
||++||.+||++|+|++|+|+||||++.
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-62 Score=432.48 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=194.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC--------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKG-------- 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-------- 72 (356)
++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 579999999999999999999999999999999976543 33456689999999999999999999987654
Q ss_pred ----eEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccc
Q 036550 73 ----NVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFG 146 (356)
Q Consensus 73 ----~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg 146 (356)
++|+||||+.| +|.+.+.... .....++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 47999999975 6777775322 2223567789999999999999999999999999999999975 799999999
Q ss_pred ceeecCCCC-------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036550 147 LAREIDAFP-------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKI 213 (356)
Q Consensus 147 ~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 213 (356)
+|+...... ..+..+||+.|||||++.+.. |+.++|||||||++|||++ ||.... +....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 998765321 123458999999999997655 8999999999999999996 776432 222222
Q ss_pred HHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 214 CSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
........++. ....++.+.+||++||+.||++|||+.|+|+||||++..+
T Consensus 238 ~~~~~~~~p~~--------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 238 TDVRNLKFPPL--------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHTTCCCHH--------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHhcCCCCCC--------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 11111111111 1133677899999999999999999999999999987544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-61 Score=463.68 Aligned_cols=260 Identities=26% Similarity=0.456 Sum_probs=229.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
|++|++.+.||+|+||+||+|+++.+|+.||+|++.+........+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 47899999999999999999999999999999999877666667778999999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC---CcEEEecccceeecCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~kL~Dfg~a~~~~~~~~ 156 (356)
+.| +|++.+. .....+++..++.+++||+.||+|||++||+||||||+|||++. +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 986 6777664 23345899999999999999999999999999999999999963 6999999999999877666
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 313 ~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------- 378 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS------------- 378 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG-------------
T ss_pred eeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc-------------
Confidence 67789999999999997765 8999999999999999999999999999888877775532222221
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.++.+|+++++||++||..||.+|||+.|+|+||||+...+
T Consensus 379 -------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 379 -------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp -------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred -------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 12367999999999999999999999999999999987544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=458.86 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=213.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhH---HHHHHHHhCCCCCeeEEeEEEEECCeE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNL---REVKCLRKLNHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~ 74 (356)
|++|++++.||+|+||+||+|+++.+|+.||+|++.+... ....... +++.+++.++|||||+++++|.+.+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 5899999999999999999999999999999999976421 1112222 346677788999999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
||||||+.| +|.+.+.. .+.+++..++.|+.||+.||+|||++|||||||||+|||++. |++||+|||+|+...
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999986 67777753 345999999999999999999999999999999999999975 899999999999876
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCccchHHHh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD---QMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 229 (356)
... ..+.+||+.|||||++.+...|+.++|||||||++|+|++|.+||.+.+..+ ....+..
T Consensus 344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-------------- 408 (689)
T 3v5w_A 344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------------- 408 (689)
T ss_dssp SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--------------
T ss_pred CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--------------
Confidence 543 3567999999999999765569999999999999999999999997643322 1212211
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYVP 292 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~~ 292 (356)
....+ +..+|+++++||.+||..||.+|++ ++|+++||||++..|..
T Consensus 409 -----~~~~~-----------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 409 -----MAVEL-----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp -----CCCCC-----------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred -----CCCCC-----------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 11122 2368999999999999999999998 79999999999887753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=415.98 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=211.0
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.++||+|+||+||+|++. .++..||||+++.........+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46899999999999999999865 3678999999987766666778899999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHH---------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecc
Q 036550 77 VFECMQC-NLYQLMEAKK---------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADF 145 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Df 145 (356)
||||+++ +|.+++.... .....+++..+..++.||+.||+|||+++|+||||||+|||+++ +.+||+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCc
Confidence 9999975 6888886532 12345999999999999999999999999999999999999976 69999999
Q ss_pred cceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 036550 146 GLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPT 221 (356)
Q Consensus 146 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (356)
|+|+....... .....||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.+..+....+.....
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~--- 248 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--- 248 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC---
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 99986644322 22346999999999997765 9999999999999999998 8999999887777666544211
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...++.+|+++.+|+.+||+.||++|||++++ ++|+++
T Consensus 249 --------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 249 --------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred --------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 11123678999999999999999999999999 446643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=415.47 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=204.1
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.++||+|+||+||+|++. .+++.||||+++.........+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 36788899999999999999865 4688999999987766666778999999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHH-----------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEe
Q 036550 77 VFECMQC-NLYQLMEAKK-----------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIA 143 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~ 143 (356)
||||+++ +|.+++.... ....++++..+..|+.||+.||+|||+++||||||||+|||+++ +.+||+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEc
Confidence 9999985 6777775422 12346999999999999999999999999999999999999986 699999
Q ss_pred cccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 036550 144 DFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGS 219 (356)
Q Consensus 144 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 219 (356)
|||+|+...... .....+||+.|||||++.+.. |+.++|||||||++|||+| |+.||...+..+....+.....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~- 278 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE- 278 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC-
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 999998764322 223567999999999996655 8999999999999999999 8999998887776666543211
Q ss_pred CCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 220 PTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
+ ..+..+++++.+|+.+||+.||++|||++|++++
T Consensus 279 ~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 279 L----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred C----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 0 1123678999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-58 Score=406.54 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=198.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+++.+.++||+|+||+||+|++.. .||||+++... ......+.+|+.+|++++|||||++++++. ++.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 578899999999999999997543 59999987543 233456789999999999999999999875 467899999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC---
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--- 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--- 154 (356)
|++| +|.+.+.. ....+++..+..|+.||+.||+|||+++||||||||+|||+++ +.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9985 67777652 3345999999999999999999999999999999999999986 59999999999866432
Q ss_pred CCCccccccccccChHHHhhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKS--GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......+||+.|||||++.+. +.|+.++|||||||++|||+||++||.+.+.......+......
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~------------- 255 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA------------- 255 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-------------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-------------
Confidence 233456899999999999643 35899999999999999999999999987766555444332111
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.| ......+.+++++.+|+.+||+.||++|||+.|+++
T Consensus 256 ------~p-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 256 ------SP-----DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp ------CC-----CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ------CC-----CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11 112233467899999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=412.38 Aligned_cols=288 Identities=35% Similarity=0.640 Sum_probs=243.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH-HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
|++|.+.+.||+|+||+||+|++..+++.||+|++....... .....+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 689999999999999999999999999999999987553322 2234579999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~ 157 (356)
|++|++.+.+... +..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++...... ...
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9999988887643 345899999999999999999999999999999999999975 79999999999866532 233
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+....|...........+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 45578999999999987667899999999999999999999999999999999999999999999988877665555556
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYV 291 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 291 (356)
.++...........+.+++++.+||.+||+.||++|||++|+|+||||.+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 666655555566667889999999999999999999999999999999875443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-57 Score=406.83 Aligned_cols=285 Identities=36% Similarity=0.683 Sum_probs=240.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|++.++||+|+||+||+|++. +|+.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 478999999999999999999986 5899999998754322 2345678999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~ 156 (356)
||++|++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++...... ..
T Consensus 99 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 99 EFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp ECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9999998887753 3345899999999999999999999999999999999999975 79999999999887533 33
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+....+.+....|...........
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 44568999999999998766789999999999999999999999999999899999999999998888866544333333
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..+.......+....+.+++++.+||.+||..||++|||++|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 33344444445556678899999999999999999999999999999998743
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-58 Score=408.12 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=208.3
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
+++++.++||+|+||+||+|+.. .+++.||||+++.... .....+.+|+.++++++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46788999999999999999853 4678999999975433 33456789999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHH------------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEE
Q 036550 76 FVFECMQC-NLYQLMEAKK------------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIK 141 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~k 141 (356)
+||||+++ +|.+++.... .....+++..+..++.||+.||+|||+++||||||||+|||+++ +.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 99999975 6888875432 12345899999999999999999999999999999999999976 7999
Q ss_pred EecccceeecCCC---CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 036550 142 IADFGLAREIDAF---PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVL 217 (356)
Q Consensus 142 L~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 217 (356)
|+|||+|+..... ......+||+.|||||++.+.. |+.++|||||||++|||+| |.+||.+.+..+....+....
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~ 264 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 264 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999866432 2234568999999999997765 9999999999999999998 899999988777666554321
Q ss_pred CCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. ...++.+++++.+|+.+||+.||++|||+.|++++
T Consensus 265 ~-----------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 265 V-----------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp C-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 11223678999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-56 Score=396.11 Aligned_cols=284 Identities=34% Similarity=0.637 Sum_probs=237.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
|++|++.++||+|+||+||+|++..+++.||+|++..... .......+|+.++++++||||+++++++.+++..++||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999999875432 22355678999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~ 156 (356)
||++|++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++...... ..
T Consensus 81 e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9999998877653 3345999999999999999999999999999999999999975 79999999999877533 33
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL-FQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....||+.|+|||++.+...++.++|||||||++|+|++|..| |...+..+....+....+.+....|..........
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 44568999999999998777689999999999999999987655 67777788889999999998888776543321111
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+.. ...........+.+++++.+||++||+.||++|||++|+|+||||++.
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPM-YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCC-CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccc-ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1100 011222334456789999999999999999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-56 Score=395.39 Aligned_cols=282 Identities=36% Similarity=0.671 Sum_probs=233.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
|++|.+.+.||+|+||+||+|++ .+|+.||+|++....... ...+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 68999999999999999999998 678999999986543222 245578999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~ 156 (356)
||+++++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++...... ..
T Consensus 80 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 80 EHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp ECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 9999998887753 2345899999999999999999999999999999999999975 79999999999876532 23
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+....|...... ....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS-TTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc-cccc
Confidence 345679999999999977666899999999999999999999999999999999999998888887777543221 1111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..++......+....+.+++++.+||.+||..||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 122223333444556688999999999999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=405.94 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=206.6
Q ss_pred CCceeecccccCCceEEEEEEEcCC-----CcEEEEEEcccccc-hHHhhhHHHHHHHHhCCC-CCeeEEeEEEEEC-Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-----GEVVAIKALKKSYS-REKCLNLREVKCLRKLNH-PNIVKVKELIVEK-GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~-~~ 73 (356)
++|++.+.||+|+||+||+|.+..+ ++.||+|++..... .+...+.+|+.+|+++.| ||||+++++|... +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 5799999999999999999987654 46899999976543 334567899999999965 8999999998764 57
Q ss_pred EEEEEEeccC-CHHHHHHHHHhh------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-Cc
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQK------------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GT 139 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~ 139 (356)
+|+||||+.+ +|.+++...... ...+++..+..++.||+.||+|||+++||||||||+|||+++ +.
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence 8999999985 688888654321 244899999999999999999999999999999999999975 79
Q ss_pred EEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036550 140 IKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICS 215 (356)
Q Consensus 140 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 215 (356)
+||+|||+|+....... ....+||+.|||||++.+.. |+.++|||||||++|||+| |.+||.+....+.+.++..
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 99999999987654332 23457999999999997765 9999999999999999998 9999988765444443332
Q ss_pred HhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....+ ..++.+++++.+++.+||+.||++|||+.|+++|
T Consensus 303 ~g~~~----------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 303 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 21111 1123578999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=397.61 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=221.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|.+.+.||+|+||.||+|++..+|+.||+|++.+.. ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999987653 233445678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++........
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99965 677777543 34999999999999999999999999999999999999975 7999999999987766556
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+... .
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------------~ 230 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------------------K 230 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------C
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------C
Confidence 667889999999999987775568999999999999999999999988877666555432 1
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
+.+| ..+++++.+||++||..||.+|||++|+++||||+...
T Consensus 231 ~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 231 YRIP-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CCCC-----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCCC-----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 1222 25689999999999999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=420.38 Aligned_cols=280 Identities=32% Similarity=0.546 Sum_probs=226.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
++|++.+.||+|+||+||+|++..+++.||+|++.+.. ........+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 68999999999999999999999999999999997642 23345567899999999999999999999654 46
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+|+||||+++++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|....
T Consensus 142 ~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 79999999999777663 23899999999999999999999999999999999999985 799999999998877
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
........+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+++.++...++.|....+.......
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 665666789999999999997765 8999999999999999999999999999999999999999998876654332222
Q ss_pred hhhcccCCCcccccccccCCC------------CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPS------------ASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~------------~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......+......+....+. .++++++||.+||.+||++|||++|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 222222222222222222111 15789999999999999999999999999999853
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-56 Score=402.03 Aligned_cols=287 Identities=35% Similarity=0.657 Sum_probs=230.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|.+.+.||+|+||+||+|++..+++.||+|++....... ...+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 478999999999999999999999999999999997654322 345578999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC------CcEEEecccceeecC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ------GTIKIADFGLAREID 152 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------~~~kL~Dfg~a~~~~ 152 (356)
||++|+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++....
T Consensus 113 e~~~~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAENDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCSEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999988887543 34899999999999999999999999999999999999952 359999999998765
Q ss_pred CC-CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 153 AF-PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||......+....+....+.+....|......
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 23345678999999999987666899999999999999999999999999999999999999998887776543221
Q ss_pred hhhhcccCCCcccccccc-cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSA-LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVP 292 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 292 (356)
......++......+.. ....+++++.+||.+||..||++|||++|+|+||||++..+.|
T Consensus 269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 269 -PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp -TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred -hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 11111222221111111 1223789999999999999999999999999999999877654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=397.22 Aligned_cols=289 Identities=30% Similarity=0.586 Sum_probs=224.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 36899999999999999999999999999999998754322 23456789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-C
Q 036550 80 CMQCNLYQLMEAKKQK--QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-P 155 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~ 155 (356)
|++|+|.+.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++...... .
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 9999999888755321 234899999999999999999999999999999999999975 79999999999877543 2
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+....|....... ..
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~ 242 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP-KY 242 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT-TC
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh-hc
Confidence 34456899999999999776668999999999999999999999999999999999999998888877765433211 00
Q ss_pred cccCCCccccc-----ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 236 NYQFPQLSGVN-----LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 236 ~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
...++...... .......++.++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11111110000 11223467899999999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=395.48 Aligned_cols=281 Identities=36% Similarity=0.643 Sum_probs=233.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-----HHhhhHHHHHHHHhC---CCCCeeEEeEEEEECC-
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-----EKCLNLREVKCLRKL---NHPNIVKVKELIVEKG- 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~- 72 (356)
++|++.+.||+|+||+||+|++..+++.||+|++...... ......+|+.+++.+ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 6899999999999999999999999999999998653211 122445677777766 4999999999998765
Q ss_pred ----eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 73 ----NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 73 ----~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
..+++|||++|+|.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 589999999999888876432 233899999999999999999999999999999999999965 7999999999
Q ss_pred eeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 148 AREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
+............+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+...++....+.++...|..
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred ccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 98777666666778999999999997665 89999999999999999999999999999999999999999888877754
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..... ...++...........+.++..+.+||.+||..||++|||+.|+|+||||++.
T Consensus 246 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 246 DVSLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSC---GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhcc---ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 32211 12233333444455567889999999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=400.36 Aligned_cols=256 Identities=31% Similarity=0.484 Sum_probs=220.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.... ....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5799999999999999999999999999999999765322 2345678999999999999999999999999999
Q ss_pred EEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C----cEEEeccccee
Q 036550 76 FVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G----TIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~----~~kL~Dfg~a~ 149 (356)
+||||+. |+|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||++.
T Consensus 92 lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 92 LILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999996 56777763 3445999999999999999999999999999999999999965 3 69999999999
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
...........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+......++..
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------ 240 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE------ 240 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH------
T ss_pred EcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch------
Confidence 887766666788999999999986554 8999999999999999999999999988877776665432221111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+..++..+++||.+||..||.+|||+.|+|+||||+..
T Consensus 241 --------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 241 --------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp --------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred --------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 123678999999999999999999999999999999854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=414.72 Aligned_cols=285 Identities=35% Similarity=0.649 Sum_probs=222.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 74 (356)
++|.+.+.||+|+||+||+|++..+++.||||++.+.. ......+.+|+.+|+.++||||+++++++... +.+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999999999999999986543 23345567899999999999999999998543 579
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
|+||||++|+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|.....
T Consensus 133 ~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999999999888874 3345999999999999999999999999999999999999976 6999999999987642
Q ss_pred CC----------------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh---------
Q 036550 154 FP----------------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL--------- 196 (356)
Q Consensus 154 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--------- 196 (356)
.. .....+||+.|+|||++.....|+.++||||||||+|+|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 23455789999999998777779999999999999999998
Q ss_pred --CCCCCCCCC--------------------hHHHHHHHHHHhCCCCccchHHHhhhh-hhhcccCCCcccccccccCCC
Q 036550 197 --FRPLFQGTD--------------------EADQMYKICSVLGSPTMDSWADGLRQA-MAINYQFPQLSGVNLSALMPS 253 (356)
Q Consensus 197 --g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 253 (356)
|.++|.+.+ ..+++..+...++.|....+....... ......++......+....+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 778887654 257788888889988876664332211 111223444555556666778
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 254 ASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 254 ~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.++++.+||++||.+||++|||++|+|+||||++..+
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 8999999999999999999999999999999987643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=404.04 Aligned_cols=280 Identities=30% Similarity=0.583 Sum_probs=238.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-----------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE----------- 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------- 70 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 68999999999999999999999999999999986542 223479999999999999999999844
Q ss_pred ---------------------------CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCc
Q 036550 71 ---------------------------KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123 (356)
Q Consensus 71 ---------------------------~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 123 (356)
...+++||||++|+|.+.+......+..+++..++.++.||+.||+|||++||
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 34589999999999999988776777789999999999999999999999999
Q ss_pred ccccCCCCCeeee--CCcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036550 124 FHRDLKPENLLVS--QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLF 201 (356)
Q Consensus 124 vH~Dlkp~NIll~--~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 201 (356)
+||||||+|||++ ++.+||+|||+|.............||+.|+|||++.+...++.++|||||||++|+|++|.+||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999999997 47899999999998876666667789999999999987766899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccc-cCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 202 QGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSA-LMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 202 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
.+.+..+++..+...++.|....+...... .....++......+.. .....++++.+||.+||..||++|||+.|+|
T Consensus 243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPH--YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCTT--C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHhCcc--cccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 999999999999999999987766543221 1223344433333322 2346899999999999999999999999999
Q ss_pred cCCCCCC
Q 036550 281 QHPFFKR 287 (356)
Q Consensus 281 ~hp~~~~ 287 (356)
+||||++
T Consensus 321 ~hp~f~~ 327 (383)
T 3eb0_A 321 AHPFFDH 327 (383)
T ss_dssp TSGGGHH
T ss_pred cCHHHHH
Confidence 9999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=405.23 Aligned_cols=283 Identities=33% Similarity=0.657 Sum_probs=219.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECC--eEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLN-HPNIVKVKELIVEKG--NVF 75 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~--~~~ 75 (356)
+++|.+.+.||+|+||+||+|.+..+|+.||+|++.... ........+|+.+++.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 368999999999999999999999999999999986542 334455678999999997 999999999998654 789
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+||||++|+|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.....
T Consensus 88 lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999999998887753 34899999999999999999999999999999999999975 79999999999875431
Q ss_pred ----------------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036550 155 ----------------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYK 212 (356)
Q Consensus 155 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 212 (356)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1234468999999999998766799999999999999999999999999999999999
Q ss_pred HHHHhCCCCccchHHH-------hhhhhhhcccCCCccccc----------ccccCCCCCHHHHHHHHHccCCCCCCCCC
Q 036550 213 ICSVLGSPTMDSWADG-------LRQAMAINYQFPQLSGVN----------LSALMPSASEDAINLIESLCSWDPCKRPT 275 (356)
Q Consensus 213 i~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~----------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 275 (356)
+....+.|....+... .................. ........++++.+||.+||..||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 9999888876544211 000000000000000000 00112367899999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 036550 276 AAEALQHPFFKRC 288 (356)
Q Consensus 276 ~~e~l~hp~~~~~ 288 (356)
++|+|+||||+..
T Consensus 323 ~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 323 ANDALKHPFVSIF 335 (388)
T ss_dssp HHHHTTSTTTTTT
T ss_pred HHHHhCCHHHHHh
Confidence 9999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=402.03 Aligned_cols=282 Identities=35% Similarity=0.612 Sum_probs=237.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe------EE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGN------VF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------~~ 75 (356)
.+|.+.+.||+|+||+||+|++..+++ ||+|++.... ....+|+.+++.++||||+++++++...+. ++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 369999999999999999999987766 8888775432 222469999999999999999999975543 88
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee--CCcEEEecccceeecCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS--QGTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~kL~Dfg~a~~~~~ 153 (356)
+||||+++++...+.........+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|.....
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9999999998888776666667799999999999999999999999999999999999998 47999999999998766
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...++.|....+.......
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~- 273 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY- 273 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG-
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh-
Confidence 6666677899999999999877679999999999999999999999999999999999999999999887765443221
Q ss_pred hhcccCCCcccccccc-cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSA-LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
....++......+.. +.+..++++.+||.+||..||++|||+.|+++||||++..+
T Consensus 274 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 274 -MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp -SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred -hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 223344333333332 23458999999999999999999999999999999987544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=407.49 Aligned_cols=285 Identities=34% Similarity=0.632 Sum_probs=232.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 74 (356)
++|.+.+.||+|+||+||+|++..+++.||||++.... ......+.+|+.+|+.++||||+++++++... +.+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 68999999999999999999999999999999997643 23345667999999999999999999999766 579
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
|+||||++|+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|.....
T Consensus 106 ~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCCcCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 9999999999888874 3345999999999999999999999999999999999999976 6999999999987654
Q ss_pred CC-----------------------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-----------CCC
Q 036550 154 FP-----------------------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-----------FRP 199 (356)
Q Consensus 154 ~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~~ 199 (356)
.. .....+||+.|+|||++.....++.++|||||||++|+|++ |.+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 32 23567899999999998777779999999999999999998 455
Q ss_pred CCCCCC-----------------hHHHHHHHHHHhCCCCccchHHHhhh-hhhhcccCCCcccccccccCCCCCHHHHHH
Q 036550 200 LFQGTD-----------------EADQMYKICSVLGSPTMDSWADGLRQ-AMAINYQFPQLSGVNLSALMPSASEDAINL 261 (356)
Q Consensus 200 pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 261 (356)
+|.+.+ ..+++..+...+|.|+...+...... .......++......+....+.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 555543 36788889999999987766432221 111122333344444455567889999999
Q ss_pred HHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 262 IESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 262 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
|.+||..||++|||++|+|+||||++..+
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999987644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=406.43 Aligned_cols=281 Identities=34% Similarity=0.601 Sum_probs=237.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------CeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK------GNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~~i 76 (356)
+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++... .++++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 6999999999999999999999999999999986532 2235799999999999999999998642 24779
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecccceeecCCC
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Dfg~a~~~~~~ 154 (356)
||||+++++.+.+.........+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+++.....
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 9999999988888766666677999999999999999999999999999999999999984 46899999999987665
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++.++...++.|..+.|..... ..
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~--~~ 288 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NY 288 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS--CC
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--hh
Confidence 5566778999999999997766699999999999999999999999999999999999999999988777654321 11
Q ss_pred hcccCCCcccccccc-cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSA-LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..+.++......+.. +.+..++++.+||.+||..||.+|||+.|+++||||++..
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 223344433333322 2346789999999999999999999999999999997643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=393.39 Aligned_cols=256 Identities=30% Similarity=0.475 Sum_probs=218.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++.+.||+|+||+||+|+++.+|+.||+|++++.. ........+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 578999999999999999999999999999999997642 22334567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-CC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-AF 154 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~~ 154 (356)
|||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++.... ..
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999986 56666643 345899999999999999999999999999999999999975 899999999998643 33
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+...
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------------ 220 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------ 220 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------------
T ss_pred CcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------------------
Confidence 3445678999999999986554 899999999999999999999999988776665555331
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
...+| ..+++++.+||.+||..||++|| +++++++||||....|.
T Consensus 221 -~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 221 -EIRFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp -CCCCC-----------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred -CCCCC-----------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 11122 36789999999999999999999 89999999999886653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=399.61 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=214.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ........+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 578999999999999999999999999999999997642 22234456899999988 79999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA- 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~- 153 (356)
||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||+|.....
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999986 56666643 244999999999999999999999999999999999999975 7999999999986432
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+...
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------- 239 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------------- 239 (353)
T ss_dssp --------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred CccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 23345678999999999997665 899999999999999999999999998887777766542
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH------HHHhcCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA------AEALQHPFFKRCLYV 291 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~~~~~~~~ 291 (356)
...+| ..+++++.+||++||..||++||++ +++++||||++..|.
T Consensus 240 --~~~~p-----------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 240 --EVVYP-----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp --CCCCC-----------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred --CCCCC-----------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 11222 2578999999999999999999998 899999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=392.41 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=221.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 68999999999999999999999999999999987543 34455678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee---CCcEEEecccceeecCCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~kL~Dfg~a~~~~~~~~~ 157 (356)
.| +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 84 ~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 84 SGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 86 6777663 2334589999999999999999999999999999999999997 479999999999988765555
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+......++...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------- 226 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------------- 226 (321)
T ss_dssp EEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------------
T ss_pred ccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------------
Confidence 6678999999999996554 79999999999999999999999999888777766655432222211
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+.+|.++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 227 -------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 -------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 13678999999999999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=383.51 Aligned_cols=286 Identities=33% Similarity=0.585 Sum_probs=226.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|++.+.||+|+||+||+|++..+|+.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 58999999999999999999999999999999998665432 2345578999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~ 156 (356)
||+++++...+. .....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++...... ..
T Consensus 82 e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999987555443 23445899999999999999999999999999999999999975 79999999999877533 23
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+....+..................
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 34568999999999998767789999999999999999999999999999888888887777665443322222111111
Q ss_pred ccCCCcc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 237 YQFPQLS-GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 237 ~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
...+... ........+.++.++.+||.+||..||++|||++|+|+||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 2222111 1112222357899999999999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=400.42 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=211.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||+||+|+++.+++.||+|++++... .......+|..+++++ +||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999999999999999976532 2233457899999887 89999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec-CC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI-DA 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~-~~ 153 (356)
||||+.| +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||+|+.. ..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999986 56666543 345999999999999999999999999999999999999975 79999999999863 33
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||......+... ............
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~----------~~~~~~~~~~i~ 275 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------QNTEDYLFQVIL 275 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------------CCHHHHHHHHH
T ss_pred CCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccc----------hhhHHHHHHHHh
Confidence 34456779999999999997655 8999999999999999999999997543211100 000000000111
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH------HHHhcCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA------AEALQHPFFKRCLYV 291 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~~~~~~~~ 291 (356)
.....+| ..++.++.+||++||+.||.+||++ +|+++||||++..|.
T Consensus 276 ~~~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 276 EKQIRIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp HCCCCCC-----------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred ccccCCC-----------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 1122222 3679999999999999999999985 899999999987664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=394.86 Aligned_cols=284 Identities=38% Similarity=0.702 Sum_probs=232.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH-----HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-----KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 68999999999999999999999999999999987543221 2345789999999999999999999999999999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
||||+++++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++......
T Consensus 90 v~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 90 VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999987777642 3345899999999999999999999999999999999999975 79999999999876543
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|.+......
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 245 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD- 245 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT-
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc-
Confidence 3345568999999999997766689999999999999999999999999999999999999999888877765432111
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
...+..............++.++.+||.+||..||++|||+.|+|+||||++...
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 246 -YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp -CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred -cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 1111122222233445678999999999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=393.08 Aligned_cols=285 Identities=32% Similarity=0.549 Sum_probs=231.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEE--------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVE-------- 70 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------- 70 (356)
+++|++.+.||+|+||+||+|++..+|+.||+|++...... ......+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999999999999999998654322 23355789999999999999999999987
Q ss_pred CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 71 KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 71 ~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
.+.+++||||++|++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999999998877753 2344899999999999999999999999999999999999975 799999999998
Q ss_pred ecCC-----CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 150 EIDA-----FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 150 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
.... ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+....+.++...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 7642 22334567899999999997767789999999999999999999999999999999999999988888777
Q ss_pred hHHHhhhhhhhcccCCCcccccccccC--CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALM--PSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
|.......................... ...++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 655433222212111111100000000 0137789999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=382.63 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=217.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|++..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 58999999999999999999999999999999987665555566789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC-CCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
.| +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....... ...
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 65 66666642 2489999999999999999999999999999999999997 4799999999998775432 344
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+........
T Consensus 175 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 236 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------------- 236 (297)
T ss_dssp CCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----------------
T ss_pred CccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 568999999999996655 89999999999999999999999998887666555443211100
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.....++..+.+||.+||..||++|||+.|+++||||+..
T Consensus 237 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 237 ----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0112568899999999999999999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=395.63 Aligned_cols=280 Identities=34% Similarity=0.599 Sum_probs=230.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
++|.+.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 579999999999999999999999999999999865432 2344567899999999999999999999765 34
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+|+||||++++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++....
T Consensus 105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 699999998888887753 34899999999999999999999999999999999999975 799999999998765
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+....+.++...+.......
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 180 S--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp S--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred c--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 4 23456899999999999876669999999999999999999999999999999999999999988765543221110
Q ss_pred -hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 -MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......+......+....+..++.+.+||.+||..||++|||++++|+||||++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 11112234444455666677889999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=401.50 Aligned_cols=262 Identities=28% Similarity=0.423 Sum_probs=220.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|+++.+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999876321 12234578999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||+|.......
T Consensus 149 E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp CCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred eCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99965 67776632 24899999999999999999999999999999999999975 799999999998775432
Q ss_pred -CCccccccccccChHHHhhCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKSG---LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.....+||+.|+|||++.+.. .++.++|||||||++|+|++|.+||.+.+..+...++.....
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------- 290 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------------- 290 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-------------
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-------------
Confidence 234678999999999997543 278899999999999999999999999888877777654311
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLYVPPH 294 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~~~~~ 294 (356)
...+|. ...+|.++++||++||..+|.+ |++++|+++||||++..|....
T Consensus 291 ----~~~~p~---------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~ 342 (410)
T 3v8s_A 291 ----SLTFPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET 342 (410)
T ss_dssp ----HCCCCT---------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTT
T ss_pred ----cccCCC---------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHh
Confidence 112221 1257999999999999999988 9999999999999987765433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=394.45 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=215.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||+||+|.+..+++.||+|++.+.... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999999999999999998754222 123567899999999999999999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
|||++|++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++........
T Consensus 88 ~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 88 IEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp ECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 999999998887643 34999999999999999999999999999999999999986 6999999999987766656
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|+|||++.+....+.++|||||||++|+|++|..||...........
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------------------------ 219 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK------------------------ 219 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC------------------------
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH------------------------
Confidence 66778999999999997666458899999999999999999999976543211000
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+..+|+++.+||++||..||.+|||++|+++||||+..
T Consensus 220 ------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 220 ------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0001112234679999999999999999999999999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=393.86 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=215.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-----hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-----REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++.+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 469999999999999999999999999999999864321 124456789999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C---cEEEecccceeec
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G---TIKIADFGLAREI 151 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~---~~kL~Dfg~a~~~ 151 (356)
||||+.| +|.+.+......+..+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999985 677777766555566899999999999999999999999999999999999974 2 4999999999887
Q ss_pred CCCCC-CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 152 DAFPP-YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 152 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
..... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.... ......+.........
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~-------- 253 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP-------- 253 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH--------
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc--------
Confidence 65433 34568999999999996654 8999999999999999999999998753 2333333222111111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.....++.++.+||.+||..||++|||+.++|+||||++.
T Consensus 254 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 254 ------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1113578999999999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=385.43 Aligned_cols=254 Identities=29% Similarity=0.525 Sum_probs=218.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++.+.||+|+||+||+|++..+|+.||+|++.+... .......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999876432 2234456899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++.....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999976 67777653 345899999999999999999999999999999999999975 7999999999987654
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+......++...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------------- 218 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------------- 218 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------------
T ss_pred ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 234568999999999986654 899999999999999999999999988877766665432
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
...+| +.+++++.++|.+||..||++|| +++++++||||++..|.
T Consensus 219 ~~~~p-----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 219 ELRFP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp CCCCC-----------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred CCCCC-----------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 11122 35789999999999999999999 99999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=398.22 Aligned_cols=282 Identities=32% Similarity=0.534 Sum_probs=227.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC------CCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL------NHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~~~ 75 (356)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+|+.+++.+ +|+||+++++++...+.++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 57999999999999999999999999999999997642 2334456788888876 5789999999999999999
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-Cc--EEEecccceeecC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GT--IKIADFGLAREID 152 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~--~kL~Dfg~a~~~~ 152 (356)
+||||++++|.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||++. +. +||+|||++....
T Consensus 176 lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 999999999998886533 234899999999999999999999999999999999999986 44 9999999997765
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++...+.......
T Consensus 254 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~ 330 (429)
T 3kvw_A 254 Q--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330 (429)
T ss_dssp C--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred C--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence 4 334568999999999997766 8999999999999999999999999999999999999999988776553322111
Q ss_pred hhhc-ccCCCc----------------------------ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 233 MAIN-YQFPQL----------------------------SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 233 ~~~~-~~~~~~----------------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
.... ..++.. .......+....++.+.+||++||.+||++|||++|+|+||
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence 1000 001100 00000112234588999999999999999999999999999
Q ss_pred CCCCCC
Q 036550 284 FFKRCL 289 (356)
Q Consensus 284 ~~~~~~ 289 (356)
||++..
T Consensus 411 w~~~~~ 416 (429)
T 3kvw_A 411 WLRRRL 416 (429)
T ss_dssp TTC---
T ss_pred hhccCC
Confidence 998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=400.03 Aligned_cols=255 Identities=33% Similarity=0.521 Sum_probs=216.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 579999999999999999999999999999999876532 334556789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEecccceeecCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~~~~~~ 154 (356)
|+.| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 91 ~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 91 LVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9976 67777653 34599999999999999999999999999999999999997 368999999999877543
Q ss_pred CC-CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 155 PP-YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.. ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+......++.+.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 236 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE--------- 236 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT---------
T ss_pred CceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc---------
Confidence 32 34568999999999986654 89999999999999999999999998887777766654332222221
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.+.+++++.+||.+||..||++|||+.|+|+||||+.
T Consensus 237 -----------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 -----------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 2367899999999999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=391.59 Aligned_cols=287 Identities=30% Similarity=0.520 Sum_probs=227.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe-------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGN------- 73 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------- 73 (356)
+++|.+.+.||+|+||+||+|++..+|+.||+|++..... ......+|+..++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 4789999999999999999999999999999998865422 22344678888888999999999999976443
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCCeeee--CCcEEEeccccee
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH--QQGYFHRDLKPENLLVS--QGTIKIADFGLAR 149 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~--~~~~kL~Dfg~a~ 149 (356)
+++||||+++++...+.........+++..++.++.||+.||.||| ++||+||||||+|||++ ++.+||+|||++.
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 8899999999988887766666777999999999999999999999 99999999999999997 4799999999999
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
............||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+....+.+....+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 88766666677899999999999777768999999999999999999999999999999999999998888776654432
Q ss_pred hhhhhhcccCCCcccccc----cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNL----SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.... ...+.......+ .......++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 261 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 261 PSHT--DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp TTCC--CGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cchh--hccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 2111 111111111111 1122346789999999999999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=384.90 Aligned_cols=256 Identities=30% Similarity=0.472 Sum_probs=218.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4699999999999999999999999999999998764322 2345678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C----cEEEeccccee
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G----TIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~----~~kL~Dfg~a~ 149 (356)
+||||+.| +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||++.
T Consensus 91 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999965 6777763 3345999999999999999999999999999999999999965 3 79999999999
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
...........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+....+....+.........
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 238 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------- 238 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-------
T ss_pred ECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-------
Confidence 886655566678999999999986554 899999999999999999999999988877666655432211111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 239 -------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 1123578999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=401.71 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=221.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.++||+|+||+||+|+++.+++.||+|++.+... .....+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999976422 12233578999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|........
T Consensus 154 Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 154 DYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred ecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99965 67777653 2345999999999999999999999999999999999999975 7999999999987654332
Q ss_pred --CccccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 157 --YTERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
....+||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+..+...++.....
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 298 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------------ 298 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------------
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc------------
Confidence 234689999999999963 44589999999999999999999999999888887777654211
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCC--CCCHHHHhcCCCCCCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCK--RPTAAEALQHPFFKRCLYVPP 293 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~hp~~~~~~~~~~ 293 (356)
.+.+|. ....+|+++++||++||..+|++ |++++|+++||||++..|...
T Consensus 299 -----~~~~p~--------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 299 -----RFQFPT--------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp -----HCCCCS--------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred -----cccCCc--------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 112221 12357999999999999998888 999999999999998887654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=396.95 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=220.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .....+.+|..++..++||||+++++++.+.+.+|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999976422 22234578999999999999999999999999999999
Q ss_pred Eecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+. |+|.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||++........
T Consensus 141 E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred cCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 9995 5777777532 235999999999999999999999999999999999999976 8999999999987754332
Q ss_pred --CccccccccccChHHHhh------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 157 --YTERVGTRWYQAPEILFK------SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
....+||+.|+|||++.. ...++.++|||||||++|+|++|.+||...+..+...++.....
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------- 287 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---------- 287 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----------
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Confidence 234689999999999974 34589999999999999999999999999888777776654210
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCC---CCHHHHhcCCCCCCCCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR---PTAAEALQHPFFKRCLYVPPH 294 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~e~l~hp~~~~~~~~~~~ 294 (356)
...+| .....+|+++++||++||. +|.+| ++++|+++||||++..|....
T Consensus 288 -------~~~~p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 288 -------HLSLP--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp -------HCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred -------CcCCC--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 11111 1123679999999999999 99998 599999999999998887653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=391.27 Aligned_cols=282 Identities=34% Similarity=0.624 Sum_probs=237.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 75 (356)
++|.+.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++... ...|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 489999999999999999999999999999999875433 2335567899999999999999999999765 4789
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+||||++|+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++......
T Consensus 107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 9999999998887743 34899999999999999999999999999999999999976 69999999999876532
Q ss_pred CC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. ....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+.....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 21 24558999999999987777789999999999999999999999999999999999999999888766543221
Q ss_pred hh-hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 QA-MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.. .......+......+....+.+++++.+||.+||..||++|||+.|+|+||||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 11 11122334444444555567889999999999999999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=389.25 Aligned_cols=256 Identities=32% Similarity=0.488 Sum_probs=217.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||+||+|+++.+|+.||+|++++.. ........+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 578999999999999999999999999999999997642 22234456789999876 99999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA- 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~- 153 (356)
||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++.....
T Consensus 96 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999975 67777653 234899999999999999999999999999999999999975 7999999999986532
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------------- 233 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----------------- 233 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred CCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence 23445678999999999997655 899999999999999999999999988877766655431
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH-HHhcCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA-EALQHPFFKRCLYV 291 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~-e~l~hp~~~~~~~~ 291 (356)
...+ +..+++++.+||.+||..||++||++. ++++||||++..|.
T Consensus 234 --~~~~-----------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 234 --NPFY-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp --CCCC-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred --CCCC-----------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 1111 125789999999999999999999998 99999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=392.38 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=221.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+..+|+.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57999999999999999999999999999999998765555566789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC---CcEEEecccceeecCCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~kL~Dfg~a~~~~~~~~~ 157 (356)
.| +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.........
T Consensus 131 ~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 131 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 76 66666542 2345899999999999999999999999999999999999963 57999999999988765555
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 208 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~------------------ 268 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE------------------ 268 (387)
T ss_dssp EEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC------------------
T ss_pred eeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------
Confidence 5678999999999986654 899999999999999999999999988877666555432111
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
++ ......+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 269 -~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 269 -FD-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -CC-------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -CC-------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11 112236799999999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=388.47 Aligned_cols=254 Identities=30% Similarity=0.474 Sum_probs=219.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||+||+|++..+|+.||+|++.+... .......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999876432 2234557899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++......
T Consensus 120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999965 677777533 34999999999999999999999999999999999999975 79999999999877543
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+...
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------------- 253 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------------- 253 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------
T ss_pred -cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 34568999999999997655 899999999999999999999999988877766665432
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
...+ +..+++++.++|.+||..||.+||+ ++++++||||+...|.
T Consensus 254 ~~~~-----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 254 KVRF-----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp CCCC-----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred CCCC-----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 1111 2367899999999999999999998 9999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=388.04 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=218.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||+||+|+++.+++.||+|++.+... .......+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 5789999999999999999999999999999999976421 2234456899999988 89999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-C
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-A 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~ 153 (356)
||||+.| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++.... .
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999976 677776532 34999999999999999999999999999999999999975 799999999998643 2
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------- 236 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------------- 236 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred CcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence 33445678999999999996655 899999999999999999999999988877776666432
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
...+| ..+++++.+||.+||..||.+||+ ++++++||||+...|.
T Consensus 237 --~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 237 --NVAYP-----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp --CCCCC-----------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred --CCCCC-----------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 11122 367999999999999999999994 7999999999986654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=388.72 Aligned_cols=279 Identities=24% Similarity=0.422 Sum_probs=225.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-----CCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-----HPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.++||+|+||+||+|++..+++.||+|++.... ........|+.+++.+. ||||+++++++...+..++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 68999999999999999999999999999999987542 23344567999999986 9999999999999999999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee--------------------
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-------------------- 136 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-------------------- 136 (356)
||||++++|.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 114 v~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 114 IFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 99999889998886533 23489999999999999999999999999999999999996
Q ss_pred ------CCcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036550 137 ------QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQM 210 (356)
Q Consensus 137 ------~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 210 (356)
++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+..
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 268 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 468999999999876543 34568999999999997665 899999999999999999999999999988888
Q ss_pred HHHHHHhCCCCccchHHHhhhhhhhcc-------cCCCccc---------ccccccCCCCCHHHHHHHHHccCCCCCCCC
Q 036550 211 YKICSVLGSPTMDSWADGLRQAMAINY-------QFPQLSG---------VNLSALMPSASEDAINLIESLCSWDPCKRP 274 (356)
Q Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 274 (356)
..+....+.++...+............ .+|.... ..........++.+.+||.+||+.||++||
T Consensus 269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 888887777665544333221111100 0110000 000111123457889999999999999999
Q ss_pred CHHHHhcCCCCC
Q 036550 275 TAAEALQHPFFK 286 (356)
Q Consensus 275 t~~e~l~hp~~~ 286 (356)
|++|+|+||||+
T Consensus 349 ta~elL~hp~f~ 360 (360)
T 3llt_A 349 SPAELLKHKFLE 360 (360)
T ss_dssp CHHHHTTSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999995
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=391.30 Aligned_cols=255 Identities=33% Similarity=0.544 Sum_probs=218.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46999999999999999999999999999999997543 2334556789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~ 154 (356)
|+.| +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 109 ~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 109 LVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred cCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9986 6766664 3345899999999999999999999999999999999999964 36999999999887765
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+......++...|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 254 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW--------- 254 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG---------
T ss_pred cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc---------
Confidence 5556678999999999986654 899999999999999999999999988877666665443222222211
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..+++++.+||.+||..||++|||+.++|+||||..
T Consensus 255 -----------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 255 -----------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -----------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -----------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 256899999999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=394.19 Aligned_cols=280 Identities=34% Similarity=0.591 Sum_probs=217.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 68999999999999999999999999999999986543 23345567899999999999999999998654 56
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.|+++|+++++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++....
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 899999998888777643 34899999999999999999999999999999999999975 799999999998765
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+....+.|....+.......
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 4 23456899999999999876669999999999999999999999999999999999999999988765543221111
Q ss_pred -hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 -MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......+......+....+..++.+.+||.+||..||++|||+.|+|+||||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 11111223333344455566789999999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=395.51 Aligned_cols=281 Identities=32% Similarity=0.519 Sum_probs=215.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKG------ 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 72 (356)
+++|.+.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999999999999999987543 233445678999999999999999999997654
Q ss_pred eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeec
Q 036550 73 NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI 151 (356)
Q Consensus 73 ~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~ 151 (356)
..|+||||++|++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++...
T Consensus 104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 789999999999887763 23899999999999999999999999999999999999975 79999999999877
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+....+.+....+......
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 6554455678999999999997654 899999999999999999999999999999999998888887765544322111
Q ss_pred hhhhcccCCCcccccccccC------------CCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALM------------PSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+......+.... ...+.++.+||.+||..||++|||++|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 11111111111111111000 0125689999999999999999999999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=384.99 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=212.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||+||+|+++.+++.||+|++.+.. ........+|+.+++++ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999997653 22334557899999988 89999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-C
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-A 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~ 153 (356)
||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||++.... .
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999976 67666643 234999999999999999999999999999999999999975 799999999998643 2
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHHhCCCCccc
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---------DQMYKICSVLGSPTMDS 224 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~ 224 (356)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...... .....+.
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~---------- 232 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---------- 232 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH----------
T ss_pred CCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH----------
Confidence 33445678999999999997655 899999999999999999999999753211 1111111
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH------HHHhcCCCCCCCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA------AEALQHPFFKRCLYV 291 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~hp~~~~~~~~ 291 (356)
.....+ +..++.++.+||.+||..||.+||++ +++++||||++..|.
T Consensus 233 ---------~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 233 ---------EKQIRI-----------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp ---------HCCCCC-----------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred ---------cCCCCC-----------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 111222 23679999999999999999999995 899999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=383.68 Aligned_cols=284 Identities=36% Similarity=0.610 Sum_probs=228.9
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 5789999999999999999999999999999999865432 22344578999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~ 156 (356)
||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++...... ..
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999986665532 2345899999999999999999999999999999999999975 79999999999776442 23
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||......+....+....+......+...........
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 34567999999999997765689999999999999999999999999999888888888877766554433333222222
Q ss_pred ccCCCcc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLS-GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...+... ........+.+++.+.+||.+||..||++|||+.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2333221 12223334578999999999999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=380.85 Aligned_cols=265 Identities=24% Similarity=0.278 Sum_probs=187.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC----eEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKG----NVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~iv 77 (356)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ......|+..+.+++|||||++++++.+++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4789999999999999999986 5899999998765322 223345677777899999999999998764 58999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCCeeeeC-CcEEEecccc
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ--------GYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
|||++| +|.+.+.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++ +.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999985 67777743 2489999999999999999999987 9999999999999975 7999999999
Q ss_pred eeecCCCCC-----CccccccccccChHHHhhCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 036550 148 AREIDAFPP-----YTERVGTRWYQAPEILFKSG-----LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217 (356)
Q Consensus 148 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 217 (356)
|+....... ....+||+.|||||++.+.. .++.++|||||||++|||+||.+||........... .
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~----~ 230 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY----D 230 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT----T
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch----h
Confidence 987654322 22457999999999996542 257799999999999999999888754332100000 0
Q ss_pred CCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+................. .|... ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-rp~~p---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKL-RPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCC-CCCCC---GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHhcccC-CCCCC---ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000000000000000000 00000 000011234578899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=389.93 Aligned_cols=257 Identities=24% Similarity=0.424 Sum_probs=215.9
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987543 22234567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. |.+||+|||++.......
T Consensus 94 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999976 5666653 3445999999999999999999999999999999999999975 799999999999887666
Q ss_pred CCccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccchHHHhh
Q 036550 156 PYTERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||...... .....+..
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------- 234 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--------------- 234 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---------------
Confidence 6677899999999999864 234899999999999999999999999754332 22111111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-HHHHhcCCCCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-AAEALQHPFFKRCLYV 291 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~l~hp~~~~~~~~ 291 (356)
.... .+..++.++.+||.+||..||.+||+ ++++++||||++..|.
T Consensus 235 ----~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 235 ----TVVT-----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp ----CCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred ----cccC-----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 0111 22367899999999999999999998 9999999999987653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=372.34 Aligned_cols=257 Identities=32% Similarity=0.475 Sum_probs=212.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.++||+|+||+||+|.+..++..||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 579999999999999999999999999999999876532 2345567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~~ 155 (356)
+.| +|.+.+......+..+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++.......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 976 788888776666677999999999999999999999999999999999999943 579999999998776655
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......||+.|+|||++. . .++.++|||||||++|+|++|..||......+....+......
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 243 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-R-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN---------------- 243 (285)
T ss_dssp -----CTTGGGCCHHHHT-T-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred cCcCcccccCcCChHHhc-c-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc----------------
Confidence 556678999999999984 3 4899999999999999999999999988766554443221100
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.......+++++.+||.+||..||++|||+.|+|+||||++
T Consensus 244 -----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 244 -----------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00111246899999999999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=386.83 Aligned_cols=258 Identities=28% Similarity=0.462 Sum_probs=200.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++..... ......+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 689999999999999999999999999999999876432 2345678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C--cEEEecccceeecCCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G--TIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~--~~kL~Dfg~a~~~~~~~~~ 157 (356)
.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||++.........
T Consensus 99 ~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 99 SGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 65 67777643 234999999999999999999999999999999999999975 3 4999999999865544445
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+||+.|+|||++.+....+.++|||||||++|+|++|.+||...........+... .....+
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~---------------~~~~~~ 239 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR---------------ILSVKY 239 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH---------------HHTTCC
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH---------------HhcCCC
Confidence 56789999999999977764455599999999999999999999875442222222111 111122
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.++. ...+++++.+||.+||..||++|||+.|+++||||...
T Consensus 240 ~~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 240 SIPD---------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCCT---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCC---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 2221 12578999999999999999999999999999999654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=379.98 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=211.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 5799999999999999999999999999999999865432 223456789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC---
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--- 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--- 154 (356)
|+.| +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9976 6666653 3345999999999999999999999999999999999999976 79999999999865422
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.................
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------- 225 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------- 225 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC----------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc----------------
Confidence 2234568999999999997776568899999999999999999999987654322221111100
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
... .....++..+.+||.+||..||++|||+.|+++||||+...
T Consensus 226 --~~~---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 226 --TYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp --TTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --ccC---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 000 01135689999999999999999999999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=391.57 Aligned_cols=286 Identities=30% Similarity=0.579 Sum_probs=215.3
Q ss_pred Ccee-ecccccCCceEEEEEEEc--CCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeEEEE
Q 036550 3 KYSL-TKKLGSGSFGCVWQAVNK--HSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNVFFV 77 (356)
Q Consensus 3 ~y~~-~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~iv 77 (356)
.|.+ .++||+|+||+||+|+++ .+++.||+|++...... ..+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4666 458999999999999965 57899999999755322 345789999999999999999999965 6789999
Q ss_pred EEeccCCHHHHHHHHHhh-----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee----e-CCcEEEecccc
Q 036550 78 FECMQCNLYQLMEAKKQK-----QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV----S-QGTIKIADFGL 147 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~-~~~~kL~Dfg~ 147 (356)
|||++|++.+.+...... ...+++..++.++.||+.||+|||++||+||||||+|||+ + .+.+||+|||+
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 999999999888754432 1248999999999999999999999999999999999999 3 36999999999
Q ss_pred eeecCCC----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 036550 148 AREIDAF----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---------ADQMYKIC 214 (356)
Q Consensus 148 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~ 214 (356)
|...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+++..+.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9876532 2234568999999999998766799999999999999999999999986654 47888999
Q ss_pred HHhCCCCccchHHHhhhhhhh----cccCCCccccc----ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 215 SVLGSPTMDSWADGLRQAMAI----NYQFPQLSGVN----LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
..++.|....|.......... .+......... ........++.+.+||.+||..||.+|||++|+|+||||+
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~ 338 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence 999999988886543211110 01000000000 0111223478899999999999999999999999999998
Q ss_pred CCCC
Q 036550 287 RCLY 290 (356)
Q Consensus 287 ~~~~ 290 (356)
+..+
T Consensus 339 ~~~~ 342 (405)
T 3rgf_A 339 EDPL 342 (405)
T ss_dssp SSSC
T ss_pred cCCC
Confidence 7544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=389.73 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=210.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHH-HHhCCCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKC-LRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||+||+|+++.+++.||+|++.+... .......+|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3689999999999999999999999999999999976532 222334566666 467899999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-C
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-A 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~ 153 (356)
||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||++.... .
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999986 57666643 334899999999999999999999999999999999999974 799999999998643 3
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+...++...
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------- 254 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------------- 254 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------------
T ss_pred CCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------
Confidence 33455678999999999996655 899999999999999999999999988877776666432
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH----HHHhcCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA----AEALQHPFFKRCLYV 291 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~hp~~~~~~~~ 291 (356)
... +.+.++..+.+||.+||..||.+||++ .++++||||+...|.
T Consensus 255 --~~~-----------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 255 --PLQ-----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp --CCC-----------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred --ccC-----------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 111 123678999999999999999999986 699999999987664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=371.51 Aligned_cols=255 Identities=30% Similarity=0.494 Sum_probs=220.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+..++..||+|++..........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 47999999999999999999999999999999997765555566789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee---e-CCcEEEecccceeecCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV---S-QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~-~~~~kL~Dfg~a~~~~~~~~ 156 (356)
.| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++ + ++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 89 TGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 76 67676643 3448999999999999999999999999999999999999 3 36899999999988876666
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......++...|
T Consensus 165 ~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 231 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW----------- 231 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-----------
T ss_pred hhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh-----------
Confidence 667789999999999854 3899999999999999999999999988877766665543222221111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+++.+.+||.+||..||++|||+.++|+||||++.
T Consensus 232 ---------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 232 ---------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ---------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 2568999999999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=386.87 Aligned_cols=251 Identities=29% Similarity=0.418 Sum_probs=212.1
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC-CH
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC-NL 85 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 85 (356)
.+.||+|+||+||+|.+..+|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||+.| +|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 67899999999999999999999999999876555666778999999999999999999999999999999999975 67
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee---CCcEEEecccceeecCCCCCCccccc
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPPYTERVG 162 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~kL~Dfg~a~~~~~~~~~~~~~g 162 (356)
.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||+. ++.+||+|||++............+|
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g 250 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence 777653 233489999999999999999999999999999999999994 35899999999998876655566789
Q ss_pred cccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCc
Q 036550 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL 242 (356)
Q Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (356)
|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......+...
T Consensus 251 t~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------------- 310 (373)
T 2x4f_A 251 TPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE------------------- 310 (373)
T ss_dssp SCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-------------------
T ss_pred CCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-------------------
Confidence 9999999998554 48999999999999999999999999988877777665432221111
Q ss_pred ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 243 SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 243 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
....+++++.+||.+||..||.+|||+.|+|+||||++
T Consensus 311 -------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 311 -------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp -------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred -------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 12367899999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=385.16 Aligned_cols=254 Identities=29% Similarity=0.496 Sum_probs=209.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|.++.+|+.||+|++.+... ...+|++++.++ +||||+++++++.+.+..|+||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 469999999999999999999999999999999976532 235688888888 799999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-----CcEEEecccceeecCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-----GTIKIADFGLAREIDAF 154 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----~~~kL~Dfg~a~~~~~~ 154 (356)
+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+.+ +.+||+|||++......
T Consensus 98 ~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 98 MKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 975 67777642 345999999999999999999999999999999999999843 25999999999876543
Q ss_pred -CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 -PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGT---DEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||... ...+....+...
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-------------- 238 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-------------- 238 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--------------
T ss_pred CCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--------------
Confidence 3345678999999999997655 889999999999999999999999863 233333333221
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.+.++ ...++.+|+++.+||++||..||++|||+.++++||||.+...
T Consensus 239 -----~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 239 -----KFSLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp -----CCCCC-------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred -----CcccC-------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 11111 1123467999999999999999999999999999999976443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=377.91 Aligned_cols=283 Identities=34% Similarity=0.564 Sum_probs=222.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEE------------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV------------ 69 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------------ 69 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 68999999999999999999999999999999987765555667789999999999999999999873
Q ss_pred --ECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--CcEEEecc
Q 036550 70 --EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--GTIKIADF 145 (356)
Q Consensus 70 --~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~kL~Df 145 (356)
+.+..++||||++|+|.+.+. ...+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 346889999999998887763 245899999999999999999999999999999999999973 58999999
Q ss_pred cceeecCCC----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 036550 146 GLAREIDAF----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT 221 (356)
Q Consensus 146 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 221 (356)
|++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999876432 2234456899999999997766689999999999999999999999999998888888877665554
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
...+.+...................+....+.++.++.+||.+||..||++|||++++|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 44433222111000000000111223334457899999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=380.28 Aligned_cols=255 Identities=33% Similarity=0.503 Sum_probs=198.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 46999999999999999999999999999999987653 2345678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEecccceeecCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~~~~~~~~ 156 (356)
.| +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 131 ~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 131 TGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 75 6777663 334589999999999999999999999999999999999996 57999999999987765544
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ-MYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+....
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~------------------ 267 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE------------------ 267 (349)
T ss_dssp ------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC------------------
T ss_pred cccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC------------------
Confidence 55678999999999996654 89999999999999999999999987665443 33332211
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
+.+ .......++.++.+||++||..||++|||+.|+|+||||++..
T Consensus 268 -~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 268 -YYF-------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp -CCC-------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred -Ccc-------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 111 0112246789999999999999999999999999999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=397.72 Aligned_cols=256 Identities=31% Similarity=0.474 Sum_probs=208.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++.+.||+|+||.||+|++..+|+.||+|++.+.. ........+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999999999999999987542 22334456899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCC-
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA- 153 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~- 153 (356)
|||+.| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. +.+||+|||+|.....
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999987 56666543 3458999999999999999999998 99999999999999975 7999999999976432
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+...
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------------- 364 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----------------- 364 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------
T ss_pred CcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence 23345678999999999996655 899999999999999999999999988776666555331
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
...+ +..+++++.+||.+||..||.+|| |++|+++||||++..|.
T Consensus 365 --~~~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 365 --EIRF-----------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp --CCCC-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --CCCC-----------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 1112 235789999999999999999999 99999999999986553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=376.16 Aligned_cols=253 Identities=31% Similarity=0.516 Sum_probs=205.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--------------------------HHhhhHHHHHHHH
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--------------------------EKCLNLREVKCLR 54 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 54 (356)
+++|.+.+.||+|+||+||+|++..+++.||+|++...... ....+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999999999999999998654311 1244678999999
Q ss_pred hCCCCCeeEEeEEEEE--CCeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 036550 55 KLNHPNIVKVKELIVE--KGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPE 131 (356)
Q Consensus 55 ~l~hp~iv~~~~~~~~--~~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 131 (356)
+++||||+++++++.+ .+..++||||++++ |.+. .....+++..++.++.||+.||+|||++||+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 9999999999999987 57899999999864 4332 23345999999999999999999999999999999999
Q ss_pred CeeeeC-CcEEEecccceeecCCCC-CCccccccccccChHHHhhCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 036550 132 NLLVSQ-GTIKIADFGLAREIDAFP-PYTERVGTRWYQAPEILFKSGL--YSSKVDMWAMGAIMAELLLFRPLFQGTDEA 207 (356)
Q Consensus 132 NIll~~-~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 207 (356)
|||++. +.+||+|||++....... ......||+.|+|||++.+... ++.++|||||||++|+|++|..||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 999975 799999999998775432 2345689999999999865442 477899999999999999999999887665
Q ss_pred HHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 208 DQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
.....+... ...++. .+.+++++.+||.+||..||++|||+.|+++||||+
T Consensus 247 ~~~~~~~~~-------------------~~~~~~---------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQ-------------------ALEFPD---------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHC-------------------CCCCCS---------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcc-------------------cCCCCC---------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 544443221 111111 136789999999999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=379.72 Aligned_cols=284 Identities=34% Similarity=0.620 Sum_probs=230.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 75 (356)
++|.+.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 689999999999999999999999999999999875433 2334557899999999999999999988654 6789
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+||||++|+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++......
T Consensus 91 lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999999998887753 34899999999999999999999999999999999999975 69999999999876532
Q ss_pred C-----------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 155 P-----------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 155 ~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 12235789999999998776678999999999999999999999999999888888888888877643
Q ss_pred chHHHhhhh--hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 224 SWADGLRQA--MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 224 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
......... .......+......+....+.+++++.+||.+||..||++|||+.++++||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 322111100 0011112222233334445678999999999999999999999999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=385.33 Aligned_cols=279 Identities=38% Similarity=0.624 Sum_probs=227.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeE-----
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNV----- 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~----- 74 (356)
++|.+.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 589999999999999999999999999999999976432 2245567899999999999999999999877654
Q ss_pred -EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 -FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 -~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++||||+.+++.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++....
T Consensus 122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 999999999877665 233899999999999999999999999999999999999975 799999999998665
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.......
T Consensus 196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 4 23456899999999999775668999999999999999999999999999999999999988887655443221111
Q ss_pred h-hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 M-AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
. ......+......+....+.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0111222333333445556789999999999999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=367.37 Aligned_cols=256 Identities=33% Similarity=0.521 Sum_probs=218.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 68999999999999999999999999999999986543 2333456789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~ 154 (356)
|+.| ++.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 86 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 86 LVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9976 566666432 44899999999999999999999999999999999999964 34999999999888766
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.......+.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 229 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----------- 229 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----------
T ss_pred ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch-----------
Confidence 6556678999999999996654 8999999999999999999999999887776665554332211111
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
....+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 230 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 230 ---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp ---------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ---------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 123678999999999999999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=383.78 Aligned_cols=283 Identities=30% Similarity=0.562 Sum_probs=222.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-----------HHhhhHHHHHHHHhCCCCCeeEEeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-----------EKCLNLREVKCLRKLNHPNIVKVKELIVE 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 70 (356)
++|.+.+.||+|+||.||+|.+.. |+.||+|++...... ....+.+|+.++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 689999999999999999999865 999999998654221 12456789999999999999999999864
Q ss_pred C-----CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEec
Q 036550 71 K-----GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIAD 144 (356)
Q Consensus 71 ~-----~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~D 144 (356)
. ..+|+||||++|++.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred ccCCCcceEEEEEccCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 3 3689999999999888876 2334589999999999999999999999999999999999997 47999999
Q ss_pred ccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 145 FGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 145 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
||++.............||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+....+.+....
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 99998766555556678999999999997766689999999999999999999999999999999999999888887665
Q ss_pred hHHHhhhhhhh--cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 225 WADGLRQAMAI--NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 225 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+.......... ...........+....+..++.+.+||.+||..||++|||+.|+|+||||++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 43221111100 01111122223344456789999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=372.76 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=202.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|++.+.||+|+||+||+|++..+|+.||+|++....... .....++...++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 68999999999999999999999999999999987653222 2233445556788899999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|++|++.+.+.........+++..++.++.||+.||+|||++ ||+||||||+||+++. +.+||+|||++.........
T Consensus 87 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred hhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 999999888887666777899999999999999999999998 9999999999999986 79999999999877665555
Q ss_pred ccccccccccChHHH---hhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 158 TERVGTRWYQAPEIL---FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE-ADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
....||+.|+|||++ .....++.++|||||||++|+|++|..||..... ........... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------------- 231 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-S-------------- 231 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-C--------------
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-C--------------
Confidence 556899999999997 3445589999999999999999999999986433 22222222110 0
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+ ......+++++.++|.+||+.||++|||+.|+++||||+.
T Consensus 232 ------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 232 ------P-------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ------C-------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------C-------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 0 0111357899999999999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=395.73 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=219.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||+||+|++..+|+.||+|++.+.... ....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999998754321 234567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999965 6777763 3455999999999999999999999999999999999999975 799999999999887665
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||...+......++....
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 232 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------------------ 232 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------------------
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------------
Confidence 56677999999999999776656889999999999999999999999887766665554321
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+.. +..+++++.+||++||..||.+|||+.++++||||+..
T Consensus 233 -~~~-----------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 -FYT-----------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -CCC-----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -cCC-----------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 111 12568999999999999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=373.68 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=218.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|++..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4699999999999999999999999999999998764322 2345678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C----cEEEeccccee
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G----TIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~----~~kL~Dfg~a~ 149 (356)
+||||+.| +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+||++++ + .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999965 6777764 2345899999999999999999999999999999999999975 3 69999999999
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
............||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+.......+.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 239 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE------- 239 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred ecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-------
Confidence 887665566678999999999986554 899999999999999999999999988877666655432111110
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......+..+.+||.+||..||++|||+.++++||||+..
T Consensus 240 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 240 -------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp -------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred -------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 1123678999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=374.70 Aligned_cols=283 Identities=34% Similarity=0.628 Sum_probs=232.6
Q ss_pred CCceeecccccCCceEEEEEEEc-CCCcEEEEEEcccccchH--HhhhHHHHHHHHhC---CCCCeeEEeEEEE-----E
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-HSGEVVAIKALKKSYSRE--KCLNLREVKCLRKL---NHPNIVKVKELIV-----E 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~hp~iv~~~~~~~-----~ 70 (356)
++|.+.+.||+|+||+||+|++. .+|+.||+|++....... .....+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 57999999999999999999995 678999999986543221 23445777777766 8999999999987 4
Q ss_pred CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 71 KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 71 ~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
....++||||++|+|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 91 ETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 56789999999999988876432 234899999999999999999999999999999999999965 799999999998
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||......+....+....+.+....|....
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred cccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 766544445678999999999996655 8999999999999999999999999999999999999888888777765332
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
... ...+............+.++..+.+||.+||..||++|||+.++++||||++...
T Consensus 248 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 248 ALP---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SSC---GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccc---hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 111 1112222223344556688999999999999999999999999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=399.23 Aligned_cols=257 Identities=34% Similarity=0.594 Sum_probs=217.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++.+.. ......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57999999999999999999999999999999986532 2234556789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~ 154 (356)
|+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9876 677776533 34999999999999999999999999999999999999953 57999999999877665
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......+..+.|
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 246 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG---------
T ss_pred CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc---------
Confidence 55667789999999999854 3899999999999999999999999998887777766554322222222
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
..+|+++++||.+||..||++|||+.++|+||||+....
T Consensus 247 -----------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 247 -----------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp -----------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred -----------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 256899999999999999999999999999999986543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=386.09 Aligned_cols=286 Identities=21% Similarity=0.301 Sum_probs=211.5
Q ss_pred CCceeecccccC--CceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSG--SFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+| +||+||+|++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 589999999999 99999999999999999999997653 23334567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCC-
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF- 154 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~- 154 (356)
|||+.| +|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999975 677776543 224489999999999999999999999999999999999997 579999999988654221
Q ss_pred -------CCCccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-----
Q 036550 155 -------PPYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPT----- 221 (356)
Q Consensus 155 -------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 221 (356)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+.......+........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 112334799999999999764 4589999999999999999999999988766555443322111000
Q ss_pred --ccch---------HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 222 --MDSW---------ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 222 --~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
...+ ..............+.............+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 0000 0000000000000111111112234457899999999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=374.58 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=202.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.++||+|+||+||+|++..+|+.||||++..... ........|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999865432 2233345566655555 9999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
||+++++.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.........
T Consensus 137 e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 99999988887643 345999999999999999999999999999999999999965 79999999999888766555
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+... .
T Consensus 214 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~---~----------------- 268 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQG---Y----------------- 268 (311)
T ss_dssp -CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTT---C-----------------
T ss_pred cccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhcc---C-----------------
Confidence 66789999999998864 48999999999999999999977665432211 11100 0
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
........+++++.+||.+||..||++|||++|+|+||||++
T Consensus 269 --------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 --------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 001122367899999999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=374.84 Aligned_cols=255 Identities=31% Similarity=0.544 Sum_probs=207.5
Q ss_pred CCceeecccccCCceEEEEEEEc---CCCcEEEEEEccccc----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||+||+|++. .+++.||+|++.+.. ........+|+.+++.++||||+++++++.+.+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 68999999999999999999985 689999999997653 12234456899999999999999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999975 67777643 234899999999999999999999999999999999999975 799999999997643
Q ss_pred CC-CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 153 AF-PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+...
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--------------- 236 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--------------- 236 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------------
T ss_pred cCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC---------------
Confidence 22 2334568999999999996655 899999999999999999999999988877666655432
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
...+ ++.++.++.+||.+||..||++|| ++.++++||||+...|.
T Consensus 237 ----~~~~-----------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 237 ----KLNL-----------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp ----CCCC-----------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred ----CCCC-----------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 1111 235789999999999999999999 89999999999876553
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=397.11 Aligned_cols=254 Identities=35% Similarity=0.591 Sum_probs=215.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||+||+|++..++..||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 36999999999999999999999999999999987653 2234456789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~ 154 (356)
|+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9976 677766433 34899999999999999999999999999999999999964 45999999999988766
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++. . .++.++|||||||++|+|++|.+||.+....+....+......+..+.|
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 261 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-K-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW--------- 261 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG---------
T ss_pred ccccccCCCcCeeCHHHHc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc---------
Confidence 6666778999999999984 3 4899999999999999999999999998887777766554333222222
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..+|+.+.+||++||..||.+|||+.++|+||||++
T Consensus 262 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 262 -----------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -----------------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 367899999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=372.14 Aligned_cols=273 Identities=29% Similarity=0.453 Sum_probs=203.8
Q ss_pred CCceee-cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLT-KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+. +.||+|+||+||+|.+..+++.||+|++..........+.+|+.++.++ +||||+++++++.+.+.+|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 579985 7899999999999999999999999999776555556678999999985 79999999999999999999999
Q ss_pred ecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C---cEEEecccceeecCCC
Q 036550 80 CMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G---TIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~---~~kL~Dfg~a~~~~~~ 154 (356)
|+. |+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 997 5777777543 34899999999999999999999999999999999999975 3 3999999998765321
Q ss_pred --------CCCccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 036550 155 --------PPYTERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTM 222 (356)
Q Consensus 155 --------~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (356)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||......+....... ...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~ 243 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE----ACP 243 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--------CCH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc----cch
Confidence 122345699999999998651 3378999999999999999999999987643110000000 000
Q ss_pred cchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..............+.++. .....++..+.+||.+||..||++|||+.|+|+||||++..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPD-------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCH-------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred hHHHHHHHHHhccCcccCc-------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 0000000000111111111 11135789999999999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=376.85 Aligned_cols=251 Identities=30% Similarity=0.484 Sum_probs=214.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+|.+.+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 58999999999999999999999999999999875432 223456789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
|+.|++.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..... ..
T Consensus 135 ~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~ 208 (348)
T 1u5q_A 135 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN 208 (348)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BC
T ss_pred cCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CC
Confidence 9999988887543 345899999999999999999999999999999999999986 7999999999977653 23
Q ss_pred cccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
..+||+.|+|||++.+ .+.++.++|||||||++|+|++|.+||...+.......+......
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----------------- 271 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------------- 271 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------------
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------------
Confidence 5689999999999863 455899999999999999999999999988776665554332110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
. .....++..+.+||.+||..||++|||++++++||||..
T Consensus 272 ----~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 272 ----A-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----C-------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0 011356889999999999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=395.88 Aligned_cols=255 Identities=34% Similarity=0.531 Sum_probs=217.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-------------hHHhhhHHHHHHHHhCCCCCeeEEeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-------------REKCLNLREVKCLRKLNHPNIVKVKELI 68 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 68 (356)
++|.+.++||+|+||+||+|.+..+++.||+|++.+... .....+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 579999999999999999999999999999999876431 1234567899999999999999999999
Q ss_pred EECCeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC----cEEEe
Q 036550 69 VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG----TIKIA 143 (356)
Q Consensus 69 ~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----~~kL~ 143 (356)
.+.+.+|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999976 677776532 349999999999999999999999999999999999999753 69999
Q ss_pred cccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 144 DFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......++.+
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 9999998876666667789999999999853 48999999999999999999999999988877777665532222222
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.| +.+|+++.+||++||..||.+|||++|+|+||||++.
T Consensus 270 ~~--------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 270 DW--------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HH--------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred cc--------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 11 3678999999999999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=373.62 Aligned_cols=278 Identities=28% Similarity=0.545 Sum_probs=217.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEE--CCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVE--KGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+|+.+++++. ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57999999999999999999999999999999987543 345678999999996 9999999999988 67889999
Q ss_pred EeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C-cEEEecccceeecCCCC
Q 036550 79 ECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G-TIKIADFGLAREIDAFP 155 (356)
Q Consensus 79 e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~-~~kL~Dfg~a~~~~~~~ 155 (356)
||+.++ +.+.+ ..+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||++.......
T Consensus 113 e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999865 44433 12899999999999999999999999999999999999984 4 89999999999877666
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCccchHHHhhhhh-
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQG-TDEADQMYKICSVLGSPTMDSWADGLRQAM- 233 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 233 (356)
......||+.|+|||++.+...++.++|||||||++|+|++|..||.. ....+.+..+....+.+....+........
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 666778999999999997766799999999999999999999999854 445555666655554332221111100000
Q ss_pred ------hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 234 ------AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 234 ------~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
........+...........+++++.+||.+||..||++|||++|+|+||||++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 00000000111111111224799999999999999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=407.19 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=220.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||+||+|+++.+++.||||++++.. .........|..++..+ +||+|+++++++.+.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999987642 22334456799999987 79999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC-C
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID-A 153 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~-~ 153 (356)
||||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||+|.... .
T Consensus 420 V~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999976 576666533 34999999999999999999999999999999999999975 799999999998643 3
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------------- 557 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------------- 557 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------------
T ss_pred CcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence 33455678999999999996554 899999999999999999999999998887777666432
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCH-----HHHhcCCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTA-----AEALQHPFFKRCLYVP 292 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~hp~~~~~~~~~ 292 (356)
...+| ..+++++.+||++||..||++||++ +|+++||||+...|..
T Consensus 558 --~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 558 --NVAYP-----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp --CCCCC-----------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred --CCCCC-----------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 12222 3679999999999999999999997 9999999999877654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=398.10 Aligned_cols=256 Identities=35% Similarity=0.586 Sum_probs=220.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|++..+|+.||+|++.+.. ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999986542 233456688999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEecccceeecCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDA 153 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~~~~~ 153 (356)
||+.| +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 106 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 98875 6766664 334599999999999999999999999999999999999994 36899999999988776
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......+..+.|
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 251 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-------- 251 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG--------
T ss_pred ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc--------
Confidence 655666789999999999865 3899999999999999999999999998887777766553322222222
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..+|+++.+||++||..||++|||+.|+|+||||+...
T Consensus 252 ------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 252 ------------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ------------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 25689999999999999999999999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=375.67 Aligned_cols=254 Identities=32% Similarity=0.520 Sum_probs=190.3
Q ss_pred CCceee---cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLT---KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~---~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+. +.||+|+||+||+|.+..+++.||+|++.+. ......+|+.+++.+. ||||+++++++.+.+..|+|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 357775 7899999999999999999999999998654 2344568999999996 99999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C---cEEEecccceeecC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G---TIKIADFGLAREID 152 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~---~~kL~Dfg~a~~~~ 152 (356)
|||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 85 MELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp ECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999976 67777643 345999999999999999999999999999999999999975 3 79999999998765
Q ss_pred CC-CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCCccc
Q 036550 153 AF-PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-------DQMYKICSVLGSPTMDS 224 (356)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~ 224 (356)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.. +....+...
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-------- 231 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-------- 231 (325)
T ss_dssp C----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--------
T ss_pred CCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--------
Confidence 43 2334567899999999986655 899999999999999999999999865432 222222111
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.+.++. .....+++++.+||.+||..||.+|||++++++||||++..
T Consensus 232 -----------~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 232 -----------DFSFEG-------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp -----------CCCCCS-------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred -----------CCCCCc-------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 111110 11125789999999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=370.05 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=212.4
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
|...++||+|+||+||+|++..+|+.||||++..........+.+|+.++++++||||+++++++...+..++||||+.|
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 77888999999999999999999999999999766555556678999999999999999999999999999999999976
Q ss_pred C-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCC-CCCccc
Q 036550 84 N-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF-PPYTER 160 (356)
Q Consensus 84 ~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~-~~~~~~ 160 (356)
+ |.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ......
T Consensus 127 ~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 4 555542 23489999999999999999999999999999999999998 479999999999877543 233456
Q ss_pred cccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCC
Q 036550 161 VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240 (356)
Q Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (356)
.||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..... +..
T Consensus 202 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~------------------ 261 (321)
T 2c30_A 202 VGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKL------------------ 261 (321)
T ss_dssp CSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCC------------------
T ss_pred cCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCc------------------
Confidence 899999999998655 489999999999999999999999998877665554432110 000
Q ss_pred CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.....+++.+.+||.+||..||++|||+.++++||||.+
T Consensus 262 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 262 --------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp --------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred --------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 001246889999999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=375.95 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=216.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--------hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--------REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 369999999999999999999999999999999865431 1123456899999999 8999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
..|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||++||+|+||||+|||+++ +.+||+|||++..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999986 67777653 234899999999999999999999999999999999999975 7999999999998
Q ss_pred cCCCCCCccccccccccChHHHhhC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccch
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKS-----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (356)
..........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+......+..+.
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~- 328 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE- 328 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH-
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc-
Confidence 8766666677899999999998643 3478899999999999999999999998777666655544322221111
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+...+..+.+||.+||..||++|||+.++|+||||++
T Consensus 329 -------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 -------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp -------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1256889999999999999999999999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=374.27 Aligned_cols=262 Identities=32% Similarity=0.486 Sum_probs=214.1
Q ss_pred Cceee-cccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLT-KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+|.+. +.||+|+||+||+|++..+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.+.+..++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 57777 899999999999999999999999999876432 2244567899999999 5699999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDA 153 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~ 153 (356)
||+.| +|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.....
T Consensus 109 e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 109 EYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp ECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99987 56655432 22345899999999999999999999999999999999999975 7999999999998876
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.........
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 254 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE----------- 254 (327)
T ss_dssp -------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred ccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-----------
Confidence 55556678999999999986554 899999999999999999999999988877766655443222111
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 293 (356)
.....+++.+.+||.+||..||.+|||++++|+||||++..+...
T Consensus 255 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 255 ---------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp ---------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred ---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 112367899999999999999999999999999999998766543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=399.53 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=214.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||.||+|++..+|+.||+|++.+.. ........+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999986542 122344578999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++........
T Consensus 264 Ey~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 264 TLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 99975 666666432 2234899999999999999999999999999999999999975 7999999999998876555
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...... ..+......
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----------------- 403 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------------- 403 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-----------------
T ss_pred ccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-----------------
Confidence 56679999999999996654 899999999999999999999999876431 111111110
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
.... +...+|+++.+||.+||..||.+|| +++|+++||||++..|
T Consensus 404 -~~~~-----------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 404 -VPEE-----------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp -CCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred -cccc-----------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 0111 1236799999999999999999999 8999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=382.58 Aligned_cols=280 Identities=27% Similarity=0.437 Sum_probs=220.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC--------CCCeeEEeEEEE----
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN--------HPNIVKVKELIV---- 69 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~~~~~~~---- 69 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.+. |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 68999999999999999999999999999999987542 33455678999999985 788999999987
Q ss_pred ECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeCC----------
Q 036550 70 EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQG---------- 138 (356)
Q Consensus 70 ~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~---------- 138 (356)
+...+|+||||+++++.+.+... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 45689999999999988887643 224589999999999999999999998 99999999999999753
Q ss_pred ----------------------------------------cEEEecccceeecCCCCCCccccccccccChHHHhhCCCC
Q 036550 139 ----------------------------------------TIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178 (356)
Q Consensus 139 ----------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 178 (356)
.+||+|||++...... ....+||+.|+|||++.+.. +
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~ 270 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-Y 270 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-C
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-C
Confidence 6999999999877643 34568999999999997765 8
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCccchHHHhhhhhhhc--ccCCCccccc----
Q 036550 179 SSKVDMWAMGAIMAELLLFRPLFQGTD------EADQMYKICSVLGSPTMDSWADGLRQAMAIN--YQFPQLSGVN---- 246 (356)
Q Consensus 179 ~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---- 246 (356)
+.++|||||||++|+|++|.+||...+ ..+....+....+.++...+........... ..........
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 999999999999999999999998655 4566777888888776554432211100000 0000000000
Q ss_pred ------ccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 247 ------LSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 247 ------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
........+..+.+||.+||..||++|||+.|+|+||||++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00011234567899999999999999999999999999963
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=377.26 Aligned_cols=282 Identities=30% Similarity=0.489 Sum_probs=222.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CC-----CeeEEeEEEEECCeE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HP-----NIVKVKELIVEKGNV 74 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~~~~~~~~~~~~ 74 (356)
+++|.+.+.||+|+||+||+|++..+++.||+|++.... .......+|+.+++.+. |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 478999999999999999999999999999999997542 22344567888888874 44 499999999999999
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCCeeee---CCcEEEeccccee
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH--QQGYFHRDLKPENLLVS---QGTIKIADFGLAR 149 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~---~~~~kL~Dfg~a~ 149 (356)
|+||||++|+|.+.+.... ...+++..++.++.||+.||.||| +.||+||||||+|||++ ++.+||+|||++.
T Consensus 132 ~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 9999999999999886542 234899999999999999999999 57999999999999995 3689999999998
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...+....
T Consensus 210 ~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (382)
T 2vx3_A 210 QLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286 (382)
T ss_dssp ETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred eccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence 8754 334578999999999997665 8999999999999999999999999999999999999988887655442211
Q ss_pred hhh------hhhcccC----------CCccccccccc------------------CCCCCHHHHHHHHHccCCCCCCCCC
Q 036550 230 RQA------MAINYQF----------PQLSGVNLSAL------------------MPSASEDAINLIESLCSWDPCKRPT 275 (356)
Q Consensus 230 ~~~------~~~~~~~----------~~~~~~~~~~~------------------~~~~s~~~~~li~~~L~~dP~~Rpt 275 (356)
... ....+.. .......+... ....++++.+||.+||++||++|||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt 366 (382)
T 2vx3_A 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366 (382)
T ss_dssp THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence 100 0000000 00000000000 0001147899999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 036550 276 AAEALQHPFFKRC 288 (356)
Q Consensus 276 ~~e~l~hp~~~~~ 288 (356)
++|+|+||||++.
T Consensus 367 a~e~L~hp~f~~~ 379 (382)
T 2vx3_A 367 PYYALQHSFFKKT 379 (382)
T ss_dssp HHHHTTSGGGCC-
T ss_pred HHHHhcCcccccC
Confidence 9999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=374.03 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=209.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 73 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++...... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4799999999999999999999999999999998765321 22345679999999999999999999999999
Q ss_pred EEEEEEeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 74 VFFVFECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 74 ~~iv~e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
.++||||+.+ ++.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999998754 5666653 3345999999999999999999999999999999999999975 6999999999998
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
..........+||+.|+|||++.+...++.++|||||||++|+|++|..||......
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------------- 236 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------------- 236 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------------
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------------
Confidence 877666667789999999999977765588999999999999999999999752210
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..... .....+++++.+||.+||..||++|||+.++++||||++
T Consensus 237 --~~~~~-----------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 --VEAAI-----------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp --TTTCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred --Hhhcc-----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 00001 112257899999999999999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=376.51 Aligned_cols=279 Identities=38% Similarity=0.616 Sum_probs=225.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGN------ 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------ 73 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 589999999999999999999999999999999876432 223456789999999999999999999987653
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.|+||||+.++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++....
T Consensus 104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 59999999988766542 23899999999999999999999999999999999999975 699999999997654
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.. .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.++...+.......
T Consensus 178 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 AE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 32 3456899999999999775668999999999999999999999999999988899998888877654432211111
Q ss_pred hh-hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 MA-INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.. .....+......+....+.+++++.+||.+||..||++|||+.++|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 011222222333444556789999999999999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=384.84 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=198.7
Q ss_pred CCceee-cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHH-hCCCCCeeEEeEEEEE----CCeEE
Q 036550 2 EKYSLT-KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLR-KLNHPNIVKVKELIVE----KGNVF 75 (356)
Q Consensus 2 ~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~----~~~~~ 75 (356)
++|.+. +.||+|+||+||+|++..+|+.||+|++... ....+|+.++. ..+||||+++++++.. .+.+|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 578777 7899999999999999999999999998643 23467888874 4589999999999876 56789
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEecccceee
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLARE 150 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~~ 150 (356)
+||||+.| +|.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 99999976 7887775322 23489999999999999999999999999999999999997 46899999999998
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCccchH
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD----QMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 226 (356)
..........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... ....+.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~------------ 280 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------------ 280 (400)
T ss_dssp CC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH------------
T ss_pred cCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH------------
Confidence 7765556677899999999998554 48999999999999999999999998654321 111111
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
...+.++. ..+..++.++.+||++||..||++|||+.++++||||.+..
T Consensus 281 -------~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 281 -------MGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp -------HTCCCCCT-------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred -------cCcccCCC-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 11222221 11236799999999999999999999999999999997643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=361.82 Aligned_cols=259 Identities=31% Similarity=0.445 Sum_probs=218.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---------chHHhhhHHHHHHHHhCC-CCCeeEEeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---------SREKCLNLREVKCLRKLN-HPNIVKVKELIVE 70 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 70 (356)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999999999999999986542 112344578999999995 9999999999999
Q ss_pred CCeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccce
Q 036550 71 KGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLA 148 (356)
Q Consensus 71 ~~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a 148 (356)
.+..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+|+||||+||+++. +.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999975 777777532 34899999999999999999999999999999999999975 79999999999
Q ss_pred eecCCCCCCccccccccccChHHHhh-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 149 REIDAFPPYTERVGTRWYQAPEILFK-----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+.........+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 88776656666789999999999862 3457899999999999999999999999887766655554422111111
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
. ...++..+.++|.+||..||++|||+.++++||||++..
T Consensus 252 ~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 252 E--------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp T--------------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred c--------------------------ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1 125688999999999999999999999999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=375.05 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=204.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCC--CCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNH--PNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.+.| |||+++++++.+.+..++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46999999999999999999885 688999999875432 233556789999999976 9999999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCCC-
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPP- 156 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~~- 156 (356)
||+.+++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++++.+||+|||++........
T Consensus 88 ~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 88 MECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp ECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC------
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCccccc
Confidence 99988899888864 3458999999999999999999999999999999999999999999999999987654322
Q ss_pred --CccccccccccChHHHhh----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcc
Q 036550 157 --YTERVGTRWYQAPEILFK----------SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMD 223 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 223 (356)
....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... .....+... ..
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~-- 238 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NH-- 238 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT---TS--
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC---Cc--
Confidence 235679999999999865 245899999999999999999999999865432 222221110 00
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 239 -----------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 239 -----------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp -----------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -----------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 011123457899999999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=392.68 Aligned_cols=259 Identities=27% Similarity=0.380 Sum_probs=215.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.... ....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999999764322 2245578999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+.........+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||++........
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 99985 676766544333456999999999999999999999999999999999999975 7999999999988765433
Q ss_pred -CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCccchHHHhhh
Q 036550 157 -YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE----ADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||..... ......+..
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~---------------- 407 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE---------------- 407 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----------------
T ss_pred ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----------------
Confidence 33458999999999997654 89999999999999999999999987542 222222221
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
....+ +..+++.+.+||++||..||++||+ ++++++||||+...|.
T Consensus 408 ---~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 408 ---QAVTY-----------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp ---CCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred ---cccCC-----------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 11111 2367999999999999999999996 5899999999986653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=376.42 Aligned_cols=262 Identities=30% Similarity=0.477 Sum_probs=212.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-----SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.+.. ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 47999999999999999999999999999999986542 2334566789999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHH------------------------------------hhcccCCHHHHHHHHHHHHHHHHHHH
Q 036550 77 VFECMQC-NLYQLMEAKK------------------------------------QKQQLFSESAVKAWLFQVFRGLDYMH 119 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~------------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH 119 (356)
||||+.| +|.+.+.... .....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999965 5666652100 00122578889999999999999999
Q ss_pred hCCcccccCCCCCeeeeC-C--cEEEecccceeecCCCC-----CCccccccccccChHHHhhC-CCCCCchhHHHHHHH
Q 036550 120 QQGYFHRDLKPENLLVSQ-G--TIKIADFGLAREIDAFP-----PYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAI 190 (356)
Q Consensus 120 ~~~ivH~Dlkp~NIll~~-~--~~kL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~i 190 (356)
++||+||||||+|||++. + .+||+|||++....... ......||+.|+|||++.+. ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 999999999999999974 3 79999999998764321 23456799999999999642 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCC
Q 036550 191 MAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDP 270 (356)
Q Consensus 191 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 270 (356)
+|+|++|..||......+....+.........+. ...+++.+.+||.+||..||
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN--------------------------YNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG--------------------------GGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc--------------------------cccCCHHHHHHHHHHcCCCh
Confidence 9999999999999888777766654322222111 12468999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 036550 271 CKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 271 ~~Rpt~~e~l~hp~~~~~~ 289 (356)
.+|||+.++|+||||++..
T Consensus 320 ~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 320 DERFDAMRALQHPWISQFS 338 (345)
T ss_dssp TTSCCHHHHHHSHHHHTTS
T ss_pred hHCCCHHHHhcChhhccCh
Confidence 9999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=360.73 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=210.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... ........+|+..+..+ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47999999999999999999999999999999987642 33445667899999999 9999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--------------------
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-------------------- 137 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-------------------- 137 (356)
||+.| +|.+.+.........+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99976 888888776655567999999999999999999999999999999999999963
Q ss_pred CcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 036550 138 GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217 (356)
Q Consensus 138 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 217 (356)
..+||+|||.+...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++...... ..+...
T Consensus 171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~- 243 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQG- 243 (289)
T ss_dssp CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHHTT-
T ss_pred eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHHcC-
Confidence 36999999999887653 23469999999999977656778999999999999999999887644321 111110
Q ss_pred CCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+++++.++|.+||..||++|||+.++++||||++.
T Consensus 244 ----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 244 ----------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp ----------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred ----------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 0112234679999999999999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=362.84 Aligned_cols=253 Identities=30% Similarity=0.516 Sum_probs=210.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 47899999999999999999999999999999998654321 134457899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+++ ++.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 999986 676666433 34899999999999999999999999999999999999965 79999999998665442
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 223 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------------ 223 (279)
T ss_dssp -----CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------------
T ss_pred cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------------
Confidence 234568999999999986554 8999999999999999999999999887766655543321
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
..+ ...++..+.+||.+||..||.+|||+.|+++||||+...
T Consensus 224 -~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 224 -FTF-----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -CCC-----------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -CCC-----------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 111 125688999999999999999999999999999997643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=379.22 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=205.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCC--CCCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLN--HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+|.+.+.||+|+||+||+|.+.. ++.||+|++.... ......+.+|+.+++++. ||||+++++++...+.+|+||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 59999999999999999999875 8999999986543 233456688999999996 599999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCC---
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFP--- 155 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~--- 155 (356)
|+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++.......
T Consensus 136 E~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 136 ECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp ECCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC-------
T ss_pred ecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccc
Confidence 98888888887542 35899999999999999999999999999999999999999999999999998765332
Q ss_pred CCccccccccccChHHHhhC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCccc
Q 036550 156 PYTERVGTRWYQAPEILFKS----------GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQMYKICSVLGSPTMDS 224 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 224 (356)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||...... ..+..+...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~-------- 283 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-------- 283 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT--------
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc--------
Confidence 22456899999999998652 35899999999999999999999999875432 222222111
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... .......+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 284 -----------~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 -----------NHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp -----------TSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -----------ccc---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 000 01112447899999999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=367.85 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=200.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC--------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKG-------- 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-------- 72 (356)
++|++.+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 579999999999999999999999999999999875432 34456789999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEEeccC-CHHHHHHHHHhhcccCCHH
Q 036550 73 -------------------------------------------------NVFFVFECMQC-NLYQLMEAKKQKQQLFSES 102 (356)
Q Consensus 73 -------------------------------------------------~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~ 102 (356)
..++||||+.| +|.+.+... ......++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhhH
Confidence 38999999986 677766543 233346777
Q ss_pred HHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC-------------CCccccccccccC
Q 036550 103 AVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP-------------PYTERVGTRWYQA 168 (356)
Q Consensus 103 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~-------------~~~~~~gt~~y~a 168 (356)
.++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....... .....+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 8999999999999999999999999999999998 5799999999998776432 2234579999999
Q ss_pred hHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCccccccc
Q 036550 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLS 248 (356)
Q Consensus 169 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
||++.+.. ++.++|||||||++|+|++|..|+.. ....+........ +
T Consensus 245 PE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~------------------~-------- 292 (332)
T 3qd2_B 245 PEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF------------------P-------- 292 (332)
T ss_dssp HHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC------------------C--------
T ss_pred hHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC------------------C--------
Confidence 99996654 89999999999999999998766521 1111111111000 0
Q ss_pred ccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 249 ALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 249 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
......++++.+||.+||..||++|||+.|+|+||||++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 001134678899999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=360.49 Aligned_cols=255 Identities=30% Similarity=0.497 Sum_probs=211.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4799999999999999999999999999999998654321 2345678999999999999999999999999999
Q ss_pred EEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C----cEEEeccccee
Q 036550 76 FVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G----TIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~----~~kL~Dfg~a~ 149 (356)
+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++++ + .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999996 577777753 234899999999999999999999999999999999999965 3 79999999998
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
............||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 231 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------- 231 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--------
T ss_pred eccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--------
Confidence 876655556678999999999986554 89999999999999999999999998877666555433211111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.......+..+.+||.+||..||++|||+.++++||||+.
T Consensus 232 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 232 ------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 1112367889999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=365.77 Aligned_cols=255 Identities=31% Similarity=0.469 Sum_probs=212.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 47999999999999999999999999999999998665444556778999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee---e-CCcEEEecccceeecCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV---S-QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~-~~~~kL~Dfg~a~~~~~~~~ 156 (356)
.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||++ + ++.+||+|||++...... .
T Consensus 89 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~ 163 (304)
T 2jam_A 89 SGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I 163 (304)
T ss_dssp CSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred CCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence 75 777776532 348999999999999999999999999999999999999 3 468999999998765432 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+........
T Consensus 164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 227 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE--------------- 227 (304)
T ss_dssp THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC---------------
T ss_pred cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 3445799999999998654 489999999999999999999999998877666655543221111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......+++.+.+||.+||..||++|||+.++++||||+..
T Consensus 228 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 -----------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -----------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 11223678999999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=384.64 Aligned_cols=256 Identities=32% Similarity=0.528 Sum_probs=198.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--------chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--------SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 73 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.+.. ......+.+|+.+|++++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 57999999999999999999999999999999986542 111234578999999999999999999975 556
Q ss_pred EEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccce
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLA 148 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a 148 (356)
.++||||+.| +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++. ..+||+|||++
T Consensus 214 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred eEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 8999999976 5655543 3456999999999999999999999999999999999999964 35999999999
Q ss_pred eecCCCCCCccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 149 REIDAFPPYTERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
............+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.................
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-------- 361 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-------- 361 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC--------
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC--------
Confidence 88776555567789999999999853 34578899999999999999999999986543322222111110
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+.+ .......+++.+.+||.+||..||++|||++|+|+||||++
T Consensus 362 ----------~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 362 ----------YNF-------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------CCC-------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------CCC-------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 000 11122367899999999999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=363.74 Aligned_cols=258 Identities=26% Similarity=0.489 Sum_probs=213.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc----chHHhhhHHHHHHHHhCCCCCeeEEeEEEE--ECCeE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNHPNIVKVKELIV--EKGNV 74 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~ 74 (356)
+++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999987643 223456678999999999999999999984 45688
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
++||||+.+++.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++.....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999999877776432 345899999999999999999999999999999999999965 7999999999987653
Q ss_pred C---CCCccccccccccChHHHhhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 154 F---PPYTERVGTRWYQAPEILFKSG-LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 154 ~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
. .......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+...
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------------- 228 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------------- 228 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-------------
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-------------
Confidence 2 2223457999999999986533 2477999999999999999999999987766555444321
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.+. ....+++.+.+||.+||..||.+|||+.++++||||++...
T Consensus 229 ------~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 229 ------SYA-----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ------CCC-----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ------CCC-----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 111 12357899999999999999999999999999999987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=358.34 Aligned_cols=252 Identities=28% Similarity=0.514 Sum_probs=214.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999998654221 234567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999975 777777543 3489999999999999999999999999999999999997 479999999999776543
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......|++.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------------- 227 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------------- 227 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------
T ss_pred ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------------------
Confidence 234568999999999986654 899999999999999999999999987766655444321
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+ ...++..+.++|.+||..||.+|||+.++++||||+..
T Consensus 228 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 228 DLKF-----------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ccCC-----------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1111 23578999999999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=366.81 Aligned_cols=280 Identities=28% Similarity=0.475 Sum_probs=221.3
Q ss_pred CCceeecccccCCceEEEEEEE-cCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCC------CeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-KHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHP------NIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~~~~ 74 (356)
++|++.+.||+|+||+||+|.+ ..+++.||+|++.... .......+|+.+++.++|+ +++++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 6899999999999999999998 5688999999987542 3345567899999988654 599999999999999
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-----------------
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----------------- 137 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----------------- 137 (356)
++||||+++++.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 93 ~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 93 CIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999999989998886432 235899999999999999999999999999999999999963
Q ss_pred ---CcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 036550 138 ---GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 138 ---~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 214 (356)
+.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+.
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 47999999999876542 34568999999999997655 8999999999999999999999999998888888777
Q ss_pred HHhCCCCccchHHHhhhhhhh--cccCCCc------------ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 215 SVLGSPTMDSWADGLRQAMAI--NYQFPQL------------SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
...+..+...+.......... ....+.. ............++++.+||.+||..||.+|||+.|++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 777766554332211100000 0000000 00000011123467899999999999999999999999
Q ss_pred cCCCCCC
Q 036550 281 QHPFFKR 287 (356)
Q Consensus 281 ~hp~~~~ 287 (356)
+||||+.
T Consensus 328 ~hp~f~~ 334 (339)
T 1z57_A 328 KHPFFDL 334 (339)
T ss_dssp TSGGGGG
T ss_pred cCHHHHH
Confidence 9999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=367.03 Aligned_cols=277 Identities=23% Similarity=0.357 Sum_probs=211.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC--eEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKG--NVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++..... .......+|+.++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 479999999999999999999999999999999875432 23345578999999999999999999998765 789999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee----eC-CcEEEecccceeecC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV----SQ-GTIKIADFGLAREID 152 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~-~~~kL~Dfg~a~~~~ 152 (356)
||+.| +|.+.+.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +. +.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp ECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred eCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99975 6777765432 23348999999999999999999999999999999999998 33 479999999999887
Q ss_pred CCCCCccccccccccChHHHhh-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Q 036550 153 AFPPYTERVGTRWYQAPEILFK-------SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE----ADQMYKICSVLGSPT 221 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~ 221 (356)
.........||+.|+|||++.. ...++.++|||||||++|+|++|..||..... .+.+..+........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 7666667789999999999863 35589999999999999999999999975432 334444433221111
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
...+.........+...++. ...+...++..+.+||++||+.||++|||++|+|+||=
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPV-----SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CEEEECSTTCCEEEESSCCT-----TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred chhhhcccCCccccCccCCc-----ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11110000000000001110 01122345678999999999999999999999999973
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=358.82 Aligned_cols=254 Identities=31% Similarity=0.517 Sum_probs=189.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH---HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE---KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||+||+|.+..+|+.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 478999999999999999999999999999999986543211 24567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
|||+.+ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999976 6666654 23355899999999999999999999999999999999999975 79999999999876532
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...........+. .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------------~ 226 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-------------------L 226 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------------------S
T ss_pred CcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------------------h
Confidence 2233467999999999986554 8999999999999999999999998765433221110 0
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
..+ .....++.++.++|.+||..||++|||++++++||||.+.
T Consensus 227 ~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 ADY-----------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ccc-----------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 001 1223578999999999999999999999999999999763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=360.18 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=207.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 57999999999999999999999999999999987665555566788999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCC-CCCCc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA-FPPYT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~-~~~~~ 158 (356)
.++ +.+.+.. ....+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+|||++..... .....
T Consensus 99 ~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 99 PGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 874 5555443 234489999999999999999999999999999999999997 57999999998754321 11223
Q ss_pred cccccccccChHHHh----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 159 ERVGTRWYQAPEILF----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
...||+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+.......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 241 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-------------- 241 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc--------------
Confidence 457999999999985 34558899999999999999999999999887766555443321100
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......++..+.++|.+||..||.+|||+.++++||||+..
T Consensus 242 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 -------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp -------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred -------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 00112568899999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=357.36 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=206.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654321 233557899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+|+||||+||+++. +.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999975 787777543 34899999999999999999999999999999999999975 799999999998776554
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......||+.|+|||++.+....+.++|||||||++|+|++|..||...........+....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 227 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV------------------ 227 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------------
Confidence 44566899999999999766645789999999999999999999998877655544432210
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.. ....++..+.++|.+||+.||++|||+.++++||||++.
T Consensus 228 -~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 -FY-----------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -CC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -cc-----------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 11 123568899999999999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=369.71 Aligned_cols=282 Identities=26% Similarity=0.439 Sum_probs=222.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCC-cEEEEEEcccccchHHhhhHHHHHHHHhCCCCC------eeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG-EVVAIKALKKSYSREKCLNLREVKCLRKLNHPN------IVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||+||+|.+..++ +.||+|++.... .......+|+.+++.+.|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 68999999999999999999998777 789999987542 33455678999999987655 99999999999999
Q ss_pred EEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee-------------------
Q 036550 75 FFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV------------------- 135 (356)
Q Consensus 75 ~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll------------------- 135 (356)
++||||+++++.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 98 ~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 98 CIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999999988887643 22458999999999999999999999999999999999999
Q ss_pred e-CCcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 036550 136 S-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 136 ~-~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 214 (356)
+ ++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+.
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 468999999999876542 34568999999999997655 8999999999999999999999999998888888888
Q ss_pred HHhCCCCccchHHHhhhhhhhc--ccCCCcc---------cc---cccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 215 SVLGSPTMDSWADGLRQAMAIN--YQFPQLS---------GV---NLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---------~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
...+.++...+........... ...+... .. .........+.++.+||.+||..||++|||+.|+|
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 8777666544332211110000 0000000 00 00001112356899999999999999999999999
Q ss_pred cCCCCCCCC
Q 036550 281 QHPFFKRCL 289 (356)
Q Consensus 281 ~hp~~~~~~ 289 (356)
+||||++..
T Consensus 333 ~hp~f~~~~ 341 (355)
T 2eu9_A 333 LHPFFAGLT 341 (355)
T ss_dssp TSGGGGGCC
T ss_pred cChhhcCCC
Confidence 999998743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=370.65 Aligned_cols=282 Identities=29% Similarity=0.459 Sum_probs=218.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-----------CCCeeEEeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-----------HPNIVKVKELIVE 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~~~~~~~~ 70 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... .......+|+.+++++. ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 58999999999999999999999999999999987543 23345678999998886 8999999999986
Q ss_pred CC----eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-------C
Q 036550 71 KG----NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-------G 138 (356)
Q Consensus 71 ~~----~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-------~ 138 (356)
.+ .++++||+++++|.+.+.... ...+++..++.++.||+.||+|||++ ||+||||||+|||++. +
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 54 789999999889998886533 23489999999999999999999998 9999999999999952 2
Q ss_pred cEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD------EADQMYK 212 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~ 212 (356)
.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+ ..+....
T Consensus 176 ~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 7999999999877643 34568999999999997655 8999999999999999999999998654 4556777
Q ss_pred HHHHhCCCCccchHHHhhhhhhhcc-----cCCCcccc-------cccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 213 ICSVLGSPTMDSWADGLRQAMAINY-----QFPQLSGV-------NLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
+...++.++...+............ ........ .........+.++.+||.+||..||++|||++|+|
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 7777777765544322111000000 00000000 00011224567899999999999999999999999
Q ss_pred cCCCCCCCC
Q 036550 281 QHPFFKRCL 289 (356)
Q Consensus 281 ~hp~~~~~~ 289 (356)
+||||++..
T Consensus 333 ~hp~f~~~~ 341 (373)
T 1q8y_A 333 NHPWLKDTL 341 (373)
T ss_dssp TCGGGTTCT
T ss_pred hChhhhccc
Confidence 999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=355.00 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=210.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999999999999999986543 23345667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC---C
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF---P 155 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~---~ 155 (356)
+.| +|.+.+. ....+++..++.++.||+.||.|||++||+|+||||+||+++. +.+||+|||.+...... .
T Consensus 87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 976 6666653 3345899999999999999999999999999999999999975 79999999999865422 2
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......||+.|+|||++.+...++.++|||||||++|+|++|..||................
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 224 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------------ 224 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT------------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc------------------
Confidence 23456799999999999766655789999999999999999999998765432211111100
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.... .....+++.+.+||.+||..||++|||+.|+++||||++.
T Consensus 225 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 225 KTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp CTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cccc---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 0000 0112568999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=364.94 Aligned_cols=256 Identities=32% Similarity=0.525 Sum_probs=205.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 73 (356)
++|.+.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 479999999999999999999999999999999865421 12234578999999999999999999987655
Q ss_pred EEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C---cEEEecccce
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G---TIKIADFGLA 148 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~---~~kL~Dfg~a 148 (356)
.|+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 8999999976 6776663 3445999999999999999999999999999999999999975 2 4999999999
Q ss_pred eecCCCCCCccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchH
Q 036550 149 REIDAFPPYTERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226 (356)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (356)
.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.................
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 236 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-------- 236 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC--------
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc--------
Confidence 88765433345679999999999853 45589999999999999999999999986543322211111100
Q ss_pred HHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+.+ .+.....++..+.+||.+||..||++|||+.++|+||||++
T Consensus 237 ----------~~~-------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 ----------YNF-------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ----------CCC-------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ----------ccc-------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 000 01112367899999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=363.38 Aligned_cols=252 Identities=30% Similarity=0.463 Sum_probs=214.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999986542 233455678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-C
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-P 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~ 155 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++...... .
T Consensus 121 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99985 56666543 245899999999999999999999999999999999999975 69999999999877532 2
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------------- 256 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------------- 256 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------------------
T ss_pred cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-------------------
Confidence 334567999999999996655 899999999999999999999999987766554444321
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+.+ ...++..+.+||.+||..||++|||+.|+++||||...
T Consensus 257 ~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 257 EYSI-----------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp CCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CCCC-----------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 1111 23568899999999999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=354.06 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=206.7
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE----CCeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE----KGNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~i 76 (356)
.|.+.+.||+|+||+||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4889999999999999999999999999999986543 3344556789999999999999999999876 356899
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeee--CCcEEEecccceeec
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVS--QGTIKIADFGLAREI 151 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~--~~~~kL~Dfg~a~~~ 151 (356)
||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++| |+||||||+||+++ ++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999966 677777532 44899999999999999999999999 99999999999996 479999999999755
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
... ......||+.|+|||++. . .++.++|||||||++|+|++|..||..................
T Consensus 183 ~~~-~~~~~~~t~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 247 (290)
T 1t4h_A 183 RAS-FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------------ 247 (290)
T ss_dssp CTT-SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------------
T ss_pred ccc-ccccccCCcCcCCHHHHh-c-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC------------
Confidence 432 334567999999999875 3 3899999999999999999999999886655444332221100
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
........++++.++|.+||..||.+|||+.++++||||++
T Consensus 248 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 ---------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 01112356789999999999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=355.32 Aligned_cols=252 Identities=30% Similarity=0.465 Sum_probs=213.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 57999999999999999999999999999999986542 233455678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-C
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-P 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~ 155 (356)
||+.| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++...... .
T Consensus 95 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp ECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99985 56665543 245899999999999999999999999999999999999975 69999999999876532 2
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 230 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------------- 230 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------
T ss_pred ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------------
Confidence 334567999999999986554 899999999999999999999999987766554443221
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... ....+++.+.++|.+||..||++|||+.++++||||.+.
T Consensus 231 ~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 231 EYS-----------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred cCC-----------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 111 123578899999999999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=357.60 Aligned_cols=255 Identities=34% Similarity=0.582 Sum_probs=215.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 579999999999999999999999999999999865432 234556789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAF 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~ 154 (356)
|+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 102 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9865 676766532 34899999999999999999999999999999999999964 37999999999877665
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+......+..+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 244 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP----------- 244 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-----------
T ss_pred CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch-----------
Confidence 55556679999999999854 38999999999999999999999999887766655554321111111
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
....+++++.++|.+||..||++|||+.++++||||++.
T Consensus 245 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 245 ---------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ---------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ---------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 113578999999999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=366.06 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=205.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECC----eE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKG----NV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~ 74 (356)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+|+.++++++||||+++++++...+ ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6899999999999999999999999999999999765322 2335578999999999999999999987654 34
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
|+||||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999965 777776532 35899999999999999999999999999999999999975 799999999998664
Q ss_pred CCC----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AFP----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+......++
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------- 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP------- 239 (311)
T ss_dssp --------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH-------
T ss_pred ccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc-------
Confidence 321 223456999999999996654 89999999999999999999999998887666555433211110
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
......++.++.++|.+||..||.+||++.+++.|+|++..
T Consensus 240 -------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 -------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 11123679999999999999999999999999999999743
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=383.04 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=198.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc---cchHHhhhHHHH---HHHHhCCCCCeeEEe-------EEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS---YSREKCLNLREV---KCLRKLNHPNIVKVK-------ELI 68 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hp~iv~~~-------~~~ 68 (356)
++|.+.+.||+|+||+||+|++..+|+.||||++... .......+.+|+ .++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4699999999999999999999999999999998743 233445667899 455556899999988 777
Q ss_pred EECC-----------------eEEEEEEeccCCHHHHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 036550 69 VEKG-----------------NVFFVFECMQCNLYQLMEAKKQK---QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDL 128 (356)
Q Consensus 69 ~~~~-----------------~~~iv~e~~~g~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 128 (356)
.+.+ ..|++|||++|+|.+.+...... ...+++..++.++.||+.||+|||++||+||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi 232 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 6554 28999999999999998754321 112334888899999999999999999999999
Q ss_pred CCCCeeeeC-CcEEEecccceeecCCCCCCccccccccccChHHHhhC----------CCCCCchhHHHHHHHHHHHHhC
Q 036550 129 KPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS----------GLYSSKVDMWAMGAIMAELLLF 197 (356)
Q Consensus 129 kp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g 197 (356)
||+|||++. +.+||+|||+|..... .....+| +.|+|||++.+. ..++.++|||||||++|+|++|
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 999999974 7999999999987543 3345678 999999999776 2489999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH
Q 036550 198 RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA 277 (356)
Q Consensus 198 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 277 (356)
..||...........+ ....+.+++++.+||.+||..||++|||+.
T Consensus 310 ~~Pf~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 310 DLPITKDAALGGSEWI----------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp SCCC------CCSGGG----------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred CCCCcccccccchhhh----------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 9999764422111000 011136789999999999999999999999
Q ss_pred HHhcCCCCCC
Q 036550 278 EALQHPFFKR 287 (356)
Q Consensus 278 e~l~hp~~~~ 287 (356)
++++||||++
T Consensus 356 e~l~hp~f~~ 365 (377)
T 3byv_A 356 QAMETPEYEQ 365 (377)
T ss_dssp HHHTSHHHHH
T ss_pred HHhhChHHHH
Confidence 9999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=359.31 Aligned_cols=267 Identities=27% Similarity=0.427 Sum_probs=194.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 689999999999999999999998999999999865432 2334557899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 81 MQC-NLYQLMEAKKQ----KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+.| +|.+.+..... ....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 965 77777764322 2345899999999999999999999999999999999999975 79999999998765432
Q ss_pred C------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 155 P------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 155 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
. ......||+.|+|||++.+...++.++|||||||++|+|++|..||.................. ..
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~------ 247 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP-SL------ 247 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC-CT------
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC-cc------
Confidence 1 1234579999999999976455899999999999999999999999887665544332211100 00
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
............++.++.++|.+||..||.+|||+.++++||||++.
T Consensus 248 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 -------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred -------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00111122345778999999999999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=369.86 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=207.9
Q ss_pred CCCceeecccccCCceEEEEEEEc---CCCcEEEEEEccccc----chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSY----SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
+++|.+.+.||+|+||+||+|++. .+++.||+|++++.. ........+|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 589999999987542 12234456799999999 7999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999976 677776532 34899999999999999999999999999999999999975 7999999999987
Q ss_pred cCCC--CCCccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 151 IDAF--PPYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 151 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
.... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+....
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------- 278 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---------- 278 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH----------
Confidence 6432 122345799999999999753 347899999999999999999999997543221111111100
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLY 290 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~ 290 (356)
.... ......++..+.+||.+||..||.+|| |++++++||||+...|
T Consensus 279 -----~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 279 -----LKSE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp -----HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -----hccC-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 0000 112236789999999999999999999 9999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=351.17 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=206.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEecc
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQ 82 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~ 82 (356)
+|.....||+|+||+||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 44555699999999999999999999999999977655555667899999999999999999999999999999999996
Q ss_pred C-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee--CCcEEEecccceeecCCCC-CCc
Q 036550 83 C-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS--QGTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 83 g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+ +|.+.+... .....+++..++.++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++....... ...
T Consensus 103 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 103 GGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp EEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred CCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 5 677776542 2233467999999999999999999999999999999999997 5799999999998765432 234
Q ss_pred cccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...||+.|+|||++.+. ..++.++|||||||++|+|++|..||.................
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------- 242 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK------------------- 242 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-------------------
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-------------------
Confidence 56799999999998654 2378999999999999999999999976543322111111000
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........++.++.+||.+||..||++|||+.++++||||+..
T Consensus 243 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 243 --------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred --------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0011224678999999999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=350.58 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=214.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~i 76 (356)
+++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368999999999999999999999999999999987543 2334566789999999999999999998865 578999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCCeeeeC-CcEEEeccccee
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG-----YFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
||||+.| +|.+.+.........+++..++.++.||+.||+|||++| |+||||||+||++++ +.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999975 888888776665666999999999999999999999999 999999999999975 789999999997
Q ss_pred ecCCCCC-CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 150 EIDAFPP-YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 150 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---------- 233 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---------- 233 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------
T ss_pred eeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----------
Confidence 7654221 22357899999999986654 89999999999999999999999998876655544433210
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
......++.++.++|.+||..||++|||+.|+++|+|+.+
T Consensus 234 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 234 -------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1112357899999999999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=365.85 Aligned_cols=272 Identities=25% Similarity=0.358 Sum_probs=211.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 579999999999999999999999999999999876533 3345567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.| +|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++. +.+||+|||++...... ..
T Consensus 113 ~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 187 (360)
T 3eqc_A 113 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 187 (360)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C-
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 976 777777533 3489999999999999999999996 9999999999999975 79999999998765432 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCccch-----------
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLG-SPTMDSW----------- 225 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~----------- 225 (356)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+..... ......+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ---CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred cCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 3468999999999996654 89999999999999999999999998776554332211110 0000000
Q ss_pred -----------HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 226 -----------ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 226 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+....... . .........++.++.+||.+||..||++|||++|+|+||||++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVN--E-------PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------CCCHHHHHHHHHH--S-------CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccCCCCcccchhhhhHHhc--c-------CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000000000 0 00111123578999999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=353.17 Aligned_cols=254 Identities=26% Similarity=0.510 Sum_probs=208.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 57999999999999999999999999999999987643 2345678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCC-CCCc
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
+| +|.+.+.. ....+++..++.++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++...... ....
T Consensus 107 ~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 107 GAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp TTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 87 67777653 334589999999999999999999999999999999999996 479999999999876543 2234
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
...||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+..... + .
T Consensus 184 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-----------------~ 244 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P-----------------T 244 (314)
T ss_dssp CCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----------------C
T ss_pred ccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c-----------------c
Confidence 567999999999986554 89999999999999999999999988776554433322100 0 0
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+ .....++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 245 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 245 F---------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp C---------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred c---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0 0112468899999999999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=356.94 Aligned_cols=256 Identities=23% Similarity=0.423 Sum_probs=205.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEE------CCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVE------KGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~------~~~~ 74 (356)
++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++++ +||||+++++++.. .+..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 589999999999999999999999999999999875432 334567899999998 89999999999987 5689
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++||||+++ +|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++. +.+||+|||++....
T Consensus 103 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 999999986 788877643 2345899999999999999999999999999999999999975 799999999988765
Q ss_pred CC-CCCccccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 153 AF-PPYTERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 153 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
.. .......||+.|+|||++.. ...++.++|||||||++|+|++|..||...........+....
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 250 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---------- 250 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------
Confidence 32 22345679999999999862 3458899999999999999999999998877665544432210
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+. .....++..+.+||.+||..||.+|||+.++++||||++.
T Consensus 251 -----------~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 251 -----------APR-------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp -----------CCC-------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred -----------ccc-------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 000 1123578999999999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=367.54 Aligned_cols=258 Identities=16% Similarity=0.206 Sum_probs=189.6
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhC--CCCCeeEEe-------EEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKL--NHPNIVKVK-------ELIVE 70 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hp~iv~~~-------~~~~~ 70 (356)
+|.+.+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 58999999999999999999999999999999987542 2333445675444444 799988755 55554
Q ss_pred C-----------------CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHH------HHHHHHHHHHHHHHHhCCccccc
Q 036550 71 K-----------------GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAV------KAWLFQVFRGLDYMHQQGYFHRD 127 (356)
Q Consensus 71 ~-----------------~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~ivH~D 127 (356)
. ..+|+||||++|+|.+++..... .+++... ..++.||+.||+|||++||+|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 3 33899999999999999876532 2455555 67779999999999999999999
Q ss_pred CCCCCeeeeC-CcEEEecccceeecCCCCCCccccccccccChHHHhhC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036550 128 LKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS-GLYSSKVDMWAMGAIMAELLLFRPLFQGTD 205 (356)
Q Consensus 128 lkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 205 (356)
|||+|||++. +.+||+|||+|...+... ....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999975 799999999998775422 245677999999999651 348999999999999999999999998764
Q ss_pred hHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 206 EADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQL-SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
.... ..+. ....... .........+.+++.+.+||.+||..||++|||+.++|+|||
T Consensus 298 ~~~~-------------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 298 PGIK-------------GSWK---------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp TTCT-------------TCCC---------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred cccc-------------cchh---------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 3110 0000 0000000 000011112478999999999999999999999999999999
Q ss_pred CCC
Q 036550 285 FKR 287 (356)
Q Consensus 285 ~~~ 287 (356)
|++
T Consensus 356 f~~ 358 (371)
T 3q60_A 356 FLQ 358 (371)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=354.90 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=191.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc---EEEEEEcccc--cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeE--
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKS--YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNV-- 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-- 74 (356)
++|.+.+.||+|+||+||+|++..++. .||+|++... .......+.+|+.++++++||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 579999999999999999999887765 8999998765 334456678999999999999999999999877654
Q ss_pred ----EEEEEeccC-CHHHHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccc
Q 036550 75 ----FFVFECMQC-NLYQLMEAKKQ--KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFG 146 (356)
Q Consensus 75 ----~iv~e~~~g-~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg 146 (356)
++||||+.+ +|.+.+..... ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 999999986 67777765432 2225899999999999999999999999999999999999975 699999999
Q ss_pred ceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 036550 147 LAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTM 222 (356)
Q Consensus 147 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (356)
++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+.....
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---- 257 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR---- 257 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred ccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC----
Confidence 9987644322 22345788999999997665 8999999999999999999 9999998877665554432210
Q ss_pred cchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-------HHHHhcCCCCCCCCCCCCC
Q 036550 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-------AAEALQHPFFKRCLYVPPH 294 (356)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-------~~e~l~hp~~~~~~~~~~~ 294 (356)
....+.++.++.+||.+||..||++||| ++++++|||+......|..
T Consensus 258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 1112367899999999999999999999 8889999999875544433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=352.80 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=203.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 58999999999999999999999999999999985432 223345678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~- 155 (356)
||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++.......
T Consensus 91 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99976 677776532 35899999999999999999999999999999999999965 799999999997664332
Q ss_pred -CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+........+......
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------- 229 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV---------------- 229 (294)
T ss_dssp --------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC----------------
T ss_pred cccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC----------------
Confidence 223457999999999997655 89999999999999999999999998876655443322100
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
+ .......+.+++.+.++|.+||..||.+||+..+.+.+.|.
T Consensus 230 -----~----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 230 -----P----NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp -----C----CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred -----C----CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 0 00112234678999999999999999999966666665554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=351.05 Aligned_cols=251 Identities=29% Similarity=0.482 Sum_probs=212.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56999999999999999999999999999999986553 23345667899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~ 157 (356)
++| +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++....... ..
T Consensus 102 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 102 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 987 5666653 245899999999999999999999999999999999999975 799999999998765432 23
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...........+....
T Consensus 177 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 235 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-------------------- 235 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------------------
T ss_pred CccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--------------------
Confidence 4567999999999996554 8999999999999999999999998877655444332210
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.......++..+.+||.+||..||.+|||+.++++||||..
T Consensus 236 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 236 ---------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ---------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ---------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 01122367899999999999999999999999999999965
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=352.11 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=200.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|++.+.||+|+||+||+|++ +|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 5799999999999999999976 588999999876532 233456789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|+.| +|.+.+.... ....+++..++.++.||+.||+|||++| |+||||||+|||+++ +.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9976 6777765322 2234899999999999999999999999 999999999999986 699999999997654322
Q ss_pred -CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+......
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--------------- 257 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--------------- 257 (309)
T ss_dssp --------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC---------------
T ss_pred cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence 234567999999999996655 899999999999999999999999988776655444221111
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc--CCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ--HPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~ 287 (356)
......+++++.+||.+||..||.+|||+.++++ +++++.
T Consensus 258 -------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 -------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1122467899999999999999999999999998 566554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=350.45 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=204.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 68999999999999999999999999999999987766666677789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC--
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY-- 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~-- 157 (356)
.| +|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 76 67777653 2345899999999999999999999999999999999999975 68999999999876432221
Q ss_pred -------------ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 158 -------------TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 158 -------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------~~~ 235 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GLN 235 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------SBC
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------hhh
Confidence 1457999999999996654 8999999999999999999999987543211000 000
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..... .....+.+++.+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 236 VRGFL-----------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHH-----------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccc-----------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00000 00112367889999999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=362.07 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=209.8
Q ss_pred CCceeecccccCCceEEEEEE-----EcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV-----NKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||+||+|+ +..+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 579999999999999999999 45678899999987543 333445678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccc
Q 036550 76 FVFECMQC-NLYQLMEAKKQ---KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~ 147 (356)
+||||+.| +|.+.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++. ..+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999965 78888765432 1234899999999999999999999999999999999999973 2599999999
Q ss_pred eeecCC---CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDA---FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+..... ........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+......
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~---- 305 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM---- 305 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 975422 22334457899999999997665 8999999999999999998 99999988877666555332110
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
.....++..+.+|+.+||+.||.+|||+.+++++.++.
T Consensus 306 -------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 306 -------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11235788999999999999999999999999998763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=353.94 Aligned_cols=246 Identities=24% Similarity=0.434 Sum_probs=208.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch------HHhhhHHHHHHHHhCC--CCCeeEEeEEEEECCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR------EKCLNLREVKCLRKLN--HPNIVKVKELIVEKGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~ 73 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++...... ....+.+|+.+++++. ||||+++++++.+.+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 5799999999999999999999999999999998765321 2234567999999996 5999999999999999
Q ss_pred EEEEEEecc--CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee--CCcEEEeccccee
Q 036550 74 VFFVFECMQ--CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS--QGTIKIADFGLAR 149 (356)
Q Consensus 74 ~~iv~e~~~--g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~kL~Dfg~a~ 149 (356)
.++|||++. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 999999987 578887754 24589999999999999999999999999999999999997 3799999999998
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||..... +..
T Consensus 199 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~-------------- 257 (320)
T 3a99_A 199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR-------------- 257 (320)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--------------
T ss_pred ccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--------------
Confidence 77643 334567999999999998777568899999999999999999999975321 100
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... .....+++++.+||.+||..||++|||++++++||||++.
T Consensus 258 -----~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 258 -----GQV-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -----CCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----ccc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 000 1123678999999999999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=354.19 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=189.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHH-HHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVK-CLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 689999999999999999999999999999999976533 23334455555 6777899999999999999999999999
Q ss_pred eccCCHHHHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 80 CMQCNLYQLMEAKKQ-KQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
|+.|++.+.+..... ....+++..++.++.|++.||.|||++ ||+||||||+||+++. +.+||+|||++........
T Consensus 102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 999998888765332 345689999999999999999999999 9999999999999975 7999999999987765544
Q ss_pred CccccccccccChHHHh---hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccchHHHhhhh
Q 036550 157 YTERVGTRWYQAPEILF---KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD-QMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.....||+.|+|||++. ....++.++|||||||++|+|++|..||....... ....+.
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------------ 243 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV------------------ 243 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC------------------
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh------------------
Confidence 45568999999999984 23448999999999999999999999998643211 110000
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
....+. ........+++.+.+||.+||..||++|||+.++++||||..
T Consensus 244 ---~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 244 ---KGDPPQ----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ---CSCCCC----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---cCCCCC----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 000000 001122467899999999999999999999999999999965
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=348.86 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=198.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-----------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE----------- 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------- 70 (356)
++|++.+.||+|+||+||+|++..+++.||+|++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4799999999999999999999999999999998654 2334566789999999999999999998865
Q ss_pred --CCeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccc
Q 036550 71 --KGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFG 146 (356)
Q Consensus 71 --~~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg 146 (356)
.+..|+||||+.| +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 4578999999975 78887764 2344789999999999999999999999999999999999975 799999999
Q ss_pred ceeecCCC---------------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHH
Q 036550 147 LAREIDAF---------------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA-DQM 210 (356)
Q Consensus 147 ~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~ 210 (356)
++...... .......||+.|+|||++.+.+.++.++|||||||++|+|++ ||...... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 99765421 122345799999999999766668999999999999999998 55432221 122
Q ss_pred HHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..+.. ....++. ......+..+.++|++||..||.+|||+.++++||||+.
T Consensus 239 ~~~~~-------------------~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKLRS-------------------VSIEFPP-------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHS-------------------TTCCCCT-------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhccc-------------------cccccCc-------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 11111 0111111 123456788999999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=352.29 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=203.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCC--CCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLN--HPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++++. ||||+++++++.+.+..++|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 46999999999999999999986 58899999986543 233455678999999996 59999999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCCC-
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPP- 156 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~~- 156 (356)
||+.+++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++........
T Consensus 107 ~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 107 MECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp ECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC-------
T ss_pred EecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCcccc
Confidence 99888899888864 3458999999999999999999999999999999999999999999999999987644321
Q ss_pred --CccccccccccChHHHhhC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcc
Q 036550 157 --YTERVGTRWYQAPEILFKS----------GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEAD-QMYKICSVLGSPTMD 223 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~ 223 (356)
.....||+.|+|||++.+. ..++.++|||||||++|+|++|..||....... ....+...
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~------- 255 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP------- 255 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT-------
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc-------
Confidence 2345799999999998652 358889999999999999999999998654322 22211110
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.. ........+.++.++|.+||..||.+|||+.++++||||+..
T Consensus 256 ------------~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 256 ------------NH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ------------TS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ------------cc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00 001123457899999999999999999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=351.40 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=190.8
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH--HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE--KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+++|.+.+.||+|+||+||+|.+..+|+.||+|++....... .....++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999999999999999997654322 223344556788889999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+++.+..+... ....+++..++.++.||+.||.|||++ ||+||||||+||+++. +.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 9995554444332 234589999999999999999999995 9999999999999975 7999999999987765545
Q ss_pred CccccccccccChHHHh----hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 157 YTERVGTRWYQAPEILF----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD-EADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.....||+.|+|||++. ....++.++|||||||++|+|++|..||.... ..+....+.... .+
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~----------- 248 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PP----------- 248 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CC-----------
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CC-----------
Confidence 55668999999999985 23458899999999999999999999998744 333333332210 00
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.. .....+++++.+||.+||..||.+|||+.++++||||++
T Consensus 249 ------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 249 ------LL---------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ------CC---------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ------CC---------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 00 011257899999999999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=362.85 Aligned_cols=271 Identities=19% Similarity=0.347 Sum_probs=211.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHH-----------------hhhHHHHHHHHhCCCCCeeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-----------------CLNLREVKCLRKLNHPNIVKV 64 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~~l~~l~hp~iv~~ 64 (356)
++|.+.+.||+|+||.||+|.+ +|+.||+|++........ ..+.+|+.++++++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 6899999999999999999998 899999999865422111 566889999999999999999
Q ss_pred eEEEEECCeEEEEEEeccC-CHHHH------HHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeee
Q 036550 65 KELIVEKGNVFFVFECMQC-NLYQL------MEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVS 136 (356)
Q Consensus 65 ~~~~~~~~~~~iv~e~~~g-~l~~~------~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~ 136 (356)
++++.+.+..++||||+.| +|.+. +.. .....+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 9999999999999999987 66655 321 124569999999999999999999999 9999999999999996
Q ss_pred C-CcEEEecccceeecCCCCCCccccccccccChHHHhhCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 036550 137 Q-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSS-KVDMWAMGAIMAELLLFRPLFQGTDE-ADQMYKI 213 (356)
Q Consensus 137 ~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i 213 (356)
. +.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||..... .+....+
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i 265 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 5 79999999999876543 3345689999999999976644555 99999999999999999999998766 4444443
Q ss_pred HHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 214 CSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.......+.. .. .................++.++.+||.+||..||.+|||+.|+++||||++.
T Consensus 266 ~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 266 RTKNIEYPLD-RN----------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp TSCCCCCCCS-SS----------SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hccCcCCccc-hh----------hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 2211111000 00 0000000011112224689999999999999999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=356.87 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=206.7
Q ss_pred CCceeecccccCCceEEEEEEEc-------CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-------HSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||+||+|++. .++..||+|+++.... .....+.+|+.+++.+ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57999999999999999999874 3556899999976543 3345668899999999 8999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
.+|+||||+.| +|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 99999999976 78888765321 1234899999999999999999999999999999999999975 7
Q ss_pred cEEEecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 319 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 99999999998765432 223456789999999996654 8999999999999999999 999999877655544332
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... ......++.++.++|.+||..||.+|||+.|++++
T Consensus 320 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 320 EGHR-----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2110 11123678999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=351.61 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=204.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc---EEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||+||+|.+..+++ .||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 579999999999999999999986554 599999976533 3445678899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 129 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 999976 67777642 2345999999999999999999999999999999999999975 799999999998775432
Q ss_pred C----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 P----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------- 273 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL----------- 273 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred cceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-----------
Confidence 1 12334678899999996655 8999999999999999999 99999988877666555332111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....+++.+.++|.+||..||.+|||+.++++.
T Consensus 274 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 274 ------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1123678999999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=353.32 Aligned_cols=248 Identities=23% Similarity=0.265 Sum_probs=202.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++..... ...+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 579999999999999999999999999999999865432 23467899999999 999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-Cc-----EEEecccceeecCCC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GT-----IKIADFGLAREIDAF 154 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~-----~kL~Dfg~a~~~~~~ 154 (356)
++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. +. +||+|||++......
T Consensus 87 ~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 87 LGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 988888887643 345999999999999999999999999999999999999975 34 999999999876543
Q ss_pred CC--------CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCcc
Q 036550 155 PP--------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMD 223 (356)
Q Consensus 155 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 223 (356)
.. ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... +.+..+.......+.
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 241 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI- 241 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-
T ss_pred CCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-
Confidence 22 24568999999999997655 899999999999999999999999875432 223332221100000
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......+ ++.+++..||..||.+||++.++++
T Consensus 242 ------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 ------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00111234 9999999999999999999988876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=357.00 Aligned_cols=259 Identities=28% Similarity=0.454 Sum_probs=180.8
Q ss_pred CCceeec-ccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE----CCeEEE
Q 036550 2 EKYSLTK-KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE----KGNVFF 76 (356)
Q Consensus 2 ~~y~~~~-~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~i 76 (356)
++|.+.+ .||+|+||+||+|++..+|+.||+|++..... ...+....++.++||||+++++++.. ...+++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 6899965 69999999999999999999999999865321 11223344667799999999999976 456899
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeec
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREI 151 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~ 151 (356)
||||+.| +|.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++...
T Consensus 104 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 104 IMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999976 787777532 2245999999999999999999999999999999999999963 46999999999876
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...............
T Consensus 182 ~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------------- 244 (336)
T 3fhr_A 182 TQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR--------------- 244 (336)
T ss_dssp -----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred ccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh---------------
Confidence 542 334567899999999985544 889999999999999999999999766543321111000
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.....+.++. .....++.++.+||.+||..||.+|||+.|+|+||||++...
T Consensus 245 ~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 245 IRLGQYGFPN-------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp ------CCCT-------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred hhccccccCc-------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 0000111111 112367999999999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=356.11 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=204.9
Q ss_pred CCceeecccccCCceEEEEEE-----EcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC-e
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV-----NKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG-N 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~ 73 (356)
++|.+.+.||+|+||.||+|+ +..+++.||+|++..... .....+.+|+.+++++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 689999999999999999998 556779999999976543 3345678999999999 7999999999998764 4
Q ss_pred EEEEEEeccC-CHHHHHHHHHhh---------------------------------------------------------
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQK--------------------------------------------------------- 95 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~--------------------------------------------------------- 95 (356)
.++||||+.| +|.+.+......
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999986 677777643221
Q ss_pred -----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC---Cccccccccc
Q 036550 96 -----QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWY 166 (356)
Q Consensus 96 -----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y 166 (356)
...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++........ .....||+.|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 122899999999999999999999999999999999999974 7999999999987644322 2345689999
Q ss_pred cChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccc
Q 036550 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGV 245 (356)
Q Consensus 167 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (356)
+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+...........+
T Consensus 262 ~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------- 315 (359)
T 3vhe_A 262 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------------- 315 (359)
T ss_dssp CCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-------------------------
T ss_pred EChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-------------------------
Confidence 9999997655 8999999999999999998 999998876554443333221111
Q ss_pred cccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 246 NLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....+++++.+++.+||..||++|||+.++++|
T Consensus 316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123578999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=342.47 Aligned_cols=250 Identities=20% Similarity=0.236 Sum_probs=205.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 57999999999999999999999999999999986543 234567899999999 899999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-Cc-----EEEecccceeecCCC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GT-----IKIADFGLAREIDAF 154 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~-----~kL~Dfg~a~~~~~~ 154 (356)
++++|.+.+... +..+++..++.++.||+.||+|||++||+||||||+||+++. +. +||+|||++......
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 88 LGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp CCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred cCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 988898888643 335899999999999999999999999999999999999964 33 999999999877543
Q ss_pred C--------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCcc
Q 036550 155 P--------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---ADQMYKICSVLGSPTMD 223 (356)
Q Consensus 155 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 223 (356)
. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+......++
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 241 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-- 241 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--
T ss_pred cccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc--
Confidence 2 234567999999999986655 89999999999999999999999987532 233333322111010
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....+.+++++.+++.+||..||++|||++++++.
T Consensus 242 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 242 -----------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp -----------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred -----------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 112223678999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=338.79 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=205.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 58999999999999999999987 4778999999765433 345788999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--CCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--PPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--~~~ 157 (356)
++ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++...... ...
T Consensus 88 ~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 76 56666642 3345899999999999999999999999999999999999965 69999999999765432 122
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 226 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------- 226 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------------
T ss_pred cCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-----------------
Confidence 3446788999999996665 8999999999999999999 99999988877665555332111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++.+.+++.+||+.||++|||+.++++|
T Consensus 227 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1112568899999999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=349.35 Aligned_cols=246 Identities=26% Similarity=0.448 Sum_probs=199.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc------hHHhhhHHHHHHHHhC----CCCCeeEEeEEEEEC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS------REKCLNLREVKCLRKL----NHPNIVKVKELIVEK 71 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~hp~iv~~~~~~~~~ 71 (356)
++|.+.+.||+|+||.||+|++..+++.||+|++..... .......+|+.+++++ +||||+++++++.+.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 579999999999999999999999999999999865432 1223445799999998 899999999999999
Q ss_pred CeEEEEEEe-cc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee--CCcEEEecccc
Q 036550 72 GNVFFVFEC-MQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS--QGTIKIADFGL 147 (356)
Q Consensus 72 ~~~~iv~e~-~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--~~~~kL~Dfg~ 147 (356)
+..++|||+ +. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 999999997 44 5788877542 3489999999999999999999999999999999999997 47899999999
Q ss_pred eeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 148 AREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
+...... ......||+.|+|||++.+....+.++|||||||++|+|++|..||..... +..
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~------------ 247 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE------------ 247 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------------
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh------------
Confidence 9877653 345567999999999998776556699999999999999999999975321 110
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.... ....++..+.+||.+||..||++|||+.|+++||||+..
T Consensus 248 -------~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 248 -------AELH-----------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -------TCCC-----------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -------hccC-----------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 0111 123678999999999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=339.34 Aligned_cols=245 Identities=28% Similarity=0.474 Sum_probs=191.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH----HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE----KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+++|.+.+.||+|+||+||+|.+. ++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 478999999999999999999874 8899999987643222 3456789999999999999999999999999999
Q ss_pred EEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCCeeee---------CCcEEEe
Q 036550 77 VFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG---YFHRDLKPENLLVS---------QGTIKIA 143 (356)
Q Consensus 77 v~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~---------~~~~kL~ 143 (356)
||||+.|+ |.+.+ ....+++..++.++.||+.||.|||++| |+||||||+||+++ ++.+||+
T Consensus 84 v~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999764 55544 2345999999999999999999999999 89999999999996 4679999
Q ss_pred cccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 144 DFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
|||++........ ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+......
T Consensus 159 Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 232 (271)
T 3dtc_A 159 DFGLAREWHRTTK-MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA---- 232 (271)
T ss_dssp CCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC----
T ss_pred cCCcccccccccc-cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC----
Confidence 9999987654332 3567999999999997655 899999999999999999999999987766554443221100
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+++.+.+++.+||+.||++|||+.|++++
T Consensus 233 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 ------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 11223678999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=335.61 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=205.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 68999999999999999999876 5778999999765433 345678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
+| +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++........ .
T Consensus 86 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 75 577777543 334899999999999999999999999999999999999975 7999999999987654322 1
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 224 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL----------------- 224 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------
T ss_pred cCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-----------------
Confidence 2345678899999997655 8999999999999999999 99999988776665544322110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++.+.+++.+||+.||++|||+.+++++
T Consensus 225 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112468899999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=342.09 Aligned_cols=262 Identities=23% Similarity=0.387 Sum_probs=200.8
Q ss_pred CCceeecccccCCceEEEEEE----EcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 75 (356)
++|++.+.||+|+||+||+|+ +..+++.||+|++..........+.+|+.++++++||||+++++++... ..++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 589999999999999999998 6678999999999876655566778999999999999999999998643 5689
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~ 153 (356)
+||||+.+ +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 99999965 788877543 23489999999999999999999999999999999999997 47999999999987654
Q ss_pred CC----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH-H
Q 036550 154 FP----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD-G 228 (356)
Q Consensus 154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~ 228 (356)
.. ......+++.|+|||++.+.. ++.++|||||||++|+|++|..||...... .. ...+......... .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~---~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HH---HHHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HH---hhhcCccccchhHHH
Confidence 32 122345788899999997665 899999999999999999999998754321 11 1111111111110 1
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
........... .....+++++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111111111 123467899999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=344.21 Aligned_cols=244 Identities=17% Similarity=0.241 Sum_probs=201.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCC-------cEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG-------EVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||+||+|++..++ ..||+|++..........+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 68999999999999999999998877 47999999776656666778999999999999999999999999999
Q ss_pred EEEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-Cc--------EEEec
Q 036550 75 FFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GT--------IKIAD 144 (356)
Q Consensus 75 ~iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~--------~kL~D 144 (356)
++||||+. |+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999998 4787777543 234899999999999999999999999999999999999975 33 99999
Q ss_pred ccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 145 FGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 145 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
||++..... .....||+.|+|||++.+...++.++|||||||++|+|++| .+||............ ..
T Consensus 165 fg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~------- 233 (289)
T 4fvq_A 165 PGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-ED------- 233 (289)
T ss_dssp CCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HT-------
T ss_pred CcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hc-------
Confidence 999865433 23456899999999997756689999999999999999995 5566555443332221 11
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
... .....+.++.+++.+||+.||++|||+.++++|
T Consensus 234 ------------~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 ------------RHQ-----------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ------------TCC-----------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ------------cCC-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 011 112457789999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=353.72 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=204.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|.+..+++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 579999999999999999999999999999999876533 2334567899999999999999999999999999999999
Q ss_pred cc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--
Q 036550 81 MQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP-- 156 (356)
Q Consensus 81 ~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~-- 156 (356)
+. |+|.+.+... +..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++........
T Consensus 194 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 97 5677777533 334899999999999999999999999999999999999975 7999999999986543211
Q ss_pred -CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 157 -YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------- 332 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----------------- 332 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-----------------
T ss_pred cCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 11224577899999996655 8999999999999999998 999999877655544332211
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.. ..+..+++++.+++.+||..||++|||+.++++
T Consensus 333 ---~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 333 ---RL---------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 112356889999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=337.99 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=202.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 58999999999999999999876 6778999999765433 345678999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--CCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--PPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--~~~ 157 (356)
.| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++...... ...
T Consensus 102 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 65 67777653 2344999999999999999999999999999999999999976 69999999999765432 112
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 179 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------- 240 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------------- 240 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------
T ss_pred cCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-----------------
Confidence 3345788999999997665 8999999999999999998 99999988877666555432111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++.+.++|.+||+.||.+|||+.++++|
T Consensus 241 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 ------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1112568899999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=352.69 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=207.8
Q ss_pred CCceeecccccCCceEEEEEEEcC-------CCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-------SGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||+||+|++.. .+..||+|++..... .....+.+|+.+++++ +||||+++++++.+.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 579999999999999999999754 336799999876543 3335667899999999 9999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
..++||||+.| +|.+.+..... ....+++..++.++.||+.||.|||++||+||||||+|||+++ +
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence 99999999976 78888765431 1235899999999999999999999999999999999999975 7
Q ss_pred cEEEecccceeecCCC---CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAF---PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 307 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876543 2233456789999999996654 8999999999999999999 999999887666554443
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... ......+++++.+||.+||..||++|||+.+++++
T Consensus 308 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 308 EGHR-----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTCC-----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2110 01123678999999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=343.32 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=207.7
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||+||+|.+ ..+++.||+|++..... .....+.+|+.+++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5799999999999999999985 45788999999976543 3345667899999999 999999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh--------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ--------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||++||+||||||+||++++ +
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence 999999976 78888765432 1234899999999999999999999999999999999999975 7
Q ss_pred cEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.............
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 999999999987765432 22345788999999997655 8999999999999999999 999998876555444433
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....+ ......+..+.++|.+||..||.+|||+.+++++
T Consensus 262 ~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 262 KEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCC----------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 321110 1113568999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=344.02 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=206.7
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 57999999999999999999873 4568999999976543 33456678999999999999999999999999999
Q ss_pred EEEEecc-CCHHHHHHHHHh--------------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCee
Q 036550 76 FVFECMQ-CNLYQLMEAKKQ--------------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLL 134 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 134 (356)
+||||+. |+|.+.+..... ....+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 9999997 578888765432 1234899999999999999999999999999999999999
Q ss_pred eeC-CcEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 036550 135 VSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQ 209 (356)
Q Consensus 135 l~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 209 (356)
+++ +.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||........
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 985 6999999999987654322 23446788999999997654 8999999999999999999 9999988776554
Q ss_pred HHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...+.... .......+++++.++|.+||..||++|||+.+++++
T Consensus 262 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 FNLLKTGH-----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcCC-----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43332210 011123678999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=349.36 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=207.0
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|++. .+++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 57999999999999999999987 4558999999976543 33456688999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhh--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCee
Q 036550 76 FVFECMQC-NLYQLMEAKKQK--------------------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLL 134 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 134 (356)
+||||+.| +|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 206 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence 99999976 788887653211 256899999999999999999999999999999999999
Q ss_pred eeC-CcEEEecccceeecCCC---CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 036550 135 VSQ-GTIKIADFGLAREIDAF---PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQ 209 (356)
Q Consensus 135 l~~-~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 209 (356)
+++ +.+||+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+.
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 975 69999999999765432 2223456899999999997665 8999999999999999999 9999998877665
Q ss_pred HHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...+.... .......++.++.+++.+||..||++|||+.+++++
T Consensus 286 ~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 286 IYYVRDGN-----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCC-----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 55443210 011223678999999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=337.54 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=193.1
Q ss_pred CCceeecccccCCceEEEEEEEcCC---CcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+|+||+||+|.+..+ +..||+|++..... .....+.+|+.++++++||||+++++++ .++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence 5799999999999999999998654 45799999876433 3345567899999999999999999998 45678999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 999986 677776532 33589999999999999999999999999999999999997 5799999999998765432
Q ss_pred C--CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 P--YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+.....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-------------- 235 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------------- 235 (281)
T ss_dssp --------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------------
T ss_pred ccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC--------------
Confidence 2 23345788999999996655 8999999999999999996 9999998776665554432110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....+.+++.+.+++.+||..||++|||+.+++++
T Consensus 236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11224678999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=361.46 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=194.3
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
+|.+.+.||+|+||+|+. ....+|+.||||++..... ....+|+.+++.+ +||||+++++++.+.+..|+||||+
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 588999999999999764 4456899999999865432 2346899999999 7999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----C--cEEEecccceeecCCC-
Q 036550 82 QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----G--TIKIADFGLAREIDAF- 154 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~--~~kL~Dfg~a~~~~~~- 154 (356)
+|+|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||+|......
T Consensus 101 ~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 101 AATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp SEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 99988887632 233556677899999999999999999999999999999952 2 5889999999876533
Q ss_pred ---CCCccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 155 ---PPYTERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 155 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
......+||+.|+|||++.+ ...++.++|||||||++|+|++ |.+||.......... +. +....
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~---~~~~~------ 247 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LL---GACSL------ 247 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HT---TCCCC------
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-Hh---ccCCc------
Confidence 22345679999999999864 3346889999999999999999 999997654433211 10 10000
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
+. .......+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 248 -----------~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 248 -----------DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp -----------TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred -----------cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 00 00011235668999999999999999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=348.30 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=205.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+. +++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 68999999999999999999964 68999999987766555667789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC---C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP---P 156 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~---~ 156 (356)
.| +|.+.+.........+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++....... .
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 75 666665433222345899999999999999999999999999999999999975 699999999998754322 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+..... .|.... ...
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~----------~~~~~~----~~~ 262 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA----------EWAVES----HNN 262 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH----------HHTHHH----HTT
T ss_pred ccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH----------HHhhhc----ccc
Confidence 23456899999999997665 899999999999999999999999765432111000 000000 000
Q ss_pred ccCCCcc-cccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 237 YQFPQLS-GVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 237 ~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
..+.... ........+..+..+.+++.+||..||++|||+.+++++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0001000 0001112224467899999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=347.19 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=204.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEE--EEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVV--AIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||.||+|++..++..+ |+|.+.... ......+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999999888865 999886532 23344567899999999 899999999999999999999
Q ss_pred EEeccC-CHHHHHHHHH------------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEe
Q 036550 78 FECMQC-NLYQLMEAKK------------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIA 143 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~ 143 (356)
|||+.+ +|.+.+.... .....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 999965 7888776432 12346899999999999999999999999999999999999975 699999
Q ss_pred cccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 036550 144 DFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTM 222 (356)
Q Consensus 144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (356)
|||++.............+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~----- 258 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----- 258 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-----
T ss_pred ccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-----
Confidence 999997654433344556789999999996654 8999999999999999998 999999887655544332110
Q ss_pred cchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. ......+++++.+||.+||..||.+|||+.+++++
T Consensus 259 ---------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 ---------------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---------------C---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------C---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 01123568999999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=348.41 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=203.8
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||+||+|.+ ..+++.||+|++.... ......+.+|+.+++++ +||||+++++++.+.+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 5799999999999999999997 3466789999997543 23345567899999999 899999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhh-------------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCee
Q 036550 75 FFVFECMQC-NLYQLMEAKKQK-------------------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLL 134 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 134 (356)
++||||+.| +|.+.+...... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 999999965 788887643211 134799999999999999999999999999999999999
Q ss_pred eeC-CcEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 036550 135 VSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQ 209 (356)
Q Consensus 135 l~~-~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 209 (356)
++. +.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||........
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 985 7999999999987654332 12345788999999997655 8999999999999999998 9999988765554
Q ss_pred HHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
...+......+ ......++++.+||.+||..||.+|||+.++++|-
T Consensus 284 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 284 FYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 44433221110 11235689999999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=362.14 Aligned_cols=256 Identities=29% Similarity=0.408 Sum_probs=192.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEEEEec
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.|.+.+.||+|+||+||.+ ...+|+.||||++.... .....+|+.+++++ +||||+++++++.+.+.+|+||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4666799999999999875 45679999999986542 23457899999876 8999999999999999999999999
Q ss_pred cCCHHHHHHHHHhhccc---CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC--------------CcEEEec
Q 036550 82 QCNLYQLMEAKKQKQQL---FSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ--------------GTIKIAD 144 (356)
Q Consensus 82 ~g~l~~~~~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--------------~~~kL~D 144 (356)
+|+|.+.+......... .++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|
T Consensus 92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999888643321111 234456789999999999999999999999999999964 3799999
Q ss_pred ccceeecCCCCC-----CccccccccccChHHHhh------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036550 145 FGLAREIDAFPP-----YTERVGTRWYQAPEILFK------SGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYK 212 (356)
Q Consensus 145 fg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 212 (356)
||++........ ....+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||....... ..
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~ 249 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SN 249 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HH
Confidence 999988754321 234579999999999965 2458999999999999999999 999997655433 12
Q ss_pred HHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 213 ICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+.... +..+.... .....+++++.+||.+||..||.+|||+.++++||||..
T Consensus 250 i~~~~-------------------~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 250 IIRGI-------------------FSLDEMKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHTC-------------------CCCCCCTT----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HhcCC-------------------CCcccccc----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 21111 11111000 001134678999999999999999999999999999964
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=338.26 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=200.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEE-EEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKEL-IVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+.. ....+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 689999999999999999999999999999999865432 2346789999999988876655554 4667888999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEecccceeecCCCCC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~~~~~~~~ 156 (356)
++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 87 ~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 LGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred cCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 988888887632 34599999999999999999999999999999999999993 57999999999987754322
Q ss_pred --------CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCccch
Q 036550 157 --------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE---ADQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 157 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 225 (356)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+.....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 235 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM------- 235 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-------
T ss_pred ccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-------
Confidence 24567999999999986655 89999999999999999999999986432 122222221100
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..+ .......+++++.+++.+||+.||++|||+.++++
T Consensus 236 ------------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 ------------STP------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ------------HSC------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ------------CCc------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 000 01122367899999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=360.75 Aligned_cols=275 Identities=24% Similarity=0.366 Sum_probs=206.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC--eEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKG--NVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~iv~ 78 (356)
++|.+.+.||+|+||+||+|++..+|+.||+|++..... .......+|+.++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 479999999999999999999999999999999875432 22345578999999999999999999998765 789999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee----eC-CcEEEecccceeecC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV----SQ-GTIKIADFGLAREID 152 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~-~~~kL~Dfg~a~~~~ 152 (356)
||+.| +|.+.+.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +. +.+||+|||++....
T Consensus 89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99975 6777765332 22338999999999999999999999999999999999998 32 469999999999877
Q ss_pred CCCCCccccccccccChHHHhhC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCC
Q 036550 153 AFPPYTERVGTRWYQAPEILFKS-------GLYSSKVDMWAMGAIMAELLLFRPLFQGTD----EADQMYKICSVLGSPT 221 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~ 221 (356)
.........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... ..+.+.++........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 65555667899999999998652 347889999999999999999999997532 2344444433211111
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...+.........+...++. ...+...++..+.++|++||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-----~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPV-----SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CEEEECSTTCCEEEESSCCT-----TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred chhheeccCCCcccCccCCc-----ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 11000000000000001111 111223456788999999999999999999998553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=338.41 Aligned_cols=253 Identities=27% Similarity=0.501 Sum_probs=195.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccc---cchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKS---YSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 36899999999999999999999999999999998753 233445667899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+++.........+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999986 788888766656677999999999999999999999999999999999999974 799999999987665432
Q ss_pred -CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 -PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA--DQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+.. .
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--------------- 253 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-C--------------- 253 (310)
T ss_dssp --------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-T---------------
T ss_pred ccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-c---------------
Confidence 223457999999999986654 899999999999999999999999764321 11111111 0
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.++. .....++.++.++|.+||..||++|||+.+++++
T Consensus 254 -----~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 254 -----DYPP-------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -----CSCC-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----cCCC-------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1111 0113578999999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=343.34 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=207.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc-----EEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE-----VVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||+||+|.+..+++ .||+|++..... .....+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 579999999999999999999877664 799999876543 3345567899999999 899999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhh----------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEE
Q 036550 75 FFVFECMQC-NLYQLMEAKKQK----------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKI 142 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL 142 (356)
++||||+.+ +|.+.+...... ...+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 999999976 788888754331 345899999999999999999999999999999999999975 69999
Q ss_pred ecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 036550 143 ADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLG 218 (356)
Q Consensus 143 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 218 (356)
+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...........+.....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 284 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC
Confidence 99999987644322 22345788999999997655 8999999999999999998 9999988765554444433211
Q ss_pred CCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 219 SPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.+ ......+..+.++|.+||..||.+|||+.+++++
T Consensus 285 ~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 285 QM----------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC----------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 11 0112468899999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=338.10 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=207.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 57999999999999999999999999999999987653 33456778999999999999999999999999999999999
Q ss_pred c-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 Q-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
. ++|.+.+... ....+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++........ .
T Consensus 92 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 92 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp TTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred CCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 8 4787777542 2345899999999999999999999999999999999999965 6899999999986654322 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+.......+.....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------------------ 230 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------------ 230 (288)
T ss_dssp TTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------------
T ss_pred cCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC------------------
Confidence 2345788999999997665 8999999999999999999 9999988776554443322110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+++.+.+|+.+||..||.+|||+.++++
T Consensus 231 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0112367899999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=338.43 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=195.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
+++|.+.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999999999999999998765322 234567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999986 777776532 35899999999999999999999999999999999999974 799999999987665432
Q ss_pred --CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 156 --PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
......|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+ ... .
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~-~-------------- 251 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQA-I-------------- 251 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSC-C--------------
T ss_pred cccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccC-C--------------
Confidence 23355799999999998654 4899999999999999999999999876544222221 110 0
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-CHHHHhc
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-TAAEALQ 281 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-t~~e~l~ 281 (356)
.......+.++.++.++|.+||..||++|| |++++++
T Consensus 252 -----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 252 -----------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -----------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -----------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 001122346789999999999999999999 8888876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=343.34 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=207.7
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 57999999999999999999876 4678999999976543 33445678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhh------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 76 FVFECMQC-NLYQLMEAKKQK------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
+||||+.| +|.+.+...... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 99999975 788887654322 134799999999999999999999999999999999999975 6999999999
Q ss_pred eeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------ 257 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG------ 257 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC------
T ss_pred ccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC------
Confidence 976543221 22346789999999987655 8999999999999999999 899999887666554443210
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.......++..+.++|.+||..||++|||+.++++|
T Consensus 258 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 -----------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011123678999999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=349.72 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=195.8
Q ss_pred CCceeecccccCCceEEEEEEEcCC-----CcEEEEEEcccccchH-----------HhhhHHHHHHHHhCCCCCeeEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-----GEVVAIKALKKSYSRE-----------KCLNLREVKCLRKLNHPNIVKVK 65 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hp~iv~~~ 65 (356)
++|.+.+.||+|+||+||+|.+..+ ++.||+|++....... ......|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4799999999999999999998765 5889999986543211 11223466677888999999999
Q ss_pred EEEEEC----CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee---CC
Q 036550 66 ELIVEK----GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS---QG 138 (356)
Q Consensus 66 ~~~~~~----~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~ 138 (356)
+++... ...|+||||++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 998765 56899999997788888754 334599999999999999999999999999999999999996 47
Q ss_pred cEEEecccceeecCCCC--------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036550 139 TIKIADFGLAREIDAFP--------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQM 210 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 210 (356)
.+||+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 99999999998764321 113445999999999996655 899999999999999999999999864332222
Q ss_pred HHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 211 YKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.........+....+ .... ++ ...++.++.+++..||..||.+||++.++++
T Consensus 271 ~~~~~~~~~~~~~~~-------~~~~--~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASL-------MDKC--FP----------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHH-------HHHH--SC----------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHH-------HHHh--cc----------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 211111000000000 0000 00 1367899999999999999999999998876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=342.39 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=204.6
Q ss_pred CCceeecccccCCceEEEEEE----EcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEE--ECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIV--EKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~ 75 (356)
++|++.+.||+|+||.||+|+ +..+++.||+|++..........+.+|+.++++++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 589999999999999999998 56789999999998776666667789999999999999999999987 456789
Q ss_pred EEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCC
Q 036550 76 FVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~ 153 (356)
+||||++ ++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999995 56777775432 3489999999999999999999999999999999999996 57999999999987754
Q ss_pred CC----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 154 FP----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ..............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCERDVPALSRL 253 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC----CCHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hcccccccccHHHH
Confidence 32 223456888999999996655 899999999999999999999998754332111 00100000000111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 254 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 254 LELLEEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111111111 11234679999999999999999999999999653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=349.22 Aligned_cols=265 Identities=25% Similarity=0.295 Sum_probs=195.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC----eEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKG----NVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~iv 77 (356)
++|++.+.||+|+||+||+|++. ++.||+|++..... ......+|+.++++++||||+++++++.+.. .+++|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 57999999999999999999875 78999999876532 3334456999999999999999999998754 47999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC----------CcccccCCCCCeeeeC-CcEEEecc
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ----------GYFHRDLKPENLLVSQ-GTIKIADF 145 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~ivH~Dlkp~NIll~~-~~~kL~Df 145 (356)
|||+.+ +|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+|||++. +.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999976 77777743 2389999999999999999999999 9999999999999976 69999999
Q ss_pred cceeecCCCCC---CccccccccccChHHHhhC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 036550 146 GLAREIDAFPP---YTERVGTRWYQAPEILFKS----GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLG 218 (356)
Q Consensus 146 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 218 (356)
|++........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+...............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654322 3345799999999999763 2356688999999999999999999986543211111111111
Q ss_pred CCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 219 SPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.+....+.+.. ......+.... .......+.++.+||.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 256 HPSLEDMQEVV----VHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SCCHHHHHHHH----TTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhhh----hcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111111110 00000010000 0000122456999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=346.78 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=188.2
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEE--------CCe
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVE--------KGN 73 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--------~~~ 73 (356)
+|++.+.||+|+||+||+|++..+++.||+|++..........+.+|+.+++++. ||||+++++++.. ...
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 7999999999999999999999999999999987665555666789999999995 9999999999853 345
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC-CcEEEecccceee
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
++++|||++|+|.+.+.... ....+++..++.++.||+.||.|||++| |+||||||+|||+++ +.+||+|||++..
T Consensus 109 ~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 109 FLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 89999999999998886543 3345999999999999999999999999 999999999999976 7999999999987
Q ss_pred cCCCCCC-------------ccccccccccChHHHh--hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036550 151 IDAFPPY-------------TERVGTRWYQAPEILF--KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICS 215 (356)
Q Consensus 151 ~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 215 (356)
....... ....||+.|+|||++. ....++.++|||||||++|+|++|..||...........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--- 264 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG--- 264 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC---
Confidence 6543221 1456999999999984 334478899999999999999999999976543221110
Q ss_pred HhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
.+..+ .....+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 265 --------------------~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 --------------------KYSIP---------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------------------CCCC---------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred --------------------cccCC---------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 01111 11355778999999999999999999999999843
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=335.86 Aligned_cols=245 Identities=27% Similarity=0.364 Sum_probs=198.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHH-------hhhHHHHHHHHhCCCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK-------CLNLREVKCLRKLNHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 74 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++........ ..+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 689999999999999999999999999999999865432211 45678999999999999999999986555
Q ss_pred EEEEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC-Cc-----EEEecc
Q 036550 75 FFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ-GT-----IKIADF 145 (356)
Q Consensus 75 ~iv~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~-----~kL~Df 145 (356)
++||||+. |+|.+.+.. ....+++..++.++.||+.||+|||++| |+||||||+||+++. +. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 69999998 567666642 3446999999999999999999999999 999999999999964 33 999999
Q ss_pred cceeecCCCCCCccccccccccChHHHhh-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCc
Q 036550 146 GLAREIDAFPPYTERVGTRWYQAPEILFK-SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ--MYKICSVLGSPTM 222 (356)
Q Consensus 146 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~ 222 (356)
|++..... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||........ ...+... +.
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~--- 247 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GL--- 247 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CC---
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CC---
Confidence 99976543 3345689999999999843 33478899999999999999999999987654332 1111110 00
Q ss_pred cchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......+++.+.++|.+||..||.+|||+.++++
T Consensus 248 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 ------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01122467899999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=343.21 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=193.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEE----EEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVV----AIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~v----avK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++.+.||+|+||+||+|++..+++.+ |+|.+..... .....+.+|+.++++++||||+++++++.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57999999999999999999998887754 7777654322 33455678999999999999999999998765 667
Q ss_pred EEEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
|++++. |+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 778766 5677776532 345899999999999999999999999999999999999975 79999999999876543
Q ss_pred CC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+.....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------ 237 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER------------ 237 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------
T ss_pred cccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC------------
Confidence 22 22345688999999997665 8999999999999999999 9999988776554433322110
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.......+.++.+++.+||..||.+|||+.+++++
T Consensus 238 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 -----------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01123568899999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=337.07 Aligned_cols=244 Identities=28% Similarity=0.409 Sum_probs=204.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-----------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE----------- 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------- 70 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46999999999999999999999999999999987543 345789999999999999999998864
Q ss_pred -----CCeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEe
Q 036550 71 -----KGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIA 143 (356)
Q Consensus 71 -----~~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~ 143 (356)
...+++||||+++ +|.+.+... ....+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 4568999999986 788887643 2345899999999999999999999999999999999999975 799999
Q ss_pred cccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 144 DFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .....+..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~-------- 233 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD-------- 233 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--------
T ss_pred cchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc--------
Confidence 999998887655556678999999999986654 8999999999999999999998874211 11111100
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
......++..+.++|.+||..||.+|||+.++++|.+.-
T Consensus 234 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 234 ------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001135688999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=344.07 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=197.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcE----EEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV----VAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++.+.||+|+||+||+|++..+++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 6899999999999999999999888876 6777664432 222234568999999999999999999886 566889
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 9999874 67777653 2345899999999999999999999999999999999999965 79999999999876443
Q ss_pred C---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 P---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+.....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 235 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER------------ 235 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB------------
T ss_pred cccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------------
Confidence 2 223456888999999997665 8999999999999999999 9999998776555443322100
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.......+.++.+++.+||..||.+|||+.+++++
T Consensus 236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -----------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01112457789999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.69 Aligned_cols=249 Identities=23% Similarity=0.278 Sum_probs=197.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEE-EEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKEL-IVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.+++.+.|++++..+.. +...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 58999999999999999999999999999999865442 22346789999999988776665554 4677889999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeee---e-CCcEEEecccceeecCCCCC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV---S-QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~-~~~~kL~Dfg~a~~~~~~~~ 156 (356)
++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++........
T Consensus 87 ~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 LGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred cCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 988888887632 3448999999999999999999999999999999999999 3 47899999999987754322
Q ss_pred --------CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccch
Q 036550 157 --------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 157 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 225 (356)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 234 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------- 234 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH--------
T ss_pred CccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc--------
Confidence 23567999999999996655 899999999999999999999999865432 1122211110
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...+ .......+++++.++|.+||+.||++|||+.++++
T Consensus 235 -----------~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 -----------MSTP------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------HHSC------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------ccch------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0000 11122367899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=348.92 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=192.7
Q ss_pred CCceeecccccCCceEEEEEEEc---CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||+||+|++. .++..||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47999999999999999999876 4677899999976533 3345678999999999999999999999999999999
Q ss_pred EEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+. |+|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 125 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99996 577777653 2345899999999999999999999999999999999999975 799999999998765432
Q ss_pred C----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 P----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~------------ 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------------ 268 (373)
T ss_dssp ------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE------------
T ss_pred ccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 1 11224577899999997655 8999999999999999998 9999988776665544432111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.+ ....++..+.+++.+||+.||.+|||+.++++
T Consensus 269 --------~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 --------LP---------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------CC---------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CC---------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11 11256889999999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=343.35 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=204.9
Q ss_pred CCceeecccccCCceEEEEEE-----EcCCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV-----NKHSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.+.||+|+||.||+|+ +..+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..|
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 589999999999999999998 55678899999997543 334456678999999999999999999999999999
Q ss_pred EEEEecc-CCHHHHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccc
Q 036550 76 FVFECMQ-CNLYQLMEAKKQK---QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~-g~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~ 147 (356)
+||||+. |+|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+|||+
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 9999995 5788887654321 134899999999999999999999999999999999999973 3699999999
Q ss_pred eeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+....... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----- 263 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR----- 263 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC-----
Confidence 87553321 223456899999999997655 8999999999999999998 9999998776655544432110
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
......++..+.++|.+||..||.+|||+.++++|.|+.
T Consensus 264 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 ------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 011236789999999999999999999999999998874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=344.44 Aligned_cols=252 Identities=24% Similarity=0.436 Sum_probs=202.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE----CCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE----KGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~iv 77 (356)
++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.. ....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 479999999999999999999999999999999876655566677899999999999999999999873 3478999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+.........+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++.......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 999986 788888776666677999999999999999999999999999999999999965 799999999987653211
Q ss_pred C----------CccccccccccChHHHhhCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCC
Q 036550 156 P----------YTERVGTRWYQAPEILFKSG--LYSSKVDMWAMGAIMAELLLFRPLFQGTDEA--DQMYKICSVLGSPT 221 (356)
Q Consensus 156 ~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~ 221 (356)
. .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... .....+
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------- 260 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-------- 260 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH--------
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh--------
Confidence 1 12335799999999985432 2688999999999999999999999531100 000000
Q ss_pred ccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+ ....++..+.++|.+||..||.+|||+.+++++
T Consensus 261 ------------~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 261 ------------QNQLSIP---------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------HCC--CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------hccCCCC---------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0011111 123678999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=344.44 Aligned_cols=256 Identities=19% Similarity=0.198 Sum_probs=193.6
Q ss_pred CCceeecccccCCceEEEEEEEcC---CCcEEEEEEcccccchH-----------HhhhHHHHHHHHhCCCCCeeEEeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH---SGEVVAIKALKKSYSRE-----------KCLNLREVKCLRKLNHPNIVKVKEL 67 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hp~iv~~~~~ 67 (356)
++|.+.+.||+|+||+||+|.+.. ++..||+|++....... .....+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 78899999987653211 1224568889999999999999999
Q ss_pred EEE----CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C--cE
Q 036550 68 IVE----KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G--TI 140 (356)
Q Consensus 68 ~~~----~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~--~~ 140 (356)
+.. .+..|+||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. + .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 988 678999999997788887643 235999999999999999999999999999999999999975 4 89
Q ss_pred EEecccceeecCCCC--------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHH
Q 036550 141 KIADFGLAREIDAFP--------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD-EADQMY 211 (356)
Q Consensus 141 kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~ 211 (356)
||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999998764321 114457999999999987654 8999999999999999999999996532 222221
Q ss_pred HHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 212 KICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.............+... .....++.++.++|.+||..||++|||++++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKW--------------------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHTTTHHHHHH--------------------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhcccccHHHHhh--------------------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11111100000000000 0012578999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=345.43 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=202.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|++. +|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 108 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence 68999999999999999999754 6899999998765432 223567899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ---GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
+.| +|.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||+++ +.+||+|||++.......
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188 (326)
T ss_dssp CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc
Confidence 976 78787765555556699999999999999999999999 9999999999999986 599999999998765332
Q ss_pred C--CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 156 P--YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
. .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ........+......
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 189 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLA-----------NDDDVMLLDWVKGLL 256 (326)
T ss_dssp SCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHT-----------TTSCSBHHHHHTTTT
T ss_pred ccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccc-----------cccchhHHHHHHHHh
Confidence 2 23456999999999997665 899999999999999999999999621100 000000000000000
Q ss_pred hhcccCCCc-ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 234 AINYQFPQL-SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 234 ~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
.. ...... ............+..+.+++.+||+.||.+|||+.++++|-.
T Consensus 257 ~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 257 KE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00 000000 000001112234578999999999999999999999999854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=329.74 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=204.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 57999999999999999999986 6788999999765433 345688999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--CCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--PPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--~~~ 157 (356)
.| +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++...... ...
T Consensus 86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 75 677776532 345899999999999999999999999999999999999965 79999999998765431 112
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||...........+......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~----------------- 224 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------- 224 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------------
T ss_pred ccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-----------------
Confidence 3446788999999997655 8999999999999999999 89999988776655544322110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+..+.+++.+||..||++|||+.+++++
T Consensus 225 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 ------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1112568899999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=333.16 Aligned_cols=262 Identities=24% Similarity=0.409 Sum_probs=200.5
Q ss_pred CCceeecccccCCceEEEEEE----EcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 74 (356)
++|++.+.||+|+||.||+|+ +..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 468999999999999999998 577899999999875432 2234567899999999999999999999876 678
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~ 152 (356)
++||||+.+ +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999976 777777533 23489999999999999999999999999999999999996 5799999999998776
Q ss_pred CCCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AFPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.... .....||..|+|||++.+.. ++.++|||||||++|+|++|..|+..... ......+..........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCHHH
Confidence 5432 23456888999999997665 78999999999999999999998653211 11111122211111111
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......... ......+++++.+||.+||..||.+|||+.++++
T Consensus 252 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1111111111 1123467899999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.79 Aligned_cols=245 Identities=19% Similarity=0.285 Sum_probs=201.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~i 76 (356)
+++|.+.+.||+|+||+||+|++. ++.||+|++.... ......+.+|+.++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 368999999999999999999875 8899999987653 23345678899999999999999999999877 78899
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
||||+.| +|.+.+... ....+++..++.++.||+.||.|||++| |+||||||+||++++ +.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999975 788877532 2235899999999999999999999999 999999999999986 689999888876533
Q ss_pred CCCCCccccccccccChHHHhhCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGL--YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. ....||+.|+|||++.+... ++.++|||||||++|+|++|..||......+....+......
T Consensus 165 ~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 229 (271)
T 3kmu_A 165 S----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR----------- 229 (271)
T ss_dssp C----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----------
T ss_pred c----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----------
Confidence 2 34578999999999976431 333799999999999999999999988776655544332111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+++++.+++.+||..||++|||+.++++
T Consensus 230 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -----------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122367899999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=340.43 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=205.2
Q ss_pred CCceeecccccCCceEEEEEEEc-------CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-------HSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||+||+|.+. .++..||+|++..... .....+.+|+.+++++ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 58999999999999999999975 4677899999976543 3345567899999999 8999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
..++||||+.| +|.+++..... ....+++..++.++.||+.||.|||++||+||||||+||+++. +
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence 99999999976 78887764321 1234899999999999999999999999999999999999974 7
Q ss_pred cEEEecccceeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 273 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence 999999999987754322 23446788999999997655 8999999999999999999 999999887666554443
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.... ......++.++.++|.+||..||.+|||+.+++++
T Consensus 274 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 274 EGHR-----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC-----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2210 01123678999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=339.31 Aligned_cols=252 Identities=25% Similarity=0.440 Sum_probs=203.7
Q ss_pred CCceeecccccCCceEEEEEEE-----cCCCcEEEEEEcccccch-HHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC-e
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVN-----KHSGEVVAIKALKKSYSR-EKCLNLREVKCLRKL-NHPNIVKVKELIVEKG-N 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~ 73 (356)
++|.+.+.||+|+||+||+|.+ ..+++.||+|++...... ....+.+|+.+++++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 5899999999999999999985 457789999999765433 344567899999999 7999999999987754 5
Q ss_pred EEEEEEeccC-CHHHHHHHHHhh------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-Cc
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQK------------QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GT 139 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~ 139 (356)
+++||||+.| +|.+.+...... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence 8999999986 788877643321 122789999999999999999999999999999999999974 79
Q ss_pred EEEecccceeecCCCCCC---ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036550 140 IKIADFGLAREIDAFPPY---TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICS 215 (356)
Q Consensus 140 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 215 (356)
+||+|||++......... ....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||..............
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 265 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence 999999999876543221 2346789999999997655 8999999999999999998 9999987765444333222
Q ss_pred HhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....+ ......++++.++|.+||..||.+|||+.++++|
T Consensus 266 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 266 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCccC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11110 1123568899999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=329.64 Aligned_cols=249 Identities=25% Similarity=0.344 Sum_probs=203.7
Q ss_pred CCceeec-ccccCCceEEEEEEEc--CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTK-KLGSGSFGCVWQAVNK--HSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~-~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+ .||+|+||+||+|.+. .++..||+|++..... .....+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4677776 9999999999999854 4688899999977533 3445667899999999999999999999 56678999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999986 6766664 2334589999999999999999999999999999999999996 4799999999998775432
Q ss_pred C----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 P----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~------------- 230 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------------- 230 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-------------
T ss_pred ceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-------------
Confidence 2 22345689999999996655 8999999999999999998 999999877666554443210
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 284 (356)
.......+++++.++|.+||..||++|||+.+++++.+
T Consensus 231 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 231 ----------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01122367899999999999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=351.56 Aligned_cols=242 Identities=23% Similarity=0.402 Sum_probs=199.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC-eEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKG-NVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~iv~e~ 80 (356)
++|.+.+.||+|+||+||+|.+. |+.||||+++... ....+.+|+.+|++++||||+++++++...+ .+++||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 57999999999999999999875 7899999997653 3456789999999999999999999987765 79999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
+.+ +|.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++....... .
T Consensus 269 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~ 344 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 344 (450)
T ss_dssp CTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--c
Confidence 975 7888876432 233799999999999999999999999999999999999975 799999999998654322 2
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 345 ~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------------------- 403 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------------- 403 (450)
T ss_dssp --CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--------------------
T ss_pred CCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence 346788999999996654 8999999999999999998 999998876655544432211
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. ...+..+++++.++|.+||..||.+|||+.++++
T Consensus 404 ~---------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 K---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 0112367899999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.40 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=206.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+|++++||||+++++++.+.+.+++||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 468999999999999999999999999999999976533 3456789999999999999999999999999999999999
Q ss_pred c-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CC
Q 036550 82 Q-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PY 157 (356)
Q Consensus 82 ~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~ 157 (356)
. |+|.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++....... ..
T Consensus 299 ~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 299 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp TTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 8 5788877542 2244899999999999999999999999999999999999975 799999999998765322 12
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+++.|+|||++.... ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 377 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------- 436 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------------- 436 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------------------
T ss_pred CCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 2345678999999996655 8999999999999999999 999999877655443332210
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.. ..+..+++.+.+||.+||+.||++|||+.++++
T Consensus 437 -~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 -RM---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CC---------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 10 112367899999999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=330.78 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=198.7
Q ss_pred CCceeecccccCCceEEEEEEEcC---CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH---SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 589999999999999999998653 345699999876533 344566789999999999999999999865 456899
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 999985 677776532 344899999999999999999999999999999999999964 799999999998765432
Q ss_pred --CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 --PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------------- 233 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------------- 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-------------
T ss_pred ccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-------------
Confidence 123446788999999996655 8999999999999999998 99999877665554443321110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....+++.+.++|.+||..||++|||+.+++++
T Consensus 234 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ----------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1123568999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=336.49 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=197.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCC----cEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG----EVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.+.||+|+||+||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 57899999999999999999876553 4699999876543 334456789999999999999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
||||+.| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999987 67777653 2345899999999999999999999999999999999999975 69999999999876542
Q ss_pred CC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 155 PP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 155 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---------- 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---------- 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred cccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC----------
Confidence 21 12234678999999986554 8999999999999999999 99999887766655444322110
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
.....++..+.+++.+||..||++|||+.+++++
T Consensus 270 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 -------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112568899999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=335.15 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=194.6
Q ss_pred CCceeecccccCCceEEEEEEEcC---CCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC----
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH---SGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKG---- 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 72 (356)
++|.+.+.||+|+||+||+|.+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 579999999999999999998765 56689999987553 233455678999999999999999999997654
Q ss_pred -eEEEEEEeccC-CHHHHHHHHH--hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 73 -NVFFVFECMQC-NLYQLMEAKK--QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 73 -~~~iv~e~~~g-~l~~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
..++||||+.+ +|.+.+.... .....+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 45999999986 6777775432 23355999999999999999999999999999999999999976 6999999999
Q ss_pred eeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
+....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||...........+.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 267 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR----- 267 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----
T ss_pred ceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-----
Confidence 98764332 223346788999999996554 8999999999999999999 9999988776655444432110
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+++.+.++|.+||..||.+|||+.+++++
T Consensus 268 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11123678999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=338.33 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=193.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEE----EEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVV----AIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~v----avK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++.+.||+|+||+||+|++..+++.| |+|.+.... ......+.+|+.+++.++||||+++++++...+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 68999999999999999999998888765 666554332 233456678999999999999999999998765 677
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
|++++.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 7787664 677776542 345899999999999999999999999999999999999965 79999999999876433
Q ss_pred CC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+.....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~------------ 237 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER------------ 237 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------
T ss_pred cccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 22 22345688999999997665 8999999999999999999 9999998776555443322110
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......++.++.++|++||..||.+|||+.++++.
T Consensus 238 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 238 -----------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01123568899999999999999999999999973
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=330.27 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=189.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.++||+|+||+||+|.+.. .||+|++.... ......+.+|+.++++++||||++++++. ..+..++|||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 579999999999999999997543 59999987543 23345567899999999999999999954 5567899999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC---C
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA---F 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~---~ 154 (356)
|+.| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++..... .
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9975 66666532 2345899999999999999999999999999999999999975 7999999999976543 2
Q ss_pred CCCccccccccccChHHHh--hCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 155 PPYTERVGTRWYQAPEILF--KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.......||+.|+|||++. ....++.++|||||||++|+|++|..||......+............+
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 245 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP----------- 245 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----------
Confidence 2234457999999999985 234478899999999999999999999998776665544433211110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
........+++.+.+||.+||..||.+|||+.++++
T Consensus 246 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 -------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111223467899999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=329.89 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=199.0
Q ss_pred CCceeec-ccccCCceEEEEEE--EcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTK-KLGSGSFGCVWQAV--NKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~-~ig~G~~g~V~~~~--~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|.+.+ .||+|+||+||+|. +..+++.||+|++..... .....+.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4688888 99999999999995 456789999999876532 2245667899999999999999999999 6678899
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~ 154 (356)
||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999975 67777753 33489999999999999999999999999999999999996 579999999999877543
Q ss_pred CCC----ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 155 PPY----TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 155 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
... ....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------ 237 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------ 237 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred CCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 221 2234678999999996655 8899999999999999999 999999887665544432210
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......+++.+.++|.+||..||.+|||+.++++
T Consensus 238 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 -----------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01122367899999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=350.99 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=202.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+. ++..||||+++.... ....+.+|+.+|++++||||+++++++. .+..++||||+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 57899999999999999999886 477899999976542 3456789999999999999999999986 66789999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--CCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--PPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--~~~ 157 (356)
.+ +|.+.+.... ...+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||++...... ...
T Consensus 265 ~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 265 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp TTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 75 7888876432 234899999999999999999999999999999999999985 69999999999866432 112
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+++.|+|||++.... ++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 343 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------------- 404 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM----------------- 404 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-----------------
T ss_pred CCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 2345678999999996655 8999999999999999999 99999988776665554332111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
+ .+..+++++.++|.+||..||++|||++++++
T Consensus 405 ---~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 ---P---------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---C---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1 11357899999999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=328.53 Aligned_cols=242 Identities=23% Similarity=0.402 Sum_probs=193.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-CeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK-GNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~iv~e~ 80 (356)
++|++.+.||+|+||+||+|.+. |+.||+|++.... ....+.+|+.++++++||||+++++++... +..++||||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 68999999999999999999764 8899999987643 334567899999999999999999987554 578999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
+.+ +|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++....... .
T Consensus 97 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 172 (278)
T ss_dssp CTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--c
Confidence 976 78888765432 23899999999999999999999999999999999999974 799999999987665432 3
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
...+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+....
T Consensus 173 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------------- 231 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------------- 231 (278)
T ss_dssp ---CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------------
T ss_pred CCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------------
Confidence 346789999999997655 8999999999999999998 999998776655443332110
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......+++.+.++|.+||+.||++|||+.++++
T Consensus 232 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ---------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01122367899999999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=342.64 Aligned_cols=253 Identities=15% Similarity=0.200 Sum_probs=198.4
Q ss_pred CCceeecccccCCceEEEEEEEcCC--------CcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeE----------
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS--------GEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK---------- 63 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~---------- 63 (356)
++|.+.+.||+|+||+||+|++..+ ++.||+|++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5899999999999999999999874 889999998654 34578999999999998887
Q ss_pred -----EeEEEEE-CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC
Q 036550 64 -----VKELIVE-KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ 137 (356)
Q Consensus 64 -----~~~~~~~-~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 137 (356)
+++++.. .+..++||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 6777776 68899999999888998886432 345999999999999999999999999999999999999987
Q ss_pred C---cEEEecccceeecCCCC--------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 036550 138 G---TIKIADFGLAREIDAFP--------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD- 205 (356)
Q Consensus 138 ~---~~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~- 205 (356)
+ .+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 5 79999999997664321 123457999999999986654 8999999999999999999999998764
Q ss_pred hHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 206 EADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
................ ..++. .......++.++.+||.+||..||++|||++++++.
T Consensus 274 ~~~~~~~~~~~~~~~~---------------~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKP---------------GPFVG-----PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp CHHHHHHHHHHHHHSC---------------CCEEC-----TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CHHHHHHHHHhccCCh---------------hhhhh-----hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 2222222211110000 00000 000112568999999999999999999999999763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=350.74 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=201.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCC-CCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH-PNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|.+.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.| ++|+.+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 689999999999999999999999999999998765432 2346789999999976 5666677777788899999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEecccceeecCCCCC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~~~~~~~~ 156 (356)
++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 85 ~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 LGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp CCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 988998888643 33499999999999999999999999999999999999993 47999999999987754322
Q ss_pred --------CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccch
Q 036550 157 --------YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMDSW 225 (356)
Q Consensus 157 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 225 (356)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ..+..+.......
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT----- 235 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-----
T ss_pred ccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-----
Confidence 22567999999999997655 899999999999999999999999875432 2222222111000
Q ss_pred HHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 226 ADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
....+...++.++.+||..||..||.+||++.++++
T Consensus 236 --------------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 --------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001112367899999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=325.66 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=201.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 57999999999999999999875 577899999876532 3455678999999999999999999886 45689999999
Q ss_pred c-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CC
Q 036550 82 Q-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PY 157 (356)
Q Consensus 82 ~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~ 157 (356)
. ++|.+.+.... ...+++..+..++.||+.||+|||++||+||||||+||++++ +.+||+|||++....... ..
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 6 57777765322 234899999999999999999999999999999999999976 699999999998775432 12
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 168 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 228 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------------ 228 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred cCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC------------------
Confidence 2345788999999996554 8999999999999999999 9999998877665544432110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++.++.+++.+||..||++|||+.++++
T Consensus 229 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 -----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112367899999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.90 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=193.2
Q ss_pred CCceeecccccCCceEEEEEEEcC-CCc--EEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-SGE--VVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|++.+.||+|+||+||+|++.. +++ .||+|++.... ......+.+|+.++++++||||+++++++.+.+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 579999999999999999998643 333 69999987542 234456678999999999999999999997765 78
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~ 153 (356)
+||||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+|+||||+||+++ ++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999874 777777643 24489999999999999999999999999999999999996 57999999999987754
Q ss_pred CCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 154 FPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 154 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 243 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--------- 243 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC---------
T ss_pred cccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC---------
Confidence 322 22346788999999996655 7999999999999999999 99999988776655544321110
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .....++.++.++|.+||..||.+|||+.+++++
T Consensus 244 ----------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 244 ----------L---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ----------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------C---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 1123678999999999999999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=328.50 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=196.6
Q ss_pred CceeecccccCCceEEEEEEEcCC---CcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEE-ECCeEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIV-EKGNVFFV 77 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~iv 77 (356)
+|.+.+.||+|+||+||+|.+..+ ...||+|.+..... .....+.+|+.++++++||||+++++++. .++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 689999999999999999987543 34689999876443 33455678999999999999999999864 45688999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
|||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 106 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999987 67777642 3345899999999999999999999999999999999999976 69999999999866432
Q ss_pred ----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 155 ----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~----------- 250 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------- 250 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-----------
T ss_pred hhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-----------
Confidence 1223456788999999997665 8999999999999999999 6788877665554444332111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......++..+.+++.+||..||.+|||+.++++
T Consensus 251 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 ------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=332.92 Aligned_cols=238 Identities=29% Similarity=0.485 Sum_probs=186.8
Q ss_pred CCCceee-cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHH-HhCCCCCeeEEeEEEEE----CCeE
Q 036550 1 MEKYSLT-KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCL-RKLNHPNIVKVKELIVE----KGNV 74 (356)
Q Consensus 1 ~~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~----~~~~ 74 (356)
+++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.. .+..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3678887 7899999999999999999999999998643 2346788888 56699999999999987 6789
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEeccccee
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAR 149 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~ 149 (356)
++||||+.| +|.+.+... ....+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999976 788877643 223589999999999999999999999999999999999997 4689999999987
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.... ..++.++|||||||++|+|++|.+||...........+...
T Consensus 169 ~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~------------- 213 (299)
T 3m2w_A 169 ETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------------- 213 (299)
T ss_dssp ECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-------------
T ss_pred cccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-------------
Confidence 5432 22688999999999999999999999765533211000000
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
.......++ ......+++++.+||.+||..||++|||+.|+++||||++..
T Consensus 214 --~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 214 --IRMGQYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp --SCTTCCSSC-------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred --HhhccccCC-------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 000000010 011146799999999999999999999999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=368.31 Aligned_cols=279 Identities=25% Similarity=0.378 Sum_probs=206.6
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE------CCe
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVE------KGN 73 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 73 (356)
+++|.+.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3689999999999999999999999999999999876533 334556789999999999999999998755 677
Q ss_pred EEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC----cEEEecccce
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG----TIKIADFGLA 148 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----~~kL~Dfg~a 148 (356)
.++||||+.| +|.+.+.... ....+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||++
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 8999999965 6777765322 22358999999999999999999999999999999999999753 4999999999
Q ss_pred eecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 149 REIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.............. ....... .
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~~~~--~ 245 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHI--V 245 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------C--C
T ss_pred cccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccchhh--h
Confidence 9887666666778999999999986554 89999999999999999999999987543321100000 0000000 0
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..........++... .....+...+++.+.+||.+||.+||++|||+.++++||||+.
T Consensus 246 ~~~~l~g~~~~~~~l-p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVL-PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSS-CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhcccccccccc-CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000000011111100 0011223356789999999999999999999999999999964
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=330.32 Aligned_cols=242 Identities=30% Similarity=0.527 Sum_probs=188.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.+.||+|+||+||+|.+. ++.||+|++... .....+.+|+.++++++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 58999999999999999999874 788999998654 33456688999999999999999999875 4578999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh---CCcccccCCCCCeeeeC-Cc-EEEecccceeecCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ---QGYFHRDLKPENLLVSQ-GT-IKIADFGLAREIDAFP 155 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~-~~-~kL~Dfg~a~~~~~~~ 155 (356)
.| +|.+.+... .....+++..+..++.||+.||+|||+ +||+||||||+||+++. +. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 75 677776532 222347899999999999999999999 89999999999999976 44 899999999766542
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCccchHHHhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ--MYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+.. +
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~--------------- 220 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--G--------------- 220 (307)
T ss_dssp ------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--T---------------
T ss_pred -cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--C---------------
Confidence 23457999999999986554 89999999999999999999999986543221 111110 0
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .......++..+.+++.+||..||++|||+.+++++
T Consensus 221 ----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 221 ----T--------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ----C--------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----C--------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 011224678999999999999999999999999883
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=347.84 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=201.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.++||+|+||+||+|.+.. +..||+|+++.... ....+.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 468999999999999999999875 46799999976543 23467899999999999999999999866 6789999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~ 157 (356)
.+ +|.+.+.... +..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++....... ..
T Consensus 261 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 261 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred cCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 75 7888875432 234899999999999999999999999999999999999975 699999999998764321 12
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+++.|+|||++.... ++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 339 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------ 399 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------ 399 (452)
T ss_dssp ----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred cCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 2345778999999997655 8999999999999999999 9999998877666554432211
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc--CCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ--HPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~ 287 (356)
. ..+..+++.+.++|.+||..||++|||++++++ ..++..
T Consensus 400 --~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 --M---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --C---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0 112367899999999999999999999999987 466643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=326.17 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=197.0
Q ss_pred CceeecccccCCceEEEEEEEcCCCc---EEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeE-EEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNV-FFV 77 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-~iv 77 (356)
+|.+.+.||+|+||+||+|.+..++. .||+|++..... .....+.+|+.++++++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 36677999999999999999765544 799999876543 3345667899999999999999999999876655 899
Q ss_pred EEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 78 FECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 78 ~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
|||+. |+|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++......
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99885 567777643 3455899999999999999999999999999999999999976 69999999999755331
Q ss_pred ----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 155 ----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------- 246 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR----------- 246 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-----------
T ss_pred ccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-----------
Confidence 2233457899999999996554 8999999999999999999 5566666655544433322110
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
......+++.+.+++.+||..||.+|||+.++++.
T Consensus 247 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 247 ------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123568899999999999999999999998863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=331.78 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=202.9
Q ss_pred CCceeecccccCCceEEEEEE----EcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 75 (356)
++|++.+.||+|+||.||+|+ +..+++.||+|++..........+.+|+.++++++||||+++++++... ...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 469999999999999999998 4678999999999876666666778999999999999999999998654 3789
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~ 153 (356)
+||||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 99999975 788777543 23489999999999999999999999999999999999997 57999999999987754
Q ss_pred CCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchH-HH
Q 036550 154 FPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA-DG 228 (356)
Q Consensus 154 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~ 228 (356)
... .....++..|+|||++.+.. ++.++|||||||++|+|++|..||..... .. ....+......+. ..
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhccccchhhhHHH
Confidence 332 22345788899999997665 89999999999999999999999864321 11 1111211111110 01
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
........... .....++.++.++|.+||..||++|||+.++++
T Consensus 272 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111111 122467899999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=331.74 Aligned_cols=259 Identities=23% Similarity=0.326 Sum_probs=198.1
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEccccc----chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
|...+.||+|+||+||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999975 68899999986532 2334556789999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC-
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP- 156 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~- 156 (356)
|+.| +|.+.+... .....+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++........
T Consensus 111 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp CCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred ecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9964 677776532 33456899999999999999999999999999999999999976 6999999999987654322
Q ss_pred --CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 157 --YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
.....||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+........ ..+.+..
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----- 261 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE-KTIEDYI----- 261 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-CCHHHHS-----
T ss_pred ccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-hhhhhhc-----
Confidence 234579999999998854 378999999999999999999999987654332222211111000 0000000
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...........+..+.+++.+||..||.+|||+.+++++
T Consensus 262 ---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 262 ---------DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---------CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000111112345689999999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=350.66 Aligned_cols=248 Identities=19% Similarity=0.209 Sum_probs=192.5
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchH---HhhhHHHHHHHHhCCC-CCe-----------------
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE---KCLNLREVKCLRKLNH-PNI----------------- 61 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h-p~i----------------- 61 (356)
+|.+.+.||+|+||+||+|++..+|+.||||++....... ...+.+|+.+++.+.| +|.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4788899999999999999999999999999987443222 3456789999999976 211
Q ss_pred ----eEEeEEEEE-----CCeEEEEEEeccCCHHHHHHHH---HhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 036550 62 ----VKVKELIVE-----KGNVFFVFECMQCNLYQLMEAK---KQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLK 129 (356)
Q Consensus 62 ----v~~~~~~~~-----~~~~~iv~e~~~g~l~~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 129 (356)
..+..++.. ...++++|+++.++|.+++... ......+++..+..++.||+.||+|||++||+|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 111111221 2357899999999999888643 2234557888999999999999999999999999999
Q ss_pred CCCeeeeC-CcEEEecccceeecCCCCCCccccccccccChHHHh---------hCCCCCCchhHHHHHHHHHHHHhCCC
Q 036550 130 PENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF---------KSGLYSSKVDMWAMGAIMAELLLFRP 199 (356)
Q Consensus 130 p~NIll~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g~~ 199 (356)
|+|||++. +.+||+|||++...... ....+| +.|+|||++. ....++.++|||||||++|+|++|+.
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999975 69999999999876543 345678 9999999994 33347889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH
Q 036550 200 LFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA 279 (356)
Q Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 279 (356)
||...+....... .+ .....+++++.+||.+||..||++|||+.++
T Consensus 316 Pf~~~~~~~~~~~-------------------------~~---------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 316 PNTDDAALGGSEW-------------------------IF---------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp CCCTTGGGSCSGG-------------------------GG---------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcchhhhHHH-------------------------HH---------hhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9986543211000 00 0112578999999999999999999999999
Q ss_pred hcCCCCCC
Q 036550 280 LQHPFFKR 287 (356)
Q Consensus 280 l~hp~~~~ 287 (356)
++||||++
T Consensus 362 l~~~~~~~ 369 (413)
T 3dzo_A 362 METPEYEQ 369 (413)
T ss_dssp TTSHHHHH
T ss_pred HhCHHHHH
Confidence 99999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=333.38 Aligned_cols=248 Identities=20% Similarity=0.312 Sum_probs=198.4
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
.++|.+.+.||+|+||+||+|.+.. .||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 3689999999999999999998764 399999875432 22234567999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCC----
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDA---- 153 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~---- 153 (356)
||+.| +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||+++++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp BCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC--------
T ss_pred ecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccccccc
Confidence 99975 67666642 23458999999999999999999999999999999999999999999999999875432
Q ss_pred --CCCCccccccccccChHHHhh--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 154 --FPPYTERVGTRWYQAPEILFK--------SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 154 --~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
........||+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+......
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 261 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP---- 261 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC----
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC----
Confidence 122334569999999999864 234788999999999999999999999988776655444321110
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
. .....++.++.+++.+||..||.+|||+.++++.
T Consensus 262 -----------------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 262 -----------------N-------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp -----------------C-------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred -----------------C-------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 0112467899999999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=325.05 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=188.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHh--CCCCCeeEEeEEEEEC----CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK--LNHPNIVKVKELIVEK----GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~----~~~~ 75 (356)
++|.+.+.||+|+||+||+|++ +++.||+|++.... .....+|.+++.. ++||||+++++++... +..+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 5899999999999999999987 68999999986542 2333456666665 7999999999987643 4689
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCCeeeeC-CcEEEecc
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH--------QQGYFHRDLKPENLLVSQ-GTIKIADF 145 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivH~Dlkp~NIll~~-~~~kL~Df 145 (356)
+||||+.+ +|.+.+. ...+++..++.++.||+.||+||| ++||+||||||+|||++. +.+||+||
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999976 6777763 235899999999999999999999 999999999999999975 79999999
Q ss_pred cceeecCCCCC-----CccccccccccChHHHhhCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 036550 146 GLAREIDAFPP-----YTERVGTRWYQAPEILFKSGL-----YSSKVDMWAMGAIMAELLLF----------RPLFQGTD 205 (356)
Q Consensus 146 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~ 205 (356)
|++........ .....||+.|+|||++.+... ++.++|||||||++|+|++| .+||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99976654322 233479999999999966532 34689999999999999999 88886532
Q ss_pred h----HHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 206 E----ADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 206 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
. ............ ..+.. .........++++.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~-------------------~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQ-------------------QRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSSCCHHHHHHHHTTSC-------------------CCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcchhhhhHHHhccC-------------------CCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 111111111100 00000 000111234678999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=338.39 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=189.9
Q ss_pred CceeecccccCCceEEEEEEEcCCC---cEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEE-ECCeEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSG---EVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIV-EKGNVFFV 77 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~iv 77 (356)
+|.+.+.||+|+||+||+|.+..++ ..||+|.+.... ......+.+|+.++++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4788899999999999999875433 468999986543 344556789999999999999999999875 45678999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++.......
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999986 67777642 3345889999999999999999999999999999999999975 699999999998654321
Q ss_pred -----CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 156 -----PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~----------- 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------- 314 (373)
T ss_dssp -----------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-----------
T ss_pred cccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 123346788999999997655 8999999999999999999 7888987665444333322100
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...+..++..+.+++.+||..||++|||+.+++++
T Consensus 315 ------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 ------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=339.95 Aligned_cols=243 Identities=14% Similarity=0.229 Sum_probs=192.8
Q ss_pred CCceeecccccCCceEEEEE-----EEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC---CCCeeEEeEEEEECCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQA-----VNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN---HPNIVKVKELIVEKGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~ 73 (356)
++|.+.+.||+|+||+||+| .+..+++.||+|++..... ..+.+|+.+++.++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 56999999999999999999 4677899999999876532 34567888888886 9999999999999999
Q ss_pred EEEEEEecc-CCHHHHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC------------Cc
Q 036550 74 VFFVFECMQ-CNLYQLMEAKKQ-KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ------------GT 139 (356)
Q Consensus 74 ~~iv~e~~~-g~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~------------~~ 139 (356)
.|+||||+. |+|.+.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++. +.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence 999999997 578888875443 3456999999999999999999999999999999999999965 79
Q ss_pred EEEecccceeecCC---CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 036550 140 IKIADFGLAREIDA---FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSV 216 (356)
Q Consensus 140 ~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 216 (356)
+||+|||+|..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~-------- 292 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------- 292 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence 99999999976542 22334568999999999997665 8999999999999999999999996432200
Q ss_pred hCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 217 LGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
+ .....+.. ...+..+.+++..||..+|.+|++..+.+.+
T Consensus 293 --------~--------~~~~~~~~----------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 --------C--------KPEGLFRR----------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp --------E--------EECSCCTT----------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred --------e--------eechhccc----------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 00000000 0236789999999999999999765544443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=350.26 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=204.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|.+.++||+|+||+||+|.+.. +..||||+++.... ....+.+|+.+|++++||||+++++++.+ +..|+||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 468999999999999999999875 46799999976543 23467899999999999999999999866 6789999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~ 157 (356)
.+ +|.+++.... +..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++....... ..
T Consensus 344 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 344 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred cCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 75 7888875432 234899999999999999999999999999999999999975 699999999997654311 12
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....++..|+|||++.... ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 422 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------ 482 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------ 482 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred cCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 2345778999999997655 8999999999999999999 9999998877666554432211
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC--CCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH--PFFK 286 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~~~ 286 (356)
. .....++..+.+||.+||..||++|||++++++. .+|.
T Consensus 483 --~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 --M---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0 1123678999999999999999999999999873 5554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=327.62 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=196.5
Q ss_pred Cc-eeecccccCCceEEEEEE----EcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC--CeE
Q 036550 3 KY-SLTKKLGSGSFGCVWQAV----NKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK--GNV 74 (356)
Q Consensus 3 ~y-~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 74 (356)
+| ++.+.||+|+||+||++. +..+++.||+|++..... .....+.+|+.++++++||||+++++++.+. ..+
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 55 999999999999998875 345789999999976543 3345568899999999999999999999884 678
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
++||||+.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999976 6766653 223899999999999999999999999999999999999976 689999999998876
Q ss_pred CCCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AFPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||......... .........-...
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-----LIGIAQGQMTVLR 259 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HHCSCCHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-----hhcccccchhHHH
Confidence 5322 23456888999999997655 789999999999999999999999754321110 0000000000000
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.......... ......++.++.+||++||..||++|||+.++++
T Consensus 260 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000000111 1123467899999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=333.15 Aligned_cols=274 Identities=23% Similarity=0.298 Sum_probs=187.9
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-----CCeEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE-----KGNVF 75 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 75 (356)
+++|.+.+.||+|+||+||+|++ +++.||+|++...... ......|+..+..++||||+++++.+.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 57999999999999999999965 6899999998654322 1222334444556899999999986653 23678
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCCeeeeC-CcEEEec
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ---------GYFHRDLKPENLLVSQ-GTIKIAD 144 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~ivH~Dlkp~NIll~~-~~~kL~D 144 (356)
+||||+++ +|.+++.. ...++..++.++.||+.||.|||++ ||+||||||+|||++. +.+||+|
T Consensus 89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 99999965 77777743 2258999999999999999999999 9999999999999986 7999999
Q ss_pred ccceeecCCC---------CCCccccccccccChHHHhhC------CCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHH
Q 036550 145 FGLAREIDAF---------PPYTERVGTRWYQAPEILFKS------GLYSSKVDMWAMGAIMAELLLFRPLFQGT-DEAD 208 (356)
Q Consensus 145 fg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~ 208 (356)
||++...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9999876432 112345799999999998652 23567899999999999999997665432 2111
Q ss_pred HHHHHHHHhCC-CCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH------hc
Q 036550 209 QMYKICSVLGS-PTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA------LQ 281 (356)
Q Consensus 209 ~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~------l~ 281 (356)
....+....+. +....+. .........+.... ........++++.+||.+||..||++|||+.|+ +-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQ----VLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHH----HHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHH----hhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 00000000111 1111000 00000000010000 000011235579999999999999999999999 44
Q ss_pred CCCCCCC
Q 036550 282 HPFFKRC 288 (356)
Q Consensus 282 hp~~~~~ 288 (356)
++|-++.
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 7887654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=352.28 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=193.4
Q ss_pred cccccCCceEEEEEEE--cCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVN--KHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
+.||+|+||+||+|.+ ..+++.||||+++.... .....+.+|+.+|++++|||||++++++. .+..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 5799999999999954 56778999999976432 22456789999999999999999999986 4568999999976
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC----C
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP----Y 157 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~----~ 157 (356)
+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++........ .
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 5777764 2345899999999999999999999999999999999999975 7899999999987643321 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 530 ~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------------------ 590 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------------ 590 (635)
T ss_dssp -----CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred cCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 2345778999999996655 8999999999999999998 9999998887666555433211
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
......+++++.+||.+||..||++|||+.++++
T Consensus 591 -----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 -----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1112367899999999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=326.75 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=186.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC--CCCCeeEEeEEEEEC----CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL--NHPNIVKVKELIVEK----GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~~~~~~~~----~~~~ 75 (356)
++|++.+.||+|+||.||+|.+. ++.||+|++.... .....+|.+++..+ +||||+++++++.+. ...+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 47999999999999999999875 8999999986442 22334455555554 999999999999887 7899
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCCeeeeC-CcEEEecc
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ--------GYFHRDLKPENLLVSQ-GTIKIADF 145 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~NIll~~-~~~kL~Df 145 (356)
+||||+.+ +|.+.+.. ..+++..++.++.||+.||+|||++ ||+||||||+|||++. +.+||+||
T Consensus 112 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 99999976 78777742 2489999999999999999999999 9999999999999975 79999999
Q ss_pred cceeecCCCCC-----CccccccccccChHHHhhCCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 036550 146 GLAREIDAFPP-----YTERVGTRWYQAPEILFKSGLYSSK------VDMWAMGAIMAELLLF----------RPLFQGT 204 (356)
Q Consensus 146 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~------~DiwslG~il~~ll~g----------~~pf~~~ 204 (356)
|++........ .....||+.|+|||++.+.. ++.. +|||||||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99977644322 12457999999999996654 4443 9999999999999999 6666543
Q ss_pred ChH----HHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 205 DEA----DQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 205 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
... ........... ....++. ......+++++.+|+.+||..||++|||+.+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKK----------------LRPSFPN------RWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp SCSSCCHHHHHHHHTTSC----------------CCCCCCG------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCCCchhhhHHHHhhhc----------------cCccccc------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 211 11111110000 0000000 001124567899999999999999999999998
Q ss_pred cC
Q 036550 281 QH 282 (356)
Q Consensus 281 ~h 282 (356)
+|
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=348.44 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=195.3
Q ss_pred Cceeec-ccccCCceEEEEEEEc--CCCcEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 3 KYSLTK-KLGSGSFGCVWQAVNK--HSGEVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 3 ~y~~~~-~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
+|.+.+ .||+|+||+||+|.+. .++..||||+++... ......+.+|+.+|++++|||||++++++.. +.+++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344454 8999999999999875 456789999997653 2345567899999999999999999999876 5689999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99986 56666642 334589999999999999999999999999999999999997 47999999999987643221
Q ss_pred ----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 157 ----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 157 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------------- 557 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------- 557 (613)
T ss_dssp ----------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-------------
T ss_pred eeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 12234568899999996655 8999999999999999998 9999998887766555433210
Q ss_pred hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...+..+++++.++|.+||..||++|||+.++++
T Consensus 558 ----------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 ----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1112367899999999999999999999999854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=342.19 Aligned_cols=244 Identities=20% Similarity=0.220 Sum_probs=187.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--------hHHhhhHHHHHHHHhCC---------CCCeeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--------REKCLNLREVKCLRKLN---------HPNIVKV 64 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------hp~iv~~ 64 (356)
++|.+.+.||+|+||+||+|++ +|+.||+|++..... .....+.+|+.+++.++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999987 689999999976532 12245678999988885 8888888
Q ss_pred eEEEE------------------------------ECCeEEEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHH
Q 036550 65 KELIV------------------------------EKGNVFFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFR 113 (356)
Q Consensus 65 ~~~~~------------------------------~~~~~~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 113 (356)
.+++. +.+.+|+||||+.++ +++.+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 87753 267899999998764 555542 134899999999999999
Q ss_pred HHHHHH-hCCcccccCCCCCeeeeC-C--------------------cEEEecccceeecCCCCCCccccccccccChHH
Q 036550 114 GLDYMH-QQGYFHRDLKPENLLVSQ-G--------------------TIKIADFGLAREIDAFPPYTERVGTRWYQAPEI 171 (356)
Q Consensus 114 aL~~LH-~~~ivH~Dlkp~NIll~~-~--------------------~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 171 (356)
||+||| ++||+||||||+|||++. + .+||+|||+|+.... ...+||+.|+|||+
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhh
Confidence 999999 999999999999999975 3 899999999987764 24589999999999
Q ss_pred HhhCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccc
Q 036550 172 LFKSGLYSSKVDMWAMGAI-MAELLLFRPLFQGTDE-ADQMYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSA 249 (356)
Q Consensus 172 ~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
+.+.. +.++||||||++ .+++++|..||..... ......+..... ++. .....
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~~---~~~~~ 303 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT--------------------FKT---KCNTP 303 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC--------------------CSS---CCCSH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc--------------------cCc---ccchh
Confidence 86543 889999998777 7778899999853211 111111111100 000 00111
Q ss_pred cCCCCCHHHHHHHHHccCCCCCCCCCHHHHh-cCCCCC
Q 036550 250 LMPSASEDAINLIESLCSWDPCKRPTAAEAL-QHPFFK 286 (356)
Q Consensus 250 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l-~hp~~~ 286 (356)
..+.+++++.+||++||.+| |++|+| +||||+
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 12246889999999999977 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.07 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=200.4
Q ss_pred CCceeecccccCCceEEEEEEEcCC---CcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS---GEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.+.||+|+||+||+|.+..+ +..||+|.+..... .....+.+|+.++++++||||+++++++. ++..|+|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 4799999999999999999998653 46799999876433 33356688999999999999999999984 5678999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.+ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 469 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 999985 67777653 233489999999999999999999999999999999999997 5899999999998765432
Q ss_pred C--CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 P--YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------- 611 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 611 (656)
T ss_dssp --------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-------------
T ss_pred ceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 2 22345778999999996654 8999999999999999997 99999988877766555432110
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...+.+++.+.++|.+||..||++|||+.++++.
T Consensus 612 ----------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 612 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1123678999999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=322.45 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=192.7
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHh--CCCCCeeEEeEEEEECC----eEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK--LNHPNIVKVKELIVEKG----NVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~~----~~~ 75 (356)
++|.+.+.||+|+||+||+|.+ +|+.||+|++.... .....+|+++++. ++||||+++++++...+ ..+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 4799999999999999999987 58999999986542 3345678888887 79999999999998775 899
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCCeeeeC-CcEEEecc
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH--------QQGYFHRDLKPENLLVSQ-GTIKIADF 145 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~ivH~Dlkp~NIll~~-~~~kL~Df 145 (356)
+||||+.+ +|.+.+.. ..+++..++.++.||+.||.||| ++||+||||||+|||++. +.+||+||
T Consensus 117 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 99999986 78887743 24899999999999999999999 899999999999999975 79999999
Q ss_pred cceeecCCCC-----CCccccccccccChHHHhhCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 036550 146 GLAREIDAFP-----PYTERVGTRWYQAPEILFKSGL-----YSSKVDMWAMGAIMAELLLF----------RPLFQGTD 205 (356)
Q Consensus 146 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~ 205 (356)
|++....... ......||+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998775543 2245579999999999865432 23689999999999999999 77886542
Q ss_pred h----HHHHHHHH-HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHh
Q 036550 206 E----ADQMYKIC-SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEAL 280 (356)
Q Consensus 206 ~----~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l 280 (356)
. ........ .....+. ++. .......+..+.+++.+||..||++|||+.+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPN-----------------IPN------RWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCC-----------------CCG------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCC-----------------Ccc------cccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 2 11111111 0000000 000 000113356799999999999999999999998
Q ss_pred cC
Q 036550 281 QH 282 (356)
Q Consensus 281 ~h 282 (356)
+|
T Consensus 329 ~~ 330 (342)
T 1b6c_B 329 KT 330 (342)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.65 Aligned_cols=238 Identities=25% Similarity=0.417 Sum_probs=196.6
Q ss_pred CCceeecccccCCceEEEEEEEcC-CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCe-----E
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGN-----V 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-----~ 74 (356)
++|++.+.||+|+||+||+|.+.. +|+.||||++..... .....+.+|+.++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999976 789999999865433 334456789999999999999999999987765 7
Q ss_pred EEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCC
Q 036550 75 FFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDA 153 (356)
Q Consensus 75 ~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~ 153 (356)
|+||||++|+ |.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhccc
Confidence 9999999864 544332 148999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 154 FPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
. ...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||....... .+....
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~~~--------- 289 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPEDDP--------- 289 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTTCH---------
T ss_pred C---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc----------cccccc---------
Confidence 3 456799999999998654 4899999999999999999999887431100 000000
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
....++.+.++|.+||..||++||+..+.+.|+|+.
T Consensus 290 -----------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 290 -----------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 002367899999999999999999999999998874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=307.61 Aligned_cols=224 Identities=15% Similarity=0.113 Sum_probs=179.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 579999999999999999999999999999999976533 22355678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.| +|.+++. . + .....+..++.||+.||+|||++||+||||||+|||+++ |.+||+++|.
T Consensus 111 e~~~g~~L~~~l~----~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--------- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVAD----T-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------- 175 (286)
T ss_dssp ECCCEEEHHHHHT----T-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------
T ss_pred EecCCCCHHHHHh----c-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------
Confidence 99975 6777652 1 2 466678899999999999999999999999999999975 7899885542
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
++| ++.++|||||||++|+|++|..||...+..+... ..
T Consensus 176 ----------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------------------~~ 214 (286)
T 3uqc_A 176 ----------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------------------PA 214 (286)
T ss_dssp ----------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------------------EC
T ss_pred ----------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------------------HH
Confidence 222 7899999999999999999999998765321100 00
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...............+.+++++.++|.+||..||++| |+.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0000001111123345789999999999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=289.35 Aligned_cols=183 Identities=17% Similarity=0.089 Sum_probs=129.2
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEccccc----------chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 9 KLGSGSFGCVWQAVNKHSGEVVAIKALKKSY----------SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 9 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
..+.|+.|.+..++....|+.|++|++.+.. ......+.+|+++|+++ +|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4667888888888888899999999986542 22234567899999999 799999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF- 154 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~- 154 (356)
|||++| +|.+.+. .++++++. .|+.||+.||+|||++|||||||||+|||+++ |++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999998 5777774 34557764 57899999999999999999999999999975 79999999999876543
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL 200 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 200 (356)
....+.+||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 334567899999999998653 67789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=248.41 Aligned_cols=181 Identities=18% Similarity=0.170 Sum_probs=140.0
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccc--------hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--------REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
..+.||+|+||+||+| ...++.+++|....... .....+.+|+.++++++||||+++..++...+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999999 44578899998643211 1123457899999999999999666666677788999
Q ss_pred EEecc-CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecccceeecCCCCC
Q 036550 78 FECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 78 ~e~~~-g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~~~~~ 156 (356)
|||++ ++|.+.+.. +..++.||+.||+|||++||+||||||+|||+++ .+||+|||+|+.......
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCccc
Confidence 99997 567766532 5689999999999999999999999999999999 999999999998765321
Q ss_pred --------CccccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036550 157 --------YTERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQ 202 (356)
Q Consensus 157 --------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~ 202 (356)
....+||+.|+|||++.. .+ |+..+|+||...-..+.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~-Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEG-YKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHH-HHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHhccccC
Confidence 135689999999999965 33 7888899999988888887777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=206.58 Aligned_cols=143 Identities=22% Similarity=0.219 Sum_probs=113.6
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc------------------hHHhhhHHHHHHHHhCCCCCeeEEe
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS------------------REKCLNLREVKCLRKLNHPNIVKVK 65 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hp~iv~~~ 65 (356)
|.+.+.||+|+||.||+|.+ .+|+.||+|+++.... .....+.+|+.++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 55669999999999999999 7899999999865321 12345678999999999 4 5666
Q ss_pred EEEEECCeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEec
Q 036550 66 ELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIAD 144 (356)
Q Consensus 66 ~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~D 144 (356)
+++.. +..|+||||++| +|.+ + .......++.||+.||.|||++||+||||||+|||++++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEE
Confidence 65544 456999999977 5554 2 112355799999999999999999999999999999988999999
Q ss_pred ccceeecCCCCCCccccccccccChHHHhh
Q 036550 145 FGLAREIDAFPPYTERVGTRWYQAPEILFK 174 (356)
Q Consensus 145 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 174 (356)
||+|.. +..++|||.+.+
T Consensus 236 FG~a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHHH
Confidence 999864 344688998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=185.20 Aligned_cols=137 Identities=16% Similarity=0.209 Sum_probs=106.5
Q ss_pred ceeecccccCCceEEEEEEEcCCCcE--EEEEEcccccch------------------------HHhhhHHHHHHHHhCC
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEV--VAIKALKKSYSR------------------------EKCLNLREVKCLRKLN 57 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 57 (356)
|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998778999 999987543111 1124578999999998
Q ss_pred CCCe--eEEeEEEEECCeEEEEEEeccC------CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH-hCCcccccC
Q 036550 58 HPNI--VKVKELIVEKGNVFFVFECMQC------NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH-QQGYFHRDL 128 (356)
Q Consensus 58 hp~i--v~~~~~~~~~~~~~iv~e~~~g------~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dl 128 (356)
|+++ +.+++. +..++||||+++ .|.+... . .++..+..++.||+.+|.||| ++||+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----E---LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----G---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----c---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 7754 334432 345899999953 3433321 1 235577899999999999999 999999999
Q ss_pred CCCCeeeeCCcEEEecccceeecC
Q 036550 129 KPENLLVSQGTIKIADFGLAREID 152 (356)
Q Consensus 129 kp~NIll~~~~~kL~Dfg~a~~~~ 152 (356)
||+|||+++ .++|+|||+|....
T Consensus 198 kp~NILl~~-~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID-KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS-SEEECCCTTCEETT
T ss_pred CHHHEEEcC-cEEEEECcccccCC
Confidence 999999999 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.6e-20 Score=166.84 Aligned_cols=137 Identities=14% Similarity=0.188 Sum_probs=98.0
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch----------------------HHhhhHHHHHHHHhCCCCCe
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR----------------------EKCLNLREVKCLRKLNHPNI 61 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp~i 61 (356)
|.+.++||+|+||.||+|.+. +|+.||||+++..... ......+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999975 6999999987532100 00112357777777755544
Q ss_pred eEEeEEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCC---
Q 036550 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQG--- 138 (356)
Q Consensus 62 v~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--- 138 (356)
....-+... . .++||||++|.....+ ........++.||+.+|.+||++|||||||||.|||++++
T Consensus 176 ~vp~p~~~~-~-~~LVME~i~G~~L~~l---------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQS-R-HTIVMSLVDALPMRQV---------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEEEE-T-TEEEEECCSCEEGGGC---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCeeeecc-C-ceEEEEecCCccHhhh---------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 322111122 2 3799999988522111 2233456789999999999999999999999999999753
Q ss_pred --------cEEEecccceeecC
Q 036550 139 --------TIKIADFGLAREID 152 (356)
Q Consensus 139 --------~~kL~Dfg~a~~~~ 152 (356)
.+.|+||+.+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999887644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-14 Score=125.30 Aligned_cols=139 Identities=19% Similarity=0.172 Sum_probs=108.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+.|.+...++.|+.+.||++.. .++.+++|+...........+.+|+.+++.+. +..++++++++.+.+..|+|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 5789999999999999999964 36789999986533233345678999999884 67788999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ---------------------------------------- 120 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 120 (356)
++|...... . .+......++.++..+|..||+
T Consensus 92 i~G~~l~~~---~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEE---Y-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHH---C-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhc---c-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999633221 0 1222334678899999999998
Q ss_pred -------------------CCcccccCCCCCeeeeCCcE-EEecccceee
Q 036550 121 -------------------QGYFHRDLKPENLLVSQGTI-KIADFGLARE 150 (356)
Q Consensus 121 -------------------~~ivH~Dlkp~NIll~~~~~-kL~Dfg~a~~ 150 (356)
..++|+|++|.|||++++.+ .|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 45899999999999988765 5999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.9e-12 Score=112.37 Aligned_cols=134 Identities=14% Similarity=0.106 Sum_probs=95.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC--eeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN--IVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~~~~~~~~~iv~e 79 (356)
..|.+....+.|..+.||++.. .+|..+++|+.... ......+|+.+++.+.+.+ +++++++....+..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3456655555677799999964 45778999987543 2234567999999885434 5668888888888999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG------------------------------------- 122 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------- 122 (356)
+++|...+ . .. .+ ...++.++...|..||+..
T Consensus 96 ~i~G~~l~-~----~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL-S----SH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT-T----SC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC-c----Cc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99985322 1 00 11 1245566667777777643
Q ss_pred ---------------------cccccCCCCCeeeeCCcE-EEecccceee
Q 036550 123 ---------------------YFHRDLKPENLLVSQGTI-KIADFGLARE 150 (356)
Q Consensus 123 ---------------------ivH~Dlkp~NIll~~~~~-kL~Dfg~a~~ 150 (356)
++|+|++|.||+++++.+ .|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 999999999999998765 5999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.1e-11 Score=109.91 Aligned_cols=139 Identities=19% Similarity=0.239 Sum_probs=101.7
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcc--ccc-chHHhhhHHHHHHHHhCC--CCCeeEEeEEEEEC---CeEEEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALK--KSY-SREKCLNLREVKCLRKLN--HPNIVKVKELIVEK---GNVFFV 77 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~---~~~~iv 77 (356)
-.+.|+.|.++.||++... +..+++|+.. ... ........+|+.+++.+. +..+++++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4678999999999999654 4678899876 332 122345678999999986 45578888888766 458999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ------------------------------------- 120 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------- 120 (356)
||+++|..... .....+++.....++.++...|..||+
T Consensus 120 me~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999852210 011226788888899999999999997
Q ss_pred ---------------------CCcccccCCCCCeeeeCC--c-EEEecccceeec
Q 036550 121 ---------------------QGYFHRDLKPENLLVSQG--T-IKIADFGLAREI 151 (356)
Q Consensus 121 ---------------------~~ivH~Dlkp~NIll~~~--~-~kL~Dfg~a~~~ 151 (356)
..++|+|++|.|||++++ . +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 368999999999999853 2 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=7.6e-11 Score=104.81 Aligned_cols=181 Identities=17% Similarity=0.121 Sum_probs=115.8
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhC-CCCC--eeEEeEEEEECC---eEEEEEEe
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NHPN--IVKVKELIVEKG---NVFFVFEC 80 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~--iv~~~~~~~~~~---~~~iv~e~ 80 (356)
.+.++.|.+..||++. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999873 45889985432 2345567899999887 3333 344544433332 34789999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ---------------------------------------- 120 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 120 (356)
++|........ ..++......++.|+...|..||+
T Consensus 98 i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 98 IKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99852221111 126777777888888888888885
Q ss_pred ------------------CCcccccCCCCCeeeeC--C-cEEEecccceeecCCCCCCccccccccc---cChHHHh---
Q 036550 121 ------------------QGYFHRDLKPENLLVSQ--G-TIKIADFGLAREIDAFPPYTERVGTRWY---QAPEILF--- 173 (356)
Q Consensus 121 ------------------~~ivH~Dlkp~NIll~~--~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y---~aPE~~~--- 173 (356)
..++|+|++|.||++++ + .+.|+||+.+......... .....+ ..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHHHHHHH
Confidence 13799999999999987 5 5789999998764321100 000111 2222211
Q ss_pred -hCCC---------CCCchhHHHHHHHHHHHHhCCCCCC
Q 036550 174 -KSGL---------YSSKVDMWAMGAIMAELLLFRPLFQ 202 (356)
Q Consensus 174 -~~~~---------~~~~~DiwslG~il~~ll~g~~pf~ 202 (356)
..+. ...-.+.|++|.++|.+.+|.++|-
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1110 1223689999999999999987763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=4.6e-08 Score=85.11 Aligned_cols=131 Identities=17% Similarity=0.183 Sum_probs=91.7
Q ss_pred ccccCCce-EEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEEeccCC-H
Q 036550 9 KLGSGSFG-CVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFECMQCN-L 85 (356)
Q Consensus 9 ~ig~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e~~~g~-l 85 (356)
.+..|..+ .||+......+..+.+|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|. +
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34456555 6999887777888999986433 3445678999998874 334678889999999999999999985 3
Q ss_pred HHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 036550 86 YQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ-------------------------------------------- 121 (356)
Q Consensus 86 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------------------------------------------- 121 (356)
.+.... .......+..++...|.-||+.
T Consensus 108 ~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 332211 1112234455556666666631
Q ss_pred --------------CcccccCCCCCeeeeCCcE-EEecccceee
Q 036550 122 --------------GYFHRDLKPENLLVSQGTI-KIADFGLARE 150 (356)
Q Consensus 122 --------------~ivH~Dlkp~NIll~~~~~-kL~Dfg~a~~ 150 (356)
.++|+|+.|.|||++++.+ -|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 2689999999999998765 5999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=8.6e-08 Score=85.09 Aligned_cols=134 Identities=19% Similarity=0.188 Sum_probs=85.7
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCC---CeeEEeEEEE-ECCeEEEEEEecc
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHP---NIVKVKELIV-EKGNVFFVFECMQ 82 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~~~~~~~-~~~~~~iv~e~~~ 82 (356)
.+.++.|....||++ |..+++|+... ......+.+|+.+|+.+.+. .+.+++.+.. ..+..++||++++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788999999988 45688888432 22334567899999998642 3556666664 3456789999999
Q ss_pred CCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 036550 83 CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ------------------------------------------ 120 (356)
Q Consensus 83 g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------------ 120 (356)
|........ ..++......+..++...|..||+
T Consensus 97 G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 852221100 002333333333333333333332
Q ss_pred ------------------CCcccccCCCCCeeeeC----CcE-EEecccceeecC
Q 036550 121 ------------------QGYFHRDLKPENLLVSQ----GTI-KIADFGLAREID 152 (356)
Q Consensus 121 ------------------~~ivH~Dlkp~NIll~~----~~~-kL~Dfg~a~~~~ 152 (356)
..++|+|++|.||++++ +.+ .|+||+.+....
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 24699999999999986 665 899999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.5e-07 Score=86.70 Aligned_cols=75 Identities=15% Similarity=0.151 Sum_probs=48.2
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccc-------hHHhhhHHHHHHHHhCCC--C-CeeEEeEEEEECCeEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-------REKCLNLREVKCLRKLNH--P-NIVKVKELIVEKGNVFF 76 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-~iv~~~~~~~~~~~~~i 76 (356)
.+.||.|.++.||++....+++.|++|....... ........|+++++.+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5689999999999997666678899998643211 012234668888887732 3 34455543 4555689
Q ss_pred EEEeccC
Q 036550 77 VFECMQC 83 (356)
Q Consensus 77 v~e~~~g 83 (356)
|||+++|
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.4e-06 Score=78.83 Aligned_cols=77 Identities=8% Similarity=0.096 Sum_probs=52.6
Q ss_pred eccc-ccCCceEEEEEEEc--C----CCcEEEEEEccccc---chHHhhhHHHHHHHHhCC-C--CCeeEEeEEEEEC--
Q 036550 7 TKKL-GSGSFGCVWQAVNK--H----SGEVVAIKALKKSY---SREKCLNLREVKCLRKLN-H--PNIVKVKELIVEK-- 71 (356)
Q Consensus 7 ~~~i-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~~~~~-- 71 (356)
.+.| +.|....+|++... . +++.+++|+..... ........+|+.+++.+. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88999999998643 1 25678999865432 101234567888888874 2 3567788776554
Q ss_pred -CeEEEEEEeccC
Q 036550 72 -GNVFFVFECMQC 83 (356)
Q Consensus 72 -~~~~iv~e~~~g 83 (356)
+..++|||+++|
T Consensus 105 ~g~~~~v~e~l~G 117 (357)
T 3ats_A 105 LGTPFFLMDYVEG 117 (357)
T ss_dssp TSSCEEEEECCCC
T ss_pred cCCceEEEEecCC
Confidence 356899999987
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.1e-05 Score=72.42 Aligned_cols=71 Identities=15% Similarity=0.260 Sum_probs=39.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-----CCCeeEEe-E--EEEECCeEEEEEE
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-----HPNIVKVK-E--LIVEKGNVFFVFE 79 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~-~--~~~~~~~~~iv~e 79 (356)
+.|+.|..+.||++... +..+++|+..... .....|+.+++.|. .|.++... + +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666788999999653 3458999886531 12234555555442 34443310 0 2235678899999
Q ss_pred eccCC
Q 036550 80 CMQCN 84 (356)
Q Consensus 80 ~~~g~ 84 (356)
|++|.
T Consensus 112 ~i~G~ 116 (346)
T 2q83_A 112 WIEGR 116 (346)
T ss_dssp CCCCB
T ss_pred eecCc
Confidence 99873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.13 E-value=7.7e-06 Score=72.17 Aligned_cols=139 Identities=16% Similarity=0.125 Sum_probs=75.9
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-eEEeEEEEECCeEEEEEEec-
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-VKVKELIVEKGNVFFVFECM- 81 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~iv~e~~- 81 (356)
+.-.+.|+.|....+|++ ..+++|+..... .......+|+.+++.+...++ .+++++ +.+.-++++||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 333678889999999999 348889875432 111223568888877642222 455543 344457899999
Q ss_pred cCCHHH------------HHHH---HHhh-cccC----C-HHHHHHHHHH--------------HHHHHHHHH-------
Q 036550 82 QCNLYQ------------LMEA---KKQK-QQLF----S-ESAVKAWLFQ--------------VFRGLDYMH------- 119 (356)
Q Consensus 82 ~g~l~~------------~~~~---~~~~-~~~l----~-~~~~~~i~~q--------------i~~aL~~LH------- 119 (356)
+|...+ .+.. +... ...+ . ...+..+..+ +...+..+.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 663110 0000 0000 0000 0 1111111111 111111111
Q ss_pred -hCCcccccCCCCCeeeeCCcEEEecccceeec
Q 036550 120 -QQGYFHRDLKPENLLVSQGTIKIADFGLAREI 151 (356)
Q Consensus 120 -~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~ 151 (356)
...++|+|+.|.||+.+++.+.|+||..+...
T Consensus 171 ~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFLDTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEEECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEEECCCCEEEEecccccCC
Confidence 12389999999999987889999999988653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.2e-05 Score=72.69 Aligned_cols=34 Identities=21% Similarity=0.278 Sum_probs=29.3
Q ss_pred HhCCcccccCCCCCeeeeCCcEEEecccceeecC
Q 036550 119 HQQGYFHRDLKPENLLVSQGTIKIADFGLAREID 152 (356)
Q Consensus 119 H~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~~~ 152 (356)
+...++|||++|.|||++++.++|+||+.+....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSCEEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCCCEEEeCcccccCc
Confidence 4567999999999999988779999999887543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=8.4e-05 Score=65.73 Aligned_cols=73 Identities=22% Similarity=0.291 Sum_probs=57.0
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC---CCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN---HPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
.+.|+.|....+|++.. ++..+++|+.... ....+..|+..|+.|. ...+++++.+....+..++|||+++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 46789999999999964 4678889986543 2445678988888873 35678888888888889999999987
Q ss_pred C
Q 036550 84 N 84 (356)
Q Consensus 84 ~ 84 (356)
.
T Consensus 116 ~ 116 (312)
T 3jr1_A 116 S 116 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.0002 Score=62.55 Aligned_cols=74 Identities=15% Similarity=0.097 Sum_probs=51.2
Q ss_pred eeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCC---CCeeEEeEEEEECCeEEEEEEec
Q 036550 5 SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH---PNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 5 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
.-++.+|.|..+.||++.. .+|+.|.+|+...........+..|+..|+.|.. -.+++++++ +. .++|||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l 92 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWV 92 (288)
T ss_dssp EEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECC
T ss_pred EEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEee
Confidence 4467899999999999975 4688999998654433333456789999988742 234455543 22 36889988
Q ss_pred cC
Q 036550 82 QC 83 (356)
Q Consensus 82 ~g 83 (356)
.+
T Consensus 93 ~~ 94 (288)
T 3f7w_A 93 DE 94 (288)
T ss_dssp CC
T ss_pred cc
Confidence 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00033 Score=57.62 Aligned_cols=97 Identities=16% Similarity=0.150 Sum_probs=58.9
Q ss_pred CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeee-CCcEEEecccceeecCCCCCCcccc
Q 036550 84 NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERV 161 (356)
Q Consensus 84 ~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~~~~~~~ 161 (356)
+|.+.+. ..+.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++. +|+|-+.+ +.+ ..
T Consensus 34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s-----------~~ 98 (229)
T 2yle_A 34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AAD-----------DA 98 (229)
T ss_dssp EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccc-----------cc
Confidence 4666665 456779999999999999999877622 1212333345777775 46776654 111 01
Q ss_pred ccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC
Q 036550 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF 197 (356)
Q Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 197 (356)
....+.|||... ...+.+.=|||||+++|.-+--
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhc
Confidence 233466787652 2256788999999999988853
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.73 E-value=9.5e-05 Score=65.63 Aligned_cols=140 Identities=14% Similarity=0.097 Sum_probs=75.0
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC--eeEEeE------EEEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN--IVKVKE------LIVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~------~~~~~~~~~iv~ 78 (356)
.+.|+.|....+|++... +| .+++|+..... ....+..|+.+++.+...+ +.+++. +....+..++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 456778988999999653 33 68899876531 1223455777777663111 233331 123456779999
Q ss_pred EeccCCH------------HHH---HHHHHhh-ccc----CC---HHHH-H-------H----HHHHHHHHHHHHHh---
Q 036550 79 ECMQCNL------------YQL---MEAKKQK-QQL----FS---ESAV-K-------A----WLFQVFRGLDYMHQ--- 120 (356)
Q Consensus 79 e~~~g~l------------~~~---~~~~~~~-~~~----l~---~~~~-~-------~----i~~qi~~aL~~LH~--- 120 (356)
++++|.. ... +...... ..+ .. +... . . +...+...++.+++
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998731 011 1111000 000 00 0000 0 0 00113344555542
Q ss_pred ----CCcccccCCCCCeeeeCCcE-EEecccceee
Q 036550 121 ----QGYFHRDLKPENLLVSQGTI-KIADFGLARE 150 (356)
Q Consensus 121 ----~~ivH~Dlkp~NIll~~~~~-kL~Dfg~a~~ 150 (356)
.+++|+|+.+.|||++++.+ .|+||+.+..
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 46999999999999998776 7999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00087 Score=59.49 Aligned_cols=139 Identities=14% Similarity=0.091 Sum_probs=76.8
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCC--CeeEEeEE-----EEECCeEEEEEEe
Q 036550 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHP--NIVKVKEL-----IVEKGNVFFVFEC 80 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~~~~~-----~~~~~~~~iv~e~ 80 (356)
..++ |....||++... +|+.+++|+...... .......|..+++.+... .+++++.. ....+..+++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 888899988532 466799999864321 223445677777776321 13333332 2345677899999
Q ss_pred ccCCH-----HHH-------H---HHHHhhc-----ccCCHHH----------------------HHHHHHHHHHHHHHH
Q 036550 81 MQCNL-----YQL-------M---EAKKQKQ-----QLFSESA----------------------VKAWLFQVFRGLDYM 118 (356)
Q Consensus 81 ~~g~l-----~~~-------~---~~~~~~~-----~~l~~~~----------------------~~~i~~qi~~aL~~L 118 (356)
++|.. .+. + ....... ..++... ....+.+++..+.-+
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98721 011 1 1111000 0111111 011122222222222
Q ss_pred ----HhCCcccccCCCCCeeeeCCcEEEecccceee
Q 036550 119 ----HQQGYFHRDLKPENLLVSQGTIKIADFGLARE 150 (356)
Q Consensus 119 ----H~~~ivH~Dlkp~NIll~~~~~kL~Dfg~a~~ 150 (356)
....++|+|+++.|||+++ .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWRD-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEESS-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEcC-CCEEEECCCCCc
Confidence 2345899999999999985 899999997754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00028 Score=64.01 Aligned_cols=72 Identities=14% Similarity=0.102 Sum_probs=43.0
Q ss_pred ecccccCCceEEEEEEEcC--------CCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC-eeEEeEEEEECCeEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKH--------SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN-IVKVKELIVEKGNVFFV 77 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~iv 77 (356)
.+.|+.|....+|++.... .++.+++|+...... .......|..+++.+...+ .+++++.. .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 4678889899999997543 136789998754321 1112356888888774333 44566543 33 689
Q ss_pred EEeccC
Q 036550 78 FECMQC 83 (356)
Q Consensus 78 ~e~~~g 83 (356)
|+|++|
T Consensus 113 ~e~i~G 118 (369)
T 3c5i_A 113 EEWLYG 118 (369)
T ss_dssp EECCCS
T ss_pred EEEecC
Confidence 999987
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00034 Score=63.53 Aligned_cols=139 Identities=9% Similarity=0.066 Sum_probs=79.5
Q ss_pred ecccccCCceEEEEEEEcC-------CCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKH-------SGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++.|..|....+|++.... +++.|++|+..... .......+|..+++.+. +.-..++++.+. + .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence 3567778889999997642 35789999864321 12344568999998874 322356666543 3 2899
Q ss_pred EeccCCHH-----------HHHHHHH---hh-----cccC--CHHHHHHHHHHHHH-------------------HHHHH
Q 036550 79 ECMQCNLY-----------QLMEAKK---QK-----QQLF--SESAVKAWLFQVFR-------------------GLDYM 118 (356)
Q Consensus 79 e~~~g~l~-----------~~~~~~~---~~-----~~~l--~~~~~~~i~~qi~~-------------------aL~~L 118 (356)
||++|... ..+.... .. .... -...+..+..++-. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99987211 1111100 00 0111 23556666655432 23333
Q ss_pred H----h----CCcccccCCCCCeeeeCC-----cEEEecccceee
Q 036550 119 H----Q----QGYFHRDLKPENLLVSQG-----TIKIADFGLARE 150 (356)
Q Consensus 119 H----~----~~ivH~Dlkp~NIll~~~-----~~kL~Dfg~a~~ 150 (356)
. . ..++|+|+.+.|||++++ .+.|+||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 2 258999999999999754 899999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00074 Score=60.17 Aligned_cols=32 Identities=28% Similarity=0.395 Sum_probs=27.3
Q ss_pred hCCcccccCCCCCeeeeC-----CcEEEecccceeec
Q 036550 120 QQGYFHRDLKPENLLVSQ-----GTIKIADFGLAREI 151 (356)
Q Consensus 120 ~~~ivH~Dlkp~NIll~~-----~~~kL~Dfg~a~~~ 151 (356)
...++|||+.+.|||+++ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 347999999999999976 57999999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0015 Score=60.43 Aligned_cols=71 Identities=10% Similarity=0.089 Sum_probs=47.4
Q ss_pred ecccccCCceEEEEEEEcC-------CCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-eEEeEEEEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKH-------SGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-VKVKELIVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~iv~ 78 (356)
.+.|+.|....||++.... +++.+++|+...... ...+.+|..+++.+...++ +++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4678889999999997642 357899998743211 1234578888888743333 56666543 3 3789
Q ss_pred EeccC
Q 036550 79 ECMQC 83 (356)
Q Consensus 79 e~~~g 83 (356)
||++|
T Consensus 152 e~l~G 156 (429)
T 1nw1_A 152 EYIPS 156 (429)
T ss_dssp CCCCE
T ss_pred EEeCC
Confidence 99876
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.004 Score=57.97 Aligned_cols=72 Identities=17% Similarity=0.044 Sum_probs=46.9
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-eEEeEEEEECCeEEEEEEeccC
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-VKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~iv~e~~~g 83 (356)
++.|+.|....+|++.....+..|++|+..... .......+|..+++.|...++ +++++++ .+ .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCC
Confidence 467888999999999765445789999874432 111122579999998865444 5677665 33 259999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0061 Score=54.41 Aligned_cols=32 Identities=25% Similarity=0.287 Sum_probs=27.1
Q ss_pred CCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
..++|+|+.+.||++++ +.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 46999999999999985 689999999876543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.017 Score=53.07 Aligned_cols=72 Identities=11% Similarity=-0.021 Sum_probs=47.0
Q ss_pred ecccccCCceEEEEEEEcCC-------CcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHS-------GEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++.+..|....+|++..... ++.|++++..... ....+..+|..+++.+. +.-..++++.+ .+ +.|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 46777888999999976521 5789999864432 12223357888888874 32244555533 33 6889
Q ss_pred EeccC
Q 036550 79 ECMQC 83 (356)
Q Consensus 79 e~~~g 83 (356)
+|++|
T Consensus 150 efI~G 154 (424)
T 3mes_A 150 EFIDG 154 (424)
T ss_dssp ECCCS
T ss_pred EEeCC
Confidence 99987
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.69 E-value=0.052 Score=50.54 Aligned_cols=61 Identities=10% Similarity=0.089 Sum_probs=18.3
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEE------EEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEE
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAI------KALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIV 69 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 69 (356)
+.++|| ||.||++.......+||+ |...... ......+.+|..+++.++|||+++.+.+..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 456777 999999988765567888 6554322 122234567889999999999999988765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.05 E-value=0.56 Score=42.60 Aligned_cols=28 Identities=21% Similarity=0.446 Sum_probs=24.0
Q ss_pred cccccCCCCCeeee-------CCcEEEecccceee
Q 036550 123 YFHRDLKPENLLVS-------QGTIKIADFGLARE 150 (356)
Q Consensus 123 ivH~Dlkp~NIll~-------~~~~kL~Dfg~a~~ 150 (356)
++|+|+.+.|||+. ++.+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999994 25799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 356 | ||||
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-83 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-81 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-80 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-78 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-77 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-77 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-76 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-76 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-75 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-75 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-74 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-74 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-72 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-72 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-70 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-70 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-69 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-69 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-65 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-65 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-65 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-62 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-62 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-61 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-61 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-56 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-55 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-26 |
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (646), Expect = 3e-83
Identities = 116/300 (38%), Positives = 176/300 (58%), Gaps = 7/300 (2%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
ME + +K+G G++G V++A NK +GEVVA+K ++ E + +RE+ L++LNH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
PNIVK+ ++I + ++ VFE + +L + M+A +K++LFQ+ +GL +
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFC 118
Query: 119 HQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSG 176
H HRDLKP+NLL++ +G IK+ADFGLAR YT V T WY+APEIL
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+ VD+W++G I AE++ R LF G E DQ+++I LG+P W G+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW-PGVTSMPDYK 237
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLR 296
FP+ + + S ++P ED +L+ + +DP KR +A AL HPFF+ PHLR
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 1e-81
Identities = 98/292 (33%), Positives = 161/292 (55%), Gaps = 15/292 (5%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVK 63
Y+ TK +G+GSFG V+QA SGE+VAIK + + +K RE++ +RKL+H NIV+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVR 77
Query: 64 VKELIVEKGN------VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
++ G + V + + +Y++ + +Q VK +++Q+FR L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 118 MHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
+H G HRD+KP+NLL+ +K+ DFG A+++ P + +R+Y+APE++F +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
Y+S +D+W+ G ++AELLL +P+F G DQ+ +I VLG+PT + +
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT-- 255
Query: 236 NYQFPQLSGVNLSALM-PSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
++FPQ+ + + P +AI L L + P R T EA H FF
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 6e-80
Identities = 107/286 (37%), Positives = 166/286 (58%), Gaps = 12/286 (4%)
Query: 8 KKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-----LREVKCLRKLNHPNIV 62
LG G F V++A +K++ ++VAIK +K + E LRE+K L++L+HPNI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 63 KVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ + K N+ VF+ M+ +L ++ K + + S +KA++ +GL+Y+HQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 123 YFHRDLKPENLLV-SQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILFKSGLYSS 180
HRDLKP NLL+ G +K+ADFGLA+ YT +V TRWY+APE+LF + +Y
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 181 KVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQFP 240
VDMWA+G I+AELLL P G + DQ+ +I LG+PT + W D + F
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT--FK 238
Query: 241 QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
G+ L + +A +D ++LI+ L ++PC R TA +AL+ +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 242 bits (618), Expect = 2e-78
Identities = 74/329 (22%), Positives = 134/329 (40%), Gaps = 32/329 (9%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
++ Y + ++LG+G+FG V + + +G A K + + +K +E++ + L HP
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+V + + + + ++E M +L E + SE ++ QV +GL +MH+
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 121 QGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
Y H DLKPEN++ + +K+ DFGL +D GT + APE+ +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKP 201
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
DMW++G + LL F G ++ + + + S + ++
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------------ 249
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRS 297
SED + I L DP R T +AL+HP+ +
Sbjct: 250 --------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295
Query: 298 TPAVAATRRGMLKQQGDRIDAEALPYPKI 326
+ R +K + D P +I
Sbjct: 296 PSSRYTKIRDSIKTKYDAWPEPLPPLGRI 324
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 2e-77
Identities = 71/304 (23%), Positives = 123/304 (40%), Gaps = 22/304 (7%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+ + +LG+G+ G V++ +K SG V+A K + +RE++ L + N P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
IV G + E M + K + E + V +GL Y+ +
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 121 Q-GYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLY 178
+ HRD+KP N+LV S+G IK+ DFG++ ++ VGTR Y +PE L + Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERL-QGTHY 180
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTD-EADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
S + D+W+MG + E+ + R D + ++ C V G +Y
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 238 QFPQLSGVNLSALMPSA-------------SEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+ + L+ S + + + +P +R + + H F
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 285 FKRC 288
KR
Sbjct: 301 IKRS 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 2e-77
Identities = 98/298 (32%), Positives = 159/298 (53%), Gaps = 17/298 (5%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPN 60
+Y+ +G G++G V A + + VAIK + + C LRE+K L + H N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 61 IVKVKELIVEKG-----NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
I+ + ++I +V+ V M +LY+L++ + S + +L+Q+ RGL
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGL 122
Query: 116 DYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID----AFPPYTERVGTRWYQAPE 170
Y+H HRDLKP NLL++ +KI DFGLAR D TE V TRWY+APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
I+ S Y+ +D+W++G I+AE+L RP+F G DQ+ I +LGSP+ + +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 231 -QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+A P + V + L P+A A++L++ + +++P KR +AL HP+ ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 236 bits (603), Expect = 5e-77
Identities = 99/290 (34%), Positives = 161/290 (55%), Gaps = 9/290 (3%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
MEKY +K+G G++G V++A N GE A+K ++ E + +RE+ L++L H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIVK+ ++I K + VFE + +L +L++ + K++L Q+ G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYC 116
Query: 119 HQQGYFHRDLKP-ENLLVSQGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSG 176
H + HRDLKP L+ +G +KIADFGLAR YT + T WY+AP++L S
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
YS+ +D+W++G I AE++ PLF G EADQ+ +I +LG+P +W + + + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN-VTELPKYD 235
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
F + + + E I+L+ + DP +R TA +AL+H +FK
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 5e-77
Identities = 95/314 (30%), Positives = 156/314 (49%), Gaps = 22/314 (7%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
+ KY K+G G+FG V++A ++ +G+ VA+K + +E LRE+K L+ L H
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 59 PNIVKVKELIVE--------KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
N+V + E+ KG+++ VF+ + +L L+ K F+ S +K +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQM 125
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-----FPPYTERVGTR 164
+ GL Y+H+ HRD+K N+L+++ G +K+ADFGLAR YT RV T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
WY+ PE+L Y +D+W G IMAE+ P+ QG E Q+ I + GS T +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPS--ASEDAINLIESLCSWDPCKRPTAAEALQH 282
W + + + + + + + A++LI+ L DP +R + +AL H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 283 PFFKRCLYVPPHLR 296
FF +P L+
Sbjct: 306 DFFWS-DPMPSDLK 318
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 1e-76
Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 35/292 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + + +LG G+FG V++A NK + + A K + E + E+ L +HPNI
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
VK+ + + N++ + E + + ++ +ES ++ Q L+Y+H
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN 129
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREI-DAFPPYTERVGTRWYQAPEILF----KS 175
HRDLK N+L G IK+ADFG++ + +GT ++ APE++ K
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
Y K D+W++G + E+ P + + KI
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---------------------A 228
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ P L+ S + + ++ + R T ++ LQHPF
Sbjct: 229 KSEPPTLA------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-76
Identities = 103/298 (34%), Positives = 169/298 (56%), Gaps = 11/298 (3%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
M+KY +K+G G++G V++A N+ + E+VA+K ++ E + LRE+ L++L H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NIV++ +++ + VFE +L + ++ VK++LFQ+ +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFC 117
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDA-FPPYTERVGTRWYQAPEILFKSG 176
H + HRDLKP+NLL+ G +K+A+FGLAR Y+ V T WY+ P++LF +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 177 LYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
LYS+ +DMW+ G I AEL RPLF G D DQ+ +I +LG+PT + W +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293
Y + +L ++P + +L+++L +P +R +A EALQHP+F + PP
Sbjct: 238 PYPMYPAT-TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD--FCPP 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 8e-76
Identities = 72/306 (23%), Positives = 135/306 (44%), Gaps = 37/306 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+KY+ +K+G G+ G V+ A++ +G+ VAI+ + +K L + E+ +R+ +PNI
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V + + ++ V E + + + E + A + + L+++H
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN 135
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYTERVGTRWYQAPEILFKSGLYS 179
HRD+K +N+L+ G++K+ DFG +I + VGT ++ APE++ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YG 194
Query: 180 SKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQF 239
KVD+W++G + E++ P + + +Y I + G+P + +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP-------------- 239
Query: 240 PQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYVPPHLRSTP 299
S + + D KR +A E LQH F K P TP
Sbjct: 240 ------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA---KPLSSLTP 284
Query: 300 AVAATR 305
+AA +
Sbjct: 285 LIAAAK 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 8e-76
Identities = 98/295 (33%), Positives = 162/295 (54%), Gaps = 17/295 (5%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
Y + +GSG++G V AV+ +G VAIK L + + E RE++ L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 60 NIVKVKELIVEKG------NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ + + V M +L +LM+ +K E ++ ++Q+ +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLK 132
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H G HRDLKP NL V++ +KI DFGLAR+ D T V TRWY+APE++
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVI 190
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD-GLRQ 231
Y+ VD+W++G IMAE++ + LF+G+D DQ+ +I V G+P + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
A P+L + ++++ +AS A+NL+E + D +R TA EAL HP+F+
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 234 bits (599), Expect = 2e-75
Identities = 75/289 (25%), Positives = 131/289 (45%), Gaps = 34/289 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ Y + ++LGSG+FG V + V K +G V K + Y +K E+ + +L+HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 62 VKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ + + +K + + E + L+ + A+ K SE+ V ++ Q GL +MH+
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHE 145
Query: 121 QGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
H D+KPEN++ ++KI DFGLA +++ T + APEI+ +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP- 204
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
DMWA+G + LL F G D+ + + + D++
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------ 252
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
S S +A + I++L +P KR T +AL+HP+ K
Sbjct: 253 --------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 3e-75
Identities = 98/297 (32%), Positives = 158/297 (53%), Gaps = 18/297 (6%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVN-KHSGEVVAIKALKKSYSREKCLN--LREVKCLRKL-- 56
++Y ++G G++G V++A + K+ G VA+K ++ E +REV LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 57 -NHPNIVKVKELIV-----EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQ 110
HPN+V++ ++ + + VFE + +L + K + +K +FQ
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQ 124
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ RGLD++H HRDLKP+N+LV S G IK+ADFGLAR T V T WY+AP
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
E+L +S Y++ VD+W++G I AE+ +PLF+G+ + DQ+ KI V+G P + W +
Sbjct: 185 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
F S + + E +L+ +++P KR +A AL HP+F+
Sbjct: 244 ALP---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 1e-74
Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 41/291 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLN 57
+E + + + LG G FG V+ A K S ++A+K L K+ + + REV+ L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
HPNI+++ + V+ + E +Y+ + QK F E ++ ++ L
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALS 120
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
Y H + HRD+KPENLL+ S G +KIADFG + + T GT Y PE++ +
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMI-EG 178
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
++ KVD+W++G + E L+ +P F+ + +I V
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------------- 219
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ FP +E A +LI L +P +RP E L+HP+
Sbjct: 220 EFTFP-----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 229 bits (586), Expect = 4e-74
Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 40/292 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNH 58
+ +S +++G GSFG V+ A + + EVVAIK + S + ++EV+ L+KL H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
PN ++ + + + + V E + L+E K+ E + A +GL Y+
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYL 131
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS-- 175
H HRD+K N+L+ G +K+ DFG A + P VGT ++ APE++
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDE 188
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
G Y KVD+W++G EL +P + +Y I
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------------------A 227
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
+ P L + SE N ++S P RPT+ L+H F R
Sbjct: 228 QNESPALQSGHW-------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-72
Identities = 70/324 (21%), Positives = 136/324 (41%), Gaps = 36/324 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
EKY + + LG G FG V + V S + K +K ++ L +E+ L H NI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 62 VKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+ + E + +FE + ++++ + + +E + +++ QV L ++H
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS 120
Query: 121 QGYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
H D++PEN++ TIKI +FG AR++ + Y APE+ + +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-QHDV 179
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
S+ DMW++G ++ LL F + I + + +++
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------ 227
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL-YVPPHLR 296
S +A++ ++ L + R TA+EALQHP+ K+ + V +
Sbjct: 228 --------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
Query: 297 STPAVAATRRGMLKQQGDRIDAEA 320
T ++K+ + + + A
Sbjct: 274 RTLKHRRYYHTLIKKDLNMVVSAA 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 3e-72
Identities = 66/293 (22%), Positives = 119/293 (40%), Gaps = 35/293 (11%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPN 60
E + L + LG G++G V AVN+ + E VA+K + + + N+ +E+ + LNH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
+VK E + E + + + E + + Q+ G+ Y+H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGE---LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 121 QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP---YTERVGTRWYQAPEILFKSG 176
G HRD+KPENLL+ + +KI+DFGLA + GT Y APE+L +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
++ VD+W+ G ++ +L + ++ Q Y ++ W
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYLNPW----------- 229
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289
+ L+ + +P R T + + ++ + L
Sbjct: 230 ---------------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 224 bits (572), Expect = 8e-72
Identities = 78/297 (26%), Positives = 145/297 (48%), Gaps = 18/297 (6%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HP 59
+ Y L +KLG G + V++A+N + E V +K LK ++ RE+K L L P
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGP 90
Query: 60 NIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
NI+ + +++ + + N KQ Q ++ ++ +++++ + LDY H
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 120 QQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
G HRD+KP N+++ +++ D+GLA Y RV +R+++ PE+L +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 178 YSSKVDMWAMGAIMAELLLFR-PLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y +DMW++G ++A ++ + P F G D DQ+ +I VLG+ + + D +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 237 YQ-------FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ + S S +A++ ++ L +D R TA EA++HP+F
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 219 bits (558), Expect = 3e-70
Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 47/303 (15%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---------LREVKC 52
E Y + LG G V + ++K + + A+K + + L+EV
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 53 LRKLN-HPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQ 110
LRK++ HPNI+++K+ F VF+ M+ L+ + ++ SE + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRA 118
Query: 111 VFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ + +H+ HRDLKPEN+L+ IK+ DFG + ++D E GT Y AP
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 170 EIL-----FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224
EI+ Y +VDMW+ G IM LL P F + + I S
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-------- 230
Query: 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
NYQF S S+ +L+ P KR TA EAL HPF
Sbjct: 231 -----------NYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 285 FKR 287
F++
Sbjct: 273 FQQ 275
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 3e-70
Identities = 98/296 (33%), Positives = 156/296 (52%), Gaps = 17/296 (5%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
E+Y +GSG++G V A + +G VA+K L + + RE++ L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 60 NIVKVKELIV------EKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
N++ + ++ E +V+ V M +L +++ +K ++ V+ ++Q+ R
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIYQILR 132
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
GL Y+H HRDLKP NL V++ +KI DFGLAR D T V TRWY+APEI+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL-RQ 231
Y+ VD+W++G IMAELL R LF GTD DQ+ I ++G+P +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287
A Q+ +N + + A+ A++L+E + D KR TAA+AL H +F +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (560), Expect = 4e-70
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 37/291 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNL-REVKCLRKLNHPN 60
+ Y LG+G+F V A +K + ++VAIK + K K ++ E+ L K+ HPN
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 61 IVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMH 119
IV + ++ G+++ + + + L+ + ++ ++E +FQV + Y+H
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 120 QQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKS 175
G HRDLKPENLL I I+DFGL++ D + GT Y APE+L +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
YS VD W++G I LL P F ++A +I W
Sbjct: 185 P-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW---------- 233
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
S+ A + I L DP KR T +ALQHP+
Sbjct: 234 ----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 2e-69
Identities = 70/295 (23%), Positives = 129/295 (43%), Gaps = 42/295 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
E Y + +G+GS+G + K G+++ K L E + EV LR+L HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 60 NIVKVKELIVEKGN--VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
NIV+ + I+++ N ++ V E + +L ++ +++Q E V + Q+ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 117 YMHQQGY-----FHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERV-GTRWYQAP 169
H++ HRDLKP N+ + + +K+ DFGLAR ++ + + GT +Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
E + Y+ K D+W++G ++ EL P F + + KI
Sbjct: 184 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--------------- 227
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPF 284
+F ++ S++ +I + + RP+ E L++P
Sbjct: 228 ------EGKFRRIP--------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 5e-69
Identities = 88/314 (28%), Positives = 143/314 (45%), Gaps = 17/314 (5%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNH 58
+++Y K +GSG+ G V A + VAIK L + + + RE+ ++ +NH
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI+ + + + + + + Q + L+Q+ G+ ++
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
H G HRDLKP N++V S T+KI DFGLAR T V TR+Y+APE++ G
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 178 YSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
Y VD+W++G IM E++ + LF G D DQ K+ LG+P +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 238 QFPQLSGVNLSALMPSA------------SEDAINLIESLCSWDPCKRPTAAEALQHPFF 285
P+ +G+ L P + + A +L+ + DP KR + +ALQHP+
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 286 KRCLYVPPHLRSTP 299
Y P + + P
Sbjct: 315 NV-WYDPAEVEAPP 327
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 8e-66
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNI 61
++G GSF V++ ++ + VA L+ + E + L+ L HPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 62 VKVKE----LIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
V+ + + K + V E M + ++ ++ +++W Q+ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTY---LKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 118 MHQQGY--FHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF 173
+H + HRDLK +N+ ++ G++KI D GLA A +GT + APE+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMY- 185
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
Y VD++A G M E+ + A Q+Y+
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------------- 225
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
SGV ++ A + +IE + +R + + L H FF+
Sbjct: 226 --------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-65
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 41/296 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLRK 55
+ Y ++LGSG F V + K +G A K +KK ++ REV L++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
+ HPN++ + E+ K +V + E + A+K+ +E +L Q+ G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126
Query: 116 DYMHQQGYFHRDLKPENLLVS-----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPE 170
Y+H H DLKPEN+++ + IKI DFGLA +ID + GT + APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 171 ILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
I+ + DMW++G I LL F G + + + + +V + +
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF----- 240
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ S A + I L DP KR T ++LQHP+ K
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-65
Identities = 78/303 (25%), Positives = 125/303 (41%), Gaps = 41/303 (13%)
Query: 1 MEKYSLTKK-LGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKL-NH 58
++ Y +T + LG G G V Q NK + E A+K L+ REV+ +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQC 64
Query: 59 PNIVKVKELI----VEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
P+IV++ ++ + + V EC+ L+ + + + Q F+E + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGE 122
Query: 114 GLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFPPYTERVGTRWYQAP 169
+ Y+H HRD+KPENLL + +K+ DFG A+E + T T +Y AP
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
E+L Y DMW++G IM LL P F +
Sbjct: 183 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------K 226
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289
+ Y+FP + SE+ LI +L +P +R T E + HP+ +
Sbjct: 227 TRIRMGQYEFPNPEWSEV-------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
Query: 290 YVP 292
VP
Sbjct: 280 KVP 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 6e-65
Identities = 78/299 (26%), Positives = 124/299 (41%), Gaps = 49/299 (16%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNH 58
E + K LG GSF V A + AIK L+K + ++ RE + +L+H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 59 PNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
P VK+ + ++F + L + + +K F E+ + + ++ L+Y
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 123
Query: 118 MHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA---FPPYTERVGTRWYQAPEILF 173
+H +G HRDLKPEN+L+++ I+I DFG A+ + VGT Y +PE+L
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 182
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
D+WA+G I+ +L+ P F+ +E KI +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-------------------I 223
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA------LQHPFFK 286
+ Y FP A +L+E L D KR E HPFF+
Sbjct: 224 KLEYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-62
Identities = 84/294 (28%), Positives = 126/294 (42%), Gaps = 43/294 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKC---LNLREVKCL-RKL 56
+E + L K LG GSFG V+ A K + + AIKALKK + E + L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
HP + + K N+FFV E + +L + Q F S + ++ GL
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGL 116
Query: 116 DYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAF-PPYTERVGTRWYQAPEILF 173
++H +G +RDLK +N+L+ G IKIADFG+ +E GT Y APEIL
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
Y+ VD W+ G ++ E+L+ + F G DE + + I
Sbjct: 177 GQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----------------- 218
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA-EALQHPFFK 286
N +P ++A +L+ L +P KR + QHP F+
Sbjct: 219 --NPFYP-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 198 bits (504), Expect = 8e-62
Identities = 72/295 (24%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLN 57
++ + + + LG+GSFG V ++H+G A+K LKK E L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP I+++ + +F + + ++ + K Q+ F K + +V L+Y
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEY 119
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
+H + +RDLKPEN+L+ G IKI DFG A+ + GT Y APE++ +
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVV-STK 176
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y+ +D W+ G ++ E+L F ++ KI +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-------------------LNAE 217
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFFK 286
+FP P +ED +L+ L + D +R + HP+FK
Sbjct: 218 LRFP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-61
Identities = 58/294 (19%), Positives = 110/294 (37%), Gaps = 49/294 (16%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLRKL 56
+Y + LGSG FG V+ + VAIK ++K + EV L+K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 57 N--HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+ ++++ + + + E + + ++ E +++ +QV
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQ--DLFDFITERGALQEELARSFFWQVLEA 122
Query: 115 LDYMHQQGYFHRDLKPENLLVSQ--GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEIL 172
+ + H G HRD+K EN+L+ G +K+ DFG + YT+ GTR Y PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 173 FKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
+ +W++G ++ +++ F+ +E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG---------------------- 219
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
F S + +LI + P RPT E HP+ +
Sbjct: 220 ---QVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 198 bits (504), Expect = 3e-61
Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 43/298 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN------LREVKCLR 54
M +S+ + +G G FG V+ +G++ A+K L K + K + +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 55 KLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRG 114
+ P IV + + F+ + M + +FSE+ ++ + ++ G
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH---LSQHGVFSEADMRFYAAEIILG 119
Query: 115 LDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILF 173
L++MH + +RDLKP N+L+ G ++I+D GLA + P+ VGT Y APE+L
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ 178
Query: 174 KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
K Y S D +++G ++ +LL F+ D+ R +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----------------RMTL 222
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFK 286
+ + P S S + +L+E L D +R A E + PFF+
Sbjct: 223 TMAVELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-61
Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 40/290 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHP 59
+ ++ +++GSGSFG V++ VA+K L + + L EV LRK H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 60 NIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
NI+ + V + + +LY + + K F + Q +G+DY+
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYL 120
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY---TERVGTRWYQAPEILF- 173
H + HRDLK N+ + T+KI DFGLA + + G+ + APE++
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 174 -KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232
YS + D++A G ++ EL+ + + + DQ+ +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------------------- 221
Query: 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
+ Y P LS V + + L+ +RP + L
Sbjct: 222 VGRGYLSPDLSKVR-----SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 4e-60
Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 44/296 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREK---CLNLREVKCLRKLN 57
M + K LG G+FG V K +G A+K L+K K + E + L+
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP + +K + FV E ++++F+E + + ++ L+Y
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFH---LSRERVFTEERARFYGAEIVSALEY 120
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTE-RVGTRWYQAPEILFKS 175
+H + +RD+K ENL++ G IKI DFGL +E + + GT Y APE+L +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 176 GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
Y VD W +G +M E++ R F D I
Sbjct: 181 D-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------- 220
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFK 286
+FP + S +A +L+ L DP +R A E ++H FF
Sbjct: 221 EIRFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-57
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN 60
M++ L + +G G FG V + G VA+K +K + + L E + +L H N
Sbjct: 6 MKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFL--AEASVMTQLRHSN 61
Query: 61 IVKVKELIVE-KGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
+V++ +IVE KG ++ V E M +L + + + + + + + V ++Y+
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 119 HQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGL 177
+ HRDL N+LVS+ K++DFGL +E + APE L +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEAL-REKK 176
Query: 178 YSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
+S+K D+W+ G ++ E+ F R + D + ++
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------------------G 216
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
Y+ G ++++ D RP+ + +
Sbjct: 217 YKMDAPDGC---------PPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (464), Expect = 2e-56
Identities = 55/298 (18%), Positives = 103/298 (34%), Gaps = 44/298 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLN---LREVKCLRKLNH 58
++Y L + LG G V A + VA+K L+ +R+ RE + LNH
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 59 PNIVKVKELIVEKGN----VFFVFECMQ-CNLYQLMEAKKQKQQLFSESAVKAWLFQVFR 113
P IV V + + + V E + L ++ + + + +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQ 122
Query: 114 GLDYMHQQGYFHRDLKPENLLVSQG-----TIKIADFGLAREIDAFPPYTERVGTRWYQA 168
L++ HQ G HRD+KP N+++S +A ++ +GT Y +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
PE + ++ D++++G ++ E+L P F G Y+ P
Sbjct: 183 PEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH--- 238
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
S D ++ + +P R A ++ +
Sbjct: 239 -----------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 3e-55
Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 45/295 (15%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL---NLREVKCLRKLN 57
++++ K LG+GSFG V +K SG A+K L K + L E + L+ +N
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
P +VK++ + N++ V E + + + FSE + + Q+ +Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEY 156
Query: 118 MHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYTERVGTRWYQAPEILFKSG 176
+H +RDLKPENLL+ QG I++ DFG A+ + GT APEI+ G
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKG 214
Query: 177 LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236
Y+ VD WA+G ++ E+ P F KI S
Sbjct: 215 -YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------------K 254
Query: 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKR-----PTAAEALQHPFFK 286
+FP S D +L+ +L D KR + H +F
Sbjct: 255 VRFP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (463), Expect = 3e-55
Identities = 78/330 (23%), Positives = 128/330 (38%), Gaps = 43/330 (13%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV 62
+Y L +KLG G F VW A + + VA+K ++ + E+K L+++N +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-EDEIKLLQRVNDADNT 72
Query: 63 KVKELIVE-------------KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLF 109
K + V V L KK + + VK
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 110 QVFRGLDYMH-QQGYFHRDLKPENLLVSQ-------GTIKIADFGLAREIDAFPPYTERV 161
Q+ GLDYMH + G H D+KPEN+L+ IKIAD G A YT +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSI 190
Query: 162 GTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQG------TDEADQMYKICS 215
TR Y++PE+L + + D+W+ ++ EL+ LF+ T + D + +I
Sbjct: 191 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 216 VLGSPTMDSWADG------------LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIE 263
+LG +G LR + + + +++ + +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 264 SLCSWDPCKRPTAAEALQHPFFKRCLYVPP 293
+ DP KR A + HP+ K L +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEE 339
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-54
Identities = 63/285 (22%), Positives = 120/285 (42%), Gaps = 38/285 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + +++GSG FG V + + VAIK +++ E+ + E + + KL+HP +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDF-IEEAEVMMKLSHPKL 62
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V++ + +E+ + VFE M+ L + + ++ LF+ + V G+ Y+ +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 122 GYFHRDLKPENLLVSQ-GTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFKSGLY 178
HRDL N LV + IK++DFG+ R + D + T + +PE+ Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SFSRY 179
Query: 179 SSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
SSK D+W+ G +M E+ + ++ ++ + I +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------------- 222
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
P+L AS ++ P RP + L+
Sbjct: 223 -KPRL-----------ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-53
Identities = 68/291 (23%), Positives = 110/291 (37%), Gaps = 40/291 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L KLG G FG VW + V AIK LK + L+E + ++KL H +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF-LQEAQVMKKLRHEKL 74
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V++ +V + ++ V E M K + + + Q+ G+ Y+ +
Sbjct: 75 VQLYA-VVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFKSGLY 178
Y HRDL+ N+LV K+ADFGLAR I + + + APE G +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGRF 191
Query: 179 SSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
+ K D+W+ G ++ EL R + G + + ++ P
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------------- 234
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ--HPFFK 286
P E +L+ +P +RPT +F
Sbjct: 235 ------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-53
Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
+ + K+LG+G FG V + VAIK +K+ E + E K + L+H +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEF-IEEAKVMMNLSHEKL 61
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V++ + ++ +F + E M L+ ++ + F + V ++Y+ +
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFKSGLY 178
+ HRDL N LV QG +K++DFGL+R + D + + PE+L +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL-MYSKF 178
Query: 179 SSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
SSK D+WA G +M E+ + ++ ++ I L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------- 221
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
P L ASE ++ S +RPT L +
Sbjct: 222 -RPHL-----------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-53
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 47/292 (16%)
Query: 8 KKLGSGSFGCVWQAV--NKHSGEVVAIKALKKSYSREKCLN--LREVKCLRKLNHPNIVK 63
K+LGSG+FG V + K + VA+K LK + + L E +++L++P IV+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 64 VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGY 123
+ I E + V E + + + + + + QV G+ Y+ + +
Sbjct: 73 MIG-ICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 124 FHRDLKPEN-LLVSQGTIKIADFGLAREIDAFPPY----TERVGTRWYQAPEILFKSGLY 178
HRDL N LLV+Q KI+DFGL++ + A Y T + APE + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-NYYKF 187
Query: 179 SSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
SSK D+W+ G +M E + + ++G ++ +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------------------GE 227
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE---ALQHPFFK 286
+ +G + +L+ ++D RP A L++ ++
Sbjct: 228 RMGCPAGC---------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-53
Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 40/290 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
E L ++LG+G FG VW VA+K+LK+ L E +++L H +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAF-LAEANLMKQLQHQRL 70
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V++ +V + ++ + E M+ +L + + + Q+ G+ ++ ++
Sbjct: 71 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEER 128
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFKSGLY 178
Y HRDL+ N+LV + KIADFGLAR I + + + APE + G +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTF 187
Query: 179 SSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237
+ K D+W+ G ++ E++ R + G + + + D+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC------------ 235
Query: 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ--HPFF 285
E+ L+ P RPT FF
Sbjct: 236 -----------------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 3e-52
Identities = 64/283 (22%), Positives = 121/283 (42%), Gaps = 34/283 (12%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
++ KLG G +G V++ V K VA+K LK+ + L+E ++++ HPN+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKEIKHPNL 75
Query: 62 VKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
V++ + + + + E M + +Q++ S + Q+ ++Y+ ++
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKK 134
Query: 122 GYFHRDLKPENLLV-SQGTIKIADFGLAREI--DAFPPYTERVGTRWYQAPEILFKSGLY 178
+ HRDL N LV +K+ADFGL+R + D + + + APE L +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKF 193
Query: 179 SSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238
S K D+WA G ++ E+ + + Q+Y++ + +Y+
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------------------LEKDYR 234
Query: 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
+ G E L+ + W+P RP+ AE Q
Sbjct: 235 MERPEGC---------PEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 6e-52
Identities = 68/317 (21%), Positives = 130/317 (41%), Gaps = 46/317 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQA---VNKHSGEVVAIKALKKSYSREKCLN----LREVKCL 53
+E + L K LG+G++G V+ +G++ A+K LKK+ +K E + L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 54 RKLNH-PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVF 112
+ P +V + + + + + + +++++ F+E V+ ++ ++
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIV 139
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP---PYTERVGTRWYQA 168
L+++H+ G +RD+K EN+L+ G + + DFGL++E A Y +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 169 PEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
+ + VD W++G +M ELL F E + +I
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--------------- 244
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHP 283
R+ + +P S A +LI+ L DP KR A E +H
Sbjct: 245 SRRILKSEPPYP-----------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293
Query: 284 FFKRCLYVPPHLRSTPA 300
FF++ + + PA
Sbjct: 294 FFQKINWDDLAAKKVPA 310
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-52
Identities = 67/307 (21%), Positives = 124/307 (40%), Gaps = 48/307 (15%)
Query: 2 EKYSLTK-KLGSGSFGCVWQAVNKHSGE--VVAIKALKKSYSREKCLN-LREVKCLRKLN 57
+ + +LG G+FG V Q V + + VAIK LK+ + +RE + + +L+
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+P IV++ + + + V E L++ + K+++ S V L QV G+
Sbjct: 68 NPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMK 123
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER----VGTRWYQAPEI 171
Y+ ++ + HRDL N+L+ ++ KI+DFGL++ + A Y + APE
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
+ +SS+ D+W+ G M E L + + ++ + M I G R
Sbjct: 184 I-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------------GKR 230
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE---ALQHPFFKR 287
+ P P + L+ + RP ++ ++
Sbjct: 231 ------MECP-----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
Query: 288 CLYVPPH 294
V H
Sbjct: 274 ASKVEGH 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 7e-52
Identities = 75/313 (23%), Positives = 129/313 (41%), Gaps = 61/313 (19%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE-----VVAIKALKKSY-SREKCLNLREVKCLRK 55
E K LGSG+FG V A + VA+K LK+ S E+ + E+K + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 56 L-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQK------------------ 95
L +H NIV + G ++ +FE C +L + +K++K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 96 -QQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153
+ + + + +QV +G++++ + HRDL N+LV+ +KI DFGLAR+I +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 154 FPPYTER---VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQ 209
Y R + APE L G+Y+ K D+W+ G ++ E+ + G
Sbjct: 217 DSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWD 269
YK+ + MD A+E+ +++S ++D
Sbjct: 276 FYKL--IQNGFKMDQP--------------------------FYATEEIYIIMQSCWAFD 307
Query: 270 PCKRPTAAEALQH 282
KRP+
Sbjct: 308 SRKRPSFPNLTSF 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 8e-52
Identities = 58/301 (19%), Positives = 107/301 (35%), Gaps = 44/301 (14%)
Query: 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIV 62
+Y L +K+GSGSFG ++ + +GE VAIK + E K + + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL--HIESKIYKMMQGGVGI 65
Query: 63 K-VKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQ 121
++ E V E + +L L +K FS V Q+ ++Y+H +
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSK 122
Query: 122 GYFHRDLKPENLLVSQ----GTIKIADFGLAREID--------AFPPYTERVGTRWYQAP 169
+ HRD+KP+N L+ + I DFGLA++ + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229
S + D+ ++G ++ L +QG A + K
Sbjct: 183 NTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---------------- 225
Query: 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA---EALQHPFFK 286
+ P + L + + S +P + + ++ F +
Sbjct: 226 ERISEKKMSTP------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 287 R 287
+
Sbjct: 280 Q 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-51
Identities = 70/304 (23%), Positives = 112/304 (36%), Gaps = 40/304 (13%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI 61
L + +G G FG VW+ K GE VA+K R E+ L H NI
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENI 59
Query: 62 VKVKELIVEKGN----VFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+ + ++ V + + +L+ + + + E +K GL
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIK-LALSTASGLA 114
Query: 117 YMHQQ--------GYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY-----TERVG 162
++H + HRDLK +N+LV GT IAD GLA D+ RVG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 163 TRWYQAPEILF-----KSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217
T+ Y APE+L K + D++AMG + E+ + G E Q+ V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA 277
P+++ R+ + P + S A ++ + R TA
Sbjct: 234 SDPSVEEM----RKVVCEQKLRPNIPNRWQS---CEALRVMAKIMRECWYANGAARLTAL 286
Query: 278 EALQ 281
+
Sbjct: 287 RIKK 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (427), Expect = 1e-50
Identities = 53/303 (17%), Positives = 97/303 (32%), Gaps = 45/303 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH-PN 60
Y + +++G GSFG +++ N + + VAIK + + E + + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL--RDEYRTYKLLAGCTG 62
Query: 61 IVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ 120
I V E + V + + +L L+ + FS V Q+ + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 121 QGYFHRDLKPENLLVSQ------GTIKIADFGLAREIDA--------FPPYTERVGTRWY 166
+ +RD+KP+N L+ + I + DFG+ + + GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 167 QAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWA 226
+ S + D+ A+G + L +QG A K
Sbjct: 180 MSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------------- 225
Query: 227 DGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286
+ P L L E+ + + P F
Sbjct: 226 ---ERIGEKKQSTP------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFS 274
Query: 287 RCL 289
+ L
Sbjct: 275 KVL 277
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-50
Identities = 61/292 (20%), Positives = 109/292 (37%), Gaps = 42/292 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYSREKCLN---LREVKCLRK 55
+ L +KLG GSFG V + VA+K LK + +REV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGL 115
L+H N++++ +V + V E L++ ++ Q F + + QV G+
Sbjct: 68 LDHRNLIRLYG-VVLTPPMKMVTELAPLG--SLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 116 DYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPY---TERVGTRWYQAPEI 171
Y+ + + HRDL NLL++ + +KI DFGL R + + E +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230
K+ +S D W G + E+ + + + G + + ++KI
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------- 227
Query: 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
+ P+ +D N++ + P RPT
Sbjct: 228 --DKEGERLPRPEDC---------PQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-50
Identities = 66/306 (21%), Positives = 122/306 (39%), Gaps = 43/306 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSYSREKCLN-LREVKCLRKL 56
+ K +G+G FG V++ + K S VAIK LK Y+ ++ ++ L E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+H NI++++ +I + + + E M+ +K + FS + L + G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTER----VGTRWYQAPEI 171
Y+ Y HRDL N+LV S K++DFGL+R ++ P T + APE
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 172 LFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231
+ ++S D+W+ G +M E++ + ++ K DG R
Sbjct: 185 I-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----------INDGFR- 231
Query: 232 AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLYV 291
P L+ + +RP A+ + + +
Sbjct: 232 -----LPTP-----------MDCPSAIYQLMMQCWQQERARRPKFADIVS--ILDKLIRA 273
Query: 292 PPHLRS 297
P L++
Sbjct: 274 PDSLKT 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-50
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 41/289 (14%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNK---HSGEVVAIKALKKSYSRE-KCLNLREVKCLRKLN 57
E+ L + +G G FG V Q + + VAIK K S + L+E +R+ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 58 HPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDY 117
HP+IVK+ +I E + C L ++ +K +++ + +Q+ L Y
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAY 123
Query: 118 MHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY--TERVGTRWYQAPEILFK 174
+ + + HRD+ N+LV S +K+ DFGL+R ++ Y ++ + APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-N 182
Query: 175 SGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
++S D+W G M E+L+ FQG D + +I + P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------- 229
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
+ P+ +L+ ++DP +RP E
Sbjct: 230 ----------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 1e-49
Identities = 66/309 (21%), Positives = 124/309 (40%), Gaps = 46/309 (14%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYSREKCLN-LREVKCLRKL 56
+ + + +G+G FG V K G+ VAIK LK Y+ ++ + L E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLD 116
+HPN++ ++ ++ + V + E M+ L +Q F+ + L + G+
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGS--LDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 117 YMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREID---AFPPYTERVG---TRWYQAP 169
Y+ Y HRDL N+LV S K++DFGL+R ++ + P YT +G + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 170 EILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADG 228
E + + ++S D+W+ G +M E++ + + D + I
Sbjct: 203 EAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------------- 248
Query: 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288
+Y+ P L+ D RP + + +
Sbjct: 249 -------DYRLPPPMDC---------PSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKM 290
Query: 289 LYVPPHLRS 297
+ P L++
Sbjct: 291 IRNPNSLKA 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-49
Identities = 57/289 (19%), Positives = 106/289 (36%), Gaps = 43/289 (14%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEV----VAIKALKKSYSREKCLN-LREVKCLRKLNH 58
+ K LGSG+FG V++ + GE VAIK L+++ S + L E + +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 59 PNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYM 118
P++ ++ + + L + K + W Q+ +G++Y+
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 127
Query: 119 HQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY---TERVGTRWYQAPEILFK 174
+ HRDL N+LV + +KI DFGLA+ + A + A E +
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI-L 186
Query: 175 SGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233
+Y+ + D+W+ G + EL+ F + G ++ + P
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------------- 233
Query: 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
P + D ++ D RP E +
Sbjct: 234 ----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-48
Identities = 67/301 (22%), Positives = 116/301 (38%), Gaps = 49/301 (16%)
Query: 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGE--VVAIKALKKSYSREKCLN-LREVKCLRKL- 56
+G G+FG V +A K G AIK +K+ S++ + E++ L KL
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 57 NHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAK------------KQKQQLFSESA 103
+HPNI+ + +G ++ E NL + S
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 104 VKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPYTERVG 162
+ + V RG+DY+ Q+ + HRDL N+LV KIADFGL+R + + T
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 163 TRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPT 221
+ A E L +Y++ D+W+ G ++ E++ L + G A+ K+
Sbjct: 189 PVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 241
Query: 222 MDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281
Y+ + ++ +L+ P +RP+ A+ L
Sbjct: 242 --------------GYRLEKPLNC---------DDEVYDLMRQCWREKPYERPSFAQILV 278
Query: 282 H 282
Sbjct: 279 S 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-47
Identities = 74/307 (24%), Positives = 123/307 (40%), Gaps = 56/307 (18%)
Query: 2 EKYSLTKKLGSGSFGCVWQA-----VNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRK 55
+ S K LG+G+FG V +A + + VA+K LK S E+ + E+K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 56 L-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKKQK--------------QQLF 99
L NH NIV + G + E C +L + K+ +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 100 SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREIDAFPPY- 157
+ ++ +QV +G+ ++ + HRDL N+L+ KI DFGLAR+I Y
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 158 --TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKIC 214
+ APE +F + +Y+ + D+W+ G + EL L + G + YK+
Sbjct: 203 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM- 260
Query: 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP 274
+G R P A + +++++ DP KRP
Sbjct: 261 ----------IKEGFR------MLSP-----------EHAPAEMYDIMKTCWDADPLKRP 293
Query: 275 TAAEALQ 281
T + +Q
Sbjct: 294 TFKQIVQ 300
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 4e-47
Identities = 65/312 (20%), Positives = 114/312 (36%), Gaps = 62/312 (19%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRK 55
+ +G G+FG V+QA +VA+K LK+ S + RE + +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQC-NLYQLMEAKKQKQQL---------------- 98
++PNIVK+ + + +FE M +L + + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 99 ----FSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLV-SQGTIKIADFGLAREI-- 151
S + QV G+ Y+ ++ + HRDL N LV +KIADFGL+R I
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 152 -DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQ 209
D + + PE +F + Y+++ D+WA G ++ E+ + G +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWD 269
+Y + N+ A + + NL+ S
Sbjct: 252 IYYVRD-----------------------------GNILACPENCPLELYNLMRLCWSKL 282
Query: 270 PCKRPTAAEALQ 281
P RP+ +
Sbjct: 283 PADRPSFCSIHR 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 64/309 (20%), Positives = 128/309 (41%), Gaps = 54/309 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRK 55
EK +++++LG GSFG V++ V K VAIK + ++ S RE+ L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 56 LNHPNIVKVKELIVEKGNVFFVFECMQ-CNLYQLMEAKKQKQ------QLFSESAVKAWL 108
N ++V++ ++ + + E M +L + + + S S +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 109 FQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREI---DAFPPYTERVGTR 164
++ G+ Y++ + HRDL N +V++ T+KI DFG+ R+I D + + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 165 WYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICSVLGSPTMD 223
+ +PE L K G++++ D+W+ G ++ E+ L +QG + +
Sbjct: 200 RWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG------- 251
Query: 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ-- 281
L + + L+ ++P RP+ E +
Sbjct: 252 ----------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 282 ----HPFFK 286
P F+
Sbjct: 290 KEEMEPGFR 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-45
Identities = 54/287 (18%), Positives = 110/287 (38%), Gaps = 44/287 (15%)
Query: 8 KKLGSGSFGCVWQAV---NKHSGEVVAIKALKKSYSREKCLN-LREVKCLRKLNHPNIVK 63
+ +G G FGCV+ N A+K+L + + L E ++ +HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 64 VKELIVE-KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG 122
+ + + +G+ V M+ L + + + + + QV +G+ ++ +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGD--LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 123 YFHRDLKPENLLVSQG-TIKIADFGLAR-----EIDAFPPYTERVGTRWYQAPEILFKSG 176
+ HRDL N ++ + T+K+ADFGLAR E D+ T + A E L ++
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-QTQ 209
Query: 177 LYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235
+++K D+W+ G ++ EL+ P + + D +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------------------- 249
Query: 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282
+ Q + ++ RP+ +E +
Sbjct: 250 GRRLLQPEYC---------PDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 67/307 (21%), Positives = 126/307 (41%), Gaps = 55/307 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAV-----NKHSGEVVAIKALKKSYSREKCLN-LREVKCLRK 55
++ L K LG G+FG V +A + VA+K LK+ + + + E+K L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 56 -LNHPNIVKVKELIVEKGNVFFV--FECMQCNLYQLMEAKKQK------------QQLFS 100
+H N+V + + G V C NL + +K+ + + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 101 ESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYTE 159
+ + FQV +G++++ + HRDL N+L+S+ +KI DFGLAR+I P Y
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 160 R---VGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELL-LFRPLFQGTDEADQMYKICS 215
+ + APE + +Y+ + D+W+ G ++ E+ L + G ++ +
Sbjct: 193 KGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-- 249
Query: 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT 275
+G R + P + + + +P +RPT
Sbjct: 250 ---------LKEGTR------MRAP-----------DYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 276 AAEALQH 282
+E ++H
Sbjct: 284 FSELVEH 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-43
Identities = 64/307 (20%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 2 EKYSLTKKLGSGSFGCVWQAVNK-------HSGEVVAIKALKKSYSREKCLN-LREVKCL 53
++ L K LG G+FG V A + VA+K LK + + + + E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 54 RKL-NHPNIVKVKELIVEKGNVFFVFE-CMQCNLYQLMEAKK------------QKQQLF 99
+ + H NI+ + + G ++ + E + NL + ++A++ ++
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 100 SESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFPPYT 158
S + + +QV RG++Y+ + HRDL N+LV+ +KIADFGLAR+I Y
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 159 E---RVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICS 215
+ + APE L +Y+ + D+W+ G ++ E+ ++++K+
Sbjct: 193 KTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-- 249
Query: 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT 275
+G R P + + + ++ P +RPT
Sbjct: 250 ---------LKEGHR------MDKP-----------SNCTNELYMMMRDCWHAVPSQRPT 283
Query: 276 AAEALQH 282
+ ++
Sbjct: 284 FKQLVED 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (255), Expect = 1e-26
Identities = 30/206 (14%), Positives = 62/206 (30%), Gaps = 32/206 (15%)
Query: 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCL----------NLREVKCL 53
++ K +G G V+ + +K K ++ K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 54 RKLNHPNIVKVKELIVEKGNVFFVFECMQCNLYQLMEAKKQKQ-QLFSESAVKAWLFQVF 112
+ + K++ + LME K+ L +
Sbjct: 61 ARNEFRALQKLQ-------GLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMIL 113
Query: 113 RGLDYMHQQGYFHRDLKPENLLVSQGTIKIADFGLAREIDA--FPPYTER---VGTRWYQ 167
+ + +G H DL N+LVS+ I I DF + E+ + ER ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 168 APEILFKSGLYSSKVDMWAMGAIMAE 193
Y ++ D+ + + +
Sbjct: 174 RT--------YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.84 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-64 Score=444.21 Aligned_cols=253 Identities=26% Similarity=0.479 Sum_probs=218.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|+++.+|+.||+|++..........+.+|+.+|++++|||||++++++.+++.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999997765555567789999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
.|+ |.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||+|...... ....
T Consensus 100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 875 555432 234999999999999999999999999999999999999974 79999999999887543 3445
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
..+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+..... +..
T Consensus 175 ~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~---------------- 236 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PEL---------------- 236 (293)
T ss_dssp CCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCC----------------
T ss_pred ccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCC----------------
Confidence 678999999999996654 89999999999999999999999998887777666544311 110
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..++.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 111357899999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-64 Score=454.86 Aligned_cols=260 Identities=26% Similarity=0.456 Sum_probs=228.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
|++|++.+.||+|+||+||+|+++.+|+.||||++.+........+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57899999999999999999999999999999999877666667778999999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee---CCcEEEecccceeecCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~kL~Dfg~a~~~~~~~~ 156 (356)
+.| +|.+.+. ...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|........
T Consensus 105 ~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 986 6767664 2334599999999999999999999999999999999999995 36899999999998887666
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------- 247 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS------------- 247 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-------------
T ss_pred cceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------
Confidence 67789999999999997655 8999999999999999999999999988888777775543222211
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
..+.+|+++++||.+||..||++|||++|+|+||||+...+
T Consensus 248 -------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 248 -------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp -------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred -------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 11357899999999999999999999999999999987543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-64 Score=442.33 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=213.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .....+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 5899999999999999999999999999999999876532 233456899999999999999999999999999999999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC---
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--- 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--- 154 (356)
|+.| +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9986 6777663 3445999999999999999999999999999999999999975 79999999999876432
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||...................
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 234566899999999999877756788999999999999999999998765543333222111000
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
....+.+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus 226 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 -------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0112357899999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-64 Score=439.36 Aligned_cols=251 Identities=30% Similarity=0.525 Sum_probs=217.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
|++|++.+.||+|+||+||+|+++.+++.||+|++.+... .....+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 5899999999999999999999999999999999875432 2234567899999999999999999999999999999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||++| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|......
T Consensus 85 mEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999986 67777653 334999999999999999999999999999999999999975 79999999999876543
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+...++...
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------------- 219 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------------- 219 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------
T ss_pred cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 335678999999999997655 899999999999999999999999988877766655331
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.+.+ ++.+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus 220 ~~~~-----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 EFTF-----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCCC-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1111 2357899999999999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-63 Score=444.20 Aligned_cols=287 Identities=38% Similarity=0.706 Sum_probs=243.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
||+|++++.||+|+||+||+|++..+|+.||+|+++..... ....+.+|+.+|++++|||||++++++.+++++|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 79999999999999999999999999999999999655322 2345678999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~ 156 (356)
||++|++.+.+... ....+++..++.++.||+.||+|||++|||||||||+|||++. +.+||+|||+|...... ..
T Consensus 81 e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 99999887776543 3345999999999999999999999999999999999999965 79999999999876543 33
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++....+.+....|..... .....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~ 237 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-MPDYK 237 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-STTCC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc-ccccc
Confidence 45568999999999998888789999999999999999999999999999999999999999888777754322 22223
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
..++...........+.+|.++++||++||..||++|||++|+|+||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 334444444445556688999999999999999999999999999999987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-63 Score=440.19 Aligned_cols=256 Identities=30% Similarity=0.482 Sum_probs=217.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999987543 222345678999999999999999999999999999999
Q ss_pred EeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC--
Q 036550 79 ECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-- 154 (356)
Q Consensus 79 e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-- 154 (356)
||+.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99986 67776643 345999999999999999999999999999999999999975 79999999999877532
Q ss_pred -CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 155 -PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+...++...
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~----------------- 225 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------------- 225 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-----------------
T ss_pred ccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-----------------
Confidence 2234568999999999996655 899999999999999999999999998877776666431
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHH------HhcCCCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAE------ALQHPFFKRCLYVP 292 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------~l~hp~~~~~~~~~ 292 (356)
.+.+| ..+|+++++||++||+.||++|||++| +++||||++..|..
T Consensus 226 --~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 226 --EYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp --CCCCC-----------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred --CCCCC-----------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 12222 367999999999999999999999988 58899999876654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-63 Score=448.98 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=225.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|++..+|+.||+|++++....+...+.+|+.+|++++|||||+++++|.+++.+|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 67999999999999999999999999999999998776566667789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee---CCcEEEecccceeecCCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS---QGTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~kL~Dfg~a~~~~~~~~~ 157 (356)
.| +|.+.+. ..+..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|.........
T Consensus 109 ~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 109 SGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 86 5655543 3344599999999999999999999999999999999999996 479999999999998876666
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 186 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~--------------- 249 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--------------- 249 (352)
T ss_dssp EEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS---------------
T ss_pred eeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------------
Confidence 7789999999999996655 899999999999999999999999998888877776543222111
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...+.+|+++.+||.+||..||.+|||++|+|+||||+..
T Consensus 250 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 -----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1224679999999999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-63 Score=442.48 Aligned_cols=256 Identities=32% Similarity=0.506 Sum_probs=203.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||+||+|+++.+|+.||||++.+... .....+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 469999999999999999999999999999999976542 2234456899999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee----CCcEEEecccceeecCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS----QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~kL~Dfg~a~~~~~~~ 155 (356)
+.| +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||+. ++.+||+|||+|.......
T Consensus 89 ~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 984 7877774 344599999999999999999999999999999999999994 4789999999998876665
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+....+....+......++
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 229 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD-------------- 229 (307)
T ss_dssp --------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC--------------
T ss_pred eeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC--------------
Confidence 566778999999999996654 89999999999999999999999998887777666654321111
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
....+.+|+++.+||.+||..||++|||++|+|+||||++.
T Consensus 230 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 230 ------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11224679999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-63 Score=437.74 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=218.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|.|++++.||+|+||+||+|+++.+|+.||+|++.+........+.+|+++|++++|||||++++++.+++.+|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46999999999999999999999999999999998776666677889999999999999999999999999999999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC-CCCc
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF-PPYT 158 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~-~~~~ 158 (356)
.|+ |.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|...... ....
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 864 5555442 2345999999999999999999999999999999999999974 79999999999766432 1234
Q ss_pred cccccccccChHHHhh----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 159 ERVGTRWYQAPEILFK----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
..+||+.|+|||++.. ...|+.++|||||||++|+|++|.+||.+.+..+.+.++..... +.
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-~~------------- 234 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PT------------- 234 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-CC-------------
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CC-------------
Confidence 5689999999999852 34488999999999999999999999998887777666644211 00
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
......+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 235 -------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 -------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0111357899999999999999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-63 Score=440.47 Aligned_cols=279 Identities=38% Similarity=0.710 Sum_probs=233.2
Q ss_pred eecccccCCceEEEEEEEcCCCcEEEEEEcccccchH-----HhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSRE-----KCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
.++.||+|+||+||+|+++.+|+.||||+++...... ...+.+|+.+|++++|||||++++++.+++++|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5688999999999999999999999999987543221 23467899999999999999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-CCc
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-PYT 158 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~~~ 158 (356)
+.|++...+. .....+++..++.+++||+.||+|||++||+||||||+|||++. +.+||+|||+|....... ...
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9998665543 34456999999999999999999999999999999999999976 799999999998765432 334
Q ss_pred cccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhccc
Q 036550 159 ERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINYQ 238 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (356)
..+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++.++....+.|....|.+........ .
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~--~ 236 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV--T 236 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC--C
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh--h
Confidence 56899999999999877778999999999999999999999999999999999999999999888775543322211 1
Q ss_pred CCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 239 FPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
+.......+....+.+++++++||.+||+.||++|||++|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 222223334445567899999999999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-63 Score=431.99 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=207.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--CCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE--KGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~iv 77 (356)
|+|++.+.||+|+||+||+|+++.+|+.||+|++.... ......+.+|+.+|++++|||||++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 78999999999999999999999999999999987653 2334556789999999999999999999865 4678999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCCeeeeC-CcEEEecccceee
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG-----YFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
|||++| +|.+++......+..+++..++.++.||+.||+|||++| |+||||||+|||+++ +.+||+|||+|..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999975 788888776666777999999999999999999999976 999999999999975 7999999999987
Q ss_pred cCCCC-CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 151 IDAFP-PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
..... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~------------ 230 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK------------ 230 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------------
T ss_pred cccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------------
Confidence 75433 234578999999999996655 8999999999999999999999999888777666554321
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
....+..+|+++.+||++||+.||++|||++|+|+|||+
T Consensus 231 -----------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 -----------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 011223679999999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-62 Score=434.13 Aligned_cols=258 Identities=31% Similarity=0.460 Sum_probs=220.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch------HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR------EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
|+|++.+.||+|+||+||+|+++.+|+.||||++.+.... ....+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999999999999999998754321 2345678999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C----cEEEeccccee
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G----TIKIADFGLAR 149 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~----~~kL~Dfg~a~ 149 (356)
+||||+.| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||+|.
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999985 677777533 35999999999999999999999999999999999999964 2 59999999999
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......++.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------- 237 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------- 237 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred hcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-------
Confidence 88766666778899999999999654 4899999999999999999999999998887777666543211111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
...+.+|+++++||++||..||++|||++|+|+||||+...+
T Consensus 238 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 238 -------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp -------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred -------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 112367999999999999999999999999999999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-62 Score=441.02 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=220.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
|++|++++.||+|+||+||+|+++.+|+.||+|++++.. ........+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 689999999999999999999999999999999997653 22334567899999999999999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC-C
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA-F 154 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~-~ 154 (356)
|||+.|+ |.+.+. +.+.+++..++.++.||+.||+|||++||+||||||+|||+++ |.+||+|||+|+.... .
T Consensus 84 ~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999865 656554 3345999999999999999999999999999999999999975 7999999999987644 3
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+.+ |+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------------ 220 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------ 220 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------------
T ss_pred cccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------------
Confidence 4455678999999999997665 899999999999999999999999998877766555432
Q ss_pred hcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 036550 235 INYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLY 290 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~ 290 (356)
.+.+ +..+|+++++||++||+.||.+|++ ++|+++||||++..|
T Consensus 221 -~~~~-----------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 221 -EIRF-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -CCCC-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -CCCC-----------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 1222 2367999999999999999999994 999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-62 Score=436.60 Aligned_cols=251 Identities=30% Similarity=0.485 Sum_probs=215.4
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
+|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999876532 223456789999999999999999999999999999999
Q ss_pred eccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCCc
Q 036550 80 CMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPYT 158 (356)
Q Consensus 80 ~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~~ 158 (356)
|+.|++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN 169 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BC
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CC
Confidence 999886655432 3355999999999999999999999999999999999999975 7999999999987654 34
Q ss_pred cccccccccChHHHhh--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 159 ERVGTRWYQAPEILFK--SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 159 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
..+||+.|+|||++.+ .+.|+.++|||||||++|+|++|.+||.+.+..+.+.++......+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~---------------- 233 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---------------- 233 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 5689999999999964 3458999999999999999999999999888777766665421111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
.....+|+++.+||.+||..||++|||++|+|+||||.+
T Consensus 234 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 011357899999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-61 Score=428.58 Aligned_cols=282 Identities=35% Similarity=0.660 Sum_probs=239.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch--HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR--EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
||||.++++||+|+||+||+|+++ +|+.||||+++..... ....+.+|+.+|++++|||||++++++.+++..+++|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 799999999999999999999986 7899999999765322 2345678999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC-C
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP-P 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~-~ 156 (356)
|++.+++...+. ...+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||.|....... .
T Consensus 80 e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 999998777664 33455999999999999999999999999999999999999975 799999999998765432 2
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
.....|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++.++....+.+....|.+.... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS-TTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh-hhcc
Confidence 345579999999999988887899999999999999999999999999999999999999999988888654332 2223
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..+............+.+++.+.+||++||+.||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 344444555556667789999999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.7e-62 Score=434.27 Aligned_cols=255 Identities=28% Similarity=0.486 Sum_probs=219.0
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
|++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 689999999999999999999999999999999997543 22234567899999999999999999999999999999
Q ss_pred EEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC
Q 036550 78 FECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP 156 (356)
Q Consensus 78 ~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~ 156 (356)
|||+.|+....+. .....+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHH---HHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccc---cccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999876433332 23445899999999999999999999999999999999999975 79999999999887653
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.+.+..+...++... .
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------------~ 217 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------------E 217 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------------C
T ss_pred cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-------------------C
Confidence 34678999999999996655 899999999999999999999999998887777666442 1
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
..+ ++.+|+++.++|.+||..||.+|+ |++++++||||++..|.
T Consensus 218 ~~~-----------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 218 LRF-----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp CCC-----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred CCC-----------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 111 236789999999999999999996 99999999999986553
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-61 Score=421.00 Aligned_cols=256 Identities=31% Similarity=0.441 Sum_probs=220.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---------HHhhhHHHHHHHHhCC-CCCeeEEeEEEEEC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---------EKCLNLREVKCLRKLN-HPNIVKVKELIVEK 71 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 71 (356)
++|++.+.||+|+||+||+|++..+|+.||||++.+.... ....+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 7999999999999999999999999999999998664311 1234578999999996 99999999999999
Q ss_pred CeEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 72 GNVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 72 ~~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
+++||||||+.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999975 78888753 345999999999999999999999999999999999999975 799999999999
Q ss_pred ecCCCCCCccccccccccChHHHhh-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFK-----SGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
...........+||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||.+.+..+....+...-..++.+
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~- 237 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP- 237 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc-
Confidence 8877666667889999999999864 2347889999999999999999999999998877776665432111111
Q ss_pred hHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
..+.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 238 -------------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 -------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 12367999999999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-61 Score=420.92 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=206.2
Q ss_pred Cc-eeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE----CCeEE
Q 036550 3 KY-SLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVE----KGNVF 75 (356)
Q Consensus 3 ~y-~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 75 (356)
|| ++.++||+|+||+||+|++..+++.||+|++.... ......+.+|+++|++++|||||++++++.+ ...+|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 44 67889999999999999999999999999986543 3344566899999999999999999999875 35689
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCCeeee--CCcEEEecccceee
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQG--YFHRDLKPENLLVS--QGTIKIADFGLARE 150 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~--~~~~kL~Dfg~a~~ 150 (356)
+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|+.
T Consensus 89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999976 66676643 345999999999999999999999999 99999999999995 36999999999975
Q ss_pred cCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 151 IDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
... ......+||+.|+|||++.+ + ++.++|||||||++|+|++|++||........+.+.......+
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~---------- 231 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 231 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred ccC-CccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC----------
Confidence 443 23456789999999998843 4 8999999999999999999999998766554443332211000
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFK 286 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 286 (356)
.......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 111235688999999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-62 Score=438.73 Aligned_cols=281 Identities=25% Similarity=0.374 Sum_probs=210.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
|+|++.++||+|+||+||+|++..+|+.||+|+++.... .....+.+|+.+|++++|||||+++++|.+.+++|+||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 689999999999999999999999999999999976532 3345668999999999999999999999999999999999
Q ss_pred ccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 81 MQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 81 ~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
+.| +|.+++... +.+++..++.++.||+.||.|||+ +||+||||||+|||+++ |++||+|||+|...... ..
T Consensus 86 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~ 160 (322)
T d1s9ja_ 86 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 160 (322)
T ss_dssp CTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC
T ss_pred CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-cc
Confidence 986 677776532 349999999999999999999997 59999999999999974 79999999999876542 23
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCccchHHHhh--hhhh
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQ-MYKICSVLGSPTMDSWADGLR--QAMA 234 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~--~~~~ 234 (356)
.+.+||+.|+|||++.+.. |+.++||||+||++|+|++|+.||.+.+.... ...+....+.+.......... ....
T Consensus 161 ~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp ---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred ccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 4578999999999997765 99999999999999999999999987654332 111111111111000000000 0000
Q ss_pred hcc-cCCCc----------ccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INY-QFPQL----------SGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~-~~~~~----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... ..+.. ...........+|.++++||.+||..||.+|||++|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000 00000 0000001112468999999999999999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-61 Score=428.87 Aligned_cols=281 Identities=33% Similarity=0.629 Sum_probs=233.2
Q ss_pred CCceeecccccCCceEEEEEEEcCC-CcEEEEEEcccccch--HHhhhHHHHHHHHhC---CCCCeeEEeEEEEE-----
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHS-GEVVAIKALKKSYSR--EKCLNLREVKCLRKL---NHPNIVKVKELIVE----- 70 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~----- 70 (356)
++|+++++||+|+||+||+|++..+ ++.||||+++..... ......+|+.+|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999765 678999998764322 223446788877766 79999999999863
Q ss_pred CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 71 KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 71 ~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
...++++|||+.+++...... .....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 247899999999987765543 23445899999999999999999999999999999999999976 899999999998
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
...........+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+++.++....+.+....|....
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 776655566788999999999997655 8999999999999999999999999999999999999999988877765432
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
... ...+..............+++.+++||++||++||++|||++|+|+||||++.
T Consensus 244 ~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 244 ALP---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SSC---GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cch---hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 211 11222223334455567889999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-61 Score=432.01 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=223.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
|+|++.+.||+|+||+||+|+++.+|+.||+|++++... +...+.+|+.+|+.++|||||++++++.+++++|+||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 799999999999999999999999999999999977543 3445679999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC---CcEEEecccceeecCCCCCC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ---GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~kL~Dfg~a~~~~~~~~~ 157 (356)
.| +|.+.+.. .+..+++..++.++.||+.||+|||++||+||||||+|||++. ..+||+|||++.........
T Consensus 84 ~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 84 SGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 86 67776642 3345999999999999999999999999999999999999964 48999999999988766656
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....+|+.|+|||++.+.. |+.++|||||||++|+|++|.+||...+..+.+.++......++...
T Consensus 161 ~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 226 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------------- 226 (321)
T ss_dssp EEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------------
T ss_pred cccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-------------
Confidence 6778999999999986554 89999999999999999999999999988888777765432222221
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
.+.+|+++++||++||..||++|||++|+|+||||++.
T Consensus 227 -------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 -------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 13579999999999999999999999999999999754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-61 Score=435.21 Aligned_cols=254 Identities=30% Similarity=0.463 Sum_probs=219.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
||+|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+|+.+|+.++|||||++++++.+.+.+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 5899999999999999999999999999999999875432 2234567899999999999999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.|+ +...+.. .+.+++..++.++.||+.||.|||++|||||||||+|||++ +|.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9998864 6666543 23599999999999999999999999999999999999997 579999999999987653
Q ss_pred CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 156 PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+......++....
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------------ 254 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------------ 254 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------
T ss_pred -cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC------------------
Confidence 34578999999999997655 8999999999999999999999999888777776664421
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
.. .+..+|+++.+||++||..||.+|+ |++++++||||++..|.
T Consensus 255 -~~-----------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 255 -VR-----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp -CC-----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred -CC-----------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 11 1236799999999999999999995 99999999999987653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=434.82 Aligned_cols=280 Identities=34% Similarity=0.609 Sum_probs=238.9
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------CeEEE
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEK------GNVFF 76 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~~i 76 (356)
+|...++||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++++||||++++++|... .++|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58999999999999999999999999999999976432 235799999999999999999998643 35899
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C-cEEEecccceeecCCC
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G-TIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~-~~kL~Dfg~a~~~~~~ 154 (356)
||||+++++...+.........+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||++......
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9999999988888766666677999999999999999999999999999999999999974 3 8999999999988766
Q ss_pred CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMA 234 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (356)
......+||+.|+|||++.+...|+.++||||+||++|+|++|.+||...+..+++..+...++.+....|........
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~- 255 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT- 255 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC----
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh-
Confidence 6667789999999999998777799999999999999999999999999999999999999999988877765443222
Q ss_pred hcccCCCcccccc-cccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 235 INYQFPQLSGVNL-SALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 235 ~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
...++......+ ....+..++++.+||.+||.+||++|||+.|+|+||||++.
T Consensus 256 -~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 256 -EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred -hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222333222222 22235689999999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-60 Score=434.56 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=213.1
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch---HHhhh---HHHHHHHHhCCCCCeeEEeEEEEECCeE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR---EKCLN---LREVKCLRKLNHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~---~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 74 (356)
|++|++.+.||+|+||+||+|++..+|+.||+|++.+.... ..... .+|+.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 68999999999999999999999999999999998654211 11222 3357778888999999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
|+||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999985 67777653 345899999999999999999999999999999999999976 799999999999876
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
... ....+||+.|+|||++.+...|+.++|||||||++|+|++|.+||......+..... .....
T Consensus 159 ~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~------------- 223 (364)
T d1omwa3 159 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLT------------- 223 (364)
T ss_dssp SSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSS-------------
T ss_pred CCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hhccc-------------
Confidence 543 345689999999999976666899999999999999999999999876543322111 11000
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPT-----AAEALQHPFFKRCLYV 291 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~hp~~~~~~~~ 291 (356)
.....+..+|+++++||.+||..||++||| ++|+++||||++..|.
T Consensus 224 -------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 224 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp -------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred -------------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 001122368999999999999999999999 7999999999986543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-60 Score=424.46 Aligned_cols=255 Identities=32% Similarity=0.491 Sum_probs=216.3
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc---chHHhhhHHHHHHHH-hCCCCCeeEEeEEEEECCeEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY---SREKCLNLREVKCLR-KLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~i 76 (356)
||+|++.+.||+|+||+||+|+++.+|+.||||++++.. ........+|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 799999999999999999999999999999999997643 222234456766665 6899999999999999999999
Q ss_pred EEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
||||+.| +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+++ +++||+|||+|......
T Consensus 81 vmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999986 67776653 334899999999999999999999999999999999999976 79999999999876543
Q ss_pred -CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhh
Q 036550 155 -PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAM 233 (356)
Q Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (356)
......+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+...++... .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~-------------- 219 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N-------------- 219 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C--------------
T ss_pred cccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence 3345578999999999997655 899999999999999999999999998877776665331 1
Q ss_pred hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH-HHhcCCCCCCCCC
Q 036550 234 AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA-EALQHPFFKRCLY 290 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~-e~l~hp~~~~~~~ 290 (356)
..+ ++.+|+++.+||++||..||++|||+. ++++||||++..|
T Consensus 220 ---~~~-----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 220 ---PFY-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp ---CCC-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ---CCC-----------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 111 235799999999999999999999995 8999999987644
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-60 Score=428.29 Aligned_cols=280 Identities=34% Similarity=0.602 Sum_probs=231.4
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC------e
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKG------N 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------~ 73 (356)
++|+++++||+|+||+||+|+++.+|+.||||++++... .......+|+.+|+.++|||||+++++|...+ +
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 589999999999999999999999999999999976432 33445678999999999999999999997654 5
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
+|+||||+++++...+. ...+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|....
T Consensus 98 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 79999999777666543 234999999999999999999999999999999999999975 799999999998876
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. ..+..+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.++...+.......
T Consensus 173 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 173 S--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp S--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred C--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 5 34567899999999999887778999999999999999999999999999999999999988888766553322111
Q ss_pred h-hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 M-AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
. ......+......+....+.+++++++||++||..||++|||++|+|+||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1 1122344444555666677899999999999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-59 Score=412.00 Aligned_cols=246 Identities=24% Similarity=0.441 Sum_probs=207.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccch------HHhhhHHHHHHHHhCC--CCCeeEEeEEEEECCe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSR------EKCLNLREVKCLRKLN--HPNIVKVKELIVEKGN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~ 73 (356)
++|++.+.||+|+||+||+|++..+|+.||||++.+.... ....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5899999999999999999999999999999998754211 1223468999999986 8999999999999999
Q ss_pred EEEEEEeccC--CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-C-CcEEEeccccee
Q 036550 74 VFFVFECMQC--NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-Q-GTIKIADFGLAR 149 (356)
Q Consensus 74 ~~iv~e~~~g--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~-~~~kL~Dfg~a~ 149 (356)
.|+||||+.+ ++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+|.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999865 45555543 34599999999999999999999999999999999999997 3 689999999998
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
.... ...+..+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+. +..
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~-------------- 218 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR-------------- 218 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--------------
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--------------
Confidence 7654 3345678999999999998877678889999999999999999999975321 111
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
....+ ...+|+++++||++||..||++|||++|+|+||||++.
T Consensus 219 -----~~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 -----GQVFF-----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----CCCCC-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----cccCC-----------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11111 23679999999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-59 Score=418.19 Aligned_cols=284 Identities=32% Similarity=0.549 Sum_probs=224.5
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE--------
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVE-------- 70 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------- 70 (356)
++||+++++||+|+||+||+|++..+|+.||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4799999999999999999999999999999999865532 223456789999999999999999999854
Q ss_pred CCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEeccccee
Q 036550 71 KGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAR 149 (356)
Q Consensus 71 ~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~ 149 (356)
.+++|+||||+.+++..... .....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 45689999999988766543 33455899999999999999999999999999999999999975 799999999997
Q ss_pred ecCCC-----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 036550 150 EIDAF-----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDS 224 (356)
Q Consensus 150 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (356)
..... ......+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+.......+....+.+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 66532 2234457999999999998877799999999999999999999999999999999999999888887666
Q ss_pred hHHHhhhhhhhcccCCCccccccccc--CCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 225 WADGLRQAMAINYQFPQLSGVNLSAL--MPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
+...........+............. ....++++++||.+||++||++|||++|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 54332211111111111111000000 0124778999999999999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-60 Score=426.48 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=209.6
Q ss_pred CCCceeec-ccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHh-CCCCCeeEEeEEEEE----CCeE
Q 036550 1 MEKYSLTK-KLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRK-LNHPNIVKVKELIVE----KGNV 74 (356)
Q Consensus 1 ~~~y~~~~-~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~----~~~~ 74 (356)
+++|.+.+ .||+|+||+||+|++..+++.||||+++.. ....+|+.++.+ ++|||||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 47899875 599999999999999999999999998643 235679988765 589999999999976 4678
Q ss_pred EEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEeccccee
Q 036550 75 FFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAR 149 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~ 149 (356)
|+||||++| +|.+.+..+ ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 999999975 788887532 2345999999999999999999999999999999999999964 579999999999
Q ss_pred ecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHh
Q 036550 150 EIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGL 229 (356)
Q Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (356)
...........+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i------------ 229 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------------ 229 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC------------
T ss_pred eccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH------------
Confidence 887766667789999999999986655 8999999999999999999999998766544433322211
Q ss_pred hhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCC
Q 036550 230 RQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCL 289 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 289 (356)
....+.+|.. ....+|+++.+||++||+.||++|||+.|+|+||||.+..
T Consensus 230 ---~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 230 ---RMGQYEFPNP-------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp ---CSCSSSCCTT-------HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred ---hcCCCCCCCc-------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 1111122211 1125789999999999999999999999999999997643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-58 Score=407.00 Aligned_cols=283 Identities=34% Similarity=0.638 Sum_probs=235.7
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~ 78 (356)
|+||+++++||+|+||+||+|++..+|+.||||+++.... .....+.+|+.+|+.++||||+++++++.+.+..++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 7999999999999999999999999999999999865432 33456679999999999999999999999999999999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC-C
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP-P 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~-~ 156 (356)
+++.|+....+. ...+.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||.|....... .
T Consensus 81 ~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999887655543 3445689999999999999999999999999999999999997 4799999999998876533 3
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPL-FQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
.....+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+...++....+.+....|..........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 34456889999999998877789999999999999999999877 55666677788888888888877765544332222
Q ss_pred cccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCC
Q 036550 236 NYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKR 287 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 287 (356)
...... ...........+++.+.+||++||+.||.+|||++|+|+||||++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccc-ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 221111 122344455678999999999999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=418.77 Aligned_cols=282 Identities=35% Similarity=0.620 Sum_probs=231.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC-----CeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEK-----GNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 75 (356)
+||+++++||+|+||+||+|++..+|+.||||++.+... .....+.+|+.+|++++||||+++++++... ..+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 579999999999999999999999999999999976543 3345667899999999999999999998754 3578
Q ss_pred EEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 76 FVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 76 iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+++++.+|+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|......
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 8888888899988753 24999999999999999999999999999999999999975 79999999999876432
Q ss_pred ----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 ----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
......+||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+..+........+..+..........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2234567999999999987777789999999999999999999999999998888888877777766543322111
Q ss_pred h-hhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 231 Q-AMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 231 ~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
. ........+......+....+.+|+++++||.+||..||.+|||++|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 1 111223344445555566677889999999999999999999999999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-58 Score=418.77 Aligned_cols=281 Identities=31% Similarity=0.518 Sum_probs=219.2
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEE------CC
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVE------KG 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 72 (356)
+++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+|+.++++++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4789999999999999999999999999999999976532 333456799999999999999999999964 36
Q ss_pred eEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeec
Q 036550 73 NVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREI 151 (356)
Q Consensus 73 ~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~ 151 (356)
++|+||||+.|++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+|++|||++...
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 899999999999776652 3489999999999999999999999999999999999997 579999999999887
Q ss_pred CCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhh
Q 036550 152 DAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQ 231 (356)
Q Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (356)
.........+||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+......++....+.+....|......
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp -----------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred ccccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 7766667778999999999997654 899999999999999999999999999999999999988888877666443332
Q ss_pred hhhhcccCCCcccccccc------------cCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 232 AMAINYQFPQLSGVNLSA------------LMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
........+......... .....|+++.+||++||..||++|||++|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 222222211111111110 011346789999999999999999999999999999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-58 Score=414.94 Aligned_cols=280 Identities=27% Similarity=0.544 Sum_probs=222.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEEC--CeEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEK--GNVFFVF 78 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~iv~ 78 (356)
|+|+++++||+|+||+||+|++..+|+.||||++++.. ...+.+|+.+|+++. ||||+++++++... ..+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999999999999999987643 234678999999995 99999999999854 5799999
Q ss_pred EeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C-cEEEecccceeecCCCCC
Q 036550 79 ECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G-TIKIADFGLAREIDAFPP 156 (356)
Q Consensus 79 e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~-~~kL~Dfg~a~~~~~~~~ 156 (356)
||+.++.+..+ .+.+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||+|........
T Consensus 112 e~~~~~~L~~~------~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 112 EHVNNTDFKQL------YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp ECCCSCBGGGT------TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred eecCCCcHHHH------hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 99997643222 234999999999999999999999999999999999999974 4 699999999998877667
Q ss_pred CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccchHHHhhhhhhh
Q 036550 157 YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD-EADQMYKICSVLGSPTMDSWADGLRQAMAI 235 (356)
Q Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (356)
....++|+.|+|||++.+...++.++||||+||++|+|++|..||.... ..++...+...++.+....+..........
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 7788999999999999887778999999999999999999999997654 455666666666654333332211110000
Q ss_pred ccc--CC-----CcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCCCC
Q 036550 236 NYQ--FP-----QLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRCLY 290 (356)
Q Consensus 236 ~~~--~~-----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 290 (356)
.+. .. .............+|+++++||++||.+||++|||++|+|+||||++..|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 00 00011111122357899999999999999999999999999999987654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=414.24 Aligned_cols=280 Identities=34% Similarity=0.597 Sum_probs=227.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc--hHHhhhHHHHHHHHhCCCCCeeEEeEEEEEC------Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS--REKCLNLREVKCLRKLNHPNIVKVKELIVEK------GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 73 (356)
+||+++++||+|+||+||+|++..+|+.||||++.+... .....+.+|+.+|++++|||||++++++... +.
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 689999999999999999999999999999999976532 3334567899999999999999999998633 34
Q ss_pred EEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 74 VFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 74 ~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
.++++++.+|+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++. +.+|++|||++....
T Consensus 98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 56666666677877763 234999999999999999999999999999999999999975 799999999997665
Q ss_pred CCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 153 AFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
. ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+.+....+.......
T Consensus 173 ~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp G--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred c--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 4 33457899999999999887778999999999999999999999999999999999998888877655443221111
Q ss_pred h-hhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCCCCC
Q 036550 233 M-AINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFFKRC 288 (356)
Q Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 288 (356)
. ......+......+......+++++++||++||..||++|||++|+|+||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 1 1112223333344445556789999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-57 Score=397.70 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=203.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.+++.+++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 478999999999999999999999999999999876543 3456789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.+ ++.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+....... .
T Consensus 96 ~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 96 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp TTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred cCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 85 567766432 2345899999999999999999999999999999999999975 7999999999987654322 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhcc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAINY 237 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (356)
....||+.|+|||++.+.. |+.++|||||||++|||++|..||..........++......
T Consensus 174 ~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~------------------ 234 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------------ 234 (287)
T ss_dssp TTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred ccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC------------------
Confidence 2345889999999997765 899999999999999999976555444433333333221110
Q ss_pred cCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 238 QFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...+..+++++.+||.+||+.||++|||++|+++
T Consensus 235 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 235 ----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1122367899999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-57 Score=396.45 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=200.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc---hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC----eE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS---REKCLNLREVKCLRKLNHPNIVKVKELIVEKG----NV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~ 74 (356)
++|++.+.||+|+||+||+|++..+|+.||||++++... .....+.+|+.+++.++|||||++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 679999999999999999999999999999999976533 22345678999999999999999999998654 38
Q ss_pred EEEEEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecC
Q 036550 75 FFVFECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREID 152 (356)
Q Consensus 75 ~iv~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~ 152 (356)
|+||||+.|+ |.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++. +..+|+|||.+....
T Consensus 87 ~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 9999999864 555543 3345999999999999999999999999999999999999975 799999999987654
Q ss_pred CC----CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 153 AF----PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|+||.+||.+.+..+...++......+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-------- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--------
T ss_pred cccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC--------
Confidence 32 2334568999999999986654 8999999999999999999999999888877766654421111
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHPFF 285 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 285 (356)
.....+.+|+++.+||++||..||++||+..+.+.|+|.
T Consensus 234 ------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 ------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 112234689999999999999999999944444445553
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=391.36 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFE 79 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e 79 (356)
++|.+.+.||+|+||+||+|+.. ..||||+++... ......+.+|+.+|++++|||||++++++. ++.+++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 57999999999999999999743 359999986542 334456789999999999999999999864 466899999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC---
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF--- 154 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~--- 154 (356)
|++| +|.+.+.. ....+++..+..++.||+.||+|||++|||||||||+|||+++ +.+||+|||+|......
T Consensus 84 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9984 77777753 3345999999999999999999999999999999999999975 69999999999766432
Q ss_pred CCCccccccccccChHHHhhC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 155 PPYTERVGTRWYQAPEILFKS--GLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 155 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
.......||+.|+|||++.+. ..|+.++|||||||++|||+||+.||.+.+..............++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p----------- 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------- 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-----------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------
Confidence 233456899999999998643 3479999999999999999999999998776665544433221111
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
........+++++.+|+.+||..||++|||++|++++
T Consensus 230 -------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 -------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122334678999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-56 Score=384.67 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=209.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.++||+|+||+||+|+++ +++.||||++++.... ...+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 68999999999999999999985 7889999999875433 356789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.+ ++.+.+.. ....+++..++.++.||++||+|||++||+||||||+|||+++ +.+||+|||++........ .
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 75 55555442 3345899999999999999999999999999999999999986 7999999999987654322 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||...+..+....+......
T Consensus 159 ~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~----------------- 220 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------------- 220 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------------
T ss_pred cccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 3457999999999997665 8999999999999999998 89999998887776666442111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+...++++.+||++||+.||++|||++++++|
T Consensus 221 ------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123568899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=400.46 Aligned_cols=252 Identities=28% Similarity=0.432 Sum_probs=205.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc-----EEEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE-----VVAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|++.+.||+|+||+||+|++..+++ .||+|.+.... ......+.+|+.+++++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999999876553 69999986543 33345567899999998 899999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh-------------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCee
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ-------------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLL 134 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 134 (356)
|+||||++| +|.+.+..... ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 999999975 68887754321 1245899999999999999999999999999999999999
Q ss_pred eeC-CcEEEecccceeecCCCCCC---ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 036550 135 VSQ-GTIKIADFGLAREIDAFPPY---TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQ 209 (356)
Q Consensus 135 l~~-~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 209 (356)
++. +.+||+|||+|+........ ....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+....
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 975 79999999999876554332 2456899999999997665 8999999999999999997 8999998776666
Q ss_pred HHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
+.++......+ ..+..+|+++.+||.+||+.||++|||++||++|
T Consensus 276 ~~~~~~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 276 FYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55554321111 1123678999999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-55 Score=391.92 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=194.8
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc---EEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE---VVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+|+||+||+|+++.+++ .||+|.+..... .....+.+|+.+|++++|||||++++++.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 578999999999999999999887664 589998866533 3445678999999999999999999999999999999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.|+ |.+++. .....+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999875 555443 23345899999999999999999999999999999999999975 699999999998765432
Q ss_pred CC------ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 156 PY------TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 156 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.. ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+....+....+......
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------- 252 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL--------- 252 (299)
T ss_dssp -------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred CcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 21 123578999999998655 48999999999999999998 89999988877666555432111
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+..++.++.+|+.+||+.||++|||+.|++++
T Consensus 253 --------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 --------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123678999999999999999999999998865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-56 Score=386.12 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=196.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|++. +++.||||+++..... ...+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc-HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 58999999999999999999986 5678999999765433 356789999999999999999999999999999999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC--C
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP--Y 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~--~ 157 (356)
.+ +|.+.+.. ....+++..+..++.||+.||+|||+++|+||||||+|||+++ +.+||+|||+|+....... .
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 75 56666542 3345899999999999999999999999999999999999986 6999999999987654322 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||...+..+....+......
T Consensus 160 ~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------------- 221 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------- 221 (263)
T ss_dssp -----CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------------
T ss_pred cceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------------
Confidence 3457899999999996655 8999999999999999999 57777776666665555432111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+...++++.+|+.+||+.||++|||++|+++|
T Consensus 222 ------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0112568899999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-56 Score=387.88 Aligned_cols=250 Identities=24% Similarity=0.414 Sum_probs=204.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|+++ +++.||||+++.... ....+.+|+.++++++|||||++++++. ++..++||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence 57999999999999999999976 578899999976543 3346789999999999999999999875 45679999999
Q ss_pred cC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CC
Q 036550 82 QC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PY 157 (356)
Q Consensus 82 ~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~ 157 (356)
.+ +|.+.+... ....+++..+..++.||+.||+|||+++|+||||||+|||+++ +.+||+|||+|+...... ..
T Consensus 90 ~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 86 565654332 2234899999999999999999999999999999999999986 699999999998875432 23
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....||+.|+|||++.+.. ++.++|||||||++|||+|| .+||...+..+....+.....
T Consensus 168 ~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~------------------ 228 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------------ 228 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred cccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence 4457899999999997655 89999999999999999995 566666666555554432111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc--CCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ--HPFFK 286 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 286 (356)
...+..+++++.+|+.+||+.||++|||++++++ |+||+
T Consensus 229 -----------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 -----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0112367899999999999999999999999998 78875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=400.57 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=211.7
Q ss_pred CCCceeecccccCCceEEEEEEE---cCCCcEEEEEEccccc----chHHhhhHHHHHHHHhCCC-CCeeEEeEEEEECC
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVN---KHSGEVVAIKALKKSY----SREKCLNLREVKCLRKLNH-PNIVKVKELIVEKG 72 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 72 (356)
|++|++++.||+|+||+||+|++ +.+|+.||||++++.. ......+.+|+.++++++| |||+++++++.+.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 57899999999999999999987 4478999999987542 1233456789999999966 89999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceee
Q 036550 73 NVFFVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLARE 150 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~ 150 (356)
.++++|||+.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. |.+||+|||+|..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999886 56666543 334899999999999999999999999999999999999975 7999999999987
Q ss_pred cCCC--CCCccccccccccChHHHhhCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHH
Q 036550 151 IDAF--PPYTERVGTRWYQAPEILFKSG-LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWAD 227 (356)
Q Consensus 151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (356)
.... .......|++.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-------- 250 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-------- 250 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--------
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--------
Confidence 6432 2234567999999999997653 4788999999999999999999999877654444443322100
Q ss_pred HhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 036550 228 GLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRP-----TAAEALQHPFFKRCLYV 291 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~ 291 (356)
... ..+..+|+++.+||.+||.+||++|| |++|+++||||++..+.
T Consensus 251 -------~~~-----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 251 -------SEP-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp -------CCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred -------CCC-----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 001 12236799999999999999999999 58999999999876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=385.33 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=204.9
Q ss_pred CCceeec-ccccCCceEEEEEEEcC--CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTK-KLGSGSFGCVWQAVNKH--SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~-~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|.+.. +||+|+||+||+|.++. ++..||||+++.... .....+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4577777 49999999999998754 455899999976543 334567899999999999999999999865 568999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee-CCcEEEecccceeecCCCC
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS-QGTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-~~~~kL~Dfg~a~~~~~~~ 155 (356)
|||++| +|.+++. .....+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999986 5666553 2334599999999999999999999999999999999999997 4799999999998875432
Q ss_pred C----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 P----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. .....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+....+.....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~------------ 230 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------ 230 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC------------
T ss_pred cccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 2 23456899999999996655 8999999999999999998 9999998877666555533110
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH---hcCCCCC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA---LQHPFFK 286 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~---l~hp~~~ 286 (356)
...++.+|+++.+||.+||..||++|||+.++ |+|+|+.
T Consensus 231 -----------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11224678999999999999999999999888 5678774
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=384.41 Aligned_cols=243 Identities=24% Similarity=0.372 Sum_probs=195.9
Q ss_pred cccccCCceEEEEEEEc--CCCcEEEEEEccccc--chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEeccC
Q 036550 8 KKLGSGSFGCVWQAVNK--HSGEVVAIKALKKSY--SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 8 ~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
++||+|+||+||+|.+. .+++.||||+++... ......+.+|+.+|++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999764 456889999986543 2334567899999999999999999999865 567899999986
Q ss_pred -CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCC----C
Q 036550 84 -NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPP----Y 157 (356)
Q Consensus 84 -~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~----~ 157 (356)
+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+....... .
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 5666654 3345999999999999999999999999999999999999975 8999999999987654322 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 168 ~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~------------------ 228 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------------ 228 (277)
T ss_dssp ---CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred cccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 2346899999999997665 8999999999999999998 8999998877665554432110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHH---hcCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEA---LQHPFF 285 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~---l~hp~~ 285 (356)
...+..+|+++.+|+.+||+.||++|||++++ |+|+|+
T Consensus 229 -----------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 -----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11223678999999999999999999999998 456654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=381.32 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=200.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEEEEec
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFVFECM 81 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv~e~~ 81 (356)
++|++.+.||+|+||+||+|+++.+ +.||||+++.... ....+.+|+.++++++|||||++++++. ++..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 6899999999999999999998755 5699999976543 3456789999999999999999999985 45678999999
Q ss_pred cCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC--CC
Q 036550 82 QCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--PY 157 (356)
Q Consensus 82 ~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--~~ 157 (356)
.++ +...+... ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+...... ..
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 875 55555433 2334899999999999999999999999999999999999975 799999999998764332 22
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....||+.|+|||++.+.. ++.++|||||||++|||++| .+||......+.+..+......
T Consensus 172 ~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~----------------- 233 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------- 233 (285)
T ss_dssp ----CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------------
T ss_pred ccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-----------------
Confidence 3457999999999997665 89999999999999999995 5556666665555554332111
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc--CCCCCCC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ--HPFFKRC 288 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~ 288 (356)
...+.++.++.+||.+||+.||++|||++++++ ++||+..
T Consensus 234 ------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 ------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 122367899999999999999999999999998 8999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=380.22 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=194.1
Q ss_pred CCceeecccccCCceEEEEEEEcCCC---cEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG---EVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+|+||+||+|++..++ ..||+|.++..... ....+.+|+.++++++|||||++++++. ++.+|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 58999999999999999999986543 56999998655433 3456789999999999999999999985 5678999
Q ss_pred EEeccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 78 FECMQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 78 ~e~~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
|||+.++ +.+.+. .....+++..++.++.||+.||+|||+++|+||||||+||++++ +.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999865 555443 23345899999999999999999999999999999999999975 799999999998765432
Q ss_pred --CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 --PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......||+.|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+....+.....
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------------- 227 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------------- 227 (273)
T ss_dssp --------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------------
T ss_pred ceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 223456899999999997655 8999999999999999998 8999998887776665543211
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...++.+|+++.+||.+||..||++|||+.|+++|
T Consensus 228 ---------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11234679999999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=377.13 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=192.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCC----cEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG----EVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
+.|++.+.||+|+||+||+|.++.++ ..||||++...... ....+.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 57999999999999999999877654 47999998765433 34456899999999999999999999999999999
Q ss_pred EEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC
Q 036550 77 VFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP 155 (356)
Q Consensus 77 v~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~ 155 (356)
||||+.+++...... .....+++..+..++.||+.||+|||+++|+||||||+|||++. +.+||+|||+|+......
T Consensus 87 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 87 ITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEECCTTEEHHHHHH--HTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEecccCcchhhhh--cccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 999998764433322 23345999999999999999999999999999999999999985 699999999998764432
Q ss_pred C----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 156 P----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 156 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
. .....||+.|+|||++.+. .++.++|||||||++|||++| .+||...+..+....+.....
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------ 231 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------------ 231 (283)
T ss_dssp ---------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------
T ss_pred ccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC------------
Confidence 1 2234689999999998655 489999999999999999995 455555555444443322111
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...+..++.++.+||.+||+.||++|||+.|+++
T Consensus 232 -----------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 -----------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0112357889999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-54 Score=384.15 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=196.2
Q ss_pred CCceeecccccCCceEEEEEEEcCCCc----EEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGE----VVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~i 76 (356)
++|++++.||+|+||+||+|.+..+|+ .||+|.++... ......+.+|+.++++++|||||++++++.+++. ++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-EE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-eE
Confidence 479999999999999999999988876 57888776543 2334567899999999999999999999987654 55
Q ss_pred EEEec-cCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCC
Q 036550 77 VFECM-QCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAF 154 (356)
Q Consensus 77 v~e~~-~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~ 154 (356)
+++++ +|+|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 55654 5677776553 3455999999999999999999999999999999999999975 69999999999876543
Q ss_pred CC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhh
Q 036550 155 PP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLR 230 (356)
Q Consensus 155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (356)
.. .....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+..... +
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~---------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-L---------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-C----------
T ss_pred cccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C----------
Confidence 22 22346899999999997765 8999999999999999998 8999988776655444432211 1
Q ss_pred hhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 231 QAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..++.+++++.+|+.+||..||.+|||+.|+++|
T Consensus 233 ------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1123578999999999999999999999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=376.79 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=193.8
Q ss_pred CCceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEEC-Ce
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEK-GN 73 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~~ 73 (356)
++|++.+.||+|+||+||+|++.. +++.||+|+++.... .....+.+|+.++.++ +|+||+.+++++... +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 579999999999999999999754 457899999876543 3344556777777776 789999999988654 56
Q ss_pred EEEEEEeccC-CHHHHHHHHHh------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-Cc
Q 036550 74 VFFVFECMQC-NLYQLMEAKKQ------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GT 139 (356)
Q Consensus 74 ~~iv~e~~~g-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~ 139 (356)
+++||||+++ +|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 8999999985 67787765432 1234899999999999999999999999999999999999975 79
Q ss_pred EEEecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 036550 140 IKIADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICS 215 (356)
Q Consensus 140 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~ 215 (356)
+||+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|||++| .+||......+.+..+..
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999998664332 233567999999999997755 89999999999999999986 578887765555444433
Q ss_pred HhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 216 VLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
....+ ..++.+++++.+|+.+||+.||++|||++|+++|
T Consensus 252 ~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21111 1123678999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=369.71 Aligned_cols=244 Identities=24% Similarity=0.408 Sum_probs=195.9
Q ss_pred CCCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-CCeEEEEEE
Q 036550 1 MEKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVE-KGNVFFVFE 79 (356)
Q Consensus 1 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~iv~e 79 (356)
+++|++.+.||+|+||.||+|+++ |..||||++++.. ..+.+.+|+.++++++||||+++++++.+ .+.+|+|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 478999999999999999999874 7889999997653 33457899999999999999999998854 467899999
Q ss_pred eccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCCCC
Q 036550 80 CMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFPPY 157 (356)
Q Consensus 80 ~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~~~ 157 (356)
|+.+ +|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+|||++. +.+||+|||++...... .
T Consensus 82 y~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~ 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 157 (262)
T ss_dssp CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred ccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--C
Confidence 9975 68888764432 34899999999999999999999999999999999999985 79999999999876543 2
Q ss_pred ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHHhhhhhhhc
Q 036550 158 TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADGLRQAMAIN 236 (356)
Q Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (356)
....+|+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+....+.....
T Consensus 158 ~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~------------------ 218 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------ 218 (262)
T ss_dssp ----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC------------------
T ss_pred ccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 3457899999999997765 8999999999999999998 7899988777666555432110
Q ss_pred ccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 237 YQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...++.+++++.+||.+||..||.+|||+.+++++
T Consensus 219 -----------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 219 -----------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11233678999999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=370.43 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=193.3
Q ss_pred CCceeecccccCCceEEEEEEEcC-CC--cEEEEEEccccc---chHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-SG--EVVAIKALKKSY---SREKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|++.+.||+|+||+||+|+... ++ ..||||++.+.. ......+.+|+.+|++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 579999999999999999998643 33 468999987643 2334466899999999999999999999965 4678
Q ss_pred EEEEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCC
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDA 153 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~ 153 (356)
+||||+.+ ++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999975 56665543 2344999999999999999999999999999999999999964 7999999999998754
Q ss_pred CCC----CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 154 FPP----YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 154 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
... .....|+..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred CCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 322 22345788999999997654 8999999999999999998 899999988887776664321111
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
..++.+|+++.+||.+||..||++|||+.++++
T Consensus 235 --------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 --------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112367899999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=378.06 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=204.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcE--EEEEEccccc-chHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEV--VAIKALKKSY-SREKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~iv 77 (356)
++|++.+.||+|+||+||+|+++.+|.. ||||.++... ......+.+|+.+|+++ +|||||++++++.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999888874 6777765432 33445678999999999 799999999999999999999
Q ss_pred EEeccC-CHHHHHHHH------------HhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEe
Q 036550 78 FECMQC-NLYQLMEAK------------KQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIA 143 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~ 143 (356)
|||++| +|.+++... ......+++..+..++.||+.||.|||+++|+||||||+|||++. +.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 999885 687877532 123456899999999999999999999999999999999999976 699999
Q ss_pred cccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCc
Q 036550 144 DFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFR-PLFQGTDEADQMYKICSVLGSPTM 222 (356)
Q Consensus 144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~ 222 (356)
|||+|.............||+.|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+....+.....
T Consensus 170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~---- 244 (309)
T d1fvra_ 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---- 244 (309)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC----
T ss_pred cccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Confidence 999998766555555667999999999997665 899999999999999999965 67887776665554432110
Q ss_pred cchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 223 DSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...+..+++++.+||.+||..||++|||++++++|
T Consensus 245 -------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 -------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11123578999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-52 Score=372.34 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=205.6
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccch-HHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYSR-EKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|++.+.||+|+||+||+|+++ .+++.||||+++..... ....+.+|+.+|++++||||+++++++.+.+..+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 57999999999999999999875 35688999999765433 3456789999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHH--------------------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCee
Q 036550 76 FVFECMQC-NLYQLMEAKK--------------------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLL 134 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~--------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 134 (356)
++|||+.+ +|.+.+.... .....+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 99999875 6777775321 12234899999999999999999999999999999999999
Q ss_pred eeC-CcEEEecccceeecCCC---CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHH
Q 036550 135 VSQ-GTIKIADFGLAREIDAF---PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFR-PLFQGTDEADQ 209 (356)
Q Consensus 135 l~~-~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~ 209 (356)
++. +.+||+|||+|...... .......||+.|+|||.+.+.. |+.++|||||||++|||++|. +||...+..+.
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 986 69999999999765432 2234567899999999997765 899999999999999999985 78988887776
Q ss_pred HHHHHHHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 210 MYKICSVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
...+..... ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 252 ~~~v~~~~~-----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 IYYVRDGNI-----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCC-----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 665533210 1123467899999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=370.30 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=200.5
Q ss_pred CCceeecccccCCceEEEEEEEcCCC-------cEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECC
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSG-------EVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKG 72 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 72 (356)
++|.+.+.||+|+||.||+|++..++ ..||||++++... .....+.+|+..+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 68999999999999999999876554 4799999977654 3345667888888888 8999999999999999
Q ss_pred eEEEEEEeccC-CHHHHHHHHH------------hhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 73 NVFFVFECMQC-NLYQLMEAKK------------QKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 73 ~~~iv~e~~~g-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
..++||||+.+ ++.+.+.... .....+++.+++.++.||+.||+|||+++|+||||||+|||++. +
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 99999999975 6777775332 12345899999999999999999999999999999999999975 6
Q ss_pred cEEEecccceeecCCCC---CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFP---PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||++....... ......||+.|+|||++.+.. |+.++|||||||++|+|++ |.+||...+.......+.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~ 251 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 99999999998775432 234467999999999997655 9999999999999999998 789998877665544432
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.. ..+ ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus 252 ~~-~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 EG-HRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TT-CCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC-CCC----------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 21 111 112367899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=367.82 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=206.3
Q ss_pred CCceeecccccCCceEEEEEEEc-----CCCcEEEEEEcccccc-hHHhhhHHHHHHHHhC-CCCCeeEEeEEEEECCeE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNK-----HSGEVVAIKALKKSYS-REKCLNLREVKCLRKL-NHPNIVKVKELIVEKGNV 74 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 74 (356)
++|++.+.||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57899999999999999999863 4678999999976543 3445668999999999 699999999999999999
Q ss_pred EEEEEeccC-CHHHHHHHHHh--------------hcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-C
Q 036550 75 FFVFECMQC-NLYQLMEAKKQ--------------KQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-G 138 (356)
Q Consensus 75 ~iv~e~~~g-~l~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~ 138 (356)
++||||+++ ++.+.+..... ....+++..++.++.||+.||+|||+++++||||||+||+++. +
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 999999976 57777654321 2235899999999999999999999999999999999999975 7
Q ss_pred cEEEecccceeecCCCCCC---ccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036550 139 TIKIADFGLAREIDAFPPY---TERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLL-FRPLFQGTDEADQMYKIC 214 (356)
Q Consensus 139 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 214 (356)
.+||+|||.++........ ...+||+.|+|||++.+.. ++.++|||||||++|+|+| |.+||...+..+.+.++.
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999877653322 3457899999999996654 8999999999999999998 677787777666655554
Q ss_pred HHhCCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 215 SVLGSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
.....+. .....++.+.+||.+||+.||.+|||++++++
T Consensus 262 ~~~~~~~----------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 262 KEGFRML----------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCC----------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3321111 11356899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=367.05 Aligned_cols=257 Identities=22% Similarity=0.277 Sum_probs=201.3
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCC-eeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPN-IVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+| |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 579999999999999999999999999999998765432 234678999999997665 55666677788999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC----CcEEEecccceeecCCCC-
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ----GTIKIADFGLAREIDAFP- 155 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----~~~kL~Dfg~a~~~~~~~- 155 (356)
+++++...+.. ....+++..+..++.||+.||+|||++||+||||||+|||++. ..+||+|||+|+......
T Consensus 85 ~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 85 LGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred cCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 99998776643 3345999999999999999999999999999999999999853 479999999998775432
Q ss_pred -------CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccchHHH
Q 036550 156 -------PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVLGSPTMDSWADG 228 (356)
Q Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (356)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---------- 230 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---------- 230 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH----------
T ss_pred ccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc----------
Confidence 223457999999999997665 89999999999999999999999987665443332211100
Q ss_pred hhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHH---HHhcCCCCC
Q 036550 229 LRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAA---EALQHPFFK 286 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~---e~l~hp~~~ 286 (356)
..... ......+.+|+++.+|+.+||..||++||+++ ++|+|+|.+
T Consensus 231 ------~~~~~------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 ------KKMST------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ------HHHHS------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------ccCCC------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00000 01122346789999999999999999999986 456777654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=368.18 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=209.6
Q ss_pred CCceeecccccCCceEEEEEEEcC-----CCcEEEEEEcccccc-hHHhhhHHHHHHHHhCCCCCeeEEeEEEEECCeEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKH-----SGEVVAIKALKKSYS-REKCLNLREVKCLRKLNHPNIVKVKELIVEKGNVF 75 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 75 (356)
++|.+.++||+|+||+||+|.++. +++.||||+++.... .+...+.+|+.++++++|||||++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 689999999999999999998753 457899999976543 33445689999999999999999999999999999
Q ss_pred EEEEeccC-CHHHHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 76 FVFECMQC-NLYQLMEAKKQKQ------QLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 76 iv~e~~~g-~l~~~~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
+||||+.+ ++.+++....... ..+++..+..++.||++||.|||+++|+||||||+|||+++ +.+||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 99999875 6777766433211 23688999999999999999999999999999999999986 5899999999
Q ss_pred eeecCCCCC---CccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcc
Q 036550 148 AREIDAFPP---YTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLF-RPLFQGTDEADQMYKICSVLGSPTMD 223 (356)
Q Consensus 148 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (356)
|+....... .....||+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+.+..+.+...
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~----- 253 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----- 253 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-----
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 986644322 23446899999999997665 89999999999999999998 588988887776665543211
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc------CCCCC
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ------HPFFK 286 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~ 286 (356)
...++.+++.+.++|.+||+.||++|||++++++ +|+|+
T Consensus 254 ------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 254 ------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred ------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 1122367899999999999999999999999998 56654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-50 Score=358.94 Aligned_cols=249 Identities=20% Similarity=0.237 Sum_probs=202.9
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCC-CCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH-PNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~iv~e~ 80 (356)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.| +|++.+++++...+..++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 58999999999999999999999999999999886543 23345789999999965 8999999999999999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeee------CCcEEEecccceeecCCC
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVS------QGTIKIADFGLAREIDAF 154 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~------~~~~kL~Dfg~a~~~~~~ 154 (356)
++++|.+.+.. .+..+++.++..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 83 LGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred cCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 99998887653 334589999999999999999999999999999999999996 368999999999876432
Q ss_pred --------CCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCcc
Q 036550 155 --------PPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDEA---DQMYKICSVLGSPTMD 223 (356)
Q Consensus 155 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 223 (356)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.... ....++......+
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~--- 235 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST--- 235 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC---
Confidence 1233557999999999997655 899999999999999999999999865432 2222222211000
Q ss_pred chHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhc
Q 036550 224 SWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQ 281 (356)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~ 281 (356)
....+.+.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 236 ----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 ----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111223467899999999999999999998776644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-50 Score=367.73 Aligned_cols=283 Identities=28% Similarity=0.410 Sum_probs=209.8
Q ss_pred CceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-----------CCCeeEEeEEEEEC
Q 036550 3 KYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-----------HPNIVKVKELIVEK 71 (356)
Q Consensus 3 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~~~~~~~~~ 71 (356)
||+++++||+|+||+||+|++..+|+.||||++++... ......+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 69999999999999999999999999999999976532 2345577888888774 57899999988643
Q ss_pred --CeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCCeeeeC-C------cEE
Q 036550 72 --GNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ-QGYFHRDLKPENLLVSQ-G------TIK 141 (356)
Q Consensus 72 --~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~------~~k 141 (356)
...++++++..+...............+++..++.++.||+.||+|||+ .||+||||||+|||++. + .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 5666777765543212222233444568999999999999999999998 89999999999999964 2 599
Q ss_pred EecccceeecCCCCCCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHH
Q 036550 142 IADFGLAREIDAFPPYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTD------EADQMYKICS 215 (356)
Q Consensus 142 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~ 215 (356)
++|||.+...... ....+||+.|+|||++.... ++.++||||+||++++|++|+.||.... ..+.......
T Consensus 173 l~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 173 IADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred Eeecccccccccc--cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 9999999876543 35678999999999987655 8999999999999999999999997543 3455666777
Q ss_pred HhCCCCccchHHHhhhhhhhc-ccCCC----cccc-------cccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcCC
Q 036550 216 VLGSPTMDSWADGLRQAMAIN-YQFPQ----LSGV-------NLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQHP 283 (356)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~hp 283 (356)
.++.++...+........... ...+. .... ......+..++++++||.+||.+||.+|||++|+|+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 778776555433221111110 00000 0000 01111234567899999999999999999999999999
Q ss_pred CCCCCC
Q 036550 284 FFKRCL 289 (356)
Q Consensus 284 ~~~~~~ 289 (356)
||++..
T Consensus 330 ~f~~~~ 335 (362)
T d1q8ya_ 330 WLKDTL 335 (362)
T ss_dssp GGTTCT
T ss_pred ccCCCC
Confidence 998643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=359.13 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=191.2
Q ss_pred eecccccCCceEEEEEEEcCCC---cEEEEEEccccc-chHHhhhHHHHHHHHhCCCCCeeEEeEEEEE-CCeEEEEEEe
Q 036550 6 LTKKLGSGSFGCVWQAVNKHSG---EVVAIKALKKSY-SREKCLNLREVKCLRKLNHPNIVKVKELIVE-KGNVFFVFEC 80 (356)
Q Consensus 6 ~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~iv~e~ 80 (356)
+.++||+|+||+||+|++..++ ..||||++++.. ......+.+|+++|++++||||+++++++.+ ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3578999999999999986543 369999987543 3444667899999999999999999999876 4689999999
Q ss_pred ccCC-HHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeC-CcEEEecccceeecCCCC---
Q 036550 81 MQCN-LYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQ-GTIKIADFGLAREIDAFP--- 155 (356)
Q Consensus 81 ~~g~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~kL~Dfg~a~~~~~~~--- 155 (356)
++++ +.+++. .....+++..+..++.|++.||.|||+++|+||||||+|||+++ +.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9975 444443 23344788899999999999999999999999999999999986 699999999998765432
Q ss_pred --CCccccccccccChHHHhhCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccchHHHhhhh
Q 036550 156 --PYTERVGTRWYQAPEILFKSGLYSSKVDMWAMGAIMAELLLFRPLFQGTDE-ADQMYKICSVLGSPTMDSWADGLRQA 232 (356)
Q Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (356)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||..... .+....+... ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~------------- 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RR------------- 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CC-------------
T ss_pred ceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CC-------------
Confidence 122346899999999997665 89999999999999999997777665432 2222222211 00
Q ss_pred hhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 233 MAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
...++.+++++.+||.+||..||++|||+.|+++|
T Consensus 253 ---------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 ---------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01123568899999999999999999999999988
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=352.39 Aligned_cols=265 Identities=24% Similarity=0.289 Sum_probs=186.6
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCeeEEeEEEEECC----eEEEE
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNIVKVKELIVEKG----NVFFV 77 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~iv 77 (356)
++|.+.+.||+|+||+||+|+. +|+.||||+++.... .......|+..+..++|||||++++++.+.+ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4789999999999999999975 689999999865432 2222334566666789999999999998654 68999
Q ss_pred EEeccC-CHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh--------CCcccccCCCCCeeeeC-CcEEEecccc
Q 036550 78 FECMQC-NLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ--------QGYFHRDLKPENLLVSQ-GTIKIADFGL 147 (356)
Q Consensus 78 ~e~~~g-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~~ivH~Dlkp~NIll~~-~~~kL~Dfg~ 147 (356)
|||+.+ +|.+.+.. ..+++..+..++.|++.||+|||+ +||+||||||+|||+++ +.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999975 67777743 238999999999999999999996 69999999999999965 7999999999
Q ss_pred eeecCCCC-----CCccccccccccChHHHhhCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 036550 148 AREIDAFP-----PYTERVGTRWYQAPEILFKSG-----LYSSKVDMWAMGAIMAELLLFRPLFQGTDEADQMYKICSVL 217 (356)
Q Consensus 148 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 217 (356)
+....... .....+||+.|+|||++.+.. .++.++|||||||++|||+||.+||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~---- 230 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD---- 230 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT----
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh----
Confidence 98775432 223467999999999986542 1466899999999999999999887543321100000
Q ss_pred CCCCccchHHHhhhhhhhcccCCCcccccccccCCCCCHHHHHHHHHccCCCCCCCCCHHHHhcC
Q 036550 218 GSPTMDSWADGLRQAMAINYQFPQLSGVNLSALMPSASEDAINLIESLCSWDPCKRPTAAEALQH 282 (356)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h 282 (356)
..+.... ..............|... ...........+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 231 LVPSDPS-VEEMRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCC-HHHHHHHHTTSCCCCCCC---GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccch-HHHHHHHHhccccCCCCC---cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000000 000000000000000000 000011223568999999999999999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=1.4e-28 Score=202.96 Aligned_cols=163 Identities=18% Similarity=0.131 Sum_probs=122.7
Q ss_pred ceeecccccCCceEEEEEEEcCCCcEEEEEEcccccc------------------hHHhhhHHHHHHHHhCCCCCeeEEe
Q 036550 4 YSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYS------------------REKCLNLREVKCLRKLNHPNIVKVK 65 (356)
Q Consensus 4 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hp~iv~~~ 65 (356)
|.+.++||+|+||+||+|++. +|+.||||+++.... .......+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578999999999999999985 689999998753211 0112234688899999999999887
Q ss_pred EEEEECCeEEEEEEeccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCCeeeeCCcEEEecc
Q 036550 66 ELIVEKGNVFFVFECMQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQQGYFHRDLKPENLLVSQGTIKIADF 145 (356)
Q Consensus 66 ~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~kL~Df 145 (356)
++. . .+++|||+++... ..+++..+..++.||+.+|+|||++||+||||||+|||++++.++|+||
T Consensus 81 ~~~--~--~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDF 146 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDF 146 (191)
T ss_dssp EEE--T--TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCC
T ss_pred Eec--C--CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEEC
Confidence 653 2 2799999988522 1256677788999999999999999999999999999999999999999
Q ss_pred cceeecCCCCCCccccccccccC------hHHHhhCCCCCCchhHHHHHHH
Q 036550 146 GLAREIDAFPPYTERVGTRWYQA------PEILFKSGLYSSKVDMWAMGAI 190 (356)
Q Consensus 146 g~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DiwslG~i 190 (356)
|.|........ ..|.. .+.+ . +.|+.++|+||+.--
T Consensus 147 G~a~~~~~~~~-------~~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGW-------REILERDVRNIITYF-S-RTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTH-------HHHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCc-------HHHHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence 99987653211 11211 1222 2 237899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.95 E-value=2.6e-09 Score=90.52 Aligned_cols=139 Identities=19% Similarity=0.167 Sum_probs=93.0
Q ss_pred CCceeecccccCCceEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEEEe
Q 036550 2 EKYSLTKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVFEC 80 (356)
Q Consensus 2 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~e~ 80 (356)
+.|+..+..+-++.+.||++. .+++.+.+|+.............+|...++.+. +--+.+++++..+++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 567777776666668999884 456678899876654444445677888888774 43467788888888999999999
Q ss_pred ccCCHHHHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 036550 81 MQCNLYQLMEAKKQKQQLFSESAVKAWLFQVFRGLDYMHQ---------------------------------------- 120 (356)
Q Consensus 81 ~~g~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------- 120 (356)
++|....... .+......++.++...+..||+
T Consensus 92 l~G~~~~~~~--------~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEY--------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHT--------TTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred cccccccccc--------cccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9885322110 0111112223333333334442
Q ss_pred -------------------CCcccccCCCCCeeeeCCcE-EEecccceee
Q 036550 121 -------------------QGYFHRDLKPENLLVSQGTI-KIADFGLARE 150 (356)
Q Consensus 121 -------------------~~ivH~Dlkp~NIll~~~~~-kL~Dfg~a~~ 150 (356)
..++|+|+.|.|||++++.+ -|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12789999999999999876 5999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.24 E-value=1.6e-06 Score=77.35 Aligned_cols=75 Identities=15% Similarity=0.139 Sum_probs=46.8
Q ss_pred ecccccCCceEEEEEEEcCCCcEEEEEEccccc-------chHHhhhHHHHHHHHhCC-C--CCeeEEeEEEEECCeEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKHSGEVVAIKALKKSY-------SREKCLNLREVKCLRKLN-H--PNIVKVKELIVEKGNVFF 76 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~~~~~~~~~i 76 (356)
.+.||.|....||++.+..+++.|++|.-.... .........|.+.|+.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 467899999999999988888899999643210 011122345888887662 2 345555543 4555688
Q ss_pred EEEeccC
Q 036550 77 VFECMQC 83 (356)
Q Consensus 77 v~e~~~g 83 (356)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=5.5e-06 Score=68.96 Aligned_cols=71 Identities=14% Similarity=0.099 Sum_probs=49.6
Q ss_pred ccccCCc-eEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCC--CCeeEEeEEEEECCeEEEEEEeccC
Q 036550 9 KLGSGSF-GCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNH--PNIVKVKELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 9 ~ig~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~iv~e~~~g 83 (356)
.+..|.. +.||++... ++..+.+|...... ...+..|+..++.+.. -.+.+++++..+++..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4455554 689998753 46668889765432 2345678888877732 3366788888888899999999987
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.58 E-value=3e-05 Score=66.99 Aligned_cols=66 Identities=18% Similarity=0.185 Sum_probs=41.3
Q ss_pred eEEEEEEEcCCCcEEEEEEcccccchHHhhhHHHHHHHHhCCCCCe-----eEE--eEEEEECCeEEEEEEeccC
Q 036550 16 GCVWQAVNKHSGEVVAIKALKKSYSREKCLNLREVKCLRKLNHPNI-----VKV--KELIVEKGNVFFVFECMQC 83 (356)
Q Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~--~~~~~~~~~~~iv~e~~~g 83 (356)
-.||++.. .+|..|++|+.+.... ....+..|...+..|....+ +.. -..+...+..+.++++++|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47999965 3678899999876532 23345568877777632111 111 1123456778899998876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.15 E-value=0.00068 Score=59.86 Aligned_cols=71 Identities=10% Similarity=0.028 Sum_probs=48.1
Q ss_pred ecccccCCceEEEEEEEcC-------CCcEEEEEEcccccchHHhhhHHHHHHHHhCC-CCCeeEEeEEEEECCeEEEEE
Q 036550 7 TKKLGSGSFGCVWQAVNKH-------SGEVVAIKALKKSYSREKCLNLREVKCLRKLN-HPNIVKVKELIVEKGNVFFVF 78 (356)
Q Consensus 7 ~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~iv~ 78 (356)
++.|+.|-.-.+|++.... ..+.|.+++..... ......+|..+++.+. +.-.+++++++. + .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEE
Confidence 4678889999999997643 34567788765322 2234567999998884 433456777663 3 5788
Q ss_pred EeccC
Q 036550 79 ECMQC 83 (356)
Q Consensus 79 e~~~g 83 (356)
||+.|
T Consensus 121 efi~g 125 (395)
T d1nw1a_ 121 EYIPS 125 (395)
T ss_dssp CCCCE
T ss_pred EEecc
Confidence 98876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.84 E-value=0.0021 Score=54.59 Aligned_cols=30 Identities=27% Similarity=0.431 Sum_probs=26.1
Q ss_pred CCcccccCCCCCeeeeCCcE-EEecccceee
Q 036550 121 QGYFHRDLKPENLLVSQGTI-KIADFGLARE 150 (356)
Q Consensus 121 ~~ivH~Dlkp~NIll~~~~~-kL~Dfg~a~~ 150 (356)
.|+||+|+.++||+++++.+ -|.||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 47999999999999998765 7999998753
|